{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import sys, os\n",
    "module_path = os.path.abspath(os.path.join('..'))\n",
    "module_path = os.path.join(module_path, 'scripts')\n",
    "if module_path not in sys.path:\n",
    "    sys.path.append(module_path)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "%load_ext autoreload\n",
    "\n",
    "%autoreload 2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\vipsharm\\AppData\\Local\\Continuum\\anaconda3\\lib\\site-packages\\fuzzywuzzy\\fuzz.py:11: UserWarning: Using slow pure-python SequenceMatcher. Install python-Levenshtein to remove this warning\n",
      "  warnings.warn('Using slow pure-python SequenceMatcher. Install python-Levenshtein to remove this warning')\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The autoreload extension is already loaded. To reload it, use:\n",
      "  %reload_ext autoreload\n"
     ]
    }
   ],
   "source": [
    "import pprint\n",
    "import pandas as pd\n",
    "import uuid\n",
    "import json\n",
    "import os\n",
    "import glob\n",
    "import re\n",
    "import sys\n",
    "from bs4 import NavigableString, BeautifulSoup\n",
    "from collections import defaultdict\n",
    "import random\n",
    "import string\n",
    "\n",
    "from utils.config import config\n",
    "from utils.logger.logger import loggerCreator\n",
    "\n",
    "## ePI Modules\n",
    "from parse.rulebook.rulebook import StyleRulesDictionary\n",
    "\n",
    "from parse.extractor.parser import parserExtractor\n",
    "from match.matchDocument.matchDocument import MatchDocument\n",
    "from documentAnnotation.documentAnnotation import DocumentAnnotation\n",
    "from htmlDocTypePartitioner.partition import DocTypePartitioner\n",
    "from extractContentBetweenHeadings.dataBetweenHeadingsExtractor import DataBetweenHeadingsExtractor\n",
    "from fhirXmlGenerator.fhirXmlGenerator import FhirXmlGenerator\n",
    "from fhirService.fhirService import FhirService\n",
    "from utils.logger.matchLogger import MatchLogger\n",
    "from languageInfo.documentTypeNames.documentTypeNames import DocumentTypeNames\n",
    "\n",
    "\n",
    "%load_ext autoreload\n",
    "\n",
    "%autoreload 2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "def getRandomString(N):\n",
    "    str_ = ''.join(random.choice(string.ascii_uppercase + string.digits \\\n",
    "            + string.ascii_lowercase) for _ in range(N))\n",
    "    return str_\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'F:\\\\Projects\\\\EMA\\\\Repository\\\\EMA EPI PoC\\\\function_code\\\\azureFunctions\\\\data\\\\partitionedJSONs\\\\H\\\\CAP\\\\en\\\\Adakveo-4874 EN PI_SmPC.json'"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "path = \"F:\\\\Projects\\\\EMA\\\\Repository\\\\EMA EPI PoC\\\\function_code\\\\azureFunctions\\\\data\\\\partitionedJSONs\\\\H\\\\CAP\\\\en\\\\Adakveo-4874 EN PI_SmPC.json\"\n",
    "path"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'bytes'>\n"
     ]
    }
   ],
   "source": [
    "s = b'Breast\\u2011feeding'\n",
    "print(type(s))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Breast\\\\u2011feeding'"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "s.decode()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'Element': '<div class=\"WordSection1\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX I</span></b></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">SUMMARY OF PRODUCT CHARACTERISTICS</span></b></p> <span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif; color:green\\'><br clear=\"all\" style=\"page-break-before:always\"/> </span> <p class=\"MsoNormal\" style=\"line-height:normal\"><img height=\"18\" src=\"Adakveo-4874%20EN%20PI_files/image001.png\" width=\"21\"/><span lang=\"EN-GB\">This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">1.       NAME OF </span></b><b><span lang=\"EN-GB\">THE MEDICINAL PRODUCT</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo 10 mg/ml concentrate for solution for infusion</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.       QUALITATIVE AND QUANTITATIVE COMPOSITION</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each ml of concentrate for solution for infusion contains 10 mg crizanlizumab.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">One vial of 10 ml contains 100 mg crizanlizumab.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab is a monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For the full list of excipients, see section 6.1.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">3.       PHARMACEUTICAL </span></b><b><span lang=\"EN-GB\" style=\\'font-family:\"Times New Roman Bold\",serif\\'>FORM</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_Toc259706902\"></a><a name=\"_Toc259707071\"></a><a name=\"_Toc259707134\"></a><a name=\"_Toc259713075\"><span lang=\"EN-GB\">Concentrate for solution for infusion</span></a><span lang=\"EN-GB\"> (sterile concentrate)</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Colourless to slightly brownish‑yellow liquid at pH 6 and with an osmolality of 300 mOsm/kg.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.       </span></b><b><span lang=\"EN-GB\">CLINICAL</span></b><b><span lang=\"EN-GB\" style=\\'font-family:\"Times New Roman Bold\",serif\\'> PARTICULARS</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.1     Therapeutic indications</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"Standard\"><span lang=\"EN-GB\">Adakveo</span><span lang=\"EN-GB\"> is indicated for the prevention of recurrent vaso‑occlusive crises (VOCs) in sickle cell disease patients aged 16 years and older. It can be given as an add‑on therapy to hydroxyurea/hydroxycarbamide (HU/HC) or as monotherapy in patients for whom HU/HC is inappropriate or inadequate.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.2     Posology and method of administration</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Treatment should be initiated by physicians experienced in the management of </span><span lang=\"EN-GB\">sickle cell disease.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Posology</span></u><a name=\"_nth_Adults_and_patients_ag4131\"></a></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The recommended dose of crizanlizumab is 5 mg/kg administered over a period of 30 minutes by intravenous infusion at week 0, week 2, and every 4 weeks thereafter.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab </span><span lang=\"EN-GB\">c</span><span lang=\"EN-GB\">an be given alone or with HU/HC.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">If a dose is missed, the treatment should be administered as soon as possible.</span></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt\"><span style=\"font-size:11.0pt\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span style=\"font-size:11.0pt\">If crizanlizumab is administered within 2 weeks after the missed dose, dosing should be continued according to the patient’s original schedule.</span></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt\"><span style=\"font-size:11.0pt\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span style=\"font-size:11.0pt\">If crizanlizumab is administered more than 2 weeks after the missed dose, dosing should be continued every 4 weeks thereafter.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Special populations</span></u></i></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Elderly</span></i></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab has not been studied in elderly patients. No dose adjustment is required as the pharmacokinetics of crizanlizumab in adults are not affected by age.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Renal impairment</span></i></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Based on the population pharmacokinetic (PK) results, no dose adjustment is required in patients with mild or moderate renal impairment (see section 5.2). Data from patients with severe renal impairment are too limited to draw conclusions on this population.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Hepatic impairment</span></i></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monoclonal antibody and is cleared via catabolism (i.e. breakdown into peptides and amino acids), and a change in dose is not expected to be required for patients with hepatic impairment (see section</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> </span><span lang=\"EN-GB\">5.2).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Paediatric population</span></i></p> <p class=\"Standard\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety and efficacy of </span><span lang=\"EN-GB\">crizanlizumab</span><span lang=\"EN-GB\"> in paediatric patients from 6 months to 16 years have not been established. No data are available.</span></p> <p class=\"Standard\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"Standard\" style=\"line-height:normal\"><span lang=\"EN-GB\">There is no relevant use of crizanlizumab in infants aged less than 6 months for the indication of prevention of recurrent vaso‑occlusive crises.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Method of administration</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo </span><span lang=\"EN-GB\">should be diluted with sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% before administration.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The diluted solution</span><span lang=\"EN-GB\"> must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by intravenous infusion over a period of 30 minutes. It must not be administered by intravenous push or bolus.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For instructions on dilution of the medicinal product before administration, see section 6.6.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.3     Contraindications</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hypersensitivity to Chinese Hamster Ovary (CHO) cell products.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.4     Special warnings and precautions for use</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Traceability</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\"> </span></span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Infusion‑related reactions</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In clinical studies, infusion‑related reactions (defined as occurring within 24 hours) were observed in 2 patients (1.8%) treated with crizanlizumab 5 mg/kg</span><span lang=\"EN-GB\">. Patients should be monitored for signs and symptoms of infusion‑related reactions, which may include fever, chills, nausea, vomiting, fatigue, dizziness, pruritus, urticaria, sweating, shortness of breath or wheezing. </span><span lang=\"EN-GB\">In the event of a severe reaction, crizanlizumab should be discontinued and appropriate therapy should be instituted.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Laboratory test interference: automated platelet counts</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Interference with automated platelet counts (platelet clumping) has been observed in patients treated with crizanlizumab in clinical studies, in particular when tubes containing EDTA (ethylenediaminetetraacetic acid) were used. This may lead to unevaluable or falsely decreased platelet counts. There is no evidence that crizanlizumab causes a reduction in circulating platelets or has a pro‑aggregant effect <i>in vivo</i>.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">To mitigate the potential for laboratory test interference, it is recommended to run the test as soon as possible (within 4 hours of blood collection) or use citrate tubes. When needed, </span><span lang=\"EN-GB\">platelet counts can be estimated via a peripheral blood smear</span><span lang=\"EN-GB\">.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Excipients with known effect</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially “sodium‑free”.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.5     Interaction with other medicinal products and other forms of interaction</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Interactions between crizanlizumab and other medicinal products have not been investigated in dedicated studies.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Monoclonal antibodies are not metabolised by cytochrome P450 (CYP450) enzymes. Therefore, medicinal products that are substrates, inhibitors or inducers of CYP450 are not expected to affect the pharmacokinetics of crizanlizumab. In clinical studies, HU/HC had no effect on crizanlizumab pharmacokinetics in patients.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No effect on exposure of co‑administered medicinal products is expected based on the metabolic pathways of monoclonal antibodies.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.6     </span></b><b><span lang=\"EN-GB\">Fertility, p</span></b><b><span lang=\"EN-GB\">regnancy and lactation</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Pregnancy</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"Standard\"><span lang=\"EN-GB\">There is a limited amount of data from the use of Adakveo in pregnant women. Based on data from animal studies, crizanlizumab has the potential to cause foetal losses when administered to a pregnant woman (see section 5.3). As a precautionary measure, it is preferable to avoid the use of Adakveo during pregnancy and in woman of childbearing potential not using contraception.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"Standard\" style=\"line-height:normal\">To help determine the effects in pregnant women, healthcare professionals are encouraged to report all pregnancy cases and complications during pregnancy (from 105 days prior to the last menstrual period onward) to <span lang=\"EN-GB\">the local representative of the</span> marketing authorisation holder (see package leaflet), in order to allow monitoring of these patients through the PRegnancy outcomes Intensive Monitoring programme (PRIM). In addition, all adverse pregnancy events should be reported <span lang=\"EN-GB\">via <span style=\"color:black;background:#D9D9D9\">the national reporting system listed in </span></span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:#D9D9D9\">Appendix V</span></a></span>.</p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Breast‑feeding</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It is unknown whether crizanlizumab is excreted in human milk after administration of Adakveo. There are no data on the effects of crizanlizumab on the breast‑fed newborn/infant or on milk production.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Because many medicinal products, including antibodies, can be excreted in human milk, a risk to the newborn/infant cannot be excluded.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">A decision must be made whether to discontinue breast‑feeding or to discontinue Adakveo therapy, taking into account the benefit of breast‑feeding for the child and the benefit of therapy for the woman.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Fertility</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There are no data on the effect of Adakveo on human fertility. Available non‑clinical data do not suggest an effect on fertility under crizanlizumab treatment (see section 5.3).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.7     Effects on ability to drive and use machines</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo may have a minor influence on the ability to drive and use machines. Dizziness, fatigue and somnolence may occur following administration of crizanlizumab.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.8     Undesirable effects</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Summary of the safety profile</span></u><a name=\"_nth_Summary_of_the_safety_6118\"></a></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The most frequently reported adverse drug reactions (≥10% of patients) in the Adakveo 5 mg/kg group were arthralgia, nausea, back pain, pyrexia and abdominal pain. Severe events were observed for pyrexia and arthralgia (each 0.9%).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Tabulated list of adverse reactions</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Table 1 lists adverse reactions based on pooled data from two studies: the pivotal study, SUSTAIN, and a single‑arm, open‑label pharmacokinetics/pharmacodynamics and safety study. Use of crizanlizumab in combination with HU/HC did not result in any meaningful differences in the safety profile.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Within each system organ class, the adverse reactions are ranked by frequency, with the most frequent reactions first. Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness. In addition, the corresponding frequency category for each adverse reaction is based on the following convention: very common (≥1/10); common (≥1/100 to &lt;1/10); uncommon (≥1/1,000 to &lt;1/100); rare (≥1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><a name=\"_Toc272145403\"></a><a name=\"_Toc272145564\"></a><a name=\"_Toc266768477\"></a><a name=\"_Toc260903679\"></a><a name=\"_Toc266264818\"></a><a name=\"_Toc499550967\"></a><a name=\"_Toc517716325\"><b><span lang=\"EN-GB\">Table 1       Adverse reactions in clinical studies</span></b></a><a name=\"_hd6_Table_7_1_Percentage_o7395\"></a></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:459.0pt;border-collapse:collapse;border:none\" width=\"612\"> <tr style=\"page-break-inside:avoid\"> <td style=\"width:175.5pt;border:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt\">System organ class</span></b></p> </td> <td style=\"width:81.0pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Frequency</span></b></p> </td> <td style=\"width:202.5pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Adverse reaction</span></b></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Respiratory, thoracic and   mediastinal disorders</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Oropharyngeal pain</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td rowspan=\"2\" style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Gastrointestinal disorders</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Very common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Nausea, abdominal pain*</span></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:13.45pt\"> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:13.45pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:13.45pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">D</span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">iarrhoea, vomiting</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Skin and subcutaneous tissue   disorders</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Pruritus*</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td rowspan=\"2\" style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Musculoskeletal and   connective tissue disorders</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Very common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Arthralgia, back pain</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Myalgia, musculoskeletal   chest pain</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td rowspan=\"2\" style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">General disorders and   administration site conditions</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Very common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Pyrexia</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Infusion site reaction*</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Injury, poisoning and   procedural complications</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Infusion‑related   reaction</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td colspan=\"3\" style=\"width:459.0pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"612\"> <p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style=\\'font-family:\"Times New Roman\",serif\\'>*The   following groupings contain the following MedDRA preferred terms:</span></p> <p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;   margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\\'font-family:   \"Times New Roman\",serif\\'>-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                   </span></span><span lang=\"EN-GB\" style=\\'font-family:\"Times New Roman\",serif\\'>Abdominal   pain: abdominal pain, abdominal pain upper, abdominal pain lower, abdominal   discomfort, and abdominal tenderness</span></p> <p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;   margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"FR-CH\" style=\\'font-family:   \"Times New Roman\",serif\\'>-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                   </span></span><span lang=\"EN-GB\" style=\\'font-family:\"Times New Roman\",serif\\'>Pruritus:   pruritus and vulvovaginal pruritus</span></p> <p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;   margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\\'font-size:   11.0pt;font-family:\"Times New Roman\",serif\\'>-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                   </span></span><span lang=\"FR-CH\" style=\\'font-family:\"Times New Roman\",serif\\'>Infusion   site reaction: infusion site extravasation, infusion site pain, and infusion   site swelling</span></p> </td> </tr> </table> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Description of selected adverse reactions</span></u></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after: avoid\"><span style=\"font-size:11.0pt\"> </span></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after: avoid\"><i><u><span style=\"font-size:11.0pt\">Immunogenicity</span></u></i></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">In clinical studies, treatment‑induced anti‑crizanlizumab antibodies were transiently detected in 1 patient (0.9%) among the 111 patients who received Adakveo 5 mg/kg.</span></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">There was no evidence of altered pharmacokinetics or of an altered safety profile with anti‑crizanlizumab antibody development.</span></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p> <p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Paediatric population</span></u></p> <p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">Frequency, type and severity of adverse reactions in patients aged 16 and 17 years are expected to be the same as in adults. The safety of crizanlizumab was evaluated in 3 patients aged &lt;18 years.</span></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Reporting of suspected adverse reactions</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via <span style=\"color:black; background:#D9D9D9\">the national reporting system listed in </span></span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:#D9D9D9\">Appendix V</span></a></span><span lang=\"EN-GB\">.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.9     Overdose</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">No cases of overdose have been reported in clinical studies.</span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">General supportive measures and symptomatic treatment should be initiated in cases of suspected overdose.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.       PHARMACOLOGICAL PROPERTIES</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.1     Pharmacodynamic properties</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Pharmacotherapeutic group: Other haematological agents, ATC code: B06AX01</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Mechanism of action</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Crizanlizumab is a selective IgG2 kappa humanised monoclonal antibody (mAb) that binds to P‑selectin with high affinity and blocks the interaction with its ligands, including P‑selectin glycoprotein ligand 1. </span><span lang=\"EN-GB\">Crizanlizumab can also dissociate preformed P‑selectin/PSGL‑1 complex. </span><span lang=\"EN-GB\">P‑selectin is an adhesion molecule expressed on activated endothelial cells and platelets. It plays an essential role in the initial recruitment of leukocytes and the aggregation of platelets to the site of vascular injury during inflammation. In the chronic pro‑inflammatory state associated with sickle cell disease, P‑selectin is over‑expressed and circulating blood cells and the endothelium are activated and become hyperadhesive. P‑selectin‑mediated multi‑cellular adhesion is a key factor in the pathogenesis of vaso‑occlusion and vaso‑occlusive crises (VOC). Elevated levels of P‑selectin are found in patients with sickle cell disease.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Binding P‑selectin on the surface of the activated endothelium and platelets has been shown to effectively block interactions between endothelial cells, platelets, red blood cells and leukocytes, thereby preventing vaso‑occlusion.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Pharmacodynamic effects</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Throughout clinical studies, treatment with crizanlizumab 5 mg/kg resulted in dose‑dependent, immediate and sustained P‑selectin inhibition </span><span lang=\"EN-GB\">(as measured <i>ex vivo</i>) </span><span lang=\"EN-GB\">in patients with sickle cell disease.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Clinical efficacy and safety</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The efficacy of crizanlizumab, with or without HU/HC, was evaluated in the pivotal study SUSTAIN, a 52‑week, randomised, placebo‑controlled, double‑blind, multicentre clinical study in sickle cell disease patients with a history of vaso‑occlusive crises (VOCs).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In this study, VOCs were defined as those leading to a healthcare visit, which captured all acute episodes of pain with no other cause than a vaso‑occlusive event that required a healthcare visit and treatment with oral or parenteral opioids or parenteral non‑steroidal anti‑inflammatory drugs (NSAIDs). Acute chest syndrome, hepatic sequestration, splenic sequestration and priapism (requiring a healthcare visit), by definition, were also considered VOCs.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">A total of 198 sickle cell disease patients aged 16 to 63 years (inclusive; mean age 30.1±10.3 years), with any sickle cell disease genotype (including HbSS [71.2%], HbSC [16.2%], HbSbeta0‑thalassaemia [6.1%], HbSbeta+‑thalassaemia [5.1%], and others [1.5%]) and a history of between 2 and 10 VOCs in the previous 12 months (62.6% and 37.4% of the patients had 2‑4 or 5‑10 VOCs, respectively), were randomised 1:1:1 to Adakveo 5 mg/kg, Adakveo 2.5 mg/kg or placebo. The majority of patients were Black or African American (91.9%). Patients received Adakveo with (62.1%) or without (37.9%) HU/HC. Randomisation was stratified by patients already receiving HU/HC (Y/N) and by number of VOCs in the previous 12 months (2 to 4, 5 to 10). Patients were allowed to take medicinal products to relieve pain (i.e. paracetamol, NSAIDs and opioids) and to receive occasional transfusions on an “as needed” basis. Patients participating in a chronic transfusion programme (pre-planned series of transfusions for prophylactic purposes) were excluded from the study.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Treatment with Adakveo 5 mg/kg resulted in a 45.3% lower median annual rate of VOCs compared to placebo (Hodges‑Lehmann, median absolute difference of ‑1.01 compared with placebo, 95% CI [‑2.00, 0.00]), which was statistically significant (p=0.010). The median annual rates of uncomplicated VOCs (any VOCs as defined above, excluding acute chest syndrome, hepatic sequestration, splenic sequestration or priapism) and days hospitalised were 62.9% and 41.8% lower in the Adakveo 5 mg/kg than in the placebo group, respectively. The VOCs occurring during the study were assessed by an independent review committee.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Main efficacy outcomes of the pivotal SUSTAIN study are summarised in Tables 2 and 3.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><a name=\"_Toc499550968\"></a><a name=\"_Toc517716326\"><b><span lang=\"EN-GB\">Table </span></b></a><b><span lang=\"EN-GB\">2       Results from SUSTAIN clinical study in </span></b><a name=\"_hd6_Table_12_1_Results_fro16811\"></a><b><span lang=\"EN-GB\">sickle cell disease</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:98.84%;border-collapse:collapse;border:none\" width=\"98%\"> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <td style=\"width:20.16%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"20%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Event</span></b></p> </td> <td style=\"width:23.82%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"23%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Adakveo 5 mg/kg</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">(N=67)</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(standard median)</span></p> </td> <td style=\"width:11.54%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"11%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Placebo</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">(N=65)</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(standard median)</span></p> </td> <td style=\"width:10.46%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"10%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Change vs placebo</span></b></p> </td> <td style=\"width:21.1%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"21%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Hodges‑Lehmann median   difference</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(95% CI)</span></p> </td> <td style=\"width:12.9%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"12%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">p-value</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(Wilcoxon rank sum)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <td style=\"width:20.18%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"20%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Primary endpoint</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Annual rate of VOCs</span></p> </td> <td style=\"width:23.82%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"23%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.63</span></p> </td> <td style=\"width:11.54%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"11%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.98</span></p> </td> <td style=\"width:10.46%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"10%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑45.3%</span></p> </td> <td style=\"width:21.1%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"21%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.01</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑2.00, 0.00)</span></p> </td> <td style=\"width:12.9%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"12%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">0.010</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td colspan=\"5\" style=\"width:87.1%;border:none;   border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"87%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Secondary endpoints</span></b></p> </td> <td style=\"width:12.9%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"12%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\"> </span></b></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <td style=\"width:20.18%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"20%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Annual rate of days hospitalised</span></p> </td> <td style=\"width:23.82%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"23%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">4.00</span></p> </td> <td style=\"width:11.54%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"11%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">6.87</span></p> </td> <td style=\"width:10.46%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"10%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑41.8%</span></p> </td> <td style=\"width:21.1%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"21%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">0.00</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑4.36, 0.00)</span></p> </td> <td style=\"width:12.9%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"12%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">0.450</span></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <td style=\"width:20.18%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"20%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Annual rate of uncomplicated VOCs</span></p> </td> <td style=\"width:23.82%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"23%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.08</span></p> </td> <td style=\"width:11.54%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"11%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.91</span></p> </td> <td style=\"width:10.46%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"10%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑62.9%</span></p> </td> <td style=\"width:21.1%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"21%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.00</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑1.98, 0.00)</span></p> </td> <td style=\"width:12.9%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"12%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">-</span></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <td colspan=\"6\" style=\"width:.02%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"0%\"> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">The primary (annual rate of VOC leading   to healthcare visit) and key secondary (annual rate of days hospitalised)   endpoints were the only ones formally tested for statistical significance   according to protocol.</span></p> </td> </tr> </table> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\"><span lang=\"EN-GB\">The clinical effect demonstrated in the primary efficacy analysis was supported by multiple supplementary analyses including a negative binomial regression on investigator assessments with a conservative method to handle missing data due to early discontinuation of treatment based on outcomes in the placebo group (RR=0.74, 95% CI=0.52, 1.06).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In the Adakveo 5 mg/kg group, clinically significant reductions in the annual rate of VOCs were observed across important subgroups (</span><span lang=\"EN-GB\">HU/HC use, 2‑4 or 5‑10 VOCs in the previous 12 months, and HbSS or non‑HbSS genotypes; </span><span lang=\"EN-GB\">see Table 3).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><b><span lang=\"EN-GB\">Table 3       Annual rate of VOCs in patients ‑ subgroup analyses</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"612\"> <tr style=\"page-break-inside:avoid\"> <td style=\"width:90.45pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"121\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Subgroup </span></b></p> </td> <td style=\"width:63.8pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\"> </span></b></p> </td> <td style=\"width:70.85pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Adakveo 5 mg/kg (N=67)</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(standard median)</span></p> </td> <td style=\"width:63.8pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Placebo (N=65)</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(standard median)</span></p> </td> <td style=\"width:63.8pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Change vs placebo</span></b></p> </td> <td style=\"width:106.3pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Hodges‑Lehmann median   difference</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">(95% CI)</span></b></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td rowspan=\"2\" style=\"width:90.45pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"121\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">HU/HC use</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Yes</span></p> </td> <td style=\"width:70.85pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=42</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.43</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n= 40</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">3.58</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑32.1%</span></p> </td> <td style=\"width:106.3pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.01</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑2.44, 0.00)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">No</span></p> </td> <td style=\"width:70.85pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=25</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.00</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=25</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.00</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑50.0%</span></p> </td> <td style=\"width:106.3pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.02</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑2.00, 0.00)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:20.2pt\"> <td rowspan=\"2\" style=\"width:90.45pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:20.2pt\" width=\"121\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Number of VOCs in previous   12 months</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:20.2pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2‑4 VOCs</span></p> </td> <td style=\"width:70.85pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:20.2pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=42</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.14</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:20.2pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=41</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.00</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:20.2pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑43.0%</span></p> </td> <td style=\"width:106.3pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:20.2pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑0.05</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑1.56, 0.01)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">5‑10 VOCs</span></p> </td> <td style=\"width:70.85pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=25</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.97</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=24</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">5.32</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑63.0%</span></p> </td> <td style=\"width:106.3pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑2.74</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑5.00, ‑0.83)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td rowspan=\"2\" style=\"width:90.45pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"121\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Sickle cell disease genotypes,   including HbSC</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">HbSS</span></p> </td> <td style=\"width:70.85pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=47</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.97</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=47</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">3.01</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑34.6%</span></p> </td> <td style=\"width:106.3pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.01</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑2.18, 0.00)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Non‑HbSS</span></p> </td> <td style=\"width:70.85pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=20</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">0.99</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=18</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.00</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑50.5%</span></p> </td> <td style=\"width:106.3pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.01</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑2.01, 0.00)</span></p> </td> </tr> </table> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">A greater than two‑fold increase in the proportion of patients with no VOC and who completed the study was observed in the Adakveo 5 mg/kg group compared to placebo (22% vs 8%; odds ratio [95% CI]: 3.57 [1.20, 10.63]). A similar difference was also observed across important subgroups (HU/HC use, genotype).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Treatment with Adakveo 5 mg/kg was also associated with a three‑fold longer Kaplan‑Meier estimated median time to first VOC compared with placebo (4.07 vs 1.38 months; HR=0.495, 95% CI: 0.331, 0.741) (Figure 1) and a two‑fold longer median time from randomisation to second VOC compared to placebo (10.32 vs 5.09 months; HR=0.534, 95% CI: 0.329, 0.866).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Figure 1      Kaplan‑Meier curve of time to first VOC</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><span style=\"position:absolute;z-index:251748352;left:0px;margin-left:61px; margin-top:211px;width:13px;height:9px\"><img alt=\"0\" height=\"9\" src=\"Adakveo-4874%20EN%20PI_files/image002.png\" width=\"13\"/></span><span style=\"position:absolute;z-index:251746304;left:0px;margin-left:63px; margin-top:190px;width:10px;height:10px\"><img alt=\"10\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image003.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251744256;left:0px;margin-left:64px; margin-top:169px;width:10px;height:10px\"><img alt=\"20\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image004.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251742208;left:0px;margin-left:64px; margin-top:149px;width:10px;height:10px\"><img alt=\"30\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image005.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251740160;left:0px;margin-left:65px; margin-top:130px;width:10px;height:10px\"><img alt=\"40\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image006.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251738112;left:0px;margin-left:64px; margin-top:110px;width:10px;height:10px\"><img alt=\"50\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image007.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251736064;left:0px;margin-left:64px; margin-top:90px;width:10px;height:10px\"><img alt=\"60\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image008.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251734016;left:0px;margin-left:64px; margin-top:70px;width:10px;height:10px\"><img alt=\"70\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image009.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251731968;left:0px;margin-left:63px; margin-top:48px;width:10px;height:10px\"><img alt=\"80\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image010.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251729920;left:0px;margin-left:65px; margin-top:28px;width:10px;height:10px\"><img alt=\"90\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image011.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251727872;left:0px;margin-left:60px; margin-top:9px;width:15px;height:10px\"><img alt=\"100\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image012.png\" width=\"15\"/></span><span style=\"position:absolute;z-index:251781120;left:0px;margin-left:459px; margin-top:8px;width:125px;height:38px\"><img height=\"38\" src=\"Adakveo-4874%20EN%20PI_files/image013.png\" width=\"125\"/></span><span style=\"position: absolute;z-index:251779072;left:0px;margin-left:494px;margin-top:7px; width:92px;height:26px\"><img height=\"26\" src=\"Adakveo-4874%20EN%20PI_files/image014.png\" width=\"92\"/></span><span style=\"position: absolute;z-index:251666432;left:0px;margin-left:22px;margin-top:28px; width:32px;height:178px\"><img alt=\"Probability of being free from first VOC (%)\" height=\"178\" src=\"Adakveo-4874%20EN%20PI_files/image015.png\" width=\"32\"/></span><span style=\"position:absolute;z-index:251725824;left:0px;margin-left:320px; margin-top:242px;width:56px;height:10px\"><img alt=\"Time (months)¬¬¬¬\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image016.png\" width=\"56\"/></span><sub><span style=\"font-size:11.0pt\">                                <img border=\"0\" height=\"223\" id=\"Picture 1243\" src=\"Adakveo-4874%20EN%20PI_files/image017.jpg\" width=\"518\"/></span></sub></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"> <table align=\"left\" cellpadding=\"0\" cellspacing=\"0\"> <tr> <td height=\"1\" width=\"3\"></td> <td width=\"36\"></td> <td width=\"33\"></td> <td width=\"2\"></td> <td width=\"2\"></td> <td width=\"5\"></td> <td width=\"10\"></td> <td width=\"3\"></td> <td width=\"23\"></td> <td width=\"10\"></td> <td width=\"27\"></td> <td width=\"10\"></td> <td width=\"26\"></td> <td width=\"3\"></td> <td width=\"7\"></td> <td width=\"28\"></td> <td width=\"10\"></td> <td width=\"28\"></td> <td width=\"10\"></td> <td width=\"25\"></td> <td width=\"10\"></td> <td width=\"26\"></td> <td width=\"13\"></td> <td width=\"26\"></td> <td width=\"10\"></td> <td width=\"26\"></td> <td width=\"10\"></td> <td width=\"30\"></td> <td width=\"10\"></td> <td width=\"26\"></td> <td width=\"10\"></td> <td width=\"26\"></td> <td width=\"10\"></td> <td width=\"27\"></td> <td width=\"10\"></td> <td width=\"18\"></td> </tr> <tr> <td height=\"10\"></td> <td colspan=\"5\"></td> <td align=\"left\" valign=\"top\"><img alt=\"0\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image018.png\" width=\"10\"/></td> <td colspan=\"2\"></td> <td align=\"left\" valign=\"top\"><img alt=\"1\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image019.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"2\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image020.png\" width=\"10\"/></td> <td></td> <td align=\"left\" colspan=\"2\" valign=\"top\"><img alt=\"3\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image021.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"4\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image022.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"5\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image023.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"6\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image024.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"7\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image025.png\" width=\"13\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"8\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image026.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"9\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image027.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"10\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image003.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"11\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image028.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"12\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image029.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"13\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image030.png\" width=\"10\"/></td> </tr> <tr> <td height=\"14\"></td> </tr> <tr> <td height=\"9\"></td> <td colspan=\"7\"></td> <td align=\"left\" colspan=\"6\" valign=\"top\"><img alt=\"Number of patients at risk\" height=\"9\" src=\"Adakveo-4874%20EN%20PI_files/image031.png\" width=\"99\"/></td> </tr> <tr> <td height=\"7\"></td> </tr> <tr> <td height=\"7\"></td> <td colspan=\"4\"></td> <td align=\"left\" colspan=\"31\" rowspan=\"5\" valign=\"top\"><img alt=\"67,49,41,35,30,26,24,20,18,17,16,15,7,65,37,23,21,17,13,12,9,8,6,5,4,1,0,0\" height=\"43\" src=\"Adakveo-4874%20EN%20PI_files/image032.png\" width=\"513\"/></td> </tr> <tr> <td height=\"10\"></td> <td align=\"left\" colspan=\"3\" valign=\"top\"><img alt=\"Adakveo 5 mg/kg \" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image033.png\" width=\"71\"/></td> </tr> <tr> <td height=\"14\"></td> </tr> <tr> <td height=\"10\"></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"Placebo\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image034.png\" width=\"33\"/></td> </tr> <tr> <td height=\"2\"></td> </tr> </table> <span lang=\"EN-GB\"> </span></p> <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><span style=\"font-size:11.0pt\"> </span></p> <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><span style=\"font-size:11.0pt\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <br clear=\"ALL\"/> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><a name=\"_hd6_Table_2_1_Patients_wit18544\"></a><u><span lang=\"EN-GB\">Paediatric population</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The efficacy of crizanlizumab in patients aged 16 and 17 years is expected to be the same as in adults. Three patients (2.7%) aged less than 18 years were treated with crizanlizumab 5 mg/kg in clinical studies.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The European Medicines Agency has deferred the obligation to submit the results of studies with Adakveo in one or more subsets of the paediatric population in the treatment of sickle cell disease (see section 4.2 for information on paediatric use).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Conditional approval</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal product has been authorised under a so‑called “conditional approval” scheme. This means that further evidence on this medicinal product is awaited.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The European Medicines Agency will review new information on this medicinal product at least every year and this SmPC will be updated as necessary.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.2     Pharmacokinetic properties</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Absorption</span></u></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The median time to reach maximum serum concentration of crizanlizumab (T<sub>max</sub>) was 1.92 hours at steady state following intravenous administration of 5 mg/kg over a period of 30 minutes in sickle cell disease patients.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Distribution</span></u></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab distribution is typical of endogenous human antibodies within the vascular and extracellular spaces. The volume of distribution (V<sub>z</sub>) was 4.26 litres after a single 5 mg/kg intravenous infusion of crizanlizumab in healthy volunteers.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Biotransformation</span></u></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Antibodies are primarily eliminated via proteolysis by lysosomal enzymes in the liver to small peptides and amino acids.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Elimination</span></u></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In healthy volunteers, the mean terminal elimination half‑life (T<sub>½</sub>) was 10.6 days and the mean clearance was 11.7 ml/h at crizanlizumab dose level 5 mg/kg. In patients with sickle cell disease, the mean elimination T<sub>½</sub> during the dosing interval was 7.5 days.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Linearity/non‑linearity</span></u></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The exposure to crizanlizumab (mean C<sub>max</sub>, AUC<sub>last</sub>, or AUC<sub>inf</sub>) increased in non‑linear manner over the dose range of 0.2 to 8 mg/kg in healthy volunteers.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Special populations</span></u></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Renal impairment</span></u></i></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In a population PK analysis in patients with eGFR ranging from 35 to 202 ml/min/1.73 m<sup>2</sup>, no clinically important differences in the pharmacokinetics of crizanlizumab were found between patients with mild or moderate renal impairment and patients with normal renal function. Data from patients with severe renal impairment are too limited to draw conclusions on this population (see section</span><span lang=\"EN-GB\"> </span><span lang=\"EN-GB\">4.2).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Hepatic impairment</span></u></i></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monoclonal antibody and is cleared via catabolism (i.e. breakdown into peptides and amino acids), and a change in dose is not expected to be required for patients with hepatic impairment.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Paediatric <a name=\"_nth_Pediatric_patients__be14752\"></a>population</span></u></i></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pharmacokinetics in paediatric patients below the age of 16 years have not been investigated.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.3     Preclinical safety data</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">N</span><span lang=\"EN-GB\">on‑clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, tissue cross‑reactivity and repeated dose toxicity.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In the 26‑week repeated dose toxicity study, administration of crizanlizumab in cynomolgus monkeys at dose levels up to 50 mg/kg/dose once every 4 weeks (at least 13.5 times the human clinical exposure based on AUC in patients with sickle cell disease at 5 mg/kg once every four weeks) was generally well tolerated. There were no primary crizanlizumab‑related findings on any endpoint evaluated. At 50 mg/kg, minimal to moderate inflammation of the vessels in multiple tissues considered to be an antigen‑antibody complex reaction (primate antihuman antibody) was observed in 2 of 10 animals. There was one death attributed to aspiration of gastric contents following a peri‑infusional reaction mediated by anti‑drug‑antibody‑dependent hypersensitivity.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\">Pharmacological effects of crizanlizumab on haemodynamic and electrocardiographic parameters in the cynomolgus monkey were evaluated in the 26‑week repeated dose toxicology study. Respiratory rate and neurological parameters were also assessed. There were no crizanlizumab‑related effects on arterial blood pressure or on heart rate, PR, RR, QRS, QT, and heart rate corrected QT (QTc) intervals on the electrocardiograms (ECG). No rhythm abnormalities or qualitative changes were observed during the qualitative ECG assessment. There were no crizanlizumab‑related effects on respiration rate or any neurological parameter evaluated.</p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Formal carcinogenicity, genotoxicity and juvenile toxicity studies have not been conducted with crizanlizumab.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In a 26‑week repeated dose toxicity study, cynomolgus monkeys were administered crizanlizumab once every 4 weeks at doses up to 50 mg/kg (at least 13.5 times the human clinical exposure based on AUC in patients with sickle cell disease at 5 mg/kg once every four weeks). </span><span lang=\"EN-GB\">There were no adverse effects of crizanlizumab on male and female reproductive organs</span>.</p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In an enhanced pre‑ and postnatal development study in cynomolgus monkeys, pregnant animals received intravenous crizanlizumab once every two weeks during the period of organogenesis, at doses of 10 and 50 mg/kg (approximately 2.8 and 16 times </span><span lang=\"EN-GB\">the human clinical exposure based on AUC in patients with sickle cell disease at 5 mg/kg/dose once every four weeks, respectively)</span><span lang=\"EN-GB\">. No maternal toxicity was observed. </span><span lang=\"EN-GB\">There was an increase in foetal loss (abortions or stillbirths) at both doses and this was higher in the third trimester. The cause of the foetal losses in monkeys is unknown but may be due to the development of anti‑drug antibodies against crizanlizumab</span><span lang=\"EN-GB\">. There were no effects on infant growth and development during the 6 months postpartum that were attributable to crizanlizumab.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Measurable crizanlizumab serum concentrations were observed in the infant monkeys at postnatal day 28, confirming that crizanlizumab, like other IgG antibodies, crosses the placental barrier.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.       PHARMACEUTICAL PARTICULARS</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.1     List of excipients</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Sucrose</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Sodium citrate (E331)</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Citric acid (E330)</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Polysorbate 80 (E433)</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Water for injections</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.2     Incompatibilities</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal product</span><span lang=\"EN-GB\"> must not be mixed with other medicinal products except those mentioned in section 6.6.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.3     Shelf life</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Unopened vial</span></u></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">18 months</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Diluted solution</span></u></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Chemical and physical in‑use stability, from the start of preparation of the diluted solution for infusion until end of infusion, has been demonstrated for up to 8 hours at room temperature (up to 25°C) and at 2°C to 8°C for up to 24 hours overall.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">From a microbiological point of view, the diluted solution for infusion should be used immediately. If not used immediately, in‑use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2°C to 8°C, including 4.5 hours at room temperature (up to 25°C) from the start of preparation to completion of the infusion, unless dilution has taken place in controlled and validated aseptic conditions.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.4     Special precautions for storage</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Store in a refrigerator (2°C – 8°C).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not freeze.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep the vial in the outer carton in order to protect from light.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For storage conditions after dilution of the medicinal product, see section 6.3.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.5     Nature and contents of container</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">10 ml concentrate for solution for infusion in a type I glass vial with a coated chlorobutyl rubber stopper sealed with an aluminium cap with a plastic flip‑off disk containing 100 mg crizanlizumab.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pack of 1 vial.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><a name=\"OLE_LINK1\"><b><span lang=\"EN-GB\">6.6     Special precautions for disposal and other handling</span></b></a></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo vials are for single use only.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Preparing the infusion</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The diluted solution for infusion should be prepared by a healthcare professional using aseptic techniques.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The total dose and required volume of Adakveo depend on the patient’s body weight; 5 mg of crizanlizumab is administered per kg body weight.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">The volume to be used for the preparation of the infusion is calculated according to the following equation:</span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:12.5pt;border-collapse:collapse\" width=\"567\"> <tr> <td rowspan=\"2\" style=\"width:85.05pt;padding:0in 5.4pt 0in 5.4pt\" width=\"113\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Volume (ml) =</span></p> </td> <td style=\"width:269.35pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"359\"> <p align=\"center\" class=\"MsoNormal\" style=\"margin-left:28.35pt;text-align:center;   text-indent:-28.35pt;line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Patient’s body weight (kg) x prescribed dose</span></p> </td> <td style=\"width:70.85pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"94\"> <p align=\"center\" class=\"MsoNormal\" style=\"margin-left:28.35pt;text-align:center;   text-indent:-28.35pt;line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">[5 mg/kg]</span></p> </td> </tr> <tr> <td style=\"width:269.35pt;border:none;padding:0in 5.4pt 0in 5.4pt\" width=\"359\"> <p align=\"center\" class=\"Text\" style=\"margin-top:0in;text-align:center;   page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Concentration   of Adakveo</span></p> </td> <td style=\"width:70.85pt;border:none;padding:0in 5.4pt 0in 5.4pt\" width=\"94\"> <p align=\"center\" class=\"Text\" style=\"margin-top:0in;text-align:center;   page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">[10 mg/ml]</span></p> </td> </tr> </table> <p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_hd6_Table_3_1_Example_of_d12477\"></a><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">1.       Obtain the number of vials required to deliver the prescribed dose and bring them to room temperature (for a maximum of 4 hours). One vial is needed for every 10 ml of Adakveo (see below table).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:28.35pt;border-collapse:collapse;border:none\" width=\"568\"> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Body weight (kg)</span></b></p> </td> <td style=\"width:92.15pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Dose (mg)</span></b></p> </td> <td style=\"width:114.75pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Volume (ml)</span></b></p> </td> <td style=\"width:114.75pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Vials (n)</span></b></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">40</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">200</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">20</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">2</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">60</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">300</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">30</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">3</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">80</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">400</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">40</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">4</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">100</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">500</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">50</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">5</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">120</span></p> </td> <td style=\"width:92.15pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">600</span></p> </td> <td style=\"width:114.75pt;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">60</span></p> </td> <td style=\"width:114.75pt;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">6</span></p> </td> </tr> </table> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">2.       Visually inspect the vials.</span></p> <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The solution in the vials should be clear to opalescent. Do not use if particles are present in the solution.</span></p> <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The solution should be colourless or may have a slight brownish‑yellow tint.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">3.       Withdraw a volume equal to the required volume of Adakveo from a 100 ml infusion bag containing either sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% and discard.</span></p> <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">No incompatibilities between the diluted Adakveo solution and infusion bags composed of polyvinylchloride (PVC), polyethylene (PE) and polypropylene (PP) have been observed.</span></p> <p class=\"MsoNormal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">4.       Withdraw the necessary volume of Adakveo from the vials and inject slowly into the previously prepared infusion bag.</span></p> <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The </span><span lang=\"EN-GB\">solution</span><span lang=\"EN-GB\"> must not be mixed or co‑administered with other medicinal products through the same intravenous line.</span></p> <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">Keep the volume of Adakveo added to the infusion bag in the range of 10 ml to 96 ml to obtain a final concentration in the infusion bag within 1 mg/ml to 9.6 mg/ml.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">5.       Mix the diluted solution by gently inverting the infusion bag. DO NOT SHAKE.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Administration</span></u><a name=\"_nth_Administration25012\"></a></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">Adakveo diluted solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by intravenous infusion over a period of 30 minutes.</span><span style=\"font-size:11.0pt\"> <span lang=\"EN-GB\">No incompatibilities have been observed between Adakveo and infusion sets composed of PVC, PE‑lined PVC, polyurethane, and in‑line filter membranes composed of polyethersulfone (PES), polyamide (PA) or polysulphone (PSU).</span></span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">After administration of Adakveo, flush the line with at least 25 ml sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5%.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Disposal</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">7.       MARKETING AUTHORISATION HOLDER</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Novartis Europharm Limited</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Vista Building</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Elm Park, Merrion Road</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Dublin 4</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">Ireland</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">8.       MARKETING AUTHORISATION NUMBER(S)</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">EU/1/20/1476/001</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">9.       DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">10.     DATE OF REVISION OF THE TEXT</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Detailed information on this medicinal product is available on the website of the European Medicines </span><span lang=\"EN-GB\">Agency <a href=\"http://www.ema.europa.eu\">http://www.ema.europa.eu</a></span><span lang=\"EN-GB\">.<br clear=\"all\" style=\"page-break-before:always\"/> </span></p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX II</span></b></p> <p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom: 0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">A.      MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom: 0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">B.      CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom: 0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">C.      OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION</span></b></p> <p class=\"MsoNormal\" style=\"margin-right:77.9pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom: 0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">D.      <span style=\"text-transform:uppercase\">conditions or restrictions with regard to the safe and effective use of the medicinal PRODUCT</span></span></b></p> <p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom: 0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">E.      SPECIFIC OBLIGATION TO COMPLETE POST-AUTHORISATION MEASURES FOR THE </span></b><b><span lang=\"EN-GB\">CONDITIONAL</span><span lang=\"EN-GB\"> MARKETING AUTHORISATION</span></b></p> <span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'><br clear=\"all\" style=\"page-break-before:always\"/> </span> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">A.      MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE</span></b></p> <p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Name and address of the manufacturer(s) of the biological active substance(s)</span></u></p> <p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal;page-break-after: avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"Standard\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis Pharma AG</span></p> <p class=\"Standard\" style=\"line-height:normal\"><span lang=\"DE-CH\">Lichtstrasse 35</span></p> <p class=\"Standard\" style=\"line-height:normal\"><span lang=\"DE-CH\">4056 Basel</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Switzerland</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Name and address of the manufacturer(s) responsible for batch release</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"Standard\" style=\"line-height:normal\">Novartis Pharma GmbH</p> <p class=\"Standard\" style=\"line-height:normal\">Roonstrasse 25</p> <p class=\"Standard\" style=\"line-height:normal\">90429 Nuremberg</p> <p class=\"MsoNormal\" style=\"line-height:normal\">Germany</p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><a name=\"OLE_LINK2\"><b><span lang=\"EN-GB\">B.</span></b></a><b><span lang=\"EN-GB\">      CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">C.      OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION</span></b></p> <p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after: avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">·<span style=\\'font:7.0pt \"Times New Roman\"\\'>                </span></span><b><span lang=\"EN-GB\">Periodic safety update reports (PSURs)</span></b></p> <p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal;page-break-after: avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal\"><span lang=\"EN-GB\">The requirements for submission of PSURs for this medicinal product are set out in the list of Union reference dates (EURD list) </span><span lang=\"EN-GB\">provided for under Article 107c(7) of Directive 2001/83</span><span lang=\"EN-GB\">/EC</span><span lang=\"EN-GB\"> and </span><span lang=\"EN-GB\">any subsequent updates published on the European medicines web‑portal.</span></p> <p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The marketing authorisation holder (MAH) shall submit the first PSUR for this product within 6 months following authorisation.</span></p> <p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">D.      CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span></b></p> <p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after: avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">·<span style=\\'font:7.0pt \"Times New Roman\"\\'>                </span></span><b><span lang=\"EN-GB\">Risk management plan (RMP)</span></b></p> <p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after: avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal\"><span lang=\"EN-GB\">The </span><span lang=\"EN-GB\">marketing</span><span lang=\"EN-GB\"> authorisation holder (</span><span lang=\"EN-GB\">MAH) shall perform the required pharmacovigilance activities and interventions detailed in the agreed RMP presented in Module 1.8.2 of the marketing authorisation and any agreed subsequent updates of the RMP.</span></p> <p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">An updated RMP should be submitted:</span></p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">·<span style=\\'font:7.0pt \"Times New Roman\"\\'>                </span></span><span lang=\"EN-GB\">At the request of the European Medicines Agency;</span></p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">·<span style=\\'font:7.0pt \"Times New Roman\"\\'>                </span></span><span lang=\"EN-GB\">Whenever the risk management system is modified, especially as the result of new information being received that may lead to a significant change to the benefit/risk profile or as the result of an important (pharmacovigilance or risk minimisation) milestone being reached.</span></p> <p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"Standard\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"Standard\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">E.      SPECIFIC OBLIGATION TO COMPLETE POST-AUTHORISATION MEASURES FOR THE CONDITIONAL MARKETING AUTHORISATION</span></b></p> <p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"Standard\" style=\"margin-right:-.05pt;line-height:normal;page-break-after: avoid\"><span lang=\"EN-GB\">This being a conditional marketing authorisation and pursuant to Article 14a(4) of Regulation (EC) No 726/2004, the MAH shall complete, within the stated timeframe, the following measures:</span></p> <p class=\"Standard\" style=\"margin-right:-.05pt;line-height:normal;page-break-after: avoid\"><span lang=\"EN-GB\"> </span></p> <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"NormaleTabelle\" style=\"border-collapse:collapse;border:none\" width=\"100%\"> <tr style=\"page-break-inside:avoid\"> <td style=\"width:82.18%;border:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"82%\"> <p class=\"Standard\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:   avoid\"><b><span lang=\"EN-GB\">Description</span></b></p> </td> <td style=\"width:17.82%;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\"> <p class=\"Standard\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:   avoid\"><b><span lang=\"EN-GB\">Due date</span></b></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:82.18%;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"82%\"> <p class=\"TabletextrowsAgency\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'>In   order to confirm the efficacy and safety of crizanlizumab, the MAH should   submit the results of the primary analysis of a phase III CSEG101A2301 study   of crizanlizumab with or without hydroxyurea/hydroxycarbamide in adolescent   and adult sickle cell disease patients with vaso-occlusive crises</span></p> </td> <td style=\"width:17.82%;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\"> <p class=\"TabletextrowsAgency\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'>Clinical   study report primary analysis:</span></p> <p class=\"TabletextrowsAgency\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'>December   2025</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:82.18%;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"82%\"> <p class=\"TabletextrowsAgency\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'>In   order to confirm the efficacy and safety of crizanlizumab, the MAH should   submit the final results of the phase II CSEG101A2202 study of   crizanlizumab with or without hydroxyurea/hydroxycarbamide in sickle cell   disease patients with vaso‑occlusive crisis.</span></p> </td> <td style=\"width:17.82%;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\"> <p class=\"TabletextrowsAgency\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'>Clinical   study report:</span></p> <p class=\"TabletextrowsAgency\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'>December   2025</span></p> </td> </tr> </table> <span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'><br clear=\"all\" style=\"page-break-before:always\"/> </span> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX III</span></b></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">LABELLING AND PACKAGE LEAFLET</span></b></p> <b><span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'><br clear=\"all\" style=\"page-break-before:always\"/> </span></b> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">A. LABELLING</span></b></p> <span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif; color:black\\'><br clear=\"all\" style=\"page-break-before:always\"/> </span> <p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;border:none;padding:0in\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">CARTON</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.       NAME OF THE MEDICINAL PRODUCT</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo 10 mg/ml concentrate for solution for infusion</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">crizanlizumab</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.       STATEMENT OF ACTIVE SUBSTANCE(S)</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each 10 ml vial contains 100 mg crizanlizumab.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.       LIST OF EXCIPIENTS</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Also contains: sucrose, sodium citrate (E331), citric acid (E330), polysorbate 80 (E433), water for injections.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.       PHARMACEUTICAL FORM AND CONTENTS</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Concentrate for solution for infusion</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1 vial</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">100 mg/10 ml</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.       METHOD AND ROUTE(S) OF ADMINISTRATION</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For intravenous use after dilution.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Single use.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package leaflet before use.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.       SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the sight and reach of children.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.       OTHER SPECIAL WARNING(S), IF NECESSARY</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.       EXPIRY DATE</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.       SPECIAL STORAGE CONDITIONS</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Store in a refrigerator.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Do not freeze.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep the vial in the outer carton in order to protect from light.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.     SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.     NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Novartis Europharm Limited</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Vista Building</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Elm Park, Merrion Road</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Dublin 4</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ireland</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.     MARKETING AUTHORISATION NUMBER(S)</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU/1/20/1476/001</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.     BATCH NUMBER</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.     GENERAL CLASSIFICATION FOR SUPPLY</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.     INSTRUCTIONS ON USE</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border: none;padding:0in\"><b><span lang=\"EN-GB\">16.     INFORMATION IN BRAILLE</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Justification for not including Braille accepted.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border: none;padding:0in\"><b><span lang=\"EN-GB\">17.     UNIQUE IDENTIFIER – 2D BARCODE</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">2D barcode carrying the unique identifier included.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border: none;padding:0in\"><b><span lang=\"EN-GB\">18.     UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">PC</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">SN</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NN</span></p> <span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif; color:black;background:#CCCCCC\\'><br clear=\"all\" style=\"page-break-before:always\"/> </span> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\"> </span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">VIAL LABEL</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.       NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION</span></b></p> </div> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">Adakveo 10 mg/ml sterile concentrate</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">crizanlizumab</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">IV</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.       METHOD OF ADMINISTRATION</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.       EXPIRY DATE</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.       BATCH NUMBER</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.       CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">100 mg/10 ml</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.       OTHER</span></b></p> </div> <b><span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'><br clear=\"all\" style=\"page-break-before:always\"/> </span></b> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">B. PACKAGE LEAFLET</span></b></p> <span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'><br clear=\"all\" style=\"page-break-before:always\"/> </span> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">Package leaflet: Information for the patient</span></b></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal; background:white\"><span lang=\"EN-GB\"> </span></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">Adakveo 10 mg/ml concentrate for solution for infusion</span></b></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">crizanlizumab</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><img alt=\"BT_1000x858px\" border=\"0\" height=\"18\" id=\"Picture 1\" src=\"Adakveo-4874%20EN%20PI_files/image035.png\" width=\"21\"/><span lang=\"EN-GB\">This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Read all of this leaflet carefully before you are given this medicine because it contains important information for you.</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">Keep this leaflet. You may need to read it again.</span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">If you have any further questions, ask your doctor or nurse.</span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">If you get any side effects, talk to your doctor or nurse.</span><span lang=\"EN-GB\"> This includes any possible side effects not listed in this leaflet. See section 4.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What is in this leaflet</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1.       What Adakveo is and what it is used for</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">2.       What you need to know before you are given Adakveo</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">3.       How Adakveo is given</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">4.       Possible side effects</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">5.       How to store Adakveo</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">6.       Contents of the pack and other information</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">1.       What Adakveo is and what it is used for</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What Adakveo is</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo </span>contains the active substance crizanlizumab, which belongs to a group of medicines called monoclonal antibodies (mAbs).</p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>What Adakveo</b><b> </b><b>is used for</b></p> <p class=\"MsoNormal\" style=\"line-height:normal\">Adakveo is used to prevent recurrent painful crises occurring in patients aged 16 years and over with sickle cell disease. Adakveo can be given in combination with hydroxyurea/hydroxycarbamide, although it may also be used alone.</p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal\">Sickle cell disease is an inherited blood disorder. It causes affected red blood cells to become sickle‑shaped and have difficulty passing through small blood vessels. Additionally in sickle cell disease the blood vessels are damaged and sticky due to ongoing chronic inflammation. This leads to blood cells sticking to the blood vessels, causing acute episodes of pain and organ damage.</p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>How Adakveo works</b></p> <p class=\"MsoNormal\" style=\"line-height:normal\">Patients with sickle cell disease have higher levels of a protein called P‑selectin. Adakveo binds P‑selectin. This should stop blood cells sticking to the vessel walls and help prevent painful crises.</p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal\">If you have any questions about how Adakveo works or why this medicine has been prescribed for you, ask your <a name=\"_Toc312231909\"></a><span lang=\"EN-GB\">doctor or nurse</span>.</p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.       What you need to know before you are given Adakveo</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">You must not be given Adakveo:</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-        if you are allergic to crizanlizumab or any of the other ingredients of this medicine (listed in section 6).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Warnings and precautions</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Infusion reactions</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Medicines of this type (called monoclonal antibodies) are administered into a vein (intravenously) as an infusion. They can cause unwanted reactions (side effects) when they are infused into your body. Such reactions may happen within 24 hours of receiving an infusion.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Tell your doctor or nurse immediately</span></b><span lang=\"EN-GB\"> if you experience any of the following, which may be signs of an infusion reaction:</span></p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">Fever, chills, shivering, nausea, vomiting, tiredness, dizziness, pain where the infusion needle is inserted, blisters, itching, shortness of breath or wheezing. See also section 4, “Possible side effects”.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Your doctor or nurse may monitor you for signs and symptoms of such infusion reactions.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Blood tests during Adakveo treatment</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you need to have any blood tests, tell the doctor or nurse that you are on treatment with Adakveo. This is important because this treatment may interfere with a laboratory test used to measure the number of platelets in your blood.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Children and adolescents</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo </span>should not be used in children or adolescents below 16 years of age.</p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><b>Other medicines and Adakveo</b></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Tell your doctor or nurse if you are taking, have recently taken or might take any other medicines.</p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Pregnancy and breast‑feeding</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Adakveo has not been tested in pregnant women therefore there is limited information about its safety in pregnant women.</p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">If you are pregnant, or are a woman who could become pregnant and is not using contraception, it is not recommended to use Adakveo.</p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">It is not known whether <span lang=\"EN-GB\">Adakveo </span>or its individual ingredients pass into breast milk.</p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">If you are pregnant or breast‑feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before receiving this medicine. Your doctor will discuss with you the potential risk(s) of <span lang=\"EN-GB\">Adakveo </span>during pregnancy or breast‑feeding.</p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Driving and using machines</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Adakveo could have a minor effect on your ability to drive and use machines. If you experience tiredness, drowsiness or dizziness, do not drive or use machines until you feel better.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Adakveo contains sodium</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\">This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially “sodium‑free”.</p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">3.       How Adakveo is given</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Adakveo will be given to you by a doctor or nurse.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you have any questions about how Adakveo is given, ask the doctor or nurse who is giving you the infusion.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Your doctor will tell you when you will have your infusions and follow‑up appointments.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">How much Adakveo you will be given</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The recommended dose is 5 mg per kilogram of body weight. You will be given the first infusion at Week 0 and the second infusion two weeks later (Week 2). After that you will be given an infusion every 4 weeks.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">How the infusion is given</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo is administered into a vein (intravenously) as an infusion lasting 30 minutes.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo can be given alone or with hydroxyurea/hydroxycarbamide.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">How long Adakveo treatment lasts</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">You should discuss with your doctor how long you will need to receive treatment. Your doctor will regularly monitor your condition to check that the treatment is having the desired effect.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">If you forget a Adakveo infusion</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It is very important that you receive all your infusions. If you miss an appointment for an infusion, contact your doctor as soon as possible to reschedule.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">If you stop Adakveo treatment</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not stop Adakveo treatment unless your doctor tells you that you can.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you have any further questions on the use of this medicine, ask your doctor or nurse.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.       Possible side effects</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Like all medicines, this medicine can cause side effects, although not everybody gets them.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:1.5in;text-indent:-1.5in;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Some side effects could be serious</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Tell the doctor or nurse giving you the infusion immediately</span></b><span lang=\"EN-GB\"> if you develop any of the following:</span></p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">Fever, chills, shivering, nausea, vomiting, tiredness, dizziness, pain where the infusion needle is inserted, blisters, itching, shortness of breath or wheezing.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">These symptoms can be signs of infusion reaction, which is a common side effect (this means it may affect up to 1 in every 10 people).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:1.5in;text-indent:-1.5in;line-height: normal;page-break-after:avoid\"><b>Other possible side effects</b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">Other possible side effects include those listed below. If these side effects become severe, tell your doctor or nurse.</p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Very common (may affect more than 1 in 10 people)</b></p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>pain in the joints (arthralgia)</p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>nausea</p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>back pain</p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>fever</p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>pain in the lower or upper abdomen, feeling of tenderness in the abdomen and abdominal discomfort</p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Common (may affect up to 1 in every 10 people)</b></p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>diarrhoea</p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>itching (including vulvovaginal itching)</p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>vomiting</p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>muscle pain (myalgia)</p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>pain in the muscles or bones of the chest (musculoskeletal chest pain)</p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>sore throat (oropharyngeal pain)</p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>redness or swelling and pain at the site of the infusion</p> <p class=\"MsoNormal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><b><span lang=\"EN-GB\">Reporting of side effects</span></b></p> <p class=\"MsoNormal\"><span lang=\"EN-GB\">If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> </span><span lang=\"EN-GB\">You can also report side effects directly via <span style=\"color:black;background:#D9D9D9\">the national reporting system listed in </span></span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:#D9D9D9\">Appendix V</span></a></span><span lang=\"EN-GB\">.</span><span lang=\"EN-GB\"> By reporting side effects you can help provide more information on the safety of this medicine.</span></p> <p class=\"MsoNormal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.       How to store Adakveo</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep this medicine out of the sight and reach of children.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"BodytextAgency\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'>Do not use this medicine after the expiry date which is stated on the outer carton and the label after “EXP”. The expiry date refers to the last day of that month.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep the vial in the outer carton in order to protect from light. Store in a refrigerator (2°C – 8°C). Do not freeze.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Infusion solutions should be used immediately after dilution.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.       Contents of the pack and other information</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What Adakveo contains</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The active substance is crizanlizumab. Each 10 ml vial contains 100 mg of crizanlizumab.</span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The other ingredients are sucrose, sodium citrate </span>(E331)<span lang=\"EN-GB\">, citric acid (E330), polysorbate 80 (E433) and water for injections.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What Adakveo looks like and contents of the pack</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo concentrate for solution for infusion is a colourless to slightly brownish‑yellow liquid.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo is available in packs containing 1 vial.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Marketing Authorisation Holder</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Novartis Europharm Limited</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Vista Building</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Elm Park, Merrion Road</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Dublin 4</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ireland</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Manufacturer</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">Novartis Pharma GmbH</p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">Roonstrasse 25</p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">90429 Nuremberg</p> <p class=\"MsoNormal\" style=\"line-height:normal\">Germany</p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:-1.7pt;border-collapse:collapse\" width=\"0\"> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-BE\">België/Belgique/Belgien</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-BE\">Novartis   Pharma N.V.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-BE\">Tél/Tel: +32 2   246 16 11</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\"> </span></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"LT\">Lietuva</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">SIA Novartis   Baltics Lietuvos filialas</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"LT\">Tel: +370 5 269   16 50</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\"> </span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"BG\">България</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">Novartis Pharma   Services Inc.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"BG\">Тел:</span>   +359 2 489 98 28</p> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NO-BOK\"> </span></b></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Luxembourg/Luxemburg</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis   Pharma N.V.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-BE\">Tél/Tel: +32 2   246 16 11</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-BOK\"> </span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Česká   republika</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">Novartis s.r.o.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +420 225   775 111</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\"> </span></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"HU\">Magyarország</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"HU\">Novartis Hungária   Kft. Pharma</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"HU\">Tel.: +36 1 457   65 00</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b>Danmark</b></p> <p class=\"MsoNormal\" style=\"line-height:normal\">Novartis Healthcare A/S</p> <p class=\"MsoNormal\" style=\"line-height:normal\">Tlf: +45 39 16 84 00</p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"MT\">Malta</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"MT\">Novartis Pharma   Services Inc.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"MT\">Tel: +</span>356 <span lang=\"FR-CH\">2122 2872</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Deutschland</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Novartis Pharma   GmbH</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Tel: +49 911 273   0</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\"> </span></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NL\">Nederland</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NL\">Novartis Pharma   B.V.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NL\">Tel: +31 88 04 52   555</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ET\">Eesti</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">SIA Novartis   Baltics Eesti filiaal</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ET\">Tel: +372 </span><span lang=\"EN-GB\">66 30 810</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ET\"> </span></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NO-BOK\">Norge</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-BOK\">Novartis   Norge AS</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-BOK\">Tlf: +47 23   05 20 00</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EL\">Ελλάδα</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ET\">Novartis (Hellas)   A.E.B.E.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EL\">Τηλ</span><span lang=\"ET\">: +30 210 281 17 12</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ET\"> </span></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-AT\">Österreich</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-AT\">Novartis   Pharma GmbH</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-AT\">Tel: +43 1 86   6570</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">España</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis   Farmacéutica, S.A.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Tel: +34 93 306   42 00</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\"> </span></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PL\">Polska</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PL\">Novartis Poland   Sp. z o.o.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PL\">Tel.: +48 22 375   4888</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR\">France</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">Novartis Pharma   S.A.S.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">Tél: +33 1 55 47   66 00</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR\"> </span></b></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT\">Portugal</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT\">Novartis Farma ‑   Produtos Farmacêuticos, S.A.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT\">Tel: +351 21 000   8600</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Hrvatska</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">Novartis Hrvatska   d.o.o.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel. +385 1   6274 220</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR\"> </span></b></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"FR-CH\">România</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"FR-CH\">Novartis Pharma Services Romania SRL</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\">Tel: +40 21 31299 01</p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis   Ireland Limited</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +353 1   260 12 55</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\"> </span></b></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SL\">Slovenija</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SL\">Novartis Pharma   Services Inc.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SL\">Tel: +386 1 300   75 50</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IS\">Ísland</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IS\">Vistor hf.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sími</span><span lang=\"IS\">: +354 535 7000</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SK\">Slovenská   republika</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SK\">Novartis Slovakia   s.r.o.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SK\">Tel: +421 2 5542   5439</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SK\"> </span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT\">Italia</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT\">Novartis Farma   S.p.A.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">Tel: +39 02 96 54   1</span></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Suomi/Finland</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">Novartis Finland   Oy</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">Puh/Tel: +358 </span><span lang=\"SV\">(0)10 6133 200</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\"> </span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EL\">Κύπρος</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis   Pharma Services Inc.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EL\">Τηλ:   +357 22 690 690</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EL\"> </span></b></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Sverige</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">Novartis Sverige   AB</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">Tel: +46 8 732 32   00</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FI\"> </span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"LV\">Latvija</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">SIA Novartis   Baltics</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"LV\">Tel: +371 67 887   070</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\"> </span></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">United Kingdom</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">Novartis   Pharmaceuticals UK Ltd.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +44 1276   698370</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> </td> </tr> </table> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">This leaflet was last revised in</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicine has been given “conditional approval”. This means that there is more evidence to come about this medicine.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The European Medicines Agency will review new information on this medicine at least every year and this leaflet will be updated as necessary.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Other sources of information</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Detailed information on this medicine is available on the European Medicines Agency web site: </span><span lang=\"EN-GB\"><span class=\"MsoHyperlink\">http://www.ema.europa.eu</span></span></p> <span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'><br clear=\"all\" style=\"page-break-before:always\"/> </span> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">The following information is intended for healthcare professionals only:</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo vials are for single use only.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Preparing the infusion</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The diluted solution for infusion  should be prepared by a healthcare professional using aseptic techniques.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The total dose and required volume of Adakveo depend on the patient’s body weight; 5 mg of crizanlizumab is administered per kg body weight.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">The volume to be used for the preparation of the infusion is calculated according to the following equation:</span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:12.5pt;border-collapse:collapse\" width=\"567\"> <tr> <td rowspan=\"2\" style=\"width:85.05pt;padding:0in 5.4pt 0in 5.4pt\" width=\"113\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Volume (ml) =</span></p> </td> <td style=\"width:269.35pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"359\"> <p align=\"center\" class=\"MsoNormal\" style=\"margin-left:28.35pt;text-align:center;   text-indent:-28.35pt;line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Patient’s body weight (kg) x prescribed dose</span></p> </td> <td style=\"width:70.85pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"94\"> <p align=\"center\" class=\"MsoNormal\" style=\"margin-left:28.35pt;text-align:center;   text-indent:-28.35pt;line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">[5 mg/kg]</span></p> </td> </tr> <tr> <td style=\"width:269.35pt;border:none;padding:0in 5.4pt 0in 5.4pt\" width=\"359\"> <p align=\"center\" class=\"Text\" style=\"margin-top:0in;text-align:center;   page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Concentration   of Adakveo</span></p> </td> <td style=\"width:70.85pt;border:none;padding:0in 5.4pt 0in 5.4pt\" width=\"94\"> <p align=\"center\" class=\"Text\" style=\"margin-top:0in;text-align:center;   page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">[10 mg/ml]</span></p> </td> </tr> </table> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">1.       Obtain the number of vials required to deliver the prescribed dose and bring them to room temperature (for a maximum of 4 hours). One vial is needed for every 10 ml of Adakveo (see below table).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:28.35pt;border-collapse:collapse;border:none\" width=\"568\"> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Body weight (kg)</span></b></p> </td> <td style=\"width:92.15pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Dose (mg)</span></b></p> </td> <td style=\"width:114.75pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Volume (ml)</span></b></p> </td> <td style=\"width:114.75pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Vials (n)</span></b></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">40</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">200</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">20</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">2</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">60</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">300</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">30</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">3</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">80</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">400</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">40</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">4</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">100</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">500</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">50</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">5</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">120</span></p> </td> <td style=\"width:92.15pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">600</span></p> </td> <td style=\"width:114.75pt;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">60</span></p> </td> <td style=\"width:114.75pt;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">6</span></p> </td> </tr> </table> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">2.       Visually inspect the vials.</span></p> <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The solution in the vials should be clear to opalescent. Do not use if particles are present in the solution.</span></p> <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The solution should be colourless or may have a slight brownish‑yellow tint.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">3.       Withdraw a volume equal to the required volume of Adakveo from a 100 ml infusion bag containing either sodium chloride </span><span lang=\"EN-GB\">9 mg/ml (</span><span lang=\"EN-GB\">0.9%) solution for injection or dextrose 5% and discard.</span></p> <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">No incompatibilities between the diluted Adakveo solution and infusion bags composed of polyvinylchloride (PVC), polyethylene (PE) and polypropylene (PP) have been observed.</span></p> <p class=\"MsoNormal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">4.       Withdraw the necessary volume of Adakveo from the vials and inject slowly into the previously prepared infusion bag.</span></p> <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The </span><span lang=\"EN-GB\">solution</span><span lang=\"EN-GB\"> must not be mixed or co‑administered with other medicinal products through the same intravenous line.</span></p> <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">Keep the volume of Adakveo added to the infusion bag in the range of 10 ml to 96 ml to obtain a final concentration in the infusion bag within 1 mg/ml to 9.6 mg/ml.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">5.       Mix the diluted solution by gently inverting the infusion bag. DO NOT SHAKE.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Storage of the diluted solution</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Chemical and physical in‑use stability, from the start of preparation of the diluted solution for infusion until end of infusion, has been demonstrated for up to 8 hours at room temperature (up to 25°C) and at 2°C to 8°C for up to 24 hours overall.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">From a microbiological point of view, the diluted solution for infusion should be used immediately. If not used immediately, in‑use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2°C to 8°C, including 4.5 hours at room temperature (up to 25°C) from the start of preparation to completion of the infusion, unless dilution has taken place in controlled and validated aseptic conditions.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Administration</span></u></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo diluted </span><span lang=\"EN-GB\">solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter</span><span lang=\"EN-GB\"> by intravenous infusion over a period of 30 minutes.</span><span lang=\"EN-GB\"> No incompatibilities have been observed between Adakveo and infusion sets composed of PVC, PE‑lined PVC, polyurethane, and in‑line filter membranes composed of polyethersulfone (PES), polyamide (PA) or polysulphone (PSU).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">After administration of Adakveo, flush the line with at least 25 ml sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5%.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Disposal</span></u></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Any unused product or waste material should be disposed of in accordance with local requirements.</span></p> </div>', 'ID': '583f04cc-251b-4aa9-a300-400d62bebe5a', 'Styles': 'None', 'Classes': \"['WordSection1']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       ', 'ParentId': '1b945380-ed32-477d-bc89-4e43eb629b1e'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '93f99a3a-3bdb-4712-b8a2-7f7151752254', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '37bd41cc-5002-4d0f-b837-d1e612a8c9f4', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'a118066d-62a7-49fe-b164-8dc28660cc13', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '048fcf44-3865-41ad-aa41-6fcf26a64a4e', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c31204d8-633f-4f10-ac97-914fcf46f5d7', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd70aeb25-5d44-4d24-b3ba-df3f0a945409', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e1477684-3361-4ca8-bd48-87fe774951b6', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '6144e956-79cb-4671-935e-0428d8ae9552', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e8d61a67-3455-4013-b0cb-8c6be91e1dd9', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '5ae63bab-fd9f-4543-8da5-95385fe2878a', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '73b2745c-30ea-4c64-8e98-aa6a807ed175', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '7a8d15de-c5dc-49a9-b9f2-c06ea2aa2812', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e4924fc5-14a2-4074-ba07-3827e2690bbe', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '5bbfb234-75ff-4d1b-ba18-79dc786c49a3', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '502e9ac3-58ab-4843-b8a0-5fd60ed4e9c5', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '48f98078-4e9d-4cf6-a2e3-6551b02a5fa4', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '53bfe434-4517-42ce-a813-b71d9f2e38cc', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'b6a38e0b-e4f8-410b-b32a-37629f9e3831', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '6bea775e-8180-4ac2-9e83-683b15a278e5', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd352b40d-10b4-4f2b-8989-ca2a32b8214e', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'cdc7ad58-c7fb-4b77-bcc2-de84faab6ac6', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '68654a8b-654b-47e1-a598-ec1c0860df89', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '7a0e81a8-d56c-4500-b4fc-ed031c115ec5', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX I</span></b></p>', 'ID': 'dd5948fb-58d2-4893-8b10-d805f0cdf739', 'Styles': 'text-align:center;line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': None, 'Text': 'ANNEX I', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '75c81091-3ccc-4ed5-947f-c6995c913347', 'Styles': 'text-align:center;line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">SUMMARY OF PRODUCT CHARACTERISTICS</span></b></p>', 'ID': '70d45c8c-f80d-484f-ace5-16d07806febf', 'Styles': 'text-align:center;line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'SUMMARY OF PRODUCT CHARACTERISTICS', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif; color:green\\'><br clear=\"all\" style=\"page-break-before:always\"/> </span>', 'ID': 'b1cb472e-16b2-4c31-9704-43221d1c8944', 'Styles': 'font-size:11.0pt;font-family:\"Times New Roman\",serif;\\ncolor:green', 'Classes': 'None', 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<br clear=\"all\" style=\"page-break-before:always\"/>', 'ID': '7b7faf20-48a0-43ba-a11c-700ccaf1b44d', 'Styles': 'page-break-before:always', 'Classes': 'None', 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '', 'ParentId': 'b1cb472e-16b2-4c31-9704-43221d1c8944'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><img height=\"18\" src=\"Adakveo-4874%20EN%20PI_files/image001.png\" width=\"21\"/><span lang=\"EN-GB\">This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.</span></p>', 'ID': '5f9f4e00-1c00-4d69-ae60-3b512d354b58', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'f468e77c-8bbb-4e8e-a650-a4bcf4292f4e', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'b6444544-1b61-4ede-bcb4-292a105fdf99', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">1.       NAME OF </span></b><b><span lang=\"EN-GB\">THE MEDICINAL PRODUCT</span></b></p>', 'ID': 'bebd747b-536c-4ae8-b191-86916bb5b392', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L1', 'Text': '1.       NAME OF THE MEDICINAL PRODUCT', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '79944278-5179-4fc2-8e1d-555b0355dd79', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo 10 mg/ml concentrate for solution for infusion</span></p>', 'ID': 'dd38be17-c16a-4a43-bd7d-7d7de217c2ab', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Adakveo 10 mg/ml concentrate for solution for infusion', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '39eb16f8-9ea5-47dc-9002-8f3bf989f47a', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ef09f9ed-de0d-4558-8fb6-f7d64aaf2336', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.       QUALITATIVE AND QUANTITATIVE COMPOSITION</span></b></p>', 'ID': 'fb95db94-3ab2-47ed-860c-1a32343cda09', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L1', 'Text': '2.       QUALITATIVE AND QUANTITATIVE COMPOSITION', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'a2e7bc93-c504-4cf0-a556-8dbc293ae03d', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each ml of concentrate for solution for infusion contains 10 mg crizanlizumab.</span></p>', 'ID': '6b8c14cb-eba7-4ba3-9de8-231605835033', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Each ml of concentrate for solution for infusion contains 10 mg crizanlizumab.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '445c2994-215c-4b60-9e68-58b10b0bebb5', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">One vial of 10 ml contains 100 mg crizanlizumab.</span></p>', 'ID': '86a20c6b-f68b-4371-9f8a-a22986385994', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'One vial of 10 ml contains 100 mg crizanlizumab.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e59ad3b0-fdc0-4860-b4cd-0ffd1f6bbfdc', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab is a monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.</span></p>', 'ID': '9b057f63-8d47-4932-bf02-b2258fe2de4f', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Crizanlizumab is a monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd82f7f95-1ede-431d-a553-e3fb38e6ff28', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For the full list of excipients, see section 6.1.</span></p>', 'ID': '603928f1-93e4-4c02-bb15-6bc6cef996af', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'For the full list of excipients, see section 6.1.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'fba2229a-f0ed-4548-ad90-a381cf1a1782', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'f630af4e-4e7d-4c18-b043-880d0facc0eb', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">3.       PHARMACEUTICAL </span></b><b><span lang=\"EN-GB\" style=\\'font-family:\"Times New Roman Bold\",serif\\'>FORM</span></b></p>', 'ID': 'b61d2001-da27-4ae0-9cd3-4fb666ce3ffe', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L1', 'Text': '3.       PHARMACEUTICAL FORM', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '31b9ed10-5866-4e63-8cca-ce18cc144980', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_Toc259706902\"></a><a name=\"_Toc259707071\"></a><a name=\"_Toc259707134\"></a><a name=\"_Toc259713075\"><span lang=\"EN-GB\">Concentrate for solution for infusion</span></a><span lang=\"EN-GB\"> (sterile concentrate)</span></p>', 'ID': '7d27d913-4b56-4995-9a02-920d4d6d616b', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Concentrate for solution for infusion (sterile concentrate)', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '261b4958-43c7-49b9-9e5a-d08543d24acf', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Colourless to slightly brownish‑yellow liquid at pH 6 and with an osmolality of 300 mOsm/kg.</span></p>', 'ID': '4252fb30-8aea-4a64-969d-9f97eac73b9b', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Colourless to slightly brownish‑yellow liquid at pH 6 and with an osmolality of 300 mOsm/kg.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'b3f0efe9-3876-4e68-b585-60721f1c25ac', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '4bf7be43-25d1-4109-903f-3037ea6db68f', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.       </span></b><b><span lang=\"EN-GB\">CLINICAL</span></b><b><span lang=\"EN-GB\" style=\\'font-family:\"Times New Roman Bold\",serif\\'> PARTICULARS</span></b></p>', 'ID': 'ee1bc075-2c6c-4e05-abb9-4907d5feeb5b', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L1', 'Text': '4.       CLINICAL PARTICULARS', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '32d06a42-9c67-427c-9011-cdfa13ede737', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.1     Therapeutic indications</span></b></p>', 'ID': '0ebcbda6-4e48-4ae4-a098-291a1bbc76ba', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '4.1     Therapeutic indications', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'adf5587b-a53f-430b-817d-38b728fcf75d', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Standard\"><span lang=\"EN-GB\">Adakveo</span><span lang=\"EN-GB\"> is indicated for the prevention of recurrent vaso‑occlusive crises (VOCs) in sickle cell disease patients aged 16 years and older. It can be given as an add‑on therapy to hydroxyurea/hydroxycarbamide (HU/HC) or as monotherapy in patients for whom HU/HC is inappropriate or inadequate.</span></p>', 'ID': '624419e5-aee7-4efc-95aa-caa3b50bc1bc', 'Styles': 'None', 'Classes': \"['Standard']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Adakveo is indicated for the prevention of recurrent vaso‑occlusive crises (VOCs) in sickle cell disease patients aged 16 years and older. It can be given as an add‑on therapy to hydroxyurea/hydroxycarbamide (HU/HC) or as monotherapy in patients for whom HU/HC is inappropriate or inadequate.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '238fb2f2-6728-400a-a31d-0a902b92cac0', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.2     Posology and method of administration</span></b></p>', 'ID': '0ba39624-d328-423e-9451-75729da49f5e', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '4.2     Posology and method of administration', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'b1d7658a-c886-4549-8199-23d497c4cc6b', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Treatment should be initiated by physicians experienced in the management of </span><span lang=\"EN-GB\">sickle cell disease.</span></p>', 'ID': 'b4a4dc54-4b41-43bd-b82f-06ee394b17a2', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Treatment should be initiated by physicians experienced in the management of sickle cell disease.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '86b7bbb5-d14b-4563-8aaf-f1f0b4aaad35', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Posology</span></u><a name=\"_nth_Adults_and_patients_ag4131\"></a></p>', 'ID': '490f404e-fff3-4d71-a062-145a626aa698', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Posology', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e714aa41-f9b5-4f9d-aa85-f59525886d3c', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The recommended dose of crizanlizumab is 5 mg/kg administered over a period of 30 minutes by intravenous infusion at week 0, week 2, and every 4 weeks thereafter.</span></p>', 'ID': 'f658b1e4-66f8-4649-978b-497e69ca133e', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The recommended dose of crizanlizumab is 5 mg/kg administered over a period of 30 minutes by intravenous infusion at week 0, week 2, and every 4 weeks thereafter.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ced5ba42-b690-4da6-8bf6-5d6835f95180', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab </span><span lang=\"EN-GB\">c</span><span lang=\"EN-GB\">an be given alone or with HU/HC.</span></p>', 'ID': '31210945-890b-4725-acdf-a354e5ca32d4', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Crizanlizumab can be given alone or with HU/HC.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '9667ffd4-bc6f-4ff2-87bf-e738f6faabdf', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">If a dose is missed, the treatment should be administered as soon as possible.</span></p>', 'ID': '7973028c-e20f-44d7-8125-8c6ded4f2aec', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['Standard']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'If a dose is missed, the treatment should be administered as soon as possible.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt\"><span style=\"font-size:11.0pt\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span style=\"font-size:11.0pt\">If crizanlizumab is administered within 2 weeks after the missed dose, dosing should be continued according to the patient’s original schedule.</span></p>', 'ID': '1355137f-9392-440f-b76b-893e39322a99', 'Styles': 'margin-top:0in;margin-right:0in;margin-bottom:\\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '-                 If crizanlizumab is administered within 2 weeks after the missed dose, dosing should be continued according to the patient’s original schedule.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt\"><span style=\"font-size:11.0pt\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span style=\"font-size:11.0pt\">If crizanlizumab is administered more than 2 weeks after the missed dose, dosing should be continued every 4 weeks thereafter.</span></p>', 'ID': '2d7b667e-921c-42ad-9bf8-c07eb6611782', 'Styles': 'margin-top:0in;margin-right:0in;margin-bottom:\\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '-                 If crizanlizumab is administered more than 2 weeks after the missed dose, dosing should be continued every 4 weeks thereafter.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '33cb5747-aeff-44e1-a295-f35fdc5df1bf', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Special populations</span></u></i></p>', 'ID': '819e866d-22fe-4467-979b-2965a5b375fb', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': True, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L4', 'Text': 'Special populations', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Elderly</span></i></p>', 'ID': '42987233-13d8-4992-85ad-cd9d26a9e675', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': True, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L4', 'Text': 'Elderly', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab has not been studied in elderly patients. No dose adjustment is required as the pharmacokinetics of crizanlizumab in adults are not affected by age.</span></p>', 'ID': '394675e6-38ca-43f4-8fa4-67bdbdb6ac0b', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Crizanlizumab has not been studied in elderly patients. No dose adjustment is required as the pharmacokinetics of crizanlizumab in adults are not affected by age.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '4116a164-0fb0-41ec-8d4d-980eee909720', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Renal impairment</span></i></p>', 'ID': '38d92515-beef-4580-a9e9-5f343ee60f2c', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': True, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L4', 'Text': 'Renal impairment', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Based on the population pharmacokinetic (PK) results, no dose adjustment is required in patients with mild or moderate renal impairment (see section 5.2). Data from patients with severe renal impairment are too limited to draw conclusions on this population.</span></p>', 'ID': 'f485a522-47e8-4737-9053-6c37b287e4da', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Based on the population pharmacokinetic (PK) results, no dose adjustment is required in patients with mild or moderate renal impairment (see section 5.2). Data from patients with severe renal impairment are too limited to draw conclusions on this population.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '2c251efd-4d57-451f-8e1b-27eaf97ac3ce', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Hepatic impairment</span></i></p>', 'ID': 'd7e68ae4-e1b1-4553-913c-12635b0a51cd', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': True, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L4', 'Text': 'Hepatic impairment', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monoclonal antibody and is cleared via catabolism (i.e. breakdown into peptides and amino acids), and a change in dose is not expected to be required for patients with hepatic impairment (see section</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> </span><span lang=\"EN-GB\">5.2).</span></p>', 'ID': 'cf701288-a867-47a0-925f-00f0a42b647b', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monoclonal antibody and is cleared via catabolism (i.e. breakdown into peptides and amino acids), and a change in dose is not expected to be required for patients with hepatic impairment (see section 5.2).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '9c89d2ad-1586-421e-b9ca-7af854ac5300', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Paediatric population</span></i></p>', 'ID': 'dec049ff-97a9-40cd-87ba-11bdfb9bb5fd', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': True, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L4', 'Text': 'Paediatric population', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Standard\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety and efficacy of </span><span lang=\"EN-GB\">crizanlizumab</span><span lang=\"EN-GB\"> in paediatric patients from 6 months to 16 years have not been established. No data are available.</span></p>', 'ID': '6c18b861-4477-41c9-9ae9-9694f443b12a', 'Styles': 'line-height:normal', 'Classes': \"['Standard']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The safety and efficacy of crizanlizumab in paediatric patients from 6 months to 16 years have not been established. No data are available.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Standard\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '16108ca5-3314-48c6-9284-f29117d61350', 'Styles': 'line-height:normal', 'Classes': \"['Standard']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Standard\" style=\"line-height:normal\"><span lang=\"EN-GB\">There is no relevant use of crizanlizumab in infants aged less than 6 months for the indication of prevention of recurrent vaso‑occlusive crises.</span></p>', 'ID': 'e007eba1-3f30-455b-8bff-f4e949cbfb82', 'Styles': 'line-height:normal', 'Classes': \"['Standard']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'There is no relevant use of crizanlizumab in infants aged less than 6 months for the indication of prevention of recurrent vaso‑occlusive crises.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'dd6230e6-42fb-460b-8a51-7d767a43daab', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Method of administration</span></u></p>', 'ID': '1f6c3414-d7c9-4cf2-aa07-d6c5b237491d', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Method of administration', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '3cb6dfbf-b485-4105-bf8a-beeb14b1cd5b', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo </span><span lang=\"EN-GB\">should be diluted with sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% before administration.</span></p>', 'ID': '90f20e2b-efa4-4ccf-a405-6e5c9d8b7bc6', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Adakveo should be diluted with sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% before administration.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '07bf33aa-2f31-4389-9771-d6b30a85d0e0', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The diluted solution</span><span lang=\"EN-GB\"> must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by intravenous infusion over a period of 30 minutes. It must not be administered by intravenous push or bolus.</span></p>', 'ID': 'e1770234-5bf8-44d0-837b-67f40bdf1237', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The diluted solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by intravenous infusion over a period of 30 minutes. It must not be administered by intravenous push or bolus.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '36d5342e-92b8-4a2e-a040-eca51b686035', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For instructions on dilution of the medicinal product before administration, see section 6.6.</span></p>', 'ID': 'f9f00845-fcc7-4f6b-be21-e64dc59b00c7', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'For instructions on dilution of the medicinal product before administration, see section 6.6.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'a86c67ac-ec53-4b50-a9df-b960de5da5c6', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.3     Contraindications</span></b></p>', 'ID': '1ff14bbd-0749-4766-99c0-ede09b34a7b7', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '4.3     Contraindications', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '10c040f8-ca46-4b5e-8749-4d38a3844796', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.</span></p>', 'ID': '3f6da897-613d-46df-b921-4ba67da45e6b', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hypersensitivity to Chinese Hamster Ovary (CHO) cell products.</span></p>', 'ID': '32559cba-bfd6-4c6e-a7ef-d4aeb35ef35d', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Hypersensitivity to Chinese Hamster Ovary (CHO) cell products.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '58f5b929-00a4-4a69-9e0a-f5ced47c136a', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.4     Special warnings and precautions for use</span></b></p>', 'ID': 'f5687243-13a4-46e0-adc6-415bb3e4afd4', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '4.4     Special warnings and precautions for use', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '31ffed79-5a24-4559-a566-8522af32fb14', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Traceability</span></u></p>', 'ID': 'dffa9fac-aacc-4a81-914f-78b314975780', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Traceability', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> </span></p>', 'ID': 'caf234ef-3b41-4f82-8ed4-bc46d48e7c7e', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.</span></p>', 'ID': '561c67cb-8f9c-4799-85cb-bd886d1151a2', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\"> </span></span></u></p>', 'ID': 'f63d4030-776d-44db-9cc6-74ff75f1134c', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Infusion‑related reactions</span></u></p>', 'ID': '001e00a6-62d2-4a45-a2ad-fab1fe9559c3', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Infusion‑related reactions', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'cb4bce22-89a4-4d8d-8cdd-b672d0c88b93', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In clinical studies, infusion‑related reactions (defined as occurring within 24 hours) were observed in 2 patients (1.8%) treated with crizanlizumab 5 mg/kg</span><span lang=\"EN-GB\">. Patients should be monitored for signs and symptoms of infusion‑related reactions, which may include fever, chills, nausea, vomiting, fatigue, dizziness, pruritus, urticaria, sweating, shortness of breath or wheezing. </span><span lang=\"EN-GB\">In the event of a severe reaction, crizanlizumab should be discontinued and appropriate therapy should be instituted.</span></p>', 'ID': 'a1a23c97-c624-4234-ace8-a766721f187c', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'In clinical studies, infusion‑related reactions (defined as occurring within 24 hours) were observed in 2 patients (1.8%) treated with crizanlizumab 5 mg/kg. Patients should be monitored for signs and symptoms of infusion‑related reactions, which may include fever, chills, nausea, vomiting, fatigue, dizziness, pruritus, urticaria, sweating, shortness of breath or wheezing. In the event of a severe reaction, crizanlizumab should be discontinued and appropriate therapy should be instituted.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'f75c3d59-7a58-45ed-943d-7d8406b98311', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Laboratory test interference: automated platelet counts</span></u></p>', 'ID': '7089a4c2-8b50-4922-b050-9cc7f27af572', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Laboratory test interference: automated platelet counts', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c55563ca-acc4-4553-8c1a-42b9387a9a78', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Interference with automated platelet counts (platelet clumping) has been observed in patients treated with crizanlizumab in clinical studies, in particular when tubes containing EDTA (ethylenediaminetetraacetic acid) were used. This may lead to unevaluable or falsely decreased platelet counts. There is no evidence that crizanlizumab causes a reduction in circulating platelets or has a pro‑aggregant effect <i>in vivo</i>.</span></p>', 'ID': 'defaa2b8-7117-4310-b347-449f40ad24ff', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Interference with automated platelet counts (platelet clumping) has been observed in patients treated with crizanlizumab in clinical studies, in particular when tubes containing EDTA (ethylenediaminetetraacetic acid) were used. This may lead to unevaluable or falsely decreased platelet counts. There is no evidence that crizanlizumab causes a reduction in circulating platelets or has a pro‑aggregant effect in vivo.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '6642c7d0-5706-4a24-9854-a9970510af06', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">To mitigate the potential for laboratory test interference, it is recommended to run the test as soon as possible (within 4 hours of blood collection) or use citrate tubes. When needed, </span><span lang=\"EN-GB\">platelet counts can be estimated via a peripheral blood smear</span><span lang=\"EN-GB\">.</span></p>', 'ID': '5acabf9d-5eae-4f56-8d4c-78dcb8e857c1', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'To mitigate the potential for laboratory test interference, it is recommended to run the test as soon as possible (within 4 hours of blood collection) or use citrate tubes. When needed, platelet counts can be estimated via a peripheral blood smear.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '6c8ceb67-f719-4af2-bc74-70e0294ebb59', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Excipients with known effect</span></u></p>', 'ID': 'eb658930-7124-408c-958f-2862d298f571', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Excipients with known effect', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c9fe79ab-335c-4e9e-9fba-13a4f3bfb5b1', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially “sodium‑free”.</span></p>', 'ID': 'db4cd1d3-f264-43fd-88c0-8d7655c1b47b', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially “sodium‑free”.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '8eb95d23-0d6c-4f26-8a07-679ab8ac0228', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.5     Interaction with other medicinal products and other forms of interaction</span></b></p>', 'ID': '11a2fcce-48eb-45a9-8b97-53ecaaa73d86', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '4.5     Interaction with other medicinal products and other forms of interaction', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c3478606-ac0b-4307-a4bd-638df28244be', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Interactions between crizanlizumab and other medicinal products have not been investigated in dedicated studies.</span></p>', 'ID': 'b9ff00f8-ef92-4508-b24f-5dbf91989902', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Interactions between crizanlizumab and other medicinal products have not been investigated in dedicated studies.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '42abd336-a0eb-44ad-9d11-88de09f8b841', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Monoclonal antibodies are not metabolised by cytochrome P450 (CYP450) enzymes. Therefore, medicinal products that are substrates, inhibitors or inducers of CYP450 are not expected to affect the pharmacokinetics of crizanlizumab. In clinical studies, HU/HC had no effect on crizanlizumab pharmacokinetics in patients.</span></p>', 'ID': '4e8df8f7-0fac-45a5-91ad-05cf93b3622f', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Monoclonal antibodies are not metabolised by cytochrome P450 (CYP450) enzymes. Therefore, medicinal products that are substrates, inhibitors or inducers of CYP450 are not expected to affect the pharmacokinetics of crizanlizumab. In clinical studies, HU/HC had no effect on crizanlizumab pharmacokinetics in patients.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '799d9c0e-6134-4c36-9d6e-aa95272f563e', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No effect on exposure of co‑administered medicinal products is expected based on the metabolic pathways of monoclonal antibodies.</span></p>', 'ID': 'ac9b1575-5662-4fc5-b691-e9ce93b95d88', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'No effect on exposure of co‑administered medicinal products is expected based on the metabolic pathways of monoclonal antibodies.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'aecf1600-19a8-484c-a6c4-f87cfacd1373', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.6     </span></b><b><span lang=\"EN-GB\">Fertility, p</span></b><b><span lang=\"EN-GB\">regnancy and lactation</span></b></p>', 'ID': 'a0f6cfdc-8042-4f0f-9d78-485a5c3c23b8', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '4.6     Fertility, pregnancy and lactation', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '8212b032-0566-40af-b4bd-ce316a313d58', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Pregnancy</span></u></p>', 'ID': '1aaf948b-addf-44cb-883c-1b19ea65cd4c', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Pregnancy', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e92c6478-4a6b-4f59-9269-f8fd7c1dad6b', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Standard\"><span lang=\"EN-GB\">There is a limited amount of data from the use of Adakveo in pregnant women. Based on data from animal studies, crizanlizumab has the potential to cause foetal losses when administered to a pregnant woman (see section 5.3). As a precautionary measure, it is preferable to avoid the use of Adakveo during pregnancy and in woman of childbearing potential not using contraception.</span></p>', 'ID': 'efbd0b19-f586-45e6-8c31-559b7ddbe773', 'Styles': 'None', 'Classes': \"['Standard']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'There is a limited amount of data from the use of Adakveo in pregnant women. Based on data from animal studies, crizanlizumab has the potential to cause foetal losses when administered to a pregnant woman (see section 5.3). As a precautionary measure, it is preferable to avoid the use of Adakveo during pregnancy and in woman of childbearing potential not using contraception.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c669fdac-8dcb-44e1-b338-f22434b3a115', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Standard\" style=\"line-height:normal\">To help determine the effects in pregnant women, healthcare professionals are encouraged to report all pregnancy cases and complications during pregnancy (from 105 days prior to the last menstrual period onward) to <span lang=\"EN-GB\">the local representative of the</span> marketing authorisation holder (see package leaflet), in order to allow monitoring of these patients through the PRegnancy outcomes Intensive Monitoring programme (PRIM). In addition, all adverse pregnancy events should be reported <span lang=\"EN-GB\">via <span style=\"color:black;background:#D9D9D9\">the national reporting system listed in </span></span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:#D9D9D9\">Appendix V</span></a></span>.</p>', 'ID': 'eef5d66e-627a-44e7-a02a-b8539854de99', 'Styles': 'line-height:normal', 'Classes': \"['Standard']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'To help determine the effects in pregnant women, healthcare professionals are encouraged to report all pregnancy cases and complications during pregnancy (from 105 days prior to the last menstrual period onward) to the local representative of the marketing authorisation holder (see package leaflet), in order to allow monitoring of these patients through the PRegnancy outcomes Intensive Monitoring programme (PRIM). In addition, all adverse pregnancy events should be reported via the national reporting system listed in Appendix V.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '0e85539e-1a02-4688-bb24-6e07397dd0de', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Breast‑feeding</span></u></p>', 'ID': 'b96d36fa-6b90-4e0c-85de-47cc7e44b538', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Breast‑feeding', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '925de404-1c57-4456-8a43-4c656c7165cb', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It is unknown whether crizanlizumab is excreted in human milk after administration of Adakveo. There are no data on the effects of crizanlizumab on the breast‑fed newborn/infant or on milk production.</span></p>', 'ID': '7498a234-2fbd-4001-be5a-f3355ad472be', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'It is unknown whether crizanlizumab is excreted in human milk after administration of Adakveo. There are no data on the effects of crizanlizumab on the breast‑fed newborn/infant or on milk production.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '7cfd4607-0430-4511-b02b-066e4be8655a', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Because many medicinal products, including antibodies, can be excreted in human milk, a risk to the newborn/infant cannot be excluded.</span></p>', 'ID': 'e2fb457a-6e5d-47fc-8456-c8f97240e96d', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Because many medicinal products, including antibodies, can be excreted in human milk, a risk to the newborn/infant cannot be excluded.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ae93d231-f8ba-47e6-af36-252c58405866', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">A decision must be made whether to discontinue breast‑feeding or to discontinue Adakveo therapy, taking into account the benefit of breast‑feeding for the child and the benefit of therapy for the woman.</span></p>', 'ID': '92fc3a0b-228c-44b6-b207-f2a812d3484a', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'A decision must be made whether to discontinue breast‑feeding or to discontinue Adakveo therapy, taking into account the benefit of breast‑feeding for the child and the benefit of therapy for the woman.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '02868645-f69f-48cf-bcbe-f15742e8f766', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Fertility</span></u></p>', 'ID': '5d59e941-1027-4d1d-ab03-b568b6674fec', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Fertility', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ca98b45d-98d6-4057-8db7-9b5c039c5cfd', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There are no data on the effect of Adakveo on human fertility. Available non‑clinical data do not suggest an effect on fertility under crizanlizumab treatment (see section 5.3).</span></p>', 'ID': 'a1786285-9b65-4742-ac7e-5ff27e9a199c', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'There are no data on the effect of Adakveo on human fertility. Available non‑clinical data do not suggest an effect on fertility under crizanlizumab treatment (see section 5.3).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"> </p>', 'ID': 'a50561fb-4abd-468d-8584-54156b98e12c', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.7     Effects on ability to drive and use machines</span></b></p>', 'ID': '38069b69-f6df-4f61-9c3a-a75dde9a859d', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '4.7     Effects on ability to drive and use machines', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '871e05ef-31a7-489f-bac3-a2f55dfdde94', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo may have a minor influence on the ability to drive and use machines. Dizziness, fatigue and somnolence may occur following administration of crizanlizumab.</span></p>', 'ID': 'c39dbd51-9328-45a4-bac6-df6d25a7b0bd', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Adakveo may have a minor influence on the ability to drive and use machines. Dizziness, fatigue and somnolence may occur following administration of crizanlizumab.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '357b6cf8-c2d7-42e1-b447-0e411a254e45', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.8     Undesirable effects</span></b></p>', 'ID': 'de8d55e0-de1c-4d68-a1de-9ba6e3db0097', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '4.8     Undesirable effects', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ebce1105-f4bf-482a-a497-471e1a6d1760', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Summary of the safety profile</span></u><a name=\"_nth_Summary_of_the_safety_6118\"></a></p>', 'ID': '88452719-0800-4b2c-96cf-ea5b386f5dd9', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Summary of the safety profile', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd5b72049-2472-41d4-9e03-f6828c98ce07', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The most frequently reported adverse drug reactions (≥10% of patients) in the Adakveo 5 mg/kg group were arthralgia, nausea, back pain, pyrexia and abdominal pain. Severe events were observed for pyrexia and arthralgia (each 0.9%).</span></p>', 'ID': 'c2a9225d-e718-4537-8929-46091366c628', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The most frequently reported adverse drug reactions (≥10% of patients) in the Adakveo 5 mg/kg group were arthralgia, nausea, back pain, pyrexia and abdominal pain. Severe events were observed for pyrexia and arthralgia (each 0.9%).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '00b99e59-7e80-422c-aef1-8e487d552f09', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Tabulated list of adverse reactions</span></u></p>', 'ID': '9e1dffa5-d254-4870-a142-824011ff734a', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Tabulated list of adverse reactions', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '9eb2ea87-aa58-40dc-9578-859810a3ca3a', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Table 1 lists adverse reactions based on pooled data from two studies: the pivotal study, SUSTAIN, and a single‑arm, open‑label pharmacokinetics/pharmacodynamics and safety study. Use of crizanlizumab in combination with HU/HC did not result in any meaningful differences in the safety profile.</span></p>', 'ID': '4d02de8f-c15b-43bc-af6d-ffe87bdf1f88', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Table 1 lists adverse reactions based on pooled data from two studies: the pivotal study, SUSTAIN, and a single‑arm, open‑label pharmacokinetics/pharmacodynamics and safety study. Use of crizanlizumab in combination with HU/HC did not result in any meaningful differences in the safety profile.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '3ccb923f-936e-4539-858f-f4e4013c9548', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Within each system organ class, the adverse reactions are ranked by frequency, with the most frequent reactions first. Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness. In addition, the corresponding frequency category for each adverse reaction is based on the following convention: very common (≥1/10); common (≥1/100 to &lt;1/10); uncommon (≥1/1,000 to &lt;1/100); rare (≥1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000).</span></p>', 'ID': 'dd4a838f-4247-40fc-b3ad-7a1ea745661a', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Within each system organ class, the adverse reactions are ranked by frequency, with the most frequent reactions first. Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness. In addition, the corresponding frequency category for each adverse reaction is based on the following convention: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '987733b6-745e-47c1-ab4a-d39014ea48b4', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><a name=\"_Toc272145403\"></a><a name=\"_Toc272145564\"></a><a name=\"_Toc266768477\"></a><a name=\"_Toc260903679\"></a><a name=\"_Toc266264818\"></a><a name=\"_Toc499550967\"></a><a name=\"_Toc517716325\"><b><span lang=\"EN-GB\">Table 1       Adverse reactions in clinical studies</span></b></a><a name=\"_hd6_Table_7_1_Percentage_o7395\"></a></p>', 'ID': '12293b6d-27fc-4f51-a392-aa1d0ab58450', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Table 1       Adverse reactions in clinical studies', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'adae8cec-c15f-466c-87a5-d9edcbc7decd', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:459.0pt;border-collapse:collapse;border:none\" width=\"612\"> <tr style=\"page-break-inside:avoid\"> <td style=\"width:175.5pt;border:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt\">System organ class</span></b></p> </td> <td style=\"width:81.0pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Frequency</span></b></p> </td> <td style=\"width:202.5pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Adverse reaction</span></b></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Respiratory, thoracic and   mediastinal disorders</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Oropharyngeal pain</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td rowspan=\"2\" style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Gastrointestinal disorders</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Very common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Nausea, abdominal pain*</span></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:13.45pt\"> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:13.45pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:13.45pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">D</span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">iarrhoea, vomiting</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Skin and subcutaneous tissue   disorders</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Pruritus*</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td rowspan=\"2\" style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Musculoskeletal and   connective tissue disorders</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Very common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Arthralgia, back pain</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Myalgia, musculoskeletal   chest pain</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td rowspan=\"2\" style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">General disorders and   administration site conditions</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Very common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Pyrexia</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Infusion site reaction*</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Injury, poisoning and   procedural complications</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Infusion‑related   reaction</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td colspan=\"3\" style=\"width:459.0pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"612\"> <p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style=\\'font-family:\"Times New Roman\",serif\\'>*The   following groupings contain the following MedDRA preferred terms:</span></p> <p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;   margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\\'font-family:   \"Times New Roman\",serif\\'>-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                   </span></span><span lang=\"EN-GB\" style=\\'font-family:\"Times New Roman\",serif\\'>Abdominal   pain: abdominal pain, abdominal pain upper, abdominal pain lower, abdominal   discomfort, and abdominal tenderness</span></p> <p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;   margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"FR-CH\" style=\\'font-family:   \"Times New Roman\",serif\\'>-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                   </span></span><span lang=\"EN-GB\" style=\\'font-family:\"Times New Roman\",serif\\'>Pruritus:   pruritus and vulvovaginal pruritus</span></p> <p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;   margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\\'font-size:   11.0pt;font-family:\"Times New Roman\",serif\\'>-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                   </span></span><span lang=\"FR-CH\" style=\\'font-family:\"Times New Roman\",serif\\'>Infusion   site reaction: infusion site extravasation, infusion site pain, and infusion   site swelling</span></p> </td> </tr> </table>', 'ID': '68495d94-1d08-4794-a87d-6fdb37a548f5', 'Styles': 'width:459.0pt;border-collapse:collapse;border:none', 'Classes': \"['MsoNormalTable']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '   System organ class   Frequency   Adverse reaction     Respiratory, thoracic and   mediastinal disorders   Common   Oropharyngeal pain     Gastrointestinal disorders   Very common   Nausea, abdominal pain*     Common   Diarrhoea, vomiting     Skin and subcutaneous tissue   disorders   Common   Pruritus*     Musculoskeletal and   connective tissue disorders   Very common   Arthralgia, back pain     Common   Myalgia, musculoskeletal   chest pain     General disorders and   administration site conditions   Very common   Pyrexia     Common   Infusion site reaction*     Injury, poisoning and   procedural complications   Common   Infusion‑related   reaction     *The   following groupings contain the following MedDRA preferred terms: -                   Abdominal   pain: abdominal pain, abdominal pain upper, abdominal pain lower, abdominal   discomfort, and abdominal tenderness -                   Pruritus:   pruritus and vulvovaginal pruritus -                   Infusion   site reaction: infusion site extravasation, infusion site pain, and infusion   site swelling   ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p>', 'ID': '5500d36a-5762-434c-8892-bf87d0e7f820', 'Styles': 'margin-top:0in;text-align:left', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Description of selected adverse reactions</span></u></p>', 'ID': '0636c563-9390-400f-9ab3-5889e217a728', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Description of selected adverse reactions', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after: avoid\"><span style=\"font-size:11.0pt\"> </span></p>', 'ID': 'f1b0b323-4845-48bd-9022-8b3498e12b3c', 'Styles': 'margin-top:0in;text-align:left;page-break-after:\\navoid', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after: avoid\"><i><u><span style=\"font-size:11.0pt\">Immunogenicity</span></u></i></p>', 'ID': '3598871e-6274-45f3-a079-92e6a6cc0f4b', 'Styles': 'margin-top:0in;text-align:left;page-break-after:\\navoid', 'Classes': \"['Text']\", 'Bold': False, 'Italics': True, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L4', 'Text': 'Immunogenicity', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">In clinical studies, treatment‑induced anti‑crizanlizumab antibodies were transiently detected in 1 patient (0.9%) among the 111 patients who received Adakveo 5 mg/kg.</span></p>', 'ID': 'd1523c7d-682b-40c5-a31d-0ed3c856ad76', 'Styles': 'margin-top:0in;text-align:left', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'In clinical studies, treatment‑induced anti‑crizanlizumab antibodies were transiently detected in 1 patient (0.9%) among the 111 patients who received Adakveo 5 mg/kg.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p>', 'ID': 'd3b08430-cd24-4b17-aeb5-65cd8c0fa6da', 'Styles': 'margin-top:0in;text-align:left', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">There was no evidence of altered pharmacokinetics or of an altered safety profile with anti‑crizanlizumab antibody development.</span></p>', 'ID': '06a145f3-a3b6-468f-9569-9c66e32cdd40', 'Styles': 'margin-top:0in;text-align:left', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'There was no evidence of altered pharmacokinetics or of an altered safety profile with anti‑crizanlizumab antibody development.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p>', 'ID': 'da312712-3361-43b0-8cb8-ebe00c656f19', 'Styles': 'margin-top:0in;text-align:left', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Paediatric population</span></u></p>', 'ID': 'b24ce283-43d1-4609-a14a-ce76aefeb6ea', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['Standard']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Paediatric population', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '837beffa-4df5-46b3-9e30-c2df0b2c0859', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['Standard']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">Frequency, type and severity of adverse reactions in patients aged 16 and 17 years are expected to be the same as in adults. The safety of crizanlizumab was evaluated in 3 patients aged &lt;18 years.</span></p>', 'ID': '440ff73a-8907-4923-a5dc-f3b4ccebeec9', 'Styles': 'margin-top:0in;text-align:left', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Frequency, type and severity of adverse reactions in patients aged 16 and 17 years are expected to be the same as in adults. The safety of crizanlizumab was evaluated in 3 patients aged <18 years.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p>', 'ID': '58b0b3ed-6191-4566-9d5d-bffd88dd7d08', 'Styles': 'margin-top:0in;text-align:left', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Reporting of suspected adverse reactions</span></u></p>', 'ID': '9a48cf61-c759-4667-ae82-3fe92599ba09', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Reporting of suspected adverse reactions', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '37538e84-41d5-4dd8-a4f1-8f9d7515630d', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via <span style=\"color:black; background:#D9D9D9\">the national reporting system listed in </span></span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:#D9D9D9\">Appendix V</span></a></span><span lang=\"EN-GB\">.</span></p>', 'ID': 'bdd4a612-1b71-48af-bb4d-b6992a0d727d', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '2d6e4e03-57ab-41aa-8bb6-50da47e524a1', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.9     Overdose</span></b></p>', 'ID': 'd64d220d-681c-41cc-be35-d2388b0fe2af', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '4.9     Overdose', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '81f7f5c9-3aa9-4ca9-a6e4-18ff45f702a1', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">No cases of overdose have been reported in clinical studies.</span></p>', 'ID': 'be23a4ff-636e-4419-a2b4-53c8da85fba7', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'No cases of overdose have been reported in clinical studies.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd95c745f-4632-4816-93a3-bf5315fb6186', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">General supportive measures and symptomatic treatment should be initiated in cases of suspected overdose.</span></p>', 'ID': '6c217e0b-6104-473f-89d1-138ec1d858ea', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'General supportive measures and symptomatic treatment should be initiated in cases of suspected overdose.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '9021bd02-b10e-4f7a-8d6f-8607a943d54d', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '05b4dc55-ce07-49e7-98d0-d74847496bdc', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.       PHARMACOLOGICAL PROPERTIES</span></b></p>', 'ID': '764acee4-ad8f-4679-bfd8-2d754f01ab88', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L1', 'Text': '5.       PHARMACOLOGICAL PROPERTIES', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '2e81c580-64f0-479b-baac-f7989c2f399c', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.1     Pharmacodynamic properties</span></b></p>', 'ID': 'a6d0a699-c8cf-4a9f-9667-b8f6e4efe584', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '5.1     Pharmacodynamic properties', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'b2231afc-7779-4625-8ac4-2819167847b6', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Pharmacotherapeutic group: Other haematological agents, ATC code: B06AX01</span></p>', 'ID': '38b60d54-b880-4fc5-a4f4-89ce63aeb5ce', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Pharmacotherapeutic group: Other haematological agents, ATC code: B06AX01', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '15ae06a0-6e38-48b6-9b98-796008d0a290', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Mechanism of action</span></u></p>', 'ID': 'fc5ac450-265a-4a49-92fd-94f18063c6e8', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Mechanism of action', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '1dd00aad-f767-4d29-ab47-a0ece231bb21', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Crizanlizumab is a selective IgG2 kappa humanised monoclonal antibody (mAb) that binds to P‑selectin with high affinity and blocks the interaction with its ligands, including P‑selectin glycoprotein ligand 1. </span><span lang=\"EN-GB\">Crizanlizumab can also dissociate preformed P‑selectin/PSGL‑1 complex. </span><span lang=\"EN-GB\">P‑selectin is an adhesion molecule expressed on activated endothelial cells and platelets. It plays an essential role in the initial recruitment of leukocytes and the aggregation of platelets to the site of vascular injury during inflammation. In the chronic pro‑inflammatory state associated with sickle cell disease, P‑selectin is over‑expressed and circulating blood cells and the endothelium are activated and become hyperadhesive. P‑selectin‑mediated multi‑cellular adhesion is a key factor in the pathogenesis of vaso‑occlusion and vaso‑occlusive crises (VOC). Elevated levels of P‑selectin are found in patients with sickle cell disease.</span></p>', 'ID': 'e7c2423f-a48a-414c-9bbd-4c511efdb528', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Crizanlizumab is a selective IgG2 kappa humanised monoclonal antibody (mAb) that binds to P‑selectin with high affinity and blocks the interaction with its ligands, including P‑selectin glycoprotein ligand 1. Crizanlizumab can also dissociate preformed P‑selectin/PSGL‑1 complex. P‑selectin is an adhesion molecule expressed on activated endothelial cells and platelets. It plays an essential role in the initial recruitment of leukocytes and the aggregation of platelets to the site of vascular injury during inflammation. In the chronic pro‑inflammatory state associated with sickle cell disease, P‑selectin is over‑expressed and circulating blood cells and the endothelium are activated and become hyperadhesive. P‑selectin‑mediated multi‑cellular adhesion is a key factor in the pathogenesis of vaso‑occlusion and vaso‑occlusive crises (VOC). Elevated levels of P‑selectin are found in patients with sickle cell disease.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '95bd2fe7-3442-4e6d-b591-1f836f48ae21', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Binding P‑selectin on the surface of the activated endothelium and platelets has been shown to effectively block interactions between endothelial cells, platelets, red blood cells and leukocytes, thereby preventing vaso‑occlusion.</span></p>', 'ID': '71575f83-7664-4637-beb1-6a5b97c16cfe', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Binding P‑selectin on the surface of the activated endothelium and platelets has been shown to effectively block interactions between endothelial cells, platelets, red blood cells and leukocytes, thereby preventing vaso‑occlusion.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '0d50548f-2482-4f8b-abd3-321304018d5f', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Pharmacodynamic effects</span></u></p>', 'ID': 'ab71b0bc-5a25-48a4-a89f-1f17e668aa1a', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Pharmacodynamic effects', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '4dd078ae-806b-4e3a-a55b-2b2c2bc1df57', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Throughout clinical studies, treatment with crizanlizumab 5 mg/kg resulted in dose‑dependent, immediate and sustained P‑selectin inhibition </span><span lang=\"EN-GB\">(as measured <i>ex vivo</i>) </span><span lang=\"EN-GB\">in patients with sickle cell disease.</span></p>', 'ID': 'f3912285-4b05-4670-a041-77eca738249c', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Throughout clinical studies, treatment with crizanlizumab 5 mg/kg resulted in dose‑dependent, immediate and sustained P‑selectin inhibition (as measured ex vivo) in patients with sickle cell disease.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '22741a98-5799-4d6d-92ac-9aa31e592b25', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Clinical efficacy and safety</span></u></p>', 'ID': '472a0d46-f38f-4b06-9377-8b14a1ca58ab', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Clinical efficacy and safety', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"> </p>', 'ID': '9abf657f-4184-406f-9882-ccdafe7d62df', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The efficacy of crizanlizumab, with or without HU/HC, was evaluated in the pivotal study SUSTAIN, a 52‑week, randomised, placebo‑controlled, double‑blind, multicentre clinical study in sickle cell disease patients with a history of vaso‑occlusive crises (VOCs).</span></p>', 'ID': '06f14b6a-445d-4929-b3f9-42c7c98bd689', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The efficacy of crizanlizumab, with or without HU/HC, was evaluated in the pivotal study SUSTAIN, a 52‑week, randomised, placebo‑controlled, double‑blind, multicentre clinical study in sickle cell disease patients with a history of vaso‑occlusive crises (VOCs).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '1cfceb45-f752-4744-add7-e75fc2b30f0d', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In this study, VOCs were defined as those leading to a healthcare visit, which captured all acute episodes of pain with no other cause than a vaso‑occlusive event that required a healthcare visit and treatment with oral or parenteral opioids or parenteral non‑steroidal anti‑inflammatory drugs (NSAIDs). Acute chest syndrome, hepatic sequestration, splenic sequestration and priapism (requiring a healthcare visit), by definition, were also considered VOCs.</span></p>', 'ID': 'f2a0e2c1-e6bd-40b3-b1f9-a3b59362d87d', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'In this study, VOCs were defined as those leading to a healthcare visit, which captured all acute episodes of pain with no other cause than a vaso‑occlusive event that required a healthcare visit and treatment with oral or parenteral opioids or parenteral non‑steroidal anti‑inflammatory drugs (NSAIDs). Acute chest syndrome, hepatic sequestration, splenic sequestration and priapism (requiring a healthcare visit), by definition, were also considered VOCs.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '746abb46-4321-4390-a3d1-57628c87ee75', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">A total of 198 sickle cell disease patients aged 16 to 63 years (inclusive; mean age 30.1±10.3 years), with any sickle cell disease genotype (including HbSS [71.2%], HbSC [16.2%], HbSbeta0‑thalassaemia [6.1%], HbSbeta+‑thalassaemia [5.1%], and others [1.5%]) and a history of between 2 and 10 VOCs in the previous 12 months (62.6% and 37.4% of the patients had 2‑4 or 5‑10 VOCs, respectively), were randomised 1:1:1 to Adakveo 5 mg/kg, Adakveo 2.5 mg/kg or placebo. The majority of patients were Black or African American (91.9%). Patients received Adakveo with (62.1%) or without (37.9%) HU/HC. Randomisation was stratified by patients already receiving HU/HC (Y/N) and by number of VOCs in the previous 12 months (2 to 4, 5 to 10). Patients were allowed to take medicinal products to relieve pain (i.e. paracetamol, NSAIDs and opioids) and to receive occasional transfusions on an “as needed” basis. Patients participating in a chronic transfusion programme (pre-planned series of transfusions for prophylactic purposes) were excluded from the study.</span></p>', 'ID': '9df75617-c6d9-4284-99eb-9c6d286028ea', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'A total of 198 sickle cell disease patients aged 16 to 63 years (inclusive; mean age 30.1±10.3 years), with any sickle cell disease genotype (including HbSS [71.2%], HbSC [16.2%], HbSbeta0‑thalassaemia [6.1%], HbSbeta+‑thalassaemia [5.1%], and others [1.5%]) and a history of between 2 and 10 VOCs in the previous 12 months (62.6% and 37.4% of the patients had 2‑4 or 5‑10 VOCs, respectively), were randomised 1:1:1 to Adakveo 5 mg/kg, Adakveo 2.5 mg/kg or placebo. The majority of patients were Black or African American (91.9%). Patients received Adakveo with (62.1%) or without (37.9%) HU/HC. Randomisation was stratified by patients already receiving HU/HC (Y/N) and by number of VOCs in the previous 12 months (2 to 4, 5 to 10). Patients were allowed to take medicinal products to relieve pain (i.e. paracetamol, NSAIDs and opioids) and to receive occasional transfusions on an “as needed” basis. Patients participating in a chronic transfusion programme (pre-planned series of transfusions for prophylactic purposes) were excluded from the study.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '8a5bfeed-92a7-4157-aa23-5e8d782ee2f3', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Treatment with Adakveo 5 mg/kg resulted in a 45.3% lower median annual rate of VOCs compared to placebo (Hodges‑Lehmann, median absolute difference of ‑1.01 compared with placebo, 95% CI [‑2.00, 0.00]), which was statistically significant (p=0.010). The median annual rates of uncomplicated VOCs (any VOCs as defined above, excluding acute chest syndrome, hepatic sequestration, splenic sequestration or priapism) and days hospitalised were 62.9% and 41.8% lower in the Adakveo 5 mg/kg than in the placebo group, respectively. The VOCs occurring during the study were assessed by an independent review committee.</span></p>', 'ID': '26b32385-ff0c-468c-8156-48e4ea2e5632', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Treatment with Adakveo 5 mg/kg resulted in a 45.3% lower median annual rate of VOCs compared to placebo (Hodges‑Lehmann, median absolute difference of ‑1.01 compared with placebo, 95% CI [‑2.00, 0.00]), which was statistically significant (p=0.010). The median annual rates of uncomplicated VOCs (any VOCs as defined above, excluding acute chest syndrome, hepatic sequestration, splenic sequestration or priapism) and days hospitalised were 62.9% and 41.8% lower in the Adakveo 5 mg/kg than in the placebo group, respectively. The VOCs occurring during the study were assessed by an independent review committee.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ddc462b4-8779-4b40-b2cd-13c11a5c35ea', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Main efficacy outcomes of the pivotal SUSTAIN study are summarised in Tables 2 and 3.</span></p>', 'ID': 'f00331f9-91ee-4ffc-9f5b-c7b8d020d857', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Main efficacy outcomes of the pivotal SUSTAIN study are summarised in Tables 2 and 3.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'cc21ce0f-b181-4775-ad96-2bb33aad2435', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><a name=\"_Toc499550968\"></a><a name=\"_Toc517716326\"><b><span lang=\"EN-GB\">Table </span></b></a><b><span lang=\"EN-GB\">2       Results from SUSTAIN clinical study in </span></b><a name=\"_hd6_Table_12_1_Results_fro16811\"></a><b><span lang=\"EN-GB\">sickle cell disease</span></b></p>', 'ID': 'c9fea0dd-a255-4ab8-957b-4a237116ff85', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Table 2       Results from SUSTAIN clinical study in sickle cell disease', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '5ff0994f-3178-439a-a684-c5b18e0ff720', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:98.84%;border-collapse:collapse;border:none\" width=\"98%\"> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <td style=\"width:20.16%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"20%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Event</span></b></p> </td> <td style=\"width:23.82%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"23%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Adakveo 5 mg/kg</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">(N=67)</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(standard median)</span></p> </td> <td style=\"width:11.54%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"11%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Placebo</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">(N=65)</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(standard median)</span></p> </td> <td style=\"width:10.46%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"10%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Change vs placebo</span></b></p> </td> <td style=\"width:21.1%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"21%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Hodges‑Lehmann median   difference</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(95% CI)</span></p> </td> <td style=\"width:12.9%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"12%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">p-value</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(Wilcoxon rank sum)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <td style=\"width:20.18%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"20%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Primary endpoint</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Annual rate of VOCs</span></p> </td> <td style=\"width:23.82%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"23%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.63</span></p> </td> <td style=\"width:11.54%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"11%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.98</span></p> </td> <td style=\"width:10.46%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"10%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑45.3%</span></p> </td> <td style=\"width:21.1%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"21%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.01</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑2.00, 0.00)</span></p> </td> <td style=\"width:12.9%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"12%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">0.010</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td colspan=\"5\" style=\"width:87.1%;border:none;   border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"87%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Secondary endpoints</span></b></p> </td> <td style=\"width:12.9%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"12%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\"> </span></b></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <td style=\"width:20.18%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"20%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Annual rate of days hospitalised</span></p> </td> <td style=\"width:23.82%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"23%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">4.00</span></p> </td> <td style=\"width:11.54%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"11%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">6.87</span></p> </td> <td style=\"width:10.46%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"10%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑41.8%</span></p> </td> <td style=\"width:21.1%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"21%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">0.00</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑4.36, 0.00)</span></p> </td> <td style=\"width:12.9%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"12%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">0.450</span></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <td style=\"width:20.18%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"20%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Annual rate of uncomplicated VOCs</span></p> </td> <td style=\"width:23.82%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"23%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.08</span></p> </td> <td style=\"width:11.54%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"11%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.91</span></p> </td> <td style=\"width:10.46%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"10%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑62.9%</span></p> </td> <td style=\"width:21.1%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"21%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.00</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑1.98, 0.00)</span></p> </td> <td style=\"width:12.9%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"12%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">-</span></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <td colspan=\"6\" style=\"width:.02%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"0%\"> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">The primary (annual rate of VOC leading   to healthcare visit) and key secondary (annual rate of days hospitalised)   endpoints were the only ones formally tested for statistical significance   according to protocol.</span></p> </td> </tr> </table>', 'ID': 'f6602db2-bba7-4d09-be01-924009293f42', 'Styles': 'width:98.84%;border-collapse:collapse;border:none', 'Classes': \"['MsoNormalTable']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '   Event   Adakveo 5 mg/kg (N=67) (standard median)   Placebo (N=65) (standard median)   Change vs placebo   Hodges‑Lehmann median   difference (95% CI)   p-value (Wilcoxon rank sum)     Primary endpoint Annual rate of VOCs   1.63   2.98   ‑45.3%   ‑1.01 (‑2.00, 0.00)   0.010     Secondary endpoints         Annual rate of days hospitalised   4.00   6.87   ‑41.8%   0.00 (‑4.36, 0.00)   0.450     Annual rate of uncomplicated VOCs   1.08   2.91   ‑62.9%   ‑1.00 (‑1.98, 0.00)   -     The primary (annual rate of VOC leading   to healthcare visit) and key secondary (annual rate of days hospitalised)   endpoints were the only ones formally tested for statistical significance   according to protocol.   ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '6d24b1e8-7bcc-499b-9560-8630cab90afd', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\"><span lang=\"EN-GB\">The clinical effect demonstrated in the primary efficacy analysis was supported by multiple supplementary analyses including a negative binomial regression on investigator assessments with a conservative method to handle missing data due to early discontinuation of treatment based on outcomes in the placebo group (RR=0.74, 95% CI=0.52, 1.06).</span></p>', 'ID': '55a081a7-69be-4ffb-aade-5eaf29f54a50', 'Styles': 'None', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The clinical effect demonstrated in the primary efficacy analysis was supported by multiple supplementary analyses including a negative binomial regression on investigator assessments with a conservative method to handle missing data due to early discontinuation of treatment based on outcomes in the placebo group (RR=0.74, 95% CI=0.52, 1.06).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"> </p>', 'ID': '90069808-d21a-40db-a5cb-79185d63ea1e', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In the Adakveo 5 mg/kg group, clinically significant reductions in the annual rate of VOCs were observed across important subgroups (</span><span lang=\"EN-GB\">HU/HC use, 2‑4 or 5‑10 VOCs in the previous 12 months, and HbSS or non‑HbSS genotypes; </span><span lang=\"EN-GB\">see Table 3).</span></p>', 'ID': '06133542-b88f-49aa-8c7f-5dbcc0f276bb', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'In the Adakveo 5 mg/kg group, clinically significant reductions in the annual rate of VOCs were observed across important subgroups (HU/HC use, 2‑4 or 5‑10 VOCs in the previous 12 months, and HbSS or non‑HbSS genotypes; see Table 3).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '40863246-ddd2-434e-9fcc-3f487cc6f3c0', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><b><span lang=\"EN-GB\">Table 3       Annual rate of VOCs in patients ‑ subgroup analyses</span></b></p>', 'ID': '0f55922a-bcc3-477f-8e53-b7b1c53ba65a', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Table 3       Annual rate of VOCs in patients ‑ subgroup analyses', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ba08dd82-6928-449e-b2bf-28bfc45990b6', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"612\"> <tr style=\"page-break-inside:avoid\"> <td style=\"width:90.45pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"121\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Subgroup </span></b></p> </td> <td style=\"width:63.8pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\"> </span></b></p> </td> <td style=\"width:70.85pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Adakveo 5 mg/kg (N=67)</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(standard median)</span></p> </td> <td style=\"width:63.8pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Placebo (N=65)</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(standard median)</span></p> </td> <td style=\"width:63.8pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Change vs placebo</span></b></p> </td> <td style=\"width:106.3pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Hodges‑Lehmann median   difference</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">(95% CI)</span></b></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td rowspan=\"2\" style=\"width:90.45pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"121\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">HU/HC use</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Yes</span></p> </td> <td style=\"width:70.85pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=42</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.43</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n= 40</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">3.58</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑32.1%</span></p> </td> <td style=\"width:106.3pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.01</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑2.44, 0.00)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">No</span></p> </td> <td style=\"width:70.85pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=25</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.00</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=25</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.00</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑50.0%</span></p> </td> <td style=\"width:106.3pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.02</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑2.00, 0.00)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:20.2pt\"> <td rowspan=\"2\" style=\"width:90.45pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:20.2pt\" width=\"121\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Number of VOCs in previous   12 months</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:20.2pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2‑4 VOCs</span></p> </td> <td style=\"width:70.85pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:20.2pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=42</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.14</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:20.2pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=41</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.00</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:20.2pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑43.0%</span></p> </td> <td style=\"width:106.3pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:20.2pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑0.05</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑1.56, 0.01)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">5‑10 VOCs</span></p> </td> <td style=\"width:70.85pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=25</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.97</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=24</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">5.32</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑63.0%</span></p> </td> <td style=\"width:106.3pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑2.74</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑5.00, ‑0.83)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td rowspan=\"2\" style=\"width:90.45pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"121\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Sickle cell disease genotypes,   including HbSC</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">HbSS</span></p> </td> <td style=\"width:70.85pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=47</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.97</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=47</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">3.01</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑34.6%</span></p> </td> <td style=\"width:106.3pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.01</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑2.18, 0.00)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Non‑HbSS</span></p> </td> <td style=\"width:70.85pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=20</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">0.99</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=18</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.00</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑50.5%</span></p> </td> <td style=\"width:106.3pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.01</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑2.01, 0.00)</span></p> </td> </tr> </table>', 'ID': '306055ba-c099-4738-bafa-dedc95f5c4e5', 'Styles': 'border-collapse:collapse;border:none', 'Classes': \"['MsoNormalTable']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '   Subgroup        Adakveo 5 mg/kg (N=67) (standard median)   Placebo (N=65) (standard median)   Change vs placebo   Hodges‑Lehmann median   difference (95% CI)     HU/HC use   Yes   n=42 2.43   n= 40 3.58   ‑32.1%   ‑1.01 (‑2.44, 0.00)     No   n=25 1.00   n=25 2.00   ‑50.0%   ‑1.02 (‑2.00, 0.00)     Number of VOCs in previous   12 months   2‑4 VOCs   n=42 1.14   n=41 2.00   ‑43.0%   ‑0.05 (‑1.56, 0.01)     5‑10 VOCs   n=25 1.97   n=24 5.32   ‑63.0%   ‑2.74 (‑5.00, ‑0.83)     Sickle cell disease genotypes,   including HbSC   HbSS   n=47 1.97   n=47 3.01   ‑34.6%   ‑1.01 (‑2.18, 0.00)     Non‑HbSS   n=20 0.99   n=18 2.00   ‑50.5%   ‑1.01 (‑2.01, 0.00)   ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c2b709f0-86b2-4fa9-98d3-6988b154be09', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">A greater than two‑fold increase in the proportion of patients with no VOC and who completed the study was observed in the Adakveo 5 mg/kg group compared to placebo (22% vs 8%; odds ratio [95% CI]: 3.57 [1.20, 10.63]). A similar difference was also observed across important subgroups (HU/HC use, genotype).</span></p>', 'ID': 'da5c88f0-dcea-4689-938e-3c1b93d7a754', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'A greater than two‑fold increase in the proportion of patients with no VOC and who completed the study was observed in the Adakveo 5 mg/kg group compared to placebo (22% vs 8%; odds ratio [95% CI]: 3.57 [1.20, 10.63]). A similar difference was also observed across important subgroups (HU/HC use, genotype).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '5208b575-d8b9-4b18-981d-40fcf95b2b71', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Treatment with Adakveo 5 mg/kg was also associated with a three‑fold longer Kaplan‑Meier estimated median time to first VOC compared with placebo (4.07 vs 1.38 months; HR=0.495, 95% CI: 0.331, 0.741) (Figure 1) and a two‑fold longer median time from randomisation to second VOC compared to placebo (10.32 vs 5.09 months; HR=0.534, 95% CI: 0.329, 0.866).</span></p>', 'ID': '976c04c1-4a00-4a08-af6a-eb33f16cc272', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Treatment with Adakveo 5 mg/kg was also associated with a three‑fold longer Kaplan‑Meier estimated median time to first VOC compared with placebo (4.07 vs 1.38 months; HR=0.495, 95% CI: 0.331, 0.741) (Figure 1) and a two‑fold longer median time from randomisation to second VOC compared to placebo (10.32 vs 5.09 months; HR=0.534, 95% CI: 0.329, 0.866).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '94b4115a-655a-4aea-9954-cf0f835aecee', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Figure 1      Kaplan‑Meier curve of time to first VOC</span></b></p>', 'ID': 'ea96e98a-b631-443f-a2a7-37382a04f305', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Figure 1      Kaplan‑Meier curve of time to first VOC', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '8d4fe1ee-a863-42e2-bef0-564ff21f6c0b', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><span style=\"position:absolute;z-index:251748352;left:0px;margin-left:61px; margin-top:211px;width:13px;height:9px\"><img alt=\"0\" height=\"9\" src=\"Adakveo-4874%20EN%20PI_files/image002.png\" width=\"13\"/></span><span style=\"position:absolute;z-index:251746304;left:0px;margin-left:63px; margin-top:190px;width:10px;height:10px\"><img alt=\"10\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image003.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251744256;left:0px;margin-left:64px; margin-top:169px;width:10px;height:10px\"><img alt=\"20\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image004.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251742208;left:0px;margin-left:64px; margin-top:149px;width:10px;height:10px\"><img alt=\"30\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image005.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251740160;left:0px;margin-left:65px; margin-top:130px;width:10px;height:10px\"><img alt=\"40\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image006.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251738112;left:0px;margin-left:64px; margin-top:110px;width:10px;height:10px\"><img alt=\"50\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image007.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251736064;left:0px;margin-left:64px; margin-top:90px;width:10px;height:10px\"><img alt=\"60\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image008.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251734016;left:0px;margin-left:64px; margin-top:70px;width:10px;height:10px\"><img alt=\"70\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image009.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251731968;left:0px;margin-left:63px; margin-top:48px;width:10px;height:10px\"><img alt=\"80\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image010.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251729920;left:0px;margin-left:65px; margin-top:28px;width:10px;height:10px\"><img alt=\"90\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image011.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251727872;left:0px;margin-left:60px; margin-top:9px;width:15px;height:10px\"><img alt=\"100\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image012.png\" width=\"15\"/></span><span style=\"position:absolute;z-index:251781120;left:0px;margin-left:459px; margin-top:8px;width:125px;height:38px\"><img height=\"38\" src=\"Adakveo-4874%20EN%20PI_files/image013.png\" width=\"125\"/></span><span style=\"position: absolute;z-index:251779072;left:0px;margin-left:494px;margin-top:7px; width:92px;height:26px\"><img height=\"26\" src=\"Adakveo-4874%20EN%20PI_files/image014.png\" width=\"92\"/></span><span style=\"position: absolute;z-index:251666432;left:0px;margin-left:22px;margin-top:28px; width:32px;height:178px\"><img alt=\"Probability of being free from first VOC (%)\" height=\"178\" src=\"Adakveo-4874%20EN%20PI_files/image015.png\" width=\"32\"/></span><span style=\"position:absolute;z-index:251725824;left:0px;margin-left:320px; margin-top:242px;width:56px;height:10px\"><img alt=\"Time (months)¬¬¬¬\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image016.png\" width=\"56\"/></span><sub><span style=\"font-size:11.0pt\">                                <img border=\"0\" height=\"223\" id=\"Picture 1243\" src=\"Adakveo-4874%20EN%20PI_files/image017.jpg\" width=\"518\"/></span></sub></p>', 'ID': '1f28a2cd-e389-410e-9522-6477de26e0cb', 'Styles': 'margin-top:0in;page-break-after:avoid', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '                                ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"> <table align=\"left\" cellpadding=\"0\" cellspacing=\"0\"> <tr> <td height=\"1\" width=\"3\"></td> <td width=\"36\"></td> <td width=\"33\"></td> <td width=\"2\"></td> <td width=\"2\"></td> <td width=\"5\"></td> <td width=\"10\"></td> <td width=\"3\"></td> <td width=\"23\"></td> <td width=\"10\"></td> <td width=\"27\"></td> <td width=\"10\"></td> <td width=\"26\"></td> <td width=\"3\"></td> <td width=\"7\"></td> <td width=\"28\"></td> <td width=\"10\"></td> <td width=\"28\"></td> <td width=\"10\"></td> <td width=\"25\"></td> <td width=\"10\"></td> <td width=\"26\"></td> <td width=\"13\"></td> <td width=\"26\"></td> <td width=\"10\"></td> <td width=\"26\"></td> <td width=\"10\"></td> <td width=\"30\"></td> <td width=\"10\"></td> <td width=\"26\"></td> <td width=\"10\"></td> <td width=\"26\"></td> <td width=\"10\"></td> <td width=\"27\"></td> <td width=\"10\"></td> <td width=\"18\"></td> </tr> <tr> <td height=\"10\"></td> <td colspan=\"5\"></td> <td align=\"left\" valign=\"top\"><img alt=\"0\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image018.png\" width=\"10\"/></td> <td colspan=\"2\"></td> <td align=\"left\" valign=\"top\"><img alt=\"1\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image019.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"2\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image020.png\" width=\"10\"/></td> <td></td> <td align=\"left\" colspan=\"2\" valign=\"top\"><img alt=\"3\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image021.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"4\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image022.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"5\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image023.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"6\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image024.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"7\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image025.png\" width=\"13\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"8\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image026.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"9\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image027.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"10\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image003.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"11\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image028.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"12\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image029.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"13\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image030.png\" width=\"10\"/></td> </tr> <tr> <td height=\"14\"></td> </tr> <tr> <td height=\"9\"></td> <td colspan=\"7\"></td> <td align=\"left\" colspan=\"6\" valign=\"top\"><img alt=\"Number of patients at risk\" height=\"9\" src=\"Adakveo-4874%20EN%20PI_files/image031.png\" width=\"99\"/></td> </tr> <tr> <td height=\"7\"></td> </tr> <tr> <td height=\"7\"></td> <td colspan=\"4\"></td> <td align=\"left\" colspan=\"31\" rowspan=\"5\" valign=\"top\"><img alt=\"67,49,41,35,30,26,24,20,18,17,16,15,7,65,37,23,21,17,13,12,9,8,6,5,4,1,0,0\" height=\"43\" src=\"Adakveo-4874%20EN%20PI_files/image032.png\" width=\"513\"/></td> </tr> <tr> <td height=\"10\"></td> <td align=\"left\" colspan=\"3\" valign=\"top\"><img alt=\"Adakveo 5 mg/kg \" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image033.png\" width=\"71\"/></td> </tr> <tr> <td height=\"14\"></td> </tr> <tr> <td height=\"10\"></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"Placebo\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image034.png\" width=\"33\"/></td> </tr> <tr> <td height=\"2\"></td> </tr> </table> <span lang=\"EN-GB\"> </span></p>', 'ID': 'e84ed10a-b1be-47cf-8814-775d712347f9', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '                                                                                                        ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><span style=\"font-size:11.0pt\"> </span></p>', 'ID': '8c14f577-cb46-494a-9162-054506680e7b', 'Styles': 'margin-top:0in;page-break-after:avoid', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><span style=\"font-size:11.0pt\"> </span></p>', 'ID': '0f6cf8d7-9223-45d8-87c5-ff279c3c38b5', 'Styles': 'margin-top:0in;page-break-after:avoid', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '8ff37dc4-c898-4d52-a5aa-697fb9731068', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '13f05400-d25d-441b-8c2e-1bbc1ae3cc2b', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e85c0863-dc1a-42dc-ab9a-7b5fac36835e', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<br clear=\"ALL\"/>', 'ID': 'fd84f968-a97f-4259-b766-a742451e77df', 'Styles': 'None', 'Classes': 'None', 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><a name=\"_hd6_Table_2_1_Patients_wit18544\"></a><u><span lang=\"EN-GB\">Paediatric population</span></u></p>', 'ID': '3f5b8c47-c06e-451b-ad88-9ec7eda2c145', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Paediatric population', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '65c2aa8e-1f0d-4f53-a9a6-31e70f0e528b', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The efficacy of crizanlizumab in patients aged 16 and 17 years is expected to be the same as in adults. Three patients (2.7%) aged less than 18 years were treated with crizanlizumab 5 mg/kg in clinical studies.</span></p>', 'ID': 'c778d352-157f-4fdd-a650-9794035bb188', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The efficacy of crizanlizumab in patients aged 16 and 17 years is expected to be the same as in adults. Three patients (2.7%) aged less than 18 years were treated with crizanlizumab 5 mg/kg in clinical studies.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '93e46389-181f-4b47-ac7a-0941c0257958', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The European Medicines Agency has deferred the obligation to submit the results of studies with Adakveo in one or more subsets of the paediatric population in the treatment of sickle cell disease (see section 4.2 for information on paediatric use).</span></p>', 'ID': '1d9f638b-9522-45d4-aade-2ea3ee357fce', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The European Medicines Agency has deferred the obligation to submit the results of studies with Adakveo in one or more subsets of the paediatric population in the treatment of sickle cell disease (see section 4.2 for information on paediatric use).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '2b0ed3b1-e815-4631-bbf0-acb3af13b8cc', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Conditional approval</span></u></p>', 'ID': '85f8de6d-913b-4eb5-acc3-e28469213af1', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Conditional approval', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd9ff4f36-ed04-4f6c-a5b5-0c77a32c3473', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal product has been authorised under a so‑called “conditional approval” scheme. This means that further evidence on this medicinal product is awaited.</span></p>', 'ID': '655e28b7-c7d4-4a3e-85e1-645ab4a9998f', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'This medicinal product has been authorised under a so‑called “conditional approval” scheme. This means that further evidence on this medicinal product is awaited.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'eee72aad-0d37-4d8b-9cdc-1ebe65c0efc2', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The European Medicines Agency will review new information on this medicinal product at least every year and this SmPC will be updated as necessary.</span></p>', 'ID': '3aeb1c53-df5f-486d-8b90-194a72885c98', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The European Medicines Agency will review new information on this medicinal product at least every year and this SmPC will be updated as necessary.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"> </p>', 'ID': 'bc77fded-79e5-41c5-afe0-7d9019610912', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.2     Pharmacokinetic properties</span></b></p>', 'ID': 'ba64cecf-46c2-47ea-af81-b647e28a94ce', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '5.2     Pharmacokinetic properties', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '8b252518-6a39-496d-a2a8-1f4de11f314b', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Absorption</span></u></p>', 'ID': '00533119-b294-4d3b-addb-f6fd4c3e35f0', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Absorption', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'f0af07b2-a8f5-48df-9990-5f017322f332', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The median time to reach maximum serum concentration of crizanlizumab (T<sub>max</sub>) was 1.92 hours at steady state following intravenous administration of 5 mg/kg over a period of 30 minutes in sickle cell disease patients.</span></p>', 'ID': '532a95ac-aa2d-482f-b98e-8087c9e1aae4', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The median time to reach maximum serum concentration of crizanlizumab (Tmax) was 1.92 hours at steady state following intravenous administration of 5 mg/kg over a period of 30 minutes in sickle cell disease patients.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '21135353-0ad7-4d0e-9182-c1205f92b29b', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Distribution</span></u></p>', 'ID': '1c6e5ea8-2fc1-4281-bc2f-96d19363107b', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Distribution', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '73ad910b-c420-4838-ae7f-51f7dfa34806', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab distribution is typical of endogenous human antibodies within the vascular and extracellular spaces. The volume of distribution (V<sub>z</sub>) was 4.26 litres after a single 5 mg/kg intravenous infusion of crizanlizumab in healthy volunteers.</span></p>', 'ID': 'ca25d772-76ad-4b7f-b51f-921b95efd10a', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Crizanlizumab distribution is typical of endogenous human antibodies within the vascular and extracellular spaces. The volume of distribution (Vz) was 4.26 litres after a single 5 mg/kg intravenous infusion of crizanlizumab in healthy volunteers.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '1bf44745-663f-43a1-9114-5512396fecf5', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Biotransformation</span></u></p>', 'ID': '3480d3aa-b931-4d9d-8a25-ff2950f70e47', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Biotransformation', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'da63ad24-98cc-4f6c-a9ac-7d4eaf9df730', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Antibodies are primarily eliminated via proteolysis by lysosomal enzymes in the liver to small peptides and amino acids.</span></p>', 'ID': '994c284c-fd5a-4bca-856c-a06ca2d991e3', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Antibodies are primarily eliminated via proteolysis by lysosomal enzymes in the liver to small peptides and amino acids.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '25c08c2a-97cd-49b7-a3e6-ed7e3b2a9398', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Elimination</span></u></p>', 'ID': '317d6b14-9c20-4bea-bf70-1dd1bfd14ee0', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Elimination', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '9644480b-9013-49d2-a9e9-2795592596a9', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In healthy volunteers, the mean terminal elimination half‑life (T<sub>½</sub>) was 10.6 days and the mean clearance was 11.7 ml/h at crizanlizumab dose level 5 mg/kg. In patients with sickle cell disease, the mean elimination T<sub>½</sub> during the dosing interval was 7.5 days.</span></p>', 'ID': '21be6999-4166-4ea3-bc2a-46e7e9c1f35f', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'In healthy volunteers, the mean terminal elimination half‑life (T½) was 10.6 days and the mean clearance was 11.7 ml/h at crizanlizumab dose level 5 mg/kg. In patients with sickle cell disease, the mean elimination T½ during the dosing interval was 7.5 days.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'fa7ee2a9-8612-4798-a0b2-e8c66dbfa3c7', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Linearity/non‑linearity</span></u></p>', 'ID': 'eb9693fa-6305-4d68-9a84-84c27a959a65', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Linearity/non‑linearity', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e3091ce6-30ef-4898-95d8-5ac8dc9582e9', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The exposure to crizanlizumab (mean C<sub>max</sub>, AUC<sub>last</sub>, or AUC<sub>inf</sub>) increased in non‑linear manner over the dose range of 0.2 to 8 mg/kg in healthy volunteers.</span></p>', 'ID': '0f8c5072-5ed3-4aec-8749-5ac476a7e75f', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The exposure to crizanlizumab (mean Cmax, AUClast, or AUCinf) increased in non‑linear manner over the dose range of 0.2 to 8 mg/kg in healthy volunteers.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '09a8d525-4272-4243-a3b6-b61c438b48b5', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Special populations</span></u></p>', 'ID': '07676513-d6ad-4403-b7f4-172327384a02', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Special populations', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '2377eb8c-a022-4bd6-9344-958346ad2a64', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Renal impairment</span></u></i></p>', 'ID': 'de6eb665-d2f6-423f-bbb4-6cf89fe19fc8', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': True, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L4', 'Text': 'Renal impairment', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In a population PK analysis in patients with eGFR ranging from 35 to 202 ml/min/1.73 m<sup>2</sup>, no clinically important differences in the pharmacokinetics of crizanlizumab were found between patients with mild or moderate renal impairment and patients with normal renal function. Data from patients with severe renal impairment are too limited to draw conclusions on this population (see section</span><span lang=\"EN-GB\"> </span><span lang=\"EN-GB\">4.2).</span></p>', 'ID': '55fdf68a-b0d0-41fd-94a5-c7462d8a9ca4', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'In a population PK analysis in patients with eGFR ranging from 35 to 202 ml/min/1.73 m2, no clinically important differences in the pharmacokinetics of crizanlizumab were found between patients with mild or moderate renal impairment and patients with normal renal function. Data from patients with severe renal impairment are too limited to draw conclusions on this population (see section 4.2).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ad169960-f812-480f-80f4-6c2f1384a117', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Hepatic impairment</span></u></i></p>', 'ID': '1481fd7d-eec3-4db9-a8c3-2a7757e2e767', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': True, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L4', 'Text': 'Hepatic impairment', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monoclonal antibody and is cleared via catabolism (i.e. breakdown into peptides and amino acids), and a change in dose is not expected to be required for patients with hepatic impairment.</span></p>', 'ID': '734175d6-c4a2-4df4-ad4f-c1289c180bf2', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monoclonal antibody and is cleared via catabolism (i.e. breakdown into peptides and amino acids), and a change in dose is not expected to be required for patients with hepatic impairment.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '83a0b34c-87a8-4941-8bd0-9a8eacba26c2', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Paediatric <a name=\"_nth_Pediatric_patients__be14752\"></a>population</span></u></i></p>', 'ID': '1db6ba87-5368-4522-a96c-6bb36868e756', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': True, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L4', 'Text': 'Paediatric population', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pharmacokinetics in paediatric patients below the age of 16 years have not been investigated.</span></p>', 'ID': 'eab04aa6-e6d1-488b-9b0a-cdf2d9fbe1d1', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Pharmacokinetics in paediatric patients below the age of 16 years have not been investigated.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '06d7dc74-1123-46c5-8e58-5baba403d620', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.3     Preclinical safety data</span></b></p>', 'ID': '4679ecf1-e9ac-4cc6-9347-882d2b80caaa', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '5.3     Preclinical safety data', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '5612455a-6bf5-4e73-875f-5525fee58655', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">N</span><span lang=\"EN-GB\">on‑clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, tissue cross‑reactivity and repeated dose toxicity.</span></p>', 'ID': '9dfe8e22-726c-48dd-a73e-0ffca677a83e', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Non‑clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, tissue cross‑reactivity and repeated dose toxicity.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c95b5e22-fa87-49b9-933e-1076b8325fc8', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In the 26‑week repeated dose toxicity study, administration of crizanlizumab in cynomolgus monkeys at dose levels up to 50 mg/kg/dose once every 4 weeks (at least 13.5 times the human clinical exposure based on AUC in patients with sickle cell disease at 5 mg/kg once every four weeks) was generally well tolerated. There were no primary crizanlizumab‑related findings on any endpoint evaluated. At 50 mg/kg, minimal to moderate inflammation of the vessels in multiple tissues considered to be an antigen‑antibody complex reaction (primate antihuman antibody) was observed in 2 of 10 animals. There was one death attributed to aspiration of gastric contents following a peri‑infusional reaction mediated by anti‑drug‑antibody‑dependent hypersensitivity.</span></p>', 'ID': '249ba44f-0806-4154-a058-151cfd72086b', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'In the 26‑week repeated dose toxicity study, administration of crizanlizumab in cynomolgus monkeys at dose levels up to 50 mg/kg/dose once every 4 weeks (at least 13.5 times the human clinical exposure based on AUC in patients with sickle cell disease at 5 mg/kg once every four weeks) was generally well tolerated. There were no primary crizanlizumab‑related findings on any endpoint evaluated. At 50 mg/kg, minimal to moderate inflammation of the vessels in multiple tissues considered to be an antigen‑antibody complex reaction (primate antihuman antibody) was observed in 2 of 10 animals. There was one death attributed to aspiration of gastric contents following a peri‑infusional reaction mediated by anti‑drug‑antibody‑dependent hypersensitivity.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'aa214270-ebc8-4f85-a58a-04986ad789e3', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\">Pharmacological effects of crizanlizumab on haemodynamic and electrocardiographic parameters in the cynomolgus monkey were evaluated in the 26‑week repeated dose toxicology study. Respiratory rate and neurological parameters were also assessed. There were no crizanlizumab‑related effects on arterial blood pressure or on heart rate, PR, RR, QRS, QT, and heart rate corrected QT (QTc) intervals on the electrocardiograms (ECG). No rhythm abnormalities or qualitative changes were observed during the qualitative ECG assessment. There were no crizanlizumab‑related effects on respiration rate or any neurological parameter evaluated.</p>', 'ID': '8fb16356-f5ab-42a4-aaac-9444a3167a9a', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Pharmacological effects of crizanlizumab on haemodynamic and electrocardiographic parameters in the cynomolgus monkey were evaluated in the 26‑week repeated dose toxicology study. Respiratory rate and neurological parameters were also assessed. There were no crizanlizumab‑related effects on arterial blood pressure or on heart rate, PR, RR, QRS, QT, and heart rate corrected QT (QTc) intervals on the electrocardiograms (ECG). No rhythm abnormalities or qualitative changes were observed during the qualitative ECG assessment. There were no crizanlizumab‑related effects on respiration rate or any neurological parameter evaluated.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"> </p>', 'ID': '46f8c14d-38a5-4dcb-9ddd-19fa5a0cfc57', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Formal carcinogenicity, genotoxicity and juvenile toxicity studies have not been conducted with crizanlizumab.</span></p>', 'ID': '4a51b9ef-c655-47df-8040-1454020aab38', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Formal carcinogenicity, genotoxicity and juvenile toxicity studies have not been conducted with crizanlizumab.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '9ccca12b-0a06-4812-95cc-48dc425408e2', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In a 26‑week repeated dose toxicity study, cynomolgus monkeys were administered crizanlizumab once every 4 weeks at doses up to 50 mg/kg (at least 13.5 times the human clinical exposure based on AUC in patients with sickle cell disease at 5 mg/kg once every four weeks). </span><span lang=\"EN-GB\">There were no adverse effects of crizanlizumab on male and female reproductive organs</span>.</p>', 'ID': '2c6442f0-201f-4775-8452-1c36a089ff2a', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'In a 26‑week repeated dose toxicity study, cynomolgus monkeys were administered crizanlizumab once every 4 weeks at doses up to 50 mg/kg (at least 13.5 times the human clinical exposure based on AUC in patients with sickle cell disease at 5 mg/kg once every four weeks). There were no adverse effects of crizanlizumab on male and female reproductive organs.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'de592949-aa05-45df-92ce-b8517448318c', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In an enhanced pre‑ and postnatal development study in cynomolgus monkeys, pregnant animals received intravenous crizanlizumab once every two weeks during the period of organogenesis, at doses of 10 and 50 mg/kg (approximately 2.8 and 16 times </span><span lang=\"EN-GB\">the human clinical exposure based on AUC in patients with sickle cell disease at 5 mg/kg/dose once every four weeks, respectively)</span><span lang=\"EN-GB\">. No maternal toxicity was observed. </span><span lang=\"EN-GB\">There was an increase in foetal loss (abortions or stillbirths) at both doses and this was higher in the third trimester. The cause of the foetal losses in monkeys is unknown but may be due to the development of anti‑drug antibodies against crizanlizumab</span><span lang=\"EN-GB\">. There were no effects on infant growth and development during the 6 months postpartum that were attributable to crizanlizumab.</span></p>', 'ID': '1bd38c10-06fd-4517-b905-bfa5009eaa54', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'In an enhanced pre‑ and postnatal development study in cynomolgus monkeys, pregnant animals received intravenous crizanlizumab once every two weeks during the period of organogenesis, at doses of 10 and 50 mg/kg (approximately 2.8 and 16 times the human clinical exposure based on AUC in patients with sickle cell disease at 5 mg/kg/dose once every four weeks, respectively). No maternal toxicity was observed. There was an increase in foetal loss (abortions or stillbirths) at both doses and this was higher in the third trimester. The cause of the foetal losses in monkeys is unknown but may be due to the development of anti‑drug antibodies against crizanlizumab. There were no effects on infant growth and development during the 6 months postpartum that were attributable to crizanlizumab.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'bfd1df42-3b6b-4eb7-9ac9-ed2f0a05e768', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Measurable crizanlizumab serum concentrations were observed in the infant monkeys at postnatal day 28, confirming that crizanlizumab, like other IgG antibodies, crosses the placental barrier.</span></p>', 'ID': '3fdc8ea7-8326-4261-ad5c-e716a34fdfa9', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Measurable crizanlizumab serum concentrations were observed in the infant monkeys at postnatal day 28, confirming that crizanlizumab, like other IgG antibodies, crosses the placental barrier.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '3d455957-9727-4c20-9bbc-88e5da60aa85', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '643d24d6-80da-4ab4-9624-0221c8465acb', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.       PHARMACEUTICAL PARTICULARS</span></b></p>', 'ID': '1ea14223-5db3-4ba2-b1ec-4f17d58dcd5f', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L1', 'Text': '6.       PHARMACEUTICAL PARTICULARS', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '966675b9-690b-41d9-98ed-60967ffd9f3c', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.1     List of excipients</span></b></p>', 'ID': 'ed327a73-30e6-4081-b6de-0fe728ce8969', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '6.1     List of excipients', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '252756a3-2ffd-4fa1-93bf-62767e7a8c66', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Sucrose</span></p>', 'ID': 'e42486b8-431d-489e-92e1-26e80f62c326', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Sucrose', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Sodium citrate (E331)</span></p>', 'ID': '3382e5f0-a081-4aa4-97d5-536842c7328e', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Sodium citrate (E331)', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Citric acid (E330)</span></p>', 'ID': 'd4798f99-bb2d-4cc7-ba65-ace4e92c99d6', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Citric acid (E330)', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Polysorbate 80 (E433)</span></p>', 'ID': '95540f6b-617d-48b0-a6bc-5f309ea429aa', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Polysorbate 80 (E433)', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Water for injections</span></p>', 'ID': '8533427e-eca8-4d27-add7-ae84359e2b3d', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Water for injections', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '0695764c-3f57-4cc5-bdc9-032776603195', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.2     Incompatibilities</span></b></p>', 'ID': '93b62773-0f41-45e2-94ac-0e36099c20e6', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '6.2     Incompatibilities', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'a2269772-413a-4a40-81f3-bff5dd940e7c', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal product</span><span lang=\"EN-GB\"> must not be mixed with other medicinal products except those mentioned in section 6.6.</span></p>', 'ID': 'c1dd7e4b-2172-4e76-b329-beee93d2cb22', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '823e1348-5e7b-4ece-8640-affd6e5ed5be', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.3     Shelf life</span></b></p>', 'ID': '8d321b8f-d147-49dc-b3f2-14c13473e828', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '6.3     Shelf life', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '37d476c0-f943-407b-b694-73edbb744cf1', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Unopened vial</span></u></p>', 'ID': '00e069bf-ec29-46b0-9da9-069be813ec77', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Unopened vial', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '8a8b2484-d59f-49da-88e1-b8fb42574e6d', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">18 months</span></p>', 'ID': '15a7da87-7151-407a-aff9-f16540d65487', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '18 months', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ccd15a79-4c3e-4920-a3e2-495f132624ad', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Diluted solution</span></u></p>', 'ID': 'fd426195-3dc5-4f10-9564-c7c5e3e9291c', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Diluted solution', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e81f948d-5467-4471-a174-5542d7d5d673', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Chemical and physical in‑use stability, from the start of preparation of the diluted solution for infusion until end of infusion, has been demonstrated for up to 8 hours at room temperature (up to 25°C) and at 2°C to 8°C for up to 24 hours overall.</span></p>', 'ID': '6289cac5-3b81-4e28-9ad6-409df65bb1d5', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Chemical and physical in‑use stability, from the start of preparation of the diluted solution for infusion until end of infusion, has been demonstrated for up to 8 hours at room temperature (up to 25°C) and at 2°C to 8°C for up to 24 hours overall.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '9e63db32-7ab4-433c-95ed-27da07885ad9', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">From a microbiological point of view, the diluted solution for infusion should be used immediately. If not used immediately, in‑use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2°C to 8°C, including 4.5 hours at room temperature (up to 25°C) from the start of preparation to completion of the infusion, unless dilution has taken place in controlled and validated aseptic conditions.</span></p>', 'ID': 'be86aea2-b55d-411b-b239-579d9ab70e79', 'Styles': 'margin-top:0in;text-align:left', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'From a microbiological point of view, the diluted solution for infusion should be used immediately. If not used immediately, in‑use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2°C to 8°C, including 4.5 hours at room temperature (up to 25°C) from the start of preparation to completion of the infusion, unless dilution has taken place in controlled and validated aseptic conditions.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"> </p>', 'ID': '30dfdf90-c7c6-46dd-81ed-34040c037707', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.4     Special precautions for storage</span></b></p>', 'ID': '0916fc58-f815-4be1-8e43-15d87212f2ff', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '6.4     Special precautions for storage', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c05a9aae-2370-4c08-8a36-30a372a87373', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Store in a refrigerator (2°C – 8°C).</span></p>', 'ID': '0ecc299e-06ef-4489-8a36-f2034f2042ab', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Store in a refrigerator (2°C – 8°C).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not freeze.</span></p>', 'ID': 'a112a3f4-75ce-4161-8661-ea3d6b64a170', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Do not freeze.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep the vial in the outer carton in order to protect from light.</span></p>', 'ID': '699fc118-68a0-4d85-91f8-68906d13d935', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Keep the vial in the outer carton in order to protect from light.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '1c6011d9-95b8-4289-88e3-be255803aa85', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For storage conditions after dilution of the medicinal product, see section 6.3.</span></p>', 'ID': '9d751841-7244-4356-92cd-d0d33db564a8', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'For storage conditions after dilution of the medicinal product, see section 6.3.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '0566d8ce-a929-4cd0-8ac2-6d814231b189', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.5     Nature and contents of container</span></b></p>', 'ID': 'd57803b0-6a88-44a7-88de-d89dae95ab44', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '6.5     Nature and contents of container', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '558e72cd-ad45-48cc-bf26-ed0c0f1fa60a', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">10 ml concentrate for solution for infusion in a type I glass vial with a coated chlorobutyl rubber stopper sealed with an aluminium cap with a plastic flip‑off disk containing 100 mg crizanlizumab.</span></p>', 'ID': '13eb2179-b33a-48a3-81da-f9ac455031fe', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '10 ml concentrate for solution for infusion in a type I glass vial with a coated chlorobutyl rubber stopper sealed with an aluminium cap with a plastic flip‑off disk containing 100 mg crizanlizumab.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'f67001d0-3ed0-46c6-a74b-ceb81076f6ca', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pack of 1 vial.</span></p>', 'ID': '2b7c8f38-c832-4a4e-a4c8-03d1672b36c5', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Pack of 1 vial.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '78af6177-82e3-47dc-bdee-a120221922fd', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><a name=\"OLE_LINK1\"><b><span lang=\"EN-GB\">6.6     Special precautions for disposal and other handling</span></b></a></p>', 'ID': '0562f34b-62da-4f2c-b64d-fbe84c7ab2ad', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '6.6     Special precautions for disposal and other handling', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '007d733a-4f29-41b2-b121-2cb115094347', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo vials are for single use only.</span></p>', 'ID': 'bc7bcab8-dac1-4983-916e-5ffcb01f938d', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Adakveo vials are for single use only.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c4a1d90f-bd32-4d0a-bf43-604c0b34c9af', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Preparing the infusion</span></u></p>', 'ID': '4512dd38-a048-42e5-8029-b540a8263f2b', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Preparing the infusion', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e23ff6b2-20ae-44b0-b64f-198e5618f75d', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The diluted solution for infusion should be prepared by a healthcare professional using aseptic techniques.</span></p>', 'ID': '1473cd1c-9b6f-4370-9f72-e83e69475737', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The diluted solution for infusion should be prepared by a healthcare professional using aseptic techniques.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '95f93264-c234-4b46-89c6-e945e5e9b31d', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The total dose and required volume of Adakveo depend on the patient’s body weight; 5 mg of crizanlizumab is administered per kg body weight.</span></p>', 'ID': '94346e88-c101-4bc7-8012-d3b0d77c943c', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The total dose and required volume of Adakveo depend on the patient’s body weight; 5 mg of crizanlizumab is administered per kg body weight.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '51d7f2e0-8d66-42f0-92ca-d00295fda75d', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">The volume to be used for the preparation of the infusion is calculated according to the following equation:</span></p>', 'ID': '30001714-d1b1-486b-99fd-1e91d0dcec95', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The volume to be used for the preparation of the infusion is calculated according to the following equation:', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '33a626aa-b331-405b-9e6e-973e963fc8ac', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:12.5pt;border-collapse:collapse\" width=\"567\"> <tr> <td rowspan=\"2\" style=\"width:85.05pt;padding:0in 5.4pt 0in 5.4pt\" width=\"113\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Volume (ml) =</span></p> </td> <td style=\"width:269.35pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"359\"> <p align=\"center\" class=\"MsoNormal\" style=\"margin-left:28.35pt;text-align:center;   text-indent:-28.35pt;line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Patient’s body weight (kg) x prescribed dose</span></p> </td> <td style=\"width:70.85pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"94\"> <p align=\"center\" class=\"MsoNormal\" style=\"margin-left:28.35pt;text-align:center;   text-indent:-28.35pt;line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">[5 mg/kg]</span></p> </td> </tr> <tr> <td style=\"width:269.35pt;border:none;padding:0in 5.4pt 0in 5.4pt\" width=\"359\"> <p align=\"center\" class=\"Text\" style=\"margin-top:0in;text-align:center;   page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Concentration   of Adakveo</span></p> </td> <td style=\"width:70.85pt;border:none;padding:0in 5.4pt 0in 5.4pt\" width=\"94\"> <p align=\"center\" class=\"Text\" style=\"margin-top:0in;text-align:center;   page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">[10 mg/ml]</span></p> </td> </tr> </table>', 'ID': 'c2a797e4-ca61-4a7f-b729-32f94c299d13', 'Styles': 'margin-left:12.5pt;border-collapse:collapse', 'Classes': \"['MsoNormalTable']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '   Volume (ml) =   Patient’s body weight (kg) x prescribed dose   [5 mg/kg]     Concentration   of Adakveo   [10 mg/ml]   ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_hd6_Table_3_1_Example_of_d12477\"></a><span lang=\"EN-GB\"> </span></p>', 'ID': '29859d43-7257-48ca-82e8-4da9831cccad', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">1.       Obtain the number of vials required to deliver the prescribed dose and bring them to room temperature (for a maximum of 4 hours). One vial is needed for every 10 ml of Adakveo (see below table).</span></p>', 'ID': '985c20b0-443f-4a52-9767-84b70deae8fc', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '1.       Obtain the number of vials required to deliver the prescribed dose and bring them to room temperature (for a maximum of 4 hours). One vial is needed for every 10 ml of Adakveo (see below table).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e105b8a5-3f7f-4323-88f6-c66f83ef9f97', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:28.35pt;border-collapse:collapse;border:none\" width=\"568\"> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Body weight (kg)</span></b></p> </td> <td style=\"width:92.15pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Dose (mg)</span></b></p> </td> <td style=\"width:114.75pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Volume (ml)</span></b></p> </td> <td style=\"width:114.75pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Vials (n)</span></b></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">40</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">200</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">20</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">2</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">60</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">300</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">30</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">3</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">80</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">400</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">40</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">4</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">100</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">500</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">50</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">5</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">120</span></p> </td> <td style=\"width:92.15pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">600</span></p> </td> <td style=\"width:114.75pt;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">60</span></p> </td> <td style=\"width:114.75pt;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">6</span></p> </td> </tr> </table>', 'ID': '88fa01d0-297f-44a4-9f1e-72b7db37da6e', 'Styles': 'margin-left:28.35pt;border-collapse:collapse;border:none', 'Classes': \"['MsoNormalTable']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '   Body weight (kg)   Dose (mg)   Volume (ml)   Vials (n)     40   200   20   2     60   300   30   3     80   400   40   4     100   500   50   5     120   600   60   6   ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '8a5434fe-20f2-4bf7-b303-a467e4500701', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">2.       Visually inspect the vials.</span></p>', 'ID': 'f9dda721-880c-4fdd-81c9-23a61f02f35a', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '2.       Visually inspect the vials.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The solution in the vials should be clear to opalescent. Do not use if particles are present in the solution.</span></p>', 'ID': 'dfe30f25-3213-49f3-8c1a-a03428471f1d', 'Styles': 'margin-left:56.7pt;text-indent:-28.35pt;line-height:\\nnormal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '-                 The solution in the vials should be clear to opalescent. Do not use if particles are present in the solution.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The solution should be colourless or may have a slight brownish‑yellow tint.</span></p>', 'ID': 'a6daa916-3929-40ec-985a-6e34ce49cc4f', 'Styles': 'margin-left:56.7pt;text-indent:-28.35pt;line-height:\\nnormal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '-                 The solution should be colourless or may have a slight brownish‑yellow tint.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '4b2604a7-15d1-4474-bf4b-c802fbbaa010', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">3.       Withdraw a volume equal to the required volume of Adakveo from a 100 ml infusion bag containing either sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% and discard.</span></p>', 'ID': 'e366bb71-b7ba-4cfc-b28f-66f0bbc90eee', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '3.       Withdraw a volume equal to the required volume of Adakveo from a 100 ml infusion bag containing either sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% and discard.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">No incompatibilities between the diluted Adakveo solution and infusion bags composed of polyvinylchloride (PVC), polyethylene (PE) and polypropylene (PP) have been observed.</span></p>', 'ID': '66a122bf-afbc-49d3-9b45-b2c7d80407c0', 'Styles': 'margin-left:56.7pt;text-indent:-28.35pt', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '-                 No incompatibilities between the diluted Adakveo solution and infusion bags composed of polyvinylchloride (PVC), polyethylene (PE) and polypropylene (PP) have been observed.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'fac9eddc-a1cd-4099-bd26-f4664ec53a90', 'Styles': 'None', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">4.       Withdraw the necessary volume of Adakveo from the vials and inject slowly into the previously prepared infusion bag.</span></p>', 'ID': 'a15ac1bf-0bfb-4400-8bc9-b4f24a526ef8', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '4.       Withdraw the necessary volume of Adakveo from the vials and inject slowly into the previously prepared infusion bag.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The </span><span lang=\"EN-GB\">solution</span><span lang=\"EN-GB\"> must not be mixed or co‑administered with other medicinal products through the same intravenous line.</span></p>', 'ID': 'af8f1547-b844-40e2-9fcf-393264f9fcbc', 'Styles': 'margin-left:56.7pt;text-indent:-28.35pt', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '-                 The solution must not be mixed or co‑administered with other medicinal products through the same intravenous line.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">Keep the volume of Adakveo added to the infusion bag in the range of 10 ml to 96 ml to obtain a final concentration in the infusion bag within 1 mg/ml to 9.6 mg/ml.</span></p>', 'ID': '4282d2cf-94c8-463c-835c-14d070734b16', 'Styles': 'margin-left:56.7pt;text-indent:-28.35pt', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '-                 Keep the volume of Adakveo added to the infusion bag in the range of 10 ml to 96 ml to obtain a final concentration in the infusion bag within 1 mg/ml to 9.6 mg/ml.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd81fb4c8-01d1-41bf-8579-8cfb069ef597', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">5.       Mix the diluted solution by gently inverting the infusion bag. DO NOT SHAKE.</span></p>', 'ID': '755f3b13-17d9-4fe3-9c2b-1f5fb1a5d6c0', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '5.       Mix the diluted solution by gently inverting the infusion bag. DO NOT SHAKE.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'a21c3ed4-49d7-4e66-9692-d9ddcbf7b9bf', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Administration</span></u><a name=\"_nth_Administration25012\"></a></p>', 'ID': 'a44b6df6-f9ab-4c89-8110-e858a2e81944', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Administration', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e1525e94-a89a-4533-bcd3-24d091a9a998', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">Adakveo diluted solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by intravenous infusion over a period of 30 minutes.</span><span style=\"font-size:11.0pt\"> <span lang=\"EN-GB\">No incompatibilities have been observed between Adakveo and infusion sets composed of PVC, PE‑lined PVC, polyurethane, and in‑line filter membranes composed of polyethersulfone (PES), polyamide (PA) or polysulphone (PSU).</span></span></p>', 'ID': 'cc618436-4d6a-4fdc-8841-f06397bdae7a', 'Styles': 'margin-top:0in;text-align:left', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Adakveo diluted solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by intravenous infusion over a period of 30 minutes. No incompatibilities have been observed between Adakveo and infusion sets composed of PVC, PE‑lined PVC, polyurethane, and in‑line filter membranes composed of polyethersulfone (PES), polyamide (PA) or polysulphone (PSU).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '2ca8a9c0-71bf-4f00-ac95-4f17769b0430', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">After administration of Adakveo, flush the line with at least 25 ml sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5%.</span></p>', 'ID': '91651b3d-52f4-4496-9120-d585bdf34f81', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'After administration of Adakveo, flush the line with at least 25 ml sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5%.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'fc23fa4e-5365-4897-8e35-081b5bc498e3', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Disposal</span></u></p>', 'ID': '790d0f73-c2bb-4287-a4fd-7353eea185e6', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Disposal', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd9bc9594-8973-438b-af6e-ce6f9f95a3e9', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</span></p>', 'ID': '88caa940-38af-4a39-85ac-496e8896c678', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Any unused medicinal product or waste material should be disposed of in accordance with local requirements.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '9f3a1ca2-3874-417a-82e6-7b6dcd3a23cc', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '17bb70bb-c856-421e-a119-655fcd74c970', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">7.       MARKETING AUTHORISATION HOLDER</span></b></p>', 'ID': '2e90cca4-467f-40f6-9d9b-7cdcc501a036', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L1', 'Text': '7.       MARKETING AUTHORISATION HOLDER', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '6a6d9cce-8b55-41c6-a9df-5a2974a1aff4', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Novartis Europharm Limited</span></p>', 'ID': 'ee815573-69e1-4b40-9bc2-5e163d630406', 'Styles': 'page-break-after:avoid', 'Classes': \"['Default']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Novartis Europharm Limited', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Vista Building</span></p>', 'ID': '80c23402-0480-4124-8f6f-46925c8e537b', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Vista Building', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Elm Park, Merrion Road</span></p>', 'ID': 'dfa537c6-eb19-410c-afb9-33186c2b6b05', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Elm Park, Merrion Road', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Dublin 4</span></p>', 'ID': '2b695489-cf12-4049-a2e1-1a2d14df92d2', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Dublin 4', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">Ireland</span></p>', 'ID': '48c00e77-77ec-4244-9d94-2fd6f4b81631', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Ireland', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '21f9fed2-00ca-44a3-9267-1078e9faf781', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e98778fc-a17b-48aa-8e8a-cbe138ff09c4', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">8.       MARKETING AUTHORISATION NUMBER(S)</span></b></p>', 'ID': 'fefa296f-e154-42b7-8416-72c6b78230fa', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L1', 'Text': '8.       MARKETING AUTHORISATION NUMBER(S)', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd3c33c17-e1b6-4954-be6b-c384593de96c', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">EU/1/20/1476/001</span></p>', 'ID': '317e074d-c34f-4f1f-890c-df3b4c5a19ae', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'EU/1/20/1476/001', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '36bce19f-089e-4025-a9d9-3b41061b9947', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'bcde3901-95f7-48b8-9dbc-01fc7f2ef0e3', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">9.       DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>', 'ID': 'acaf6790-3f91-4b6f-99bc-199765791f5a', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L1', 'Text': '9.       DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd56760a9-7b6c-406d-a591-5c8012b57d75', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '0c85ada6-10f3-4235-9810-45b382d68edb', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">10.     DATE OF REVISION OF THE TEXT</span></b></p>', 'ID': 'a86741a5-547d-4084-bbdb-e8eea5a9da42', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L1', 'Text': '10.     DATE OF REVISION OF THE TEXT', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'fd5536d3-3d24-4f8a-9a87-763251e3817b', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '66026015-c5e3-417c-ab6e-ac77e1a42b13', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Detailed information on this medicinal product is available on the website of the European Medicines </span><span lang=\"EN-GB\">Agency <a href=\"http://www.ema.europa.eu\">http://www.ema.europa.eu</a></span><span lang=\"EN-GB\">.<br clear=\"all\" style=\"page-break-before:always\"/> </span></p>', 'ID': '3cd86c01-ce4b-404f-9774-5467f495dcf0', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu. ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '201cb4bb-4df3-45ab-aaa5-bd46bb419470', 'Styles': 'margin-right:-.1pt;line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c2d1acd4-1298-4014-91a6-a105a1c9be38', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '3731cb55-5fdb-475d-bec8-bcf2fb4a5692', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '2103b9cc-b2dd-4dc7-9cca-7aaf2ca8e6dd', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'cb897326-186f-4a5f-b3b6-5eb11a2091a4', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c33d0918-4f07-4b10-981d-3a7a2e51f4ee', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '4dc1eeca-1565-4651-86de-bb0549d7050c', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ee2b1bb5-2900-4e3b-bfcc-570e2dde38e2', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '19b053f2-d9c9-4930-85f2-1f860db8cfef', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'b1edb48c-264b-4d54-92fb-cd63dad463b7', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '0e9207b1-a497-45e4-8eee-6c06c1bc16dd', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ca99e9aa-9e9e-456d-ab1b-e2d19669890d', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ade7361e-e0bb-48cc-a7c7-2a6674f5329f', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'f0c6c67a-380f-4da4-9e5a-02cd72cc4a71', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '055a5227-34c3-439a-8046-f928d2d0ea70', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '1dd82cf7-9f12-4867-91a0-c450f9ce6fcc', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'f6251986-fd21-4691-88e4-edb89b0422a4', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'a3a9a54e-fb50-404d-9510-f6300d2bbb11', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '20b168cc-9f45-4b6d-933f-6077b8af5595', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd1d3015a-8a2b-4ab0-842d-a3cc8c9e169a', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '66e9038f-c383-4cff-95af-818e76a2091d', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '658742af-a192-4d57-8624-0f9a44426e15', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '4af52237-24ea-434e-9e10-08277413103e', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}]\n"
     ]
    }
   ],
   "source": [
    "from scripts.jsonHandlingUtils import loadJSON_Convert_to_DF, mkdir, addjson\n",
    "with open(path) as f:\n",
    "    json_html = json.load(f)\n",
    "print(json_html)\n",
    "dic_json = {}\n",
    "# print(json_html)\n",
    "# print(type(json_html))\n",
    "for i in json_html:\n",
    "    for j in i.keys():\n",
    "        dic_json = addjson(dic_json, j, i[j])\n",
    "\n",
    "# print(loadJSON_Convert_to_DF(output_filename))\n",
    "df = pd.DataFrame(dic_json)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'Element': '<div class=\"WordSection1\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX I</span></b></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">SUMMARY OF PRODUCT CHARACTERISTICS</span></b></p> <span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif; color:green\\'><br clear=\"all\" style=\"page-break-before:always\"/> </span> <p class=\"MsoNormal\" style=\"line-height:normal\"><img height=\"18\" src=\"Adakveo-4874%20EN%20PI_files/image001.png\" width=\"21\"/><span lang=\"EN-GB\">This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">1.       NAME OF </span></b><b><span lang=\"EN-GB\">THE MEDICINAL PRODUCT</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo 10 mg/ml concentrate for solution for infusion</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.       QUALITATIVE AND QUANTITATIVE COMPOSITION</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each ml of concentrate for solution for infusion contains 10 mg crizanlizumab.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">One vial of 10 ml contains 100 mg crizanlizumab.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab is a monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For the full list of excipients, see section 6.1.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">3.       PHARMACEUTICAL </span></b><b><span lang=\"EN-GB\" style=\\'font-family:\"Times New Roman Bold\",serif\\'>FORM</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_Toc259706902\"></a><a name=\"_Toc259707071\"></a><a name=\"_Toc259707134\"></a><a name=\"_Toc259713075\"><span lang=\"EN-GB\">Concentrate for solution for infusion</span></a><span lang=\"EN-GB\"> (sterile concentrate)</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Colourless to slightly brownish‑yellow liquid at pH 6 and with an osmolality of 300 mOsm/kg.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.       </span></b><b><span lang=\"EN-GB\">CLINICAL</span></b><b><span lang=\"EN-GB\" style=\\'font-family:\"Times New Roman Bold\",serif\\'> PARTICULARS</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.1     Therapeutic indications</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"Standard\"><span lang=\"EN-GB\">Adakveo</span><span lang=\"EN-GB\"> is indicated for the prevention of recurrent vaso‑occlusive crises (VOCs) in sickle cell disease patients aged 16 years and older. It can be given as an add‑on therapy to hydroxyurea/hydroxycarbamide (HU/HC) or as monotherapy in patients for whom HU/HC is inappropriate or inadequate.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.2     Posology and method of administration</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Treatment should be initiated by physicians experienced in the management of </span><span lang=\"EN-GB\">sickle cell disease.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Posology</span></u><a name=\"_nth_Adults_and_patients_ag4131\"></a></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The recommended dose of crizanlizumab is 5 mg/kg administered over a period of 30 minutes by intravenous infusion at week 0, week 2, and every 4 weeks thereafter.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab </span><span lang=\"EN-GB\">c</span><span lang=\"EN-GB\">an be given alone or with HU/HC.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">If a dose is missed, the treatment should be administered as soon as possible.</span></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt\"><span style=\"font-size:11.0pt\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span style=\"font-size:11.0pt\">If crizanlizumab is administered within 2 weeks after the missed dose, dosing should be continued according to the patient’s original schedule.</span></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt\"><span style=\"font-size:11.0pt\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span style=\"font-size:11.0pt\">If crizanlizumab is administered more than 2 weeks after the missed dose, dosing should be continued every 4 weeks thereafter.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Special populations</span></u></i></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Elderly</span></i></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab has not been studied in elderly patients. No dose adjustment is required as the pharmacokinetics of crizanlizumab in adults are not affected by age.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Renal impairment</span></i></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Based on the population pharmacokinetic (PK) results, no dose adjustment is required in patients with mild or moderate renal impairment (see section 5.2). Data from patients with severe renal impairment are too limited to draw conclusions on this population.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Hepatic impairment</span></i></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monoclonal antibody and is cleared via catabolism (i.e. breakdown into peptides and amino acids), and a change in dose is not expected to be required for patients with hepatic impairment (see section</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> </span><span lang=\"EN-GB\">5.2).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Paediatric population</span></i></p> <p class=\"Standard\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety and efficacy of </span><span lang=\"EN-GB\">crizanlizumab</span><span lang=\"EN-GB\"> in paediatric patients from 6 months to 16 years have not been established. No data are available.</span></p> <p class=\"Standard\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"Standard\" style=\"line-height:normal\"><span lang=\"EN-GB\">There is no relevant use of crizanlizumab in infants aged less than 6 months for the indication of prevention of recurrent vaso‑occlusive crises.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Method of administration</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo </span><span lang=\"EN-GB\">should be diluted with sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% before administration.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The diluted solution</span><span lang=\"EN-GB\"> must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by intravenous infusion over a period of 30 minutes. It must not be administered by intravenous push or bolus.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For instructions on dilution of the medicinal product before administration, see section 6.6.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.3     Contraindications</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hypersensitivity to Chinese Hamster Ovary (CHO) cell products.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.4     Special warnings and precautions for use</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Traceability</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\"> </span></span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Infusion‑related reactions</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In clinical studies, infusion‑related reactions (defined as occurring within 24 hours) were observed in 2 patients (1.8%) treated with crizanlizumab 5 mg/kg</span><span lang=\"EN-GB\">. Patients should be monitored for signs and symptoms of infusion‑related reactions, which may include fever, chills, nausea, vomiting, fatigue, dizziness, pruritus, urticaria, sweating, shortness of breath or wheezing. </span><span lang=\"EN-GB\">In the event of a severe reaction, crizanlizumab should be discontinued and appropriate therapy should be instituted.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Laboratory test interference: automated platelet counts</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Interference with automated platelet counts (platelet clumping) has been observed in patients treated with crizanlizumab in clinical studies, in particular when tubes containing EDTA (ethylenediaminetetraacetic acid) were used. This may lead to unevaluable or falsely decreased platelet counts. There is no evidence that crizanlizumab causes a reduction in circulating platelets or has a pro‑aggregant effect <i>in vivo</i>.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">To mitigate the potential for laboratory test interference, it is recommended to run the test as soon as possible (within 4 hours of blood collection) or use citrate tubes. When needed, </span><span lang=\"EN-GB\">platelet counts can be estimated via a peripheral blood smear</span><span lang=\"EN-GB\">.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Excipients with known effect</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially “sodium‑free”.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.5     Interaction with other medicinal products and other forms of interaction</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Interactions between crizanlizumab and other medicinal products have not been investigated in dedicated studies.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Monoclonal antibodies are not metabolised by cytochrome P450 (CYP450) enzymes. Therefore, medicinal products that are substrates, inhibitors or inducers of CYP450 are not expected to affect the pharmacokinetics of crizanlizumab. In clinical studies, HU/HC had no effect on crizanlizumab pharmacokinetics in patients.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No effect on exposure of co‑administered medicinal products is expected based on the metabolic pathways of monoclonal antibodies.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.6     </span></b><b><span lang=\"EN-GB\">Fertility, p</span></b><b><span lang=\"EN-GB\">regnancy and lactation</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Pregnancy</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"Standard\"><span lang=\"EN-GB\">There is a limited amount of data from the use of Adakveo in pregnant women. Based on data from animal studies, crizanlizumab has the potential to cause foetal losses when administered to a pregnant woman (see section 5.3). As a precautionary measure, it is preferable to avoid the use of Adakveo during pregnancy and in woman of childbearing potential not using contraception.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"Standard\" style=\"line-height:normal\">To help determine the effects in pregnant women, healthcare professionals are encouraged to report all pregnancy cases and complications during pregnancy (from 105 days prior to the last menstrual period onward) to <span lang=\"EN-GB\">the local representative of the</span> marketing authorisation holder (see package leaflet), in order to allow monitoring of these patients through the PRegnancy outcomes Intensive Monitoring programme (PRIM). In addition, all adverse pregnancy events should be reported <span lang=\"EN-GB\">via <span style=\"color:black;background:#D9D9D9\">the national reporting system listed in </span></span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:#D9D9D9\">Appendix V</span></a></span>.</p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Breast‑feeding</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It is unknown whether crizanlizumab is excreted in human milk after administration of Adakveo. There are no data on the effects of crizanlizumab on the breast‑fed newborn/infant or on milk production.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Because many medicinal products, including antibodies, can be excreted in human milk, a risk to the newborn/infant cannot be excluded.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">A decision must be made whether to discontinue breast‑feeding or to discontinue Adakveo therapy, taking into account the benefit of breast‑feeding for the child and the benefit of therapy for the woman.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Fertility</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There are no data on the effect of Adakveo on human fertility. Available non‑clinical data do not suggest an effect on fertility under crizanlizumab treatment (see section 5.3).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.7     Effects on ability to drive and use machines</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo may have a minor influence on the ability to drive and use machines. Dizziness, fatigue and somnolence may occur following administration of crizanlizumab.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.8     Undesirable effects</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Summary of the safety profile</span></u><a name=\"_nth_Summary_of_the_safety_6118\"></a></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The most frequently reported adverse drug reactions (≥10% of patients) in the Adakveo 5 mg/kg group were arthralgia, nausea, back pain, pyrexia and abdominal pain. Severe events were observed for pyrexia and arthralgia (each 0.9%).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Tabulated list of adverse reactions</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Table 1 lists adverse reactions based on pooled data from two studies: the pivotal study, SUSTAIN, and a single‑arm, open‑label pharmacokinetics/pharmacodynamics and safety study. Use of crizanlizumab in combination with HU/HC did not result in any meaningful differences in the safety profile.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Within each system organ class, the adverse reactions are ranked by frequency, with the most frequent reactions first. Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness. In addition, the corresponding frequency category for each adverse reaction is based on the following convention: very common (≥1/10); common (≥1/100 to &lt;1/10); uncommon (≥1/1,000 to &lt;1/100); rare (≥1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><a name=\"_Toc272145403\"></a><a name=\"_Toc272145564\"></a><a name=\"_Toc266768477\"></a><a name=\"_Toc260903679\"></a><a name=\"_Toc266264818\"></a><a name=\"_Toc499550967\"></a><a name=\"_Toc517716325\"><b><span lang=\"EN-GB\">Table 1       Adverse reactions in clinical studies</span></b></a><a name=\"_hd6_Table_7_1_Percentage_o7395\"></a></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:459.0pt;border-collapse:collapse;border:none\" width=\"612\"> <tr style=\"page-break-inside:avoid\"> <td style=\"width:175.5pt;border:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt\">System organ class</span></b></p> </td> <td style=\"width:81.0pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Frequency</span></b></p> </td> <td style=\"width:202.5pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Adverse reaction</span></b></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Respiratory, thoracic and   mediastinal disorders</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Oropharyngeal pain</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td rowspan=\"2\" style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Gastrointestinal disorders</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Very common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Nausea, abdominal pain*</span></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:13.45pt\"> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:13.45pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:13.45pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">D</span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">iarrhoea, vomiting</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Skin and subcutaneous tissue   disorders</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Pruritus*</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td rowspan=\"2\" style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Musculoskeletal and   connective tissue disorders</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Very common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Arthralgia, back pain</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Myalgia, musculoskeletal   chest pain</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td rowspan=\"2\" style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">General disorders and   administration site conditions</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Very common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Pyrexia</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Infusion site reaction*</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Injury, poisoning and   procedural complications</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Infusion‑related   reaction</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td colspan=\"3\" style=\"width:459.0pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"612\"> <p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style=\\'font-family:\"Times New Roman\",serif\\'>*The   following groupings contain the following MedDRA preferred terms:</span></p> <p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;   margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\\'font-family:   \"Times New Roman\",serif\\'>-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                   </span></span><span lang=\"EN-GB\" style=\\'font-family:\"Times New Roman\",serif\\'>Abdominal   pain: abdominal pain, abdominal pain upper, abdominal pain lower, abdominal   discomfort, and abdominal tenderness</span></p> <p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;   margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"FR-CH\" style=\\'font-family:   \"Times New Roman\",serif\\'>-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                   </span></span><span lang=\"EN-GB\" style=\\'font-family:\"Times New Roman\",serif\\'>Pruritus:   pruritus and vulvovaginal pruritus</span></p> <p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;   margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\\'font-size:   11.0pt;font-family:\"Times New Roman\",serif\\'>-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                   </span></span><span lang=\"FR-CH\" style=\\'font-family:\"Times New Roman\",serif\\'>Infusion   site reaction: infusion site extravasation, infusion site pain, and infusion   site swelling</span></p> </td> </tr> </table> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Description of selected adverse reactions</span></u></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after: avoid\"><span style=\"font-size:11.0pt\"> </span></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after: avoid\"><i><u><span style=\"font-size:11.0pt\">Immunogenicity</span></u></i></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">In clinical studies, treatment‑induced anti‑crizanlizumab antibodies were transiently detected in 1 patient (0.9%) among the 111 patients who received Adakveo 5 mg/kg.</span></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">There was no evidence of altered pharmacokinetics or of an altered safety profile with anti‑crizanlizumab antibody development.</span></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p> <p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Paediatric population</span></u></p> <p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">Frequency, type and severity of adverse reactions in patients aged 16 and 17 years are expected to be the same as in adults. The safety of crizanlizumab was evaluated in 3 patients aged &lt;18 years.</span></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Reporting of suspected adverse reactions</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via <span style=\"color:black; background:#D9D9D9\">the national reporting system listed in </span></span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:#D9D9D9\">Appendix V</span></a></span><span lang=\"EN-GB\">.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.9     Overdose</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">No cases of overdose have been reported in clinical studies.</span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">General supportive measures and symptomatic treatment should be initiated in cases of suspected overdose.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.       PHARMACOLOGICAL PROPERTIES</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.1     Pharmacodynamic properties</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Pharmacotherapeutic group: Other haematological agents, ATC code: B06AX01</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Mechanism of action</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Crizanlizumab is a selective IgG2 kappa humanised monoclonal antibody (mAb) that binds to P‑selectin with high affinity and blocks the interaction with its ligands, including P‑selectin glycoprotein ligand 1. </span><span lang=\"EN-GB\">Crizanlizumab can also dissociate preformed P‑selectin/PSGL‑1 complex. </span><span lang=\"EN-GB\">P‑selectin is an adhesion molecule expressed on activated endothelial cells and platelets. It plays an essential role in the initial recruitment of leukocytes and the aggregation of platelets to the site of vascular injury during inflammation. In the chronic pro‑inflammatory state associated with sickle cell disease, P‑selectin is over‑expressed and circulating blood cells and the endothelium are activated and become hyperadhesive. P‑selectin‑mediated multi‑cellular adhesion is a key factor in the pathogenesis of vaso‑occlusion and vaso‑occlusive crises (VOC). Elevated levels of P‑selectin are found in patients with sickle cell disease.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Binding P‑selectin on the surface of the activated endothelium and platelets has been shown to effectively block interactions between endothelial cells, platelets, red blood cells and leukocytes, thereby preventing vaso‑occlusion.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Pharmacodynamic effects</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Throughout clinical studies, treatment with crizanlizumab 5 mg/kg resulted in dose‑dependent, immediate and sustained P‑selectin inhibition </span><span lang=\"EN-GB\">(as measured <i>ex vivo</i>) </span><span lang=\"EN-GB\">in patients with sickle cell disease.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Clinical efficacy and safety</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The efficacy of crizanlizumab, with or without HU/HC, was evaluated in the pivotal study SUSTAIN, a 52‑week, randomised, placebo‑controlled, double‑blind, multicentre clinical study in sickle cell disease patients with a history of vaso‑occlusive crises (VOCs).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In this study, VOCs were defined as those leading to a healthcare visit, which captured all acute episodes of pain with no other cause than a vaso‑occlusive event that required a healthcare visit and treatment with oral or parenteral opioids or parenteral non‑steroidal anti‑inflammatory drugs (NSAIDs). Acute chest syndrome, hepatic sequestration, splenic sequestration and priapism (requiring a healthcare visit), by definition, were also considered VOCs.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">A total of 198 sickle cell disease patients aged 16 to 63 years (inclusive; mean age 30.1±10.3 years), with any sickle cell disease genotype (including HbSS [71.2%], HbSC [16.2%], HbSbeta0‑thalassaemia [6.1%], HbSbeta+‑thalassaemia [5.1%], and others [1.5%]) and a history of between 2 and 10 VOCs in the previous 12 months (62.6% and 37.4% of the patients had 2‑4 or 5‑10 VOCs, respectively), were randomised 1:1:1 to Adakveo 5 mg/kg, Adakveo 2.5 mg/kg or placebo. The majority of patients were Black or African American (91.9%). Patients received Adakveo with (62.1%) or without (37.9%) HU/HC. Randomisation was stratified by patients already receiving HU/HC (Y/N) and by number of VOCs in the previous 12 months (2 to 4, 5 to 10). Patients were allowed to take medicinal products to relieve pain (i.e. paracetamol, NSAIDs and opioids) and to receive occasional transfusions on an “as needed” basis. Patients participating in a chronic transfusion programme (pre-planned series of transfusions for prophylactic purposes) were excluded from the study.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Treatment with Adakveo 5 mg/kg resulted in a 45.3% lower median annual rate of VOCs compared to placebo (Hodges‑Lehmann, median absolute difference of ‑1.01 compared with placebo, 95% CI [‑2.00, 0.00]), which was statistically significant (p=0.010). The median annual rates of uncomplicated VOCs (any VOCs as defined above, excluding acute chest syndrome, hepatic sequestration, splenic sequestration or priapism) and days hospitalised were 62.9% and 41.8% lower in the Adakveo 5 mg/kg than in the placebo group, respectively. The VOCs occurring during the study were assessed by an independent review committee.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Main efficacy outcomes of the pivotal SUSTAIN study are summarised in Tables 2 and 3.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><a name=\"_Toc499550968\"></a><a name=\"_Toc517716326\"><b><span lang=\"EN-GB\">Table </span></b></a><b><span lang=\"EN-GB\">2       Results from SUSTAIN clinical study in </span></b><a name=\"_hd6_Table_12_1_Results_fro16811\"></a><b><span lang=\"EN-GB\">sickle cell disease</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:98.84%;border-collapse:collapse;border:none\" width=\"98%\"> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <td style=\"width:20.16%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"20%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Event</span></b></p> </td> <td style=\"width:23.82%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"23%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Adakveo 5 mg/kg</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">(N=67)</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(standard median)</span></p> </td> <td style=\"width:11.54%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"11%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Placebo</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">(N=65)</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(standard median)</span></p> </td> <td style=\"width:10.46%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"10%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Change vs placebo</span></b></p> </td> <td style=\"width:21.1%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"21%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Hodges‑Lehmann median   difference</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(95% CI)</span></p> </td> <td style=\"width:12.9%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"12%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">p-value</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(Wilcoxon rank sum)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <td style=\"width:20.18%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"20%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Primary endpoint</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Annual rate of VOCs</span></p> </td> <td style=\"width:23.82%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"23%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.63</span></p> </td> <td style=\"width:11.54%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"11%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.98</span></p> </td> <td style=\"width:10.46%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"10%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑45.3%</span></p> </td> <td style=\"width:21.1%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"21%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.01</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑2.00, 0.00)</span></p> </td> <td style=\"width:12.9%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"12%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">0.010</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td colspan=\"5\" style=\"width:87.1%;border:none;   border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"87%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Secondary endpoints</span></b></p> </td> <td style=\"width:12.9%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"12%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\"> </span></b></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <td style=\"width:20.18%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"20%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Annual rate of days hospitalised</span></p> </td> <td style=\"width:23.82%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"23%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">4.00</span></p> </td> <td style=\"width:11.54%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"11%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">6.87</span></p> </td> <td style=\"width:10.46%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"10%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑41.8%</span></p> </td> <td style=\"width:21.1%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"21%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">0.00</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑4.36, 0.00)</span></p> </td> <td style=\"width:12.9%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"12%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">0.450</span></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <td style=\"width:20.18%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"20%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Annual rate of uncomplicated VOCs</span></p> </td> <td style=\"width:23.82%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"23%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.08</span></p> </td> <td style=\"width:11.54%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"11%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.91</span></p> </td> <td style=\"width:10.46%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"10%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑62.9%</span></p> </td> <td style=\"width:21.1%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"21%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.00</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑1.98, 0.00)</span></p> </td> <td style=\"width:12.9%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"12%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">-</span></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <td colspan=\"6\" style=\"width:.02%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"0%\"> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">The primary (annual rate of VOC leading   to healthcare visit) and key secondary (annual rate of days hospitalised)   endpoints were the only ones formally tested for statistical significance   according to protocol.</span></p> </td> </tr> </table> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\"><span lang=\"EN-GB\">The clinical effect demonstrated in the primary efficacy analysis was supported by multiple supplementary analyses including a negative binomial regression on investigator assessments with a conservative method to handle missing data due to early discontinuation of treatment based on outcomes in the placebo group (RR=0.74, 95% CI=0.52, 1.06).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In the Adakveo 5 mg/kg group, clinically significant reductions in the annual rate of VOCs were observed across important subgroups (</span><span lang=\"EN-GB\">HU/HC use, 2‑4 or 5‑10 VOCs in the previous 12 months, and HbSS or non‑HbSS genotypes; </span><span lang=\"EN-GB\">see Table 3).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><b><span lang=\"EN-GB\">Table 3       Annual rate of VOCs in patients ‑ subgroup analyses</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"612\"> <tr style=\"page-break-inside:avoid\"> <td style=\"width:90.45pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"121\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Subgroup </span></b></p> </td> <td style=\"width:63.8pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\"> </span></b></p> </td> <td style=\"width:70.85pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Adakveo 5 mg/kg (N=67)</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(standard median)</span></p> </td> <td style=\"width:63.8pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Placebo (N=65)</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(standard median)</span></p> </td> <td style=\"width:63.8pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Change vs placebo</span></b></p> </td> <td style=\"width:106.3pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Hodges‑Lehmann median   difference</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">(95% CI)</span></b></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td rowspan=\"2\" style=\"width:90.45pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"121\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">HU/HC use</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Yes</span></p> </td> <td style=\"width:70.85pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=42</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.43</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n= 40</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">3.58</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑32.1%</span></p> </td> <td style=\"width:106.3pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.01</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑2.44, 0.00)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">No</span></p> </td> <td style=\"width:70.85pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=25</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.00</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=25</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.00</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑50.0%</span></p> </td> <td style=\"width:106.3pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.02</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑2.00, 0.00)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:20.2pt\"> <td rowspan=\"2\" style=\"width:90.45pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:20.2pt\" width=\"121\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Number of VOCs in previous   12 months</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:20.2pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2‑4 VOCs</span></p> </td> <td style=\"width:70.85pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:20.2pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=42</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.14</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:20.2pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=41</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.00</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:20.2pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑43.0%</span></p> </td> <td style=\"width:106.3pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:20.2pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑0.05</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑1.56, 0.01)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">5‑10 VOCs</span></p> </td> <td style=\"width:70.85pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=25</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.97</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=24</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">5.32</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑63.0%</span></p> </td> <td style=\"width:106.3pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑2.74</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑5.00, ‑0.83)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td rowspan=\"2\" style=\"width:90.45pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"121\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Sickle cell disease genotypes,   including HbSC</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">HbSS</span></p> </td> <td style=\"width:70.85pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=47</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.97</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=47</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">3.01</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑34.6%</span></p> </td> <td style=\"width:106.3pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.01</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑2.18, 0.00)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Non‑HbSS</span></p> </td> <td style=\"width:70.85pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=20</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">0.99</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=18</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.00</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑50.5%</span></p> </td> <td style=\"width:106.3pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.01</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑2.01, 0.00)</span></p> </td> </tr> </table> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">A greater than two‑fold increase in the proportion of patients with no VOC and who completed the study was observed in the Adakveo 5 mg/kg group compared to placebo (22% vs 8%; odds ratio [95% CI]: 3.57 [1.20, 10.63]). A similar difference was also observed across important subgroups (HU/HC use, genotype).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Treatment with Adakveo 5 mg/kg was also associated with a three‑fold longer Kaplan‑Meier estimated median time to first VOC compared with placebo (4.07 vs 1.38 months; HR=0.495, 95% CI: 0.331, 0.741) (Figure 1) and a two‑fold longer median time from randomisation to second VOC compared to placebo (10.32 vs 5.09 months; HR=0.534, 95% CI: 0.329, 0.866).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Figure 1      Kaplan‑Meier curve of time to first VOC</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><span style=\"position:absolute;z-index:251748352;left:0px;margin-left:61px; margin-top:211px;width:13px;height:9px\"><img alt=\"0\" height=\"9\" src=\"Adakveo-4874%20EN%20PI_files/image002.png\" width=\"13\"/></span><span style=\"position:absolute;z-index:251746304;left:0px;margin-left:63px; margin-top:190px;width:10px;height:10px\"><img alt=\"10\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image003.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251744256;left:0px;margin-left:64px; margin-top:169px;width:10px;height:10px\"><img alt=\"20\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image004.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251742208;left:0px;margin-left:64px; margin-top:149px;width:10px;height:10px\"><img alt=\"30\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image005.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251740160;left:0px;margin-left:65px; margin-top:130px;width:10px;height:10px\"><img alt=\"40\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image006.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251738112;left:0px;margin-left:64px; margin-top:110px;width:10px;height:10px\"><img alt=\"50\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image007.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251736064;left:0px;margin-left:64px; margin-top:90px;width:10px;height:10px\"><img alt=\"60\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image008.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251734016;left:0px;margin-left:64px; margin-top:70px;width:10px;height:10px\"><img alt=\"70\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image009.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251731968;left:0px;margin-left:63px; margin-top:48px;width:10px;height:10px\"><img alt=\"80\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image010.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251729920;left:0px;margin-left:65px; margin-top:28px;width:10px;height:10px\"><img alt=\"90\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image011.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251727872;left:0px;margin-left:60px; margin-top:9px;width:15px;height:10px\"><img alt=\"100\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image012.png\" width=\"15\"/></span><span style=\"position:absolute;z-index:251781120;left:0px;margin-left:459px; margin-top:8px;width:125px;height:38px\"><img height=\"38\" src=\"Adakveo-4874%20EN%20PI_files/image013.png\" width=\"125\"/></span><span style=\"position: absolute;z-index:251779072;left:0px;margin-left:494px;margin-top:7px; width:92px;height:26px\"><img height=\"26\" src=\"Adakveo-4874%20EN%20PI_files/image014.png\" width=\"92\"/></span><span style=\"position: absolute;z-index:251666432;left:0px;margin-left:22px;margin-top:28px; width:32px;height:178px\"><img alt=\"Probability of being free from first VOC (%)\" height=\"178\" src=\"Adakveo-4874%20EN%20PI_files/image015.png\" width=\"32\"/></span><span style=\"position:absolute;z-index:251725824;left:0px;margin-left:320px; margin-top:242px;width:56px;height:10px\"><img alt=\"Time (months)¬¬¬¬\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image016.png\" width=\"56\"/></span><sub><span style=\"font-size:11.0pt\">                                <img border=\"0\" height=\"223\" id=\"Picture 1243\" src=\"Adakveo-4874%20EN%20PI_files/image017.jpg\" width=\"518\"/></span></sub></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"> <table align=\"left\" cellpadding=\"0\" cellspacing=\"0\"> <tr> <td height=\"1\" width=\"3\"></td> <td width=\"36\"></td> <td width=\"33\"></td> <td width=\"2\"></td> <td width=\"2\"></td> <td width=\"5\"></td> <td width=\"10\"></td> <td width=\"3\"></td> <td width=\"23\"></td> <td width=\"10\"></td> <td width=\"27\"></td> <td width=\"10\"></td> <td width=\"26\"></td> <td width=\"3\"></td> <td width=\"7\"></td> <td width=\"28\"></td> <td width=\"10\"></td> <td width=\"28\"></td> <td width=\"10\"></td> <td width=\"25\"></td> <td width=\"10\"></td> <td width=\"26\"></td> <td width=\"13\"></td> <td width=\"26\"></td> <td width=\"10\"></td> <td width=\"26\"></td> <td width=\"10\"></td> <td width=\"30\"></td> <td width=\"10\"></td> <td width=\"26\"></td> <td width=\"10\"></td> <td width=\"26\"></td> <td width=\"10\"></td> <td width=\"27\"></td> <td width=\"10\"></td> <td width=\"18\"></td> </tr> <tr> <td height=\"10\"></td> <td colspan=\"5\"></td> <td align=\"left\" valign=\"top\"><img alt=\"0\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image018.png\" width=\"10\"/></td> <td colspan=\"2\"></td> <td align=\"left\" valign=\"top\"><img alt=\"1\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image019.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"2\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image020.png\" width=\"10\"/></td> <td></td> <td align=\"left\" colspan=\"2\" valign=\"top\"><img alt=\"3\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image021.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"4\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image022.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"5\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image023.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"6\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image024.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"7\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image025.png\" width=\"13\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"8\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image026.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"9\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image027.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"10\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image003.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"11\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image028.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"12\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image029.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"13\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image030.png\" width=\"10\"/></td> </tr> <tr> <td height=\"14\"></td> </tr> <tr> <td height=\"9\"></td> <td colspan=\"7\"></td> <td align=\"left\" colspan=\"6\" valign=\"top\"><img alt=\"Number of patients at risk\" height=\"9\" src=\"Adakveo-4874%20EN%20PI_files/image031.png\" width=\"99\"/></td> </tr> <tr> <td height=\"7\"></td> </tr> <tr> <td height=\"7\"></td> <td colspan=\"4\"></td> <td align=\"left\" colspan=\"31\" rowspan=\"5\" valign=\"top\"><img alt=\"67,49,41,35,30,26,24,20,18,17,16,15,7,65,37,23,21,17,13,12,9,8,6,5,4,1,0,0\" height=\"43\" src=\"Adakveo-4874%20EN%20PI_files/image032.png\" width=\"513\"/></td> </tr> <tr> <td height=\"10\"></td> <td align=\"left\" colspan=\"3\" valign=\"top\"><img alt=\"Adakveo 5 mg/kg \" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image033.png\" width=\"71\"/></td> </tr> <tr> <td height=\"14\"></td> </tr> <tr> <td height=\"10\"></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"Placebo\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image034.png\" width=\"33\"/></td> </tr> <tr> <td height=\"2\"></td> </tr> </table> <span lang=\"EN-GB\"> </span></p> <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><span style=\"font-size:11.0pt\"> </span></p> <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><span style=\"font-size:11.0pt\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <br clear=\"ALL\"/> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><a name=\"_hd6_Table_2_1_Patients_wit18544\"></a><u><span lang=\"EN-GB\">Paediatric population</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The efficacy of crizanlizumab in patients aged 16 and 17 years is expected to be the same as in adults. Three patients (2.7%) aged less than 18 years were treated with crizanlizumab 5 mg/kg in clinical studies.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The European Medicines Agency has deferred the obligation to submit the results of studies with Adakveo in one or more subsets of the paediatric population in the treatment of sickle cell disease (see section 4.2 for information on paediatric use).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Conditional approval</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal product has been authorised under a so‑called “conditional approval” scheme. This means that further evidence on this medicinal product is awaited.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The European Medicines Agency will review new information on this medicinal product at least every year and this SmPC will be updated as necessary.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.2     Pharmacokinetic properties</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Absorption</span></u></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The median time to reach maximum serum concentration of crizanlizumab (T<sub>max</sub>) was 1.92 hours at steady state following intravenous administration of 5 mg/kg over a period of 30 minutes in sickle cell disease patients.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Distribution</span></u></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab distribution is typical of endogenous human antibodies within the vascular and extracellular spaces. The volume of distribution (V<sub>z</sub>) was 4.26 litres after a single 5 mg/kg intravenous infusion of crizanlizumab in healthy volunteers.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Biotransformation</span></u></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Antibodies are primarily eliminated via proteolysis by lysosomal enzymes in the liver to small peptides and amino acids.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Elimination</span></u></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In healthy volunteers, the mean terminal elimination half‑life (T<sub>½</sub>) was 10.6 days and the mean clearance was 11.7 ml/h at crizanlizumab dose level 5 mg/kg. In patients with sickle cell disease, the mean elimination T<sub>½</sub> during the dosing interval was 7.5 days.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Linearity/non‑linearity</span></u></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The exposure to crizanlizumab (mean C<sub>max</sub>, AUC<sub>last</sub>, or AUC<sub>inf</sub>) increased in non‑linear manner over the dose range of 0.2 to 8 mg/kg in healthy volunteers.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Special populations</span></u></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Renal impairment</span></u></i></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In a population PK analysis in patients with eGFR ranging from 35 to 202 ml/min/1.73 m<sup>2</sup>, no clinically important differences in the pharmacokinetics of crizanlizumab were found between patients with mild or moderate renal impairment and patients with normal renal function. Data from patients with severe renal impairment are too limited to draw conclusions on this population (see section</span><span lang=\"EN-GB\"> </span><span lang=\"EN-GB\">4.2).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Hepatic impairment</span></u></i></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monoclonal antibody and is cleared via catabolism (i.e. breakdown into peptides and amino acids), and a change in dose is not expected to be required for patients with hepatic impairment.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Paediatric <a name=\"_nth_Pediatric_patients__be14752\"></a>population</span></u></i></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pharmacokinetics in paediatric patients below the age of 16 years have not been investigated.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.3     Preclinical safety data</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">N</span><span lang=\"EN-GB\">on‑clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, tissue cross‑reactivity and repeated dose toxicity.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In the 26‑week repeated dose toxicity study, administration of crizanlizumab in cynomolgus monkeys at dose levels up to 50 mg/kg/dose once every 4 weeks (at least 13.5 times the human clinical exposure based on AUC in patients with sickle cell disease at 5 mg/kg once every four weeks) was generally well tolerated. There were no primary crizanlizumab‑related findings on any endpoint evaluated. At 50 mg/kg, minimal to moderate inflammation of the vessels in multiple tissues considered to be an antigen‑antibody complex reaction (primate antihuman antibody) was observed in 2 of 10 animals. There was one death attributed to aspiration of gastric contents following a peri‑infusional reaction mediated by anti‑drug‑antibody‑dependent hypersensitivity.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\">Pharmacological effects of crizanlizumab on haemodynamic and electrocardiographic parameters in the cynomolgus monkey were evaluated in the 26‑week repeated dose toxicology study. Respiratory rate and neurological parameters were also assessed. There were no crizanlizumab‑related effects on arterial blood pressure or on heart rate, PR, RR, QRS, QT, and heart rate corrected QT (QTc) intervals on the electrocardiograms (ECG). No rhythm abnormalities or qualitative changes were observed during the qualitative ECG assessment. There were no crizanlizumab‑related effects on respiration rate or any neurological parameter evaluated.</p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Formal carcinogenicity, genotoxicity and juvenile toxicity studies have not been conducted with crizanlizumab.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In a 26‑week repeated dose toxicity study, cynomolgus monkeys were administered crizanlizumab once every 4 weeks at doses up to 50 mg/kg (at least 13.5 times the human clinical exposure based on AUC in patients with sickle cell disease at 5 mg/kg once every four weeks). </span><span lang=\"EN-GB\">There were no adverse effects of crizanlizumab on male and female reproductive organs</span>.</p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In an enhanced pre‑ and postnatal development study in cynomolgus monkeys, pregnant animals received intravenous crizanlizumab once every two weeks during the period of organogenesis, at doses of 10 and 50 mg/kg (approximately 2.8 and 16 times </span><span lang=\"EN-GB\">the human clinical exposure based on AUC in patients with sickle cell disease at 5 mg/kg/dose once every four weeks, respectively)</span><span lang=\"EN-GB\">. No maternal toxicity was observed. </span><span lang=\"EN-GB\">There was an increase in foetal loss (abortions or stillbirths) at both doses and this was higher in the third trimester. The cause of the foetal losses in monkeys is unknown but may be due to the development of anti‑drug antibodies against crizanlizumab</span><span lang=\"EN-GB\">. There were no effects on infant growth and development during the 6 months postpartum that were attributable to crizanlizumab.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Measurable crizanlizumab serum concentrations were observed in the infant monkeys at postnatal day 28, confirming that crizanlizumab, like other IgG antibodies, crosses the placental barrier.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.       PHARMACEUTICAL PARTICULARS</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.1     List of excipients</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Sucrose</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Sodium citrate (E331)</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Citric acid (E330)</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Polysorbate 80 (E433)</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Water for injections</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.2     Incompatibilities</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal product</span><span lang=\"EN-GB\"> must not be mixed with other medicinal products except those mentioned in section 6.6.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.3     Shelf life</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Unopened vial</span></u></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">18 months</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Diluted solution</span></u></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Chemical and physical in‑use stability, from the start of preparation of the diluted solution for infusion until end of infusion, has been demonstrated for up to 8 hours at room temperature (up to 25°C) and at 2°C to 8°C for up to 24 hours overall.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">From a microbiological point of view, the diluted solution for infusion should be used immediately. If not used immediately, in‑use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2°C to 8°C, including 4.5 hours at room temperature (up to 25°C) from the start of preparation to completion of the infusion, unless dilution has taken place in controlled and validated aseptic conditions.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.4     Special precautions for storage</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Store in a refrigerator (2°C – 8°C).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not freeze.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep the vial in the outer carton in order to protect from light.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For storage conditions after dilution of the medicinal product, see section 6.3.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.5     Nature and contents of container</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">10 ml concentrate for solution for infusion in a type I glass vial with a coated chlorobutyl rubber stopper sealed with an aluminium cap with a plastic flip‑off disk containing 100 mg crizanlizumab.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pack of 1 vial.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><a name=\"OLE_LINK1\"><b><span lang=\"EN-GB\">6.6     Special precautions for disposal and other handling</span></b></a></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo vials are for single use only.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Preparing the infusion</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The diluted solution for infusion should be prepared by a healthcare professional using aseptic techniques.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The total dose and required volume of Adakveo depend on the patient’s body weight; 5 mg of crizanlizumab is administered per kg body weight.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">The volume to be used for the preparation of the infusion is calculated according to the following equation:</span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:12.5pt;border-collapse:collapse\" width=\"567\"> <tr> <td rowspan=\"2\" style=\"width:85.05pt;padding:0in 5.4pt 0in 5.4pt\" width=\"113\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Volume (ml) =</span></p> </td> <td style=\"width:269.35pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"359\"> <p align=\"center\" class=\"MsoNormal\" style=\"margin-left:28.35pt;text-align:center;   text-indent:-28.35pt;line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Patient’s body weight (kg) x prescribed dose</span></p> </td> <td style=\"width:70.85pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"94\"> <p align=\"center\" class=\"MsoNormal\" style=\"margin-left:28.35pt;text-align:center;   text-indent:-28.35pt;line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">[5 mg/kg]</span></p> </td> </tr> <tr> <td style=\"width:269.35pt;border:none;padding:0in 5.4pt 0in 5.4pt\" width=\"359\"> <p align=\"center\" class=\"Text\" style=\"margin-top:0in;text-align:center;   page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Concentration   of Adakveo</span></p> </td> <td style=\"width:70.85pt;border:none;padding:0in 5.4pt 0in 5.4pt\" width=\"94\"> <p align=\"center\" class=\"Text\" style=\"margin-top:0in;text-align:center;   page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">[10 mg/ml]</span></p> </td> </tr> </table> <p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_hd6_Table_3_1_Example_of_d12477\"></a><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">1.       Obtain the number of vials required to deliver the prescribed dose and bring them to room temperature (for a maximum of 4 hours). One vial is needed for every 10 ml of Adakveo (see below table).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:28.35pt;border-collapse:collapse;border:none\" width=\"568\"> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Body weight (kg)</span></b></p> </td> <td style=\"width:92.15pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Dose (mg)</span></b></p> </td> <td style=\"width:114.75pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Volume (ml)</span></b></p> </td> <td style=\"width:114.75pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Vials (n)</span></b></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">40</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">200</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">20</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">2</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">60</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">300</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">30</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">3</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">80</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">400</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">40</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">4</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">100</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">500</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">50</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">5</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">120</span></p> </td> <td style=\"width:92.15pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">600</span></p> </td> <td style=\"width:114.75pt;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">60</span></p> </td> <td style=\"width:114.75pt;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">6</span></p> </td> </tr> </table> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">2.       Visually inspect the vials.</span></p> <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The solution in the vials should be clear to opalescent. Do not use if particles are present in the solution.</span></p> <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The solution should be colourless or may have a slight brownish‑yellow tint.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">3.       Withdraw a volume equal to the required volume of Adakveo from a 100 ml infusion bag containing either sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% and discard.</span></p> <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">No incompatibilities between the diluted Adakveo solution and infusion bags composed of polyvinylchloride (PVC), polyethylene (PE) and polypropylene (PP) have been observed.</span></p> <p class=\"MsoNormal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">4.       Withdraw the necessary volume of Adakveo from the vials and inject slowly into the previously prepared infusion bag.</span></p> <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The </span><span lang=\"EN-GB\">solution</span><span lang=\"EN-GB\"> must not be mixed or co‑administered with other medicinal products through the same intravenous line.</span></p> <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">Keep the volume of Adakveo added to the infusion bag in the range of 10 ml to 96 ml to obtain a final concentration in the infusion bag within 1 mg/ml to 9.6 mg/ml.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">5.       Mix the diluted solution by gently inverting the infusion bag. DO NOT SHAKE.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Administration</span></u><a name=\"_nth_Administration25012\"></a></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">Adakveo diluted solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by intravenous infusion over a period of 30 minutes.</span><span style=\"font-size:11.0pt\"> <span lang=\"EN-GB\">No incompatibilities have been observed between Adakveo and infusion sets composed of PVC, PE‑lined PVC, polyurethane, and in‑line filter membranes composed of polyethersulfone (PES), polyamide (PA) or polysulphone (PSU).</span></span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">After administration of Adakveo, flush the line with at least 25 ml sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5%.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Disposal</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">7.       MARKETING AUTHORISATION HOLDER</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Novartis Europharm Limited</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Vista Building</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Elm Park, Merrion Road</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Dublin 4</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">Ireland</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">8.       MARKETING AUTHORISATION NUMBER(S)</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">EU/1/20/1476/001</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">9.       DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">10.     DATE OF REVISION OF THE TEXT</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Detailed information on this medicinal product is available on the website of the European Medicines </span><span lang=\"EN-GB\">Agency <a href=\"http://www.ema.europa.eu\">http://www.ema.europa.eu</a></span><span lang=\"EN-GB\">.<br clear=\"all\" style=\"page-break-before:always\"/> </span></p> <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX II</span></b></p> <p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom: 0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">A.      MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom: 0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">B.      CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom: 0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">C.      OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION</span></b></p> <p class=\"MsoNormal\" style=\"margin-right:77.9pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom: 0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">D.      <span style=\"text-transform:uppercase\">conditions or restrictions with regard to the safe and effective use of the medicinal PRODUCT</span></span></b></p> <p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom: 0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">E.      SPECIFIC OBLIGATION TO COMPLETE POST-AUTHORISATION MEASURES FOR THE </span></b><b><span lang=\"EN-GB\">CONDITIONAL</span><span lang=\"EN-GB\"> MARKETING AUTHORISATION</span></b></p> <span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'><br clear=\"all\" style=\"page-break-before:always\"/> </span> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">A.      MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE</span></b></p> <p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Name and address of the manufacturer(s) of the biological active substance(s)</span></u></p> <p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal;page-break-after: avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"Standard\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis Pharma AG</span></p> <p class=\"Standard\" style=\"line-height:normal\"><span lang=\"DE-CH\">Lichtstrasse 35</span></p> <p class=\"Standard\" style=\"line-height:normal\"><span lang=\"DE-CH\">4056 Basel</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Switzerland</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Name and address of the manufacturer(s) responsible for batch release</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"Standard\" style=\"line-height:normal\">Novartis Pharma GmbH</p> <p class=\"Standard\" style=\"line-height:normal\">Roonstrasse 25</p> <p class=\"Standard\" style=\"line-height:normal\">90429 Nuremberg</p> <p class=\"MsoNormal\" style=\"line-height:normal\">Germany</p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><a name=\"OLE_LINK2\"><b><span lang=\"EN-GB\">B.</span></b></a><b><span lang=\"EN-GB\">      CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">C.      OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION</span></b></p> <p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after: avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">·<span style=\\'font:7.0pt \"Times New Roman\"\\'>                </span></span><b><span lang=\"EN-GB\">Periodic safety update reports (PSURs)</span></b></p> <p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal;page-break-after: avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal\"><span lang=\"EN-GB\">The requirements for submission of PSURs for this medicinal product are set out in the list of Union reference dates (EURD list) </span><span lang=\"EN-GB\">provided for under Article 107c(7) of Directive 2001/83</span><span lang=\"EN-GB\">/EC</span><span lang=\"EN-GB\"> and </span><span lang=\"EN-GB\">any subsequent updates published on the European medicines web‑portal.</span></p> <p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The marketing authorisation holder (MAH) shall submit the first PSUR for this product within 6 months following authorisation.</span></p> <p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">D.      CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</span></b></p> <p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after: avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">·<span style=\\'font:7.0pt \"Times New Roman\"\\'>                </span></span><b><span lang=\"EN-GB\">Risk management plan (RMP)</span></b></p> <p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal;page-break-after: avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-right:28.35pt;line-height:normal\"><span lang=\"EN-GB\">The </span><span lang=\"EN-GB\">marketing</span><span lang=\"EN-GB\"> authorisation holder (</span><span lang=\"EN-GB\">MAH) shall perform the required pharmacovigilance activities and interventions detailed in the agreed RMP presented in Module 1.8.2 of the marketing authorisation and any agreed subsequent updates of the RMP.</span></p> <p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">An updated RMP should be submitted:</span></p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">·<span style=\\'font:7.0pt \"Times New Roman\"\\'>                </span></span><span lang=\"EN-GB\">At the request of the European Medicines Agency;</span></p> <p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.05pt;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">·<span style=\\'font:7.0pt \"Times New Roman\"\\'>                </span></span><span lang=\"EN-GB\">Whenever the risk management system is modified, especially as the result of new information being received that may lead to a significant change to the benefit/risk profile or as the result of an important (pharmacovigilance or risk minimisation) milestone being reached.</span></p> <p class=\"MsoNormal\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"Standard\" style=\"margin-right:-.05pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"Standard\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">E.      SPECIFIC OBLIGATION TO COMPLETE POST-AUTHORISATION MEASURES FOR THE CONDITIONAL MARKETING AUTHORISATION</span></b></p> <p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"Standard\" style=\"margin-right:-.05pt;line-height:normal;page-break-after: avoid\"><span lang=\"EN-GB\">This being a conditional marketing authorisation and pursuant to Article 14a(4) of Regulation (EC) No 726/2004, the MAH shall complete, within the stated timeframe, the following measures:</span></p> <p class=\"Standard\" style=\"margin-right:-.05pt;line-height:normal;page-break-after: avoid\"><span lang=\"EN-GB\"> </span></p> <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"NormaleTabelle\" style=\"border-collapse:collapse;border:none\" width=\"100%\"> <tr style=\"page-break-inside:avoid\"> <td style=\"width:82.18%;border:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"82%\"> <p class=\"Standard\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:   avoid\"><b><span lang=\"EN-GB\">Description</span></b></p> </td> <td style=\"width:17.82%;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\"> <p class=\"Standard\" style=\"margin-right:-.05pt;line-height:normal;page-break-after:   avoid\"><b><span lang=\"EN-GB\">Due date</span></b></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:82.18%;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"82%\"> <p class=\"TabletextrowsAgency\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'>In   order to confirm the efficacy and safety of crizanlizumab, the MAH should   submit the results of the primary analysis of a phase III CSEG101A2301 study   of crizanlizumab with or without hydroxyurea/hydroxycarbamide in adolescent   and adult sickle cell disease patients with vaso-occlusive crises</span></p> </td> <td style=\"width:17.82%;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\"> <p class=\"TabletextrowsAgency\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'>Clinical   study report primary analysis:</span></p> <p class=\"TabletextrowsAgency\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'>December   2025</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:82.18%;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"82%\"> <p class=\"TabletextrowsAgency\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'>In   order to confirm the efficacy and safety of crizanlizumab, the MAH should   submit the final results of the phase II CSEG101A2202 study of   crizanlizumab with or without hydroxyurea/hydroxycarbamide in sickle cell   disease patients with vaso‑occlusive crisis.</span></p> </td> <td style=\"width:17.82%;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"17%\"> <p class=\"TabletextrowsAgency\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'>Clinical   study report:</span></p> <p class=\"TabletextrowsAgency\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'>December   2025</span></p> </td> </tr> </table> <span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'><br clear=\"all\" style=\"page-break-before:always\"/> </span> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX III</span></b></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">LABELLING AND PACKAGE LEAFLET</span></b></p> <b><span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'><br clear=\"all\" style=\"page-break-before:always\"/> </span></b> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">A. LABELLING</span></b></p> <span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif; color:black\\'><br clear=\"all\" style=\"page-break-before:always\"/> </span> <p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;border:none;padding:0in\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">CARTON</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.       NAME OF THE MEDICINAL PRODUCT</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo 10 mg/ml concentrate for solution for infusion</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">crizanlizumab</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.       STATEMENT OF ACTIVE SUBSTANCE(S)</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each 10 ml vial contains 100 mg crizanlizumab.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.       LIST OF EXCIPIENTS</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Also contains: sucrose, sodium citrate (E331), citric acid (E330), polysorbate 80 (E433), water for injections.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.       PHARMACEUTICAL FORM AND CONTENTS</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Concentrate for solution for infusion</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1 vial</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">100 mg/10 ml</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.       METHOD AND ROUTE(S) OF ADMINISTRATION</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For intravenous use after dilution.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Single use.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package leaflet before use.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.       SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the sight and reach of children.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.       OTHER SPECIAL WARNING(S), IF NECESSARY</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.       EXPIRY DATE</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.       SPECIAL STORAGE CONDITIONS</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Store in a refrigerator.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Do not freeze.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep the vial in the outer carton in order to protect from light.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.     SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.     NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Novartis Europharm Limited</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Vista Building</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Elm Park, Merrion Road</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Dublin 4</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ireland</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.     MARKETING AUTHORISATION NUMBER(S)</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU/1/20/1476/001</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.     BATCH NUMBER</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.     GENERAL CLASSIFICATION FOR SUPPLY</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.     INSTRUCTIONS ON USE</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border: none;padding:0in\"><b><span lang=\"EN-GB\">16.     INFORMATION IN BRAILLE</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Justification for not including Braille accepted.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border: none;padding:0in\"><b><span lang=\"EN-GB\">17.     UNIQUE IDENTIFIER – 2D BARCODE</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">2D barcode carrying the unique identifier included.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border: none;padding:0in\"><b><span lang=\"EN-GB\">18.     UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">PC</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">SN</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NN</span></p> <span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif; color:black;background:#CCCCCC\\'><br clear=\"all\" style=\"page-break-before:always\"/> </span> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\"> </span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">VIAL LABEL</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.       NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION</span></b></p> </div> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">Adakveo 10 mg/ml sterile concentrate</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">crizanlizumab</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">IV</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.       METHOD OF ADMINISTRATION</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.       EXPIRY DATE</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.       BATCH NUMBER</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.       CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT</span></b></p> </div> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">100 mg/10 ml</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\"> <p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.       OTHER</span></b></p> </div> <b><span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'><br clear=\"all\" style=\"page-break-before:always\"/> </span></b> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">B. PACKAGE LEAFLET</span></b></p> <span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'><br clear=\"all\" style=\"page-break-before:always\"/> </span> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">Package leaflet: Information for the patient</span></b></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal; background:white\"><span lang=\"EN-GB\"> </span></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">Adakveo 10 mg/ml concentrate for solution for infusion</span></b></p> <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">crizanlizumab</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><img alt=\"BT_1000x858px\" border=\"0\" height=\"18\" id=\"Picture 1\" src=\"Adakveo-4874%20EN%20PI_files/image035.png\" width=\"21\"/><span lang=\"EN-GB\">This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Read all of this leaflet carefully before you are given this medicine because it contains important information for you.</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">Keep this leaflet. You may need to read it again.</span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">If you have any further questions, ask your doctor or nurse.</span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">If you get any side effects, talk to your doctor or nurse.</span><span lang=\"EN-GB\"> This includes any possible side effects not listed in this leaflet. See section 4.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What is in this leaflet</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1.       What Adakveo is and what it is used for</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">2.       What you need to know before you are given Adakveo</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">3.       How Adakveo is given</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">4.       Possible side effects</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">5.       How to store Adakveo</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">6.       Contents of the pack and other information</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">1.       What Adakveo is and what it is used for</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What Adakveo is</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo </span>contains the active substance crizanlizumab, which belongs to a group of medicines called monoclonal antibodies (mAbs).</p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>What Adakveo</b><b> </b><b>is used for</b></p> <p class=\"MsoNormal\" style=\"line-height:normal\">Adakveo is used to prevent recurrent painful crises occurring in patients aged 16 years and over with sickle cell disease. Adakveo can be given in combination with hydroxyurea/hydroxycarbamide, although it may also be used alone.</p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal\">Sickle cell disease is an inherited blood disorder. It causes affected red blood cells to become sickle‑shaped and have difficulty passing through small blood vessels. Additionally in sickle cell disease the blood vessels are damaged and sticky due to ongoing chronic inflammation. This leads to blood cells sticking to the blood vessels, causing acute episodes of pain and organ damage.</p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>How Adakveo works</b></p> <p class=\"MsoNormal\" style=\"line-height:normal\">Patients with sickle cell disease have higher levels of a protein called P‑selectin. Adakveo binds P‑selectin. This should stop blood cells sticking to the vessel walls and help prevent painful crises.</p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal\">If you have any questions about how Adakveo works or why this medicine has been prescribed for you, ask your <a name=\"_Toc312231909\"></a><span lang=\"EN-GB\">doctor or nurse</span>.</p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.       What you need to know before you are given Adakveo</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">You must not be given Adakveo:</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-        if you are allergic to crizanlizumab or any of the other ingredients of this medicine (listed in section 6).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Warnings and precautions</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Infusion reactions</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Medicines of this type (called monoclonal antibodies) are administered into a vein (intravenously) as an infusion. They can cause unwanted reactions (side effects) when they are infused into your body. Such reactions may happen within 24 hours of receiving an infusion.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Tell your doctor or nurse immediately</span></b><span lang=\"EN-GB\"> if you experience any of the following, which may be signs of an infusion reaction:</span></p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">Fever, chills, shivering, nausea, vomiting, tiredness, dizziness, pain where the infusion needle is inserted, blisters, itching, shortness of breath or wheezing. See also section 4, “Possible side effects”.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Your doctor or nurse may monitor you for signs and symptoms of such infusion reactions.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Blood tests during Adakveo treatment</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you need to have any blood tests, tell the doctor or nurse that you are on treatment with Adakveo. This is important because this treatment may interfere with a laboratory test used to measure the number of platelets in your blood.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Children and adolescents</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo </span>should not be used in children or adolescents below 16 years of age.</p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><b>Other medicines and Adakveo</b></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Tell your doctor or nurse if you are taking, have recently taken or might take any other medicines.</p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Pregnancy and breast‑feeding</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Adakveo has not been tested in pregnant women therefore there is limited information about its safety in pregnant women.</p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">If you are pregnant, or are a woman who could become pregnant and is not using contraception, it is not recommended to use Adakveo.</p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">It is not known whether <span lang=\"EN-GB\">Adakveo </span>or its individual ingredients pass into breast milk.</p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">If you are pregnant or breast‑feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before receiving this medicine. Your doctor will discuss with you the potential risk(s) of <span lang=\"EN-GB\">Adakveo </span>during pregnancy or breast‑feeding.</p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Driving and using machines</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Adakveo could have a minor effect on your ability to drive and use machines. If you experience tiredness, drowsiness or dizziness, do not drive or use machines until you feel better.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Adakveo contains sodium</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\">This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially “sodium‑free”.</p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">3.       How Adakveo is given</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Adakveo will be given to you by a doctor or nurse.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you have any questions about how Adakveo is given, ask the doctor or nurse who is giving you the infusion.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Your doctor will tell you when you will have your infusions and follow‑up appointments.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">How much Adakveo you will be given</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The recommended dose is 5 mg per kilogram of body weight. You will be given the first infusion at Week 0 and the second infusion two weeks later (Week 2). After that you will be given an infusion every 4 weeks.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">How the infusion is given</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo is administered into a vein (intravenously) as an infusion lasting 30 minutes.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo can be given alone or with hydroxyurea/hydroxycarbamide.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">How long Adakveo treatment lasts</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">You should discuss with your doctor how long you will need to receive treatment. Your doctor will regularly monitor your condition to check that the treatment is having the desired effect.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">If you forget a Adakveo infusion</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It is very important that you receive all your infusions. If you miss an appointment for an infusion, contact your doctor as soon as possible to reschedule.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">If you stop Adakveo treatment</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not stop Adakveo treatment unless your doctor tells you that you can.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you have any further questions on the use of this medicine, ask your doctor or nurse.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.       Possible side effects</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Like all medicines, this medicine can cause side effects, although not everybody gets them.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:1.5in;text-indent:-1.5in;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Some side effects could be serious</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Tell the doctor or nurse giving you the infusion immediately</span></b><span lang=\"EN-GB\"> if you develop any of the following:</span></p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">Fever, chills, shivering, nausea, vomiting, tiredness, dizziness, pain where the infusion needle is inserted, blisters, itching, shortness of breath or wheezing.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">These symptoms can be signs of infusion reaction, which is a common side effect (this means it may affect up to 1 in every 10 people).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:1.5in;text-indent:-1.5in;line-height: normal;page-break-after:avoid\"><b>Other possible side effects</b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">Other possible side effects include those listed below. If these side effects become severe, tell your doctor or nurse.</p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Very common (may affect more than 1 in 10 people)</b></p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>pain in the joints (arthralgia)</p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>nausea</p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>back pain</p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>fever</p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>pain in the lower or upper abdomen, feeling of tenderness in the abdomen and abdominal discomfort</p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b>Common (may affect up to 1 in every 10 people)</b></p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>diarrhoea</p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>itching (including vulvovaginal itching)</p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>vomiting</p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>muscle pain (myalgia)</p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>pain in the muscles or bones of the chest (musculoskeletal chest pain)</p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>sore throat (oropharyngeal pain)</p> <p class=\"MsoListParagraph\" style=\"margin-left:28.35pt;text-indent:-28.35pt; line-height:normal\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span>redness or swelling and pain at the site of the infusion</p> <p class=\"MsoNormal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"page-break-after:avoid\"><b><span lang=\"EN-GB\">Reporting of side effects</span></b></p> <p class=\"MsoNormal\"><span lang=\"EN-GB\">If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet.</span><span lang=\"EN-GB\" style=\"font-size:9.0pt\"> </span><span lang=\"EN-GB\">You can also report side effects directly via <span style=\"color:black;background:#D9D9D9\">the national reporting system listed in </span></span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:#D9D9D9\">Appendix V</span></a></span><span lang=\"EN-GB\">.</span><span lang=\"EN-GB\"> By reporting side effects you can help provide more information on the safety of this medicine.</span></p> <p class=\"MsoNormal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.       How to store Adakveo</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep this medicine out of the sight and reach of children.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"BodytextAgency\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'>Do not use this medicine after the expiry date which is stated on the outer carton and the label after “EXP”. The expiry date refers to the last day of that month.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep the vial in the outer carton in order to protect from light. Store in a refrigerator (2°C – 8°C). Do not freeze.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Infusion solutions should be used immediately after dilution.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.       Contents of the pack and other information</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What Adakveo contains</span></b></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The active substance is crizanlizumab. Each 10 ml vial contains 100 mg of crizanlizumab.</span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The other ingredients are sucrose, sodium citrate </span>(E331)<span lang=\"EN-GB\">, citric acid (E330), polysorbate 80 (E433) and water for injections.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What Adakveo looks like and contents of the pack</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo concentrate for solution for infusion is a colourless to slightly brownish‑yellow liquid.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo is available in packs containing 1 vial.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Marketing Authorisation Holder</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Novartis Europharm Limited</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Vista Building</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Elm Park, Merrion Road</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Dublin 4</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ireland</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Manufacturer</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">Novartis Pharma GmbH</p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">Roonstrasse 25</p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">90429 Nuremberg</p> <p class=\"MsoNormal\" style=\"line-height:normal\">Germany</p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:-1.7pt;border-collapse:collapse\" width=\"0\"> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR-BE\">België/Belgique/Belgien</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-BE\">Novartis   Pharma N.V.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-BE\">Tél/Tel: +32 2   246 16 11</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\"> </span></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"LT\">Lietuva</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">SIA Novartis   Baltics Lietuvos filialas</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"LT\">Tel: +370 5 269   16 50</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\"> </span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"BG\">България</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">Novartis Pharma   Services Inc.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"BG\">Тел:</span>   +359 2 489 98 28</p> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NO-BOK\"> </span></b></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-CH\">Luxembourg/Luxemburg</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Novartis   Pharma N.V.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-BE\">Tél/Tel: +32 2   246 16 11</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-BOK\"> </span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Česká   republika</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">Novartis s.r.o.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\">Tel: +420 225   775 111</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-CH\"> </span></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"HU\">Magyarország</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"HU\">Novartis Hungária   Kft. Pharma</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"HU\">Tel.: +36 1 457   65 00</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b>Danmark</b></p> <p class=\"MsoNormal\" style=\"line-height:normal\">Novartis Healthcare A/S</p> <p class=\"MsoNormal\" style=\"line-height:normal\">Tlf: +45 39 16 84 00</p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"MT\">Malta</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"MT\">Novartis Pharma   Services Inc.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"MT\">Tel: +</span>356 <span lang=\"FR-CH\">2122 2872</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Deutschland</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Novartis Pharma   GmbH</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">Tel: +49 911 273   0</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\"> </span></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NL\">Nederland</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NL\">Novartis Pharma   B.V.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NL\">Tel: +31 88 04 52   555</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ET\">Eesti</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">SIA Novartis   Baltics Eesti filiaal</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ET\">Tel: +372 </span><span lang=\"EN-GB\">66 30 810</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ET\"> </span></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NO-BOK\">Norge</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-BOK\">Novartis   Norge AS</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-BOK\">Tlf: +47 23   05 20 00</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EL\">Ελλάδα</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ET\">Novartis (Hellas)   A.E.B.E.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EL\">Τηλ</span><span lang=\"ET\">: +30 210 281 17 12</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ET\"> </span></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE-AT\">Österreich</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-AT\">Novartis   Pharma GmbH</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE-AT\">Tel: +43 1 86   6570</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">España</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Novartis   Farmacéutica, S.A.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\">Tel: +34 93 306   42 00</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"ES\"> </span></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PL\">Polska</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PL\">Novartis Poland   Sp. z o.o.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PL\">Tel.: +48 22 375   4888</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR\">France</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">Novartis Pharma   S.A.S.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">Tél: +33 1 55 47   66 00</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR\"> </span></b></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT\">Portugal</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT\">Novartis Farma ‑   Produtos Farmacêuticos, S.A.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT\">Tel: +351 21 000   8600</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Hrvatska</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">Novartis Hrvatska   d.o.o.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel. +385 1   6274 220</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR\"> </span></b></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"FR-CH\">România</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"FR-CH\">Novartis Pharma Services Romania SRL</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\">Tel: +40 21 31299 01</p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Novartis   Ireland Limited</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +353 1   260 12 55</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\"> </span></b></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SL\">Slovenija</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SL\">Novartis Pharma   Services Inc.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SL\">Tel: +386 1 300   75 50</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IS\">Ísland</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IS\">Vistor hf.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Sími</span><span lang=\"IS\">: +354 535 7000</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SK\">Slovenská   republika</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SK\">Novartis Slovakia   s.r.o.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SK\">Tel: +421 2 5542   5439</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SK\"> </span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT\">Italia</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT\">Novartis Farma   S.p.A.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">Tel: +39 02 96 54   1</span></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Suomi/Finland</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">Novartis Finland   Oy</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">Puh/Tel: +358 </span><span lang=\"SV\">(0)10 6133 200</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\"> </span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EL\">Κύπρος</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR-CH\">Novartis   Pharma Services Inc.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EL\">Τηλ:   +357 22 690 690</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EL\"> </span></b></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Sverige</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">Novartis Sverige   AB</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">Tel: +46 8 732 32   00</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FI\"> </span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"LV\">Latvija</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">SIA Novartis   Baltics</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"LV\">Tel: +371 67 887   070</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\"> </span></p> </td> <td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">United Kingdom</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"IT\">Novartis   Pharmaceuticals UK Ltd.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +44 1276   698370</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> </td> </tr> </table> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">This leaflet was last revised in</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicine has been given “conditional approval”. This means that there is more evidence to come about this medicine.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The European Medicines Agency will review new information on this medicine at least every year and this leaflet will be updated as necessary.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Other sources of information</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Detailed information on this medicine is available on the European Medicines Agency web site: </span><span lang=\"EN-GB\"><span class=\"MsoHyperlink\">http://www.ema.europa.eu</span></span></p> <span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif\\'><br clear=\"all\" style=\"page-break-before:always\"/> </span> <p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">The following information is intended for healthcare professionals only:</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo vials are for single use only.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Preparing the infusion</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The diluted solution for infusion  should be prepared by a healthcare professional using aseptic techniques.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The total dose and required volume of Adakveo depend on the patient’s body weight; 5 mg of crizanlizumab is administered per kg body weight.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">The volume to be used for the preparation of the infusion is calculated according to the following equation:</span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:12.5pt;border-collapse:collapse\" width=\"567\"> <tr> <td rowspan=\"2\" style=\"width:85.05pt;padding:0in 5.4pt 0in 5.4pt\" width=\"113\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Volume (ml) =</span></p> </td> <td style=\"width:269.35pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"359\"> <p align=\"center\" class=\"MsoNormal\" style=\"margin-left:28.35pt;text-align:center;   text-indent:-28.35pt;line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Patient’s body weight (kg) x prescribed dose</span></p> </td> <td style=\"width:70.85pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"94\"> <p align=\"center\" class=\"MsoNormal\" style=\"margin-left:28.35pt;text-align:center;   text-indent:-28.35pt;line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">[5 mg/kg]</span></p> </td> </tr> <tr> <td style=\"width:269.35pt;border:none;padding:0in 5.4pt 0in 5.4pt\" width=\"359\"> <p align=\"center\" class=\"Text\" style=\"margin-top:0in;text-align:center;   page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Concentration   of Adakveo</span></p> </td> <td style=\"width:70.85pt;border:none;padding:0in 5.4pt 0in 5.4pt\" width=\"94\"> <p align=\"center\" class=\"Text\" style=\"margin-top:0in;text-align:center;   page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">[10 mg/ml]</span></p> </td> </tr> </table> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">1.       Obtain the number of vials required to deliver the prescribed dose and bring them to room temperature (for a maximum of 4 hours). One vial is needed for every 10 ml of Adakveo (see below table).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:28.35pt;border-collapse:collapse;border:none\" width=\"568\"> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Body weight (kg)</span></b></p> </td> <td style=\"width:92.15pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Dose (mg)</span></b></p> </td> <td style=\"width:114.75pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Volume (ml)</span></b></p> </td> <td style=\"width:114.75pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Vials (n)</span></b></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">40</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">200</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">20</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">2</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">60</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">300</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">30</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">3</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">80</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">400</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">40</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">4</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">100</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">500</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">50</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">5</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">120</span></p> </td> <td style=\"width:92.15pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">600</span></p> </td> <td style=\"width:114.75pt;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">60</span></p> </td> <td style=\"width:114.75pt;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">6</span></p> </td> </tr> </table> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">2.       Visually inspect the vials.</span></p> <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The solution in the vials should be clear to opalescent. Do not use if particles are present in the solution.</span></p> <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The solution should be colourless or may have a slight brownish‑yellow tint.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">3.       Withdraw a volume equal to the required volume of Adakveo from a 100 ml infusion bag containing either sodium chloride </span><span lang=\"EN-GB\">9 mg/ml (</span><span lang=\"EN-GB\">0.9%) solution for injection or dextrose 5% and discard.</span></p> <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">No incompatibilities between the diluted Adakveo solution and infusion bags composed of polyvinylchloride (PVC), polyethylene (PE) and polypropylene (PP) have been observed.</span></p> <p class=\"MsoNormal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">4.       Withdraw the necessary volume of Adakveo from the vials and inject slowly into the previously prepared infusion bag.</span></p> <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The </span><span lang=\"EN-GB\">solution</span><span lang=\"EN-GB\"> must not be mixed or co‑administered with other medicinal products through the same intravenous line.</span></p> <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">Keep the volume of Adakveo added to the infusion bag in the range of 10 ml to 96 ml to obtain a final concentration in the infusion bag within 1 mg/ml to 9.6 mg/ml.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">5.       Mix the diluted solution by gently inverting the infusion bag. DO NOT SHAKE.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Storage of the diluted solution</span></u></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Chemical and physical in‑use stability, from the start of preparation of the diluted solution for infusion until end of infusion, has been demonstrated for up to 8 hours at room temperature (up to 25°C) and at 2°C to 8°C for up to 24 hours overall.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">From a microbiological point of view, the diluted solution for infusion should be used immediately. If not used immediately, in‑use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2°C to 8°C, including 4.5 hours at room temperature (up to 25°C) from the start of preparation to completion of the infusion, unless dilution has taken place in controlled and validated aseptic conditions.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"> </p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Administration</span></u></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo diluted </span><span lang=\"EN-GB\">solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter</span><span lang=\"EN-GB\"> by intravenous infusion over a period of 30 minutes.</span><span lang=\"EN-GB\"> No incompatibilities have been observed between Adakveo and infusion sets composed of PVC, PE‑lined PVC, polyurethane, and in‑line filter membranes composed of polyethersulfone (PES), polyamide (PA) or polysulphone (PSU).</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">After administration of Adakveo, flush the line with at least 25 ml sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5%.</span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Disposal</span></u></p> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Any unused product or waste material should be disposed of in accordance with local requirements.</span></p> </div>', 'ID': '583f04cc-251b-4aa9-a300-400d62bebe5a', 'Styles': 'None', 'Classes': \"['WordSection1']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       ', 'ParentId': '1b945380-ed32-477d-bc89-4e43eb629b1e'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '93f99a3a-3bdb-4712-b8a2-7f7151752254', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '37bd41cc-5002-4d0f-b837-d1e612a8c9f4', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'a118066d-62a7-49fe-b164-8dc28660cc13', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '048fcf44-3865-41ad-aa41-6fcf26a64a4e', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c31204d8-633f-4f10-ac97-914fcf46f5d7', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd70aeb25-5d44-4d24-b3ba-df3f0a945409', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e1477684-3361-4ca8-bd48-87fe774951b6', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '6144e956-79cb-4671-935e-0428d8ae9552', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e8d61a67-3455-4013-b0cb-8c6be91e1dd9', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '5ae63bab-fd9f-4543-8da5-95385fe2878a', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '73b2745c-30ea-4c64-8e98-aa6a807ed175', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '7a8d15de-c5dc-49a9-b9f2-c06ea2aa2812', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e4924fc5-14a2-4074-ba07-3827e2690bbe', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '5bbfb234-75ff-4d1b-ba18-79dc786c49a3', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '502e9ac3-58ab-4843-b8a0-5fd60ed4e9c5', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '48f98078-4e9d-4cf6-a2e3-6551b02a5fa4', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '53bfe434-4517-42ce-a813-b71d9f2e38cc', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'b6a38e0b-e4f8-410b-b32a-37629f9e3831', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '6bea775e-8180-4ac2-9e83-683b15a278e5', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd352b40d-10b4-4f2b-8989-ca2a32b8214e', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'cdc7ad58-c7fb-4b77-bcc2-de84faab6ac6', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '68654a8b-654b-47e1-a598-ec1c0860df89', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '7a0e81a8-d56c-4500-b4fc-ed031c115ec5', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX I</span></b></p>', 'ID': 'dd5948fb-58d2-4893-8b10-d805f0cdf739', 'Styles': 'text-align:center;line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': None, 'Text': 'ANNEX I', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '75c81091-3ccc-4ed5-947f-c6995c913347', 'Styles': 'text-align:center;line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">SUMMARY OF PRODUCT CHARACTERISTICS</span></b></p>', 'ID': '70d45c8c-f80d-484f-ace5-16d07806febf', 'Styles': 'text-align:center;line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'SUMMARY OF PRODUCT CHARACTERISTICS', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<span lang=\"EN-GB\" style=\\'font-size:11.0pt;font-family:\"Times New Roman\",serif; color:green\\'><br clear=\"all\" style=\"page-break-before:always\"/> </span>', 'ID': 'b1cb472e-16b2-4c31-9704-43221d1c8944', 'Styles': 'font-size:11.0pt;font-family:\"Times New Roman\",serif;\\ncolor:green', 'Classes': 'None', 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<br clear=\"all\" style=\"page-break-before:always\"/>', 'ID': '7b7faf20-48a0-43ba-a11c-700ccaf1b44d', 'Styles': 'page-break-before:always', 'Classes': 'None', 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '', 'ParentId': 'b1cb472e-16b2-4c31-9704-43221d1c8944'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><img height=\"18\" src=\"Adakveo-4874%20EN%20PI_files/image001.png\" width=\"21\"/><span lang=\"EN-GB\">This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.</span></p>', 'ID': '5f9f4e00-1c00-4d69-ae60-3b512d354b58', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'f468e77c-8bbb-4e8e-a650-a4bcf4292f4e', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'b6444544-1b61-4ede-bcb4-292a105fdf99', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">1.       NAME OF </span></b><b><span lang=\"EN-GB\">THE MEDICINAL PRODUCT</span></b></p>', 'ID': 'bebd747b-536c-4ae8-b191-86916bb5b392', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L1', 'Text': '1.       NAME OF THE MEDICINAL PRODUCT', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '79944278-5179-4fc2-8e1d-555b0355dd79', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo 10 mg/ml concentrate for solution for infusion</span></p>', 'ID': 'dd38be17-c16a-4a43-bd7d-7d7de217c2ab', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Adakveo 10 mg/ml concentrate for solution for infusion', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '39eb16f8-9ea5-47dc-9002-8f3bf989f47a', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ef09f9ed-de0d-4558-8fb6-f7d64aaf2336', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.       QUALITATIVE AND QUANTITATIVE COMPOSITION</span></b></p>', 'ID': 'fb95db94-3ab2-47ed-860c-1a32343cda09', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L1', 'Text': '2.       QUALITATIVE AND QUANTITATIVE COMPOSITION', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'a2e7bc93-c504-4cf0-a556-8dbc293ae03d', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each ml of concentrate for solution for infusion contains 10 mg crizanlizumab.</span></p>', 'ID': '6b8c14cb-eba7-4ba3-9de8-231605835033', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Each ml of concentrate for solution for infusion contains 10 mg crizanlizumab.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '445c2994-215c-4b60-9e68-58b10b0bebb5', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">One vial of 10 ml contains 100 mg crizanlizumab.</span></p>', 'ID': '86a20c6b-f68b-4371-9f8a-a22986385994', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'One vial of 10 ml contains 100 mg crizanlizumab.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e59ad3b0-fdc0-4860-b4cd-0ffd1f6bbfdc', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab is a monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.</span></p>', 'ID': '9b057f63-8d47-4932-bf02-b2258fe2de4f', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Crizanlizumab is a monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd82f7f95-1ede-431d-a553-e3fb38e6ff28', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For the full list of excipients, see section 6.1.</span></p>', 'ID': '603928f1-93e4-4c02-bb15-6bc6cef996af', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'For the full list of excipients, see section 6.1.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'fba2229a-f0ed-4548-ad90-a381cf1a1782', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'f630af4e-4e7d-4c18-b043-880d0facc0eb', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">3.       PHARMACEUTICAL </span></b><b><span lang=\"EN-GB\" style=\\'font-family:\"Times New Roman Bold\",serif\\'>FORM</span></b></p>', 'ID': 'b61d2001-da27-4ae0-9cd3-4fb666ce3ffe', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L1', 'Text': '3.       PHARMACEUTICAL FORM', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '31b9ed10-5866-4e63-8cca-ce18cc144980', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_Toc259706902\"></a><a name=\"_Toc259707071\"></a><a name=\"_Toc259707134\"></a><a name=\"_Toc259713075\"><span lang=\"EN-GB\">Concentrate for solution for infusion</span></a><span lang=\"EN-GB\"> (sterile concentrate)</span></p>', 'ID': '7d27d913-4b56-4995-9a02-920d4d6d616b', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Concentrate for solution for infusion (sterile concentrate)', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '261b4958-43c7-49b9-9e5a-d08543d24acf', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Colourless to slightly brownish‑yellow liquid at pH 6 and with an osmolality of 300 mOsm/kg.</span></p>', 'ID': '4252fb30-8aea-4a64-969d-9f97eac73b9b', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Colourless to slightly brownish‑yellow liquid at pH 6 and with an osmolality of 300 mOsm/kg.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'b3f0efe9-3876-4e68-b585-60721f1c25ac', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '4bf7be43-25d1-4109-903f-3037ea6db68f', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.       </span></b><b><span lang=\"EN-GB\">CLINICAL</span></b><b><span lang=\"EN-GB\" style=\\'font-family:\"Times New Roman Bold\",serif\\'> PARTICULARS</span></b></p>', 'ID': 'ee1bc075-2c6c-4e05-abb9-4907d5feeb5b', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L1', 'Text': '4.       CLINICAL PARTICULARS', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '32d06a42-9c67-427c-9011-cdfa13ede737', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.1     Therapeutic indications</span></b></p>', 'ID': '0ebcbda6-4e48-4ae4-a098-291a1bbc76ba', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '4.1     Therapeutic indications', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'adf5587b-a53f-430b-817d-38b728fcf75d', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Standard\"><span lang=\"EN-GB\">Adakveo</span><span lang=\"EN-GB\"> is indicated for the prevention of recurrent vaso‑occlusive crises (VOCs) in sickle cell disease patients aged 16 years and older. It can be given as an add‑on therapy to hydroxyurea/hydroxycarbamide (HU/HC) or as monotherapy in patients for whom HU/HC is inappropriate or inadequate.</span></p>', 'ID': '624419e5-aee7-4efc-95aa-caa3b50bc1bc', 'Styles': 'None', 'Classes': \"['Standard']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Adakveo is indicated for the prevention of recurrent vaso‑occlusive crises (VOCs) in sickle cell disease patients aged 16 years and older. It can be given as an add‑on therapy to hydroxyurea/hydroxycarbamide (HU/HC) or as monotherapy in patients for whom HU/HC is inappropriate or inadequate.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '238fb2f2-6728-400a-a31d-0a902b92cac0', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.2     Posology and method of administration</span></b></p>', 'ID': '0ba39624-d328-423e-9451-75729da49f5e', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '4.2     Posology and method of administration', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'b1d7658a-c886-4549-8199-23d497c4cc6b', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Treatment should be initiated by physicians experienced in the management of </span><span lang=\"EN-GB\">sickle cell disease.</span></p>', 'ID': 'b4a4dc54-4b41-43bd-b82f-06ee394b17a2', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Treatment should be initiated by physicians experienced in the management of sickle cell disease.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '86b7bbb5-d14b-4563-8aaf-f1f0b4aaad35', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Posology</span></u><a name=\"_nth_Adults_and_patients_ag4131\"></a></p>', 'ID': '490f404e-fff3-4d71-a062-145a626aa698', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Posology', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e714aa41-f9b5-4f9d-aa85-f59525886d3c', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The recommended dose of crizanlizumab is 5 mg/kg administered over a period of 30 minutes by intravenous infusion at week 0, week 2, and every 4 weeks thereafter.</span></p>', 'ID': 'f658b1e4-66f8-4649-978b-497e69ca133e', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The recommended dose of crizanlizumab is 5 mg/kg administered over a period of 30 minutes by intravenous infusion at week 0, week 2, and every 4 weeks thereafter.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ced5ba42-b690-4da6-8bf6-5d6835f95180', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab </span><span lang=\"EN-GB\">c</span><span lang=\"EN-GB\">an be given alone or with HU/HC.</span></p>', 'ID': '31210945-890b-4725-acdf-a354e5ca32d4', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Crizanlizumab can be given alone or with HU/HC.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '9667ffd4-bc6f-4ff2-87bf-e738f6faabdf', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">If a dose is missed, the treatment should be administered as soon as possible.</span></p>', 'ID': '7973028c-e20f-44d7-8125-8c6ded4f2aec', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['Standard']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'If a dose is missed, the treatment should be administered as soon as possible.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt\"><span style=\"font-size:11.0pt\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span style=\"font-size:11.0pt\">If crizanlizumab is administered within 2 weeks after the missed dose, dosing should be continued according to the patient’s original schedule.</span></p>', 'ID': '1355137f-9392-440f-b76b-893e39322a99', 'Styles': 'margin-top:0in;margin-right:0in;margin-bottom:\\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '-                 If crizanlizumab is administered within 2 weeks after the missed dose, dosing should be continued according to the patient’s original schedule.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt\"><span style=\"font-size:11.0pt\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span style=\"font-size:11.0pt\">If crizanlizumab is administered more than 2 weeks after the missed dose, dosing should be continued every 4 weeks thereafter.</span></p>', 'ID': '2d7b667e-921c-42ad-9bf8-c07eb6611782', 'Styles': 'margin-top:0in;margin-right:0in;margin-bottom:\\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '-                 If crizanlizumab is administered more than 2 weeks after the missed dose, dosing should be continued every 4 weeks thereafter.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '33cb5747-aeff-44e1-a295-f35fdc5df1bf', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Special populations</span></u></i></p>', 'ID': '819e866d-22fe-4467-979b-2965a5b375fb', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': True, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L4', 'Text': 'Special populations', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Elderly</span></i></p>', 'ID': '42987233-13d8-4992-85ad-cd9d26a9e675', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': True, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L4', 'Text': 'Elderly', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab has not been studied in elderly patients. No dose adjustment is required as the pharmacokinetics of crizanlizumab in adults are not affected by age.</span></p>', 'ID': '394675e6-38ca-43f4-8fa4-67bdbdb6ac0b', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Crizanlizumab has not been studied in elderly patients. No dose adjustment is required as the pharmacokinetics of crizanlizumab in adults are not affected by age.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '4116a164-0fb0-41ec-8d4d-980eee909720', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Renal impairment</span></i></p>', 'ID': '38d92515-beef-4580-a9e9-5f343ee60f2c', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': True, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L4', 'Text': 'Renal impairment', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Based on the population pharmacokinetic (PK) results, no dose adjustment is required in patients with mild or moderate renal impairment (see section 5.2). Data from patients with severe renal impairment are too limited to draw conclusions on this population.</span></p>', 'ID': 'f485a522-47e8-4737-9053-6c37b287e4da', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Based on the population pharmacokinetic (PK) results, no dose adjustment is required in patients with mild or moderate renal impairment (see section 5.2). Data from patients with severe renal impairment are too limited to draw conclusions on this population.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '2c251efd-4d57-451f-8e1b-27eaf97ac3ce', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Hepatic impairment</span></i></p>', 'ID': 'd7e68ae4-e1b1-4553-913c-12635b0a51cd', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': True, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L4', 'Text': 'Hepatic impairment', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monoclonal antibody and is cleared via catabolism (i.e. breakdown into peptides and amino acids), and a change in dose is not expected to be required for patients with hepatic impairment (see section</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> </span><span lang=\"EN-GB\">5.2).</span></p>', 'ID': 'cf701288-a867-47a0-925f-00f0a42b647b', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monoclonal antibody and is cleared via catabolism (i.e. breakdown into peptides and amino acids), and a change in dose is not expected to be required for patients with hepatic impairment (see section 5.2).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '9c89d2ad-1586-421e-b9ca-7af854ac5300', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Paediatric population</span></i></p>', 'ID': 'dec049ff-97a9-40cd-87ba-11bdfb9bb5fd', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': True, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L4', 'Text': 'Paediatric population', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Standard\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety and efficacy of </span><span lang=\"EN-GB\">crizanlizumab</span><span lang=\"EN-GB\"> in paediatric patients from 6 months to 16 years have not been established. No data are available.</span></p>', 'ID': '6c18b861-4477-41c9-9ae9-9694f443b12a', 'Styles': 'line-height:normal', 'Classes': \"['Standard']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The safety and efficacy of crizanlizumab in paediatric patients from 6 months to 16 years have not been established. No data are available.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Standard\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '16108ca5-3314-48c6-9284-f29117d61350', 'Styles': 'line-height:normal', 'Classes': \"['Standard']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Standard\" style=\"line-height:normal\"><span lang=\"EN-GB\">There is no relevant use of crizanlizumab in infants aged less than 6 months for the indication of prevention of recurrent vaso‑occlusive crises.</span></p>', 'ID': 'e007eba1-3f30-455b-8bff-f4e949cbfb82', 'Styles': 'line-height:normal', 'Classes': \"['Standard']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'There is no relevant use of crizanlizumab in infants aged less than 6 months for the indication of prevention of recurrent vaso‑occlusive crises.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'dd6230e6-42fb-460b-8a51-7d767a43daab', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Method of administration</span></u></p>', 'ID': '1f6c3414-d7c9-4cf2-aa07-d6c5b237491d', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Method of administration', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '3cb6dfbf-b485-4105-bf8a-beeb14b1cd5b', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo </span><span lang=\"EN-GB\">should be diluted with sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% before administration.</span></p>', 'ID': '90f20e2b-efa4-4ccf-a405-6e5c9d8b7bc6', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Adakveo should be diluted with sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% before administration.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '07bf33aa-2f31-4389-9771-d6b30a85d0e0', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The diluted solution</span><span lang=\"EN-GB\"> must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by intravenous infusion over a period of 30 minutes. It must not be administered by intravenous push or bolus.</span></p>', 'ID': 'e1770234-5bf8-44d0-837b-67f40bdf1237', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The diluted solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by intravenous infusion over a period of 30 minutes. It must not be administered by intravenous push or bolus.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '36d5342e-92b8-4a2e-a040-eca51b686035', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For instructions on dilution of the medicinal product before administration, see section 6.6.</span></p>', 'ID': 'f9f00845-fcc7-4f6b-be21-e64dc59b00c7', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'For instructions on dilution of the medicinal product before administration, see section 6.6.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'a86c67ac-ec53-4b50-a9df-b960de5da5c6', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.3     Contraindications</span></b></p>', 'ID': '1ff14bbd-0749-4766-99c0-ede09b34a7b7', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '4.3     Contraindications', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '10c040f8-ca46-4b5e-8749-4d38a3844796', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.</span></p>', 'ID': '3f6da897-613d-46df-b921-4ba67da45e6b', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hypersensitivity to Chinese Hamster Ovary (CHO) cell products.</span></p>', 'ID': '32559cba-bfd6-4c6e-a7ef-d4aeb35ef35d', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Hypersensitivity to Chinese Hamster Ovary (CHO) cell products.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '58f5b929-00a4-4a69-9e0a-f5ced47c136a', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.4     Special warnings and precautions for use</span></b></p>', 'ID': 'f5687243-13a4-46e0-adc6-415bb3e4afd4', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '4.4     Special warnings and precautions for use', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '31ffed79-5a24-4559-a566-8522af32fb14', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Traceability</span></u></p>', 'ID': 'dffa9fac-aacc-4a81-914f-78b314975780', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Traceability', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> </span></p>', 'ID': 'caf234ef-3b41-4f82-8ed4-bc46d48e7c7e', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.</span></p>', 'ID': '561c67cb-8f9c-4799-85cb-bd886d1151a2', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\"> </span></span></u></p>', 'ID': 'f63d4030-776d-44db-9cc6-74ff75f1134c', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Infusion‑related reactions</span></u></p>', 'ID': '001e00a6-62d2-4a45-a2ad-fab1fe9559c3', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Infusion‑related reactions', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'cb4bce22-89a4-4d8d-8cdd-b672d0c88b93', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In clinical studies, infusion‑related reactions (defined as occurring within 24 hours) were observed in 2 patients (1.8%) treated with crizanlizumab 5 mg/kg</span><span lang=\"EN-GB\">. Patients should be monitored for signs and symptoms of infusion‑related reactions, which may include fever, chills, nausea, vomiting, fatigue, dizziness, pruritus, urticaria, sweating, shortness of breath or wheezing. </span><span lang=\"EN-GB\">In the event of a severe reaction, crizanlizumab should be discontinued and appropriate therapy should be instituted.</span></p>', 'ID': 'a1a23c97-c624-4234-ace8-a766721f187c', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'In clinical studies, infusion‑related reactions (defined as occurring within 24 hours) were observed in 2 patients (1.8%) treated with crizanlizumab 5 mg/kg. Patients should be monitored for signs and symptoms of infusion‑related reactions, which may include fever, chills, nausea, vomiting, fatigue, dizziness, pruritus, urticaria, sweating, shortness of breath or wheezing. In the event of a severe reaction, crizanlizumab should be discontinued and appropriate therapy should be instituted.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'f75c3d59-7a58-45ed-943d-7d8406b98311', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Laboratory test interference: automated platelet counts</span></u></p>', 'ID': '7089a4c2-8b50-4922-b050-9cc7f27af572', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Laboratory test interference: automated platelet counts', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c55563ca-acc4-4553-8c1a-42b9387a9a78', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Interference with automated platelet counts (platelet clumping) has been observed in patients treated with crizanlizumab in clinical studies, in particular when tubes containing EDTA (ethylenediaminetetraacetic acid) were used. This may lead to unevaluable or falsely decreased platelet counts. There is no evidence that crizanlizumab causes a reduction in circulating platelets or has a pro‑aggregant effect <i>in vivo</i>.</span></p>', 'ID': 'defaa2b8-7117-4310-b347-449f40ad24ff', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Interference with automated platelet counts (platelet clumping) has been observed in patients treated with crizanlizumab in clinical studies, in particular when tubes containing EDTA (ethylenediaminetetraacetic acid) were used. This may lead to unevaluable or falsely decreased platelet counts. There is no evidence that crizanlizumab causes a reduction in circulating platelets or has a pro‑aggregant effect in vivo.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '6642c7d0-5706-4a24-9854-a9970510af06', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">To mitigate the potential for laboratory test interference, it is recommended to run the test as soon as possible (within 4 hours of blood collection) or use citrate tubes. When needed, </span><span lang=\"EN-GB\">platelet counts can be estimated via a peripheral blood smear</span><span lang=\"EN-GB\">.</span></p>', 'ID': '5acabf9d-5eae-4f56-8d4c-78dcb8e857c1', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'To mitigate the potential for laboratory test interference, it is recommended to run the test as soon as possible (within 4 hours of blood collection) or use citrate tubes. When needed, platelet counts can be estimated via a peripheral blood smear.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '6c8ceb67-f719-4af2-bc74-70e0294ebb59', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Excipients with known effect</span></u></p>', 'ID': 'eb658930-7124-408c-958f-2862d298f571', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Excipients with known effect', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c9fe79ab-335c-4e9e-9fba-13a4f3bfb5b1', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially “sodium‑free”.</span></p>', 'ID': 'db4cd1d3-f264-43fd-88c0-8d7655c1b47b', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially “sodium‑free”.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '8eb95d23-0d6c-4f26-8a07-679ab8ac0228', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.5     Interaction with other medicinal products and other forms of interaction</span></b></p>', 'ID': '11a2fcce-48eb-45a9-8b97-53ecaaa73d86', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '4.5     Interaction with other medicinal products and other forms of interaction', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c3478606-ac0b-4307-a4bd-638df28244be', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Interactions between crizanlizumab and other medicinal products have not been investigated in dedicated studies.</span></p>', 'ID': 'b9ff00f8-ef92-4508-b24f-5dbf91989902', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Interactions between crizanlizumab and other medicinal products have not been investigated in dedicated studies.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '42abd336-a0eb-44ad-9d11-88de09f8b841', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Monoclonal antibodies are not metabolised by cytochrome P450 (CYP450) enzymes. Therefore, medicinal products that are substrates, inhibitors or inducers of CYP450 are not expected to affect the pharmacokinetics of crizanlizumab. In clinical studies, HU/HC had no effect on crizanlizumab pharmacokinetics in patients.</span></p>', 'ID': '4e8df8f7-0fac-45a5-91ad-05cf93b3622f', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Monoclonal antibodies are not metabolised by cytochrome P450 (CYP450) enzymes. Therefore, medicinal products that are substrates, inhibitors or inducers of CYP450 are not expected to affect the pharmacokinetics of crizanlizumab. In clinical studies, HU/HC had no effect on crizanlizumab pharmacokinetics in patients.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '799d9c0e-6134-4c36-9d6e-aa95272f563e', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No effect on exposure of co‑administered medicinal products is expected based on the metabolic pathways of monoclonal antibodies.</span></p>', 'ID': 'ac9b1575-5662-4fc5-b691-e9ce93b95d88', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'No effect on exposure of co‑administered medicinal products is expected based on the metabolic pathways of monoclonal antibodies.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'aecf1600-19a8-484c-a6c4-f87cfacd1373', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.6     </span></b><b><span lang=\"EN-GB\">Fertility, p</span></b><b><span lang=\"EN-GB\">regnancy and lactation</span></b></p>', 'ID': 'a0f6cfdc-8042-4f0f-9d78-485a5c3c23b8', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '4.6     Fertility, pregnancy and lactation', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '8212b032-0566-40af-b4bd-ce316a313d58', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Pregnancy</span></u></p>', 'ID': '1aaf948b-addf-44cb-883c-1b19ea65cd4c', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Pregnancy', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e92c6478-4a6b-4f59-9269-f8fd7c1dad6b', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Standard\"><span lang=\"EN-GB\">There is a limited amount of data from the use of Adakveo in pregnant women. Based on data from animal studies, crizanlizumab has the potential to cause foetal losses when administered to a pregnant woman (see section 5.3). As a precautionary measure, it is preferable to avoid the use of Adakveo during pregnancy and in woman of childbearing potential not using contraception.</span></p>', 'ID': 'efbd0b19-f586-45e6-8c31-559b7ddbe773', 'Styles': 'None', 'Classes': \"['Standard']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'There is a limited amount of data from the use of Adakveo in pregnant women. Based on data from animal studies, crizanlizumab has the potential to cause foetal losses when administered to a pregnant woman (see section 5.3). As a precautionary measure, it is preferable to avoid the use of Adakveo during pregnancy and in woman of childbearing potential not using contraception.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c669fdac-8dcb-44e1-b338-f22434b3a115', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Standard\" style=\"line-height:normal\">To help determine the effects in pregnant women, healthcare professionals are encouraged to report all pregnancy cases and complications during pregnancy (from 105 days prior to the last menstrual period onward) to <span lang=\"EN-GB\">the local representative of the</span> marketing authorisation holder (see package leaflet), in order to allow monitoring of these patients through the PRegnancy outcomes Intensive Monitoring programme (PRIM). In addition, all adverse pregnancy events should be reported <span lang=\"EN-GB\">via <span style=\"color:black;background:#D9D9D9\">the national reporting system listed in </span></span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:#D9D9D9\">Appendix V</span></a></span>.</p>', 'ID': 'eef5d66e-627a-44e7-a02a-b8539854de99', 'Styles': 'line-height:normal', 'Classes': \"['Standard']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'To help determine the effects in pregnant women, healthcare professionals are encouraged to report all pregnancy cases and complications during pregnancy (from 105 days prior to the last menstrual period onward) to the local representative of the marketing authorisation holder (see package leaflet), in order to allow monitoring of these patients through the PRegnancy outcomes Intensive Monitoring programme (PRIM). In addition, all adverse pregnancy events should be reported via the national reporting system listed in Appendix V.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '0e85539e-1a02-4688-bb24-6e07397dd0de', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Breast‑feeding</span></u></p>', 'ID': 'b96d36fa-6b90-4e0c-85de-47cc7e44b538', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Breast‑feeding', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '925de404-1c57-4456-8a43-4c656c7165cb', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It is unknown whether crizanlizumab is excreted in human milk after administration of Adakveo. There are no data on the effects of crizanlizumab on the breast‑fed newborn/infant or on milk production.</span></p>', 'ID': '7498a234-2fbd-4001-be5a-f3355ad472be', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'It is unknown whether crizanlizumab is excreted in human milk after administration of Adakveo. There are no data on the effects of crizanlizumab on the breast‑fed newborn/infant or on milk production.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '7cfd4607-0430-4511-b02b-066e4be8655a', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Because many medicinal products, including antibodies, can be excreted in human milk, a risk to the newborn/infant cannot be excluded.</span></p>', 'ID': 'e2fb457a-6e5d-47fc-8456-c8f97240e96d', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Because many medicinal products, including antibodies, can be excreted in human milk, a risk to the newborn/infant cannot be excluded.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ae93d231-f8ba-47e6-af36-252c58405866', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">A decision must be made whether to discontinue breast‑feeding or to discontinue Adakveo therapy, taking into account the benefit of breast‑feeding for the child and the benefit of therapy for the woman.</span></p>', 'ID': '92fc3a0b-228c-44b6-b207-f2a812d3484a', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'A decision must be made whether to discontinue breast‑feeding or to discontinue Adakveo therapy, taking into account the benefit of breast‑feeding for the child and the benefit of therapy for the woman.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '02868645-f69f-48cf-bcbe-f15742e8f766', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Fertility</span></u></p>', 'ID': '5d59e941-1027-4d1d-ab03-b568b6674fec', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Fertility', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ca98b45d-98d6-4057-8db7-9b5c039c5cfd', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There are no data on the effect of Adakveo on human fertility. Available non‑clinical data do not suggest an effect on fertility under crizanlizumab treatment (see section 5.3).</span></p>', 'ID': 'a1786285-9b65-4742-ac7e-5ff27e9a199c', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'There are no data on the effect of Adakveo on human fertility. Available non‑clinical data do not suggest an effect on fertility under crizanlizumab treatment (see section 5.3).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"> </p>', 'ID': 'a50561fb-4abd-468d-8584-54156b98e12c', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.7     Effects on ability to drive and use machines</span></b></p>', 'ID': '38069b69-f6df-4f61-9c3a-a75dde9a859d', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '4.7     Effects on ability to drive and use machines', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '871e05ef-31a7-489f-bac3-a2f55dfdde94', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo may have a minor influence on the ability to drive and use machines. Dizziness, fatigue and somnolence may occur following administration of crizanlizumab.</span></p>', 'ID': 'c39dbd51-9328-45a4-bac6-df6d25a7b0bd', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Adakveo may have a minor influence on the ability to drive and use machines. Dizziness, fatigue and somnolence may occur following administration of crizanlizumab.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '357b6cf8-c2d7-42e1-b447-0e411a254e45', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.8     Undesirable effects</span></b></p>', 'ID': 'de8d55e0-de1c-4d68-a1de-9ba6e3db0097', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '4.8     Undesirable effects', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ebce1105-f4bf-482a-a497-471e1a6d1760', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Summary of the safety profile</span></u><a name=\"_nth_Summary_of_the_safety_6118\"></a></p>', 'ID': '88452719-0800-4b2c-96cf-ea5b386f5dd9', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Summary of the safety profile', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd5b72049-2472-41d4-9e03-f6828c98ce07', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The most frequently reported adverse drug reactions (≥10% of patients) in the Adakveo 5 mg/kg group were arthralgia, nausea, back pain, pyrexia and abdominal pain. Severe events were observed for pyrexia and arthralgia (each 0.9%).</span></p>', 'ID': 'c2a9225d-e718-4537-8929-46091366c628', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The most frequently reported adverse drug reactions (≥10% of patients) in the Adakveo 5 mg/kg group were arthralgia, nausea, back pain, pyrexia and abdominal pain. Severe events were observed for pyrexia and arthralgia (each 0.9%).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '00b99e59-7e80-422c-aef1-8e487d552f09', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Tabulated list of adverse reactions</span></u></p>', 'ID': '9e1dffa5-d254-4870-a142-824011ff734a', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Tabulated list of adverse reactions', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '9eb2ea87-aa58-40dc-9578-859810a3ca3a', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Table 1 lists adverse reactions based on pooled data from two studies: the pivotal study, SUSTAIN, and a single‑arm, open‑label pharmacokinetics/pharmacodynamics and safety study. Use of crizanlizumab in combination with HU/HC did not result in any meaningful differences in the safety profile.</span></p>', 'ID': '4d02de8f-c15b-43bc-af6d-ffe87bdf1f88', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Table 1 lists adverse reactions based on pooled data from two studies: the pivotal study, SUSTAIN, and a single‑arm, open‑label pharmacokinetics/pharmacodynamics and safety study. Use of crizanlizumab in combination with HU/HC did not result in any meaningful differences in the safety profile.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '3ccb923f-936e-4539-858f-f4e4013c9548', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Within each system organ class, the adverse reactions are ranked by frequency, with the most frequent reactions first. Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness. In addition, the corresponding frequency category for each adverse reaction is based on the following convention: very common (≥1/10); common (≥1/100 to &lt;1/10); uncommon (≥1/1,000 to &lt;1/100); rare (≥1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000).</span></p>', 'ID': 'dd4a838f-4247-40fc-b3ad-7a1ea745661a', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Within each system organ class, the adverse reactions are ranked by frequency, with the most frequent reactions first. Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness. In addition, the corresponding frequency category for each adverse reaction is based on the following convention: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '987733b6-745e-47c1-ab4a-d39014ea48b4', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><a name=\"_Toc272145403\"></a><a name=\"_Toc272145564\"></a><a name=\"_Toc266768477\"></a><a name=\"_Toc260903679\"></a><a name=\"_Toc266264818\"></a><a name=\"_Toc499550967\"></a><a name=\"_Toc517716325\"><b><span lang=\"EN-GB\">Table 1       Adverse reactions in clinical studies</span></b></a><a name=\"_hd6_Table_7_1_Percentage_o7395\"></a></p>', 'ID': '12293b6d-27fc-4f51-a392-aa1d0ab58450', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Table 1       Adverse reactions in clinical studies', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'adae8cec-c15f-466c-87a5-d9edcbc7decd', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:459.0pt;border-collapse:collapse;border:none\" width=\"612\"> <tr style=\"page-break-inside:avoid\"> <td style=\"width:175.5pt;border:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt\">System organ class</span></b></p> </td> <td style=\"width:81.0pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Frequency</span></b></p> </td> <td style=\"width:202.5pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Adverse reaction</span></b></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Respiratory, thoracic and   mediastinal disorders</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Oropharyngeal pain</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td rowspan=\"2\" style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Gastrointestinal disorders</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Very common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Nausea, abdominal pain*</span></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:13.45pt\"> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:13.45pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:13.45pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">D</span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">iarrhoea, vomiting</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Skin and subcutaneous tissue   disorders</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Pruritus*</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td rowspan=\"2\" style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Musculoskeletal and   connective tissue disorders</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Very common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Arthralgia, back pain</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Myalgia, musculoskeletal   chest pain</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td rowspan=\"2\" style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">General disorders and   administration site conditions</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Very common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Pyrexia</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Infusion site reaction*</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:175.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"234\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Injury, poisoning and   procedural complications</span></p> </td> <td style=\"width:81.0pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"108\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Common</span></p> </td> <td style=\"width:202.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"270\"> <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after:   avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Infusion‑related   reaction</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td colspan=\"3\" style=\"width:459.0pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"612\"> <p class=\"Table\" style=\"margin:0in\"><span lang=\"EN-GB\" style=\\'font-family:\"Times New Roman\",serif\\'>*The   following groupings contain the following MedDRA preferred terms:</span></p> <p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;   margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\\'font-family:   \"Times New Roman\",serif\\'>-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                   </span></span><span lang=\"EN-GB\" style=\\'font-family:\"Times New Roman\",serif\\'>Abdominal   pain: abdominal pain, abdominal pain upper, abdominal pain lower, abdominal   discomfort, and abdominal tenderness</span></p> <p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;   margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"FR-CH\" style=\\'font-family:   \"Times New Roman\",serif\\'>-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                   </span></span><span lang=\"EN-GB\" style=\\'font-family:\"Times New Roman\",serif\\'>Pruritus:   pruritus and vulvovaginal pruritus</span></p> <p class=\"Table\" style=\"margin-top:0in;margin-right:0in;margin-bottom:0in;   margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\\'font-size:   11.0pt;font-family:\"Times New Roman\",serif\\'>-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                   </span></span><span lang=\"FR-CH\" style=\\'font-family:\"Times New Roman\",serif\\'>Infusion   site reaction: infusion site extravasation, infusion site pain, and infusion   site swelling</span></p> </td> </tr> </table>', 'ID': '68495d94-1d08-4794-a87d-6fdb37a548f5', 'Styles': 'width:459.0pt;border-collapse:collapse;border:none', 'Classes': \"['MsoNormalTable']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '   System organ class   Frequency   Adverse reaction     Respiratory, thoracic and   mediastinal disorders   Common   Oropharyngeal pain     Gastrointestinal disorders   Very common   Nausea, abdominal pain*     Common   Diarrhoea, vomiting     Skin and subcutaneous tissue   disorders   Common   Pruritus*     Musculoskeletal and   connective tissue disorders   Very common   Arthralgia, back pain     Common   Myalgia, musculoskeletal   chest pain     General disorders and   administration site conditions   Very common   Pyrexia     Common   Infusion site reaction*     Injury, poisoning and   procedural complications   Common   Infusion‑related   reaction     *The   following groupings contain the following MedDRA preferred terms: -                   Abdominal   pain: abdominal pain, abdominal pain upper, abdominal pain lower, abdominal   discomfort, and abdominal tenderness -                   Pruritus:   pruritus and vulvovaginal pruritus -                   Infusion   site reaction: infusion site extravasation, infusion site pain, and infusion   site swelling   ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p>', 'ID': '5500d36a-5762-434c-8892-bf87d0e7f820', 'Styles': 'margin-top:0in;text-align:left', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Description of selected adverse reactions</span></u></p>', 'ID': '0636c563-9390-400f-9ab3-5889e217a728', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Description of selected adverse reactions', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after: avoid\"><span style=\"font-size:11.0pt\"> </span></p>', 'ID': 'f1b0b323-4845-48bd-9022-8b3498e12b3c', 'Styles': 'margin-top:0in;text-align:left;page-break-after:\\navoid', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after: avoid\"><i><u><span style=\"font-size:11.0pt\">Immunogenicity</span></u></i></p>', 'ID': '3598871e-6274-45f3-a079-92e6a6cc0f4b', 'Styles': 'margin-top:0in;text-align:left;page-break-after:\\navoid', 'Classes': \"['Text']\", 'Bold': False, 'Italics': True, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L4', 'Text': 'Immunogenicity', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">In clinical studies, treatment‑induced anti‑crizanlizumab antibodies were transiently detected in 1 patient (0.9%) among the 111 patients who received Adakveo 5 mg/kg.</span></p>', 'ID': 'd1523c7d-682b-40c5-a31d-0ed3c856ad76', 'Styles': 'margin-top:0in;text-align:left', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'In clinical studies, treatment‑induced anti‑crizanlizumab antibodies were transiently detected in 1 patient (0.9%) among the 111 patients who received Adakveo 5 mg/kg.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p>', 'ID': 'd3b08430-cd24-4b17-aeb5-65cd8c0fa6da', 'Styles': 'margin-top:0in;text-align:left', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">There was no evidence of altered pharmacokinetics or of an altered safety profile with anti‑crizanlizumab antibody development.</span></p>', 'ID': '06a145f3-a3b6-468f-9569-9c66e32cdd40', 'Styles': 'margin-top:0in;text-align:left', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'There was no evidence of altered pharmacokinetics or of an altered safety profile with anti‑crizanlizumab antibody development.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p>', 'ID': 'da312712-3361-43b0-8cb8-ebe00c656f19', 'Styles': 'margin-top:0in;text-align:left', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Paediatric population</span></u></p>', 'ID': 'b24ce283-43d1-4609-a14a-ce76aefeb6ea', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['Standard']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Paediatric population', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '837beffa-4df5-46b3-9e30-c2df0b2c0859', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['Standard']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">Frequency, type and severity of adverse reactions in patients aged 16 and 17 years are expected to be the same as in adults. The safety of crizanlizumab was evaluated in 3 patients aged &lt;18 years.</span></p>', 'ID': '440ff73a-8907-4923-a5dc-f3b4ccebeec9', 'Styles': 'margin-top:0in;text-align:left', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Frequency, type and severity of adverse reactions in patients aged 16 and 17 years are expected to be the same as in adults. The safety of crizanlizumab was evaluated in 3 patients aged <18 years.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p>', 'ID': '58b0b3ed-6191-4566-9d5d-bffd88dd7d08', 'Styles': 'margin-top:0in;text-align:left', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Reporting of suspected adverse reactions</span></u></p>', 'ID': '9a48cf61-c759-4667-ae82-3fe92599ba09', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Reporting of suspected adverse reactions', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '37538e84-41d5-4dd8-a4f1-8f9d7515630d', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via <span style=\"color:black; background:#D9D9D9\">the national reporting system listed in </span></span><span lang=\"EN-GB\"><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:#D9D9D9\">Appendix V</span></a></span><span lang=\"EN-GB\">.</span></p>', 'ID': 'bdd4a612-1b71-48af-bb4d-b6992a0d727d', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '2d6e4e03-57ab-41aa-8bb6-50da47e524a1', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.9     Overdose</span></b></p>', 'ID': 'd64d220d-681c-41cc-be35-d2388b0fe2af', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '4.9     Overdose', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '81f7f5c9-3aa9-4ca9-a6e4-18ff45f702a1', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">No cases of overdose have been reported in clinical studies.</span></p>', 'ID': 'be23a4ff-636e-4419-a2b4-53c8da85fba7', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'No cases of overdose have been reported in clinical studies.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd95c745f-4632-4816-93a3-bf5315fb6186', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">General supportive measures and symptomatic treatment should be initiated in cases of suspected overdose.</span></p>', 'ID': '6c217e0b-6104-473f-89d1-138ec1d858ea', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'General supportive measures and symptomatic treatment should be initiated in cases of suspected overdose.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '9021bd02-b10e-4f7a-8d6f-8607a943d54d', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '05b4dc55-ce07-49e7-98d0-d74847496bdc', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.       PHARMACOLOGICAL PROPERTIES</span></b></p>', 'ID': '764acee4-ad8f-4679-bfd8-2d754f01ab88', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L1', 'Text': '5.       PHARMACOLOGICAL PROPERTIES', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '2e81c580-64f0-479b-baac-f7989c2f399c', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.1     Pharmacodynamic properties</span></b></p>', 'ID': 'a6d0a699-c8cf-4a9f-9667-b8f6e4efe584', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '5.1     Pharmacodynamic properties', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'b2231afc-7779-4625-8ac4-2819167847b6', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Pharmacotherapeutic group: Other haematological agents, ATC code: B06AX01</span></p>', 'ID': '38b60d54-b880-4fc5-a4f4-89ce63aeb5ce', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Pharmacotherapeutic group: Other haematological agents, ATC code: B06AX01', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '15ae06a0-6e38-48b6-9b98-796008d0a290', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Mechanism of action</span></u></p>', 'ID': 'fc5ac450-265a-4a49-92fd-94f18063c6e8', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Mechanism of action', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '1dd00aad-f767-4d29-ab47-a0ece231bb21', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Crizanlizumab is a selective IgG2 kappa humanised monoclonal antibody (mAb) that binds to P‑selectin with high affinity and blocks the interaction with its ligands, including P‑selectin glycoprotein ligand 1. </span><span lang=\"EN-GB\">Crizanlizumab can also dissociate preformed P‑selectin/PSGL‑1 complex. </span><span lang=\"EN-GB\">P‑selectin is an adhesion molecule expressed on activated endothelial cells and platelets. It plays an essential role in the initial recruitment of leukocytes and the aggregation of platelets to the site of vascular injury during inflammation. In the chronic pro‑inflammatory state associated with sickle cell disease, P‑selectin is over‑expressed and circulating blood cells and the endothelium are activated and become hyperadhesive. P‑selectin‑mediated multi‑cellular adhesion is a key factor in the pathogenesis of vaso‑occlusion and vaso‑occlusive crises (VOC). Elevated levels of P‑selectin are found in patients with sickle cell disease.</span></p>', 'ID': 'e7c2423f-a48a-414c-9bbd-4c511efdb528', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Crizanlizumab is a selective IgG2 kappa humanised monoclonal antibody (mAb) that binds to P‑selectin with high affinity and blocks the interaction with its ligands, including P‑selectin glycoprotein ligand 1. Crizanlizumab can also dissociate preformed P‑selectin/PSGL‑1 complex. P‑selectin is an adhesion molecule expressed on activated endothelial cells and platelets. It plays an essential role in the initial recruitment of leukocytes and the aggregation of platelets to the site of vascular injury during inflammation. In the chronic pro‑inflammatory state associated with sickle cell disease, P‑selectin is over‑expressed and circulating blood cells and the endothelium are activated and become hyperadhesive. P‑selectin‑mediated multi‑cellular adhesion is a key factor in the pathogenesis of vaso‑occlusion and vaso‑occlusive crises (VOC). Elevated levels of P‑selectin are found in patients with sickle cell disease.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '95bd2fe7-3442-4e6d-b591-1f836f48ae21', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Binding P‑selectin on the surface of the activated endothelium and platelets has been shown to effectively block interactions between endothelial cells, platelets, red blood cells and leukocytes, thereby preventing vaso‑occlusion.</span></p>', 'ID': '71575f83-7664-4637-beb1-6a5b97c16cfe', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Binding P‑selectin on the surface of the activated endothelium and platelets has been shown to effectively block interactions between endothelial cells, platelets, red blood cells and leukocytes, thereby preventing vaso‑occlusion.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '0d50548f-2482-4f8b-abd3-321304018d5f', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Pharmacodynamic effects</span></u></p>', 'ID': 'ab71b0bc-5a25-48a4-a89f-1f17e668aa1a', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Pharmacodynamic effects', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '4dd078ae-806b-4e3a-a55b-2b2c2bc1df57', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Throughout clinical studies, treatment with crizanlizumab 5 mg/kg resulted in dose‑dependent, immediate and sustained P‑selectin inhibition </span><span lang=\"EN-GB\">(as measured <i>ex vivo</i>) </span><span lang=\"EN-GB\">in patients with sickle cell disease.</span></p>', 'ID': 'f3912285-4b05-4670-a041-77eca738249c', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Throughout clinical studies, treatment with crizanlizumab 5 mg/kg resulted in dose‑dependent, immediate and sustained P‑selectin inhibition (as measured ex vivo) in patients with sickle cell disease.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '22741a98-5799-4d6d-92ac-9aa31e592b25', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Clinical efficacy and safety</span></u></p>', 'ID': '472a0d46-f38f-4b06-9377-8b14a1ca58ab', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Clinical efficacy and safety', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"> </p>', 'ID': '9abf657f-4184-406f-9882-ccdafe7d62df', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The efficacy of crizanlizumab, with or without HU/HC, was evaluated in the pivotal study SUSTAIN, a 52‑week, randomised, placebo‑controlled, double‑blind, multicentre clinical study in sickle cell disease patients with a history of vaso‑occlusive crises (VOCs).</span></p>', 'ID': '06f14b6a-445d-4929-b3f9-42c7c98bd689', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The efficacy of crizanlizumab, with or without HU/HC, was evaluated in the pivotal study SUSTAIN, a 52‑week, randomised, placebo‑controlled, double‑blind, multicentre clinical study in sickle cell disease patients with a history of vaso‑occlusive crises (VOCs).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '1cfceb45-f752-4744-add7-e75fc2b30f0d', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In this study, VOCs were defined as those leading to a healthcare visit, which captured all acute episodes of pain with no other cause than a vaso‑occlusive event that required a healthcare visit and treatment with oral or parenteral opioids or parenteral non‑steroidal anti‑inflammatory drugs (NSAIDs). Acute chest syndrome, hepatic sequestration, splenic sequestration and priapism (requiring a healthcare visit), by definition, were also considered VOCs.</span></p>', 'ID': 'f2a0e2c1-e6bd-40b3-b1f9-a3b59362d87d', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'In this study, VOCs were defined as those leading to a healthcare visit, which captured all acute episodes of pain with no other cause than a vaso‑occlusive event that required a healthcare visit and treatment with oral or parenteral opioids or parenteral non‑steroidal anti‑inflammatory drugs (NSAIDs). Acute chest syndrome, hepatic sequestration, splenic sequestration and priapism (requiring a healthcare visit), by definition, were also considered VOCs.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '746abb46-4321-4390-a3d1-57628c87ee75', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">A total of 198 sickle cell disease patients aged 16 to 63 years (inclusive; mean age 30.1±10.3 years), with any sickle cell disease genotype (including HbSS [71.2%], HbSC [16.2%], HbSbeta0‑thalassaemia [6.1%], HbSbeta+‑thalassaemia [5.1%], and others [1.5%]) and a history of between 2 and 10 VOCs in the previous 12 months (62.6% and 37.4% of the patients had 2‑4 or 5‑10 VOCs, respectively), were randomised 1:1:1 to Adakveo 5 mg/kg, Adakveo 2.5 mg/kg or placebo. The majority of patients were Black or African American (91.9%). Patients received Adakveo with (62.1%) or without (37.9%) HU/HC. Randomisation was stratified by patients already receiving HU/HC (Y/N) and by number of VOCs in the previous 12 months (2 to 4, 5 to 10). Patients were allowed to take medicinal products to relieve pain (i.e. paracetamol, NSAIDs and opioids) and to receive occasional transfusions on an “as needed” basis. Patients participating in a chronic transfusion programme (pre-planned series of transfusions for prophylactic purposes) were excluded from the study.</span></p>', 'ID': '9df75617-c6d9-4284-99eb-9c6d286028ea', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'A total of 198 sickle cell disease patients aged 16 to 63 years (inclusive; mean age 30.1±10.3 years), with any sickle cell disease genotype (including HbSS [71.2%], HbSC [16.2%], HbSbeta0‑thalassaemia [6.1%], HbSbeta+‑thalassaemia [5.1%], and others [1.5%]) and a history of between 2 and 10 VOCs in the previous 12 months (62.6% and 37.4% of the patients had 2‑4 or 5‑10 VOCs, respectively), were randomised 1:1:1 to Adakveo 5 mg/kg, Adakveo 2.5 mg/kg or placebo. The majority of patients were Black or African American (91.9%). Patients received Adakveo with (62.1%) or without (37.9%) HU/HC. Randomisation was stratified by patients already receiving HU/HC (Y/N) and by number of VOCs in the previous 12 months (2 to 4, 5 to 10). Patients were allowed to take medicinal products to relieve pain (i.e. paracetamol, NSAIDs and opioids) and to receive occasional transfusions on an “as needed” basis. Patients participating in a chronic transfusion programme (pre-planned series of transfusions for prophylactic purposes) were excluded from the study.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '8a5bfeed-92a7-4157-aa23-5e8d782ee2f3', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Treatment with Adakveo 5 mg/kg resulted in a 45.3% lower median annual rate of VOCs compared to placebo (Hodges‑Lehmann, median absolute difference of ‑1.01 compared with placebo, 95% CI [‑2.00, 0.00]), which was statistically significant (p=0.010). The median annual rates of uncomplicated VOCs (any VOCs as defined above, excluding acute chest syndrome, hepatic sequestration, splenic sequestration or priapism) and days hospitalised were 62.9% and 41.8% lower in the Adakveo 5 mg/kg than in the placebo group, respectively. The VOCs occurring during the study were assessed by an independent review committee.</span></p>', 'ID': '26b32385-ff0c-468c-8156-48e4ea2e5632', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Treatment with Adakveo 5 mg/kg resulted in a 45.3% lower median annual rate of VOCs compared to placebo (Hodges‑Lehmann, median absolute difference of ‑1.01 compared with placebo, 95% CI [‑2.00, 0.00]), which was statistically significant (p=0.010). The median annual rates of uncomplicated VOCs (any VOCs as defined above, excluding acute chest syndrome, hepatic sequestration, splenic sequestration or priapism) and days hospitalised were 62.9% and 41.8% lower in the Adakveo 5 mg/kg than in the placebo group, respectively. The VOCs occurring during the study were assessed by an independent review committee.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ddc462b4-8779-4b40-b2cd-13c11a5c35ea', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Main efficacy outcomes of the pivotal SUSTAIN study are summarised in Tables 2 and 3.</span></p>', 'ID': 'f00331f9-91ee-4ffc-9f5b-c7b8d020d857', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Main efficacy outcomes of the pivotal SUSTAIN study are summarised in Tables 2 and 3.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'cc21ce0f-b181-4775-ad96-2bb33aad2435', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><a name=\"_Toc499550968\"></a><a name=\"_Toc517716326\"><b><span lang=\"EN-GB\">Table </span></b></a><b><span lang=\"EN-GB\">2       Results from SUSTAIN clinical study in </span></b><a name=\"_hd6_Table_12_1_Results_fro16811\"></a><b><span lang=\"EN-GB\">sickle cell disease</span></b></p>', 'ID': 'c9fea0dd-a255-4ab8-957b-4a237116ff85', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Table 2       Results from SUSTAIN clinical study in sickle cell disease', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '5ff0994f-3178-439a-a684-c5b18e0ff720', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:98.84%;border-collapse:collapse;border:none\" width=\"98%\"> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <td style=\"width:20.16%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"20%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Event</span></b></p> </td> <td style=\"width:23.82%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"23%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Adakveo 5 mg/kg</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">(N=67)</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(standard median)</span></p> </td> <td style=\"width:11.54%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"11%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Placebo</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">(N=65)</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(standard median)</span></p> </td> <td style=\"width:10.46%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"10%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Change vs placebo</span></b></p> </td> <td style=\"width:21.1%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"21%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Hodges‑Lehmann median   difference</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(95% CI)</span></p> </td> <td style=\"width:12.9%;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"12%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">p-value</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(Wilcoxon rank sum)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <td style=\"width:20.18%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"20%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Primary endpoint</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Annual rate of VOCs</span></p> </td> <td style=\"width:23.82%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"23%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.63</span></p> </td> <td style=\"width:11.54%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"11%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.98</span></p> </td> <td style=\"width:10.46%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"10%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑45.3%</span></p> </td> <td style=\"width:21.1%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"21%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.01</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑2.00, 0.00)</span></p> </td> <td style=\"width:12.9%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"12%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">0.010</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td colspan=\"5\" style=\"width:87.1%;border:none;   border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"87%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Secondary endpoints</span></b></p> </td> <td style=\"width:12.9%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"12%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\"> </span></b></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <td style=\"width:20.18%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"20%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Annual rate of days hospitalised</span></p> </td> <td style=\"width:23.82%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"23%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">4.00</span></p> </td> <td style=\"width:11.54%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"11%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">6.87</span></p> </td> <td style=\"width:10.46%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"10%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑41.8%</span></p> </td> <td style=\"width:21.1%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"21%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">0.00</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑4.36, 0.00)</span></p> </td> <td style=\"width:12.9%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"12%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">0.450</span></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <td style=\"width:20.18%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"20%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Annual rate of uncomplicated VOCs</span></p> </td> <td style=\"width:23.82%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"23%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.08</span></p> </td> <td style=\"width:11.54%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"11%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.91</span></p> </td> <td style=\"width:10.46%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"10%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑62.9%</span></p> </td> <td style=\"width:21.1%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"21%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.00</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑1.98, 0.00)</span></p> </td> <td style=\"width:12.9%;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"12%\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">-</span></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <td colspan=\"6\" style=\"width:.02%;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:1.0pt\" valign=\"top\" width=\"0%\"> <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">The primary (annual rate of VOC leading   to healthcare visit) and key secondary (annual rate of days hospitalised)   endpoints were the only ones formally tested for statistical significance   according to protocol.</span></p> </td> </tr> </table>', 'ID': 'f6602db2-bba7-4d09-be01-924009293f42', 'Styles': 'width:98.84%;border-collapse:collapse;border:none', 'Classes': \"['MsoNormalTable']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '   Event   Adakveo 5 mg/kg (N=67) (standard median)   Placebo (N=65) (standard median)   Change vs placebo   Hodges‑Lehmann median   difference (95% CI)   p-value (Wilcoxon rank sum)     Primary endpoint Annual rate of VOCs   1.63   2.98   ‑45.3%   ‑1.01 (‑2.00, 0.00)   0.010     Secondary endpoints         Annual rate of days hospitalised   4.00   6.87   ‑41.8%   0.00 (‑4.36, 0.00)   0.450     Annual rate of uncomplicated VOCs   1.08   2.91   ‑62.9%   ‑1.00 (‑1.98, 0.00)   -     The primary (annual rate of VOC leading   to healthcare visit) and key secondary (annual rate of days hospitalised)   endpoints were the only ones formally tested for statistical significance   according to protocol.   ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '6d24b1e8-7bcc-499b-9560-8630cab90afd', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\"><span lang=\"EN-GB\">The clinical effect demonstrated in the primary efficacy analysis was supported by multiple supplementary analyses including a negative binomial regression on investigator assessments with a conservative method to handle missing data due to early discontinuation of treatment based on outcomes in the placebo group (RR=0.74, 95% CI=0.52, 1.06).</span></p>', 'ID': '55a081a7-69be-4ffb-aade-5eaf29f54a50', 'Styles': 'None', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The clinical effect demonstrated in the primary efficacy analysis was supported by multiple supplementary analyses including a negative binomial regression on investigator assessments with a conservative method to handle missing data due to early discontinuation of treatment based on outcomes in the placebo group (RR=0.74, 95% CI=0.52, 1.06).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"> </p>', 'ID': '90069808-d21a-40db-a5cb-79185d63ea1e', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In the Adakveo 5 mg/kg group, clinically significant reductions in the annual rate of VOCs were observed across important subgroups (</span><span lang=\"EN-GB\">HU/HC use, 2‑4 or 5‑10 VOCs in the previous 12 months, and HbSS or non‑HbSS genotypes; </span><span lang=\"EN-GB\">see Table 3).</span></p>', 'ID': '06133542-b88f-49aa-8c7f-5dbcc0f276bb', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'In the Adakveo 5 mg/kg group, clinically significant reductions in the annual rate of VOCs were observed across important subgroups (HU/HC use, 2‑4 or 5‑10 VOCs in the previous 12 months, and HbSS or non‑HbSS genotypes; see Table 3).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '40863246-ddd2-434e-9fcc-3f487cc6f3c0', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><b><span lang=\"EN-GB\">Table 3       Annual rate of VOCs in patients ‑ subgroup analyses</span></b></p>', 'ID': '0f55922a-bcc3-477f-8e53-b7b1c53ba65a', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Table 3       Annual rate of VOCs in patients ‑ subgroup analyses', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ba08dd82-6928-449e-b2bf-28bfc45990b6', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"612\"> <tr style=\"page-break-inside:avoid\"> <td style=\"width:90.45pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"121\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Subgroup </span></b></p> </td> <td style=\"width:63.8pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\"> </span></b></p> </td> <td style=\"width:70.85pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Adakveo 5 mg/kg (N=67)</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(standard median)</span></p> </td> <td style=\"width:63.8pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Placebo (N=65)</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(standard median)</span></p> </td> <td style=\"width:63.8pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Change vs placebo</span></b></p> </td> <td style=\"width:106.3pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">Hodges‑Lehmann median   difference</span></b></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><b><span lang=\"EN-GB\">(95% CI)</span></b></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td rowspan=\"2\" style=\"width:90.45pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"121\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">HU/HC use</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Yes</span></p> </td> <td style=\"width:70.85pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=42</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.43</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n= 40</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">3.58</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑32.1%</span></p> </td> <td style=\"width:106.3pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.01</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑2.44, 0.00)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">No</span></p> </td> <td style=\"width:70.85pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=25</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.00</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=25</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.00</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑50.0%</span></p> </td> <td style=\"width:106.3pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.02</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑2.00, 0.00)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid;height:20.2pt\"> <td rowspan=\"2\" style=\"width:90.45pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:20.2pt\" width=\"121\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Number of VOCs in previous   12 months</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:20.2pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2‑4 VOCs</span></p> </td> <td style=\"width:70.85pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:20.2pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=42</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.14</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:20.2pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=41</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.00</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:20.2pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑43.0%</span></p> </td> <td style=\"width:106.3pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:20.2pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑0.05</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑1.56, 0.01)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">5‑10 VOCs</span></p> </td> <td style=\"width:70.85pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=25</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.97</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=24</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">5.32</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑63.0%</span></p> </td> <td style=\"width:106.3pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑2.74</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑5.00, ‑0.83)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td rowspan=\"2\" style=\"width:90.45pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"121\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Sickle cell disease genotypes,   including HbSC</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">HbSS</span></p> </td> <td style=\"width:70.85pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=47</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">1.97</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=47</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">3.01</span></p> </td> <td style=\"width:63.8pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑34.6%</span></p> </td> <td style=\"width:106.3pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.01</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑2.18, 0.00)</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">Non‑HbSS</span></p> </td> <td style=\"width:70.85pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"94\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=20</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">0.99</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">n=18</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">2.00</span></p> </td> <td style=\"width:63.8pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑50.5%</span></p> </td> <td style=\"width:106.3pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"142\"> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">‑1.01</span></p> <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;   text-autospace:none\"><span lang=\"EN-GB\">(‑2.01, 0.00)</span></p> </td> </tr> </table>', 'ID': '306055ba-c099-4738-bafa-dedc95f5c4e5', 'Styles': 'border-collapse:collapse;border:none', 'Classes': \"['MsoNormalTable']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '   Subgroup        Adakveo 5 mg/kg (N=67) (standard median)   Placebo (N=65) (standard median)   Change vs placebo   Hodges‑Lehmann median   difference (95% CI)     HU/HC use   Yes   n=42 2.43   n= 40 3.58   ‑32.1%   ‑1.01 (‑2.44, 0.00)     No   n=25 1.00   n=25 2.00   ‑50.0%   ‑1.02 (‑2.00, 0.00)     Number of VOCs in previous   12 months   2‑4 VOCs   n=42 1.14   n=41 2.00   ‑43.0%   ‑0.05 (‑1.56, 0.01)     5‑10 VOCs   n=25 1.97   n=24 5.32   ‑63.0%   ‑2.74 (‑5.00, ‑0.83)     Sickle cell disease genotypes,   including HbSC   HbSS   n=47 1.97   n=47 3.01   ‑34.6%   ‑1.01 (‑2.18, 0.00)     Non‑HbSS   n=20 0.99   n=18 2.00   ‑50.5%   ‑1.01 (‑2.01, 0.00)   ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c2b709f0-86b2-4fa9-98d3-6988b154be09', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">A greater than two‑fold increase in the proportion of patients with no VOC and who completed the study was observed in the Adakveo 5 mg/kg group compared to placebo (22% vs 8%; odds ratio [95% CI]: 3.57 [1.20, 10.63]). A similar difference was also observed across important subgroups (HU/HC use, genotype).</span></p>', 'ID': 'da5c88f0-dcea-4689-938e-3c1b93d7a754', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'A greater than two‑fold increase in the proportion of patients with no VOC and who completed the study was observed in the Adakveo 5 mg/kg group compared to placebo (22% vs 8%; odds ratio [95% CI]: 3.57 [1.20, 10.63]). A similar difference was also observed across important subgroups (HU/HC use, genotype).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '5208b575-d8b9-4b18-981d-40fcf95b2b71', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Treatment with Adakveo 5 mg/kg was also associated with a three‑fold longer Kaplan‑Meier estimated median time to first VOC compared with placebo (4.07 vs 1.38 months; HR=0.495, 95% CI: 0.331, 0.741) (Figure 1) and a two‑fold longer median time from randomisation to second VOC compared to placebo (10.32 vs 5.09 months; HR=0.534, 95% CI: 0.329, 0.866).</span></p>', 'ID': '976c04c1-4a00-4a08-af6a-eb33f16cc272', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Treatment with Adakveo 5 mg/kg was also associated with a three‑fold longer Kaplan‑Meier estimated median time to first VOC compared with placebo (4.07 vs 1.38 months; HR=0.495, 95% CI: 0.331, 0.741) (Figure 1) and a two‑fold longer median time from randomisation to second VOC compared to placebo (10.32 vs 5.09 months; HR=0.534, 95% CI: 0.329, 0.866).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '94b4115a-655a-4aea-9954-cf0f835aecee', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Figure 1      Kaplan‑Meier curve of time to first VOC</span></b></p>', 'ID': 'ea96e98a-b631-443f-a2a7-37382a04f305', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Figure 1      Kaplan‑Meier curve of time to first VOC', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '8d4fe1ee-a863-42e2-bef0-564ff21f6c0b', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><span style=\"position:absolute;z-index:251748352;left:0px;margin-left:61px; margin-top:211px;width:13px;height:9px\"><img alt=\"0\" height=\"9\" src=\"Adakveo-4874%20EN%20PI_files/image002.png\" width=\"13\"/></span><span style=\"position:absolute;z-index:251746304;left:0px;margin-left:63px; margin-top:190px;width:10px;height:10px\"><img alt=\"10\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image003.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251744256;left:0px;margin-left:64px; margin-top:169px;width:10px;height:10px\"><img alt=\"20\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image004.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251742208;left:0px;margin-left:64px; margin-top:149px;width:10px;height:10px\"><img alt=\"30\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image005.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251740160;left:0px;margin-left:65px; margin-top:130px;width:10px;height:10px\"><img alt=\"40\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image006.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251738112;left:0px;margin-left:64px; margin-top:110px;width:10px;height:10px\"><img alt=\"50\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image007.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251736064;left:0px;margin-left:64px; margin-top:90px;width:10px;height:10px\"><img alt=\"60\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image008.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251734016;left:0px;margin-left:64px; margin-top:70px;width:10px;height:10px\"><img alt=\"70\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image009.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251731968;left:0px;margin-left:63px; margin-top:48px;width:10px;height:10px\"><img alt=\"80\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image010.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251729920;left:0px;margin-left:65px; margin-top:28px;width:10px;height:10px\"><img alt=\"90\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image011.png\" width=\"10\"/></span><span style=\"position:absolute;z-index:251727872;left:0px;margin-left:60px; margin-top:9px;width:15px;height:10px\"><img alt=\"100\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image012.png\" width=\"15\"/></span><span style=\"position:absolute;z-index:251781120;left:0px;margin-left:459px; margin-top:8px;width:125px;height:38px\"><img height=\"38\" src=\"Adakveo-4874%20EN%20PI_files/image013.png\" width=\"125\"/></span><span style=\"position: absolute;z-index:251779072;left:0px;margin-left:494px;margin-top:7px; width:92px;height:26px\"><img height=\"26\" src=\"Adakveo-4874%20EN%20PI_files/image014.png\" width=\"92\"/></span><span style=\"position: absolute;z-index:251666432;left:0px;margin-left:22px;margin-top:28px; width:32px;height:178px\"><img alt=\"Probability of being free from first VOC (%)\" height=\"178\" src=\"Adakveo-4874%20EN%20PI_files/image015.png\" width=\"32\"/></span><span style=\"position:absolute;z-index:251725824;left:0px;margin-left:320px; margin-top:242px;width:56px;height:10px\"><img alt=\"Time (months)¬¬¬¬\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image016.png\" width=\"56\"/></span><sub><span style=\"font-size:11.0pt\">                                <img border=\"0\" height=\"223\" id=\"Picture 1243\" src=\"Adakveo-4874%20EN%20PI_files/image017.jpg\" width=\"518\"/></span></sub></p>', 'ID': '1f28a2cd-e389-410e-9522-6477de26e0cb', 'Styles': 'margin-top:0in;page-break-after:avoid', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '                                ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"> <table align=\"left\" cellpadding=\"0\" cellspacing=\"0\"> <tr> <td height=\"1\" width=\"3\"></td> <td width=\"36\"></td> <td width=\"33\"></td> <td width=\"2\"></td> <td width=\"2\"></td> <td width=\"5\"></td> <td width=\"10\"></td> <td width=\"3\"></td> <td width=\"23\"></td> <td width=\"10\"></td> <td width=\"27\"></td> <td width=\"10\"></td> <td width=\"26\"></td> <td width=\"3\"></td> <td width=\"7\"></td> <td width=\"28\"></td> <td width=\"10\"></td> <td width=\"28\"></td> <td width=\"10\"></td> <td width=\"25\"></td> <td width=\"10\"></td> <td width=\"26\"></td> <td width=\"13\"></td> <td width=\"26\"></td> <td width=\"10\"></td> <td width=\"26\"></td> <td width=\"10\"></td> <td width=\"30\"></td> <td width=\"10\"></td> <td width=\"26\"></td> <td width=\"10\"></td> <td width=\"26\"></td> <td width=\"10\"></td> <td width=\"27\"></td> <td width=\"10\"></td> <td width=\"18\"></td> </tr> <tr> <td height=\"10\"></td> <td colspan=\"5\"></td> <td align=\"left\" valign=\"top\"><img alt=\"0\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image018.png\" width=\"10\"/></td> <td colspan=\"2\"></td> <td align=\"left\" valign=\"top\"><img alt=\"1\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image019.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"2\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image020.png\" width=\"10\"/></td> <td></td> <td align=\"left\" colspan=\"2\" valign=\"top\"><img alt=\"3\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image021.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"4\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image022.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"5\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image023.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"6\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image024.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"7\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image025.png\" width=\"13\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"8\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image026.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"9\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image027.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"10\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image003.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"11\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image028.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"12\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image029.png\" width=\"10\"/></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"13\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image030.png\" width=\"10\"/></td> </tr> <tr> <td height=\"14\"></td> </tr> <tr> <td height=\"9\"></td> <td colspan=\"7\"></td> <td align=\"left\" colspan=\"6\" valign=\"top\"><img alt=\"Number of patients at risk\" height=\"9\" src=\"Adakveo-4874%20EN%20PI_files/image031.png\" width=\"99\"/></td> </tr> <tr> <td height=\"7\"></td> </tr> <tr> <td height=\"7\"></td> <td colspan=\"4\"></td> <td align=\"left\" colspan=\"31\" rowspan=\"5\" valign=\"top\"><img alt=\"67,49,41,35,30,26,24,20,18,17,16,15,7,65,37,23,21,17,13,12,9,8,6,5,4,1,0,0\" height=\"43\" src=\"Adakveo-4874%20EN%20PI_files/image032.png\" width=\"513\"/></td> </tr> <tr> <td height=\"10\"></td> <td align=\"left\" colspan=\"3\" valign=\"top\"><img alt=\"Adakveo 5 mg/kg \" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image033.png\" width=\"71\"/></td> </tr> <tr> <td height=\"14\"></td> </tr> <tr> <td height=\"10\"></td> <td></td> <td align=\"left\" valign=\"top\"><img alt=\"Placebo\" height=\"10\" src=\"Adakveo-4874%20EN%20PI_files/image034.png\" width=\"33\"/></td> </tr> <tr> <td height=\"2\"></td> </tr> </table> <span lang=\"EN-GB\"> </span></p>', 'ID': 'e84ed10a-b1be-47cf-8814-775d712347f9', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '                                                                                                        ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><span style=\"font-size:11.0pt\"> </span></p>', 'ID': '8c14f577-cb46-494a-9162-054506680e7b', 'Styles': 'margin-top:0in;page-break-after:avoid', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><span style=\"font-size:11.0pt\"> </span></p>', 'ID': '0f6cf8d7-9223-45d8-87c5-ff279c3c38b5', 'Styles': 'margin-top:0in;page-break-after:avoid', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '8ff37dc4-c898-4d52-a5aa-697fb9731068', 'Styles': 'line-height:normal;page-break-after:avoid;text-autospace:\\nnone', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': '13f05400-d25d-441b-8c2e-1bbc1ae3cc2b', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e85c0863-dc1a-42dc-ab9a-7b5fac36835e', 'Styles': 'line-height:normal;text-autospace:none', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<br clear=\"ALL\"/>', 'ID': 'fd84f968-a97f-4259-b766-a742451e77df', 'Styles': 'None', 'Classes': 'None', 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><a name=\"_hd6_Table_2_1_Patients_wit18544\"></a><u><span lang=\"EN-GB\">Paediatric population</span></u></p>', 'ID': '3f5b8c47-c06e-451b-ad88-9ec7eda2c145', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Paediatric population', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '65c2aa8e-1f0d-4f53-a9a6-31e70f0e528b', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The efficacy of crizanlizumab in patients aged 16 and 17 years is expected to be the same as in adults. Three patients (2.7%) aged less than 18 years were treated with crizanlizumab 5 mg/kg in clinical studies.</span></p>', 'ID': 'c778d352-157f-4fdd-a650-9794035bb188', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The efficacy of crizanlizumab in patients aged 16 and 17 years is expected to be the same as in adults. Three patients (2.7%) aged less than 18 years were treated with crizanlizumab 5 mg/kg in clinical studies.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '93e46389-181f-4b47-ac7a-0941c0257958', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The European Medicines Agency has deferred the obligation to submit the results of studies with Adakveo in one or more subsets of the paediatric population in the treatment of sickle cell disease (see section 4.2 for information on paediatric use).</span></p>', 'ID': '1d9f638b-9522-45d4-aade-2ea3ee357fce', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The European Medicines Agency has deferred the obligation to submit the results of studies with Adakveo in one or more subsets of the paediatric population in the treatment of sickle cell disease (see section 4.2 for information on paediatric use).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '2b0ed3b1-e815-4631-bbf0-acb3af13b8cc', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Conditional approval</span></u></p>', 'ID': '85f8de6d-913b-4eb5-acc3-e28469213af1', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Conditional approval', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd9ff4f36-ed04-4f6c-a5b5-0c77a32c3473', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal product has been authorised under a so‑called “conditional approval” scheme. This means that further evidence on this medicinal product is awaited.</span></p>', 'ID': '655e28b7-c7d4-4a3e-85e1-645ab4a9998f', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'This medicinal product has been authorised under a so‑called “conditional approval” scheme. This means that further evidence on this medicinal product is awaited.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'eee72aad-0d37-4d8b-9cdc-1ebe65c0efc2', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The European Medicines Agency will review new information on this medicinal product at least every year and this SmPC will be updated as necessary.</span></p>', 'ID': '3aeb1c53-df5f-486d-8b90-194a72885c98', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The European Medicines Agency will review new information on this medicinal product at least every year and this SmPC will be updated as necessary.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"> </p>', 'ID': 'bc77fded-79e5-41c5-afe0-7d9019610912', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.2     Pharmacokinetic properties</span></b></p>', 'ID': 'ba64cecf-46c2-47ea-af81-b647e28a94ce', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '5.2     Pharmacokinetic properties', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '8b252518-6a39-496d-a2a8-1f4de11f314b', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Absorption</span></u></p>', 'ID': '00533119-b294-4d3b-addb-f6fd4c3e35f0', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Absorption', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'f0af07b2-a8f5-48df-9990-5f017322f332', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The median time to reach maximum serum concentration of crizanlizumab (T<sub>max</sub>) was 1.92 hours at steady state following intravenous administration of 5 mg/kg over a period of 30 minutes in sickle cell disease patients.</span></p>', 'ID': '532a95ac-aa2d-482f-b98e-8087c9e1aae4', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The median time to reach maximum serum concentration of crizanlizumab (Tmax) was 1.92 hours at steady state following intravenous administration of 5 mg/kg over a period of 30 minutes in sickle cell disease patients.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '21135353-0ad7-4d0e-9182-c1205f92b29b', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Distribution</span></u></p>', 'ID': '1c6e5ea8-2fc1-4281-bc2f-96d19363107b', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Distribution', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '73ad910b-c420-4838-ae7f-51f7dfa34806', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab distribution is typical of endogenous human antibodies within the vascular and extracellular spaces. The volume of distribution (V<sub>z</sub>) was 4.26 litres after a single 5 mg/kg intravenous infusion of crizanlizumab in healthy volunteers.</span></p>', 'ID': 'ca25d772-76ad-4b7f-b51f-921b95efd10a', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Crizanlizumab distribution is typical of endogenous human antibodies within the vascular and extracellular spaces. The volume of distribution (Vz) was 4.26 litres after a single 5 mg/kg intravenous infusion of crizanlizumab in healthy volunteers.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '1bf44745-663f-43a1-9114-5512396fecf5', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Biotransformation</span></u></p>', 'ID': '3480d3aa-b931-4d9d-8a25-ff2950f70e47', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Biotransformation', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'da63ad24-98cc-4f6c-a9ac-7d4eaf9df730', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Antibodies are primarily eliminated via proteolysis by lysosomal enzymes in the liver to small peptides and amino acids.</span></p>', 'ID': '994c284c-fd5a-4bca-856c-a06ca2d991e3', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Antibodies are primarily eliminated via proteolysis by lysosomal enzymes in the liver to small peptides and amino acids.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '25c08c2a-97cd-49b7-a3e6-ed7e3b2a9398', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Elimination</span></u></p>', 'ID': '317d6b14-9c20-4bea-bf70-1dd1bfd14ee0', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Elimination', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '9644480b-9013-49d2-a9e9-2795592596a9', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In healthy volunteers, the mean terminal elimination half‑life (T<sub>½</sub>) was 10.6 days and the mean clearance was 11.7 ml/h at crizanlizumab dose level 5 mg/kg. In patients with sickle cell disease, the mean elimination T<sub>½</sub> during the dosing interval was 7.5 days.</span></p>', 'ID': '21be6999-4166-4ea3-bc2a-46e7e9c1f35f', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'In healthy volunteers, the mean terminal elimination half‑life (T½) was 10.6 days and the mean clearance was 11.7 ml/h at crizanlizumab dose level 5 mg/kg. In patients with sickle cell disease, the mean elimination T½ during the dosing interval was 7.5 days.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'fa7ee2a9-8612-4798-a0b2-e8c66dbfa3c7', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Linearity/non‑linearity</span></u></p>', 'ID': 'eb9693fa-6305-4d68-9a84-84c27a959a65', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Linearity/non‑linearity', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e3091ce6-30ef-4898-95d8-5ac8dc9582e9', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The exposure to crizanlizumab (mean C<sub>max</sub>, AUC<sub>last</sub>, or AUC<sub>inf</sub>) increased in non‑linear manner over the dose range of 0.2 to 8 mg/kg in healthy volunteers.</span></p>', 'ID': '0f8c5072-5ed3-4aec-8749-5ac476a7e75f', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The exposure to crizanlizumab (mean Cmax, AUClast, or AUCinf) increased in non‑linear manner over the dose range of 0.2 to 8 mg/kg in healthy volunteers.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '09a8d525-4272-4243-a3b6-b61c438b48b5', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Special populations</span></u></p>', 'ID': '07676513-d6ad-4403-b7f4-172327384a02', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Special populations', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '2377eb8c-a022-4bd6-9344-958346ad2a64', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Renal impairment</span></u></i></p>', 'ID': 'de6eb665-d2f6-423f-bbb4-6cf89fe19fc8', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': True, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L4', 'Text': 'Renal impairment', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In a population PK analysis in patients with eGFR ranging from 35 to 202 ml/min/1.73 m<sup>2</sup>, no clinically important differences in the pharmacokinetics of crizanlizumab were found between patients with mild or moderate renal impairment and patients with normal renal function. Data from patients with severe renal impairment are too limited to draw conclusions on this population (see section</span><span lang=\"EN-GB\"> </span><span lang=\"EN-GB\">4.2).</span></p>', 'ID': '55fdf68a-b0d0-41fd-94a5-c7462d8a9ca4', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'In a population PK analysis in patients with eGFR ranging from 35 to 202 ml/min/1.73 m2, no clinically important differences in the pharmacokinetics of crizanlizumab were found between patients with mild or moderate renal impairment and patients with normal renal function. Data from patients with severe renal impairment are too limited to draw conclusions on this population (see section 4.2).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ad169960-f812-480f-80f4-6c2f1384a117', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Hepatic impairment</span></u></i></p>', 'ID': '1481fd7d-eec3-4db9-a8c3-2a7757e2e767', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': True, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L4', 'Text': 'Hepatic impairment', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monoclonal antibody and is cleared via catabolism (i.e. breakdown into peptides and amino acids), and a change in dose is not expected to be required for patients with hepatic impairment.</span></p>', 'ID': '734175d6-c4a2-4df4-ad4f-c1289c180bf2', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monoclonal antibody and is cleared via catabolism (i.e. breakdown into peptides and amino acids), and a change in dose is not expected to be required for patients with hepatic impairment.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '83a0b34c-87a8-4941-8bd0-9a8eacba26c2', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Paediatric <a name=\"_nth_Pediatric_patients__be14752\"></a>population</span></u></i></p>', 'ID': '1db6ba87-5368-4522-a96c-6bb36868e756', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': True, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L4', 'Text': 'Paediatric population', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pharmacokinetics in paediatric patients below the age of 16 years have not been investigated.</span></p>', 'ID': 'eab04aa6-e6d1-488b-9b0a-cdf2d9fbe1d1', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Pharmacokinetics in paediatric patients below the age of 16 years have not been investigated.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '06d7dc74-1123-46c5-8e58-5baba403d620', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.3     Preclinical safety data</span></b></p>', 'ID': '4679ecf1-e9ac-4cc6-9347-882d2b80caaa', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '5.3     Preclinical safety data', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '5612455a-6bf5-4e73-875f-5525fee58655', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">N</span><span lang=\"EN-GB\">on‑clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, tissue cross‑reactivity and repeated dose toxicity.</span></p>', 'ID': '9dfe8e22-726c-48dd-a73e-0ffca677a83e', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Non‑clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, tissue cross‑reactivity and repeated dose toxicity.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c95b5e22-fa87-49b9-933e-1076b8325fc8', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In the 26‑week repeated dose toxicity study, administration of crizanlizumab in cynomolgus monkeys at dose levels up to 50 mg/kg/dose once every 4 weeks (at least 13.5 times the human clinical exposure based on AUC in patients with sickle cell disease at 5 mg/kg once every four weeks) was generally well tolerated. There were no primary crizanlizumab‑related findings on any endpoint evaluated. At 50 mg/kg, minimal to moderate inflammation of the vessels in multiple tissues considered to be an antigen‑antibody complex reaction (primate antihuman antibody) was observed in 2 of 10 animals. There was one death attributed to aspiration of gastric contents following a peri‑infusional reaction mediated by anti‑drug‑antibody‑dependent hypersensitivity.</span></p>', 'ID': '249ba44f-0806-4154-a058-151cfd72086b', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'In the 26‑week repeated dose toxicity study, administration of crizanlizumab in cynomolgus monkeys at dose levels up to 50 mg/kg/dose once every 4 weeks (at least 13.5 times the human clinical exposure based on AUC in patients with sickle cell disease at 5 mg/kg once every four weeks) was generally well tolerated. There were no primary crizanlizumab‑related findings on any endpoint evaluated. At 50 mg/kg, minimal to moderate inflammation of the vessels in multiple tissues considered to be an antigen‑antibody complex reaction (primate antihuman antibody) was observed in 2 of 10 animals. There was one death attributed to aspiration of gastric contents following a peri‑infusional reaction mediated by anti‑drug‑antibody‑dependent hypersensitivity.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'aa214270-ebc8-4f85-a58a-04986ad789e3', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\">Pharmacological effects of crizanlizumab on haemodynamic and electrocardiographic parameters in the cynomolgus monkey were evaluated in the 26‑week repeated dose toxicology study. Respiratory rate and neurological parameters were also assessed. There were no crizanlizumab‑related effects on arterial blood pressure or on heart rate, PR, RR, QRS, QT, and heart rate corrected QT (QTc) intervals on the electrocardiograms (ECG). No rhythm abnormalities or qualitative changes were observed during the qualitative ECG assessment. There were no crizanlizumab‑related effects on respiration rate or any neurological parameter evaluated.</p>', 'ID': '8fb16356-f5ab-42a4-aaac-9444a3167a9a', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Pharmacological effects of crizanlizumab on haemodynamic and electrocardiographic parameters in the cynomolgus monkey were evaluated in the 26‑week repeated dose toxicology study. Respiratory rate and neurological parameters were also assessed. There were no crizanlizumab‑related effects on arterial blood pressure or on heart rate, PR, RR, QRS, QT, and heart rate corrected QT (QTc) intervals on the electrocardiograms (ECG). No rhythm abnormalities or qualitative changes were observed during the qualitative ECG assessment. There were no crizanlizumab‑related effects on respiration rate or any neurological parameter evaluated.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"> </p>', 'ID': '46f8c14d-38a5-4dcb-9ddd-19fa5a0cfc57', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Formal carcinogenicity, genotoxicity and juvenile toxicity studies have not been conducted with crizanlizumab.</span></p>', 'ID': '4a51b9ef-c655-47df-8040-1454020aab38', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Formal carcinogenicity, genotoxicity and juvenile toxicity studies have not been conducted with crizanlizumab.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '9ccca12b-0a06-4812-95cc-48dc425408e2', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In a 26‑week repeated dose toxicity study, cynomolgus monkeys were administered crizanlizumab once every 4 weeks at doses up to 50 mg/kg (at least 13.5 times the human clinical exposure based on AUC in patients with sickle cell disease at 5 mg/kg once every four weeks). </span><span lang=\"EN-GB\">There were no adverse effects of crizanlizumab on male and female reproductive organs</span>.</p>', 'ID': '2c6442f0-201f-4775-8452-1c36a089ff2a', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'In a 26‑week repeated dose toxicity study, cynomolgus monkeys were administered crizanlizumab once every 4 weeks at doses up to 50 mg/kg (at least 13.5 times the human clinical exposure based on AUC in patients with sickle cell disease at 5 mg/kg once every four weeks). There were no adverse effects of crizanlizumab on male and female reproductive organs.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'de592949-aa05-45df-92ce-b8517448318c', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In an enhanced pre‑ and postnatal development study in cynomolgus monkeys, pregnant animals received intravenous crizanlizumab once every two weeks during the period of organogenesis, at doses of 10 and 50 mg/kg (approximately 2.8 and 16 times </span><span lang=\"EN-GB\">the human clinical exposure based on AUC in patients with sickle cell disease at 5 mg/kg/dose once every four weeks, respectively)</span><span lang=\"EN-GB\">. No maternal toxicity was observed. </span><span lang=\"EN-GB\">There was an increase in foetal loss (abortions or stillbirths) at both doses and this was higher in the third trimester. The cause of the foetal losses in monkeys is unknown but may be due to the development of anti‑drug antibodies against crizanlizumab</span><span lang=\"EN-GB\">. There were no effects on infant growth and development during the 6 months postpartum that were attributable to crizanlizumab.</span></p>', 'ID': '1bd38c10-06fd-4517-b905-bfa5009eaa54', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'In an enhanced pre‑ and postnatal development study in cynomolgus monkeys, pregnant animals received intravenous crizanlizumab once every two weeks during the period of organogenesis, at doses of 10 and 50 mg/kg (approximately 2.8 and 16 times the human clinical exposure based on AUC in patients with sickle cell disease at 5 mg/kg/dose once every four weeks, respectively). No maternal toxicity was observed. There was an increase in foetal loss (abortions or stillbirths) at both doses and this was higher in the third trimester. The cause of the foetal losses in monkeys is unknown but may be due to the development of anti‑drug antibodies against crizanlizumab. There were no effects on infant growth and development during the 6 months postpartum that were attributable to crizanlizumab.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'bfd1df42-3b6b-4eb7-9ac9-ed2f0a05e768', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Measurable crizanlizumab serum concentrations were observed in the infant monkeys at postnatal day 28, confirming that crizanlizumab, like other IgG antibodies, crosses the placental barrier.</span></p>', 'ID': '3fdc8ea7-8326-4261-ad5c-e716a34fdfa9', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Measurable crizanlizumab serum concentrations were observed in the infant monkeys at postnatal day 28, confirming that crizanlizumab, like other IgG antibodies, crosses the placental barrier.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '3d455957-9727-4c20-9bbc-88e5da60aa85', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '643d24d6-80da-4ab4-9624-0221c8465acb', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.       PHARMACEUTICAL PARTICULARS</span></b></p>', 'ID': '1ea14223-5db3-4ba2-b1ec-4f17d58dcd5f', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L1', 'Text': '6.       PHARMACEUTICAL PARTICULARS', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '966675b9-690b-41d9-98ed-60967ffd9f3c', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.1     List of excipients</span></b></p>', 'ID': 'ed327a73-30e6-4081-b6de-0fe728ce8969', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '6.1     List of excipients', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '252756a3-2ffd-4fa1-93bf-62767e7a8c66', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Sucrose</span></p>', 'ID': 'e42486b8-431d-489e-92e1-26e80f62c326', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Sucrose', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Sodium citrate (E331)</span></p>', 'ID': '3382e5f0-a081-4aa4-97d5-536842c7328e', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Sodium citrate (E331)', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Citric acid (E330)</span></p>', 'ID': 'd4798f99-bb2d-4cc7-ba65-ace4e92c99d6', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Citric acid (E330)', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Polysorbate 80 (E433)</span></p>', 'ID': '95540f6b-617d-48b0-a6bc-5f309ea429aa', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Polysorbate 80 (E433)', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Water for injections</span></p>', 'ID': '8533427e-eca8-4d27-add7-ae84359e2b3d', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Water for injections', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '0695764c-3f57-4cc5-bdc9-032776603195', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.2     Incompatibilities</span></b></p>', 'ID': '93b62773-0f41-45e2-94ac-0e36099c20e6', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '6.2     Incompatibilities', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'a2269772-413a-4a40-81f3-bff5dd940e7c', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal product</span><span lang=\"EN-GB\"> must not be mixed with other medicinal products except those mentioned in section 6.6.</span></p>', 'ID': 'c1dd7e4b-2172-4e76-b329-beee93d2cb22', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '823e1348-5e7b-4ece-8640-affd6e5ed5be', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.3     Shelf life</span></b></p>', 'ID': '8d321b8f-d147-49dc-b3f2-14c13473e828', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '6.3     Shelf life', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '37d476c0-f943-407b-b694-73edbb744cf1', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Unopened vial</span></u></p>', 'ID': '00e069bf-ec29-46b0-9da9-069be813ec77', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Unopened vial', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '8a8b2484-d59f-49da-88e1-b8fb42574e6d', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">18 months</span></p>', 'ID': '15a7da87-7151-407a-aff9-f16540d65487', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '18 months', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ccd15a79-4c3e-4920-a3e2-495f132624ad', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Diluted solution</span></u></p>', 'ID': 'fd426195-3dc5-4f10-9564-c7c5e3e9291c', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Diluted solution', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e81f948d-5467-4471-a174-5542d7d5d673', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Chemical and physical in‑use stability, from the start of preparation of the diluted solution for infusion until end of infusion, has been demonstrated for up to 8 hours at room temperature (up to 25°C) and at 2°C to 8°C for up to 24 hours overall.</span></p>', 'ID': '6289cac5-3b81-4e28-9ad6-409df65bb1d5', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Chemical and physical in‑use stability, from the start of preparation of the diluted solution for infusion until end of infusion, has been demonstrated for up to 8 hours at room temperature (up to 25°C) and at 2°C to 8°C for up to 24 hours overall.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '9e63db32-7ab4-433c-95ed-27da07885ad9', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">From a microbiological point of view, the diluted solution for infusion should be used immediately. If not used immediately, in‑use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2°C to 8°C, including 4.5 hours at room temperature (up to 25°C) from the start of preparation to completion of the infusion, unless dilution has taken place in controlled and validated aseptic conditions.</span></p>', 'ID': 'be86aea2-b55d-411b-b239-579d9ab70e79', 'Styles': 'margin-top:0in;text-align:left', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'From a microbiological point of view, the diluted solution for infusion should be used immediately. If not used immediately, in‑use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2°C to 8°C, including 4.5 hours at room temperature (up to 25°C) from the start of preparation to completion of the infusion, unless dilution has taken place in controlled and validated aseptic conditions.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"> </p>', 'ID': '30dfdf90-c7c6-46dd-81ed-34040c037707', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.4     Special precautions for storage</span></b></p>', 'ID': '0916fc58-f815-4be1-8e43-15d87212f2ff', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '6.4     Special precautions for storage', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c05a9aae-2370-4c08-8a36-30a372a87373', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Store in a refrigerator (2°C – 8°C).</span></p>', 'ID': '0ecc299e-06ef-4489-8a36-f2034f2042ab', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Store in a refrigerator (2°C – 8°C).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not freeze.</span></p>', 'ID': 'a112a3f4-75ce-4161-8661-ea3d6b64a170', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Do not freeze.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep the vial in the outer carton in order to protect from light.</span></p>', 'ID': '699fc118-68a0-4d85-91f8-68906d13d935', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Keep the vial in the outer carton in order to protect from light.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '1c6011d9-95b8-4289-88e3-be255803aa85', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For storage conditions after dilution of the medicinal product, see section 6.3.</span></p>', 'ID': '9d751841-7244-4356-92cd-d0d33db564a8', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'For storage conditions after dilution of the medicinal product, see section 6.3.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '0566d8ce-a929-4cd0-8ac2-6d814231b189', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.5     Nature and contents of container</span></b></p>', 'ID': 'd57803b0-6a88-44a7-88de-d89dae95ab44', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '6.5     Nature and contents of container', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '558e72cd-ad45-48cc-bf26-ed0c0f1fa60a', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">10 ml concentrate for solution for infusion in a type I glass vial with a coated chlorobutyl rubber stopper sealed with an aluminium cap with a plastic flip‑off disk containing 100 mg crizanlizumab.</span></p>', 'ID': '13eb2179-b33a-48a3-81da-f9ac455031fe', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '10 ml concentrate for solution for infusion in a type I glass vial with a coated chlorobutyl rubber stopper sealed with an aluminium cap with a plastic flip‑off disk containing 100 mg crizanlizumab.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'f67001d0-3ed0-46c6-a74b-ceb81076f6ca', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pack of 1 vial.</span></p>', 'ID': '2b7c8f38-c832-4a4e-a4c8-03d1672b36c5', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Pack of 1 vial.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '78af6177-82e3-47dc-bdee-a120221922fd', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><a name=\"OLE_LINK1\"><b><span lang=\"EN-GB\">6.6     Special precautions for disposal and other handling</span></b></a></p>', 'ID': '0562f34b-62da-4f2c-b64d-fbe84c7ab2ad', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L2', 'Text': '6.6     Special precautions for disposal and other handling', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '007d733a-4f29-41b2-b121-2cb115094347', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo vials are for single use only.</span></p>', 'ID': 'bc7bcab8-dac1-4983-916e-5ffcb01f938d', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Adakveo vials are for single use only.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c4a1d90f-bd32-4d0a-bf43-604c0b34c9af', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Preparing the infusion</span></u></p>', 'ID': '4512dd38-a048-42e5-8029-b540a8263f2b', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Preparing the infusion', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e23ff6b2-20ae-44b0-b64f-198e5618f75d', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The diluted solution for infusion should be prepared by a healthcare professional using aseptic techniques.</span></p>', 'ID': '1473cd1c-9b6f-4370-9f72-e83e69475737', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The diluted solution for infusion should be prepared by a healthcare professional using aseptic techniques.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '95f93264-c234-4b46-89c6-e945e5e9b31d', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The total dose and required volume of Adakveo depend on the patient’s body weight; 5 mg of crizanlizumab is administered per kg body weight.</span></p>', 'ID': '94346e88-c101-4bc7-8012-d3b0d77c943c', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The total dose and required volume of Adakveo depend on the patient’s body weight; 5 mg of crizanlizumab is administered per kg body weight.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '51d7f2e0-8d66-42f0-92ca-d00295fda75d', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">The volume to be used for the preparation of the infusion is calculated according to the following equation:</span></p>', 'ID': '30001714-d1b1-486b-99fd-1e91d0dcec95', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'The volume to be used for the preparation of the infusion is calculated according to the following equation:', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '33a626aa-b331-405b-9e6e-973e963fc8ac', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:12.5pt;border-collapse:collapse\" width=\"567\"> <tr> <td rowspan=\"2\" style=\"width:85.05pt;padding:0in 5.4pt 0in 5.4pt\" width=\"113\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Volume (ml) =</span></p> </td> <td style=\"width:269.35pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"359\"> <p align=\"center\" class=\"MsoNormal\" style=\"margin-left:28.35pt;text-align:center;   text-indent:-28.35pt;line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Patient’s body weight (kg) x prescribed dose</span></p> </td> <td style=\"width:70.85pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" width=\"94\"> <p align=\"center\" class=\"MsoNormal\" style=\"margin-left:28.35pt;text-align:center;   text-indent:-28.35pt;line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">[5 mg/kg]</span></p> </td> </tr> <tr> <td style=\"width:269.35pt;border:none;padding:0in 5.4pt 0in 5.4pt\" width=\"359\"> <p align=\"center\" class=\"Text\" style=\"margin-top:0in;text-align:center;   page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Concentration   of Adakveo</span></p> </td> <td style=\"width:70.85pt;border:none;padding:0in 5.4pt 0in 5.4pt\" width=\"94\"> <p align=\"center\" class=\"Text\" style=\"margin-top:0in;text-align:center;   page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">[10 mg/ml]</span></p> </td> </tr> </table>', 'ID': 'c2a797e4-ca61-4a7f-b729-32f94c299d13', 'Styles': 'margin-left:12.5pt;border-collapse:collapse', 'Classes': \"['MsoNormalTable']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '   Volume (ml) =   Patient’s body weight (kg) x prescribed dose   [5 mg/kg]     Concentration   of Adakveo   [10 mg/ml]   ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_hd6_Table_3_1_Example_of_d12477\"></a><span lang=\"EN-GB\"> </span></p>', 'ID': '29859d43-7257-48ca-82e8-4da9831cccad', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">1.       Obtain the number of vials required to deliver the prescribed dose and bring them to room temperature (for a maximum of 4 hours). One vial is needed for every 10 ml of Adakveo (see below table).</span></p>', 'ID': '985c20b0-443f-4a52-9767-84b70deae8fc', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '1.       Obtain the number of vials required to deliver the prescribed dose and bring them to room temperature (for a maximum of 4 hours). One vial is needed for every 10 ml of Adakveo (see below table).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e105b8a5-3f7f-4323-88f6-c66f83ef9f97', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:28.35pt;border-collapse:collapse;border:none\" width=\"568\"> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Body weight (kg)</span></b></p> </td> <td style=\"width:92.15pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Dose (mg)</span></b></p> </td> <td style=\"width:114.75pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Volume (ml)</span></b></p> </td> <td style=\"width:114.75pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><b><span lang=\"EN-GB\">Vials (n)</span></b></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">40</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">200</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">20</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">2</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">60</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">300</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">30</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">3</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">80</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">400</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">40</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">4</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">100</span></p> </td> <td style=\"width:92.15pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">500</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">50</span></p> </td> <td style=\"width:114.75pt;border:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;page-break-after:   avoid;text-autospace:none\"><span lang=\"EN-GB\">5</span></p> </td> </tr> <tr style=\"page-break-inside:avoid\"> <td style=\"width:104.65pt;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"140\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">120</span></p> </td> <td style=\"width:92.15pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">600</span></p> </td> <td style=\"width:114.75pt;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">60</span></p> </td> <td style=\"width:114.75pt;border:none;border-bottom:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"153\"> <p class=\"MsoNormal\" style=\"margin-left:28.35pt;line-height:normal;text-autospace:   none\"><span lang=\"EN-GB\">6</span></p> </td> </tr> </table>', 'ID': '88fa01d0-297f-44a4-9f1e-72b7db37da6e', 'Styles': 'margin-left:28.35pt;border-collapse:collapse;border:none', 'Classes': \"['MsoNormalTable']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '   Body weight (kg)   Dose (mg)   Volume (ml)   Vials (n)     40   200   20   2     60   300   30   3     80   400   40   4     100   500   50   5     120   600   60   6   ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '8a5434fe-20f2-4bf7-b303-a467e4500701', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">2.       Visually inspect the vials.</span></p>', 'ID': 'f9dda721-880c-4fdd-81c9-23a61f02f35a', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '2.       Visually inspect the vials.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The solution in the vials should be clear to opalescent. Do not use if particles are present in the solution.</span></p>', 'ID': 'dfe30f25-3213-49f3-8c1a-a03428471f1d', 'Styles': 'margin-left:56.7pt;text-indent:-28.35pt;line-height:\\nnormal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '-                 The solution in the vials should be clear to opalescent. Do not use if particles are present in the solution.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The solution should be colourless or may have a slight brownish‑yellow tint.</span></p>', 'ID': 'a6daa916-3929-40ec-985a-6e34ce49cc4f', 'Styles': 'margin-left:56.7pt;text-indent:-28.35pt;line-height:\\nnormal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '-                 The solution should be colourless or may have a slight brownish‑yellow tint.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '4b2604a7-15d1-4474-bf4b-c802fbbaa010', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">3.       Withdraw a volume equal to the required volume of Adakveo from a 100 ml infusion bag containing either sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% and discard.</span></p>', 'ID': 'e366bb71-b7ba-4cfc-b28f-66f0bbc90eee', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '3.       Withdraw a volume equal to the required volume of Adakveo from a 100 ml infusion bag containing either sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% and discard.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">No incompatibilities between the diluted Adakveo solution and infusion bags composed of polyvinylchloride (PVC), polyethylene (PE) and polypropylene (PP) have been observed.</span></p>', 'ID': '66a122bf-afbc-49d3-9b45-b2c7d80407c0', 'Styles': 'margin-left:56.7pt;text-indent:-28.35pt', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '-                 No incompatibilities between the diluted Adakveo solution and infusion bags composed of polyvinylchloride (PVC), polyethylene (PE) and polypropylene (PP) have been observed.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'fac9eddc-a1cd-4099-bd26-f4664ec53a90', 'Styles': 'None', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">4.       Withdraw the necessary volume of Adakveo from the vials and inject slowly into the previously prepared infusion bag.</span></p>', 'ID': 'a15ac1bf-0bfb-4400-8bc9-b4f24a526ef8', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '4.       Withdraw the necessary volume of Adakveo from the vials and inject slowly into the previously prepared infusion bag.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">The </span><span lang=\"EN-GB\">solution</span><span lang=\"EN-GB\"> must not be mixed or co‑administered with other medicinal products through the same intravenous line.</span></p>', 'ID': 'af8f1547-b844-40e2-9fcf-393264f9fcbc', 'Styles': 'margin-left:56.7pt;text-indent:-28.35pt', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '-                 The solution must not be mixed or co‑administered with other medicinal products through the same intravenous line.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style=\\'font:7.0pt \"Times New Roman\"\\'>                 </span></span><span lang=\"EN-GB\">Keep the volume of Adakveo added to the infusion bag in the range of 10 ml to 96 ml to obtain a final concentration in the infusion bag within 1 mg/ml to 9.6 mg/ml.</span></p>', 'ID': '4282d2cf-94c8-463c-835c-14d070734b16', 'Styles': 'margin-left:56.7pt;text-indent:-28.35pt', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': True, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '-                 Keep the volume of Adakveo added to the infusion bag in the range of 10 ml to 96 ml to obtain a final concentration in the infusion bag within 1 mg/ml to 9.6 mg/ml.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd81fb4c8-01d1-41bf-8579-8cfb069ef597', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">5.       Mix the diluted solution by gently inverting the infusion bag. DO NOT SHAKE.</span></p>', 'ID': '755f3b13-17d9-4fe3-9c2b-1f5fb1a5d6c0', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': '5.       Mix the diluted solution by gently inverting the infusion bag. DO NOT SHAKE.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'a21c3ed4-49d7-4e66-9692-d9ddcbf7b9bf', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Administration</span></u><a name=\"_nth_Administration25012\"></a></p>', 'ID': 'a44b6df6-f9ab-4c89-8110-e858a2e81944', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Administration', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e1525e94-a89a-4533-bcd3-24d091a9a998', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">Adakveo diluted solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by intravenous infusion over a period of 30 minutes.</span><span style=\"font-size:11.0pt\"> <span lang=\"EN-GB\">No incompatibilities have been observed between Adakveo and infusion sets composed of PVC, PE‑lined PVC, polyurethane, and in‑line filter membranes composed of polyethersulfone (PES), polyamide (PA) or polysulphone (PSU).</span></span></p>', 'ID': 'cc618436-4d6a-4fdc-8841-f06397bdae7a', 'Styles': 'margin-top:0in;text-align:left', 'Classes': \"['Text']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Adakveo diluted solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by intravenous infusion over a period of 30 minutes. No incompatibilities have been observed between Adakveo and infusion sets composed of PVC, PE‑lined PVC, polyurethane, and in‑line filter membranes composed of polyethersulfone (PES), polyamide (PA) or polysulphone (PSU).', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '2ca8a9c0-71bf-4f00-ac95-4f17769b0430', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">After administration of Adakveo, flush the line with at least 25 ml sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5%.</span></p>', 'ID': '91651b3d-52f4-4496-9120-d585bdf34f81', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'After administration of Adakveo, flush the line with at least 25 ml sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5%.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'fc23fa4e-5365-4897-8e35-081b5bc498e3', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Disposal</span></u></p>', 'ID': '790d0f73-c2bb-4287-a4fd-7353eea185e6', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': True, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L3', 'Text': 'Disposal', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd9bc9594-8973-438b-af6e-ce6f9f95a3e9', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</span></p>', 'ID': '88caa940-38af-4a39-85ac-496e8896c678', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Any unused medicinal product or waste material should be disposed of in accordance with local requirements.', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '9f3a1ca2-3874-417a-82e6-7b6dcd3a23cc', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '17bb70bb-c856-421e-a119-655fcd74c970', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">7.       MARKETING AUTHORISATION HOLDER</span></b></p>', 'ID': '2e90cca4-467f-40f6-9d9b-7cdcc501a036', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L1', 'Text': '7.       MARKETING AUTHORISATION HOLDER', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': '6a6d9cce-8b55-41c6-a9df-5a2974a1aff4', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Novartis Europharm Limited</span></p>', 'ID': 'ee815573-69e1-4b40-9bc2-5e163d630406', 'Styles': 'page-break-after:avoid', 'Classes': \"['Default']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Novartis Europharm Limited', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Vista Building</span></p>', 'ID': '80c23402-0480-4124-8f6f-46925c8e537b', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Vista Building', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Elm Park, Merrion Road</span></p>', 'ID': 'dfa537c6-eb19-410c-afb9-33186c2b6b05', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Elm Park, Merrion Road', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Dublin 4</span></p>', 'ID': '2b695489-cf12-4049-a2e1-1a2d14df92d2', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Dublin 4', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">Ireland</span></p>', 'ID': '48c00e77-77ec-4244-9d94-2fd6f4b81631', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Ireland', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '21f9fed2-00ca-44a3-9267-1078e9faf781', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'e98778fc-a17b-48aa-8e8a-cbe138ff09c4', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">8.       MARKETING AUTHORISATION NUMBER(S)</span></b></p>', 'ID': 'fefa296f-e154-42b7-8416-72c6b78230fa', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L1', 'Text': '8.       MARKETING AUTHORISATION NUMBER(S)', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd3c33c17-e1b6-4954-be6b-c384593de96c', 'Styles': 'line-height:normal;page-break-after:avoid', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">EU/1/20/1476/001</span></p>', 'ID': '317e074d-c34f-4f1f-890c-df3b4c5a19ae', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'EU/1/20/1476/001', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '36bce19f-089e-4025-a9d9-3b41061b9947', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'bcde3901-95f7-48b8-9dbc-01fc7f2ef0e3', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">9.       DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>', 'ID': 'acaf6790-3f91-4b6f-99bc-199765791f5a', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L1', 'Text': '9.       DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd56760a9-7b6c-406d-a591-5c8012b57d75', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '0c85ada6-10f3-4235-9810-45b382d68edb', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">10.     DATE OF REVISION OF THE TEXT</span></b></p>', 'ID': 'a86741a5-547d-4084-bbdb-e8eea5a9da42', 'Styles': 'margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal', 'Classes': \"['MsoNormal']\", 'Bold': True, 'Italics': False, 'Uppercased': True, 'Underlined': False, 'Indexed': True, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': True, 'IsHeadingType': 'L1', 'Text': '10.     DATE OF REVISION OF THE TEXT', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'fd5536d3-3d24-4f8a-9a87-763251e3817b', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '66026015-c5e3-417c-ab6e-ac77e1a42b13', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Detailed information on this medicinal product is available on the website of the European Medicines </span><span lang=\"EN-GB\">Agency <a href=\"http://www.ema.europa.eu\">http://www.ema.europa.eu</a></span><span lang=\"EN-GB\">.<br clear=\"all\" style=\"page-break-before:always\"/> </span></p>', 'ID': '3cd86c01-ce4b-404f-9774-5467f495dcf0', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': 'Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu. ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '201cb4bb-4df3-45ab-aaa5-bd46bb419470', 'Styles': 'margin-right:-.1pt;line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c2d1acd4-1298-4014-91a6-a105a1c9be38', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '3731cb55-5fdb-475d-bec8-bcf2fb4a5692', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '2103b9cc-b2dd-4dc7-9cca-7aaf2ca8e6dd', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'cb897326-186f-4a5f-b3b6-5eb11a2091a4', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'c33d0918-4f07-4b10-981d-3a7a2e51f4ee', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '4dc1eeca-1565-4651-86de-bb0549d7050c', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ee2b1bb5-2900-4e3b-bfcc-570e2dde38e2', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '19b053f2-d9c9-4930-85f2-1f860db8cfef', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'b1edb48c-264b-4d54-92fb-cd63dad463b7', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '0e9207b1-a497-45e4-8eee-6c06c1bc16dd', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ca99e9aa-9e9e-456d-ab1b-e2d19669890d', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'ade7361e-e0bb-48cc-a7c7-2a6674f5329f', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'f0c6c67a-380f-4da4-9e5a-02cd72cc4a71', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '055a5227-34c3-439a-8046-f928d2d0ea70', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '1dd82cf7-9f12-4867-91a0-c450f9ce6fcc', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'f6251986-fd21-4691-88e4-edb89b0422a4', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'a3a9a54e-fb50-404d-9510-f6300d2bbb11', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '20b168cc-9f45-4b6d-933f-6077b8af5595', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': 'd1d3015a-8a2b-4ab0-842d-a3cc8c9e169a', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '66e9038f-c383-4cff-95af-818e76a2091d', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '658742af-a192-4d57-8624-0f9a44426e15', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}, {'Element': '<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>', 'ID': '4af52237-24ea-434e-9e10-08277413103e', 'Styles': 'line-height:normal', 'Classes': \"['MsoNormal']\", 'Bold': False, 'Italics': False, 'Uppercased': False, 'Underlined': False, 'Indexed': False, 'IsListItem': False, 'HasBorder': False, 'IsPossibleHeading': False, 'IsHeadingType': None, 'Text': ' ', 'ParentId': '583f04cc-251b-4aa9-a300-400d62bebe5a'}]\n"
     ]
    }
   ],
   "source": [
    "from scripts.jsonHandlingUtils import loadJSON_Convert_to_DF, mkdir, addjson\n",
    "with open(path, encoding='utf-8') as f:\n",
    "    json_html = json.load(f)\n",
    "print(json_html)\n",
    "dic_json = {}\n",
    "# print(json_html)\n",
    "# print(type(json_html))\n",
    "for i in json_html:\n",
    "    for j in i.keys():\n",
    "        dic_json = addjson(dic_json, j, i[j])\n",
    "\n",
    "# print(loadJSON_Convert_to_DF(output_filename))\n",
    "df = pd.DataFrame(dic_json)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Element</th>\n",
       "      <th>ID</th>\n",
       "      <th>Styles</th>\n",
       "      <th>Classes</th>\n",
       "      <th>Bold</th>\n",
       "      <th>Italics</th>\n",
       "      <th>Uppercased</th>\n",
       "      <th>Underlined</th>\n",
       "      <th>Indexed</th>\n",
       "      <th>IsListItem</th>\n",
       "      <th>HasBorder</th>\n",
       "      <th>IsPossibleHeading</th>\n",
       "      <th>IsHeadingType</th>\n",
       "      <th>Text</th>\n",
       "      <th>ParentId</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>&lt;div class=\"WordSection1\"&gt; &lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt; &lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt; &lt;p class=...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "      <td>None</td>\n",
       "      <td>['WordSection1']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>...</td>\n",
       "      <td>1b945380-ed32-477d-bc89-4e43eb629b1e</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>93f99a3a-3bdb-4712-b8a2-7f7151752254</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>37bd41cc-5002-4d0f-b837-d1e612a8c9f4</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a118066d-62a7-49fe-b164-8dc28660cc13</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>048fcf44-3865-41ad-aa41-6fcf26a64a4e</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c31204d8-633f-4f10-ac97-914fcf46f5d7</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d70aeb25-5d44-4d24-b3ba-df3f0a945409</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e1477684-3361-4ca8-bd48-87fe774951b6</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6144e956-79cb-4671-935e-0428d8ae9552</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e8d61a67-3455-4013-b0cb-8c6be91e1dd9</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5ae63bab-fd9f-4543-8da5-95385fe2878a</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>73b2745c-30ea-4c64-8e98-aa6a807ed175</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7a8d15de-c5dc-49a9-b9f2-c06ea2aa2812</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e4924fc5-14a2-4074-ba07-3827e2690bbe</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5bbfb234-75ff-4d1b-ba18-79dc786c49a3</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>502e9ac3-58ab-4843-b8a0-5fd60ed4e9c5</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>48f98078-4e9d-4cf6-a2e3-6551b02a5fa4</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>53bfe434-4517-42ce-a813-b71d9f2e38cc</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b6a38e0b-e4f8-410b-b32a-37629f9e3831</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6bea775e-8180-4ac2-9e83-683b15a278e5</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d352b40d-10b4-4f2b-8989-ca2a32b8214e</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>cdc7ad58-c7fb-4b77-bcc2-de84faab6ac6</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>68654a8b-654b-47e1-a598-ec1c0860df89</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7a0e81a8-d56c-4500-b4fc-ed031c115ec5</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;ANNEX I&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>dd5948fb-58d2-4893-8b10-d805f0cdf739</td>\n",
       "      <td>text-align:center;line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>None</td>\n",
       "      <td>ANNEX I</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>75c81091-3ccc-4ed5-947f-c6995c913347</td>\n",
       "      <td>text-align:center;line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;SUMMARY OF PRODUCT CHARACTERISTICS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>70d45c8c-f80d-484f-ace5-16d07806febf</td>\n",
       "      <td>text-align:center;line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>SUMMARY OF PRODUCT CHARACTERISTICS</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>&lt;span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif; color:green'&gt;&lt;br clear=\"all\" style=\"page-break-before:always\"/&gt; &lt;/span&gt;</td>\n",
       "      <td>b1cb472e-16b2-4c31-9704-43221d1c8944</td>\n",
       "      <td>font-size:11.0pt;font-family:\"Times New Roman\",serif;\\ncolor:green</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>&lt;br clear=\"all\" style=\"page-break-before:always\"/&gt;</td>\n",
       "      <td>7b7faf20-48a0-43ba-a11c-700ccaf1b44d</td>\n",
       "      <td>page-break-before:always</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>b1cb472e-16b2-4c31-9704-43221d1c8944</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;img height=\"18\" src=\"Adakveo-4874%20EN%20PI_files/image001.png\" width=\"21\"/&gt;&lt;span lang=\"EN-GB\"&gt;This medicinal product is subject to additional moni...</td>\n",
       "      <td>5f9f4e00-1c00-4d69-ae60-3b512d354b58</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse react...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f468e77c-8bbb-4e8e-a650-a4bcf4292f4e</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b6444544-1b61-4ede-bcb4-292a105fdf99</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;1.       NAME OF &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;THE MEDICIN...</td>\n",
       "      <td>bebd747b-536c-4ae8-b191-86916bb5b392</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>1.       NAME OF THE MEDICINAL PRODUCT</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>79944278-5179-4fc2-8e1d-555b0355dd79</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Adakveo 10 mg/ml concentrate for solution for infusion&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>dd38be17-c16a-4a43-bd7d-7d7de217c2ab</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Adakveo 10 mg/ml concentrate for solution for infusion</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>39eb16f8-9ea5-47dc-9002-8f3bf989f47a</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ef09f9ed-de0d-4558-8fb6-f7d64aaf2336</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;2.       QUALITATIVE AND QUANTITATIVE COMPOSITION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>fb95db94-3ab2-47ed-860c-1a32343cda09</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>2.       QUALITATIVE AND QUANTITATIVE COMPOSITION</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a2e7bc93-c504-4cf0-a556-8dbc293ae03d</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Each ml of concentrate for solution for infusion contains 10 mg crizanlizumab.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6b8c14cb-eba7-4ba3-9de8-231605835033</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Each ml of concentrate for solution for infusion contains 10 mg crizanlizumab.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>445c2994-215c-4b60-9e68-58b10b0bebb5</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;One vial of 10 ml contains 100 mg crizanlizumab.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>86a20c6b-f68b-4371-9f8a-a22986385994</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>One vial of 10 ml contains 100 mg crizanlizumab.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e59ad3b0-fdc0-4860-b4cd-0ffd1f6bbfdc</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Crizanlizumab is a monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9b057f63-8d47-4932-bf02-b2258fe2de4f</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Crizanlizumab is a monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d82f7f95-1ede-431d-a553-e3fb38e6ff28</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;For the full list of excipients, see section 6.1.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>603928f1-93e4-4c02-bb15-6bc6cef996af</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>For the full list of excipients, see section 6.1.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>fba2229a-f0ed-4548-ad90-a381cf1a1782</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f630af4e-4e7d-4c18-b043-880d0facc0eb</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;3.       PHARMACEUTICAL &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" styl...</td>\n",
       "      <td>b61d2001-da27-4ae0-9cd3-4fb666ce3ffe</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>3.       PHARMACEUTICAL FORM</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>31b9ed10-5866-4e63-8cca-ce18cc144980</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;a name=\"_Toc259706902\"&gt;&lt;/a&gt;&lt;a name=\"_Toc259707071\"&gt;&lt;/a&gt;&lt;a name=\"_Toc259707134\"&gt;&lt;/a&gt;&lt;a name=\"_Toc259713075\"&gt;&lt;span lang=\"EN-GB\"&gt;Concentrate for solut...</td>\n",
       "      <td>7d27d913-4b56-4995-9a02-920d4d6d616b</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Concentrate for solution for infusion (sterile concentrate)</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>261b4958-43c7-49b9-9e5a-d08543d24acf</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Colourless to slightly brownish‑yellow liquid at pH 6 and with an osmolality of 300 mOsm/kg.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4252fb30-8aea-4a64-969d-9f97eac73b9b</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Colourless to slightly brownish‑yellow liquid at pH 6 and with an osmolality of 300 mOsm/kg.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b3f0efe9-3876-4e68-b585-60721f1c25ac</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4bf7be43-25d1-4109-903f-3037ea6db68f</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"text-transform:uppercase\"&gt;4.       &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span...</td>\n",
       "      <td>ee1bc075-2c6c-4e05-abb9-4907d5feeb5b</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>4.       CLINICAL PARTICULARS</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>32d06a42-9c67-427c-9011-cdfa13ede737</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;4.1     Therapeutic indications&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>0ebcbda6-4e48-4ae4-a098-291a1bbc76ba</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.1     Therapeutic indications</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>adf5587b-a53f-430b-817d-38b728fcf75d</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>&lt;p class=\"Standard\"&gt;&lt;span lang=\"EN-GB\"&gt;Adakveo&lt;/span&gt;&lt;span lang=\"EN-GB\"&gt; is indicated for the prevention of recurrent vaso‑occlusive crises (VOCs) in sickle cell disease patients aged 16 years and...</td>\n",
       "      <td>624419e5-aee7-4efc-95aa-caa3b50bc1bc</td>\n",
       "      <td>None</td>\n",
       "      <td>['Standard']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Adakveo is indicated for the prevention of recurrent vaso‑occlusive crises (VOCs) in sickle cell disease patients aged 16 years and older. It can be given as an add‑on therapy to hydroxyurea/hydro...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>238fb2f2-6728-400a-a31d-0a902b92cac0</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;4.2     Posology and method of administration&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>0ba39624-d328-423e-9451-75729da49f5e</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.2     Posology and method of administration</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b1d7658a-c886-4549-8199-23d497c4cc6b</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Treatment should be initiated by physicians experienced in the management of &lt;/span&gt;&lt;span lang=\"EN-GB\"&gt;sickle cell disease.&lt;/span...</td>\n",
       "      <td>b4a4dc54-4b41-43bd-b82f-06ee394b17a2</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Treatment should be initiated by physicians experienced in the management of sickle cell disease.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>86b7bbb5-d14b-4563-8aaf-f1f0b4aaad35</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Posology&lt;/span&gt;&lt;/u&gt;&lt;a name=\"_nth_Adults_and_patients_ag4131\"&gt;&lt;/a&gt;&lt;/p&gt;</td>\n",
       "      <td>490f404e-fff3-4d71-a062-145a626aa698</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Posology</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e714aa41-f9b5-4f9d-aa85-f59525886d3c</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The recommended dose of crizanlizumab is 5 mg/kg administered over a period of 30 minutes by intravenous infusion at week 0, week...</td>\n",
       "      <td>f658b1e4-66f8-4649-978b-497e69ca133e</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The recommended dose of crizanlizumab is 5 mg/kg administered over a period of 30 minutes by intravenous infusion at week 0, week 2, and every 4 weeks thereafter.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ced5ba42-b690-4da6-8bf6-5d6835f95180</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Crizanlizumab &lt;/span&gt;&lt;span lang=\"EN-GB\"&gt;c&lt;/span&gt;&lt;span lang=\"EN-GB\"&gt;an be given alone or with HU/HC.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>31210945-890b-4725-acdf-a354e5ca32d4</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Crizanlizumab can be given alone or with HU/HC.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9667ffd4-bc6f-4ff2-87bf-e738f6faabdf</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>&lt;p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;If a dose is missed, the treatment should be administered as soon as possible.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7973028c-e20f-44d7-8125-8c6ded4f2aec</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['Standard']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>If a dose is missed, the treatment should be administered as soon as possible.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt\"&gt;&lt;span style=\"font-size:11.0pt...</td>\n",
       "      <td>1355137f-9392-440f-b76b-893e39322a99</td>\n",
       "      <td>margin-top:0in;margin-right:0in;margin-bottom:\\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>-                 If crizanlizumab is administered within 2 weeks after the missed dose, dosing should be continued according to the patient’s original schedule.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt\"&gt;&lt;span style=\"font-size:11.0pt...</td>\n",
       "      <td>2d7b667e-921c-42ad-9bf8-c07eb6611782</td>\n",
       "      <td>margin-top:0in;margin-right:0in;margin-bottom:\\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>-                 If crizanlizumab is administered more than 2 weeks after the missed dose, dosing should be continued every 4 weeks thereafter.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>33cb5747-aeff-44e1-a295-f35fdc5df1bf</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;i&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Special populations&lt;/span&gt;&lt;/u&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>819e866d-22fe-4467-979b-2965a5b375fb</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Special populations</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"EN-GB\"&gt;Elderly&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>42987233-13d8-4992-85ad-cd9d26a9e675</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Elderly</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Crizanlizumab has not been studied in elderly patients. No dose adjustment is required as the pharmacokinetics of crizanlizumab i...</td>\n",
       "      <td>394675e6-38ca-43f4-8fa4-67bdbdb6ac0b</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Crizanlizumab has not been studied in elderly patients. No dose adjustment is required as the pharmacokinetics of crizanlizumab in adults are not affected by age.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4116a164-0fb0-41ec-8d4d-980eee909720</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"EN-GB\"&gt;Renal impairment&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>38d92515-beef-4580-a9e9-5f343ee60f2c</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Renal impairment</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Based on the population pharmacokinetic (PK) results, no dose adjustment is required in patients with mild or moderate renal impa...</td>\n",
       "      <td>f485a522-47e8-4737-9053-6c37b287e4da</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Based on the population pharmacokinetic (PK) results, no dose adjustment is required in patients with mild or moderate renal impairment (see section 5.2). Data from patients with severe renal impa...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2c251efd-4d57-451f-8e1b-27eaf97ac3ce</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"EN-GB\"&gt;Hepatic impairment&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>d7e68ae4-e1b1-4553-913c-12635b0a51cd</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Hepatic impairment</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monocl...</td>\n",
       "      <td>cf701288-a867-47a0-925f-00f0a42b647b</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monoclonal antibody and is cleared via catabolism (i.e. breakdown into pe...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9c89d2ad-1586-421e-b9ca-7af854ac5300</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"EN-GB\"&gt;Paediatric population&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>dec049ff-97a9-40cd-87ba-11bdfb9bb5fd</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Paediatric population</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>&lt;p class=\"Standard\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The safety and efficacy of &lt;/span&gt;&lt;span lang=\"EN-GB\"&gt;crizanlizumab&lt;/span&gt;&lt;span lang=\"EN-GB\"&gt; in paediatric patients from 6 months ...</td>\n",
       "      <td>6c18b861-4477-41c9-9ae9-9694f443b12a</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['Standard']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The safety and efficacy of crizanlizumab in paediatric patients from 6 months to 16 years have not been established. No data are available.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>&lt;p class=\"Standard\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>16108ca5-3314-48c6-9284-f29117d61350</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['Standard']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>&lt;p class=\"Standard\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;There is no relevant use of crizanlizumab in infants aged less than 6 months for the indication of prevention of recurrent vaso‑oc...</td>\n",
       "      <td>e007eba1-3f30-455b-8bff-f4e949cbfb82</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['Standard']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>There is no relevant use of crizanlizumab in infants aged less than 6 months for the indication of prevention of recurrent vaso‑occlusive crises.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>dd6230e6-42fb-460b-8a51-7d767a43daab</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Method of administration&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>1f6c3414-d7c9-4cf2-aa07-d6c5b237491d</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Method of administration</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3cb6dfbf-b485-4105-bf8a-beeb14b1cd5b</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Adakveo &lt;/span&gt;&lt;span lang=\"EN-GB\"&gt;should be diluted with sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% bef...</td>\n",
       "      <td>90f20e2b-efa4-4ccf-a405-6e5c9d8b7bc6</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Adakveo should be diluted with sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% before administration.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>07bf33aa-2f31-4389-9771-d6b30a85d0e0</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The diluted solution&lt;/span&gt;&lt;span lang=\"EN-GB\"&gt; must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by...</td>\n",
       "      <td>e1770234-5bf8-44d0-837b-67f40bdf1237</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The diluted solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by intravenous infusion over a period of 30 minutes. It must not be administered by intravenous...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>36d5342e-92b8-4a2e-a040-eca51b686035</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;For instructions on dilution of the medicinal product before administration, see section 6.6.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f9f00845-fcc7-4f6b-be21-e64dc59b00c7</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>For instructions on dilution of the medicinal product before administration, see section 6.6.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a86c67ac-ec53-4b50-a9df-b960de5da5c6</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;4.3     Contraindications&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>1ff14bbd-0749-4766-99c0-ede09b34a7b7</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.3     Contraindications</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>10c040f8-ca46-4b5e-8749-4d38a3844796</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3f6da897-613d-46df-b921-4ba67da45e6b</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Hypersensitivity to Chinese Hamster Ovary (CHO) cell products.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>32559cba-bfd6-4c6e-a7ef-d4aeb35ef35d</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Hypersensitivity to Chinese Hamster Ovary (CHO) cell products.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>58f5b929-00a4-4a69-9e0a-f5ced47c136a</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;4.4     Special warnings and precautions for use&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>f5687243-13a4-46e0-adc6-415bb3e4afd4</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.4     Special warnings and precautions for use</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>104</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>31ffed79-5a24-4559-a566-8522af32fb14</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>105</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Traceability&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>dffa9fac-aacc-4a81-914f-78b314975780</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Traceability</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\" style=\"font-size:10.0pt\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>caf234ef-3b41-4f82-8ed4-bc46d48e7c7e</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product ...</td>\n",
       "      <td>561c67cb-8f9c-4799-85cb-bd886d1151a2</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>108</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>f63d4030-776d-44db-9cc6-74ff75f1134c</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>109</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Infusion‑related reactions&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>001e00a6-62d2-4a45-a2ad-fab1fe9559c3</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Infusion‑related reactions</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>110</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>cb4bce22-89a4-4d8d-8cdd-b672d0c88b93</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>111</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;In clinical studies, infusion‑related reactions (defined as occurring within 24 hours) were observed in 2 patients (1.8%) treated...</td>\n",
       "      <td>a1a23c97-c624-4234-ace8-a766721f187c</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>In clinical studies, infusion‑related reactions (defined as occurring within 24 hours) were observed in 2 patients (1.8%) treated with crizanlizumab 5 mg/kg. Patients should be monitored for signs...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>112</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f75c3d59-7a58-45ed-943d-7d8406b98311</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>113</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Laboratory test interference: automated platelet counts&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>7089a4c2-8b50-4922-b050-9cc7f27af572</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Laboratory test interference: automated platelet counts</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>114</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c55563ca-acc4-4553-8c1a-42b9387a9a78</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>115</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Interference with automated platelet counts (platelet clumping) has been observed in patients treated with crizanlizumab in clini...</td>\n",
       "      <td>defaa2b8-7117-4310-b347-449f40ad24ff</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Interference with automated platelet counts (platelet clumping) has been observed in patients treated with crizanlizumab in clinical studies, in particular when tubes containing EDTA (ethylenediam...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>116</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6642c7d0-5706-4a24-9854-a9970510af06</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>117</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;To mitigate the potential for laboratory test interference, it is recommended to run the test as soon as possible (within 4 hours...</td>\n",
       "      <td>5acabf9d-5eae-4f56-8d4c-78dcb8e857c1</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>To mitigate the potential for laboratory test interference, it is recommended to run the test as soon as possible (within 4 hours of blood collection) or use citrate tubes. When needed, platelet c...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>118</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6c8ceb67-f719-4af2-bc74-70e0294ebb59</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Excipients with known effect&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>eb658930-7124-408c-958f-2862d298f571</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Excipients with known effect</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c9fe79ab-335c-4e9e-9fba-13a4f3bfb5b1</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially “sodium‑free”.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>db4cd1d3-f264-43fd-88c0-8d7655c1b47b</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially “sodium‑free”.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>122</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8eb95d23-0d6c-4f26-8a07-679ab8ac0228</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;4.5     Interaction with other medicinal products and other f...</td>\n",
       "      <td>11a2fcce-48eb-45a9-8b97-53ecaaa73d86</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.5     Interaction with other medicinal products and other forms of interaction</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>124</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c3478606-ac0b-4307-a4bd-638df28244be</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>125</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Interactions between crizanlizumab and other medicinal products have not been investigated in dedicated studies.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b9ff00f8-ef92-4508-b24f-5dbf91989902</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Interactions between crizanlizumab and other medicinal products have not been investigated in dedicated studies.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>126</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>42abd336-a0eb-44ad-9d11-88de09f8b841</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>127</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Monoclonal antibodies are not metabolised by cytochrome P450 (CYP450) enzymes. Therefore, medicinal products that are substrates,...</td>\n",
       "      <td>4e8df8f7-0fac-45a5-91ad-05cf93b3622f</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Monoclonal antibodies are not metabolised by cytochrome P450 (CYP450) enzymes. Therefore, medicinal products that are substrates, inhibitors or inducers of CYP450 are not expected to affect the ph...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>128</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>799d9c0e-6134-4c36-9d6e-aa95272f563e</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>129</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;No effect on exposure of co‑administered medicinal products is expected based on the metabolic pathways of monoclonal antibodies....</td>\n",
       "      <td>ac9b1575-5662-4fc5-b691-e9ce93b95d88</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No effect on exposure of co‑administered medicinal products is expected based on the metabolic pathways of monoclonal antibodies.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>130</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>aecf1600-19a8-484c-a6c4-f87cfacd1373</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>131</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;4.6     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;Fertility, p&lt;/span&gt;&lt;...</td>\n",
       "      <td>a0f6cfdc-8042-4f0f-9d78-485a5c3c23b8</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.6     Fertility, pregnancy and lactation</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>132</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8212b032-0566-40af-b4bd-ce316a313d58</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>133</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Pregnancy&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>1aaf948b-addf-44cb-883c-1b19ea65cd4c</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Pregnancy</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>134</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e92c6478-4a6b-4f59-9269-f8fd7c1dad6b</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>135</th>\n",
       "      <td>&lt;p class=\"Standard\"&gt;&lt;span lang=\"EN-GB\"&gt;There is a limited amount of data from the use of Adakveo in pregnant women. Based on data from animal studies, crizanlizumab has the potential to cause foet...</td>\n",
       "      <td>efbd0b19-f586-45e6-8c31-559b7ddbe773</td>\n",
       "      <td>None</td>\n",
       "      <td>['Standard']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>There is a limited amount of data from the use of Adakveo in pregnant women. Based on data from animal studies, crizanlizumab has the potential to cause foetal losses when administered to a pregna...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>136</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c669fdac-8dcb-44e1-b338-f22434b3a115</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>137</th>\n",
       "      <td>&lt;p class=\"Standard\" style=\"line-height:normal\"&gt;To help determine the effects in pregnant women, healthcare professionals are encouraged to report all pregnancy cases and complications during pregn...</td>\n",
       "      <td>eef5d66e-627a-44e7-a02a-b8539854de99</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['Standard']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>To help determine the effects in pregnant women, healthcare professionals are encouraged to report all pregnancy cases and complications during pregnancy (from 105 days prior to the last menstrual...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>138</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0e85539e-1a02-4688-bb24-6e07397dd0de</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>139</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Breast‑feeding&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>b96d36fa-6b90-4e0c-85de-47cc7e44b538</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Breast‑feeding</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>140</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>925de404-1c57-4456-8a43-4c656c7165cb</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>141</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;It is unknown whether crizanlizumab is excreted in human milk after administration of Adakveo. There are no data on the effects o...</td>\n",
       "      <td>7498a234-2fbd-4001-be5a-f3355ad472be</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>It is unknown whether crizanlizumab is excreted in human milk after administration of Adakveo. There are no data on the effects of crizanlizumab on the breast‑fed newborn/infant or on milk product...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>142</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7cfd4607-0430-4511-b02b-066e4be8655a</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>143</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Because many medicinal products, including antibodies, can be excreted in human milk, a risk to the newborn/infant cannot be excl...</td>\n",
       "      <td>e2fb457a-6e5d-47fc-8456-c8f97240e96d</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Because many medicinal products, including antibodies, can be excreted in human milk, a risk to the newborn/infant cannot be excluded.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>144</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ae93d231-f8ba-47e6-af36-252c58405866</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>145</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;A decision must be made whether to discontinue breast‑feeding or to discontinue Adakveo therapy, taking into account the benefit ...</td>\n",
       "      <td>92fc3a0b-228c-44b6-b207-f2a812d3484a</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>A decision must be made whether to discontinue breast‑feeding or to discontinue Adakveo therapy, taking into account the benefit of breast‑feeding for the child and the benefit of therapy for the ...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>146</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>02868645-f69f-48cf-bcbe-f15742e8f766</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>147</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Fertility&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>5d59e941-1027-4d1d-ab03-b568b6674fec</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Fertility</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>148</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ca98b45d-98d6-4057-8db7-9b5c039c5cfd</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>149</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;There are no data on the effect of Adakveo on human fertility. Available non‑clinical data do not suggest an effect on fertility ...</td>\n",
       "      <td>a1786285-9b65-4742-ac7e-5ff27e9a199c</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>There are no data on the effect of Adakveo on human fertility. Available non‑clinical data do not suggest an effect on fertility under crizanlizumab treatment (see section 5.3).</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>150</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt; &lt;/p&gt;</td>\n",
       "      <td>a50561fb-4abd-468d-8584-54156b98e12c</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>151</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;4.7     Effects on ability to drive and use machines&lt;/span&gt;&lt;/...</td>\n",
       "      <td>38069b69-f6df-4f61-9c3a-a75dde9a859d</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.7     Effects on ability to drive and use machines</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>152</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>871e05ef-31a7-489f-bac3-a2f55dfdde94</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>153</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Adakveo may have a minor influence on the ability to drive and use machines. Dizziness, fatigue and somnolence may occur followin...</td>\n",
       "      <td>c39dbd51-9328-45a4-bac6-df6d25a7b0bd</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Adakveo may have a minor influence on the ability to drive and use machines. Dizziness, fatigue and somnolence may occur following administration of crizanlizumab.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>154</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>357b6cf8-c2d7-42e1-b447-0e411a254e45</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>155</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;4.8     Undesirable effects&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>de8d55e0-de1c-4d68-a1de-9ba6e3db0097</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.8     Undesirable effects</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>156</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ebce1105-f4bf-482a-a497-471e1a6d1760</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>157</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Summary of the safety profile&lt;/span&gt;&lt;/u&gt;&lt;a name=\"_nth_Summary_of_the_safety_6118\"&gt;...</td>\n",
       "      <td>88452719-0800-4b2c-96cf-ea5b386f5dd9</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Summary of the safety profile</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>158</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d5b72049-2472-41d4-9e03-f6828c98ce07</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>159</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;The most frequently reported adverse drug reactions (≥10% of patients) in the Adakveo 5 mg/kg group were arth...</td>\n",
       "      <td>c2a9225d-e718-4537-8929-46091366c628</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The most frequently reported adverse drug reactions (≥10% of patients) in the Adakveo 5 mg/kg group were arthralgia, nausea, back pain, pyrexia and abdominal pain. Severe events were observed for ...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>160</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>00b99e59-7e80-422c-aef1-8e487d552f09</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Tabulated list of adverse reactions&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>9e1dffa5-d254-4870-a142-824011ff734a</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Tabulated list of adverse reactions</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>162</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9eb2ea87-aa58-40dc-9578-859810a3ca3a</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>163</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;Table 1 lists adverse reactions based on pooled data from two studies: the pivotal study, SUSTAIN, and a sing...</td>\n",
       "      <td>4d02de8f-c15b-43bc-af6d-ffe87bdf1f88</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Table 1 lists adverse reactions based on pooled data from two studies: the pivotal study, SUSTAIN, and a single‑arm, open‑label pharmacokinetics/pharmacodynamics and safety study. Use of crizanliz...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>164</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3ccb923f-936e-4539-858f-f4e4013c9548</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>165</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;Within each system organ class, the adverse reactions are ranked by frequency, with the most frequent reactio...</td>\n",
       "      <td>dd4a838f-4247-40fc-b3ad-7a1ea745661a</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Within each system organ class, the adverse reactions are ranked by frequency, with the most frequent reactions first. Within each frequency grouping, adverse reactions are presented in order of d...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>166</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>987733b6-745e-47c1-ab4a-d39014ea48b4</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>167</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;a name=\"_Toc272145403\"&gt;&lt;/a&gt;&lt;a name=\"_Toc272145564\"&gt;&lt;/a&gt;&lt;a name=\"_Toc266768477\"&gt;&lt;/a&gt;&lt;a name=\"_Toc2609036...</td>\n",
       "      <td>12293b6d-27fc-4f51-a392-aa1d0ab58450</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Table 1       Adverse reactions in clinical studies</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>168</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>adae8cec-c15f-466c-87a5-d9edcbc7decd</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>169</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:459.0pt;border-collapse:collapse;border:none\" width=\"612\"&gt; &lt;tr style=\"page-break-inside:avoid\"&gt; &lt;td style=\"wid...</td>\n",
       "      <td>68495d94-1d08-4794-a87d-6fdb37a548f5</td>\n",
       "      <td>width:459.0pt;border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>System organ class   Frequency   Adverse reaction     Respiratory, thoracic and   mediastinal disorders   Common   Oropharyngeal pain     Gastrointestinal disorders   Very common   Nausea, abdo...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>170</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"&gt;&lt;span style=\"font-size:11.0pt\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5500d36a-5762-434c-8892-bf87d0e7f820</td>\n",
       "      <td>margin-top:0in;text-align:left</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Description of selected adverse reactions&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>0636c563-9390-400f-9ab3-5889e217a728</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Description of selected adverse reactions</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>172</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after: avoid\"&gt;&lt;span style=\"font-size:11.0pt\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f1b0b323-4845-48bd-9022-8b3498e12b3c</td>\n",
       "      <td>margin-top:0in;text-align:left;page-break-after:\\navoid</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>173</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after: avoid\"&gt;&lt;i&gt;&lt;u&gt;&lt;span style=\"font-size:11.0pt\"&gt;Immunogenicity&lt;/span&gt;&lt;/u&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>3598871e-6274-45f3-a079-92e6a6cc0f4b</td>\n",
       "      <td>margin-top:0in;text-align:left;page-break-after:\\navoid</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Immunogenicity</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>174</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"&gt;&lt;span style=\"font-size:11.0pt\"&gt;In clinical studies, treatment‑induced anti‑crizanlizumab antibodies were transiently detected in...</td>\n",
       "      <td>d1523c7d-682b-40c5-a31d-0ed3c856ad76</td>\n",
       "      <td>margin-top:0in;text-align:left</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>In clinical studies, treatment‑induced anti‑crizanlizumab antibodies were transiently detected in 1 patient (0.9%) among the 111 patients who received Adakveo 5 mg/kg.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>175</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"&gt;&lt;span style=\"font-size:11.0pt\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d3b08430-cd24-4b17-aeb5-65cd8c0fa6da</td>\n",
       "      <td>margin-top:0in;text-align:left</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>176</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"&gt;&lt;span style=\"font-size:11.0pt\"&gt;There was no evidence of altered pharmacokinetics or of an altered safety profile with anti‑criza...</td>\n",
       "      <td>06a145f3-a3b6-468f-9569-9c66e32cdd40</td>\n",
       "      <td>margin-top:0in;text-align:left</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>There was no evidence of altered pharmacokinetics or of an altered safety profile with anti‑crizanlizumab antibody development.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>177</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"&gt;&lt;span style=\"font-size:11.0pt\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>da312712-3361-43b0-8cb8-ebe00c656f19</td>\n",
       "      <td>margin-top:0in;text-align:left</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>178</th>\n",
       "      <td>&lt;p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Paediatric population&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>b24ce283-43d1-4609-a14a-ce76aefeb6ea</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['Standard']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Paediatric population</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>179</th>\n",
       "      <td>&lt;p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>837beffa-4df5-46b3-9e30-c2df0b2c0859</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['Standard']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>180</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"&gt;&lt;span style=\"font-size:11.0pt\"&gt;Frequency, type and severity of adverse reactions in patients aged 16 and 17 years are expected t...</td>\n",
       "      <td>440ff73a-8907-4923-a5dc-f3b4ccebeec9</td>\n",
       "      <td>margin-top:0in;text-align:left</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Frequency, type and severity of adverse reactions in patients aged 16 and 17 years are expected to be the same as in adults. The safety of crizanlizumab was evaluated in 3 patients aged &lt;18 years.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>181</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"&gt;&lt;span style=\"font-size:11.0pt\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>58b0b3ed-6191-4566-9d5d-bffd88dd7d08</td>\n",
       "      <td>margin-top:0in;text-align:left</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>182</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Reporting of suspected adverse reactions&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>9a48cf61-c759-4667-ae82-3fe92599ba09</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Reporting of suspected adverse reactions</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>183</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>37538e84-41d5-4dd8-a4f1-8f9d7515630d</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows co...</td>\n",
       "      <td>bdd4a612-1b71-48af-bb4d-b6992a0d727d</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare pro...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>185</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2d6e4e03-57ab-41aa-8bb6-50da47e524a1</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>186</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;4.9     Overdose&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>d64d220d-681c-41cc-be35-d2388b0fe2af</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.9     Overdose</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>187</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>81f7f5c9-3aa9-4ca9-a6e4-18ff45f702a1</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>188</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"&gt;&lt;span lang=\"EN-GB\"&gt;No cases of overdose have been reported in clinical studies.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>be23a4ff-636e-4419-a2b4-53c8da85fba7</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No cases of overdose have been reported in clinical studies.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>189</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d95c745f-4632-4816-93a3-bf5315fb6186</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>190</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;General supportive measures and symptomatic treatment should be initiated in cases of suspected overdose.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6c217e0b-6104-473f-89d1-138ec1d858ea</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>General supportive measures and symptomatic treatment should be initiated in cases of suspected overdose.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>191</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9021bd02-b10e-4f7a-8d6f-8607a943d54d</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>192</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>05b4dc55-ce07-49e7-98d0-d74847496bdc</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>193</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;5.       PHARMACOLOGICAL PROPERTIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>764acee4-ad8f-4679-bfd8-2d754f01ab88</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>5.       PHARMACOLOGICAL PROPERTIES</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>194</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2e81c580-64f0-479b-baac-f7989c2f399c</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>195</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;5.1     Pharmacodynamic properties&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>a6d0a699-c8cf-4a9f-9667-b8f6e4efe584</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>5.1     Pharmacodynamic properties</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>196</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b2231afc-7779-4625-8ac4-2819167847b6</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>197</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;Pharmacotherapeutic group: Other haematological agents, ATC code: B06AX01&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>38b60d54-b880-4fc5-a4f4-89ce63aeb5ce</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Pharmacotherapeutic group: Other haematological agents, ATC code: B06AX01</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>198</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>15ae06a0-6e38-48b6-9b98-796008d0a290</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>199</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Mechanism of action&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>fc5ac450-265a-4a49-92fd-94f18063c6e8</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Mechanism of action</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>200</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1dd00aad-f767-4d29-ab47-a0ece231bb21</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>201</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;Crizanlizumab is a selective IgG2 kappa humanised monoclonal antibody (mAb) that binds to P‑selectin with hig...</td>\n",
       "      <td>e7c2423f-a48a-414c-9bbd-4c511efdb528</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Crizanlizumab is a selective IgG2 kappa humanised monoclonal antibody (mAb) that binds to P‑selectin with high affinity and blocks the interaction with its ligands, including P‑selectin glycoprote...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>202</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>95bd2fe7-3442-4e6d-b591-1f836f48ae21</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>203</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;Binding P‑selectin on the surface of the activated endothelium and platelets has been shown to effectively bl...</td>\n",
       "      <td>71575f83-7664-4637-beb1-6a5b97c16cfe</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Binding P‑selectin on the surface of the activated endothelium and platelets has been shown to effectively block interactions between endothelial cells, platelets, red blood cells and leukocytes, ...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>204</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0d50548f-2482-4f8b-abd3-321304018d5f</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>205</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Pharmacodynamic effects&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>ab71b0bc-5a25-48a4-a89f-1f17e668aa1a</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Pharmacodynamic effects</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>206</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4dd078ae-806b-4e3a-a55b-2b2c2bc1df57</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>207</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Throughout clinical studies, treatment with crizanlizumab 5 mg/kg resulted in dose‑dependent, immediate and sustained P‑selectin ...</td>\n",
       "      <td>f3912285-4b05-4670-a041-77eca738249c</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Throughout clinical studies, treatment with crizanlizumab 5 mg/kg resulted in dose‑dependent, immediate and sustained P‑selectin inhibition (as measured ex vivo) in patients with sickle cell disease.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>208</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>22741a98-5799-4d6d-92ac-9aa31e592b25</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>209</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Clinical efficacy and safety&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>472a0d46-f38f-4b06-9377-8b14a1ca58ab</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Clinical efficacy and safety</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>210</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt; &lt;/p&gt;</td>\n",
       "      <td>9abf657f-4184-406f-9882-ccdafe7d62df</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>211</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;The efficacy of crizanlizumab, with or without HU/HC, was evaluated in the pivotal study SUSTAIN, a 52‑week, ...</td>\n",
       "      <td>06f14b6a-445d-4929-b3f9-42c7c98bd689</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The efficacy of crizanlizumab, with or without HU/HC, was evaluated in the pivotal study SUSTAIN, a 52‑week, randomised, placebo‑controlled, double‑blind, multicentre clinical study in sickle cell...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>212</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1cfceb45-f752-4744-add7-e75fc2b30f0d</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>213</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;In this study, VOCs were defined as those leading to a healthcare visit, which captured all acute episodes of...</td>\n",
       "      <td>f2a0e2c1-e6bd-40b3-b1f9-a3b59362d87d</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>In this study, VOCs were defined as those leading to a healthcare visit, which captured all acute episodes of pain with no other cause than a vaso‑occlusive event that required a healthcare visit ...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>214</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>746abb46-4321-4390-a3d1-57628c87ee75</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>215</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;A total of 198 sickle cell disease patients aged 16 to 63 years (inclusive; mean age 30.1±10.3 years), with a...</td>\n",
       "      <td>9df75617-c6d9-4284-99eb-9c6d286028ea</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>A total of 198 sickle cell disease patients aged 16 to 63 years (inclusive; mean age 30.1±10.3 years), with any sickle cell disease genotype (including HbSS [71.2%], HbSC [16.2%], HbSbeta0‑thalass...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>216</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8a5bfeed-92a7-4157-aa23-5e8d782ee2f3</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>217</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;Treatment with Adakveo 5 mg/kg resulted in a 45.3% lower median annual rate of VOCs compared to placebo (Hodg...</td>\n",
       "      <td>26b32385-ff0c-468c-8156-48e4ea2e5632</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Treatment with Adakveo 5 mg/kg resulted in a 45.3% lower median annual rate of VOCs compared to placebo (Hodges‑Lehmann, median absolute difference of ‑1.01 compared with placebo, 95% CI [‑2.00, 0...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ddc462b4-8779-4b40-b2cd-13c11a5c35ea</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>219</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;Main efficacy outcomes of the pivotal SUSTAIN study are summarised in Tables 2 and 3.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f00331f9-91ee-4ffc-9f5b-c7b8d020d857</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Main efficacy outcomes of the pivotal SUSTAIN study are summarised in Tables 2 and 3.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>220</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>cc21ce0f-b181-4775-ad96-2bb33aad2435</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>221</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;a name=\"_Toc499550968\"&gt;&lt;/a&gt;&lt;a name=\"_Toc517716326\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;Table &lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;b&gt;&lt;span ...</td>\n",
       "      <td>c9fea0dd-a255-4ab8-957b-4a237116ff85</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Table 2       Results from SUSTAIN clinical study in sickle cell disease</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>222</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5ff0994f-3178-439a-a684-c5b18e0ff720</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>223</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:98.84%;border-collapse:collapse;border:none\" width=\"98%\"&gt; &lt;tr style=\"page-break-inside:avoid;height:1.0pt\"&gt; &lt;t...</td>\n",
       "      <td>f6602db2-bba7-4d09-be01-924009293f42</td>\n",
       "      <td>width:98.84%;border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Event   Adakveo 5 mg/kg (N=67) (standard median)   Placebo (N=65) (standard median)   Change vs placebo   Hodges‑Lehmann median   difference (95% CI)   p-value (Wilcoxon rank sum)     Primary e...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>224</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6d24b1e8-7bcc-499b-9560-8630cab90afd</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>225</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"EN-GB\"&gt;The clinical effect demonstrated in the primary efficacy analysis was supported by multiple supplementary analyses including a negative binomial regression ...</td>\n",
       "      <td>55a081a7-69be-4ffb-aade-5eaf29f54a50</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The clinical effect demonstrated in the primary efficacy analysis was supported by multiple supplementary analyses including a negative binomial regression on investigator assessments with a conse...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>226</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt; &lt;/p&gt;</td>\n",
       "      <td>90069808-d21a-40db-a5cb-79185d63ea1e</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>227</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;In the Adakveo 5 mg/kg group, clinically significant reductions in the annual rate of VOCs were observed acro...</td>\n",
       "      <td>06133542-b88f-49aa-8c7f-5dbcc0f276bb</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>In the Adakveo 5 mg/kg group, clinically significant reductions in the annual rate of VOCs were observed across important subgroups (HU/HC use, 2‑4 or 5‑10 VOCs in the previous 12 months, and HbSS...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>228</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>40863246-ddd2-434e-9fcc-3f487cc6f3c0</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>229</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;Table 3       Annual rate of VOCs in patients ‑ subgroup analyses&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>0f55922a-bcc3-477f-8e53-b7b1c53ba65a</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Table 3       Annual rate of VOCs in patients ‑ subgroup analyses</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>230</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ba08dd82-6928-449e-b2bf-28bfc45990b6</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>231</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"612\"&gt; &lt;tr style=\"page-break-inside:avoid\"&gt; &lt;td style=\"width:90.45pt;bor...</td>\n",
       "      <td>306055ba-c099-4738-bafa-dedc95f5c4e5</td>\n",
       "      <td>border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Subgroup        Adakveo 5 mg/kg (N=67) (standard median)   Placebo (N=65) (standard median)   Change vs placebo   Hodges‑Lehmann median   difference (95% CI)     HU/HC use   Yes   n=42 2.43   n...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>232</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c2b709f0-86b2-4fa9-98d3-6988b154be09</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>233</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;A greater than two‑fold increase in the proportion of patients with no VOC and who completed the study was ob...</td>\n",
       "      <td>da5c88f0-dcea-4689-938e-3c1b93d7a754</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>A greater than two‑fold increase in the proportion of patients with no VOC and who completed the study was observed in the Adakveo 5 mg/kg group compared to placebo (22% vs 8%; odds ratio [95% CI]...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>234</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5208b575-d8b9-4b18-981d-40fcf95b2b71</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>235</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;Treatment with Adakveo 5 mg/kg was also associated with a three‑fold longer Kaplan‑Meier estimated median tim...</td>\n",
       "      <td>976c04c1-4a00-4a08-af6a-eb33f16cc272</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Treatment with Adakveo 5 mg/kg was also associated with a three‑fold longer Kaplan‑Meier estimated median time to first VOC compared with placebo (4.07 vs 1.38 months; HR=0.495, 95% CI: 0.331, 0.7...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>236</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>94b4115a-655a-4aea-9954-cf0f835aecee</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>237</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;Figure 1      Kaplan‑Meier curve of time to first VOC&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>ea96e98a-b631-443f-a2a7-37382a04f305</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Figure 1      Kaplan‑Meier curve of time to first VOC</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>238</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8d4fe1ee-a863-42e2-bef0-564ff21f6c0b</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>239</th>\n",
       "      <td>&lt;p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"&gt;&lt;span style=\"position:absolute;z-index:251748352;left:0px;margin-left:61px; margin-top:211px;width:13px;height:9px\"&gt;&lt;img alt=\"0\" heigh...</td>\n",
       "      <td>1f28a2cd-e389-410e-9522-6477de26e0cb</td>\n",
       "      <td>margin-top:0in;page-break-after:avoid</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt; &lt;table align=\"left\" cellpadding=\"0\" cellspacing=\"0\"&gt; &lt;tr&gt; &lt;td height=\"1\" width=\"3\"&gt;&lt;/td&gt; &lt;td width=\"36\"&gt;&lt;/td&gt; &lt;td width=\"33\"...</td>\n",
       "      <td>e84ed10a-b1be-47cf-8814-775d712347f9</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>241</th>\n",
       "      <td>&lt;p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"&gt;&lt;span style=\"font-size:11.0pt\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8c14f577-cb46-494a-9162-054506680e7b</td>\n",
       "      <td>margin-top:0in;page-break-after:avoid</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>242</th>\n",
       "      <td>&lt;p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"&gt;&lt;span style=\"font-size:11.0pt\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0f6cf8d7-9223-45d8-87c5-ff279c3c38b5</td>\n",
       "      <td>margin-top:0in;page-break-after:avoid</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>243</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8ff37dc4-c898-4d52-a5aa-697fb9731068</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>244</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>13f05400-d25d-441b-8c2e-1bbc1ae3cc2b</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>245</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e85c0863-dc1a-42dc-ab9a-7b5fac36835e</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>246</th>\n",
       "      <td>&lt;br clear=\"ALL\"/&gt;</td>\n",
       "      <td>fd84f968-a97f-4259-b766-a742451e77df</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>247</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;a name=\"_hd6_Table_2_1_Patients_wit18544\"&gt;&lt;/a&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Paediatric population&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>3f5b8c47-c06e-451b-ad88-9ec7eda2c145</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Paediatric population</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>248</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>65c2aa8e-1f0d-4f53-a9a6-31e70f0e528b</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>249</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The efficacy of crizanlizumab in patients aged 16 and 17 years is expected to be the same as in adults. Three patients (2.7%) age...</td>\n",
       "      <td>c778d352-157f-4fdd-a650-9794035bb188</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The efficacy of crizanlizumab in patients aged 16 and 17 years is expected to be the same as in adults. Three patients (2.7%) aged less than 18 years were treated with crizanlizumab 5 mg/kg in cli...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>250</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>93e46389-181f-4b47-ac7a-0941c0257958</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>251</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The European Medicines Agency has deferred the obligation to submit the results of studies with Adakveo in one or more subsets of...</td>\n",
       "      <td>1d9f638b-9522-45d4-aade-2ea3ee357fce</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The European Medicines Agency has deferred the obligation to submit the results of studies with Adakveo in one or more subsets of the paediatric population in the treatment of sickle cell disease ...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>252</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2b0ed3b1-e815-4631-bbf0-acb3af13b8cc</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>253</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Conditional approval&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>85f8de6d-913b-4eb5-acc3-e28469213af1</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Conditional approval</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>254</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d9ff4f36-ed04-4f6c-a5b5-0c77a32c3473</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>255</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;This medicinal product has been authorised under a so‑called “conditional approval” scheme. This means that further evidence on t...</td>\n",
       "      <td>655e28b7-c7d4-4a3e-85e1-645ab4a9998f</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>This medicinal product has been authorised under a so‑called “conditional approval” scheme. This means that further evidence on this medicinal product is awaited.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>256</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>eee72aad-0d37-4d8b-9cdc-1ebe65c0efc2</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>257</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The European Medicines Agency will review new information on this medicinal product at least every year and this SmPC will be upd...</td>\n",
       "      <td>3aeb1c53-df5f-486d-8b90-194a72885c98</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The European Medicines Agency will review new information on this medicinal product at least every year and this SmPC will be updated as necessary.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>258</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt; &lt;/p&gt;</td>\n",
       "      <td>bc77fded-79e5-41c5-afe0-7d9019610912</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>259</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;5.2     Pharmacokinetic properties&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>ba64cecf-46c2-47ea-af81-b647e28a94ce</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>5.2     Pharmacokinetic properties</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>260</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8b252518-6a39-496d-a2a8-1f4de11f314b</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>261</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Absorption&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>00533119-b294-4d3b-addb-f6fd4c3e35f0</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Absorption</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>262</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f0af07b2-a8f5-48df-9990-5f017322f332</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>263</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The median time to reach maximum serum concentration of crizanlizumab (T&lt;sub&gt;max&lt;/sub&gt;) was 1.92 hours at steady state following ...</td>\n",
       "      <td>532a95ac-aa2d-482f-b98e-8087c9e1aae4</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The median time to reach maximum serum concentration of crizanlizumab (Tmax) was 1.92 hours at steady state following intravenous administration of 5 mg/kg over a period of 30 minutes in sickle ce...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>264</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>21135353-0ad7-4d0e-9182-c1205f92b29b</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>265</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Distribution&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>1c6e5ea8-2fc1-4281-bc2f-96d19363107b</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Distribution</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>266</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>73ad910b-c420-4838-ae7f-51f7dfa34806</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>267</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Crizanlizumab distribution is typical of endogenous human antibodies within the vascular and extracellular spaces. The volume of ...</td>\n",
       "      <td>ca25d772-76ad-4b7f-b51f-921b95efd10a</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Crizanlizumab distribution is typical of endogenous human antibodies within the vascular and extracellular spaces. The volume of distribution (Vz) was 4.26 litres after a single 5 mg/kg intravenou...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>268</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1bf44745-663f-43a1-9114-5512396fecf5</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>269</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Biotransformation&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>3480d3aa-b931-4d9d-8a25-ff2950f70e47</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Biotransformation</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>270</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>da63ad24-98cc-4f6c-a9ac-7d4eaf9df730</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>271</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Antibodies are primarily eliminated via proteolysis by lysosomal enzymes in the liver to small peptides and amino acids.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>994c284c-fd5a-4bca-856c-a06ca2d991e3</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Antibodies are primarily eliminated via proteolysis by lysosomal enzymes in the liver to small peptides and amino acids.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>272</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>25c08c2a-97cd-49b7-a3e6-ed7e3b2a9398</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>273</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Elimination&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>317d6b14-9c20-4bea-bf70-1dd1bfd14ee0</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Elimination</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>274</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9644480b-9013-49d2-a9e9-2795592596a9</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>275</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;In healthy volunteers, the mean terminal elimination half‑life (T&lt;sub&gt;½&lt;/sub&gt;) was 10.6 days and the mean clearance was 11.7 ml/h...</td>\n",
       "      <td>21be6999-4166-4ea3-bc2a-46e7e9c1f35f</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>In healthy volunteers, the mean terminal elimination half‑life (T½) was 10.6 days and the mean clearance was 11.7 ml/h at crizanlizumab dose level 5 mg/kg. In patients with sickle cell disease, th...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>276</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>fa7ee2a9-8612-4798-a0b2-e8c66dbfa3c7</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>277</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Linearity/non‑linearity&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>eb9693fa-6305-4d68-9a84-84c27a959a65</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Linearity/non‑linearity</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>278</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e3091ce6-30ef-4898-95d8-5ac8dc9582e9</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>279</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The exposure to crizanlizumab (mean C&lt;sub&gt;max&lt;/sub&gt;, AUC&lt;sub&gt;last&lt;/sub&gt;, or AUC&lt;sub&gt;inf&lt;/sub&gt;) increased in non‑linear manner ove...</td>\n",
       "      <td>0f8c5072-5ed3-4aec-8749-5ac476a7e75f</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The exposure to crizanlizumab (mean Cmax, AUClast, or AUCinf) increased in non‑linear manner over the dose range of 0.2 to 8 mg/kg in healthy volunteers.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>280</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>09a8d525-4272-4243-a3b6-b61c438b48b5</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>281</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Special populations&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>07676513-d6ad-4403-b7f4-172327384a02</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Special populations</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>282</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2377eb8c-a022-4bd6-9344-958346ad2a64</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>283</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;i&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Renal impairment&lt;/span&gt;&lt;/u&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>de6eb665-d2f6-423f-bbb4-6cf89fe19fc8</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Renal impairment</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>284</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;In a population PK analysis in patients with eGFR ranging from 35 to 202 ml/min/1.73 m&lt;sup&gt;2&lt;/sup&gt;, no clinically important diffe...</td>\n",
       "      <td>55fdf68a-b0d0-41fd-94a5-c7462d8a9ca4</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>In a population PK analysis in patients with eGFR ranging from 35 to 202 ml/min/1.73 m2, no clinically important differences in the pharmacokinetics of crizanlizumab were found between patients wi...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>285</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ad169960-f812-480f-80f4-6c2f1384a117</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>286</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;i&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Hepatic impairment&lt;/span&gt;&lt;/u&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>1481fd7d-eec3-4db9-a8c3-2a7757e2e767</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Hepatic impairment</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>287</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monocl...</td>\n",
       "      <td>734175d6-c4a2-4df4-ad4f-c1289c180bf2</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monoclonal antibody and is cleared via catabolism (i.e. breakdown into pe...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>288</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>83a0b34c-87a8-4941-8bd0-9a8eacba26c2</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>289</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;i&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Paediatric &lt;a name=\"_nth_Pediatric_patients__be14752\"&gt;&lt;/a&gt;population&lt;/span&gt;&lt;/u&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>1db6ba87-5368-4522-a96c-6bb36868e756</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Paediatric population</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>290</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Pharmacokinetics in paediatric patients below the age of 16 years have not been investigated.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>eab04aa6-e6d1-488b-9b0a-cdf2d9fbe1d1</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Pharmacokinetics in paediatric patients below the age of 16 years have not been investigated.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>291</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>06d7dc74-1123-46c5-8e58-5baba403d620</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>292</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;5.3     Preclinical safety data&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>4679ecf1-e9ac-4cc6-9347-882d2b80caaa</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>5.3     Preclinical safety data</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>293</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5612455a-6bf5-4e73-875f-5525fee58655</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>294</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;N&lt;/span&gt;&lt;span lang=\"EN-GB\"&gt;on‑clinical data revealed no special hazard for humans based on conventional studies of safety pharmac...</td>\n",
       "      <td>9dfe8e22-726c-48dd-a73e-0ffca677a83e</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Non‑clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, tissue cross‑reactivity and repeated dose toxicity.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>295</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c95b5e22-fa87-49b9-933e-1076b8325fc8</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>296</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;In the 26‑week repeated dose toxicity study, administration of crizanlizumab in cynomolgus monkeys at dose levels up to 50 mg/kg/...</td>\n",
       "      <td>249ba44f-0806-4154-a058-151cfd72086b</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>In the 26‑week repeated dose toxicity study, administration of crizanlizumab in cynomolgus monkeys at dose levels up to 50 mg/kg/dose once every 4 weeks (at least 13.5 times the human clinical exp...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>297</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>aa214270-ebc8-4f85-a58a-04986ad789e3</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>298</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;Pharmacological effects of crizanlizumab on haemodynamic and electrocardiographic parameters in the cynomolgus monkey were evaluated in the 26‑week ...</td>\n",
       "      <td>8fb16356-f5ab-42a4-aaac-9444a3167a9a</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Pharmacological effects of crizanlizumab on haemodynamic and electrocardiographic parameters in the cynomolgus monkey were evaluated in the 26‑week repeated dose toxicology study. Respiratory rate...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>299</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt; &lt;/p&gt;</td>\n",
       "      <td>46f8c14d-38a5-4dcb-9ddd-19fa5a0cfc57</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>300</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Formal carcinogenicity, genotoxicity and juvenile toxicity studies have not been conducted with crizanlizumab.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4a51b9ef-c655-47df-8040-1454020aab38</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Formal carcinogenicity, genotoxicity and juvenile toxicity studies have not been conducted with crizanlizumab.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>301</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9ccca12b-0a06-4812-95cc-48dc425408e2</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>302</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;In a 26‑week repeated dose toxicity study, cynomolgus monkeys were administered crizanlizumab once every 4 weeks at doses up to 5...</td>\n",
       "      <td>2c6442f0-201f-4775-8452-1c36a089ff2a</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>In a 26‑week repeated dose toxicity study, cynomolgus monkeys were administered crizanlizumab once every 4 weeks at doses up to 50 mg/kg (at least 13.5 times the human clinical exposure based on A...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>303</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>de592949-aa05-45df-92ce-b8517448318c</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>304</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;In an enhanced pre‑ and postnatal development study in cynomolgus monkeys, pregnant animals received intravenous crizanlizumab on...</td>\n",
       "      <td>1bd38c10-06fd-4517-b905-bfa5009eaa54</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>In an enhanced pre‑ and postnatal development study in cynomolgus monkeys, pregnant animals received intravenous crizanlizumab once every two weeks during the period of organogenesis, at doses of ...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>305</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>bfd1df42-3b6b-4eb7-9ac9-ed2f0a05e768</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>306</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Measurable crizanlizumab serum concentrations were observed in the infant monkeys at postnatal day 28, confirming that crizanlizu...</td>\n",
       "      <td>3fdc8ea7-8326-4261-ad5c-e716a34fdfa9</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Measurable crizanlizumab serum concentrations were observed in the infant monkeys at postnatal day 28, confirming that crizanlizumab, like other IgG antibodies, crosses the placental barrier.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>307</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3d455957-9727-4c20-9bbc-88e5da60aa85</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>308</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>643d24d6-80da-4ab4-9624-0221c8465acb</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>309</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;6.       PHARMACEUTICAL PARTICULARS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>1ea14223-5db3-4ba2-b1ec-4f17d58dcd5f</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>6.       PHARMACEUTICAL PARTICULARS</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>310</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>966675b9-690b-41d9-98ed-60967ffd9f3c</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>311</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;6.1     List of excipients&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>ed327a73-30e6-4081-b6de-0fe728ce8969</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.1     List of excipients</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>312</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>252756a3-2ffd-4fa1-93bf-62767e7a8c66</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>313</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;Sucrose&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e42486b8-431d-489e-92e1-26e80f62c326</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Sucrose</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>314</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;Sodium citrate (E331)&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3382e5f0-a081-4aa4-97d5-536842c7328e</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Sodium citrate (E331)</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>315</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;Citric acid (E330)&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d4798f99-bb2d-4cc7-ba65-ace4e92c99d6</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Citric acid (E330)</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>316</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;Polysorbate 80 (E433)&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>95540f6b-617d-48b0-a6bc-5f309ea429aa</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Polysorbate 80 (E433)</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>317</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Water for injections&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8533427e-eca8-4d27-add7-ae84359e2b3d</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Water for injections</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>318</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0695764c-3f57-4cc5-bdc9-032776603195</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>319</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;6.2     Incompatibilities&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>93b62773-0f41-45e2-94ac-0e36099c20e6</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.2     Incompatibilities</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>320</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a2269772-413a-4a40-81f3-bff5dd940e7c</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>321</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;This medicinal product&lt;/span&gt;&lt;span lang=\"EN-GB\"&gt; must not be mixed with other medicinal products except those mentioned in sectio...</td>\n",
       "      <td>c1dd7e4b-2172-4e76-b329-beee93d2cb22</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>322</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>823e1348-5e7b-4ece-8640-affd6e5ed5be</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>323</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;6.3     Shelf life&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>8d321b8f-d147-49dc-b3f2-14c13473e828</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.3     Shelf life</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>324</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>37d476c0-f943-407b-b694-73edbb744cf1</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>325</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Unopened vial&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>00e069bf-ec29-46b0-9da9-069be813ec77</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Unopened vial</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>326</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8a8b2484-d59f-49da-88e1-b8fb42574e6d</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>327</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"&gt;&lt;span lang=\"EN-GB\"&gt;18 months&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>15a7da87-7151-407a-aff9-f16540d65487</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>18 months</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>328</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ccd15a79-4c3e-4920-a3e2-495f132624ad</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>329</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Diluted solution&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>fd426195-3dc5-4f10-9564-c7c5e3e9291c</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Diluted solution</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>330</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e81f948d-5467-4471-a174-5542d7d5d673</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>331</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Chemical and physical in‑use stability, from the start of preparation of the diluted solution for infusion until end of infusion,...</td>\n",
       "      <td>6289cac5-3b81-4e28-9ad6-409df65bb1d5</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Chemical and physical in‑use stability, from the start of preparation of the diluted solution for infusion until end of infusion, has been demonstrated for up to 8 hours at room temperature (up to...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>332</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9e63db32-7ab4-433c-95ed-27da07885ad9</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>333</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"&gt;&lt;span style=\"font-size:11.0pt\"&gt;From a microbiological point of view, the diluted solution for infusion should be used immediatel...</td>\n",
       "      <td>be86aea2-b55d-411b-b239-579d9ab70e79</td>\n",
       "      <td>margin-top:0in;text-align:left</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>From a microbiological point of view, the diluted solution for infusion should be used immediately. If not used immediately, in‑use storage times and conditions prior to use are the responsibility...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>334</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt; &lt;/p&gt;</td>\n",
       "      <td>30dfdf90-c7c6-46dd-81ed-34040c037707</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>335</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;6.4     Special precautions for storage&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>0916fc58-f815-4be1-8e43-15d87212f2ff</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.4     Special precautions for storage</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>336</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c05a9aae-2370-4c08-8a36-30a372a87373</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>337</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Store in a refrigerator (2°C – 8°C).&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0ecc299e-06ef-4489-8a36-f2034f2042ab</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Store in a refrigerator (2°C – 8°C).</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>338</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Do not freeze.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a112a3f4-75ce-4161-8661-ea3d6b64a170</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Do not freeze.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>339</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Keep the vial in the outer carton in order to protect from light.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>699fc118-68a0-4d85-91f8-68906d13d935</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Keep the vial in the outer carton in order to protect from light.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>340</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1c6011d9-95b8-4289-88e3-be255803aa85</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>341</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;For storage conditions after dilution of the medicinal product, see section 6.3.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9d751841-7244-4356-92cd-d0d33db564a8</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>For storage conditions after dilution of the medicinal product, see section 6.3.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>342</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0566d8ce-a929-4cd0-8ac2-6d814231b189</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>343</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;6.5     Nature and contents of container&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>d57803b0-6a88-44a7-88de-d89dae95ab44</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.5     Nature and contents of container</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>344</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>558e72cd-ad45-48cc-bf26-ed0c0f1fa60a</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>345</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;10 ml concentrate for solution for infusion in a type I glass vial with a coated chlorobutyl rubber stopper sealed with an alumin...</td>\n",
       "      <td>13eb2179-b33a-48a3-81da-f9ac455031fe</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>10 ml concentrate for solution for infusion in a type I glass vial with a coated chlorobutyl rubber stopper sealed with an aluminium cap with a plastic flip‑off disk containing 100 mg crizanlizumab.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>346</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f67001d0-3ed0-46c6-a74b-ceb81076f6ca</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>347</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Pack of 1 vial.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2b7c8f38-c832-4a4e-a4c8-03d1672b36c5</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Pack of 1 vial.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>348</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>78af6177-82e3-47dc-bdee-a120221922fd</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>349</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;a name=\"OLE_LINK1\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;6.6     Special precautions for disposal ...</td>\n",
       "      <td>0562f34b-62da-4f2c-b64d-fbe84c7ab2ad</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.6     Special precautions for disposal and other handling</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>350</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>007d733a-4f29-41b2-b121-2cb115094347</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>351</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Adakveo vials are for single use only.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>bc7bcab8-dac1-4983-916e-5ffcb01f938d</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Adakveo vials are for single use only.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>352</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c4a1d90f-bd32-4d0a-bf43-604c0b34c9af</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>353</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Preparing the infusion&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>4512dd38-a048-42e5-8029-b540a8263f2b</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Preparing the infusion</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>354</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e23ff6b2-20ae-44b0-b64f-198e5618f75d</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>355</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The diluted solution for infusion should be prepared by a healthcare professional using aseptic techniques.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1473cd1c-9b6f-4370-9f72-e83e69475737</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The diluted solution for infusion should be prepared by a healthcare professional using aseptic techniques.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>356</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>95f93264-c234-4b46-89c6-e945e5e9b31d</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>357</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The total dose and required volume of Adakveo depend on the patient’s body weight; 5 mg of crizanlizumab is administered per kg b...</td>\n",
       "      <td>94346e88-c101-4bc7-8012-d3b0d77c943c</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The total dose and required volume of Adakveo depend on the patient’s body weight; 5 mg of crizanlizumab is administered per kg body weight.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>358</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>51d7f2e0-8d66-42f0-92ca-d00295fda75d</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>359</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;The volume to be used for the preparation of the infusion is calculated according to the following equatio...</td>\n",
       "      <td>30001714-d1b1-486b-99fd-1e91d0dcec95</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The volume to be used for the preparation of the infusion is calculated according to the following equation:</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>360</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>33a626aa-b331-405b-9e6e-973e963fc8ac</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>361</th>\n",
       "      <td>&lt;table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:12.5pt;border-collapse:collapse\" width=\"567\"&gt; &lt;tr&gt; &lt;td rowspan=\"2\" style=\"width:85.05pt;padding:0in 5.4p...</td>\n",
       "      <td>c2a797e4-ca61-4a7f-b729-32f94c299d13</td>\n",
       "      <td>margin-left:12.5pt;border-collapse:collapse</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Volume (ml) =   Patient’s body weight (kg) x prescribed dose   [5 mg/kg]     Concentration   of Adakveo   [10 mg/ml]</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>362</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;a name=\"_hd6_Table_3_1_Example_of_d12477\"&gt;&lt;/a&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>29859d43-7257-48ca-82e8-4da9831cccad</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>363</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;1.       Obtain the number of vials required to deliver the pres...</td>\n",
       "      <td>985c20b0-443f-4a52-9767-84b70deae8fc</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>1.       Obtain the number of vials required to deliver the prescribed dose and bring them to room temperature (for a maximum of 4 hours). One vial is needed for every 10 ml of Adakveo (see below ...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>364</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e105b8a5-3f7f-4323-88f6-c66f83ef9f97</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>365</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:28.35pt;border-collapse:collapse;border:none\" width=\"568\"&gt; &lt;tr style=\"page-break-inside:avoid\"&gt; &lt;td styl...</td>\n",
       "      <td>88fa01d0-297f-44a4-9f1e-72b7db37da6e</td>\n",
       "      <td>margin-left:28.35pt;border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Body weight (kg)   Dose (mg)   Volume (ml)   Vials (n)     40   200   20   2     60   300   30   3     80   400   40   4     100   500   50   5     120   600   60   6</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>366</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8a5434fe-20f2-4bf7-b303-a467e4500701</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>367</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;2.       Visually inspect the vials.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f9dda721-880c-4fdd-81c9-23a61f02f35a</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>2.       Visually inspect the vials.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>368</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height: normal\"&gt;&lt;span lang=\"EN-GB\"&gt;-&lt;span style='font:7.0pt \"Times New Roman\"'&gt;                 &lt;/span&gt;&lt;/span&gt;&lt;span lang=\"E...</td>\n",
       "      <td>dfe30f25-3213-49f3-8c1a-a03428471f1d</td>\n",
       "      <td>margin-left:56.7pt;text-indent:-28.35pt;line-height:\\nnormal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>-                 The solution in the vials should be clear to opalescent. Do not use if particles are present in the solution.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>369</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height: normal\"&gt;&lt;span lang=\"EN-GB\"&gt;-&lt;span style='font:7.0pt \"Times New Roman\"'&gt;                 &lt;/span&gt;&lt;/span&gt;&lt;span lang=\"E...</td>\n",
       "      <td>a6daa916-3929-40ec-985a-6e34ce49cc4f</td>\n",
       "      <td>margin-left:56.7pt;text-indent:-28.35pt;line-height:\\nnormal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>-                 The solution should be colourless or may have a slight brownish‑yellow tint.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>370</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4b2604a7-15d1-4474-bf4b-c802fbbaa010</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>371</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;3.       Withdraw a volume equal to the required volume of Adakv...</td>\n",
       "      <td>e366bb71-b7ba-4cfc-b28f-66f0bbc90eee</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>3.       Withdraw a volume equal to the required volume of Adakveo from a 100 ml infusion bag containing either sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% and discard.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>372</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"&gt;&lt;span lang=\"EN-GB\"&gt;-&lt;span style='font:7.0pt \"Times New Roman\"'&gt;                 &lt;/span&gt;&lt;/span&gt;&lt;span lang=\"EN-GB\"&gt;No incompatibi...</td>\n",
       "      <td>66a122bf-afbc-49d3-9b45-b2c7d80407c0</td>\n",
       "      <td>margin-left:56.7pt;text-indent:-28.35pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>-                 No incompatibilities between the diluted Adakveo solution and infusion bags composed of polyvinylchloride (PVC), polyethylene (PE) and polypropylene (PP) have been observed.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>373</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>fac9eddc-a1cd-4099-bd26-f4664ec53a90</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>374</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;4.       Withdraw the necessary volume of Adakveo from the vials...</td>\n",
       "      <td>a15ac1bf-0bfb-4400-8bc9-b4f24a526ef8</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>4.       Withdraw the necessary volume of Adakveo from the vials and inject slowly into the previously prepared infusion bag.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>375</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"&gt;&lt;span lang=\"EN-GB\"&gt;-&lt;span style='font:7.0pt \"Times New Roman\"'&gt;                 &lt;/span&gt;&lt;/span&gt;&lt;span lang=\"EN-GB\"&gt;The &lt;/span&gt;&lt;sp...</td>\n",
       "      <td>af8f1547-b844-40e2-9fcf-393264f9fcbc</td>\n",
       "      <td>margin-left:56.7pt;text-indent:-28.35pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>-                 The solution must not be mixed or co‑administered with other medicinal products through the same intravenous line.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>376</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"&gt;&lt;span lang=\"EN-GB\"&gt;-&lt;span style='font:7.0pt \"Times New Roman\"'&gt;                 &lt;/span&gt;&lt;/span&gt;&lt;span lang=\"EN-GB\"&gt;Keep the volum...</td>\n",
       "      <td>4282d2cf-94c8-463c-835c-14d070734b16</td>\n",
       "      <td>margin-left:56.7pt;text-indent:-28.35pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>-                 Keep the volume of Adakveo added to the infusion bag in the range of 10 ml to 96 ml to obtain a final concentration in the infusion bag within 1 mg/ml to 9.6 mg/ml.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>377</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d81fb4c8-01d1-41bf-8579-8cfb069ef597</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>378</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;5.       Mix the diluted solution by gently inverting the infusion bag. DO NOT SHAKE.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>755f3b13-17d9-4fe3-9c2b-1f5fb1a5d6c0</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>5.       Mix the diluted solution by gently inverting the infusion bag. DO NOT SHAKE.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>379</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a21c3ed4-49d7-4e66-9692-d9ddcbf7b9bf</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>380</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Administration&lt;/span&gt;&lt;/u&gt;&lt;a name=\"_nth_Administration25012\"&gt;&lt;/a&gt;&lt;/p&gt;</td>\n",
       "      <td>a44b6df6-f9ab-4c89-8110-e858a2e81944</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Administration</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>381</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e1525e94-a89a-4533-bcd3-24d091a9a998</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>382</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"&gt;&lt;span style=\"font-size:11.0pt\"&gt;Adakveo diluted solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line...</td>\n",
       "      <td>cc618436-4d6a-4fdc-8841-f06397bdae7a</td>\n",
       "      <td>margin-top:0in;text-align:left</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Adakveo diluted solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by intravenous infusion over a period of 30 minutes. No incompatibilities have been observe...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>383</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2ca8a9c0-71bf-4f00-ac95-4f17769b0430</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>384</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;After administration of Adakveo, flush the line with at least 25 ml sodium chloride 9 mg/ml (0.9%) solution for injection or dext...</td>\n",
       "      <td>91651b3d-52f4-4496-9120-d585bdf34f81</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>After administration of Adakveo, flush the line with at least 25 ml sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5%.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>385</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>fc23fa4e-5365-4897-8e35-081b5bc498e3</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>386</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Disposal&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>790d0f73-c2bb-4287-a4fd-7353eea185e6</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Disposal</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>387</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d9bc9594-8973-438b-af6e-ce6f9f95a3e9</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>388</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Any unused medicinal product or waste material should be disposed of in accordance with local requirements.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>88caa940-38af-4a39-85ac-496e8896c678</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>389</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9f3a1ca2-3874-417a-82e6-7b6dcd3a23cc</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>390</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>17bb70bb-c856-421e-a119-655fcd74c970</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>391</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;7.       MARKETING AUTHORISATION HOLDER&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>2e90cca4-467f-40f6-9d9b-7cdcc501a036</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>7.       MARKETING AUTHORISATION HOLDER</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>392</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6a6d9cce-8b55-41c6-a9df-5a2974a1aff4</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>393</th>\n",
       "      <td>&lt;p class=\"Default\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"&gt;Novartis Europharm Limited&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ee815573-69e1-4b40-9bc2-5e163d630406</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['Default']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Novartis Europharm Limited</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>394</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Vista Building&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>80c23402-0480-4124-8f6f-46925c8e537b</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Vista Building</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>395</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Elm Park, Merrion Road&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>dfa537c6-eb19-410c-afb9-33186c2b6b05</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Elm Park, Merrion Road</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>396</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Dublin 4&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2b695489-cf12-4049-a2e1-1a2d14df92d2</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Dublin 4</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>397</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Ireland&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>48c00e77-77ec-4244-9d94-2fd6f4b81631</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Ireland</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>398</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>21f9fed2-00ca-44a3-9267-1078e9faf781</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>399</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e98778fc-a17b-48aa-8e8a-cbe138ff09c4</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>400</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;8.       MARKETING AUTHORISATION NUMBER(S)&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>fefa296f-e154-42b7-8416-72c6b78230fa</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>8.       MARKETING AUTHORISATION NUMBER(S)</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>401</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d3c33c17-e1b6-4954-be6b-c384593de96c</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>402</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;EU/1/20/1476/001&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>317e074d-c34f-4f1f-890c-df3b4c5a19ae</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>EU/1/20/1476/001</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>403</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>36bce19f-089e-4025-a9d9-3b41061b9947</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>404</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>bcde3901-95f7-48b8-9dbc-01fc7f2ef0e3</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>405</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;9.       DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>acaf6790-3f91-4b6f-99bc-199765791f5a</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>9.       DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>406</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d56760a9-7b6c-406d-a591-5c8012b57d75</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>407</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0c85ada6-10f3-4235-9810-45b382d68edb</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>408</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;10.     DATE OF REVISION OF THE TEXT&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>a86741a5-547d-4084-bbdb-e8eea5a9da42</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>10.     DATE OF REVISION OF THE TEXT</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>409</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>fd5536d3-3d24-4f8a-9a87-763251e3817b</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>410</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>66026015-c5e3-417c-ab6e-ac77e1a42b13</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>411</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Detailed information on this medicinal product is available on the website of the European Medicines &lt;/span&gt;&lt;span lang=\"EN-GB\"&gt;Ag...</td>\n",
       "      <td>3cd86c01-ce4b-404f-9774-5467f495dcf0</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>412</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>201cb4bb-4df3-45ab-aaa5-bd46bb419470</td>\n",
       "      <td>margin-right:-.1pt;line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>413</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c2d1acd4-1298-4014-91a6-a105a1c9be38</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>414</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3731cb55-5fdb-475d-bec8-bcf2fb4a5692</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>415</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2103b9cc-b2dd-4dc7-9cca-7aaf2ca8e6dd</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>416</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>cb897326-186f-4a5f-b3b6-5eb11a2091a4</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>417</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c33d0918-4f07-4b10-981d-3a7a2e51f4ee</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>418</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4dc1eeca-1565-4651-86de-bb0549d7050c</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>419</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ee2b1bb5-2900-4e3b-bfcc-570e2dde38e2</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>420</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>19b053f2-d9c9-4930-85f2-1f860db8cfef</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>421</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b1edb48c-264b-4d54-92fb-cd63dad463b7</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>422</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0e9207b1-a497-45e4-8eee-6c06c1bc16dd</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>423</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ca99e9aa-9e9e-456d-ab1b-e2d19669890d</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>424</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ade7361e-e0bb-48cc-a7c7-2a6674f5329f</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>425</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f0c6c67a-380f-4da4-9e5a-02cd72cc4a71</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>426</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>055a5227-34c3-439a-8046-f928d2d0ea70</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>427</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1dd82cf7-9f12-4867-91a0-c450f9ce6fcc</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>428</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f6251986-fd21-4691-88e4-edb89b0422a4</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>429</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a3a9a54e-fb50-404d-9510-f6300d2bbb11</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>430</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>20b168cc-9f45-4b6d-933f-6077b8af5595</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>431</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d1d3015a-8a2b-4ab0-842d-a3cc8c9e169a</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>432</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>66e9038f-c383-4cff-95af-818e76a2091d</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>433</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>658742af-a192-4d57-8624-0f9a44426e15</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>434</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4af52237-24ea-434e-9e10-08277413103e</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                     Element  \\\n",
       "0    <div class=\"WordSection1\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=...   \n",
       "1                                                                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "2                                                                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "3                                                                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "4                                                                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "5                                                                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "6                                                                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "7                                                                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "8                                                                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "9                                                                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "10                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "11                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "12                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "13                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "14                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "15                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "16                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "17                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "18                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "19                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "20                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "21                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "22                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "23                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "24                                                                             <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX I</span></b></p>   \n",
       "25                                                                                          <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "26                                                  <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">SUMMARY OF PRODUCT CHARACTERISTICS</span></b></p>   \n",
       "27                                                   <span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif; color:green'><br clear=\"all\" style=\"page-break-before:always\"/> </span>   \n",
       "28                                                                                                                                                        <br clear=\"all\" style=\"page-break-before:always\"/>   \n",
       "29   <p class=\"MsoNormal\" style=\"line-height:normal\"><img height=\"18\" src=\"Adakveo-4874%20EN%20PI_files/image001.png\" width=\"21\"/><span lang=\"EN-GB\">This medicinal product is subject to additional moni...   \n",
       "30                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "31                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "32   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">1.       NAME OF </span></b><b><span lang=\"EN-GB\">THE MEDICIN...   \n",
       "33                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "34                                                                      <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo 10 mg/ml concentrate for solution for infusion</span></p>   \n",
       "35                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "36                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "37   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.       QUALITATIVE AND QUANTITATIVE COMPOSITION</span></b></p>   \n",
       "38                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "39                                              <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each ml of concentrate for solution for infusion contains 10 mg crizanlizumab.</span></p>   \n",
       "40                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "41                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">One vial of 10 ml contains 100 mg crizanlizumab.</span></p>   \n",
       "42                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "43         <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab is a monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.</span></p>   \n",
       "44                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "45                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For the full list of excipients, see section 6.1.</span></p>   \n",
       "46                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "47                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "48   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">3.       PHARMACEUTICAL </span></b><b><span lang=\"EN-GB\" styl...   \n",
       "49                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "50   <p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_Toc259706902\"></a><a name=\"_Toc259707071\"></a><a name=\"_Toc259707134\"></a><a name=\"_Toc259713075\"><span lang=\"EN-GB\">Concentrate for solut...   \n",
       "51                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "52                                <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Colourless to slightly brownish‑yellow liquid at pH 6 and with an osmolality of 300 mOsm/kg.</span></p>   \n",
       "53                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "54                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "55   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.       </span></b><b><span...   \n",
       "56                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "57                     <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.1     Therapeutic indications</span></b></p>   \n",
       "58                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "59   <p class=\"Standard\"><span lang=\"EN-GB\">Adakveo</span><span lang=\"EN-GB\"> is indicated for the prevention of recurrent vaso‑occlusive crises (VOCs) in sickle cell disease patients aged 16 years and...   \n",
       "60                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "61                                                 <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.2     Posology and method of administration</span></b></p>   \n",
       "62                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "63   <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Treatment should be initiated by physicians experienced in the management of </span><span lang=\"EN-GB\">sickle cell disease.</span...   \n",
       "64                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "65                                        <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Posology</span></u><a name=\"_nth_Adults_and_patients_ag4131\"></a></p>   \n",
       "66                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "67   <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The recommended dose of crizanlizumab is 5 mg/kg administered over a period of 30 minutes by intravenous infusion at week 0, week...   \n",
       "68                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "69                         <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab </span><span lang=\"EN-GB\">c</span><span lang=\"EN-GB\">an be given alone or with HU/HC.</span></p>   \n",
       "70                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "71                        <p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">If a dose is missed, the treatment should be administered as soon as possible.</span></p>   \n",
       "72   <p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt\"><span style=\"font-size:11.0pt...   \n",
       "73   <p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt\"><span style=\"font-size:11.0pt...   \n",
       "74                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "75                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Special populations</span></u></i></p>   \n",
       "76                                                                                       <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Elderly</span></i></p>   \n",
       "77   <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab has not been studied in elderly patients. No dose adjustment is required as the pharmacokinetics of crizanlizumab i...   \n",
       "78                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "79                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Renal impairment</span></i></p>   \n",
       "80   <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Based on the population pharmacokinetic (PK) results, no dose adjustment is required in patients with mild or moderate renal impa...   \n",
       "81                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "82                                                                            <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Hepatic impairment</span></i></p>   \n",
       "83   <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monocl...   \n",
       "84                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "85                                                                         <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Paediatric population</span></i></p>   \n",
       "86   <p class=\"Standard\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety and efficacy of </span><span lang=\"EN-GB\">crizanlizumab</span><span lang=\"EN-GB\"> in paediatric patients from 6 months ...   \n",
       "87                                                                                                                            <p class=\"Standard\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "88   <p class=\"Standard\" style=\"line-height:normal\"><span lang=\"EN-GB\">There is no relevant use of crizanlizumab in infants aged less than 6 months for the indication of prevention of recurrent vaso‑oc...   \n",
       "89                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "90                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Method of administration</span></u></p>   \n",
       "91                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "92   <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo </span><span lang=\"EN-GB\">should be diluted with sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% bef...   \n",
       "93                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "94   <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The diluted solution</span><span lang=\"EN-GB\"> must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by...   \n",
       "95                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "96                               <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For instructions on dilution of the medicinal product before administration, see section 6.6.</span></p>   \n",
       "97                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "98                           <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.3     Contraindications</span></b></p>   \n",
       "99                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "100                                <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.</span></p>   \n",
       "101                                                             <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hypersensitivity to Chinese Hamster Ovary (CHO) cell products.</span></p>   \n",
       "102                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "103   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.4     Special warnings and precautions for use</span></b></p>   \n",
       "104                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "105                                                                                 <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Traceability</span></u></p>   \n",
       "106                                                                          <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> </span></p>   \n",
       "107  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product ...   \n",
       "108                                                                         <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "109                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Infusion‑related reactions</span></u></p>   \n",
       "110                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "111  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In clinical studies, infusion‑related reactions (defined as occurring within 24 hours) were observed in 2 patients (1.8%) treated...   \n",
       "112                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "113                                      <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Laboratory test interference: automated platelet counts</span></u></p>   \n",
       "114                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "115  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Interference with automated platelet counts (platelet clumping) has been observed in patients treated with crizanlizumab in clini...   \n",
       "116                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "117  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">To mitigate the potential for laboratory test interference, it is recommended to run the test as soon as possible (within 4 hours...   \n",
       "118                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "119                                                                 <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Excipients with known effect</span></u></p>   \n",
       "120                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "121                 <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially “sodium‑free”.</span></p>   \n",
       "122                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "123  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.5     Interaction with other medicinal products and other f...   \n",
       "124                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "125           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Interactions between crizanlizumab and other medicinal products have not been investigated in dedicated studies.</span></p>   \n",
       "126                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "127  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Monoclonal antibodies are not metabolised by cytochrome P450 (CYP450) enzymes. Therefore, medicinal products that are substrates,...   \n",
       "128                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "129  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No effect on exposure of co‑administered medicinal products is expected based on the metabolic pathways of monoclonal antibodies....   \n",
       "130                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "131  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.6     </span></b><b><span lang=\"EN-GB\">Fertility, p</span><...   \n",
       "132                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "133                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Pregnancy</span></u></p>   \n",
       "134                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "135  <p class=\"Standard\"><span lang=\"EN-GB\">There is a limited amount of data from the use of Adakveo in pregnant women. Based on data from animal studies, crizanlizumab has the potential to cause foet...   \n",
       "136                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "137  <p class=\"Standard\" style=\"line-height:normal\">To help determine the effects in pregnant women, healthcare professionals are encouraged to report all pregnancy cases and complications during pregn...   \n",
       "138                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "139                                                                               <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Breast‑feeding</span></u></p>   \n",
       "140                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "141  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It is unknown whether crizanlizumab is excreted in human milk after administration of Adakveo. There are no data on the effects o...   \n",
       "142                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "143  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Because many medicinal products, including antibodies, can be excreted in human milk, a risk to the newborn/infant cannot be excl...   \n",
       "144                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "145  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">A decision must be made whether to discontinue breast‑feeding or to discontinue Adakveo therapy, taking into account the benefit ...   \n",
       "146                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "147                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Fertility</span></u></p>   \n",
       "148                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "149  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There are no data on the effect of Adakveo on human fertility. Available non‑clinical data do not suggest an effect on fertility ...   \n",
       "150                                                                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal\"> </p>   \n",
       "151  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.7     Effects on ability to drive and use machines</span></...   \n",
       "152                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "153  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo may have a minor influence on the ability to drive and use machines. Dizziness, fatigue and somnolence may occur followin...   \n",
       "154                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "155                                                                  <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.8     Undesirable effects</span></b></p>   \n",
       "156                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "157  <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Summary of the safety profile</span></u><a name=\"_nth_Summary_of_the_safety_6118\">...   \n",
       "158                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "159  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The most frequently reported adverse drug reactions (≥10% of patients) in the Adakveo 5 mg/kg group were arth...   \n",
       "160                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "161                                     <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Tabulated list of adverse reactions</span></u></p>   \n",
       "162                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "163  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Table 1 lists adverse reactions based on pooled data from two studies: the pivotal study, SUSTAIN, and a sing...   \n",
       "164                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "165  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Within each system organ class, the adverse reactions are ranked by frequency, with the most frequent reactio...   \n",
       "166                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "167  <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><a name=\"_Toc272145403\"></a><a name=\"_Toc272145564\"></a><a name=\"_Toc266768477\"></a><a name=\"_Toc2609036...   \n",
       "168                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "169  <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:459.0pt;border-collapse:collapse;border:none\" width=\"612\"> <tr style=\"page-break-inside:avoid\"> <td style=\"wid...   \n",
       "170                                                                                          <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p>   \n",
       "171                               <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Description of selected adverse reactions</span></u></p>   \n",
       "172                                                                  <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after: avoid\"><span style=\"font-size:11.0pt\"> </span></p>   \n",
       "173                                       <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after: avoid\"><i><u><span style=\"font-size:11.0pt\">Immunogenicity</span></u></i></p>   \n",
       "174  <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">In clinical studies, treatment‑induced anti‑crizanlizumab antibodies were transiently detected in...   \n",
       "175                                                                                          <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p>   \n",
       "176  <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">There was no evidence of altered pharmacokinetics or of an altered safety profile with anti‑criza...   \n",
       "177                                                                                          <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p>   \n",
       "178                                                    <p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Paediatric population</span></u></p>   \n",
       "179                                                                               <p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "180  <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">Frequency, type and severity of adverse reactions in patients aged 16 and 17 years are expected t...   \n",
       "181                                                                                          <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p>   \n",
       "182                                <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Reporting of suspected adverse reactions</span></u></p>   \n",
       "183                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "184  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows co...   \n",
       "185                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "186                                   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.9     Overdose</span></b></p>   \n",
       "187                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "188                     <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">No cases of overdose have been reported in clinical studies.</span></p>   \n",
       "189                                                                                <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "190                  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">General supportive measures and symptomatic treatment should be initiated in cases of suspected overdose.</span></p>   \n",
       "191                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "192                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "193                <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.       PHARMACOLOGICAL PROPERTIES</span></b></p>   \n",
       "194                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "195                 <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.1     Pharmacodynamic properties</span></b></p>   \n",
       "196                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "197                           <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Pharmacotherapeutic group: Other haematological agents, ATC code: B06AX01</span></p>   \n",
       "198                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "199                                                     <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Mechanism of action</span></u></p>   \n",
       "200                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "201  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Crizanlizumab is a selective IgG2 kappa humanised monoclonal antibody (mAb) that binds to P‑selectin with hig...   \n",
       "202                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "203  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Binding P‑selectin on the surface of the activated endothelium and platelets has been shown to effectively bl...   \n",
       "204                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "205                                                 <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Pharmacodynamic effects</span></u></p>   \n",
       "206                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "207  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Throughout clinical studies, treatment with crizanlizumab 5 mg/kg resulted in dose‑dependent, immediate and sustained P‑selectin ...   \n",
       "208                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "209                                            <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Clinical efficacy and safety</span></u></p>   \n",
       "210                                                                                                        <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"> </p>   \n",
       "211  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The efficacy of crizanlizumab, with or without HU/HC, was evaluated in the pivotal study SUSTAIN, a 52‑week, ...   \n",
       "212                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "213  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In this study, VOCs were defined as those leading to a healthcare visit, which captured all acute episodes of...   \n",
       "214                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "215  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">A total of 198 sickle cell disease patients aged 16 to 63 years (inclusive; mean age 30.1±10.3 years), with a...   \n",
       "216                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "217  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Treatment with Adakveo 5 mg/kg resulted in a 45.3% lower median annual rate of VOCs compared to placebo (Hodg...   \n",
       "218                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "219                  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Main efficacy outcomes of the pivotal SUSTAIN study are summarised in Tables 2 and 3.</span></p>   \n",
       "220                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "221  <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><a name=\"_Toc499550968\"></a><a name=\"_Toc517716326\"><b><span lang=\"EN-GB\">Table </span></b></a><b><span ...   \n",
       "222                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "223  <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:98.84%;border-collapse:collapse;border:none\" width=\"98%\"> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <t...   \n",
       "224                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "225  <p class=\"MsoNormal\"><span lang=\"EN-GB\">The clinical effect demonstrated in the primary efficacy analysis was supported by multiple supplementary analyses including a negative binomial regression ...   \n",
       "226                                                                                                                                <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"> </p>   \n",
       "227  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In the Adakveo 5 mg/kg group, clinically significant reductions in the annual rate of VOCs were observed acro...   \n",
       "228                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "229       <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><b><span lang=\"EN-GB\">Table 3       Annual rate of VOCs in patients ‑ subgroup analyses</span></b></p>   \n",
       "230                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "231  <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"612\"> <tr style=\"page-break-inside:avoid\"> <td style=\"width:90.45pt;bor...   \n",
       "232                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "233  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">A greater than two‑fold increase in the proportion of patients with no VOC and who completed the study was ob...   \n",
       "234                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "235  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Treatment with Adakveo 5 mg/kg was also associated with a three‑fold longer Kaplan‑Meier estimated median tim...   \n",
       "236                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "237                                        <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Figure 1      Kaplan‑Meier curve of time to first VOC</span></b></p>   \n",
       "238                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "239  <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><span style=\"position:absolute;z-index:251748352;left:0px;margin-left:61px; margin-top:211px;width:13px;height:9px\"><img alt=\"0\" heigh...   \n",
       "240  <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"> <table align=\"left\" cellpadding=\"0\" cellspacing=\"0\"> <tr> <td height=\"1\" width=\"3\"></td> <td width=\"36\"></td> <td width=\"33\"...   \n",
       "241                                                                                                <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><span style=\"font-size:11.0pt\"> </span></p>   \n",
       "242                                                                                                <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><span style=\"font-size:11.0pt\"> </span></p>   \n",
       "243                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "244                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "245                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "246                                                                                                                                                                                        <br clear=\"ALL\"/>   \n",
       "247                         <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><a name=\"_hd6_Table_2_1_Patients_wit18544\"></a><u><span lang=\"EN-GB\">Paediatric population</span></u></p>   \n",
       "248                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "249  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The efficacy of crizanlizumab in patients aged 16 and 17 years is expected to be the same as in adults. Three patients (2.7%) age...   \n",
       "250                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "251  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The European Medicines Agency has deferred the obligation to submit the results of studies with Adakveo in one or more subsets of...   \n",
       "252                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "253                                                                         <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Conditional approval</span></u></p>   \n",
       "254                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "255  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal product has been authorised under a so‑called “conditional approval” scheme. This means that further evidence on t...   \n",
       "256                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "257  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The European Medicines Agency will review new information on this medicinal product at least every year and this SmPC will be upd...   \n",
       "258                                                                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal\"> </p>   \n",
       "259                 <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.2     Pharmacokinetic properties</span></b></p>   \n",
       "260                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "261                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Absorption</span></u></p>   \n",
       "262                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "263  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The median time to reach maximum serum concentration of crizanlizumab (T<sub>max</sub>) was 1.92 hours at steady state following ...   \n",
       "264                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "265                                                                                 <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Distribution</span></u></p>   \n",
       "266                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "267  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab distribution is typical of endogenous human antibodies within the vascular and extracellular spaces. The volume of ...   \n",
       "268                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "269                                                                            <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Biotransformation</span></u></p>   \n",
       "270                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "271   <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Antibodies are primarily eliminated via proteolysis by lysosomal enzymes in the liver to small peptides and amino acids.</span></p>   \n",
       "272                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "273                                                                                  <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Elimination</span></u></p>   \n",
       "274                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "275  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In healthy volunteers, the mean terminal elimination half‑life (T<sub>½</sub>) was 10.6 days and the mean clearance was 11.7 ml/h...   \n",
       "276                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "277                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Linearity/non‑linearity</span></u></p>   \n",
       "278                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "279  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The exposure to crizanlizumab (mean C<sub>max</sub>, AUC<sub>last</sub>, or AUC<sub>inf</sub>) increased in non‑linear manner ove...   \n",
       "280                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "281                                                                          <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Special populations</span></u></p>   \n",
       "282                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "283                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Renal impairment</span></u></i></p>   \n",
       "284  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In a population PK analysis in patients with eGFR ranging from 35 to 202 ml/min/1.73 m<sup>2</sup>, no clinically important diffe...   \n",
       "285                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "286                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Hepatic impairment</span></u></i></p>   \n",
       "287  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monocl...   \n",
       "288                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "289                  <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Paediatric <a name=\"_nth_Pediatric_patients__be14752\"></a>population</span></u></i></p>   \n",
       "290                              <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pharmacokinetics in paediatric patients below the age of 16 years have not been investigated.</span></p>   \n",
       "291                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "292                    <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.3     Preclinical safety data</span></b></p>   \n",
       "293                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "294  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">N</span><span lang=\"EN-GB\">on‑clinical data revealed no special hazard for humans based on conventional studies of safety pharmac...   \n",
       "295                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "296  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In the 26‑week repeated dose toxicity study, administration of crizanlizumab in cynomolgus monkeys at dose levels up to 50 mg/kg/...   \n",
       "297                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "298  <p class=\"MsoNormal\" style=\"line-height:normal\">Pharmacological effects of crizanlizumab on haemodynamic and electrocardiographic parameters in the cynomolgus monkey were evaluated in the 26‑week ...   \n",
       "299                                                                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal\"> </p>   \n",
       "300             <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Formal carcinogenicity, genotoxicity and juvenile toxicity studies have not been conducted with crizanlizumab.</span></p>   \n",
       "301                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "302  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In a 26‑week repeated dose toxicity study, cynomolgus monkeys were administered crizanlizumab once every 4 weeks at doses up to 5...   \n",
       "303                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "304  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In an enhanced pre‑ and postnatal development study in cynomolgus monkeys, pregnant animals received intravenous crizanlizumab on...   \n",
       "305                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "306  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Measurable crizanlizumab serum concentrations were observed in the infant monkeys at postnatal day 28, confirming that crizanlizu...   \n",
       "307                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "308                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "309                <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.       PHARMACEUTICAL PARTICULARS</span></b></p>   \n",
       "310                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "311                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.1     List of excipients</span></b></p>   \n",
       "312                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "313                                                                                             <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Sucrose</span></p>   \n",
       "314                                                                               <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Sodium citrate (E331)</span></p>   \n",
       "315                                                                                  <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Citric acid (E330)</span></p>   \n",
       "316                                                                               <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Polysorbate 80 (E433)</span></p>   \n",
       "317                                                                                                       <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Water for injections</span></p>   \n",
       "318                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "319                          <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.2     Incompatibilities</span></b></p>   \n",
       "320                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "321  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal product</span><span lang=\"EN-GB\"> must not be mixed with other medicinal products except those mentioned in sectio...   \n",
       "322                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "323                                 <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.3     Shelf life</span></b></p>   \n",
       "324                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "325                                                                                <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Unopened vial</span></u></p>   \n",
       "326                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "327                                                                        <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">18 months</span></p>   \n",
       "328                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "329                                                                             <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Diluted solution</span></u></p>   \n",
       "330                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "331  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Chemical and physical in‑use stability, from the start of preparation of the diluted solution for infusion until end of infusion,...   \n",
       "332                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "333  <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">From a microbiological point of view, the diluted solution for infusion should be used immediatel...   \n",
       "334                                                                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal\"> </p>   \n",
       "335            <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.4     Special precautions for storage</span></b></p>   \n",
       "336                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "337                                                                                       <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Store in a refrigerator (2°C – 8°C).</span></p>   \n",
       "338                                                                                                             <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not freeze.</span></p>   \n",
       "339                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep the vial in the outer carton in order to protect from light.</span></p>   \n",
       "340                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "341                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For storage conditions after dilution of the medicinal product, see section 6.3.</span></p>   \n",
       "342                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "343           <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.5     Nature and contents of container</span></b></p>   \n",
       "344                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "345  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">10 ml concentrate for solution for infusion in a type I glass vial with a coated chlorobutyl rubber stopper sealed with an alumin...   \n",
       "346                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "347                                                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pack of 1 vial.</span></p>   \n",
       "348                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "349  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><a name=\"OLE_LINK1\"><b><span lang=\"EN-GB\">6.6     Special precautions for disposal ...   \n",
       "350                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "351                                                                                     <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo vials are for single use only.</span></p>   \n",
       "352                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "353                                                                       <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Preparing the infusion</span></u></p>   \n",
       "354                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "355                <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The diluted solution for infusion should be prepared by a healthcare professional using aseptic techniques.</span></p>   \n",
       "356                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "357  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The total dose and required volume of Adakveo depend on the patient’s body weight; 5 mg of crizanlizumab is administered per kg b...   \n",
       "358                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "359  <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">The volume to be used for the preparation of the infusion is calculated according to the following equatio...   \n",
       "360                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "361  <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:12.5pt;border-collapse:collapse\" width=\"567\"> <tr> <td rowspan=\"2\" style=\"width:85.05pt;padding:0in 5.4p...   \n",
       "362                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_hd6_Table_3_1_Example_of_d12477\"></a><span lang=\"EN-GB\"> </span></p>   \n",
       "363  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">1.       Obtain the number of vials required to deliver the pres...   \n",
       "364                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "365  <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:28.35pt;border-collapse:collapse;border:none\" width=\"568\"> <tr style=\"page-break-inside:avoid\"> <td styl...   \n",
       "366                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "367                                                                <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">2.       Visually inspect the vials.</span></p>   \n",
       "368  <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>                 </span></span><span lang=\"E...   \n",
       "369  <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>                 </span></span><span lang=\"E...   \n",
       "370                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "371  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">3.       Withdraw a volume equal to the required volume of Adakv...   \n",
       "372  <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>                 </span></span><span lang=\"EN-GB\">No incompatibi...   \n",
       "373                                                                                                                                                     <p class=\"MsoNormal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "374  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">4.       Withdraw the necessary volume of Adakveo from the vials...   \n",
       "375  <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>                 </span></span><span lang=\"EN-GB\">The </span><sp...   \n",
       "376  <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>                 </span></span><span lang=\"EN-GB\">Keep the volum...   \n",
       "377                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "378                                      <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">5.       Mix the diluted solution by gently inverting the infusion bag. DO NOT SHAKE.</span></p>   \n",
       "379                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "380                                        <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Administration</span></u><a name=\"_nth_Administration25012\"></a></p>   \n",
       "381                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "382  <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">Adakveo diluted solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line...   \n",
       "383                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "384  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">After administration of Adakveo, flush the line with at least 25 ml sodium chloride 9 mg/ml (0.9%) solution for injection or dext...   \n",
       "385                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "386                                                                                     <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Disposal</span></u></p>   \n",
       "387                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "388                <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</span></p>   \n",
       "389                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "390                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "391            <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">7.       MARKETING AUTHORISATION HOLDER</span></b></p>   \n",
       "392                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "393                                                     <p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Novartis Europharm Limited</span></p>   \n",
       "394                                                                  <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Vista Building</span></p>   \n",
       "395                                                          <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Elm Park, Merrion Road</span></p>   \n",
       "396                                                                        <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Dublin 4</span></p>   \n",
       "397                                                                                                <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">Ireland</span></p>   \n",
       "398                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "399                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "400         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">8.       MARKETING AUTHORISATION NUMBER(S)</span></b></p>   \n",
       "401                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "402                                                                                       <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">EU/1/20/1476/001</span></p>   \n",
       "403                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "404                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "405         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">9.       DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>   \n",
       "406                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "407                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "408                                      <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">10.     DATE OF REVISION OF THE TEXT</span></b></p>   \n",
       "409                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "410                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "411  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Detailed information on this medicinal product is available on the website of the European Medicines </span><span lang=\"EN-GB\">Ag...   \n",
       "412                                                                                                       <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "413                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "414                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "415                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "416                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "417                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "418                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "419                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "420                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "421                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "422                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "423                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "424                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "425                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "426                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "427                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "428                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "429                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "430                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "431                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "432                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "433                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "434                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "\n",
       "                                       ID  \\\n",
       "0    583f04cc-251b-4aa9-a300-400d62bebe5a   \n",
       "1    93f99a3a-3bdb-4712-b8a2-7f7151752254   \n",
       "2    37bd41cc-5002-4d0f-b837-d1e612a8c9f4   \n",
       "3    a118066d-62a7-49fe-b164-8dc28660cc13   \n",
       "4    048fcf44-3865-41ad-aa41-6fcf26a64a4e   \n",
       "5    c31204d8-633f-4f10-ac97-914fcf46f5d7   \n",
       "6    d70aeb25-5d44-4d24-b3ba-df3f0a945409   \n",
       "7    e1477684-3361-4ca8-bd48-87fe774951b6   \n",
       "8    6144e956-79cb-4671-935e-0428d8ae9552   \n",
       "9    e8d61a67-3455-4013-b0cb-8c6be91e1dd9   \n",
       "10   5ae63bab-fd9f-4543-8da5-95385fe2878a   \n",
       "11   73b2745c-30ea-4c64-8e98-aa6a807ed175   \n",
       "12   7a8d15de-c5dc-49a9-b9f2-c06ea2aa2812   \n",
       "13   e4924fc5-14a2-4074-ba07-3827e2690bbe   \n",
       "14   5bbfb234-75ff-4d1b-ba18-79dc786c49a3   \n",
       "15   502e9ac3-58ab-4843-b8a0-5fd60ed4e9c5   \n",
       "16   48f98078-4e9d-4cf6-a2e3-6551b02a5fa4   \n",
       "17   53bfe434-4517-42ce-a813-b71d9f2e38cc   \n",
       "18   b6a38e0b-e4f8-410b-b32a-37629f9e3831   \n",
       "19   6bea775e-8180-4ac2-9e83-683b15a278e5   \n",
       "20   d352b40d-10b4-4f2b-8989-ca2a32b8214e   \n",
       "21   cdc7ad58-c7fb-4b77-bcc2-de84faab6ac6   \n",
       "22   68654a8b-654b-47e1-a598-ec1c0860df89   \n",
       "23   7a0e81a8-d56c-4500-b4fc-ed031c115ec5   \n",
       "24   dd5948fb-58d2-4893-8b10-d805f0cdf739   \n",
       "25   75c81091-3ccc-4ed5-947f-c6995c913347   \n",
       "26   70d45c8c-f80d-484f-ace5-16d07806febf   \n",
       "27   b1cb472e-16b2-4c31-9704-43221d1c8944   \n",
       "28   7b7faf20-48a0-43ba-a11c-700ccaf1b44d   \n",
       "29   5f9f4e00-1c00-4d69-ae60-3b512d354b58   \n",
       "30   f468e77c-8bbb-4e8e-a650-a4bcf4292f4e   \n",
       "31   b6444544-1b61-4ede-bcb4-292a105fdf99   \n",
       "32   bebd747b-536c-4ae8-b191-86916bb5b392   \n",
       "33   79944278-5179-4fc2-8e1d-555b0355dd79   \n",
       "34   dd38be17-c16a-4a43-bd7d-7d7de217c2ab   \n",
       "35   39eb16f8-9ea5-47dc-9002-8f3bf989f47a   \n",
       "36   ef09f9ed-de0d-4558-8fb6-f7d64aaf2336   \n",
       "37   fb95db94-3ab2-47ed-860c-1a32343cda09   \n",
       "38   a2e7bc93-c504-4cf0-a556-8dbc293ae03d   \n",
       "39   6b8c14cb-eba7-4ba3-9de8-231605835033   \n",
       "40   445c2994-215c-4b60-9e68-58b10b0bebb5   \n",
       "41   86a20c6b-f68b-4371-9f8a-a22986385994   \n",
       "42   e59ad3b0-fdc0-4860-b4cd-0ffd1f6bbfdc   \n",
       "43   9b057f63-8d47-4932-bf02-b2258fe2de4f   \n",
       "44   d82f7f95-1ede-431d-a553-e3fb38e6ff28   \n",
       "45   603928f1-93e4-4c02-bb15-6bc6cef996af   \n",
       "46   fba2229a-f0ed-4548-ad90-a381cf1a1782   \n",
       "47   f630af4e-4e7d-4c18-b043-880d0facc0eb   \n",
       "48   b61d2001-da27-4ae0-9cd3-4fb666ce3ffe   \n",
       "49   31b9ed10-5866-4e63-8cca-ce18cc144980   \n",
       "50   7d27d913-4b56-4995-9a02-920d4d6d616b   \n",
       "51   261b4958-43c7-49b9-9e5a-d08543d24acf   \n",
       "52   4252fb30-8aea-4a64-969d-9f97eac73b9b   \n",
       "53   b3f0efe9-3876-4e68-b585-60721f1c25ac   \n",
       "54   4bf7be43-25d1-4109-903f-3037ea6db68f   \n",
       "55   ee1bc075-2c6c-4e05-abb9-4907d5feeb5b   \n",
       "56   32d06a42-9c67-427c-9011-cdfa13ede737   \n",
       "57   0ebcbda6-4e48-4ae4-a098-291a1bbc76ba   \n",
       "58   adf5587b-a53f-430b-817d-38b728fcf75d   \n",
       "59   624419e5-aee7-4efc-95aa-caa3b50bc1bc   \n",
       "60   238fb2f2-6728-400a-a31d-0a902b92cac0   \n",
       "61   0ba39624-d328-423e-9451-75729da49f5e   \n",
       "62   b1d7658a-c886-4549-8199-23d497c4cc6b   \n",
       "63   b4a4dc54-4b41-43bd-b82f-06ee394b17a2   \n",
       "64   86b7bbb5-d14b-4563-8aaf-f1f0b4aaad35   \n",
       "65   490f404e-fff3-4d71-a062-145a626aa698   \n",
       "66   e714aa41-f9b5-4f9d-aa85-f59525886d3c   \n",
       "67   f658b1e4-66f8-4649-978b-497e69ca133e   \n",
       "68   ced5ba42-b690-4da6-8bf6-5d6835f95180   \n",
       "69   31210945-890b-4725-acdf-a354e5ca32d4   \n",
       "70   9667ffd4-bc6f-4ff2-87bf-e738f6faabdf   \n",
       "71   7973028c-e20f-44d7-8125-8c6ded4f2aec   \n",
       "72   1355137f-9392-440f-b76b-893e39322a99   \n",
       "73   2d7b667e-921c-42ad-9bf8-c07eb6611782   \n",
       "74   33cb5747-aeff-44e1-a295-f35fdc5df1bf   \n",
       "75   819e866d-22fe-4467-979b-2965a5b375fb   \n",
       "76   42987233-13d8-4992-85ad-cd9d26a9e675   \n",
       "77   394675e6-38ca-43f4-8fa4-67bdbdb6ac0b   \n",
       "78   4116a164-0fb0-41ec-8d4d-980eee909720   \n",
       "79   38d92515-beef-4580-a9e9-5f343ee60f2c   \n",
       "80   f485a522-47e8-4737-9053-6c37b287e4da   \n",
       "81   2c251efd-4d57-451f-8e1b-27eaf97ac3ce   \n",
       "82   d7e68ae4-e1b1-4553-913c-12635b0a51cd   \n",
       "83   cf701288-a867-47a0-925f-00f0a42b647b   \n",
       "84   9c89d2ad-1586-421e-b9ca-7af854ac5300   \n",
       "85   dec049ff-97a9-40cd-87ba-11bdfb9bb5fd   \n",
       "86   6c18b861-4477-41c9-9ae9-9694f443b12a   \n",
       "87   16108ca5-3314-48c6-9284-f29117d61350   \n",
       "88   e007eba1-3f30-455b-8bff-f4e949cbfb82   \n",
       "89   dd6230e6-42fb-460b-8a51-7d767a43daab   \n",
       "90   1f6c3414-d7c9-4cf2-aa07-d6c5b237491d   \n",
       "91   3cb6dfbf-b485-4105-bf8a-beeb14b1cd5b   \n",
       "92   90f20e2b-efa4-4ccf-a405-6e5c9d8b7bc6   \n",
       "93   07bf33aa-2f31-4389-9771-d6b30a85d0e0   \n",
       "94   e1770234-5bf8-44d0-837b-67f40bdf1237   \n",
       "95   36d5342e-92b8-4a2e-a040-eca51b686035   \n",
       "96   f9f00845-fcc7-4f6b-be21-e64dc59b00c7   \n",
       "97   a86c67ac-ec53-4b50-a9df-b960de5da5c6   \n",
       "98   1ff14bbd-0749-4766-99c0-ede09b34a7b7   \n",
       "99   10c040f8-ca46-4b5e-8749-4d38a3844796   \n",
       "100  3f6da897-613d-46df-b921-4ba67da45e6b   \n",
       "101  32559cba-bfd6-4c6e-a7ef-d4aeb35ef35d   \n",
       "102  58f5b929-00a4-4a69-9e0a-f5ced47c136a   \n",
       "103  f5687243-13a4-46e0-adc6-415bb3e4afd4   \n",
       "104  31ffed79-5a24-4559-a566-8522af32fb14   \n",
       "105  dffa9fac-aacc-4a81-914f-78b314975780   \n",
       "106  caf234ef-3b41-4f82-8ed4-bc46d48e7c7e   \n",
       "107  561c67cb-8f9c-4799-85cb-bd886d1151a2   \n",
       "108  f63d4030-776d-44db-9cc6-74ff75f1134c   \n",
       "109  001e00a6-62d2-4a45-a2ad-fab1fe9559c3   \n",
       "110  cb4bce22-89a4-4d8d-8cdd-b672d0c88b93   \n",
       "111  a1a23c97-c624-4234-ace8-a766721f187c   \n",
       "112  f75c3d59-7a58-45ed-943d-7d8406b98311   \n",
       "113  7089a4c2-8b50-4922-b050-9cc7f27af572   \n",
       "114  c55563ca-acc4-4553-8c1a-42b9387a9a78   \n",
       "115  defaa2b8-7117-4310-b347-449f40ad24ff   \n",
       "116  6642c7d0-5706-4a24-9854-a9970510af06   \n",
       "117  5acabf9d-5eae-4f56-8d4c-78dcb8e857c1   \n",
       "118  6c8ceb67-f719-4af2-bc74-70e0294ebb59   \n",
       "119  eb658930-7124-408c-958f-2862d298f571   \n",
       "120  c9fe79ab-335c-4e9e-9fba-13a4f3bfb5b1   \n",
       "121  db4cd1d3-f264-43fd-88c0-8d7655c1b47b   \n",
       "122  8eb95d23-0d6c-4f26-8a07-679ab8ac0228   \n",
       "123  11a2fcce-48eb-45a9-8b97-53ecaaa73d86   \n",
       "124  c3478606-ac0b-4307-a4bd-638df28244be   \n",
       "125  b9ff00f8-ef92-4508-b24f-5dbf91989902   \n",
       "126  42abd336-a0eb-44ad-9d11-88de09f8b841   \n",
       "127  4e8df8f7-0fac-45a5-91ad-05cf93b3622f   \n",
       "128  799d9c0e-6134-4c36-9d6e-aa95272f563e   \n",
       "129  ac9b1575-5662-4fc5-b691-e9ce93b95d88   \n",
       "130  aecf1600-19a8-484c-a6c4-f87cfacd1373   \n",
       "131  a0f6cfdc-8042-4f0f-9d78-485a5c3c23b8   \n",
       "132  8212b032-0566-40af-b4bd-ce316a313d58   \n",
       "133  1aaf948b-addf-44cb-883c-1b19ea65cd4c   \n",
       "134  e92c6478-4a6b-4f59-9269-f8fd7c1dad6b   \n",
       "135  efbd0b19-f586-45e6-8c31-559b7ddbe773   \n",
       "136  c669fdac-8dcb-44e1-b338-f22434b3a115   \n",
       "137  eef5d66e-627a-44e7-a02a-b8539854de99   \n",
       "138  0e85539e-1a02-4688-bb24-6e07397dd0de   \n",
       "139  b96d36fa-6b90-4e0c-85de-47cc7e44b538   \n",
       "140  925de404-1c57-4456-8a43-4c656c7165cb   \n",
       "141  7498a234-2fbd-4001-be5a-f3355ad472be   \n",
       "142  7cfd4607-0430-4511-b02b-066e4be8655a   \n",
       "143  e2fb457a-6e5d-47fc-8456-c8f97240e96d   \n",
       "144  ae93d231-f8ba-47e6-af36-252c58405866   \n",
       "145  92fc3a0b-228c-44b6-b207-f2a812d3484a   \n",
       "146  02868645-f69f-48cf-bcbe-f15742e8f766   \n",
       "147  5d59e941-1027-4d1d-ab03-b568b6674fec   \n",
       "148  ca98b45d-98d6-4057-8db7-9b5c039c5cfd   \n",
       "149  a1786285-9b65-4742-ac7e-5ff27e9a199c   \n",
       "150  a50561fb-4abd-468d-8584-54156b98e12c   \n",
       "151  38069b69-f6df-4f61-9c3a-a75dde9a859d   \n",
       "152  871e05ef-31a7-489f-bac3-a2f55dfdde94   \n",
       "153  c39dbd51-9328-45a4-bac6-df6d25a7b0bd   \n",
       "154  357b6cf8-c2d7-42e1-b447-0e411a254e45   \n",
       "155  de8d55e0-de1c-4d68-a1de-9ba6e3db0097   \n",
       "156  ebce1105-f4bf-482a-a497-471e1a6d1760   \n",
       "157  88452719-0800-4b2c-96cf-ea5b386f5dd9   \n",
       "158  d5b72049-2472-41d4-9e03-f6828c98ce07   \n",
       "159  c2a9225d-e718-4537-8929-46091366c628   \n",
       "160  00b99e59-7e80-422c-aef1-8e487d552f09   \n",
       "161  9e1dffa5-d254-4870-a142-824011ff734a   \n",
       "162  9eb2ea87-aa58-40dc-9578-859810a3ca3a   \n",
       "163  4d02de8f-c15b-43bc-af6d-ffe87bdf1f88   \n",
       "164  3ccb923f-936e-4539-858f-f4e4013c9548   \n",
       "165  dd4a838f-4247-40fc-b3ad-7a1ea745661a   \n",
       "166  987733b6-745e-47c1-ab4a-d39014ea48b4   \n",
       "167  12293b6d-27fc-4f51-a392-aa1d0ab58450   \n",
       "168  adae8cec-c15f-466c-87a5-d9edcbc7decd   \n",
       "169  68495d94-1d08-4794-a87d-6fdb37a548f5   \n",
       "170  5500d36a-5762-434c-8892-bf87d0e7f820   \n",
       "171  0636c563-9390-400f-9ab3-5889e217a728   \n",
       "172  f1b0b323-4845-48bd-9022-8b3498e12b3c   \n",
       "173  3598871e-6274-45f3-a079-92e6a6cc0f4b   \n",
       "174  d1523c7d-682b-40c5-a31d-0ed3c856ad76   \n",
       "175  d3b08430-cd24-4b17-aeb5-65cd8c0fa6da   \n",
       "176  06a145f3-a3b6-468f-9569-9c66e32cdd40   \n",
       "177  da312712-3361-43b0-8cb8-ebe00c656f19   \n",
       "178  b24ce283-43d1-4609-a14a-ce76aefeb6ea   \n",
       "179  837beffa-4df5-46b3-9e30-c2df0b2c0859   \n",
       "180  440ff73a-8907-4923-a5dc-f3b4ccebeec9   \n",
       "181  58b0b3ed-6191-4566-9d5d-bffd88dd7d08   \n",
       "182  9a48cf61-c759-4667-ae82-3fe92599ba09   \n",
       "183  37538e84-41d5-4dd8-a4f1-8f9d7515630d   \n",
       "184  bdd4a612-1b71-48af-bb4d-b6992a0d727d   \n",
       "185  2d6e4e03-57ab-41aa-8bb6-50da47e524a1   \n",
       "186  d64d220d-681c-41cc-be35-d2388b0fe2af   \n",
       "187  81f7f5c9-3aa9-4ca9-a6e4-18ff45f702a1   \n",
       "188  be23a4ff-636e-4419-a2b4-53c8da85fba7   \n",
       "189  d95c745f-4632-4816-93a3-bf5315fb6186   \n",
       "190  6c217e0b-6104-473f-89d1-138ec1d858ea   \n",
       "191  9021bd02-b10e-4f7a-8d6f-8607a943d54d   \n",
       "192  05b4dc55-ce07-49e7-98d0-d74847496bdc   \n",
       "193  764acee4-ad8f-4679-bfd8-2d754f01ab88   \n",
       "194  2e81c580-64f0-479b-baac-f7989c2f399c   \n",
       "195  a6d0a699-c8cf-4a9f-9667-b8f6e4efe584   \n",
       "196  b2231afc-7779-4625-8ac4-2819167847b6   \n",
       "197  38b60d54-b880-4fc5-a4f4-89ce63aeb5ce   \n",
       "198  15ae06a0-6e38-48b6-9b98-796008d0a290   \n",
       "199  fc5ac450-265a-4a49-92fd-94f18063c6e8   \n",
       "200  1dd00aad-f767-4d29-ab47-a0ece231bb21   \n",
       "201  e7c2423f-a48a-414c-9bbd-4c511efdb528   \n",
       "202  95bd2fe7-3442-4e6d-b591-1f836f48ae21   \n",
       "203  71575f83-7664-4637-beb1-6a5b97c16cfe   \n",
       "204  0d50548f-2482-4f8b-abd3-321304018d5f   \n",
       "205  ab71b0bc-5a25-48a4-a89f-1f17e668aa1a   \n",
       "206  4dd078ae-806b-4e3a-a55b-2b2c2bc1df57   \n",
       "207  f3912285-4b05-4670-a041-77eca738249c   \n",
       "208  22741a98-5799-4d6d-92ac-9aa31e592b25   \n",
       "209  472a0d46-f38f-4b06-9377-8b14a1ca58ab   \n",
       "210  9abf657f-4184-406f-9882-ccdafe7d62df   \n",
       "211  06f14b6a-445d-4929-b3f9-42c7c98bd689   \n",
       "212  1cfceb45-f752-4744-add7-e75fc2b30f0d   \n",
       "213  f2a0e2c1-e6bd-40b3-b1f9-a3b59362d87d   \n",
       "214  746abb46-4321-4390-a3d1-57628c87ee75   \n",
       "215  9df75617-c6d9-4284-99eb-9c6d286028ea   \n",
       "216  8a5bfeed-92a7-4157-aa23-5e8d782ee2f3   \n",
       "217  26b32385-ff0c-468c-8156-48e4ea2e5632   \n",
       "218  ddc462b4-8779-4b40-b2cd-13c11a5c35ea   \n",
       "219  f00331f9-91ee-4ffc-9f5b-c7b8d020d857   \n",
       "220  cc21ce0f-b181-4775-ad96-2bb33aad2435   \n",
       "221  c9fea0dd-a255-4ab8-957b-4a237116ff85   \n",
       "222  5ff0994f-3178-439a-a684-c5b18e0ff720   \n",
       "223  f6602db2-bba7-4d09-be01-924009293f42   \n",
       "224  6d24b1e8-7bcc-499b-9560-8630cab90afd   \n",
       "225  55a081a7-69be-4ffb-aade-5eaf29f54a50   \n",
       "226  90069808-d21a-40db-a5cb-79185d63ea1e   \n",
       "227  06133542-b88f-49aa-8c7f-5dbcc0f276bb   \n",
       "228  40863246-ddd2-434e-9fcc-3f487cc6f3c0   \n",
       "229  0f55922a-bcc3-477f-8e53-b7b1c53ba65a   \n",
       "230  ba08dd82-6928-449e-b2bf-28bfc45990b6   \n",
       "231  306055ba-c099-4738-bafa-dedc95f5c4e5   \n",
       "232  c2b709f0-86b2-4fa9-98d3-6988b154be09   \n",
       "233  da5c88f0-dcea-4689-938e-3c1b93d7a754   \n",
       "234  5208b575-d8b9-4b18-981d-40fcf95b2b71   \n",
       "235  976c04c1-4a00-4a08-af6a-eb33f16cc272   \n",
       "236  94b4115a-655a-4aea-9954-cf0f835aecee   \n",
       "237  ea96e98a-b631-443f-a2a7-37382a04f305   \n",
       "238  8d4fe1ee-a863-42e2-bef0-564ff21f6c0b   \n",
       "239  1f28a2cd-e389-410e-9522-6477de26e0cb   \n",
       "240  e84ed10a-b1be-47cf-8814-775d712347f9   \n",
       "241  8c14f577-cb46-494a-9162-054506680e7b   \n",
       "242  0f6cf8d7-9223-45d8-87c5-ff279c3c38b5   \n",
       "243  8ff37dc4-c898-4d52-a5aa-697fb9731068   \n",
       "244  13f05400-d25d-441b-8c2e-1bbc1ae3cc2b   \n",
       "245  e85c0863-dc1a-42dc-ab9a-7b5fac36835e   \n",
       "246  fd84f968-a97f-4259-b766-a742451e77df   \n",
       "247  3f5b8c47-c06e-451b-ad88-9ec7eda2c145   \n",
       "248  65c2aa8e-1f0d-4f53-a9a6-31e70f0e528b   \n",
       "249  c778d352-157f-4fdd-a650-9794035bb188   \n",
       "250  93e46389-181f-4b47-ac7a-0941c0257958   \n",
       "251  1d9f638b-9522-45d4-aade-2ea3ee357fce   \n",
       "252  2b0ed3b1-e815-4631-bbf0-acb3af13b8cc   \n",
       "253  85f8de6d-913b-4eb5-acc3-e28469213af1   \n",
       "254  d9ff4f36-ed04-4f6c-a5b5-0c77a32c3473   \n",
       "255  655e28b7-c7d4-4a3e-85e1-645ab4a9998f   \n",
       "256  eee72aad-0d37-4d8b-9cdc-1ebe65c0efc2   \n",
       "257  3aeb1c53-df5f-486d-8b90-194a72885c98   \n",
       "258  bc77fded-79e5-41c5-afe0-7d9019610912   \n",
       "259  ba64cecf-46c2-47ea-af81-b647e28a94ce   \n",
       "260  8b252518-6a39-496d-a2a8-1f4de11f314b   \n",
       "261  00533119-b294-4d3b-addb-f6fd4c3e35f0   \n",
       "262  f0af07b2-a8f5-48df-9990-5f017322f332   \n",
       "263  532a95ac-aa2d-482f-b98e-8087c9e1aae4   \n",
       "264  21135353-0ad7-4d0e-9182-c1205f92b29b   \n",
       "265  1c6e5ea8-2fc1-4281-bc2f-96d19363107b   \n",
       "266  73ad910b-c420-4838-ae7f-51f7dfa34806   \n",
       "267  ca25d772-76ad-4b7f-b51f-921b95efd10a   \n",
       "268  1bf44745-663f-43a1-9114-5512396fecf5   \n",
       "269  3480d3aa-b931-4d9d-8a25-ff2950f70e47   \n",
       "270  da63ad24-98cc-4f6c-a9ac-7d4eaf9df730   \n",
       "271  994c284c-fd5a-4bca-856c-a06ca2d991e3   \n",
       "272  25c08c2a-97cd-49b7-a3e6-ed7e3b2a9398   \n",
       "273  317d6b14-9c20-4bea-bf70-1dd1bfd14ee0   \n",
       "274  9644480b-9013-49d2-a9e9-2795592596a9   \n",
       "275  21be6999-4166-4ea3-bc2a-46e7e9c1f35f   \n",
       "276  fa7ee2a9-8612-4798-a0b2-e8c66dbfa3c7   \n",
       "277  eb9693fa-6305-4d68-9a84-84c27a959a65   \n",
       "278  e3091ce6-30ef-4898-95d8-5ac8dc9582e9   \n",
       "279  0f8c5072-5ed3-4aec-8749-5ac476a7e75f   \n",
       "280  09a8d525-4272-4243-a3b6-b61c438b48b5   \n",
       "281  07676513-d6ad-4403-b7f4-172327384a02   \n",
       "282  2377eb8c-a022-4bd6-9344-958346ad2a64   \n",
       "283  de6eb665-d2f6-423f-bbb4-6cf89fe19fc8   \n",
       "284  55fdf68a-b0d0-41fd-94a5-c7462d8a9ca4   \n",
       "285  ad169960-f812-480f-80f4-6c2f1384a117   \n",
       "286  1481fd7d-eec3-4db9-a8c3-2a7757e2e767   \n",
       "287  734175d6-c4a2-4df4-ad4f-c1289c180bf2   \n",
       "288  83a0b34c-87a8-4941-8bd0-9a8eacba26c2   \n",
       "289  1db6ba87-5368-4522-a96c-6bb36868e756   \n",
       "290  eab04aa6-e6d1-488b-9b0a-cdf2d9fbe1d1   \n",
       "291  06d7dc74-1123-46c5-8e58-5baba403d620   \n",
       "292  4679ecf1-e9ac-4cc6-9347-882d2b80caaa   \n",
       "293  5612455a-6bf5-4e73-875f-5525fee58655   \n",
       "294  9dfe8e22-726c-48dd-a73e-0ffca677a83e   \n",
       "295  c95b5e22-fa87-49b9-933e-1076b8325fc8   \n",
       "296  249ba44f-0806-4154-a058-151cfd72086b   \n",
       "297  aa214270-ebc8-4f85-a58a-04986ad789e3   \n",
       "298  8fb16356-f5ab-42a4-aaac-9444a3167a9a   \n",
       "299  46f8c14d-38a5-4dcb-9ddd-19fa5a0cfc57   \n",
       "300  4a51b9ef-c655-47df-8040-1454020aab38   \n",
       "301  9ccca12b-0a06-4812-95cc-48dc425408e2   \n",
       "302  2c6442f0-201f-4775-8452-1c36a089ff2a   \n",
       "303  de592949-aa05-45df-92ce-b8517448318c   \n",
       "304  1bd38c10-06fd-4517-b905-bfa5009eaa54   \n",
       "305  bfd1df42-3b6b-4eb7-9ac9-ed2f0a05e768   \n",
       "306  3fdc8ea7-8326-4261-ad5c-e716a34fdfa9   \n",
       "307  3d455957-9727-4c20-9bbc-88e5da60aa85   \n",
       "308  643d24d6-80da-4ab4-9624-0221c8465acb   \n",
       "309  1ea14223-5db3-4ba2-b1ec-4f17d58dcd5f   \n",
       "310  966675b9-690b-41d9-98ed-60967ffd9f3c   \n",
       "311  ed327a73-30e6-4081-b6de-0fe728ce8969   \n",
       "312  252756a3-2ffd-4fa1-93bf-62767e7a8c66   \n",
       "313  e42486b8-431d-489e-92e1-26e80f62c326   \n",
       "314  3382e5f0-a081-4aa4-97d5-536842c7328e   \n",
       "315  d4798f99-bb2d-4cc7-ba65-ace4e92c99d6   \n",
       "316  95540f6b-617d-48b0-a6bc-5f309ea429aa   \n",
       "317  8533427e-eca8-4d27-add7-ae84359e2b3d   \n",
       "318  0695764c-3f57-4cc5-bdc9-032776603195   \n",
       "319  93b62773-0f41-45e2-94ac-0e36099c20e6   \n",
       "320  a2269772-413a-4a40-81f3-bff5dd940e7c   \n",
       "321  c1dd7e4b-2172-4e76-b329-beee93d2cb22   \n",
       "322  823e1348-5e7b-4ece-8640-affd6e5ed5be   \n",
       "323  8d321b8f-d147-49dc-b3f2-14c13473e828   \n",
       "324  37d476c0-f943-407b-b694-73edbb744cf1   \n",
       "325  00e069bf-ec29-46b0-9da9-069be813ec77   \n",
       "326  8a8b2484-d59f-49da-88e1-b8fb42574e6d   \n",
       "327  15a7da87-7151-407a-aff9-f16540d65487   \n",
       "328  ccd15a79-4c3e-4920-a3e2-495f132624ad   \n",
       "329  fd426195-3dc5-4f10-9564-c7c5e3e9291c   \n",
       "330  e81f948d-5467-4471-a174-5542d7d5d673   \n",
       "331  6289cac5-3b81-4e28-9ad6-409df65bb1d5   \n",
       "332  9e63db32-7ab4-433c-95ed-27da07885ad9   \n",
       "333  be86aea2-b55d-411b-b239-579d9ab70e79   \n",
       "334  30dfdf90-c7c6-46dd-81ed-34040c037707   \n",
       "335  0916fc58-f815-4be1-8e43-15d87212f2ff   \n",
       "336  c05a9aae-2370-4c08-8a36-30a372a87373   \n",
       "337  0ecc299e-06ef-4489-8a36-f2034f2042ab   \n",
       "338  a112a3f4-75ce-4161-8661-ea3d6b64a170   \n",
       "339  699fc118-68a0-4d85-91f8-68906d13d935   \n",
       "340  1c6011d9-95b8-4289-88e3-be255803aa85   \n",
       "341  9d751841-7244-4356-92cd-d0d33db564a8   \n",
       "342  0566d8ce-a929-4cd0-8ac2-6d814231b189   \n",
       "343  d57803b0-6a88-44a7-88de-d89dae95ab44   \n",
       "344  558e72cd-ad45-48cc-bf26-ed0c0f1fa60a   \n",
       "345  13eb2179-b33a-48a3-81da-f9ac455031fe   \n",
       "346  f67001d0-3ed0-46c6-a74b-ceb81076f6ca   \n",
       "347  2b7c8f38-c832-4a4e-a4c8-03d1672b36c5   \n",
       "348  78af6177-82e3-47dc-bdee-a120221922fd   \n",
       "349  0562f34b-62da-4f2c-b64d-fbe84c7ab2ad   \n",
       "350  007d733a-4f29-41b2-b121-2cb115094347   \n",
       "351  bc7bcab8-dac1-4983-916e-5ffcb01f938d   \n",
       "352  c4a1d90f-bd32-4d0a-bf43-604c0b34c9af   \n",
       "353  4512dd38-a048-42e5-8029-b540a8263f2b   \n",
       "354  e23ff6b2-20ae-44b0-b64f-198e5618f75d   \n",
       "355  1473cd1c-9b6f-4370-9f72-e83e69475737   \n",
       "356  95f93264-c234-4b46-89c6-e945e5e9b31d   \n",
       "357  94346e88-c101-4bc7-8012-d3b0d77c943c   \n",
       "358  51d7f2e0-8d66-42f0-92ca-d00295fda75d   \n",
       "359  30001714-d1b1-486b-99fd-1e91d0dcec95   \n",
       "360  33a626aa-b331-405b-9e6e-973e963fc8ac   \n",
       "361  c2a797e4-ca61-4a7f-b729-32f94c299d13   \n",
       "362  29859d43-7257-48ca-82e8-4da9831cccad   \n",
       "363  985c20b0-443f-4a52-9767-84b70deae8fc   \n",
       "364  e105b8a5-3f7f-4323-88f6-c66f83ef9f97   \n",
       "365  88fa01d0-297f-44a4-9f1e-72b7db37da6e   \n",
       "366  8a5434fe-20f2-4bf7-b303-a467e4500701   \n",
       "367  f9dda721-880c-4fdd-81c9-23a61f02f35a   \n",
       "368  dfe30f25-3213-49f3-8c1a-a03428471f1d   \n",
       "369  a6daa916-3929-40ec-985a-6e34ce49cc4f   \n",
       "370  4b2604a7-15d1-4474-bf4b-c802fbbaa010   \n",
       "371  e366bb71-b7ba-4cfc-b28f-66f0bbc90eee   \n",
       "372  66a122bf-afbc-49d3-9b45-b2c7d80407c0   \n",
       "373  fac9eddc-a1cd-4099-bd26-f4664ec53a90   \n",
       "374  a15ac1bf-0bfb-4400-8bc9-b4f24a526ef8   \n",
       "375  af8f1547-b844-40e2-9fcf-393264f9fcbc   \n",
       "376  4282d2cf-94c8-463c-835c-14d070734b16   \n",
       "377  d81fb4c8-01d1-41bf-8579-8cfb069ef597   \n",
       "378  755f3b13-17d9-4fe3-9c2b-1f5fb1a5d6c0   \n",
       "379  a21c3ed4-49d7-4e66-9692-d9ddcbf7b9bf   \n",
       "380  a44b6df6-f9ab-4c89-8110-e858a2e81944   \n",
       "381  e1525e94-a89a-4533-bcd3-24d091a9a998   \n",
       "382  cc618436-4d6a-4fdc-8841-f06397bdae7a   \n",
       "383  2ca8a9c0-71bf-4f00-ac95-4f17769b0430   \n",
       "384  91651b3d-52f4-4496-9120-d585bdf34f81   \n",
       "385  fc23fa4e-5365-4897-8e35-081b5bc498e3   \n",
       "386  790d0f73-c2bb-4287-a4fd-7353eea185e6   \n",
       "387  d9bc9594-8973-438b-af6e-ce6f9f95a3e9   \n",
       "388  88caa940-38af-4a39-85ac-496e8896c678   \n",
       "389  9f3a1ca2-3874-417a-82e6-7b6dcd3a23cc   \n",
       "390  17bb70bb-c856-421e-a119-655fcd74c970   \n",
       "391  2e90cca4-467f-40f6-9d9b-7cdcc501a036   \n",
       "392  6a6d9cce-8b55-41c6-a9df-5a2974a1aff4   \n",
       "393  ee815573-69e1-4b40-9bc2-5e163d630406   \n",
       "394  80c23402-0480-4124-8f6f-46925c8e537b   \n",
       "395  dfa537c6-eb19-410c-afb9-33186c2b6b05   \n",
       "396  2b695489-cf12-4049-a2e1-1a2d14df92d2   \n",
       "397  48c00e77-77ec-4244-9d94-2fd6f4b81631   \n",
       "398  21f9fed2-00ca-44a3-9267-1078e9faf781   \n",
       "399  e98778fc-a17b-48aa-8e8a-cbe138ff09c4   \n",
       "400  fefa296f-e154-42b7-8416-72c6b78230fa   \n",
       "401  d3c33c17-e1b6-4954-be6b-c384593de96c   \n",
       "402  317e074d-c34f-4f1f-890c-df3b4c5a19ae   \n",
       "403  36bce19f-089e-4025-a9d9-3b41061b9947   \n",
       "404  bcde3901-95f7-48b8-9dbc-01fc7f2ef0e3   \n",
       "405  acaf6790-3f91-4b6f-99bc-199765791f5a   \n",
       "406  d56760a9-7b6c-406d-a591-5c8012b57d75   \n",
       "407  0c85ada6-10f3-4235-9810-45b382d68edb   \n",
       "408  a86741a5-547d-4084-bbdb-e8eea5a9da42   \n",
       "409  fd5536d3-3d24-4f8a-9a87-763251e3817b   \n",
       "410  66026015-c5e3-417c-ab6e-ac77e1a42b13   \n",
       "411  3cd86c01-ce4b-404f-9774-5467f495dcf0   \n",
       "412  201cb4bb-4df3-45ab-aaa5-bd46bb419470   \n",
       "413  c2d1acd4-1298-4014-91a6-a105a1c9be38   \n",
       "414  3731cb55-5fdb-475d-bec8-bcf2fb4a5692   \n",
       "415  2103b9cc-b2dd-4dc7-9cca-7aaf2ca8e6dd   \n",
       "416  cb897326-186f-4a5f-b3b6-5eb11a2091a4   \n",
       "417  c33d0918-4f07-4b10-981d-3a7a2e51f4ee   \n",
       "418  4dc1eeca-1565-4651-86de-bb0549d7050c   \n",
       "419  ee2b1bb5-2900-4e3b-bfcc-570e2dde38e2   \n",
       "420  19b053f2-d9c9-4930-85f2-1f860db8cfef   \n",
       "421  b1edb48c-264b-4d54-92fb-cd63dad463b7   \n",
       "422  0e9207b1-a497-45e4-8eee-6c06c1bc16dd   \n",
       "423  ca99e9aa-9e9e-456d-ab1b-e2d19669890d   \n",
       "424  ade7361e-e0bb-48cc-a7c7-2a6674f5329f   \n",
       "425  f0c6c67a-380f-4da4-9e5a-02cd72cc4a71   \n",
       "426  055a5227-34c3-439a-8046-f928d2d0ea70   \n",
       "427  1dd82cf7-9f12-4867-91a0-c450f9ce6fcc   \n",
       "428  f6251986-fd21-4691-88e4-edb89b0422a4   \n",
       "429  a3a9a54e-fb50-404d-9510-f6300d2bbb11   \n",
       "430  20b168cc-9f45-4b6d-933f-6077b8af5595   \n",
       "431  d1d3015a-8a2b-4ab0-842d-a3cc8c9e169a   \n",
       "432  66e9038f-c383-4cff-95af-818e76a2091d   \n",
       "433  658742af-a192-4d57-8624-0f9a44426e15   \n",
       "434  4af52237-24ea-434e-9e10-08277413103e   \n",
       "\n",
       "                                                                                                                                 Styles  \\\n",
       "0                                                                                                                                  None   \n",
       "1                                                                                                                    line-height:normal   \n",
       "2                                                                                                                    line-height:normal   \n",
       "3                                                                                                                    line-height:normal   \n",
       "4                                                                                                                    line-height:normal   \n",
       "5                                                                                                                    line-height:normal   \n",
       "6                                                                                                                    line-height:normal   \n",
       "7                                                                                                                    line-height:normal   \n",
       "8                                                                                                                    line-height:normal   \n",
       "9                                                                                                                    line-height:normal   \n",
       "10                                                                                                                   line-height:normal   \n",
       "11                                                                                                                   line-height:normal   \n",
       "12                                                                                                                   line-height:normal   \n",
       "13                                                                                                                   line-height:normal   \n",
       "14                                                                                                                   line-height:normal   \n",
       "15                                                                                                                   line-height:normal   \n",
       "16                                                                                                                   line-height:normal   \n",
       "17                                                                                                                   line-height:normal   \n",
       "18                                                                                                                   line-height:normal   \n",
       "19                                                                                                                   line-height:normal   \n",
       "20                                                                                                                   line-height:normal   \n",
       "21                                                                                                                   line-height:normal   \n",
       "22                                                                                                                   line-height:normal   \n",
       "23                                                                                                                   line-height:normal   \n",
       "24                                                                                                 text-align:center;line-height:normal   \n",
       "25                                                                                                 text-align:center;line-height:normal   \n",
       "26                                                                                                 text-align:center;line-height:normal   \n",
       "27                                                                   font-size:11.0pt;font-family:\"Times New Roman\",serif;\\ncolor:green   \n",
       "28                                                                                                             page-break-before:always   \n",
       "29                                                                                                                   line-height:normal   \n",
       "30                                                                                                                   line-height:normal   \n",
       "31                                                                                                                   line-height:normal   \n",
       "32                                                 margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "33                                                                                            line-height:normal;page-break-after:avoid   \n",
       "34                                                                                                                   line-height:normal   \n",
       "35                                                                                                                   line-height:normal   \n",
       "36                                                                                                                   line-height:normal   \n",
       "37                                                 margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "38                                                                                            line-height:normal;page-break-after:avoid   \n",
       "39                                                                                                                   line-height:normal   \n",
       "40                                                                                                                   line-height:normal   \n",
       "41                                                                                                                   line-height:normal   \n",
       "42                                                                                                                   line-height:normal   \n",
       "43                                                                                                                   line-height:normal   \n",
       "44                                                                                                                   line-height:normal   \n",
       "45                                                                                                                   line-height:normal   \n",
       "46                                                                                                                   line-height:normal   \n",
       "47                                                                                                                   line-height:normal   \n",
       "48                                                 margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "49                                                                                            line-height:normal;page-break-after:avoid   \n",
       "50                                                                                                                   line-height:normal   \n",
       "51                                                                                                                   line-height:normal   \n",
       "52                                                                                                                   line-height:normal   \n",
       "53                                                                                                                   line-height:normal   \n",
       "54                                                                                                                   line-height:normal   \n",
       "55                                                 margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "56                                                                                            line-height:normal;page-break-after:avoid   \n",
       "57                                                 margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "58                                                                                            line-height:normal;page-break-after:avoid   \n",
       "59                                                                                                                                 None   \n",
       "60                                                                                                                   line-height:normal   \n",
       "61                                                                                            line-height:normal;page-break-after:avoid   \n",
       "62                                                                                            line-height:normal;page-break-after:avoid   \n",
       "63                                                                                                                   line-height:normal   \n",
       "64                                                                                                                   line-height:normal   \n",
       "65                                                                                            line-height:normal;page-break-after:avoid   \n",
       "66                                                                                            line-height:normal;page-break-after:avoid   \n",
       "67                                                                                                                   line-height:normal   \n",
       "68                                                                                                                   line-height:normal   \n",
       "69                                                                                                                   line-height:normal   \n",
       "70                                                                                                                   line-height:normal   \n",
       "71                                                                                            line-height:normal;page-break-after:avoid   \n",
       "72   margin-top:0in;margin-right:0in;margin-bottom:\\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt   \n",
       "73   margin-top:0in;margin-right:0in;margin-bottom:\\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt   \n",
       "74                                                                                                                   line-height:normal   \n",
       "75                                                                                            line-height:normal;page-break-after:avoid   \n",
       "76                                                                                            line-height:normal;page-break-after:avoid   \n",
       "77                                                                                                                   line-height:normal   \n",
       "78                                                                                                                   line-height:normal   \n",
       "79                                                                                            line-height:normal;page-break-after:avoid   \n",
       "80                                                                                                                   line-height:normal   \n",
       "81                                                                                                                   line-height:normal   \n",
       "82                                                                                            line-height:normal;page-break-after:avoid   \n",
       "83                                                                                                                   line-height:normal   \n",
       "84                                                                                                                   line-height:normal   \n",
       "85                                                                                            line-height:normal;page-break-after:avoid   \n",
       "86                                                                                                                   line-height:normal   \n",
       "87                                                                                                                   line-height:normal   \n",
       "88                                                                                                                   line-height:normal   \n",
       "89                                                                                                                   line-height:normal   \n",
       "90                                                                                            line-height:normal;page-break-after:avoid   \n",
       "91                                                                                            line-height:normal;page-break-after:avoid   \n",
       "92                                                                                                                   line-height:normal   \n",
       "93                                                                                                                   line-height:normal   \n",
       "94                                                                                                                   line-height:normal   \n",
       "95                                                                                                                   line-height:normal   \n",
       "96                                                                                                                   line-height:normal   \n",
       "97                                                                                                                   line-height:normal   \n",
       "98                                                 margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "99                                                                                            line-height:normal;page-break-after:avoid   \n",
       "100                                                                                                                  line-height:normal   \n",
       "101                                                                                                                  line-height:normal   \n",
       "102                                                                                                                  line-height:normal   \n",
       "103                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "104                                                                                           line-height:normal;page-break-after:avoid   \n",
       "105                                                                                           line-height:normal;page-break-after:avoid   \n",
       "106                                                                                           line-height:normal;page-break-after:avoid   \n",
       "107                                                                                                                  line-height:normal   \n",
       "108                                                                                                                  line-height:normal   \n",
       "109                                                                                           line-height:normal;page-break-after:avoid   \n",
       "110                                                                                           line-height:normal;page-break-after:avoid   \n",
       "111                                                                                                                  line-height:normal   \n",
       "112                                                                                                                  line-height:normal   \n",
       "113                                                                                           line-height:normal;page-break-after:avoid   \n",
       "114                                                                                           line-height:normal;page-break-after:avoid   \n",
       "115                                                                                                                  line-height:normal   \n",
       "116                                                                                                                  line-height:normal   \n",
       "117                                                                                                                  line-height:normal   \n",
       "118                                                                                                                  line-height:normal   \n",
       "119                                                                                           line-height:normal;page-break-after:avoid   \n",
       "120                                                                                           line-height:normal;page-break-after:avoid   \n",
       "121                                                                                                                  line-height:normal   \n",
       "122                                                                                                                  line-height:normal   \n",
       "123                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "124                                                                                           line-height:normal;page-break-after:avoid   \n",
       "125                                                                                                                  line-height:normal   \n",
       "126                                                                                                                  line-height:normal   \n",
       "127                                                                                                                  line-height:normal   \n",
       "128                                                                                                                  line-height:normal   \n",
       "129                                                                                                                  line-height:normal   \n",
       "130                                                                                                                  line-height:normal   \n",
       "131                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "132                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "133                                                                                           line-height:normal;page-break-after:avoid   \n",
       "134                                                                                           line-height:normal;page-break-after:avoid   \n",
       "135                                                                                                                                None   \n",
       "136                                                                                                                  line-height:normal   \n",
       "137                                                                                                                  line-height:normal   \n",
       "138                                                                                                                  line-height:normal   \n",
       "139                                                                                           line-height:normal;page-break-after:avoid   \n",
       "140                                                                                           line-height:normal;page-break-after:avoid   \n",
       "141                                                                                                                  line-height:normal   \n",
       "142                                                                                                                  line-height:normal   \n",
       "143                                                                                                                  line-height:normal   \n",
       "144                                                                                                                  line-height:normal   \n",
       "145                                                                                                                  line-height:normal   \n",
       "146                                                                                                                  line-height:normal   \n",
       "147                                                                                           line-height:normal;page-break-after:avoid   \n",
       "148                                                                                           line-height:normal;page-break-after:avoid   \n",
       "149                                                                                                                  line-height:normal   \n",
       "150                                                                                                                  line-height:normal   \n",
       "151                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "152                                                                                           line-height:normal;page-break-after:avoid   \n",
       "153                                                                                                                  line-height:normal   \n",
       "154                                                                                                                  line-height:normal   \n",
       "155                                                                                           line-height:normal;page-break-after:avoid   \n",
       "156                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "157                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "158                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "159                                                                                              line-height:normal;text-autospace:none   \n",
       "160                                                                                              line-height:normal;text-autospace:none   \n",
       "161                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "162                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "163                                                                                              line-height:normal;text-autospace:none   \n",
       "164                                                                                              line-height:normal;text-autospace:none   \n",
       "165                                                                                              line-height:normal;text-autospace:none   \n",
       "166                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "167                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "168                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "169                                                                                  width:459.0pt;border-collapse:collapse;border:none   \n",
       "170                                                                                                      margin-top:0in;text-align:left   \n",
       "171                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "172                                                                             margin-top:0in;text-align:left;page-break-after:\\navoid   \n",
       "173                                                                             margin-top:0in;text-align:left;page-break-after:\\navoid   \n",
       "174                                                                                                      margin-top:0in;text-align:left   \n",
       "175                                                                                                      margin-top:0in;text-align:left   \n",
       "176                                                                                                      margin-top:0in;text-align:left   \n",
       "177                                                                                                      margin-top:0in;text-align:left   \n",
       "178                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "179                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "180                                                                                                      margin-top:0in;text-align:left   \n",
       "181                                                                                                      margin-top:0in;text-align:left   \n",
       "182                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "183                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "184                                                                                              line-height:normal;text-autospace:none   \n",
       "185                                                                                                                  line-height:normal   \n",
       "186                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "187                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "188                                                                       margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal   \n",
       "189                                                                       margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal   \n",
       "190                                                                                                                  line-height:normal   \n",
       "191                                                                                                                  line-height:normal   \n",
       "192                                                                                                                  line-height:normal   \n",
       "193                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "194                                                                                           line-height:normal;page-break-after:avoid   \n",
       "195                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "196                                                                                           line-height:normal;page-break-after:avoid   \n",
       "197                                                                                           line-height:normal;page-break-after:avoid   \n",
       "198                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "199                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "200                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "201                                                                                              line-height:normal;text-autospace:none   \n",
       "202                                                                                              line-height:normal;text-autospace:none   \n",
       "203                                                                                              line-height:normal;text-autospace:none   \n",
       "204                                                                                              line-height:normal;text-autospace:none   \n",
       "205                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "206                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "207                                                                                                                  line-height:normal   \n",
       "208                                                                                              line-height:normal;text-autospace:none   \n",
       "209                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "210                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "211                                                                                              line-height:normal;text-autospace:none   \n",
       "212                                                                                              line-height:normal;text-autospace:none   \n",
       "213                                                                                              line-height:normal;text-autospace:none   \n",
       "214                                                                                              line-height:normal;text-autospace:none   \n",
       "215                                                                                              line-height:normal;text-autospace:none   \n",
       "216                                                                                              line-height:normal;text-autospace:none   \n",
       "217                                                                                              line-height:normal;text-autospace:none   \n",
       "218                                                                                              line-height:normal;text-autospace:none   \n",
       "219                                                                                              line-height:normal;text-autospace:none   \n",
       "220                                                                                              line-height:normal;text-autospace:none   \n",
       "221                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "222                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "223                                                                                   width:98.84%;border-collapse:collapse;border:none   \n",
       "224                                                                                              line-height:normal;text-autospace:none   \n",
       "225                                                                                                                                None   \n",
       "226                                                                                              line-height:normal;text-autospace:none   \n",
       "227                                                                                              line-height:normal;text-autospace:none   \n",
       "228                                                                                              line-height:normal;text-autospace:none   \n",
       "229                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "230                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "231                                                                                                border-collapse:collapse;border:none   \n",
       "232                                                                                              line-height:normal;text-autospace:none   \n",
       "233                                                                                              line-height:normal;text-autospace:none   \n",
       "234                                                                                              line-height:normal;text-autospace:none   \n",
       "235                                                                                              line-height:normal;text-autospace:none   \n",
       "236                                                                                              line-height:normal;text-autospace:none   \n",
       "237                                                                                           line-height:normal;page-break-after:avoid   \n",
       "238                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "239                                                                                               margin-top:0in;page-break-after:avoid   \n",
       "240                                                                                           line-height:normal;page-break-after:avoid   \n",
       "241                                                                                               margin-top:0in;page-break-after:avoid   \n",
       "242                                                                                               margin-top:0in;page-break-after:avoid   \n",
       "243                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "244                                                                                              line-height:normal;text-autospace:none   \n",
       "245                                                                                              line-height:normal;text-autospace:none   \n",
       "246                                                                                                                                None   \n",
       "247                                                                                           line-height:normal;page-break-after:avoid   \n",
       "248                                                                                           line-height:normal;page-break-after:avoid   \n",
       "249                                                                                                                  line-height:normal   \n",
       "250                                                                                                                  line-height:normal   \n",
       "251                                                                                                                  line-height:normal   \n",
       "252                                                                                                                  line-height:normal   \n",
       "253                                                                                           line-height:normal;page-break-after:avoid   \n",
       "254                                                                                           line-height:normal;page-break-after:avoid   \n",
       "255                                                                                                                  line-height:normal   \n",
       "256                                                                                                                  line-height:normal   \n",
       "257                                                                                                                  line-height:normal   \n",
       "258                                                                                                                  line-height:normal   \n",
       "259                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "260                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "261                                                                                           line-height:normal;page-break-after:avoid   \n",
       "262                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "263                                                                                                                  line-height:normal   \n",
       "264                                                                                                                  line-height:normal   \n",
       "265                                                                                           line-height:normal;page-break-after:avoid   \n",
       "266                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "267                                                                                                                  line-height:normal   \n",
       "268                                                                                                                  line-height:normal   \n",
       "269                                                                                           line-height:normal;page-break-after:avoid   \n",
       "270                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "271                                                                                                                  line-height:normal   \n",
       "272                                                                                                                  line-height:normal   \n",
       "273                                                                                           line-height:normal;page-break-after:avoid   \n",
       "274                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "275                                                                                                                  line-height:normal   \n",
       "276                                                                                                                  line-height:normal   \n",
       "277                                                                                           line-height:normal;page-break-after:avoid   \n",
       "278                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "279                                                                                                                  line-height:normal   \n",
       "280                                                                                                                  line-height:normal   \n",
       "281                                                                                           line-height:normal;page-break-after:avoid   \n",
       "282                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "283                                                                                           line-height:normal;page-break-after:avoid   \n",
       "284                                                                                                                  line-height:normal   \n",
       "285                                                                                                                  line-height:normal   \n",
       "286                                                                                           line-height:normal;page-break-after:avoid   \n",
       "287                                                                                                                  line-height:normal   \n",
       "288                                                                                                                  line-height:normal   \n",
       "289                                                                                           line-height:normal;page-break-after:avoid   \n",
       "290                                                                                                                  line-height:normal   \n",
       "291                                                                                                                  line-height:normal   \n",
       "292                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "293                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "294                                                                                                                  line-height:normal   \n",
       "295                                                                                                                  line-height:normal   \n",
       "296                                                                                                                  line-height:normal   \n",
       "297                                                                                                                  line-height:normal   \n",
       "298                                                                                                                  line-height:normal   \n",
       "299                                                                                                                  line-height:normal   \n",
       "300                                                                                                                  line-height:normal   \n",
       "301                                                                                                                  line-height:normal   \n",
       "302                                                                                                                  line-height:normal   \n",
       "303                                                                                                                  line-height:normal   \n",
       "304                                                                                                                  line-height:normal   \n",
       "305                                                                                                                  line-height:normal   \n",
       "306                                                                                                                  line-height:normal   \n",
       "307                                                                                                                  line-height:normal   \n",
       "308                                                                                                                  line-height:normal   \n",
       "309                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "310                                                                                           line-height:normal;page-break-after:avoid   \n",
       "311                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "312                                                                                           line-height:normal;page-break-after:avoid   \n",
       "313                                                                                           line-height:normal;page-break-after:avoid   \n",
       "314                                                                                           line-height:normal;page-break-after:avoid   \n",
       "315                                                                                           line-height:normal;page-break-after:avoid   \n",
       "316                                                                                           line-height:normal;page-break-after:avoid   \n",
       "317                                                                                                                  line-height:normal   \n",
       "318                                                                                                                  line-height:normal   \n",
       "319                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "320                                                                                           line-height:normal;page-break-after:avoid   \n",
       "321                                                                                                                  line-height:normal   \n",
       "322                                                                                                                  line-height:normal   \n",
       "323                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "324                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "325                                                                                           line-height:normal;page-break-after:avoid   \n",
       "326                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "327                                                                       margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal   \n",
       "328                                                                                                                  line-height:normal   \n",
       "329                                                                                           line-height:normal;page-break-after:avoid   \n",
       "330                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "331                                                                                                                  line-height:normal   \n",
       "332                                                                                                                  line-height:normal   \n",
       "333                                                                                                      margin-top:0in;text-align:left   \n",
       "334                                                                                                                  line-height:normal   \n",
       "335                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "336                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "337                                                                                                                  line-height:normal   \n",
       "338                                                                                                                  line-height:normal   \n",
       "339                                                                                                                  line-height:normal   \n",
       "340                                                                                                                  line-height:normal   \n",
       "341                                                                                                                  line-height:normal   \n",
       "342                                                                                                                  line-height:normal   \n",
       "343                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "344                                                                                           line-height:normal;page-break-after:avoid   \n",
       "345                                                                                                                  line-height:normal   \n",
       "346                                                                                                                  line-height:normal   \n",
       "347                                                                                                                  line-height:normal   \n",
       "348                                                                                                                  line-height:normal   \n",
       "349                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "350                                                                                           line-height:normal;page-break-after:avoid   \n",
       "351                                                                                                                  line-height:normal   \n",
       "352                                                                                                                  line-height:normal   \n",
       "353                                                                                           line-height:normal;page-break-after:avoid   \n",
       "354                                                                                           line-height:normal;page-break-after:avoid   \n",
       "355                                                                                                                  line-height:normal   \n",
       "356                                                                                                                  line-height:normal   \n",
       "357                                                                                                                  line-height:normal   \n",
       "358                                                                                                                  line-height:normal   \n",
       "359                                                                                           line-height:normal;page-break-after:avoid   \n",
       "360                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "361                                                                                         margin-left:12.5pt;border-collapse:collapse   \n",
       "362                                                                                                                  line-height:normal   \n",
       "363                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "364                                                                                           line-height:normal;page-break-after:avoid   \n",
       "365                                                                            margin-left:28.35pt;border-collapse:collapse;border:none   \n",
       "366                                                                                                                  line-height:normal   \n",
       "367                                                                                           line-height:normal;page-break-after:avoid   \n",
       "368                                                                        margin-left:56.7pt;text-indent:-28.35pt;line-height:\\nnormal   \n",
       "369                                                                        margin-left:56.7pt;text-indent:-28.35pt;line-height:\\nnormal   \n",
       "370                                                                                                                  line-height:normal   \n",
       "371                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "372                                                                                             margin-left:56.7pt;text-indent:-28.35pt   \n",
       "373                                                                                                                                None   \n",
       "374                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "375                                                                                             margin-left:56.7pt;text-indent:-28.35pt   \n",
       "376                                                                                             margin-left:56.7pt;text-indent:-28.35pt   \n",
       "377                                                                                                                  line-height:normal   \n",
       "378                                                                                                                  line-height:normal   \n",
       "379                                                                                                                  line-height:normal   \n",
       "380                                                                                           line-height:normal;page-break-after:avoid   \n",
       "381                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "382                                                                                                      margin-top:0in;text-align:left   \n",
       "383                                                                                                                  line-height:normal   \n",
       "384                                                                                                                  line-height:normal   \n",
       "385                                                                                                                  line-height:normal   \n",
       "386                                                                                           line-height:normal;page-break-after:avoid   \n",
       "387                                                                                           line-height:normal;page-break-after:avoid   \n",
       "388                                                                                                                  line-height:normal   \n",
       "389                                                                                                                  line-height:normal   \n",
       "390                                                                                                                  line-height:normal   \n",
       "391                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "392                                                                                           line-height:normal;page-break-after:avoid   \n",
       "393                                                                                                              page-break-after:avoid   \n",
       "394                                                                                           line-height:normal;page-break-after:avoid   \n",
       "395                                                                                           line-height:normal;page-break-after:avoid   \n",
       "396                                                                                           line-height:normal;page-break-after:avoid   \n",
       "397                                                                                                                  line-height:normal   \n",
       "398                                                                                                                  line-height:normal   \n",
       "399                                                                                                                  line-height:normal   \n",
       "400                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "401                                                                                           line-height:normal;page-break-after:avoid   \n",
       "402                                                                                                                  line-height:normal   \n",
       "403                                                                                                                  line-height:normal   \n",
       "404                                                                                                                  line-height:normal   \n",
       "405                                                                       margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal   \n",
       "406                                                                                                                  line-height:normal   \n",
       "407                                                                                                                  line-height:normal   \n",
       "408                                                                       margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal   \n",
       "409                                                                                                                  line-height:normal   \n",
       "410                                                                                                                  line-height:normal   \n",
       "411                                                                                                                  line-height:normal   \n",
       "412                                                                                               margin-right:-.1pt;line-height:normal   \n",
       "413                                                                                                                  line-height:normal   \n",
       "414                                                                                                                  line-height:normal   \n",
       "415                                                                                                                  line-height:normal   \n",
       "416                                                                                                                  line-height:normal   \n",
       "417                                                                                                                  line-height:normal   \n",
       "418                                                                                                                  line-height:normal   \n",
       "419                                                                                                                  line-height:normal   \n",
       "420                                                                                                                  line-height:normal   \n",
       "421                                                                                                                  line-height:normal   \n",
       "422                                                                                                                  line-height:normal   \n",
       "423                                                                                                                  line-height:normal   \n",
       "424                                                                                                                  line-height:normal   \n",
       "425                                                                                                                  line-height:normal   \n",
       "426                                                                                                                  line-height:normal   \n",
       "427                                                                                                                  line-height:normal   \n",
       "428                                                                                                                  line-height:normal   \n",
       "429                                                                                                                  line-height:normal   \n",
       "430                                                                                                                  line-height:normal   \n",
       "431                                                                                                                  line-height:normal   \n",
       "432                                                                                                                  line-height:normal   \n",
       "433                                                                                                                  line-height:normal   \n",
       "434                                                                                                                  line-height:normal   \n",
       "\n",
       "                Classes   Bold  Italics  Uppercased  Underlined  Indexed  \\\n",
       "0      ['WordSection1']  False    False       False       False    False   \n",
       "1         ['MsoNormal']  False    False       False       False    False   \n",
       "2         ['MsoNormal']  False    False       False       False    False   \n",
       "3         ['MsoNormal']  False    False       False       False    False   \n",
       "4         ['MsoNormal']  False    False       False       False    False   \n",
       "5         ['MsoNormal']  False    False       False       False    False   \n",
       "6         ['MsoNormal']  False    False       False       False    False   \n",
       "7         ['MsoNormal']  False    False       False       False    False   \n",
       "8         ['MsoNormal']  False    False       False       False    False   \n",
       "9         ['MsoNormal']  False    False       False       False    False   \n",
       "10        ['MsoNormal']  False    False       False       False    False   \n",
       "11        ['MsoNormal']  False    False       False       False    False   \n",
       "12        ['MsoNormal']  False    False       False       False    False   \n",
       "13        ['MsoNormal']  False    False       False       False    False   \n",
       "14        ['MsoNormal']  False    False       False       False    False   \n",
       "15        ['MsoNormal']  False    False       False       False    False   \n",
       "16        ['MsoNormal']  False    False       False       False    False   \n",
       "17        ['MsoNormal']  False    False       False       False    False   \n",
       "18        ['MsoNormal']  False    False       False       False    False   \n",
       "19        ['MsoNormal']  False    False       False       False    False   \n",
       "20        ['MsoNormal']  False    False       False       False    False   \n",
       "21        ['MsoNormal']  False    False       False       False    False   \n",
       "22        ['MsoNormal']  False    False       False       False    False   \n",
       "23        ['MsoNormal']  False    False       False       False    False   \n",
       "24        ['MsoNormal']   True    False        True       False    False   \n",
       "25        ['MsoNormal']  False    False       False       False    False   \n",
       "26        ['MsoNormal']   True    False        True       False    False   \n",
       "27                 None  False    False       False       False    False   \n",
       "28                 None  False    False       False       False    False   \n",
       "29        ['MsoNormal']  False    False       False       False    False   \n",
       "30        ['MsoNormal']  False    False       False       False    False   \n",
       "31        ['MsoNormal']  False    False       False       False    False   \n",
       "32        ['MsoNormal']   True    False        True       False     True   \n",
       "33        ['MsoNormal']  False    False       False       False    False   \n",
       "34        ['MsoNormal']  False    False       False       False    False   \n",
       "35        ['MsoNormal']  False    False       False       False    False   \n",
       "36        ['MsoNormal']  False    False       False       False    False   \n",
       "37        ['MsoNormal']   True    False        True       False     True   \n",
       "38        ['MsoNormal']  False    False       False       False    False   \n",
       "39        ['MsoNormal']  False    False       False       False    False   \n",
       "40        ['MsoNormal']  False    False       False       False    False   \n",
       "41        ['MsoNormal']  False    False       False       False    False   \n",
       "42        ['MsoNormal']  False    False       False       False    False   \n",
       "43        ['MsoNormal']  False    False       False       False    False   \n",
       "44        ['MsoNormal']  False    False       False       False    False   \n",
       "45        ['MsoNormal']  False    False       False       False    False   \n",
       "46        ['MsoNormal']  False    False       False       False    False   \n",
       "47        ['MsoNormal']  False    False       False       False    False   \n",
       "48        ['MsoNormal']   True    False        True       False     True   \n",
       "49        ['MsoNormal']  False    False       False       False    False   \n",
       "50        ['MsoNormal']  False    False       False       False    False   \n",
       "51        ['MsoNormal']  False    False       False       False    False   \n",
       "52        ['MsoNormal']  False    False       False       False    False   \n",
       "53        ['MsoNormal']  False    False       False       False    False   \n",
       "54        ['MsoNormal']  False    False       False       False    False   \n",
       "55        ['MsoNormal']   True    False        True       False     True   \n",
       "56        ['MsoNormal']  False    False       False       False    False   \n",
       "57        ['MsoNormal']   True    False       False       False     True   \n",
       "58        ['MsoNormal']  False    False       False       False    False   \n",
       "59         ['Standard']  False    False       False       False    False   \n",
       "60        ['MsoNormal']  False    False       False       False    False   \n",
       "61        ['MsoNormal']   True    False       False       False     True   \n",
       "62        ['MsoNormal']  False    False       False       False    False   \n",
       "63        ['MsoNormal']  False    False       False       False    False   \n",
       "64        ['MsoNormal']  False    False       False       False    False   \n",
       "65        ['MsoNormal']  False    False       False        True    False   \n",
       "66        ['MsoNormal']  False    False       False       False    False   \n",
       "67        ['MsoNormal']  False    False       False       False    False   \n",
       "68        ['MsoNormal']  False    False       False       False    False   \n",
       "69        ['MsoNormal']  False    False       False       False    False   \n",
       "70        ['MsoNormal']  False    False       False       False    False   \n",
       "71         ['Standard']  False    False       False       False    False   \n",
       "72             ['Text']  False    False       False       False    False   \n",
       "73             ['Text']  False    False       False       False    False   \n",
       "74        ['MsoNormal']  False    False       False       False    False   \n",
       "75        ['MsoNormal']  False     True       False        True    False   \n",
       "76        ['MsoNormal']  False     True       False       False    False   \n",
       "77        ['MsoNormal']  False    False       False       False    False   \n",
       "78        ['MsoNormal']  False    False       False       False    False   \n",
       "79        ['MsoNormal']  False     True       False       False    False   \n",
       "80        ['MsoNormal']  False    False       False       False    False   \n",
       "81        ['MsoNormal']  False    False       False       False    False   \n",
       "82        ['MsoNormal']  False     True       False       False    False   \n",
       "83        ['MsoNormal']  False    False       False       False    False   \n",
       "84        ['MsoNormal']  False    False       False       False    False   \n",
       "85        ['MsoNormal']  False     True       False       False    False   \n",
       "86         ['Standard']  False    False       False       False    False   \n",
       "87         ['Standard']  False    False       False       False    False   \n",
       "88         ['Standard']  False    False       False       False    False   \n",
       "89        ['MsoNormal']  False    False       False       False    False   \n",
       "90        ['MsoNormal']  False    False       False        True    False   \n",
       "91        ['MsoNormal']  False    False       False       False    False   \n",
       "92        ['MsoNormal']  False    False       False       False    False   \n",
       "93        ['MsoNormal']  False    False       False       False    False   \n",
       "94        ['MsoNormal']  False    False       False       False    False   \n",
       "95        ['MsoNormal']  False    False       False       False    False   \n",
       "96        ['MsoNormal']  False    False       False       False    False   \n",
       "97        ['MsoNormal']  False    False       False       False    False   \n",
       "98        ['MsoNormal']   True    False       False       False     True   \n",
       "99        ['MsoNormal']  False    False       False       False    False   \n",
       "100       ['MsoNormal']  False    False       False       False    False   \n",
       "101       ['MsoNormal']  False    False       False       False    False   \n",
       "102       ['MsoNormal']  False    False       False       False    False   \n",
       "103       ['MsoNormal']   True    False       False       False     True   \n",
       "104       ['MsoNormal']  False    False       False       False    False   \n",
       "105       ['MsoNormal']  False    False       False        True    False   \n",
       "106       ['MsoNormal']  False    False       False       False    False   \n",
       "107       ['MsoNormal']  False    False       False       False    False   \n",
       "108       ['MsoNormal']  False    False       False       False    False   \n",
       "109       ['MsoNormal']  False    False       False        True    False   \n",
       "110       ['MsoNormal']  False    False       False       False    False   \n",
       "111       ['MsoNormal']  False    False       False       False    False   \n",
       "112       ['MsoNormal']  False    False       False       False    False   \n",
       "113       ['MsoNormal']  False    False       False        True    False   \n",
       "114       ['MsoNormal']  False    False       False       False    False   \n",
       "115       ['MsoNormal']  False    False       False       False    False   \n",
       "116       ['MsoNormal']  False    False       False       False    False   \n",
       "117       ['MsoNormal']  False    False       False       False    False   \n",
       "118       ['MsoNormal']  False    False       False       False    False   \n",
       "119       ['MsoNormal']  False    False       False        True    False   \n",
       "120       ['MsoNormal']  False    False       False       False    False   \n",
       "121       ['MsoNormal']  False    False       False       False    False   \n",
       "122       ['MsoNormal']  False    False       False       False    False   \n",
       "123       ['MsoNormal']   True    False       False       False     True   \n",
       "124       ['MsoNormal']  False    False       False       False    False   \n",
       "125       ['MsoNormal']  False    False       False       False    False   \n",
       "126       ['MsoNormal']  False    False       False       False    False   \n",
       "127       ['MsoNormal']  False    False       False       False    False   \n",
       "128       ['MsoNormal']  False    False       False       False    False   \n",
       "129       ['MsoNormal']  False    False       False       False    False   \n",
       "130       ['MsoNormal']  False    False       False       False    False   \n",
       "131       ['MsoNormal']   True    False       False       False     True   \n",
       "132       ['MsoNormal']  False    False       False       False    False   \n",
       "133       ['MsoNormal']  False    False       False        True    False   \n",
       "134       ['MsoNormal']  False    False       False       False    False   \n",
       "135        ['Standard']  False    False       False       False    False   \n",
       "136       ['MsoNormal']  False    False       False       False    False   \n",
       "137        ['Standard']  False    False       False       False    False   \n",
       "138       ['MsoNormal']  False    False       False       False    False   \n",
       "139       ['MsoNormal']  False    False       False        True    False   \n",
       "140       ['MsoNormal']  False    False       False       False    False   \n",
       "141       ['MsoNormal']  False    False       False       False    False   \n",
       "142       ['MsoNormal']  False    False       False       False    False   \n",
       "143       ['MsoNormal']  False    False       False       False    False   \n",
       "144       ['MsoNormal']  False    False       False       False    False   \n",
       "145       ['MsoNormal']  False    False       False       False    False   \n",
       "146       ['MsoNormal']  False    False       False       False    False   \n",
       "147       ['MsoNormal']  False    False       False        True    False   \n",
       "148       ['MsoNormal']  False    False       False       False    False   \n",
       "149       ['MsoNormal']  False    False       False       False    False   \n",
       "150       ['MsoNormal']  False    False       False       False    False   \n",
       "151       ['MsoNormal']   True    False       False       False     True   \n",
       "152       ['MsoNormal']  False    False       False       False    False   \n",
       "153       ['MsoNormal']  False    False       False       False    False   \n",
       "154       ['MsoNormal']  False    False       False       False    False   \n",
       "155       ['MsoNormal']   True    False       False       False     True   \n",
       "156       ['MsoNormal']  False    False       False       False    False   \n",
       "157       ['MsoNormal']  False    False       False        True    False   \n",
       "158       ['MsoNormal']  False    False       False       False    False   \n",
       "159       ['MsoNormal']  False    False       False       False    False   \n",
       "160       ['MsoNormal']  False    False       False       False    False   \n",
       "161       ['MsoNormal']  False    False       False        True    False   \n",
       "162       ['MsoNormal']  False    False       False       False    False   \n",
       "163       ['MsoNormal']  False    False       False       False    False   \n",
       "164       ['MsoNormal']  False    False       False       False    False   \n",
       "165       ['MsoNormal']  False    False       False       False    False   \n",
       "166       ['MsoNormal']  False    False       False       False    False   \n",
       "167       ['MsoNormal']   True    False       False       False    False   \n",
       "168       ['MsoNormal']  False    False       False       False    False   \n",
       "169  ['MsoNormalTable']  False    False       False       False    False   \n",
       "170            ['Text']  False    False       False       False    False   \n",
       "171       ['MsoNormal']  False    False       False        True    False   \n",
       "172            ['Text']  False    False       False       False    False   \n",
       "173            ['Text']  False     True       False        True    False   \n",
       "174            ['Text']  False    False       False       False    False   \n",
       "175            ['Text']  False    False       False       False    False   \n",
       "176            ['Text']  False    False       False       False    False   \n",
       "177            ['Text']  False    False       False       False    False   \n",
       "178        ['Standard']  False    False       False        True    False   \n",
       "179        ['Standard']  False    False       False       False    False   \n",
       "180            ['Text']  False    False       False       False    False   \n",
       "181            ['Text']  False    False       False       False    False   \n",
       "182       ['MsoNormal']  False    False       False        True    False   \n",
       "183       ['MsoNormal']  False    False       False       False    False   \n",
       "184       ['MsoNormal']  False    False       False       False    False   \n",
       "185       ['MsoNormal']  False    False       False       False    False   \n",
       "186       ['MsoNormal']   True    False       False       False     True   \n",
       "187       ['MsoNormal']  False    False       False       False    False   \n",
       "188       ['MsoNormal']  False    False       False       False    False   \n",
       "189       ['MsoNormal']  False    False       False       False    False   \n",
       "190       ['MsoNormal']  False    False       False       False    False   \n",
       "191       ['MsoNormal']  False    False       False       False    False   \n",
       "192       ['MsoNormal']  False    False       False       False    False   \n",
       "193       ['MsoNormal']   True    False        True       False     True   \n",
       "194       ['MsoNormal']  False    False       False       False    False   \n",
       "195       ['MsoNormal']   True    False       False       False     True   \n",
       "196       ['MsoNormal']  False    False       False       False    False   \n",
       "197       ['MsoNormal']  False    False       False       False    False   \n",
       "198       ['MsoNormal']  False    False       False       False    False   \n",
       "199       ['MsoNormal']  False    False       False        True    False   \n",
       "200       ['MsoNormal']  False    False       False       False    False   \n",
       "201       ['MsoNormal']  False    False       False       False    False   \n",
       "202       ['MsoNormal']  False    False       False       False    False   \n",
       "203       ['MsoNormal']  False    False       False       False    False   \n",
       "204       ['MsoNormal']  False    False       False       False    False   \n",
       "205       ['MsoNormal']  False    False       False        True    False   \n",
       "206       ['MsoNormal']  False    False       False       False    False   \n",
       "207       ['MsoNormal']  False    False       False       False    False   \n",
       "208       ['MsoNormal']  False    False       False       False    False   \n",
       "209       ['MsoNormal']  False    False       False        True    False   \n",
       "210       ['MsoNormal']  False    False       False       False    False   \n",
       "211       ['MsoNormal']  False    False       False       False    False   \n",
       "212       ['MsoNormal']  False    False       False       False    False   \n",
       "213       ['MsoNormal']  False    False       False       False    False   \n",
       "214       ['MsoNormal']  False    False       False       False    False   \n",
       "215       ['MsoNormal']  False    False       False       False    False   \n",
       "216       ['MsoNormal']  False    False       False       False    False   \n",
       "217       ['MsoNormal']  False    False       False       False    False   \n",
       "218       ['MsoNormal']  False    False       False       False    False   \n",
       "219       ['MsoNormal']  False    False       False       False    False   \n",
       "220       ['MsoNormal']  False    False       False       False    False   \n",
       "221       ['MsoNormal']   True    False       False       False    False   \n",
       "222       ['MsoNormal']  False    False       False       False    False   \n",
       "223  ['MsoNormalTable']  False    False       False       False    False   \n",
       "224       ['MsoNormal']  False    False       False       False    False   \n",
       "225       ['MsoNormal']  False    False       False       False    False   \n",
       "226       ['MsoNormal']  False    False       False       False    False   \n",
       "227       ['MsoNormal']  False    False       False       False    False   \n",
       "228       ['MsoNormal']  False    False       False       False    False   \n",
       "229       ['MsoNormal']   True    False       False       False    False   \n",
       "230       ['MsoNormal']  False    False       False       False    False   \n",
       "231  ['MsoNormalTable']  False    False       False       False    False   \n",
       "232       ['MsoNormal']  False    False       False       False    False   \n",
       "233       ['MsoNormal']  False    False       False       False    False   \n",
       "234       ['MsoNormal']  False    False       False       False    False   \n",
       "235       ['MsoNormal']  False    False       False       False    False   \n",
       "236       ['MsoNormal']  False    False       False       False    False   \n",
       "237       ['MsoNormal']   True    False       False       False    False   \n",
       "238       ['MsoNormal']  False    False       False       False    False   \n",
       "239            ['Text']  False    False       False       False    False   \n",
       "240       ['MsoNormal']  False    False       False       False    False   \n",
       "241            ['Text']  False    False       False       False    False   \n",
       "242            ['Text']  False    False       False       False    False   \n",
       "243       ['MsoNormal']  False    False       False       False    False   \n",
       "244       ['MsoNormal']  False    False       False       False    False   \n",
       "245       ['MsoNormal']  False    False       False       False    False   \n",
       "246                None  False    False       False       False    False   \n",
       "247       ['MsoNormal']  False    False       False        True    False   \n",
       "248       ['MsoNormal']  False    False       False       False    False   \n",
       "249       ['MsoNormal']  False    False       False       False    False   \n",
       "250       ['MsoNormal']  False    False       False       False    False   \n",
       "251       ['MsoNormal']  False    False       False       False    False   \n",
       "252       ['MsoNormal']  False    False       False       False    False   \n",
       "253       ['MsoNormal']  False    False       False        True    False   \n",
       "254       ['MsoNormal']  False    False       False       False    False   \n",
       "255       ['MsoNormal']  False    False       False       False    False   \n",
       "256       ['MsoNormal']  False    False       False       False    False   \n",
       "257       ['MsoNormal']  False    False       False       False    False   \n",
       "258       ['MsoNormal']  False    False       False       False    False   \n",
       "259       ['MsoNormal']   True    False       False       False     True   \n",
       "260       ['MsoNormal']  False    False       False       False    False   \n",
       "261       ['MsoNormal']  False    False       False        True    False   \n",
       "262       ['MsoNormal']  False    False       False       False    False   \n",
       "263       ['MsoNormal']  False    False       False       False    False   \n",
       "264       ['MsoNormal']  False    False       False       False    False   \n",
       "265       ['MsoNormal']  False    False       False        True    False   \n",
       "266       ['MsoNormal']  False    False       False       False    False   \n",
       "267       ['MsoNormal']  False    False       False       False    False   \n",
       "268       ['MsoNormal']  False    False       False       False    False   \n",
       "269       ['MsoNormal']  False    False       False        True    False   \n",
       "270       ['MsoNormal']  False    False       False       False    False   \n",
       "271       ['MsoNormal']  False    False       False       False    False   \n",
       "272       ['MsoNormal']  False    False       False       False    False   \n",
       "273       ['MsoNormal']  False    False       False        True    False   \n",
       "274       ['MsoNormal']  False    False       False       False    False   \n",
       "275       ['MsoNormal']  False    False       False       False    False   \n",
       "276       ['MsoNormal']  False    False       False       False    False   \n",
       "277       ['MsoNormal']  False    False       False        True    False   \n",
       "278       ['MsoNormal']  False    False       False       False    False   \n",
       "279       ['MsoNormal']  False    False       False       False    False   \n",
       "280       ['MsoNormal']  False    False       False       False    False   \n",
       "281       ['MsoNormal']  False    False       False        True    False   \n",
       "282       ['MsoNormal']  False    False       False       False    False   \n",
       "283       ['MsoNormal']  False     True       False        True    False   \n",
       "284       ['MsoNormal']  False    False       False       False    False   \n",
       "285       ['MsoNormal']  False    False       False       False    False   \n",
       "286       ['MsoNormal']  False     True       False        True    False   \n",
       "287       ['MsoNormal']  False    False       False       False    False   \n",
       "288       ['MsoNormal']  False    False       False       False    False   \n",
       "289       ['MsoNormal']  False     True       False        True    False   \n",
       "290       ['MsoNormal']  False    False       False       False    False   \n",
       "291       ['MsoNormal']  False    False       False       False    False   \n",
       "292       ['MsoNormal']   True    False       False       False     True   \n",
       "293       ['MsoNormal']  False    False       False       False    False   \n",
       "294       ['MsoNormal']  False    False       False       False    False   \n",
       "295       ['MsoNormal']  False    False       False       False    False   \n",
       "296       ['MsoNormal']  False    False       False       False    False   \n",
       "297       ['MsoNormal']  False    False       False       False    False   \n",
       "298       ['MsoNormal']  False    False       False       False    False   \n",
       "299       ['MsoNormal']  False    False       False       False    False   \n",
       "300       ['MsoNormal']  False    False       False       False    False   \n",
       "301       ['MsoNormal']  False    False       False       False    False   \n",
       "302       ['MsoNormal']  False    False       False       False    False   \n",
       "303       ['MsoNormal']  False    False       False       False    False   \n",
       "304       ['MsoNormal']  False    False       False       False    False   \n",
       "305       ['MsoNormal']  False    False       False       False    False   \n",
       "306       ['MsoNormal']  False    False       False       False    False   \n",
       "307       ['MsoNormal']  False    False       False       False    False   \n",
       "308       ['MsoNormal']  False    False       False       False    False   \n",
       "309       ['MsoNormal']   True    False        True       False     True   \n",
       "310       ['MsoNormal']  False    False       False       False    False   \n",
       "311       ['MsoNormal']   True    False       False       False     True   \n",
       "312       ['MsoNormal']  False    False       False       False    False   \n",
       "313       ['MsoNormal']  False    False       False       False    False   \n",
       "314       ['MsoNormal']  False    False       False       False    False   \n",
       "315       ['MsoNormal']  False    False       False       False    False   \n",
       "316       ['MsoNormal']  False    False       False       False    False   \n",
       "317       ['MsoNormal']  False    False       False       False    False   \n",
       "318       ['MsoNormal']  False    False       False       False    False   \n",
       "319       ['MsoNormal']   True    False       False       False     True   \n",
       "320       ['MsoNormal']  False    False       False       False    False   \n",
       "321       ['MsoNormal']  False    False       False       False    False   \n",
       "322       ['MsoNormal']  False    False       False       False    False   \n",
       "323       ['MsoNormal']   True    False       False       False     True   \n",
       "324       ['MsoNormal']  False    False       False       False    False   \n",
       "325       ['MsoNormal']  False    False       False        True    False   \n",
       "326       ['MsoNormal']  False    False       False       False    False   \n",
       "327       ['MsoNormal']  False    False       False       False    False   \n",
       "328       ['MsoNormal']  False    False       False       False    False   \n",
       "329       ['MsoNormal']  False    False       False        True    False   \n",
       "330       ['MsoNormal']  False    False       False       False    False   \n",
       "331       ['MsoNormal']  False    False       False       False    False   \n",
       "332       ['MsoNormal']  False    False       False       False    False   \n",
       "333            ['Text']  False    False       False       False    False   \n",
       "334       ['MsoNormal']  False    False       False       False    False   \n",
       "335       ['MsoNormal']   True    False       False       False     True   \n",
       "336       ['MsoNormal']  False    False       False       False    False   \n",
       "337       ['MsoNormal']  False    False       False       False    False   \n",
       "338       ['MsoNormal']  False    False       False       False    False   \n",
       "339       ['MsoNormal']  False    False       False       False    False   \n",
       "340       ['MsoNormal']  False    False       False       False    False   \n",
       "341       ['MsoNormal']  False    False       False       False    False   \n",
       "342       ['MsoNormal']  False    False       False       False    False   \n",
       "343       ['MsoNormal']   True    False       False       False     True   \n",
       "344       ['MsoNormal']  False    False       False       False    False   \n",
       "345       ['MsoNormal']  False    False       False       False    False   \n",
       "346       ['MsoNormal']  False    False       False       False    False   \n",
       "347       ['MsoNormal']  False    False       False       False    False   \n",
       "348       ['MsoNormal']  False    False       False       False    False   \n",
       "349       ['MsoNormal']   True    False       False       False     True   \n",
       "350       ['MsoNormal']  False    False       False       False    False   \n",
       "351       ['MsoNormal']  False    False       False       False    False   \n",
       "352       ['MsoNormal']  False    False       False       False    False   \n",
       "353       ['MsoNormal']  False    False       False        True    False   \n",
       "354       ['MsoNormal']  False    False       False       False    False   \n",
       "355       ['MsoNormal']  False    False       False       False    False   \n",
       "356       ['MsoNormal']  False    False       False       False    False   \n",
       "357       ['MsoNormal']  False    False       False       False    False   \n",
       "358       ['MsoNormal']  False    False       False       False    False   \n",
       "359       ['MsoNormal']  False    False       False       False    False   \n",
       "360       ['MsoNormal']  False    False       False       False    False   \n",
       "361  ['MsoNormalTable']  False    False       False       False    False   \n",
       "362       ['MsoNormal']  False    False       False       False    False   \n",
       "363       ['MsoNormal']  False    False       False       False    False   \n",
       "364       ['MsoNormal']  False    False       False       False    False   \n",
       "365  ['MsoNormalTable']  False    False       False       False    False   \n",
       "366       ['MsoNormal']  False    False       False       False    False   \n",
       "367       ['MsoNormal']  False    False       False       False     True   \n",
       "368       ['MsoNormal']  False    False       False       False    False   \n",
       "369       ['MsoNormal']  False    False       False       False    False   \n",
       "370       ['MsoNormal']  False    False       False       False    False   \n",
       "371       ['MsoNormal']  False    False       False       False     True   \n",
       "372       ['MsoNormal']  False    False       False       False    False   \n",
       "373       ['MsoNormal']  False    False       False       False    False   \n",
       "374       ['MsoNormal']  False    False       False       False     True   \n",
       "375       ['MsoNormal']  False    False       False       False    False   \n",
       "376       ['MsoNormal']  False    False       False       False    False   \n",
       "377       ['MsoNormal']  False    False       False       False    False   \n",
       "378       ['MsoNormal']  False    False       False       False     True   \n",
       "379       ['MsoNormal']  False    False       False       False    False   \n",
       "380       ['MsoNormal']  False    False       False        True    False   \n",
       "381       ['MsoNormal']  False    False       False       False    False   \n",
       "382            ['Text']  False    False       False       False    False   \n",
       "383       ['MsoNormal']  False    False       False       False    False   \n",
       "384       ['MsoNormal']  False    False       False       False    False   \n",
       "385       ['MsoNormal']  False    False       False       False    False   \n",
       "386       ['MsoNormal']  False    False       False        True    False   \n",
       "387       ['MsoNormal']  False    False       False       False    False   \n",
       "388       ['MsoNormal']  False    False       False       False    False   \n",
       "389       ['MsoNormal']  False    False       False       False    False   \n",
       "390       ['MsoNormal']  False    False       False       False    False   \n",
       "391       ['MsoNormal']   True    False        True       False     True   \n",
       "392       ['MsoNormal']  False    False       False       False    False   \n",
       "393         ['Default']  False    False       False       False    False   \n",
       "394       ['MsoNormal']  False    False       False       False    False   \n",
       "395       ['MsoNormal']  False    False       False       False    False   \n",
       "396       ['MsoNormal']  False    False       False       False    False   \n",
       "397       ['MsoNormal']  False    False       False       False    False   \n",
       "398       ['MsoNormal']  False    False       False       False    False   \n",
       "399       ['MsoNormal']  False    False       False       False    False   \n",
       "400       ['MsoNormal']   True    False        True       False     True   \n",
       "401       ['MsoNormal']  False    False       False       False    False   \n",
       "402       ['MsoNormal']  False    False        True       False    False   \n",
       "403       ['MsoNormal']  False    False       False       False    False   \n",
       "404       ['MsoNormal']  False    False       False       False    False   \n",
       "405       ['MsoNormal']   True    False        True       False     True   \n",
       "406       ['MsoNormal']  False    False       False       False    False   \n",
       "407       ['MsoNormal']  False    False       False       False    False   \n",
       "408       ['MsoNormal']   True    False        True       False     True   \n",
       "409       ['MsoNormal']  False    False       False       False    False   \n",
       "410       ['MsoNormal']  False    False       False       False    False   \n",
       "411       ['MsoNormal']  False    False       False       False    False   \n",
       "412       ['MsoNormal']  False    False       False       False    False   \n",
       "413       ['MsoNormal']  False    False       False       False    False   \n",
       "414       ['MsoNormal']  False    False       False       False    False   \n",
       "415       ['MsoNormal']  False    False       False       False    False   \n",
       "416       ['MsoNormal']  False    False       False       False    False   \n",
       "417       ['MsoNormal']  False    False       False       False    False   \n",
       "418       ['MsoNormal']  False    False       False       False    False   \n",
       "419       ['MsoNormal']  False    False       False       False    False   \n",
       "420       ['MsoNormal']  False    False       False       False    False   \n",
       "421       ['MsoNormal']  False    False       False       False    False   \n",
       "422       ['MsoNormal']  False    False       False       False    False   \n",
       "423       ['MsoNormal']  False    False       False       False    False   \n",
       "424       ['MsoNormal']  False    False       False       False    False   \n",
       "425       ['MsoNormal']  False    False       False       False    False   \n",
       "426       ['MsoNormal']  False    False       False       False    False   \n",
       "427       ['MsoNormal']  False    False       False       False    False   \n",
       "428       ['MsoNormal']  False    False       False       False    False   \n",
       "429       ['MsoNormal']  False    False       False       False    False   \n",
       "430       ['MsoNormal']  False    False       False       False    False   \n",
       "431       ['MsoNormal']  False    False       False       False    False   \n",
       "432       ['MsoNormal']  False    False       False       False    False   \n",
       "433       ['MsoNormal']  False    False       False       False    False   \n",
       "434       ['MsoNormal']  False    False       False       False    False   \n",
       "\n",
       "     IsListItem  HasBorder  IsPossibleHeading IsHeadingType  \\\n",
       "0         False      False              False          None   \n",
       "1         False      False              False          None   \n",
       "2         False      False              False          None   \n",
       "3         False      False              False          None   \n",
       "4         False      False              False          None   \n",
       "5         False      False              False          None   \n",
       "6         False      False              False          None   \n",
       "7         False      False              False          None   \n",
       "8         False      False              False          None   \n",
       "9         False      False              False          None   \n",
       "10        False      False              False          None   \n",
       "11        False      False              False          None   \n",
       "12        False      False              False          None   \n",
       "13        False      False              False          None   \n",
       "14        False      False              False          None   \n",
       "15        False      False              False          None   \n",
       "16        False      False              False          None   \n",
       "17        False      False              False          None   \n",
       "18        False      False              False          None   \n",
       "19        False      False              False          None   \n",
       "20        False      False              False          None   \n",
       "21        False      False              False          None   \n",
       "22        False      False              False          None   \n",
       "23        False      False              False          None   \n",
       "24        False      False               True          None   \n",
       "25        False      False              False          None   \n",
       "26        False      False              False          None   \n",
       "27        False      False              False          None   \n",
       "28        False      False              False          None   \n",
       "29        False      False              False          None   \n",
       "30        False      False              False          None   \n",
       "31        False      False              False          None   \n",
       "32        False      False               True            L1   \n",
       "33        False      False              False          None   \n",
       "34        False      False              False          None   \n",
       "35        False      False              False          None   \n",
       "36        False      False              False          None   \n",
       "37        False      False               True            L1   \n",
       "38        False      False              False          None   \n",
       "39        False      False              False          None   \n",
       "40        False      False              False          None   \n",
       "41        False      False              False          None   \n",
       "42        False      False              False          None   \n",
       "43        False      False              False          None   \n",
       "44        False      False              False          None   \n",
       "45        False      False              False          None   \n",
       "46        False      False              False          None   \n",
       "47        False      False              False          None   \n",
       "48        False      False               True            L1   \n",
       "49        False      False              False          None   \n",
       "50        False      False              False          None   \n",
       "51        False      False              False          None   \n",
       "52        False      False              False          None   \n",
       "53        False      False              False          None   \n",
       "54        False      False              False          None   \n",
       "55        False      False               True            L1   \n",
       "56        False      False              False          None   \n",
       "57        False      False               True            L2   \n",
       "58        False      False              False          None   \n",
       "59        False      False              False          None   \n",
       "60        False      False              False          None   \n",
       "61        False      False               True            L2   \n",
       "62        False      False              False          None   \n",
       "63        False      False              False          None   \n",
       "64        False      False              False          None   \n",
       "65        False      False               True            L3   \n",
       "66        False      False              False          None   \n",
       "67        False      False              False          None   \n",
       "68        False      False              False          None   \n",
       "69        False      False              False          None   \n",
       "70        False      False              False          None   \n",
       "71        False      False              False          None   \n",
       "72         True      False              False          None   \n",
       "73         True      False              False          None   \n",
       "74        False      False              False          None   \n",
       "75        False      False               True            L4   \n",
       "76        False      False               True            L4   \n",
       "77        False      False              False          None   \n",
       "78        False      False              False          None   \n",
       "79        False      False               True            L4   \n",
       "80        False      False              False          None   \n",
       "81        False      False              False          None   \n",
       "82        False      False               True            L4   \n",
       "83        False      False              False          None   \n",
       "84        False      False              False          None   \n",
       "85        False      False               True            L4   \n",
       "86        False      False              False          None   \n",
       "87        False      False              False          None   \n",
       "88        False      False              False          None   \n",
       "89        False      False              False          None   \n",
       "90        False      False               True            L3   \n",
       "91        False      False              False          None   \n",
       "92        False      False              False          None   \n",
       "93        False      False              False          None   \n",
       "94        False      False              False          None   \n",
       "95        False      False              False          None   \n",
       "96        False      False              False          None   \n",
       "97        False      False              False          None   \n",
       "98        False      False               True            L2   \n",
       "99        False      False              False          None   \n",
       "100       False      False              False          None   \n",
       "101       False      False              False          None   \n",
       "102       False      False              False          None   \n",
       "103       False      False               True            L2   \n",
       "104       False      False              False          None   \n",
       "105       False      False               True            L3   \n",
       "106       False      False              False          None   \n",
       "107       False      False              False          None   \n",
       "108       False      False              False          None   \n",
       "109       False      False               True            L3   \n",
       "110       False      False              False          None   \n",
       "111       False      False              False          None   \n",
       "112       False      False              False          None   \n",
       "113       False      False               True            L3   \n",
       "114       False      False              False          None   \n",
       "115       False      False              False          None   \n",
       "116       False      False              False          None   \n",
       "117       False      False              False          None   \n",
       "118       False      False              False          None   \n",
       "119       False      False               True            L3   \n",
       "120       False      False              False          None   \n",
       "121       False      False              False          None   \n",
       "122       False      False              False          None   \n",
       "123       False      False               True            L2   \n",
       "124       False      False              False          None   \n",
       "125       False      False              False          None   \n",
       "126       False      False              False          None   \n",
       "127       False      False              False          None   \n",
       "128       False      False              False          None   \n",
       "129       False      False              False          None   \n",
       "130       False      False              False          None   \n",
       "131       False      False               True            L2   \n",
       "132       False      False              False          None   \n",
       "133       False      False               True            L3   \n",
       "134       False      False              False          None   \n",
       "135       False      False              False          None   \n",
       "136       False      False              False          None   \n",
       "137       False      False              False          None   \n",
       "138       False      False              False          None   \n",
       "139       False      False               True            L3   \n",
       "140       False      False              False          None   \n",
       "141       False      False              False          None   \n",
       "142       False      False              False          None   \n",
       "143       False      False              False          None   \n",
       "144       False      False              False          None   \n",
       "145       False      False              False          None   \n",
       "146       False      False              False          None   \n",
       "147       False      False               True            L3   \n",
       "148       False      False              False          None   \n",
       "149       False      False              False          None   \n",
       "150       False      False              False          None   \n",
       "151       False      False               True            L2   \n",
       "152       False      False              False          None   \n",
       "153       False      False              False          None   \n",
       "154       False      False              False          None   \n",
       "155       False      False               True            L2   \n",
       "156       False      False              False          None   \n",
       "157       False      False               True            L3   \n",
       "158       False      False              False          None   \n",
       "159       False      False              False          None   \n",
       "160       False      False              False          None   \n",
       "161       False      False               True            L3   \n",
       "162       False      False              False          None   \n",
       "163       False      False              False          None   \n",
       "164       False      False              False          None   \n",
       "165       False      False              False          None   \n",
       "166       False      False              False          None   \n",
       "167       False      False              False          None   \n",
       "168       False      False              False          None   \n",
       "169       False      False              False          None   \n",
       "170       False      False              False          None   \n",
       "171       False      False               True            L3   \n",
       "172       False      False              False          None   \n",
       "173       False      False               True            L4   \n",
       "174       False      False              False          None   \n",
       "175       False      False              False          None   \n",
       "176       False      False              False          None   \n",
       "177       False      False              False          None   \n",
       "178       False      False               True            L3   \n",
       "179       False      False              False          None   \n",
       "180       False      False              False          None   \n",
       "181       False      False              False          None   \n",
       "182       False      False               True            L3   \n",
       "183       False      False              False          None   \n",
       "184       False      False              False          None   \n",
       "185       False      False              False          None   \n",
       "186       False      False               True            L2   \n",
       "187       False      False              False          None   \n",
       "188       False      False              False          None   \n",
       "189       False      False              False          None   \n",
       "190       False      False              False          None   \n",
       "191       False      False              False          None   \n",
       "192       False      False              False          None   \n",
       "193       False      False               True            L1   \n",
       "194       False      False              False          None   \n",
       "195       False      False               True            L2   \n",
       "196       False      False              False          None   \n",
       "197       False      False              False          None   \n",
       "198       False      False              False          None   \n",
       "199       False      False               True            L3   \n",
       "200       False      False              False          None   \n",
       "201       False      False              False          None   \n",
       "202       False      False              False          None   \n",
       "203       False      False              False          None   \n",
       "204       False      False              False          None   \n",
       "205       False      False               True            L3   \n",
       "206       False      False              False          None   \n",
       "207       False      False              False          None   \n",
       "208       False      False              False          None   \n",
       "209       False      False               True            L3   \n",
       "210       False      False              False          None   \n",
       "211       False      False              False          None   \n",
       "212       False      False              False          None   \n",
       "213       False      False              False          None   \n",
       "214       False      False              False          None   \n",
       "215       False      False              False          None   \n",
       "216       False      False              False          None   \n",
       "217       False      False              False          None   \n",
       "218       False      False              False          None   \n",
       "219       False      False              False          None   \n",
       "220       False      False              False          None   \n",
       "221       False      False              False          None   \n",
       "222       False      False              False          None   \n",
       "223       False      False              False          None   \n",
       "224       False      False              False          None   \n",
       "225       False      False              False          None   \n",
       "226       False      False              False          None   \n",
       "227       False      False              False          None   \n",
       "228       False      False              False          None   \n",
       "229       False      False              False          None   \n",
       "230       False      False              False          None   \n",
       "231       False      False              False          None   \n",
       "232       False      False              False          None   \n",
       "233       False      False              False          None   \n",
       "234       False      False              False          None   \n",
       "235       False      False              False          None   \n",
       "236       False      False              False          None   \n",
       "237       False      False              False          None   \n",
       "238       False      False              False          None   \n",
       "239        True      False              False          None   \n",
       "240        True      False              False          None   \n",
       "241       False      False              False          None   \n",
       "242       False      False              False          None   \n",
       "243       False      False              False          None   \n",
       "244       False      False              False          None   \n",
       "245       False      False              False          None   \n",
       "246       False      False              False          None   \n",
       "247       False      False               True            L3   \n",
       "248       False      False              False          None   \n",
       "249       False      False              False          None   \n",
       "250       False      False              False          None   \n",
       "251       False      False              False          None   \n",
       "252       False      False              False          None   \n",
       "253       False      False               True            L3   \n",
       "254       False      False              False          None   \n",
       "255       False      False              False          None   \n",
       "256       False      False              False          None   \n",
       "257       False      False              False          None   \n",
       "258       False      False              False          None   \n",
       "259       False      False               True            L2   \n",
       "260       False      False              False          None   \n",
       "261       False      False               True            L3   \n",
       "262       False      False              False          None   \n",
       "263       False      False              False          None   \n",
       "264       False      False              False          None   \n",
       "265       False      False               True            L3   \n",
       "266       False      False              False          None   \n",
       "267       False      False              False          None   \n",
       "268       False      False              False          None   \n",
       "269       False      False               True            L3   \n",
       "270       False      False              False          None   \n",
       "271       False      False              False          None   \n",
       "272       False      False              False          None   \n",
       "273       False      False               True            L3   \n",
       "274       False      False              False          None   \n",
       "275       False      False              False          None   \n",
       "276       False      False              False          None   \n",
       "277       False      False               True            L3   \n",
       "278       False      False              False          None   \n",
       "279       False      False              False          None   \n",
       "280       False      False              False          None   \n",
       "281       False      False               True            L3   \n",
       "282       False      False              False          None   \n",
       "283       False      False               True            L4   \n",
       "284       False      False              False          None   \n",
       "285       False      False              False          None   \n",
       "286       False      False               True            L4   \n",
       "287       False      False              False          None   \n",
       "288       False      False              False          None   \n",
       "289       False      False               True            L4   \n",
       "290       False      False              False          None   \n",
       "291       False      False              False          None   \n",
       "292       False      False               True            L2   \n",
       "293       False      False              False          None   \n",
       "294       False      False              False          None   \n",
       "295       False      False              False          None   \n",
       "296       False      False              False          None   \n",
       "297       False      False              False          None   \n",
       "298       False      False              False          None   \n",
       "299       False      False              False          None   \n",
       "300       False      False              False          None   \n",
       "301       False      False              False          None   \n",
       "302       False      False              False          None   \n",
       "303       False      False              False          None   \n",
       "304       False      False              False          None   \n",
       "305       False      False              False          None   \n",
       "306       False      False              False          None   \n",
       "307       False      False              False          None   \n",
       "308       False      False              False          None   \n",
       "309       False      False               True            L1   \n",
       "310       False      False              False          None   \n",
       "311       False      False               True            L2   \n",
       "312       False      False              False          None   \n",
       "313       False      False              False          None   \n",
       "314       False      False              False          None   \n",
       "315       False      False              False          None   \n",
       "316       False      False              False          None   \n",
       "317       False      False              False          None   \n",
       "318       False      False              False          None   \n",
       "319       False      False               True            L2   \n",
       "320       False      False              False          None   \n",
       "321       False      False              False          None   \n",
       "322       False      False              False          None   \n",
       "323       False      False               True            L2   \n",
       "324       False      False              False          None   \n",
       "325       False      False               True            L3   \n",
       "326       False      False              False          None   \n",
       "327       False      False              False          None   \n",
       "328       False      False              False          None   \n",
       "329       False      False               True            L3   \n",
       "330       False      False              False          None   \n",
       "331       False      False              False          None   \n",
       "332       False      False              False          None   \n",
       "333       False      False              False          None   \n",
       "334       False      False              False          None   \n",
       "335       False      False               True            L2   \n",
       "336       False      False              False          None   \n",
       "337       False      False              False          None   \n",
       "338       False      False              False          None   \n",
       "339       False      False              False          None   \n",
       "340       False      False              False          None   \n",
       "341       False      False              False          None   \n",
       "342       False      False              False          None   \n",
       "343       False      False               True            L2   \n",
       "344       False      False              False          None   \n",
       "345       False      False              False          None   \n",
       "346       False      False              False          None   \n",
       "347       False      False              False          None   \n",
       "348       False      False              False          None   \n",
       "349       False      False               True            L2   \n",
       "350       False      False              False          None   \n",
       "351       False      False              False          None   \n",
       "352       False      False              False          None   \n",
       "353       False      False               True            L3   \n",
       "354       False      False              False          None   \n",
       "355       False      False              False          None   \n",
       "356       False      False              False          None   \n",
       "357       False      False              False          None   \n",
       "358       False      False              False          None   \n",
       "359       False      False              False          None   \n",
       "360       False      False              False          None   \n",
       "361        True      False              False          None   \n",
       "362       False      False              False          None   \n",
       "363       False      False              False          None   \n",
       "364       False      False              False          None   \n",
       "365        True      False              False          None   \n",
       "366       False      False              False          None   \n",
       "367       False      False              False          None   \n",
       "368        True      False              False          None   \n",
       "369        True      False              False          None   \n",
       "370       False      False              False          None   \n",
       "371       False      False              False          None   \n",
       "372        True      False              False          None   \n",
       "373       False      False              False          None   \n",
       "374       False      False              False          None   \n",
       "375        True      False              False          None   \n",
       "376        True      False              False          None   \n",
       "377       False      False              False          None   \n",
       "378       False      False              False          None   \n",
       "379       False      False              False          None   \n",
       "380       False      False               True            L3   \n",
       "381       False      False              False          None   \n",
       "382       False      False              False          None   \n",
       "383       False      False              False          None   \n",
       "384       False      False              False          None   \n",
       "385       False      False              False          None   \n",
       "386       False      False               True            L3   \n",
       "387       False      False              False          None   \n",
       "388       False      False              False          None   \n",
       "389       False      False              False          None   \n",
       "390       False      False              False          None   \n",
       "391       False      False               True            L1   \n",
       "392       False      False              False          None   \n",
       "393       False      False              False          None   \n",
       "394       False      False              False          None   \n",
       "395       False      False              False          None   \n",
       "396       False      False              False          None   \n",
       "397       False      False              False          None   \n",
       "398       False      False              False          None   \n",
       "399       False      False              False          None   \n",
       "400       False      False               True            L1   \n",
       "401       False      False              False          None   \n",
       "402       False      False              False          None   \n",
       "403       False      False              False          None   \n",
       "404       False      False              False          None   \n",
       "405       False      False               True            L1   \n",
       "406       False      False              False          None   \n",
       "407       False      False              False          None   \n",
       "408       False      False               True            L1   \n",
       "409       False      False              False          None   \n",
       "410       False      False              False          None   \n",
       "411       False      False              False          None   \n",
       "412       False      False              False          None   \n",
       "413       False      False              False          None   \n",
       "414       False      False              False          None   \n",
       "415       False      False              False          None   \n",
       "416       False      False              False          None   \n",
       "417       False      False              False          None   \n",
       "418       False      False              False          None   \n",
       "419       False      False              False          None   \n",
       "420       False      False              False          None   \n",
       "421       False      False              False          None   \n",
       "422       False      False              False          None   \n",
       "423       False      False              False          None   \n",
       "424       False      False              False          None   \n",
       "425       False      False              False          None   \n",
       "426       False      False              False          None   \n",
       "427       False      False              False          None   \n",
       "428       False      False              False          None   \n",
       "429       False      False              False          None   \n",
       "430       False      False              False          None   \n",
       "431       False      False              False          None   \n",
       "432       False      False              False          None   \n",
       "433       False      False              False          None   \n",
       "434       False      False              False          None   \n",
       "\n",
       "                                                                                                                                                                                                        Text  \\\n",
       "0                                                                                                                                                                                                        ...   \n",
       "1                                                                                                                                                                                                              \n",
       "2                                                                                                                                                                                                              \n",
       "3                                                                                                                                                                                                              \n",
       "4                                                                                                                                                                                                              \n",
       "5                                                                                                                                                                                                              \n",
       "6                                                                                                                                                                                                              \n",
       "7                                                                                                                                                                                                              \n",
       "8                                                                                                                                                                                                              \n",
       "9                                                                                                                                                                                                              \n",
       "10                                                                                                                                                                                                             \n",
       "11                                                                                                                                                                                                             \n",
       "12                                                                                                                                                                                                             \n",
       "13                                                                                                                                                                                                             \n",
       "14                                                                                                                                                                                                             \n",
       "15                                                                                                                                                                                                             \n",
       "16                                                                                                                                                                                                             \n",
       "17                                                                                                                                                                                                             \n",
       "18                                                                                                                                                                                                             \n",
       "19                                                                                                                                                                                                             \n",
       "20                                                                                                                                                                                                             \n",
       "21                                                                                                                                                                                                             \n",
       "22                                                                                                                                                                                                             \n",
       "23                                                                                                                                                                                                             \n",
       "24                                                                                                                                                                                                   ANNEX I   \n",
       "25                                                                                                                                                                                                             \n",
       "26                                                                                                                                                                        SUMMARY OF PRODUCT CHARACTERISTICS   \n",
       "27                                                                                                                                                                                                             \n",
       "28                                                                                                                                                                                                             \n",
       "29   This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse react...   \n",
       "30                                                                                                                                                                                                             \n",
       "31                                                                                                                                                                                                             \n",
       "32                                                                                                                                                                    1.       NAME OF THE MEDICINAL PRODUCT   \n",
       "33                                                                                                                                                                                                             \n",
       "34                                                                                                                                                    Adakveo 10 mg/ml concentrate for solution for infusion   \n",
       "35                                                                                                                                                                                                             \n",
       "36                                                                                                                                                                                                             \n",
       "37                                                                                                                                                         2.       QUALITATIVE AND QUANTITATIVE COMPOSITION   \n",
       "38                                                                                                                                                                                                             \n",
       "39                                                                                                                            Each ml of concentrate for solution for infusion contains 10 mg crizanlizumab.   \n",
       "40                                                                                                                                                                                                             \n",
       "41                                                                                                                                                          One vial of 10 ml contains 100 mg crizanlizumab.   \n",
       "42                                                                                                                                                                                                             \n",
       "43                                                                                       Crizanlizumab is a monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.   \n",
       "44                                                                                                                                                                                                             \n",
       "45                                                                                                                                                         For the full list of excipients, see section 6.1.   \n",
       "46                                                                                                                                                                                                             \n",
       "47                                                                                                                                                                                                             \n",
       "48                                                                                                                                                                              3.       PHARMACEUTICAL FORM   \n",
       "49                                                                                                                                                                                                             \n",
       "50                                                                                                                                               Concentrate for solution for infusion (sterile concentrate)   \n",
       "51                                                                                                                                                                                                             \n",
       "52                                                                                                              Colourless to slightly brownish‑yellow liquid at pH 6 and with an osmolality of 300 mOsm/kg.   \n",
       "53                                                                                                                                                                                                             \n",
       "54                                                                                                                                                                                                             \n",
       "55                                                                                                                                                                             4.       CLINICAL PARTICULARS   \n",
       "56                                                                                                                                                                                                             \n",
       "57                                                                                                                                                                           4.1     Therapeutic indications   \n",
       "58                                                                                                                                                                                                             \n",
       "59   Adakveo is indicated for the prevention of recurrent vaso‑occlusive crises (VOCs) in sickle cell disease patients aged 16 years and older. It can be given as an add‑on therapy to hydroxyurea/hydro...   \n",
       "60                                                                                                                                                                                                             \n",
       "61                                                                                                                                                             4.2     Posology and method of administration   \n",
       "62                                                                                                                                                                                                             \n",
       "63                                                                                                         Treatment should be initiated by physicians experienced in the management of sickle cell disease.   \n",
       "64                                                                                                                                                                                                             \n",
       "65                                                                                                                                                                                                  Posology   \n",
       "66                                                                                                                                                                                                             \n",
       "67                                        The recommended dose of crizanlizumab is 5 mg/kg administered over a period of 30 minutes by intravenous infusion at week 0, week 2, and every 4 weeks thereafter.   \n",
       "68                                                                                                                                                                                                             \n",
       "69                                                                                                                                                           Crizanlizumab can be given alone or with HU/HC.   \n",
       "70                                                                                                                                                                                                             \n",
       "71                                                                                                                            If a dose is missed, the treatment should be administered as soon as possible.   \n",
       "72                                         -                 If crizanlizumab is administered within 2 weeks after the missed dose, dosing should be continued according to the patient’s original schedule.   \n",
       "73                                                          -                 If crizanlizumab is administered more than 2 weeks after the missed dose, dosing should be continued every 4 weeks thereafter.   \n",
       "74                                                                                                                                                                                                             \n",
       "75                                                                                                                                                                                       Special populations   \n",
       "76                                                                                                                                                                                                   Elderly   \n",
       "77                                        Crizanlizumab has not been studied in elderly patients. No dose adjustment is required as the pharmacokinetics of crizanlizumab in adults are not affected by age.   \n",
       "78                                                                                                                                                                                                             \n",
       "79                                                                                                                                                                                          Renal impairment   \n",
       "80   Based on the population pharmacokinetic (PK) results, no dose adjustment is required in patients with mild or moderate renal impairment (see section 5.2). Data from patients with severe renal impa...   \n",
       "81                                                                                                                                                                                                             \n",
       "82                                                                                                                                                                                        Hepatic impairment   \n",
       "83   The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monoclonal antibody and is cleared via catabolism (i.e. breakdown into pe...   \n",
       "84                                                                                                                                                                                                             \n",
       "85                                                                                                                                                                                     Paediatric population   \n",
       "86                                                               The safety and efficacy of crizanlizumab in paediatric patients from 6 months to 16 years have not been established. No data are available.   \n",
       "87                                                                                                                                                                                                             \n",
       "88                                                         There is no relevant use of crizanlizumab in infants aged less than 6 months for the indication of prevention of recurrent vaso‑occlusive crises.   \n",
       "89                                                                                                                                                                                                             \n",
       "90                                                                                                                                                                                  Method of administration   \n",
       "91                                                                                                                                                                                                             \n",
       "92                                                                                Adakveo should be diluted with sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% before administration.   \n",
       "93                                                                                                                                                                                                             \n",
       "94   The diluted solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by intravenous infusion over a period of 30 minutes. It must not be administered by intravenous...   \n",
       "95                                                                                                                                                                                                             \n",
       "96                                                                                                             For instructions on dilution of the medicinal product before administration, see section 6.6.   \n",
       "97                                                                                                                                                                                                             \n",
       "98                                                                                                                                                                                 4.3     Contraindications   \n",
       "99                                                                                                                                                                                                             \n",
       "100                                                                                                              Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.   \n",
       "101                                                                                                                                           Hypersensitivity to Chinese Hamster Ovary (CHO) cell products.   \n",
       "102                                                                                                                                                                                                            \n",
       "103                                                                                                                                                         4.4     Special warnings and precautions for use   \n",
       "104                                                                                                                                                                                                            \n",
       "105                                                                                                                                                                                             Traceability   \n",
       "106                                                                                                                                                                                                            \n",
       "107                                             In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.   \n",
       "108                                                                                                                                                                                                            \n",
       "109                                                                                                                                                                               Infusion‑related reactions   \n",
       "110                                                                                                                                                                                                            \n",
       "111  In clinical studies, infusion‑related reactions (defined as occurring within 24 hours) were observed in 2 patients (1.8%) treated with crizanlizumab 5 mg/kg. Patients should be monitored for signs...   \n",
       "112                                                                                                                                                                                                            \n",
       "113                                                                                                                                                  Laboratory test interference: automated platelet counts   \n",
       "114                                                                                                                                                                                                            \n",
       "115  Interference with automated platelet counts (platelet clumping) has been observed in patients treated with crizanlizumab in clinical studies, in particular when tubes containing EDTA (ethylenediam...   \n",
       "116                                                                                                                                                                                                            \n",
       "117  To mitigate the potential for laboratory test interference, it is recommended to run the test as soon as possible (within 4 hours of blood collection) or use citrate tubes. When needed, platelet c...   \n",
       "118                                                                                                                                                                                                            \n",
       "119                                                                                                                                                                             Excipients with known effect   \n",
       "120                                                                                                                                                                                                            \n",
       "121                                                                                               This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially “sodium‑free”.   \n",
       "122                                                                                                                                                                                                            \n",
       "123                                                                                                                         4.5     Interaction with other medicinal products and other forms of interaction   \n",
       "124                                                                                                                                                                                                            \n",
       "125                                                                                         Interactions between crizanlizumab and other medicinal products have not been investigated in dedicated studies.   \n",
       "126                                                                                                                                                                                                            \n",
       "127  Monoclonal antibodies are not metabolised by cytochrome P450 (CYP450) enzymes. Therefore, medicinal products that are substrates, inhibitors or inducers of CYP450 are not expected to affect the ph...   \n",
       "128                                                                                                                                                                                                            \n",
       "129                                                                        No effect on exposure of co‑administered medicinal products is expected based on the metabolic pathways of monoclonal antibodies.   \n",
       "130                                                                                                                                                                                                            \n",
       "131                                                                                                                                                               4.6     Fertility, pregnancy and lactation   \n",
       "132                                                                                                                                                                                                            \n",
       "133                                                                                                                                                                                                Pregnancy   \n",
       "134                                                                                                                                                                                                            \n",
       "135  There is a limited amount of data from the use of Adakveo in pregnant women. Based on data from animal studies, crizanlizumab has the potential to cause foetal losses when administered to a pregna...   \n",
       "136                                                                                                                                                                                                            \n",
       "137  To help determine the effects in pregnant women, healthcare professionals are encouraged to report all pregnancy cases and complications during pregnancy (from 105 days prior to the last menstrual...   \n",
       "138                                                                                                                                                                                                            \n",
       "139                                                                                                                                                                                           Breast‑feeding   \n",
       "140                                                                                                                                                                                                            \n",
       "141  It is unknown whether crizanlizumab is excreted in human milk after administration of Adakveo. There are no data on the effects of crizanlizumab on the breast‑fed newborn/infant or on milk product...   \n",
       "142                                                                                                                                                                                                            \n",
       "143                                                                   Because many medicinal products, including antibodies, can be excreted in human milk, a risk to the newborn/infant cannot be excluded.   \n",
       "144                                                                                                                                                                                                            \n",
       "145  A decision must be made whether to discontinue breast‑feeding or to discontinue Adakveo therapy, taking into account the benefit of breast‑feeding for the child and the benefit of therapy for the ...   \n",
       "146                                                                                                                                                                                                            \n",
       "147                                                                                                                                                                                                Fertility   \n",
       "148                                                                                                                                                                                                            \n",
       "149                        There are no data on the effect of Adakveo on human fertility. Available non‑clinical data do not suggest an effect on fertility under crizanlizumab treatment (see section 5.3).   \n",
       "150                                                                                                                                                                                                            \n",
       "151                                                                                                                                                     4.7     Effects on ability to drive and use machines   \n",
       "152                                                                                                                                                                                                            \n",
       "153                                      Adakveo may have a minor influence on the ability to drive and use machines. Dizziness, fatigue and somnolence may occur following administration of crizanlizumab.   \n",
       "154                                                                                                                                                                                                            \n",
       "155                                                                                                                                                                              4.8     Undesirable effects   \n",
       "156                                                                                                                                                                                                            \n",
       "157                                                                                                                                                                            Summary of the safety profile   \n",
       "158                                                                                                                                                                                                            \n",
       "159  The most frequently reported adverse drug reactions (≥10% of patients) in the Adakveo 5 mg/kg group were arthralgia, nausea, back pain, pyrexia and abdominal pain. Severe events were observed for ...   \n",
       "160                                                                                                                                                                                                            \n",
       "161                                                                                                                                                                      Tabulated list of adverse reactions   \n",
       "162                                                                                                                                                                                                            \n",
       "163  Table 1 lists adverse reactions based on pooled data from two studies: the pivotal study, SUSTAIN, and a single‑arm, open‑label pharmacokinetics/pharmacodynamics and safety study. Use of crizanliz...   \n",
       "164                                                                                                                                                                                                            \n",
       "165  Within each system organ class, the adverse reactions are ranked by frequency, with the most frequent reactions first. Within each frequency grouping, adverse reactions are presented in order of d...   \n",
       "166                                                                                                                                                                                                            \n",
       "167                                                                                                                                                      Table 1       Adverse reactions in clinical studies   \n",
       "168                                                                                                                                                                                                            \n",
       "169     System organ class   Frequency   Adverse reaction     Respiratory, thoracic and   mediastinal disorders   Common   Oropharyngeal pain     Gastrointestinal disorders   Very common   Nausea, abdo...   \n",
       "170                                                                                                                                                                                                            \n",
       "171                                                                                                                                                                Description of selected adverse reactions   \n",
       "172                                                                                                                                                                                                            \n",
       "173                                                                                                                                                                                           Immunogenicity   \n",
       "174                                  In clinical studies, treatment‑induced anti‑crizanlizumab antibodies were transiently detected in 1 patient (0.9%) among the 111 patients who received Adakveo 5 mg/kg.   \n",
       "175                                                                                                                                                                                                            \n",
       "176                                                                          There was no evidence of altered pharmacokinetics or of an altered safety profile with anti‑crizanlizumab antibody development.   \n",
       "177                                                                                                                                                                                                            \n",
       "178                                                                                                                                                                                    Paediatric population   \n",
       "179                                                                                                                                                                                                            \n",
       "180     Frequency, type and severity of adverse reactions in patients aged 16 and 17 years are expected to be the same as in adults. The safety of crizanlizumab was evaluated in 3 patients aged <18 years.   \n",
       "181                                                                                                                                                                                                            \n",
       "182                                                                                                                                                                 Reporting of suspected adverse reactions   \n",
       "183                                                                                                                                                                                                            \n",
       "184  Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare pro...   \n",
       "185                                                                                                                                                                                                            \n",
       "186                                                                                                                                                                                         4.9     Overdose   \n",
       "187                                                                                                                                                                                                            \n",
       "188                                                                                                                                             No cases of overdose have been reported in clinical studies.   \n",
       "189                                                                                                                                                                                                            \n",
       "190                                                                                                General supportive measures and symptomatic treatment should be initiated in cases of suspected overdose.   \n",
       "191                                                                                                                                                                                                            \n",
       "192                                                                                                                                                                                                            \n",
       "193                                                                                                                                                                      5.       PHARMACOLOGICAL PROPERTIES   \n",
       "194                                                                                                                                                                                                            \n",
       "195                                                                                                                                                                       5.1     Pharmacodynamic properties   \n",
       "196                                                                                                                                                                                                            \n",
       "197                                                                                                                                Pharmacotherapeutic group: Other haematological agents, ATC code: B06AX01   \n",
       "198                                                                                                                                                                                                            \n",
       "199                                                                                                                                                                                      Mechanism of action   \n",
       "200                                                                                                                                                                                                            \n",
       "201  Crizanlizumab is a selective IgG2 kappa humanised monoclonal antibody (mAb) that binds to P‑selectin with high affinity and blocks the interaction with its ligands, including P‑selectin glycoprote...   \n",
       "202                                                                                                                                                                                                            \n",
       "203  Binding P‑selectin on the surface of the activated endothelium and platelets has been shown to effectively block interactions between endothelial cells, platelets, red blood cells and leukocytes, ...   \n",
       "204                                                                                                                                                                                                            \n",
       "205                                                                                                                                                                                  Pharmacodynamic effects   \n",
       "206                                                                                                                                                                                                            \n",
       "207  Throughout clinical studies, treatment with crizanlizumab 5 mg/kg resulted in dose‑dependent, immediate and sustained P‑selectin inhibition (as measured ex vivo) in patients with sickle cell disease.   \n",
       "208                                                                                                                                                                                                            \n",
       "209                                                                                                                                                                             Clinical efficacy and safety   \n",
       "210                                                                                                                                                                                                            \n",
       "211  The efficacy of crizanlizumab, with or without HU/HC, was evaluated in the pivotal study SUSTAIN, a 52‑week, randomised, placebo‑controlled, double‑blind, multicentre clinical study in sickle cell...   \n",
       "212                                                                                                                                                                                                            \n",
       "213  In this study, VOCs were defined as those leading to a healthcare visit, which captured all acute episodes of pain with no other cause than a vaso‑occlusive event that required a healthcare visit ...   \n",
       "214                                                                                                                                                                                                            \n",
       "215  A total of 198 sickle cell disease patients aged 16 to 63 years (inclusive; mean age 30.1±10.3 years), with any sickle cell disease genotype (including HbSS [71.2%], HbSC [16.2%], HbSbeta0‑thalass...   \n",
       "216                                                                                                                                                                                                            \n",
       "217  Treatment with Adakveo 5 mg/kg resulted in a 45.3% lower median annual rate of VOCs compared to placebo (Hodges‑Lehmann, median absolute difference of ‑1.01 compared with placebo, 95% CI [‑2.00, 0...   \n",
       "218                                                                                                                                                                                                            \n",
       "219                                                                                                                    Main efficacy outcomes of the pivotal SUSTAIN study are summarised in Tables 2 and 3.   \n",
       "220                                                                                                                                                                                                            \n",
       "221                                                                                                                                 Table 2       Results from SUSTAIN clinical study in sickle cell disease   \n",
       "222                                                                                                                                                                                                            \n",
       "223     Event   Adakveo 5 mg/kg (N=67) (standard median)   Placebo (N=65) (standard median)   Change vs placebo   Hodges‑Lehmann median   difference (95% CI)   p-value (Wilcoxon rank sum)     Primary e...   \n",
       "224                                                                                                                                                                                                            \n",
       "225  The clinical effect demonstrated in the primary efficacy analysis was supported by multiple supplementary analyses including a negative binomial regression on investigator assessments with a conse...   \n",
       "226                                                                                                                                                                                                            \n",
       "227  In the Adakveo 5 mg/kg group, clinically significant reductions in the annual rate of VOCs were observed across important subgroups (HU/HC use, 2‑4 or 5‑10 VOCs in the previous 12 months, and HbSS...   \n",
       "228                                                                                                                                                                                                            \n",
       "229                                                                                                                                        Table 3       Annual rate of VOCs in patients ‑ subgroup analyses   \n",
       "230                                                                                                                                                                                                            \n",
       "231     Subgroup        Adakveo 5 mg/kg (N=67) (standard median)   Placebo (N=65) (standard median)   Change vs placebo   Hodges‑Lehmann median   difference (95% CI)     HU/HC use   Yes   n=42 2.43   n...   \n",
       "232                                                                                                                                                                                                            \n",
       "233  A greater than two‑fold increase in the proportion of patients with no VOC and who completed the study was observed in the Adakveo 5 mg/kg group compared to placebo (22% vs 8%; odds ratio [95% CI]...   \n",
       "234                                                                                                                                                                                                            \n",
       "235  Treatment with Adakveo 5 mg/kg was also associated with a three‑fold longer Kaplan‑Meier estimated median time to first VOC compared with placebo (4.07 vs 1.38 months; HR=0.495, 95% CI: 0.331, 0.7...   \n",
       "236                                                                                                                                                                                                            \n",
       "237                                                                                                                                                    Figure 1      Kaplan‑Meier curve of time to first VOC   \n",
       "238                                                                                                                                                                                                            \n",
       "239                                                                                                                                                                                                            \n",
       "240                                                                                                                                                                                                            \n",
       "241                                                                                                                                                                                                            \n",
       "242                                                                                                                                                                                                            \n",
       "243                                                                                                                                                                                                            \n",
       "244                                                                                                                                                                                                            \n",
       "245                                                                                                                                                                                                            \n",
       "246                                                                                                                                                                                                            \n",
       "247                                                                                                                                                                                    Paediatric population   \n",
       "248                                                                                                                                                                                                            \n",
       "249  The efficacy of crizanlizumab in patients aged 16 and 17 years is expected to be the same as in adults. Three patients (2.7%) aged less than 18 years were treated with crizanlizumab 5 mg/kg in cli...   \n",
       "250                                                                                                                                                                                                            \n",
       "251  The European Medicines Agency has deferred the obligation to submit the results of studies with Adakveo in one or more subsets of the paediatric population in the treatment of sickle cell disease ...   \n",
       "252                                                                                                                                                                                                            \n",
       "253                                                                                                                                                                                     Conditional approval   \n",
       "254                                                                                                                                                                                                            \n",
       "255                                       This medicinal product has been authorised under a so‑called “conditional approval” scheme. This means that further evidence on this medicinal product is awaited.   \n",
       "256                                                                                                                                                                                                            \n",
       "257                                                      The European Medicines Agency will review new information on this medicinal product at least every year and this SmPC will be updated as necessary.   \n",
       "258                                                                                                                                                                                                            \n",
       "259                                                                                                                                                                       5.2     Pharmacokinetic properties   \n",
       "260                                                                                                                                                                                                            \n",
       "261                                                                                                                                                                                               Absorption   \n",
       "262                                                                                                                                                                                                            \n",
       "263  The median time to reach maximum serum concentration of crizanlizumab (Tmax) was 1.92 hours at steady state following intravenous administration of 5 mg/kg over a period of 30 minutes in sickle ce...   \n",
       "264                                                                                                                                                                                                            \n",
       "265                                                                                                                                                                                             Distribution   \n",
       "266                                                                                                                                                                                                            \n",
       "267  Crizanlizumab distribution is typical of endogenous human antibodies within the vascular and extracellular spaces. The volume of distribution (Vz) was 4.26 litres after a single 5 mg/kg intravenou...   \n",
       "268                                                                                                                                                                                                            \n",
       "269                                                                                                                                                                                        Biotransformation   \n",
       "270                                                                                                                                                                                                            \n",
       "271                                                                                 Antibodies are primarily eliminated via proteolysis by lysosomal enzymes in the liver to small peptides and amino acids.   \n",
       "272                                                                                                                                                                                                            \n",
       "273                                                                                                                                                                                              Elimination   \n",
       "274                                                                                                                                                                                                            \n",
       "275  In healthy volunteers, the mean terminal elimination half‑life (T½) was 10.6 days and the mean clearance was 11.7 ml/h at crizanlizumab dose level 5 mg/kg. In patients with sickle cell disease, th...   \n",
       "276                                                                                                                                                                                                            \n",
       "277                                                                                                                                                                                  Linearity/non‑linearity   \n",
       "278                                                                                                                                                                                                            \n",
       "279                                                The exposure to crizanlizumab (mean Cmax, AUClast, or AUCinf) increased in non‑linear manner over the dose range of 0.2 to 8 mg/kg in healthy volunteers.   \n",
       "280                                                                                                                                                                                                            \n",
       "281                                                                                                                                                                                      Special populations   \n",
       "282                                                                                                                                                                                                            \n",
       "283                                                                                                                                                                                         Renal impairment   \n",
       "284  In a population PK analysis in patients with eGFR ranging from 35 to 202 ml/min/1.73 m2, no clinically important differences in the pharmacokinetics of crizanlizumab were found between patients wi...   \n",
       "285                                                                                                                                                                                                            \n",
       "286                                                                                                                                                                                       Hepatic impairment   \n",
       "287  The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monoclonal antibody and is cleared via catabolism (i.e. breakdown into pe...   \n",
       "288                                                                                                                                                                                                            \n",
       "289                                                                                                                                                                                    Paediatric population   \n",
       "290                                                                                                            Pharmacokinetics in paediatric patients below the age of 16 years have not been investigated.   \n",
       "291                                                                                                                                                                                                            \n",
       "292                                                                                                                                                                          5.3     Preclinical safety data   \n",
       "293                                                                                                                                                                                                            \n",
       "294                                        Non‑clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, tissue cross‑reactivity and repeated dose toxicity.   \n",
       "295                                                                                                                                                                                                            \n",
       "296  In the 26‑week repeated dose toxicity study, administration of crizanlizumab in cynomolgus monkeys at dose levels up to 50 mg/kg/dose once every 4 weeks (at least 13.5 times the human clinical exp...   \n",
       "297                                                                                                                                                                                                            \n",
       "298  Pharmacological effects of crizanlizumab on haemodynamic and electrocardiographic parameters in the cynomolgus monkey were evaluated in the 26‑week repeated dose toxicology study. Respiratory rate...   \n",
       "299                                                                                                                                                                                                            \n",
       "300                                                                                           Formal carcinogenicity, genotoxicity and juvenile toxicity studies have not been conducted with crizanlizumab.   \n",
       "301                                                                                                                                                                                                            \n",
       "302  In a 26‑week repeated dose toxicity study, cynomolgus monkeys were administered crizanlizumab once every 4 weeks at doses up to 50 mg/kg (at least 13.5 times the human clinical exposure based on A...   \n",
       "303                                                                                                                                                                                                            \n",
       "304  In an enhanced pre‑ and postnatal development study in cynomolgus monkeys, pregnant animals received intravenous crizanlizumab once every two weeks during the period of organogenesis, at doses of ...   \n",
       "305                                                                                                                                                                                                            \n",
       "306          Measurable crizanlizumab serum concentrations were observed in the infant monkeys at postnatal day 28, confirming that crizanlizumab, like other IgG antibodies, crosses the placental barrier.   \n",
       "307                                                                                                                                                                                                            \n",
       "308                                                                                                                                                                                                            \n",
       "309                                                                                                                                                                      6.       PHARMACEUTICAL PARTICULARS   \n",
       "310                                                                                                                                                                                                            \n",
       "311                                                                                                                                                                               6.1     List of excipients   \n",
       "312                                                                                                                                                                                                            \n",
       "313                                                                                                                                                                                                  Sucrose   \n",
       "314                                                                                                                                                                                    Sodium citrate (E331)   \n",
       "315                                                                                                                                                                                       Citric acid (E330)   \n",
       "316                                                                                                                                                                                    Polysorbate 80 (E433)   \n",
       "317                                                                                                                                                                                     Water for injections   \n",
       "318                                                                                                                                                                                                            \n",
       "319                                                                                                                                                                                6.2     Incompatibilities   \n",
       "320                                                                                                                                                                                                            \n",
       "321                                                                                            This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6.   \n",
       "322                                                                                                                                                                                                            \n",
       "323                                                                                                                                                                                       6.3     Shelf life   \n",
       "324                                                                                                                                                                                                            \n",
       "325                                                                                                                                                                                            Unopened vial   \n",
       "326                                                                                                                                                                                                            \n",
       "327                                                                                                                                                                                                18 months   \n",
       "328                                                                                                                                                                                                            \n",
       "329                                                                                                                                                                                         Diluted solution   \n",
       "330                                                                                                                                                                                                            \n",
       "331  Chemical and physical in‑use stability, from the start of preparation of the diluted solution for infusion until end of infusion, has been demonstrated for up to 8 hours at room temperature (up to...   \n",
       "332                                                                                                                                                                                                            \n",
       "333  From a microbiological point of view, the diluted solution for infusion should be used immediately. If not used immediately, in‑use storage times and conditions prior to use are the responsibility...   \n",
       "334                                                                                                                                                                                                            \n",
       "335                                                                                                                                                                  6.4     Special precautions for storage   \n",
       "336                                                                                                                                                                                                            \n",
       "337                                                                                                                                                                     Store in a refrigerator (2°C – 8°C).   \n",
       "338                                                                                                                                                                                           Do not freeze.   \n",
       "339                                                                                                                                        Keep the vial in the outer carton in order to protect from light.   \n",
       "340                                                                                                                                                                                                            \n",
       "341                                                                                                                         For storage conditions after dilution of the medicinal product, see section 6.3.   \n",
       "342                                                                                                                                                                                                            \n",
       "343                                                                                                                                                                 6.5     Nature and contents of container   \n",
       "344                                                                                                                                                                                                            \n",
       "345   10 ml concentrate for solution for infusion in a type I glass vial with a coated chlorobutyl rubber stopper sealed with an aluminium cap with a plastic flip‑off disk containing 100 mg crizanlizumab.   \n",
       "346                                                                                                                                                                                                            \n",
       "347                                                                                                                                                                                          Pack of 1 vial.   \n",
       "348                                                                                                                                                                                                            \n",
       "349                                                                                                                                              6.6     Special precautions for disposal and other handling   \n",
       "350                                                                                                                                                                                                            \n",
       "351                                                                                                                                                                   Adakveo vials are for single use only.   \n",
       "352                                                                                                                                                                                                            \n",
       "353                                                                                                                                                                                   Preparing the infusion   \n",
       "354                                                                                                                                                                                                            \n",
       "355                                                                                              The diluted solution for infusion should be prepared by a healthcare professional using aseptic techniques.   \n",
       "356                                                                                                                                                                                                            \n",
       "357                                                             The total dose and required volume of Adakveo depend on the patient’s body weight; 5 mg of crizanlizumab is administered per kg body weight.   \n",
       "358                                                                                                                                                                                                            \n",
       "359                                                                                             The volume to be used for the preparation of the infusion is calculated according to the following equation:   \n",
       "360                                                                                                                                                                                                            \n",
       "361                                                                                  Volume (ml) =   Patient’s body weight (kg) x prescribed dose   [5 mg/kg]     Concentration   of Adakveo   [10 mg/ml]      \n",
       "362                                                                                                                                                                                                            \n",
       "363  1.       Obtain the number of vials required to deliver the prescribed dose and bring them to room temperature (for a maximum of 4 hours). One vial is needed for every 10 ml of Adakveo (see below ...   \n",
       "364                                                                                                                                                                                                            \n",
       "365                                Body weight (kg)   Dose (mg)   Volume (ml)   Vials (n)     40   200   20   2     60   300   30   3     80   400   40   4     100   500   50   5     120   600   60   6      \n",
       "366                                                                                                                                                                                                            \n",
       "367                                                                                                                                                                     2.       Visually inspect the vials.   \n",
       "368                                                                          -                 The solution in the vials should be clear to opalescent. Do not use if particles are present in the solution.   \n",
       "369                                                                                                           -                 The solution should be colourless or may have a slight brownish‑yellow tint.   \n",
       "370                                                                                                                                                                                                            \n",
       "371        3.       Withdraw a volume equal to the required volume of Adakveo from a 100 ml infusion bag containing either sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% and discard.   \n",
       "372          -                 No incompatibilities between the diluted Adakveo solution and infusion bags composed of polyvinylchloride (PVC), polyethylene (PE) and polypropylene (PP) have been observed.   \n",
       "373                                                                                                                                                                                                            \n",
       "374                                                                            4.       Withdraw the necessary volume of Adakveo from the vials and inject slowly into the previously prepared infusion bag.   \n",
       "375                                                                     -                 The solution must not be mixed or co‑administered with other medicinal products through the same intravenous line.   \n",
       "376                   -                 Keep the volume of Adakveo added to the infusion bag in the range of 10 ml to 96 ml to obtain a final concentration in the infusion bag within 1 mg/ml to 9.6 mg/ml.   \n",
       "377                                                                                                                                                                                                            \n",
       "378                                                                                                                    5.       Mix the diluted solution by gently inverting the infusion bag. DO NOT SHAKE.   \n",
       "379                                                                                                                                                                                                            \n",
       "380                                                                                                                                                                                           Administration   \n",
       "381                                                                                                                                                                                                            \n",
       "382  Adakveo diluted solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by intravenous infusion over a period of 30 minutes. No incompatibilities have been observe...   \n",
       "383                                                                                                                                                                                                            \n",
       "384                                                                After administration of Adakveo, flush the line with at least 25 ml sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5%.   \n",
       "385                                                                                                                                                                                                            \n",
       "386                                                                                                                                                                                                 Disposal   \n",
       "387                                                                                                                                                                                                            \n",
       "388                                                                                              Any unused medicinal product or waste material should be disposed of in accordance with local requirements.   \n",
       "389                                                                                                                                                                                                            \n",
       "390                                                                                                                                                                                                            \n",
       "391                                                                                                                                                                  7.       MARKETING AUTHORISATION HOLDER   \n",
       "392                                                                                                                                                                                                            \n",
       "393                                                                                                                                                                               Novartis Europharm Limited   \n",
       "394                                                                                                                                                                                           Vista Building   \n",
       "395                                                                                                                                                                                   Elm Park, Merrion Road   \n",
       "396                                                                                                                                                                                                 Dublin 4   \n",
       "397                                                                                                                                                                                                  Ireland   \n",
       "398                                                                                                                                                                                                            \n",
       "399                                                                                                                                                                                                            \n",
       "400                                                                                                                                                               8.       MARKETING AUTHORISATION NUMBER(S)   \n",
       "401                                                                                                                                                                                                            \n",
       "402                                                                                                                                                                                         EU/1/20/1476/001   \n",
       "403                                                                                                                                                                                                            \n",
       "404                                                                                                                                                                                                            \n",
       "405                                                                                                                                        9.       DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION   \n",
       "406                                                                                                                                                                                                            \n",
       "407                                                                                                                                                                                                            \n",
       "408                                                                                                                                                                     10.     DATE OF REVISION OF THE TEXT   \n",
       "409                                                                                                                                                                                                            \n",
       "410                                                                                                                                                                                                            \n",
       "411                                                                   Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu.    \n",
       "412                                                                                                                                                                                                            \n",
       "413                                                                                                                                                                                                            \n",
       "414                                                                                                                                                                                                            \n",
       "415                                                                                                                                                                                                            \n",
       "416                                                                                                                                                                                                            \n",
       "417                                                                                                                                                                                                            \n",
       "418                                                                                                                                                                                                            \n",
       "419                                                                                                                                                                                                            \n",
       "420                                                                                                                                                                                                            \n",
       "421                                                                                                                                                                                                            \n",
       "422                                                                                                                                                                                                            \n",
       "423                                                                                                                                                                                                            \n",
       "424                                                                                                                                                                                                            \n",
       "425                                                                                                                                                                                                            \n",
       "426                                                                                                                                                                                                            \n",
       "427                                                                                                                                                                                                            \n",
       "428                                                                                                                                                                                                            \n",
       "429                                                                                                                                                                                                            \n",
       "430                                                                                                                                                                                                            \n",
       "431                                                                                                                                                                                                            \n",
       "432                                                                                                                                                                                                            \n",
       "433                                                                                                                                                                                                            \n",
       "434                                                                                                                                                                                                            \n",
       "\n",
       "                                 ParentId  \n",
       "0    1b945380-ed32-477d-bc89-4e43eb629b1e  \n",
       "1    583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "2    583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "3    583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "4    583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "5    583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "6    583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "7    583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "8    583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "9    583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "10   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "11   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "12   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "13   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "14   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "15   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "16   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "17   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "18   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "19   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "20   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "21   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "22   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "23   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "24   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "25   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "26   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "27   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "28   b1cb472e-16b2-4c31-9704-43221d1c8944  \n",
       "29   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "30   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "31   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "32   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "33   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "34   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "35   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "36   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "37   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "38   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "39   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "40   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "41   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "42   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "43   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "44   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "45   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "46   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "47   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "48   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "49   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "50   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "51   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "52   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "53   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "54   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "55   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "56   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "57   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "58   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "59   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "60   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "61   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "62   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "63   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "64   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "65   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "66   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "67   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "68   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "69   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "70   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "71   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "72   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "73   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "74   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "75   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "76   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "77   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "78   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "79   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "80   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "81   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "82   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "83   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "84   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "85   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "86   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "87   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "88   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "89   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "90   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "91   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "92   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "93   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "94   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "95   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "96   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "97   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "98   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "99   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "100  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "101  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "102  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "103  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "104  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "105  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "106  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "107  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "108  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "109  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "110  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "111  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "112  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "113  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "114  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "115  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "116  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "117  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "118  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "119  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "120  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "121  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "122  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "123  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "124  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "125  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "126  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "127  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "128  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "129  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "130  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "131  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "132  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "133  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "134  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "135  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "136  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "137  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "138  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "139  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "140  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "141  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "142  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "143  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "144  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "145  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "146  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "147  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "148  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "149  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "150  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "151  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "152  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "153  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "154  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "155  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "156  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "157  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "158  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "159  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "160  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "161  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "162  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "163  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "164  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "165  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "166  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "167  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "168  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "169  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "170  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "171  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "172  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "173  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "174  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "175  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "176  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "177  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "178  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "179  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "180  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "181  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "182  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "183  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "184  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "185  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "186  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "187  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "188  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "189  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "190  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "191  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "192  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "193  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "194  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "195  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "196  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "197  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "198  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "199  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "200  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "201  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "202  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "203  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "204  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "205  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "206  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "207  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "208  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "209  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "210  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "211  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "212  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "213  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "214  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "215  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "216  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "217  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "218  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "219  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "220  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "221  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "222  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "223  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "224  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "225  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "226  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "227  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "228  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "229  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "230  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "231  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "232  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "233  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "234  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "235  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "236  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "237  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "238  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "239  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "240  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "241  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "242  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "243  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "244  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "245  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "246  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "247  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "248  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "249  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "250  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "251  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "252  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "253  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "254  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "255  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "256  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "257  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "258  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "259  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "260  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "261  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "262  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "263  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "264  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "265  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "266  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "267  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "268  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "269  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "270  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "271  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "272  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "273  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "274  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "275  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "276  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "277  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "278  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "279  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "280  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "281  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "282  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "283  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "284  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "285  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "286  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "287  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "288  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "289  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "290  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "291  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "292  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "293  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "294  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "295  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "296  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "297  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "298  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "299  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "300  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "301  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "302  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "303  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "304  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "305  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "306  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "307  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "308  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "309  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "310  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "311  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "312  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "313  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "314  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "315  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "316  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "317  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "318  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "319  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "320  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "321  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "322  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "323  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "324  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "325  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "326  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "327  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "328  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "329  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "330  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "331  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "332  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "333  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "334  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "335  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "336  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "337  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "338  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "339  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "340  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "341  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "342  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "343  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "344  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "345  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "346  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "347  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "348  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "349  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "350  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "351  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "352  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "353  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "354  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "355  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "356  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "357  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "358  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "359  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "360  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "361  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "362  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "363  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "364  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "365  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "366  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "367  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "368  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "369  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "370  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "371  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "372  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "373  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "374  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "375  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "376  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "377  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "378  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "379  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "380  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "381  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "382  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "383  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "384  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "385  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "386  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "387  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "388  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "389  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "390  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "391  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "392  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "393  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "394  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "395  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "396  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "397  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "398  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "399  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "400  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "401  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "402  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "403  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "404  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "405  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "406  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "407  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "408  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "409  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "410  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "411  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "412  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "413  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "414  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "415  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "416  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "417  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "418  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "419  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "420  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "421  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "422  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "423  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "424  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "425  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "426  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "427  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "428  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "429  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "430  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "431  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "432  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "433  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "434  583f04cc-251b-4aa9-a300-400d62bebe5a  "
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Element</th>\n",
       "      <th>ID</th>\n",
       "      <th>Styles</th>\n",
       "      <th>Classes</th>\n",
       "      <th>Bold</th>\n",
       "      <th>Italics</th>\n",
       "      <th>Uppercased</th>\n",
       "      <th>Underlined</th>\n",
       "      <th>Indexed</th>\n",
       "      <th>IsListItem</th>\n",
       "      <th>HasBorder</th>\n",
       "      <th>IsPossibleHeading</th>\n",
       "      <th>IsHeadingType</th>\n",
       "      <th>Text</th>\n",
       "      <th>ParentId</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>&lt;div class=\"WordSection1\"&gt; &lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt; &lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt; &lt;p class=...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "      <td>None</td>\n",
       "      <td>['WordSection1']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>...</td>\n",
       "      <td>1b945380-ed32-477d-bc89-4e43eb629b1e</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>93f99a3a-3bdb-4712-b8a2-7f7151752254</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>37bd41cc-5002-4d0f-b837-d1e612a8c9f4</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a118066d-62a7-49fe-b164-8dc28660cc13</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>048fcf44-3865-41ad-aa41-6fcf26a64a4e</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c31204d8-633f-4f10-ac97-914fcf46f5d7</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d70aeb25-5d44-4d24-b3ba-df3f0a945409</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e1477684-3361-4ca8-bd48-87fe774951b6</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6144e956-79cb-4671-935e-0428d8ae9552</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e8d61a67-3455-4013-b0cb-8c6be91e1dd9</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5ae63bab-fd9f-4543-8da5-95385fe2878a</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>73b2745c-30ea-4c64-8e98-aa6a807ed175</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7a8d15de-c5dc-49a9-b9f2-c06ea2aa2812</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e4924fc5-14a2-4074-ba07-3827e2690bbe</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5bbfb234-75ff-4d1b-ba18-79dc786c49a3</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>502e9ac3-58ab-4843-b8a0-5fd60ed4e9c5</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>48f98078-4e9d-4cf6-a2e3-6551b02a5fa4</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>53bfe434-4517-42ce-a813-b71d9f2e38cc</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b6a38e0b-e4f8-410b-b32a-37629f9e3831</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6bea775e-8180-4ac2-9e83-683b15a278e5</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d352b40d-10b4-4f2b-8989-ca2a32b8214e</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>cdc7ad58-c7fb-4b77-bcc2-de84faab6ac6</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>68654a8b-654b-47e1-a598-ec1c0860df89</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7a0e81a8-d56c-4500-b4fc-ed031c115ec5</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;ANNEX I&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>dd5948fb-58d2-4893-8b10-d805f0cdf739</td>\n",
       "      <td>text-align:center;line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>None</td>\n",
       "      <td>ANNEX I</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>75c81091-3ccc-4ed5-947f-c6995c913347</td>\n",
       "      <td>text-align:center;line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>&lt;p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;SUMMARY OF PRODUCT CHARACTERISTICS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>70d45c8c-f80d-484f-ace5-16d07806febf</td>\n",
       "      <td>text-align:center;line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>SUMMARY OF PRODUCT CHARACTERISTICS</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>&lt;span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif; color:green'&gt;&lt;br clear=\"all\" style=\"page-break-before:always\"/&gt; &lt;/span&gt;</td>\n",
       "      <td>b1cb472e-16b2-4c31-9704-43221d1c8944</td>\n",
       "      <td>font-size:11.0pt;font-family:\"Times New Roman\",serif;\\ncolor:green</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>&lt;br clear=\"all\" style=\"page-break-before:always\"/&gt;</td>\n",
       "      <td>7b7faf20-48a0-43ba-a11c-700ccaf1b44d</td>\n",
       "      <td>page-break-before:always</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>b1cb472e-16b2-4c31-9704-43221d1c8944</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;img height=\"18\" src=\"Adakveo-4874%20EN%20PI_files/image001.png\" width=\"21\"/&gt;&lt;span lang=\"EN-GB\"&gt;This medicinal product is subject to additional moni...</td>\n",
       "      <td>5f9f4e00-1c00-4d69-ae60-3b512d354b58</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse react...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f468e77c-8bbb-4e8e-a650-a4bcf4292f4e</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b6444544-1b61-4ede-bcb4-292a105fdf99</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;1.       NAME OF &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;THE MEDICIN...</td>\n",
       "      <td>bebd747b-536c-4ae8-b191-86916bb5b392</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>1.       NAME OF THE MEDICINAL PRODUCT</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>79944278-5179-4fc2-8e1d-555b0355dd79</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Adakveo 10 mg/ml concentrate for solution for infusion&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>dd38be17-c16a-4a43-bd7d-7d7de217c2ab</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Adakveo 10 mg/ml concentrate for solution for infusion</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>39eb16f8-9ea5-47dc-9002-8f3bf989f47a</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ef09f9ed-de0d-4558-8fb6-f7d64aaf2336</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;2.       QUALITATIVE AND QUANTITATIVE COMPOSITION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>fb95db94-3ab2-47ed-860c-1a32343cda09</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>2.       QUALITATIVE AND QUANTITATIVE COMPOSITION</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a2e7bc93-c504-4cf0-a556-8dbc293ae03d</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Each ml of concentrate for solution for infusion contains 10 mg crizanlizumab.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6b8c14cb-eba7-4ba3-9de8-231605835033</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Each ml of concentrate for solution for infusion contains 10 mg crizanlizumab.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>445c2994-215c-4b60-9e68-58b10b0bebb5</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;One vial of 10 ml contains 100 mg crizanlizumab.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>86a20c6b-f68b-4371-9f8a-a22986385994</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>One vial of 10 ml contains 100 mg crizanlizumab.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e59ad3b0-fdc0-4860-b4cd-0ffd1f6bbfdc</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Crizanlizumab is a monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9b057f63-8d47-4932-bf02-b2258fe2de4f</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Crizanlizumab is a monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d82f7f95-1ede-431d-a553-e3fb38e6ff28</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;For the full list of excipients, see section 6.1.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>603928f1-93e4-4c02-bb15-6bc6cef996af</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>For the full list of excipients, see section 6.1.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>fba2229a-f0ed-4548-ad90-a381cf1a1782</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f630af4e-4e7d-4c18-b043-880d0facc0eb</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;3.       PHARMACEUTICAL &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" styl...</td>\n",
       "      <td>b61d2001-da27-4ae0-9cd3-4fb666ce3ffe</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>3.       PHARMACEUTICAL FORM</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>31b9ed10-5866-4e63-8cca-ce18cc144980</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;a name=\"_Toc259706902\"&gt;&lt;/a&gt;&lt;a name=\"_Toc259707071\"&gt;&lt;/a&gt;&lt;a name=\"_Toc259707134\"&gt;&lt;/a&gt;&lt;a name=\"_Toc259713075\"&gt;&lt;span lang=\"EN-GB\"&gt;Concentrate for solut...</td>\n",
       "      <td>7d27d913-4b56-4995-9a02-920d4d6d616b</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Concentrate for solution for infusion (sterile concentrate)</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>261b4958-43c7-49b9-9e5a-d08543d24acf</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Colourless to slightly brownish‑yellow liquid at pH 6 and with an osmolality of 300 mOsm/kg.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4252fb30-8aea-4a64-969d-9f97eac73b9b</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Colourless to slightly brownish‑yellow liquid at pH 6 and with an osmolality of 300 mOsm/kg.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b3f0efe9-3876-4e68-b585-60721f1c25ac</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4bf7be43-25d1-4109-903f-3037ea6db68f</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\" style=\"text-transform:uppercase\"&gt;4.       &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span...</td>\n",
       "      <td>ee1bc075-2c6c-4e05-abb9-4907d5feeb5b</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>4.       CLINICAL PARTICULARS</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>32d06a42-9c67-427c-9011-cdfa13ede737</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;4.1     Therapeutic indications&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>0ebcbda6-4e48-4ae4-a098-291a1bbc76ba</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.1     Therapeutic indications</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>adf5587b-a53f-430b-817d-38b728fcf75d</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>&lt;p class=\"Standard\"&gt;&lt;span lang=\"EN-GB\"&gt;Adakveo&lt;/span&gt;&lt;span lang=\"EN-GB\"&gt; is indicated for the prevention of recurrent vaso‑occlusive crises (VOCs) in sickle cell disease patients aged 16 years and...</td>\n",
       "      <td>624419e5-aee7-4efc-95aa-caa3b50bc1bc</td>\n",
       "      <td>None</td>\n",
       "      <td>['Standard']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Adakveo is indicated for the prevention of recurrent vaso‑occlusive crises (VOCs) in sickle cell disease patients aged 16 years and older. It can be given as an add‑on therapy to hydroxyurea/hydro...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>238fb2f2-6728-400a-a31d-0a902b92cac0</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;4.2     Posology and method of administration&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>0ba39624-d328-423e-9451-75729da49f5e</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.2     Posology and method of administration</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b1d7658a-c886-4549-8199-23d497c4cc6b</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Treatment should be initiated by physicians experienced in the management of &lt;/span&gt;&lt;span lang=\"EN-GB\"&gt;sickle cell disease.&lt;/span...</td>\n",
       "      <td>b4a4dc54-4b41-43bd-b82f-06ee394b17a2</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Treatment should be initiated by physicians experienced in the management of sickle cell disease.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>86b7bbb5-d14b-4563-8aaf-f1f0b4aaad35</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Posology&lt;/span&gt;&lt;/u&gt;&lt;a name=\"_nth_Adults_and_patients_ag4131\"&gt;&lt;/a&gt;&lt;/p&gt;</td>\n",
       "      <td>490f404e-fff3-4d71-a062-145a626aa698</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Posology</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e714aa41-f9b5-4f9d-aa85-f59525886d3c</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The recommended dose of crizanlizumab is 5 mg/kg administered over a period of 30 minutes by intravenous infusion at week 0, week...</td>\n",
       "      <td>f658b1e4-66f8-4649-978b-497e69ca133e</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The recommended dose of crizanlizumab is 5 mg/kg administered over a period of 30 minutes by intravenous infusion at week 0, week 2, and every 4 weeks thereafter.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ced5ba42-b690-4da6-8bf6-5d6835f95180</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Crizanlizumab &lt;/span&gt;&lt;span lang=\"EN-GB\"&gt;c&lt;/span&gt;&lt;span lang=\"EN-GB\"&gt;an be given alone or with HU/HC.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>31210945-890b-4725-acdf-a354e5ca32d4</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Crizanlizumab can be given alone or with HU/HC.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9667ffd4-bc6f-4ff2-87bf-e738f6faabdf</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>&lt;p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;If a dose is missed, the treatment should be administered as soon as possible.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7973028c-e20f-44d7-8125-8c6ded4f2aec</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['Standard']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>If a dose is missed, the treatment should be administered as soon as possible.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt\"&gt;&lt;span style=\"font-size:11.0pt...</td>\n",
       "      <td>1355137f-9392-440f-b76b-893e39322a99</td>\n",
       "      <td>margin-top:0in;margin-right:0in;margin-bottom:\\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>-                 If crizanlizumab is administered within 2 weeks after the missed dose, dosing should be continued according to the patient’s original schedule.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt\"&gt;&lt;span style=\"font-size:11.0pt...</td>\n",
       "      <td>2d7b667e-921c-42ad-9bf8-c07eb6611782</td>\n",
       "      <td>margin-top:0in;margin-right:0in;margin-bottom:\\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>-                 If crizanlizumab is administered more than 2 weeks after the missed dose, dosing should be continued every 4 weeks thereafter.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>33cb5747-aeff-44e1-a295-f35fdc5df1bf</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;i&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Special populations&lt;/span&gt;&lt;/u&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>819e866d-22fe-4467-979b-2965a5b375fb</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Special populations</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"EN-GB\"&gt;Elderly&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>42987233-13d8-4992-85ad-cd9d26a9e675</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Elderly</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Crizanlizumab has not been studied in elderly patients. No dose adjustment is required as the pharmacokinetics of crizanlizumab i...</td>\n",
       "      <td>394675e6-38ca-43f4-8fa4-67bdbdb6ac0b</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Crizanlizumab has not been studied in elderly patients. No dose adjustment is required as the pharmacokinetics of crizanlizumab in adults are not affected by age.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4116a164-0fb0-41ec-8d4d-980eee909720</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"EN-GB\"&gt;Renal impairment&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>38d92515-beef-4580-a9e9-5f343ee60f2c</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Renal impairment</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Based on the population pharmacokinetic (PK) results, no dose adjustment is required in patients with mild or moderate renal impa...</td>\n",
       "      <td>f485a522-47e8-4737-9053-6c37b287e4da</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Based on the population pharmacokinetic (PK) results, no dose adjustment is required in patients with mild or moderate renal impairment (see section 5.2). Data from patients with severe renal impa...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2c251efd-4d57-451f-8e1b-27eaf97ac3ce</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"EN-GB\"&gt;Hepatic impairment&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>d7e68ae4-e1b1-4553-913c-12635b0a51cd</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Hepatic impairment</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monocl...</td>\n",
       "      <td>cf701288-a867-47a0-925f-00f0a42b647b</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monoclonal antibody and is cleared via catabolism (i.e. breakdown into pe...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9c89d2ad-1586-421e-b9ca-7af854ac5300</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;i&gt;&lt;span lang=\"EN-GB\"&gt;Paediatric population&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>dec049ff-97a9-40cd-87ba-11bdfb9bb5fd</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Paediatric population</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>&lt;p class=\"Standard\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The safety and efficacy of &lt;/span&gt;&lt;span lang=\"EN-GB\"&gt;crizanlizumab&lt;/span&gt;&lt;span lang=\"EN-GB\"&gt; in paediatric patients from 6 months ...</td>\n",
       "      <td>6c18b861-4477-41c9-9ae9-9694f443b12a</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['Standard']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The safety and efficacy of crizanlizumab in paediatric patients from 6 months to 16 years have not been established. No data are available.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>&lt;p class=\"Standard\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>16108ca5-3314-48c6-9284-f29117d61350</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['Standard']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td>&lt;p class=\"Standard\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;There is no relevant use of crizanlizumab in infants aged less than 6 months for the indication of prevention of recurrent vaso‑oc...</td>\n",
       "      <td>e007eba1-3f30-455b-8bff-f4e949cbfb82</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['Standard']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>There is no relevant use of crizanlizumab in infants aged less than 6 months for the indication of prevention of recurrent vaso‑occlusive crises.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>dd6230e6-42fb-460b-8a51-7d767a43daab</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Method of administration&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>1f6c3414-d7c9-4cf2-aa07-d6c5b237491d</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Method of administration</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3cb6dfbf-b485-4105-bf8a-beeb14b1cd5b</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Adakveo &lt;/span&gt;&lt;span lang=\"EN-GB\"&gt;should be diluted with sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% bef...</td>\n",
       "      <td>90f20e2b-efa4-4ccf-a405-6e5c9d8b7bc6</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Adakveo should be diluted with sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% before administration.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>07bf33aa-2f31-4389-9771-d6b30a85d0e0</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The diluted solution&lt;/span&gt;&lt;span lang=\"EN-GB\"&gt; must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by...</td>\n",
       "      <td>e1770234-5bf8-44d0-837b-67f40bdf1237</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The diluted solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by intravenous infusion over a period of 30 minutes. It must not be administered by intravenous...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>36d5342e-92b8-4a2e-a040-eca51b686035</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;For instructions on dilution of the medicinal product before administration, see section 6.6.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f9f00845-fcc7-4f6b-be21-e64dc59b00c7</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>For instructions on dilution of the medicinal product before administration, see section 6.6.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a86c67ac-ec53-4b50-a9df-b960de5da5c6</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;4.3     Contraindications&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>1ff14bbd-0749-4766-99c0-ede09b34a7b7</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.3     Contraindications</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>10c040f8-ca46-4b5e-8749-4d38a3844796</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3f6da897-613d-46df-b921-4ba67da45e6b</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Hypersensitivity to Chinese Hamster Ovary (CHO) cell products.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>32559cba-bfd6-4c6e-a7ef-d4aeb35ef35d</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Hypersensitivity to Chinese Hamster Ovary (CHO) cell products.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>58f5b929-00a4-4a69-9e0a-f5ced47c136a</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;4.4     Special warnings and precautions for use&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>f5687243-13a4-46e0-adc6-415bb3e4afd4</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.4     Special warnings and precautions for use</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>104</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>31ffed79-5a24-4559-a566-8522af32fb14</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>105</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Traceability&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>dffa9fac-aacc-4a81-914f-78b314975780</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Traceability</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\" style=\"font-size:10.0pt\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>caf234ef-3b41-4f82-8ed4-bc46d48e7c7e</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product ...</td>\n",
       "      <td>561c67cb-8f9c-4799-85cb-bd886d1151a2</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>108</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;&lt;span style=\"text-decoration:none\"&gt; &lt;/span&gt;&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>f63d4030-776d-44db-9cc6-74ff75f1134c</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>109</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Infusion‑related reactions&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>001e00a6-62d2-4a45-a2ad-fab1fe9559c3</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Infusion‑related reactions</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>110</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>cb4bce22-89a4-4d8d-8cdd-b672d0c88b93</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>111</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;In clinical studies, infusion‑related reactions (defined as occurring within 24 hours) were observed in 2 patients (1.8%) treated...</td>\n",
       "      <td>a1a23c97-c624-4234-ace8-a766721f187c</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>In clinical studies, infusion‑related reactions (defined as occurring within 24 hours) were observed in 2 patients (1.8%) treated with crizanlizumab 5 mg/kg. Patients should be monitored for signs...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>112</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f75c3d59-7a58-45ed-943d-7d8406b98311</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>113</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Laboratory test interference: automated platelet counts&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>7089a4c2-8b50-4922-b050-9cc7f27af572</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Laboratory test interference: automated platelet counts</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>114</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c55563ca-acc4-4553-8c1a-42b9387a9a78</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>115</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Interference with automated platelet counts (platelet clumping) has been observed in patients treated with crizanlizumab in clini...</td>\n",
       "      <td>defaa2b8-7117-4310-b347-449f40ad24ff</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Interference with automated platelet counts (platelet clumping) has been observed in patients treated with crizanlizumab in clinical studies, in particular when tubes containing EDTA (ethylenediam...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>116</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6642c7d0-5706-4a24-9854-a9970510af06</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>117</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;To mitigate the potential for laboratory test interference, it is recommended to run the test as soon as possible (within 4 hours...</td>\n",
       "      <td>5acabf9d-5eae-4f56-8d4c-78dcb8e857c1</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>To mitigate the potential for laboratory test interference, it is recommended to run the test as soon as possible (within 4 hours of blood collection) or use citrate tubes. When needed, platelet c...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>118</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6c8ceb67-f719-4af2-bc74-70e0294ebb59</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Excipients with known effect&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>eb658930-7124-408c-958f-2862d298f571</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Excipients with known effect</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c9fe79ab-335c-4e9e-9fba-13a4f3bfb5b1</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially “sodium‑free”.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>db4cd1d3-f264-43fd-88c0-8d7655c1b47b</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially “sodium‑free”.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>122</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8eb95d23-0d6c-4f26-8a07-679ab8ac0228</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;4.5     Interaction with other medicinal products and other f...</td>\n",
       "      <td>11a2fcce-48eb-45a9-8b97-53ecaaa73d86</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.5     Interaction with other medicinal products and other forms of interaction</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>124</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c3478606-ac0b-4307-a4bd-638df28244be</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>125</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Interactions between crizanlizumab and other medicinal products have not been investigated in dedicated studies.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b9ff00f8-ef92-4508-b24f-5dbf91989902</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Interactions between crizanlizumab and other medicinal products have not been investigated in dedicated studies.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>126</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>42abd336-a0eb-44ad-9d11-88de09f8b841</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>127</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Monoclonal antibodies are not metabolised by cytochrome P450 (CYP450) enzymes. Therefore, medicinal products that are substrates,...</td>\n",
       "      <td>4e8df8f7-0fac-45a5-91ad-05cf93b3622f</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Monoclonal antibodies are not metabolised by cytochrome P450 (CYP450) enzymes. Therefore, medicinal products that are substrates, inhibitors or inducers of CYP450 are not expected to affect the ph...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>128</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>799d9c0e-6134-4c36-9d6e-aa95272f563e</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>129</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;No effect on exposure of co‑administered medicinal products is expected based on the metabolic pathways of monoclonal antibodies....</td>\n",
       "      <td>ac9b1575-5662-4fc5-b691-e9ce93b95d88</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No effect on exposure of co‑administered medicinal products is expected based on the metabolic pathways of monoclonal antibodies.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>130</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>aecf1600-19a8-484c-a6c4-f87cfacd1373</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>131</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;4.6     &lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;Fertility, p&lt;/span&gt;&lt;...</td>\n",
       "      <td>a0f6cfdc-8042-4f0f-9d78-485a5c3c23b8</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.6     Fertility, pregnancy and lactation</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>132</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8212b032-0566-40af-b4bd-ce316a313d58</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>133</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Pregnancy&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>1aaf948b-addf-44cb-883c-1b19ea65cd4c</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Pregnancy</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>134</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e92c6478-4a6b-4f59-9269-f8fd7c1dad6b</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>135</th>\n",
       "      <td>&lt;p class=\"Standard\"&gt;&lt;span lang=\"EN-GB\"&gt;There is a limited amount of data from the use of Adakveo in pregnant women. Based on data from animal studies, crizanlizumab has the potential to cause foet...</td>\n",
       "      <td>efbd0b19-f586-45e6-8c31-559b7ddbe773</td>\n",
       "      <td>None</td>\n",
       "      <td>['Standard']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>There is a limited amount of data from the use of Adakveo in pregnant women. Based on data from animal studies, crizanlizumab has the potential to cause foetal losses when administered to a pregna...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>136</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c669fdac-8dcb-44e1-b338-f22434b3a115</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>137</th>\n",
       "      <td>&lt;p class=\"Standard\" style=\"line-height:normal\"&gt;To help determine the effects in pregnant women, healthcare professionals are encouraged to report all pregnancy cases and complications during pregn...</td>\n",
       "      <td>eef5d66e-627a-44e7-a02a-b8539854de99</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['Standard']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>To help determine the effects in pregnant women, healthcare professionals are encouraged to report all pregnancy cases and complications during pregnancy (from 105 days prior to the last menstrual...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>138</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0e85539e-1a02-4688-bb24-6e07397dd0de</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>139</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Breast‑feeding&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>b96d36fa-6b90-4e0c-85de-47cc7e44b538</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Breast‑feeding</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>140</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>925de404-1c57-4456-8a43-4c656c7165cb</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>141</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;It is unknown whether crizanlizumab is excreted in human milk after administration of Adakveo. There are no data on the effects o...</td>\n",
       "      <td>7498a234-2fbd-4001-be5a-f3355ad472be</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>It is unknown whether crizanlizumab is excreted in human milk after administration of Adakveo. There are no data on the effects of crizanlizumab on the breast‑fed newborn/infant or on milk product...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>142</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>7cfd4607-0430-4511-b02b-066e4be8655a</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>143</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Because many medicinal products, including antibodies, can be excreted in human milk, a risk to the newborn/infant cannot be excl...</td>\n",
       "      <td>e2fb457a-6e5d-47fc-8456-c8f97240e96d</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Because many medicinal products, including antibodies, can be excreted in human milk, a risk to the newborn/infant cannot be excluded.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>144</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ae93d231-f8ba-47e6-af36-252c58405866</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>145</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;A decision must be made whether to discontinue breast‑feeding or to discontinue Adakveo therapy, taking into account the benefit ...</td>\n",
       "      <td>92fc3a0b-228c-44b6-b207-f2a812d3484a</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>A decision must be made whether to discontinue breast‑feeding or to discontinue Adakveo therapy, taking into account the benefit of breast‑feeding for the child and the benefit of therapy for the ...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>146</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>02868645-f69f-48cf-bcbe-f15742e8f766</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>147</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Fertility&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>5d59e941-1027-4d1d-ab03-b568b6674fec</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Fertility</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>148</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ca98b45d-98d6-4057-8db7-9b5c039c5cfd</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>149</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;There are no data on the effect of Adakveo on human fertility. Available non‑clinical data do not suggest an effect on fertility ...</td>\n",
       "      <td>a1786285-9b65-4742-ac7e-5ff27e9a199c</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>There are no data on the effect of Adakveo on human fertility. Available non‑clinical data do not suggest an effect on fertility under crizanlizumab treatment (see section 5.3).</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>150</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt; &lt;/p&gt;</td>\n",
       "      <td>a50561fb-4abd-468d-8584-54156b98e12c</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>151</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;4.7     Effects on ability to drive and use machines&lt;/span&gt;&lt;/...</td>\n",
       "      <td>38069b69-f6df-4f61-9c3a-a75dde9a859d</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.7     Effects on ability to drive and use machines</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>152</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>871e05ef-31a7-489f-bac3-a2f55dfdde94</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>153</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Adakveo may have a minor influence on the ability to drive and use machines. Dizziness, fatigue and somnolence may occur followin...</td>\n",
       "      <td>c39dbd51-9328-45a4-bac6-df6d25a7b0bd</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Adakveo may have a minor influence on the ability to drive and use machines. Dizziness, fatigue and somnolence may occur following administration of crizanlizumab.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>154</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>357b6cf8-c2d7-42e1-b447-0e411a254e45</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>155</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;4.8     Undesirable effects&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>de8d55e0-de1c-4d68-a1de-9ba6e3db0097</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.8     Undesirable effects</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>156</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ebce1105-f4bf-482a-a497-471e1a6d1760</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>157</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Summary of the safety profile&lt;/span&gt;&lt;/u&gt;&lt;a name=\"_nth_Summary_of_the_safety_6118\"&gt;...</td>\n",
       "      <td>88452719-0800-4b2c-96cf-ea5b386f5dd9</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Summary of the safety profile</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>158</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d5b72049-2472-41d4-9e03-f6828c98ce07</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>159</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;The most frequently reported adverse drug reactions (≥10% of patients) in the Adakveo 5 mg/kg group were arth...</td>\n",
       "      <td>c2a9225d-e718-4537-8929-46091366c628</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The most frequently reported adverse drug reactions (≥10% of patients) in the Adakveo 5 mg/kg group were arthralgia, nausea, back pain, pyrexia and abdominal pain. Severe events were observed for ...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>160</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>00b99e59-7e80-422c-aef1-8e487d552f09</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Tabulated list of adverse reactions&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>9e1dffa5-d254-4870-a142-824011ff734a</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Tabulated list of adverse reactions</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>162</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9eb2ea87-aa58-40dc-9578-859810a3ca3a</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>163</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;Table 1 lists adverse reactions based on pooled data from two studies: the pivotal study, SUSTAIN, and a sing...</td>\n",
       "      <td>4d02de8f-c15b-43bc-af6d-ffe87bdf1f88</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Table 1 lists adverse reactions based on pooled data from two studies: the pivotal study, SUSTAIN, and a single‑arm, open‑label pharmacokinetics/pharmacodynamics and safety study. Use of crizanliz...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>164</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3ccb923f-936e-4539-858f-f4e4013c9548</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>165</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;Within each system organ class, the adverse reactions are ranked by frequency, with the most frequent reactio...</td>\n",
       "      <td>dd4a838f-4247-40fc-b3ad-7a1ea745661a</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Within each system organ class, the adverse reactions are ranked by frequency, with the most frequent reactions first. Within each frequency grouping, adverse reactions are presented in order of d...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>166</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>987733b6-745e-47c1-ab4a-d39014ea48b4</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>167</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;a name=\"_Toc272145403\"&gt;&lt;/a&gt;&lt;a name=\"_Toc272145564\"&gt;&lt;/a&gt;&lt;a name=\"_Toc266768477\"&gt;&lt;/a&gt;&lt;a name=\"_Toc2609036...</td>\n",
       "      <td>12293b6d-27fc-4f51-a392-aa1d0ab58450</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Table 1       Adverse reactions in clinical studies</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>168</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>adae8cec-c15f-466c-87a5-d9edcbc7decd</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>169</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:459.0pt;border-collapse:collapse;border:none\" width=\"612\"&gt; &lt;tr style=\"page-break-inside:avoid\"&gt; &lt;td style=\"wid...</td>\n",
       "      <td>68495d94-1d08-4794-a87d-6fdb37a548f5</td>\n",
       "      <td>width:459.0pt;border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>System organ class   Frequency   Adverse reaction     Respiratory, thoracic and   mediastinal disorders   Common   Oropharyngeal pain     Gastrointestinal disorders   Very common   Nausea, abdo...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>170</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"&gt;&lt;span style=\"font-size:11.0pt\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5500d36a-5762-434c-8892-bf87d0e7f820</td>\n",
       "      <td>margin-top:0in;text-align:left</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Description of selected adverse reactions&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>0636c563-9390-400f-9ab3-5889e217a728</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Description of selected adverse reactions</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>172</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after: avoid\"&gt;&lt;span style=\"font-size:11.0pt\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f1b0b323-4845-48bd-9022-8b3498e12b3c</td>\n",
       "      <td>margin-top:0in;text-align:left;page-break-after:\\navoid</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>173</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after: avoid\"&gt;&lt;i&gt;&lt;u&gt;&lt;span style=\"font-size:11.0pt\"&gt;Immunogenicity&lt;/span&gt;&lt;/u&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>3598871e-6274-45f3-a079-92e6a6cc0f4b</td>\n",
       "      <td>margin-top:0in;text-align:left;page-break-after:\\navoid</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Immunogenicity</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>174</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"&gt;&lt;span style=\"font-size:11.0pt\"&gt;In clinical studies, treatment‑induced anti‑crizanlizumab antibodies were transiently detected in...</td>\n",
       "      <td>d1523c7d-682b-40c5-a31d-0ed3c856ad76</td>\n",
       "      <td>margin-top:0in;text-align:left</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>In clinical studies, treatment‑induced anti‑crizanlizumab antibodies were transiently detected in 1 patient (0.9%) among the 111 patients who received Adakveo 5 mg/kg.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>175</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"&gt;&lt;span style=\"font-size:11.0pt\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d3b08430-cd24-4b17-aeb5-65cd8c0fa6da</td>\n",
       "      <td>margin-top:0in;text-align:left</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>176</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"&gt;&lt;span style=\"font-size:11.0pt\"&gt;There was no evidence of altered pharmacokinetics or of an altered safety profile with anti‑criza...</td>\n",
       "      <td>06a145f3-a3b6-468f-9569-9c66e32cdd40</td>\n",
       "      <td>margin-top:0in;text-align:left</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>There was no evidence of altered pharmacokinetics or of an altered safety profile with anti‑crizanlizumab antibody development.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>177</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"&gt;&lt;span style=\"font-size:11.0pt\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>da312712-3361-43b0-8cb8-ebe00c656f19</td>\n",
       "      <td>margin-top:0in;text-align:left</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>178</th>\n",
       "      <td>&lt;p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Paediatric population&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>b24ce283-43d1-4609-a14a-ce76aefeb6ea</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['Standard']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Paediatric population</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>179</th>\n",
       "      <td>&lt;p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>837beffa-4df5-46b3-9e30-c2df0b2c0859</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['Standard']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>180</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"&gt;&lt;span style=\"font-size:11.0pt\"&gt;Frequency, type and severity of adverse reactions in patients aged 16 and 17 years are expected t...</td>\n",
       "      <td>440ff73a-8907-4923-a5dc-f3b4ccebeec9</td>\n",
       "      <td>margin-top:0in;text-align:left</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Frequency, type and severity of adverse reactions in patients aged 16 and 17 years are expected to be the same as in adults. The safety of crizanlizumab was evaluated in 3 patients aged &lt;18 years.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>181</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"&gt;&lt;span style=\"font-size:11.0pt\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>58b0b3ed-6191-4566-9d5d-bffd88dd7d08</td>\n",
       "      <td>margin-top:0in;text-align:left</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>182</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Reporting of suspected adverse reactions&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>9a48cf61-c759-4667-ae82-3fe92599ba09</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Reporting of suspected adverse reactions</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>183</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>37538e84-41d5-4dd8-a4f1-8f9d7515630d</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows co...</td>\n",
       "      <td>bdd4a612-1b71-48af-bb4d-b6992a0d727d</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare pro...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>185</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2d6e4e03-57ab-41aa-8bb6-50da47e524a1</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>186</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;4.9     Overdose&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>d64d220d-681c-41cc-be35-d2388b0fe2af</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>4.9     Overdose</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>187</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>81f7f5c9-3aa9-4ca9-a6e4-18ff45f702a1</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>188</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"&gt;&lt;span lang=\"EN-GB\"&gt;No cases of overdose have been reported in clinical studies.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>be23a4ff-636e-4419-a2b4-53c8da85fba7</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>No cases of overdose have been reported in clinical studies.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>189</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d95c745f-4632-4816-93a3-bf5315fb6186</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>190</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;General supportive measures and symptomatic treatment should be initiated in cases of suspected overdose.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6c217e0b-6104-473f-89d1-138ec1d858ea</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>General supportive measures and symptomatic treatment should be initiated in cases of suspected overdose.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>191</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9021bd02-b10e-4f7a-8d6f-8607a943d54d</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>192</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>05b4dc55-ce07-49e7-98d0-d74847496bdc</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>193</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;5.       PHARMACOLOGICAL PROPERTIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>764acee4-ad8f-4679-bfd8-2d754f01ab88</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>5.       PHARMACOLOGICAL PROPERTIES</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>194</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2e81c580-64f0-479b-baac-f7989c2f399c</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>195</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;5.1     Pharmacodynamic properties&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>a6d0a699-c8cf-4a9f-9667-b8f6e4efe584</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>5.1     Pharmacodynamic properties</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>196</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b2231afc-7779-4625-8ac4-2819167847b6</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>197</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;Pharmacotherapeutic group: Other haematological agents, ATC code: B06AX01&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>38b60d54-b880-4fc5-a4f4-89ce63aeb5ce</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Pharmacotherapeutic group: Other haematological agents, ATC code: B06AX01</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>198</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>15ae06a0-6e38-48b6-9b98-796008d0a290</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>199</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Mechanism of action&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>fc5ac450-265a-4a49-92fd-94f18063c6e8</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Mechanism of action</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>200</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1dd00aad-f767-4d29-ab47-a0ece231bb21</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>201</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;Crizanlizumab is a selective IgG2 kappa humanised monoclonal antibody (mAb) that binds to P‑selectin with hig...</td>\n",
       "      <td>e7c2423f-a48a-414c-9bbd-4c511efdb528</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Crizanlizumab is a selective IgG2 kappa humanised monoclonal antibody (mAb) that binds to P‑selectin with high affinity and blocks the interaction with its ligands, including P‑selectin glycoprote...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>202</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>95bd2fe7-3442-4e6d-b591-1f836f48ae21</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>203</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;Binding P‑selectin on the surface of the activated endothelium and platelets has been shown to effectively bl...</td>\n",
       "      <td>71575f83-7664-4637-beb1-6a5b97c16cfe</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Binding P‑selectin on the surface of the activated endothelium and platelets has been shown to effectively block interactions between endothelial cells, platelets, red blood cells and leukocytes, ...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>204</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0d50548f-2482-4f8b-abd3-321304018d5f</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>205</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Pharmacodynamic effects&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>ab71b0bc-5a25-48a4-a89f-1f17e668aa1a</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Pharmacodynamic effects</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>206</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4dd078ae-806b-4e3a-a55b-2b2c2bc1df57</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>207</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Throughout clinical studies, treatment with crizanlizumab 5 mg/kg resulted in dose‑dependent, immediate and sustained P‑selectin ...</td>\n",
       "      <td>f3912285-4b05-4670-a041-77eca738249c</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Throughout clinical studies, treatment with crizanlizumab 5 mg/kg resulted in dose‑dependent, immediate and sustained P‑selectin inhibition (as measured ex vivo) in patients with sickle cell disease.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>208</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>22741a98-5799-4d6d-92ac-9aa31e592b25</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>209</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Clinical efficacy and safety&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>472a0d46-f38f-4b06-9377-8b14a1ca58ab</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Clinical efficacy and safety</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>210</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt; &lt;/p&gt;</td>\n",
       "      <td>9abf657f-4184-406f-9882-ccdafe7d62df</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>211</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;The efficacy of crizanlizumab, with or without HU/HC, was evaluated in the pivotal study SUSTAIN, a 52‑week, ...</td>\n",
       "      <td>06f14b6a-445d-4929-b3f9-42c7c98bd689</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The efficacy of crizanlizumab, with or without HU/HC, was evaluated in the pivotal study SUSTAIN, a 52‑week, randomised, placebo‑controlled, double‑blind, multicentre clinical study in sickle cell...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>212</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1cfceb45-f752-4744-add7-e75fc2b30f0d</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>213</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;In this study, VOCs were defined as those leading to a healthcare visit, which captured all acute episodes of...</td>\n",
       "      <td>f2a0e2c1-e6bd-40b3-b1f9-a3b59362d87d</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>In this study, VOCs were defined as those leading to a healthcare visit, which captured all acute episodes of pain with no other cause than a vaso‑occlusive event that required a healthcare visit ...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>214</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>746abb46-4321-4390-a3d1-57628c87ee75</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>215</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;A total of 198 sickle cell disease patients aged 16 to 63 years (inclusive; mean age 30.1±10.3 years), with a...</td>\n",
       "      <td>9df75617-c6d9-4284-99eb-9c6d286028ea</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>A total of 198 sickle cell disease patients aged 16 to 63 years (inclusive; mean age 30.1±10.3 years), with any sickle cell disease genotype (including HbSS [71.2%], HbSC [16.2%], HbSbeta0‑thalass...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>216</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8a5bfeed-92a7-4157-aa23-5e8d782ee2f3</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>217</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;Treatment with Adakveo 5 mg/kg resulted in a 45.3% lower median annual rate of VOCs compared to placebo (Hodg...</td>\n",
       "      <td>26b32385-ff0c-468c-8156-48e4ea2e5632</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Treatment with Adakveo 5 mg/kg resulted in a 45.3% lower median annual rate of VOCs compared to placebo (Hodges‑Lehmann, median absolute difference of ‑1.01 compared with placebo, 95% CI [‑2.00, 0...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ddc462b4-8779-4b40-b2cd-13c11a5c35ea</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>219</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;Main efficacy outcomes of the pivotal SUSTAIN study are summarised in Tables 2 and 3.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f00331f9-91ee-4ffc-9f5b-c7b8d020d857</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Main efficacy outcomes of the pivotal SUSTAIN study are summarised in Tables 2 and 3.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>220</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>cc21ce0f-b181-4775-ad96-2bb33aad2435</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>221</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;a name=\"_Toc499550968\"&gt;&lt;/a&gt;&lt;a name=\"_Toc517716326\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;Table &lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;b&gt;&lt;span ...</td>\n",
       "      <td>c9fea0dd-a255-4ab8-957b-4a237116ff85</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Table 2       Results from SUSTAIN clinical study in sickle cell disease</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>222</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5ff0994f-3178-439a-a684-c5b18e0ff720</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>223</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:98.84%;border-collapse:collapse;border:none\" width=\"98%\"&gt; &lt;tr style=\"page-break-inside:avoid;height:1.0pt\"&gt; &lt;t...</td>\n",
       "      <td>f6602db2-bba7-4d09-be01-924009293f42</td>\n",
       "      <td>width:98.84%;border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Event   Adakveo 5 mg/kg (N=67) (standard median)   Placebo (N=65) (standard median)   Change vs placebo   Hodges‑Lehmann median   difference (95% CI)   p-value (Wilcoxon rank sum)     Primary e...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>224</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6d24b1e8-7bcc-499b-9560-8630cab90afd</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>225</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"EN-GB\"&gt;The clinical effect demonstrated in the primary efficacy analysis was supported by multiple supplementary analyses including a negative binomial regression ...</td>\n",
       "      <td>55a081a7-69be-4ffb-aade-5eaf29f54a50</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The clinical effect demonstrated in the primary efficacy analysis was supported by multiple supplementary analyses including a negative binomial regression on investigator assessments with a conse...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>226</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt; &lt;/p&gt;</td>\n",
       "      <td>90069808-d21a-40db-a5cb-79185d63ea1e</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>227</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;In the Adakveo 5 mg/kg group, clinically significant reductions in the annual rate of VOCs were observed acro...</td>\n",
       "      <td>06133542-b88f-49aa-8c7f-5dbcc0f276bb</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>In the Adakveo 5 mg/kg group, clinically significant reductions in the annual rate of VOCs were observed across important subgroups (HU/HC use, 2‑4 or 5‑10 VOCs in the previous 12 months, and HbSS...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>228</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>40863246-ddd2-434e-9fcc-3f487cc6f3c0</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>229</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;Table 3       Annual rate of VOCs in patients ‑ subgroup analyses&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>0f55922a-bcc3-477f-8e53-b7b1c53ba65a</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Table 3       Annual rate of VOCs in patients ‑ subgroup analyses</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>230</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ba08dd82-6928-449e-b2bf-28bfc45990b6</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>231</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"612\"&gt; &lt;tr style=\"page-break-inside:avoid\"&gt; &lt;td style=\"width:90.45pt;bor...</td>\n",
       "      <td>306055ba-c099-4738-bafa-dedc95f5c4e5</td>\n",
       "      <td>border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Subgroup        Adakveo 5 mg/kg (N=67) (standard median)   Placebo (N=65) (standard median)   Change vs placebo   Hodges‑Lehmann median   difference (95% CI)     HU/HC use   Yes   n=42 2.43   n...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>232</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c2b709f0-86b2-4fa9-98d3-6988b154be09</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>233</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;A greater than two‑fold increase in the proportion of patients with no VOC and who completed the study was ob...</td>\n",
       "      <td>da5c88f0-dcea-4689-938e-3c1b93d7a754</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>A greater than two‑fold increase in the proportion of patients with no VOC and who completed the study was observed in the Adakveo 5 mg/kg group compared to placebo (22% vs 8%; odds ratio [95% CI]...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>234</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5208b575-d8b9-4b18-981d-40fcf95b2b71</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>235</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt;Treatment with Adakveo 5 mg/kg was also associated with a three‑fold longer Kaplan‑Meier estimated median tim...</td>\n",
       "      <td>976c04c1-4a00-4a08-af6a-eb33f16cc272</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Treatment with Adakveo 5 mg/kg was also associated with a three‑fold longer Kaplan‑Meier estimated median time to first VOC compared with placebo (4.07 vs 1.38 months; HR=0.495, 95% CI: 0.331, 0.7...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>236</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>94b4115a-655a-4aea-9954-cf0f835aecee</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>237</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;Figure 1      Kaplan‑Meier curve of time to first VOC&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>ea96e98a-b631-443f-a2a7-37382a04f305</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Figure 1      Kaplan‑Meier curve of time to first VOC</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>238</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8d4fe1ee-a863-42e2-bef0-564ff21f6c0b</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>239</th>\n",
       "      <td>&lt;p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"&gt;&lt;span style=\"position:absolute;z-index:251748352;left:0px;margin-left:61px; margin-top:211px;width:13px;height:9px\"&gt;&lt;img alt=\"0\" heigh...</td>\n",
       "      <td>1f28a2cd-e389-410e-9522-6477de26e0cb</td>\n",
       "      <td>margin-top:0in;page-break-after:avoid</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>240</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt; &lt;table align=\"left\" cellpadding=\"0\" cellspacing=\"0\"&gt; &lt;tr&gt; &lt;td height=\"1\" width=\"3\"&gt;&lt;/td&gt; &lt;td width=\"36\"&gt;&lt;/td&gt; &lt;td width=\"33\"...</td>\n",
       "      <td>e84ed10a-b1be-47cf-8814-775d712347f9</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>241</th>\n",
       "      <td>&lt;p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"&gt;&lt;span style=\"font-size:11.0pt\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8c14f577-cb46-494a-9162-054506680e7b</td>\n",
       "      <td>margin-top:0in;page-break-after:avoid</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>242</th>\n",
       "      <td>&lt;p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"&gt;&lt;span style=\"font-size:11.0pt\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0f6cf8d7-9223-45d8-87c5-ff279c3c38b5</td>\n",
       "      <td>margin-top:0in;page-break-after:avoid</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>243</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8ff37dc4-c898-4d52-a5aa-697fb9731068</td>\n",
       "      <td>line-height:normal;page-break-after:avoid;text-autospace:\\nnone</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>244</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>13f05400-d25d-441b-8c2e-1bbc1ae3cc2b</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>245</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e85c0863-dc1a-42dc-ab9a-7b5fac36835e</td>\n",
       "      <td>line-height:normal;text-autospace:none</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>246</th>\n",
       "      <td>&lt;br clear=\"ALL\"/&gt;</td>\n",
       "      <td>fd84f968-a97f-4259-b766-a742451e77df</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>247</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;a name=\"_hd6_Table_2_1_Patients_wit18544\"&gt;&lt;/a&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Paediatric population&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>3f5b8c47-c06e-451b-ad88-9ec7eda2c145</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Paediatric population</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>248</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>65c2aa8e-1f0d-4f53-a9a6-31e70f0e528b</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>249</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The efficacy of crizanlizumab in patients aged 16 and 17 years is expected to be the same as in adults. Three patients (2.7%) age...</td>\n",
       "      <td>c778d352-157f-4fdd-a650-9794035bb188</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The efficacy of crizanlizumab in patients aged 16 and 17 years is expected to be the same as in adults. Three patients (2.7%) aged less than 18 years were treated with crizanlizumab 5 mg/kg in cli...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>250</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>93e46389-181f-4b47-ac7a-0941c0257958</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>251</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The European Medicines Agency has deferred the obligation to submit the results of studies with Adakveo in one or more subsets of...</td>\n",
       "      <td>1d9f638b-9522-45d4-aade-2ea3ee357fce</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The European Medicines Agency has deferred the obligation to submit the results of studies with Adakveo in one or more subsets of the paediatric population in the treatment of sickle cell disease ...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>252</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2b0ed3b1-e815-4631-bbf0-acb3af13b8cc</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>253</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Conditional approval&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>85f8de6d-913b-4eb5-acc3-e28469213af1</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Conditional approval</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>254</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d9ff4f36-ed04-4f6c-a5b5-0c77a32c3473</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>255</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;This medicinal product has been authorised under a so‑called “conditional approval” scheme. This means that further evidence on t...</td>\n",
       "      <td>655e28b7-c7d4-4a3e-85e1-645ab4a9998f</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>This medicinal product has been authorised under a so‑called “conditional approval” scheme. This means that further evidence on this medicinal product is awaited.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>256</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>eee72aad-0d37-4d8b-9cdc-1ebe65c0efc2</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>257</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The European Medicines Agency will review new information on this medicinal product at least every year and this SmPC will be upd...</td>\n",
       "      <td>3aeb1c53-df5f-486d-8b90-194a72885c98</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The European Medicines Agency will review new information on this medicinal product at least every year and this SmPC will be updated as necessary.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>258</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt; &lt;/p&gt;</td>\n",
       "      <td>bc77fded-79e5-41c5-afe0-7d9019610912</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>259</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;5.2     Pharmacokinetic properties&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>ba64cecf-46c2-47ea-af81-b647e28a94ce</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>5.2     Pharmacokinetic properties</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>260</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8b252518-6a39-496d-a2a8-1f4de11f314b</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>261</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Absorption&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>00533119-b294-4d3b-addb-f6fd4c3e35f0</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Absorption</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>262</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f0af07b2-a8f5-48df-9990-5f017322f332</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>263</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The median time to reach maximum serum concentration of crizanlizumab (T&lt;sub&gt;max&lt;/sub&gt;) was 1.92 hours at steady state following ...</td>\n",
       "      <td>532a95ac-aa2d-482f-b98e-8087c9e1aae4</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The median time to reach maximum serum concentration of crizanlizumab (Tmax) was 1.92 hours at steady state following intravenous administration of 5 mg/kg over a period of 30 minutes in sickle ce...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>264</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>21135353-0ad7-4d0e-9182-c1205f92b29b</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>265</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Distribution&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>1c6e5ea8-2fc1-4281-bc2f-96d19363107b</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Distribution</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>266</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>73ad910b-c420-4838-ae7f-51f7dfa34806</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>267</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Crizanlizumab distribution is typical of endogenous human antibodies within the vascular and extracellular spaces. The volume of ...</td>\n",
       "      <td>ca25d772-76ad-4b7f-b51f-921b95efd10a</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Crizanlizumab distribution is typical of endogenous human antibodies within the vascular and extracellular spaces. The volume of distribution (Vz) was 4.26 litres after a single 5 mg/kg intravenou...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>268</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1bf44745-663f-43a1-9114-5512396fecf5</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>269</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Biotransformation&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>3480d3aa-b931-4d9d-8a25-ff2950f70e47</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Biotransformation</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>270</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>da63ad24-98cc-4f6c-a9ac-7d4eaf9df730</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>271</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Antibodies are primarily eliminated via proteolysis by lysosomal enzymes in the liver to small peptides and amino acids.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>994c284c-fd5a-4bca-856c-a06ca2d991e3</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Antibodies are primarily eliminated via proteolysis by lysosomal enzymes in the liver to small peptides and amino acids.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>272</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>25c08c2a-97cd-49b7-a3e6-ed7e3b2a9398</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>273</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Elimination&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>317d6b14-9c20-4bea-bf70-1dd1bfd14ee0</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Elimination</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>274</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9644480b-9013-49d2-a9e9-2795592596a9</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>275</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;In healthy volunteers, the mean terminal elimination half‑life (T&lt;sub&gt;½&lt;/sub&gt;) was 10.6 days and the mean clearance was 11.7 ml/h...</td>\n",
       "      <td>21be6999-4166-4ea3-bc2a-46e7e9c1f35f</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>In healthy volunteers, the mean terminal elimination half‑life (T½) was 10.6 days and the mean clearance was 11.7 ml/h at crizanlizumab dose level 5 mg/kg. In patients with sickle cell disease, th...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>276</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>fa7ee2a9-8612-4798-a0b2-e8c66dbfa3c7</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>277</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Linearity/non‑linearity&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>eb9693fa-6305-4d68-9a84-84c27a959a65</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Linearity/non‑linearity</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>278</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e3091ce6-30ef-4898-95d8-5ac8dc9582e9</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>279</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The exposure to crizanlizumab (mean C&lt;sub&gt;max&lt;/sub&gt;, AUC&lt;sub&gt;last&lt;/sub&gt;, or AUC&lt;sub&gt;inf&lt;/sub&gt;) increased in non‑linear manner ove...</td>\n",
       "      <td>0f8c5072-5ed3-4aec-8749-5ac476a7e75f</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The exposure to crizanlizumab (mean Cmax, AUClast, or AUCinf) increased in non‑linear manner over the dose range of 0.2 to 8 mg/kg in healthy volunteers.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>280</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>09a8d525-4272-4243-a3b6-b61c438b48b5</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>281</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Special populations&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>07676513-d6ad-4403-b7f4-172327384a02</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Special populations</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>282</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2377eb8c-a022-4bd6-9344-958346ad2a64</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>283</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;i&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Renal impairment&lt;/span&gt;&lt;/u&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>de6eb665-d2f6-423f-bbb4-6cf89fe19fc8</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Renal impairment</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>284</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;In a population PK analysis in patients with eGFR ranging from 35 to 202 ml/min/1.73 m&lt;sup&gt;2&lt;/sup&gt;, no clinically important diffe...</td>\n",
       "      <td>55fdf68a-b0d0-41fd-94a5-c7462d8a9ca4</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>In a population PK analysis in patients with eGFR ranging from 35 to 202 ml/min/1.73 m2, no clinically important differences in the pharmacokinetics of crizanlizumab were found between patients wi...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>285</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ad169960-f812-480f-80f4-6c2f1384a117</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>286</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;i&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Hepatic impairment&lt;/span&gt;&lt;/u&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>1481fd7d-eec3-4db9-a8c3-2a7757e2e767</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Hepatic impairment</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>287</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monocl...</td>\n",
       "      <td>734175d6-c4a2-4df4-ad4f-c1289c180bf2</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monoclonal antibody and is cleared via catabolism (i.e. breakdown into pe...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>288</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>83a0b34c-87a8-4941-8bd0-9a8eacba26c2</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>289</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;i&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Paediatric &lt;a name=\"_nth_Pediatric_patients__be14752\"&gt;&lt;/a&gt;population&lt;/span&gt;&lt;/u&gt;&lt;/i&gt;&lt;/p&gt;</td>\n",
       "      <td>1db6ba87-5368-4522-a96c-6bb36868e756</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L4</td>\n",
       "      <td>Paediatric population</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>290</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Pharmacokinetics in paediatric patients below the age of 16 years have not been investigated.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>eab04aa6-e6d1-488b-9b0a-cdf2d9fbe1d1</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Pharmacokinetics in paediatric patients below the age of 16 years have not been investigated.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>291</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>06d7dc74-1123-46c5-8e58-5baba403d620</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>292</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;5.3     Preclinical safety data&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>4679ecf1-e9ac-4cc6-9347-882d2b80caaa</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>5.3     Preclinical safety data</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>293</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>5612455a-6bf5-4e73-875f-5525fee58655</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>294</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;N&lt;/span&gt;&lt;span lang=\"EN-GB\"&gt;on‑clinical data revealed no special hazard for humans based on conventional studies of safety pharmac...</td>\n",
       "      <td>9dfe8e22-726c-48dd-a73e-0ffca677a83e</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Non‑clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, tissue cross‑reactivity and repeated dose toxicity.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>295</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c95b5e22-fa87-49b9-933e-1076b8325fc8</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>296</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;In the 26‑week repeated dose toxicity study, administration of crizanlizumab in cynomolgus monkeys at dose levels up to 50 mg/kg/...</td>\n",
       "      <td>249ba44f-0806-4154-a058-151cfd72086b</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>In the 26‑week repeated dose toxicity study, administration of crizanlizumab in cynomolgus monkeys at dose levels up to 50 mg/kg/dose once every 4 weeks (at least 13.5 times the human clinical exp...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>297</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>aa214270-ebc8-4f85-a58a-04986ad789e3</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>298</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;Pharmacological effects of crizanlizumab on haemodynamic and electrocardiographic parameters in the cynomolgus monkey were evaluated in the 26‑week ...</td>\n",
       "      <td>8fb16356-f5ab-42a4-aaac-9444a3167a9a</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Pharmacological effects of crizanlizumab on haemodynamic and electrocardiographic parameters in the cynomolgus monkey were evaluated in the 26‑week repeated dose toxicology study. Respiratory rate...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>299</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt; &lt;/p&gt;</td>\n",
       "      <td>46f8c14d-38a5-4dcb-9ddd-19fa5a0cfc57</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>300</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Formal carcinogenicity, genotoxicity and juvenile toxicity studies have not been conducted with crizanlizumab.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4a51b9ef-c655-47df-8040-1454020aab38</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Formal carcinogenicity, genotoxicity and juvenile toxicity studies have not been conducted with crizanlizumab.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>301</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9ccca12b-0a06-4812-95cc-48dc425408e2</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>302</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;In a 26‑week repeated dose toxicity study, cynomolgus monkeys were administered crizanlizumab once every 4 weeks at doses up to 5...</td>\n",
       "      <td>2c6442f0-201f-4775-8452-1c36a089ff2a</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>In a 26‑week repeated dose toxicity study, cynomolgus monkeys were administered crizanlizumab once every 4 weeks at doses up to 50 mg/kg (at least 13.5 times the human clinical exposure based on A...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>303</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>de592949-aa05-45df-92ce-b8517448318c</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>304</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;In an enhanced pre‑ and postnatal development study in cynomolgus monkeys, pregnant animals received intravenous crizanlizumab on...</td>\n",
       "      <td>1bd38c10-06fd-4517-b905-bfa5009eaa54</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>In an enhanced pre‑ and postnatal development study in cynomolgus monkeys, pregnant animals received intravenous crizanlizumab once every two weeks during the period of organogenesis, at doses of ...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>305</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>bfd1df42-3b6b-4eb7-9ac9-ed2f0a05e768</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>306</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Measurable crizanlizumab serum concentrations were observed in the infant monkeys at postnatal day 28, confirming that crizanlizu...</td>\n",
       "      <td>3fdc8ea7-8326-4261-ad5c-e716a34fdfa9</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Measurable crizanlizumab serum concentrations were observed in the infant monkeys at postnatal day 28, confirming that crizanlizumab, like other IgG antibodies, crosses the placental barrier.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>307</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3d455957-9727-4c20-9bbc-88e5da60aa85</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>308</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>643d24d6-80da-4ab4-9624-0221c8465acb</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>309</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;6.       PHARMACEUTICAL PARTICULARS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>1ea14223-5db3-4ba2-b1ec-4f17d58dcd5f</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>6.       PHARMACEUTICAL PARTICULARS</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>310</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>966675b9-690b-41d9-98ed-60967ffd9f3c</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>311</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;6.1     List of excipients&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>ed327a73-30e6-4081-b6de-0fe728ce8969</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.1     List of excipients</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>312</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>252756a3-2ffd-4fa1-93bf-62767e7a8c66</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>313</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;Sucrose&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e42486b8-431d-489e-92e1-26e80f62c326</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Sucrose</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>314</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;Sodium citrate (E331)&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3382e5f0-a081-4aa4-97d5-536842c7328e</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Sodium citrate (E331)</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>315</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;Citric acid (E330)&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d4798f99-bb2d-4cc7-ba65-ace4e92c99d6</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Citric acid (E330)</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>316</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;Polysorbate 80 (E433)&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>95540f6b-617d-48b0-a6bc-5f309ea429aa</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Polysorbate 80 (E433)</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>317</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Water for injections&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8533427e-eca8-4d27-add7-ae84359e2b3d</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Water for injections</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>318</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0695764c-3f57-4cc5-bdc9-032776603195</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>319</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;6.2     Incompatibilities&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>93b62773-0f41-45e2-94ac-0e36099c20e6</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.2     Incompatibilities</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>320</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a2269772-413a-4a40-81f3-bff5dd940e7c</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>321</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;This medicinal product&lt;/span&gt;&lt;span lang=\"EN-GB\"&gt; must not be mixed with other medicinal products except those mentioned in sectio...</td>\n",
       "      <td>c1dd7e4b-2172-4e76-b329-beee93d2cb22</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>322</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>823e1348-5e7b-4ece-8640-affd6e5ed5be</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>323</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;6.3     Shelf life&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>8d321b8f-d147-49dc-b3f2-14c13473e828</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.3     Shelf life</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>324</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>37d476c0-f943-407b-b694-73edbb744cf1</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>325</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Unopened vial&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>00e069bf-ec29-46b0-9da9-069be813ec77</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Unopened vial</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>326</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8a8b2484-d59f-49da-88e1-b8fb42574e6d</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>327</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"&gt;&lt;span lang=\"EN-GB\"&gt;18 months&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>15a7da87-7151-407a-aff9-f16540d65487</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>18 months</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>328</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ccd15a79-4c3e-4920-a3e2-495f132624ad</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>329</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Diluted solution&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>fd426195-3dc5-4f10-9564-c7c5e3e9291c</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Diluted solution</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>330</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e81f948d-5467-4471-a174-5542d7d5d673</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>331</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Chemical and physical in‑use stability, from the start of preparation of the diluted solution for infusion until end of infusion,...</td>\n",
       "      <td>6289cac5-3b81-4e28-9ad6-409df65bb1d5</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Chemical and physical in‑use stability, from the start of preparation of the diluted solution for infusion until end of infusion, has been demonstrated for up to 8 hours at room temperature (up to...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>332</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9e63db32-7ab4-433c-95ed-27da07885ad9</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>333</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"&gt;&lt;span style=\"font-size:11.0pt\"&gt;From a microbiological point of view, the diluted solution for infusion should be used immediatel...</td>\n",
       "      <td>be86aea2-b55d-411b-b239-579d9ab70e79</td>\n",
       "      <td>margin-top:0in;text-align:left</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>From a microbiological point of view, the diluted solution for infusion should be used immediately. If not used immediately, in‑use storage times and conditions prior to use are the responsibility...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>334</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt; &lt;/p&gt;</td>\n",
       "      <td>30dfdf90-c7c6-46dd-81ed-34040c037707</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>335</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;6.4     Special precautions for storage&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>0916fc58-f815-4be1-8e43-15d87212f2ff</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.4     Special precautions for storage</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>336</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c05a9aae-2370-4c08-8a36-30a372a87373</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>337</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Store in a refrigerator (2°C – 8°C).&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0ecc299e-06ef-4489-8a36-f2034f2042ab</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Store in a refrigerator (2°C – 8°C).</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>338</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Do not freeze.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a112a3f4-75ce-4161-8661-ea3d6b64a170</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Do not freeze.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>339</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Keep the vial in the outer carton in order to protect from light.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>699fc118-68a0-4d85-91f8-68906d13d935</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Keep the vial in the outer carton in order to protect from light.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>340</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1c6011d9-95b8-4289-88e3-be255803aa85</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>341</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;For storage conditions after dilution of the medicinal product, see section 6.3.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9d751841-7244-4356-92cd-d0d33db564a8</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>For storage conditions after dilution of the medicinal product, see section 6.3.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>342</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0566d8ce-a929-4cd0-8ac2-6d814231b189</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>343</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;6.5     Nature and contents of container&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>d57803b0-6a88-44a7-88de-d89dae95ab44</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.5     Nature and contents of container</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>344</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>558e72cd-ad45-48cc-bf26-ed0c0f1fa60a</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>345</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;10 ml concentrate for solution for infusion in a type I glass vial with a coated chlorobutyl rubber stopper sealed with an alumin...</td>\n",
       "      <td>13eb2179-b33a-48a3-81da-f9ac455031fe</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>10 ml concentrate for solution for infusion in a type I glass vial with a coated chlorobutyl rubber stopper sealed with an aluminium cap with a plastic flip‑off disk containing 100 mg crizanlizumab.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>346</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f67001d0-3ed0-46c6-a74b-ceb81076f6ca</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>347</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Pack of 1 vial.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2b7c8f38-c832-4a4e-a4c8-03d1672b36c5</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Pack of 1 vial.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>348</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>78af6177-82e3-47dc-bdee-a120221922fd</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>349</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;a name=\"OLE_LINK1\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;6.6     Special precautions for disposal ...</td>\n",
       "      <td>0562f34b-62da-4f2c-b64d-fbe84c7ab2ad</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L2</td>\n",
       "      <td>6.6     Special precautions for disposal and other handling</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>350</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>007d733a-4f29-41b2-b121-2cb115094347</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>351</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Adakveo vials are for single use only.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>bc7bcab8-dac1-4983-916e-5ffcb01f938d</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Adakveo vials are for single use only.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>352</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c4a1d90f-bd32-4d0a-bf43-604c0b34c9af</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>353</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Preparing the infusion&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>4512dd38-a048-42e5-8029-b540a8263f2b</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Preparing the infusion</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>354</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e23ff6b2-20ae-44b0-b64f-198e5618f75d</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>355</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The diluted solution for infusion should be prepared by a healthcare professional using aseptic techniques.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1473cd1c-9b6f-4370-9f72-e83e69475737</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The diluted solution for infusion should be prepared by a healthcare professional using aseptic techniques.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>356</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>95f93264-c234-4b46-89c6-e945e5e9b31d</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>357</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;The total dose and required volume of Adakveo depend on the patient’s body weight; 5 mg of crizanlizumab is administered per kg b...</td>\n",
       "      <td>94346e88-c101-4bc7-8012-d3b0d77c943c</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The total dose and required volume of Adakveo depend on the patient’s body weight; 5 mg of crizanlizumab is administered per kg body weight.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>358</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>51d7f2e0-8d66-42f0-92ca-d00295fda75d</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>359</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;The volume to be used for the preparation of the infusion is calculated according to the following equatio...</td>\n",
       "      <td>30001714-d1b1-486b-99fd-1e91d0dcec95</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>The volume to be used for the preparation of the infusion is calculated according to the following equation:</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>360</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>33a626aa-b331-405b-9e6e-973e963fc8ac</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>361</th>\n",
       "      <td>&lt;table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:12.5pt;border-collapse:collapse\" width=\"567\"&gt; &lt;tr&gt; &lt;td rowspan=\"2\" style=\"width:85.05pt;padding:0in 5.4p...</td>\n",
       "      <td>c2a797e4-ca61-4a7f-b729-32f94c299d13</td>\n",
       "      <td>margin-left:12.5pt;border-collapse:collapse</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Volume (ml) =   Patient’s body weight (kg) x prescribed dose   [5 mg/kg]     Concentration   of Adakveo   [10 mg/ml]</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>362</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;a name=\"_hd6_Table_3_1_Example_of_d12477\"&gt;&lt;/a&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>29859d43-7257-48ca-82e8-4da9831cccad</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>363</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;1.       Obtain the number of vials required to deliver the pres...</td>\n",
       "      <td>985c20b0-443f-4a52-9767-84b70deae8fc</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>1.       Obtain the number of vials required to deliver the prescribed dose and bring them to room temperature (for a maximum of 4 hours). One vial is needed for every 10 ml of Adakveo (see below ...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>364</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e105b8a5-3f7f-4323-88f6-c66f83ef9f97</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>365</th>\n",
       "      <td>&lt;table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:28.35pt;border-collapse:collapse;border:none\" width=\"568\"&gt; &lt;tr style=\"page-break-inside:avoid\"&gt; &lt;td styl...</td>\n",
       "      <td>88fa01d0-297f-44a4-9f1e-72b7db37da6e</td>\n",
       "      <td>margin-left:28.35pt;border-collapse:collapse;border:none</td>\n",
       "      <td>['MsoNormalTable']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Body weight (kg)   Dose (mg)   Volume (ml)   Vials (n)     40   200   20   2     60   300   30   3     80   400   40   4     100   500   50   5     120   600   60   6</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>366</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>8a5434fe-20f2-4bf7-b303-a467e4500701</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>367</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;2.       Visually inspect the vials.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f9dda721-880c-4fdd-81c9-23a61f02f35a</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>2.       Visually inspect the vials.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>368</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height: normal\"&gt;&lt;span lang=\"EN-GB\"&gt;-&lt;span style='font:7.0pt \"Times New Roman\"'&gt;                 &lt;/span&gt;&lt;/span&gt;&lt;span lang=\"E...</td>\n",
       "      <td>dfe30f25-3213-49f3-8c1a-a03428471f1d</td>\n",
       "      <td>margin-left:56.7pt;text-indent:-28.35pt;line-height:\\nnormal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>-                 The solution in the vials should be clear to opalescent. Do not use if particles are present in the solution.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>369</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height: normal\"&gt;&lt;span lang=\"EN-GB\"&gt;-&lt;span style='font:7.0pt \"Times New Roman\"'&gt;                 &lt;/span&gt;&lt;/span&gt;&lt;span lang=\"E...</td>\n",
       "      <td>a6daa916-3929-40ec-985a-6e34ce49cc4f</td>\n",
       "      <td>margin-left:56.7pt;text-indent:-28.35pt;line-height:\\nnormal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>-                 The solution should be colourless or may have a slight brownish‑yellow tint.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>370</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4b2604a7-15d1-4474-bf4b-c802fbbaa010</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>371</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;3.       Withdraw a volume equal to the required volume of Adakv...</td>\n",
       "      <td>e366bb71-b7ba-4cfc-b28f-66f0bbc90eee</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>3.       Withdraw a volume equal to the required volume of Adakveo from a 100 ml infusion bag containing either sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% and discard.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>372</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"&gt;&lt;span lang=\"EN-GB\"&gt;-&lt;span style='font:7.0pt \"Times New Roman\"'&gt;                 &lt;/span&gt;&lt;/span&gt;&lt;span lang=\"EN-GB\"&gt;No incompatibi...</td>\n",
       "      <td>66a122bf-afbc-49d3-9b45-b2c7d80407c0</td>\n",
       "      <td>margin-left:56.7pt;text-indent:-28.35pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>-                 No incompatibilities between the diluted Adakveo solution and infusion bags composed of polyvinylchloride (PVC), polyethylene (PE) and polypropylene (PP) have been observed.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>373</th>\n",
       "      <td>&lt;p class=\"MsoNormal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>fac9eddc-a1cd-4099-bd26-f4664ec53a90</td>\n",
       "      <td>None</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>374</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt;4.       Withdraw the necessary volume of Adakveo from the vials...</td>\n",
       "      <td>a15ac1bf-0bfb-4400-8bc9-b4f24a526ef8</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>4.       Withdraw the necessary volume of Adakveo from the vials and inject slowly into the previously prepared infusion bag.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>375</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"&gt;&lt;span lang=\"EN-GB\"&gt;-&lt;span style='font:7.0pt \"Times New Roman\"'&gt;                 &lt;/span&gt;&lt;/span&gt;&lt;span lang=\"EN-GB\"&gt;The &lt;/span&gt;&lt;sp...</td>\n",
       "      <td>af8f1547-b844-40e2-9fcf-393264f9fcbc</td>\n",
       "      <td>margin-left:56.7pt;text-indent:-28.35pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>-                 The solution must not be mixed or co‑administered with other medicinal products through the same intravenous line.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>376</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"&gt;&lt;span lang=\"EN-GB\"&gt;-&lt;span style='font:7.0pt \"Times New Roman\"'&gt;                 &lt;/span&gt;&lt;/span&gt;&lt;span lang=\"EN-GB\"&gt;Keep the volum...</td>\n",
       "      <td>4282d2cf-94c8-463c-835c-14d070734b16</td>\n",
       "      <td>margin-left:56.7pt;text-indent:-28.35pt</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>-                 Keep the volume of Adakveo added to the infusion bag in the range of 10 ml to 96 ml to obtain a final concentration in the infusion bag within 1 mg/ml to 9.6 mg/ml.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>377</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d81fb4c8-01d1-41bf-8579-8cfb069ef597</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>378</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;5.       Mix the diluted solution by gently inverting the infusion bag. DO NOT SHAKE.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>755f3b13-17d9-4fe3-9c2b-1f5fb1a5d6c0</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>5.       Mix the diluted solution by gently inverting the infusion bag. DO NOT SHAKE.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>379</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a21c3ed4-49d7-4e66-9692-d9ddcbf7b9bf</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>380</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Administration&lt;/span&gt;&lt;/u&gt;&lt;a name=\"_nth_Administration25012\"&gt;&lt;/a&gt;&lt;/p&gt;</td>\n",
       "      <td>a44b6df6-f9ab-4c89-8110-e858a2e81944</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Administration</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>381</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e1525e94-a89a-4533-bcd3-24d091a9a998</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>382</th>\n",
       "      <td>&lt;p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"&gt;&lt;span style=\"font-size:11.0pt\"&gt;Adakveo diluted solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line...</td>\n",
       "      <td>cc618436-4d6a-4fdc-8841-f06397bdae7a</td>\n",
       "      <td>margin-top:0in;text-align:left</td>\n",
       "      <td>['Text']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Adakveo diluted solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by intravenous infusion over a period of 30 minutes. No incompatibilities have been observe...</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>383</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2ca8a9c0-71bf-4f00-ac95-4f17769b0430</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>384</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;After administration of Adakveo, flush the line with at least 25 ml sodium chloride 9 mg/ml (0.9%) solution for injection or dext...</td>\n",
       "      <td>91651b3d-52f4-4496-9120-d585bdf34f81</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>After administration of Adakveo, flush the line with at least 25 ml sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5%.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>385</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>fc23fa4e-5365-4897-8e35-081b5bc498e3</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>386</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;u&gt;&lt;span lang=\"EN-GB\"&gt;Disposal&lt;/span&gt;&lt;/u&gt;&lt;/p&gt;</td>\n",
       "      <td>790d0f73-c2bb-4287-a4fd-7353eea185e6</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L3</td>\n",
       "      <td>Disposal</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>387</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d9bc9594-8973-438b-af6e-ce6f9f95a3e9</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>388</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Any unused medicinal product or waste material should be disposed of in accordance with local requirements.&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>88caa940-38af-4a39-85ac-496e8896c678</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>389</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>9f3a1ca2-3874-417a-82e6-7b6dcd3a23cc</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>390</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>17bb70bb-c856-421e-a119-655fcd74c970</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>391</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;7.       MARKETING AUTHORISATION HOLDER&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>2e90cca4-467f-40f6-9d9b-7cdcc501a036</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>7.       MARKETING AUTHORISATION HOLDER</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>392</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>6a6d9cce-8b55-41c6-a9df-5a2974a1aff4</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>393</th>\n",
       "      <td>&lt;p class=\"Default\" style=\"page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"&gt;Novartis Europharm Limited&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ee815573-69e1-4b40-9bc2-5e163d630406</td>\n",
       "      <td>page-break-after:avoid</td>\n",
       "      <td>['Default']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Novartis Europharm Limited</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>394</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Vista Building&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>80c23402-0480-4124-8f6f-46925c8e537b</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Vista Building</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>395</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Elm Park, Merrion Road&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>dfa537c6-eb19-410c-afb9-33186c2b6b05</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Elm Park, Merrion Road</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>396</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Dublin 4&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2b695489-cf12-4049-a2e1-1a2d14df92d2</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Dublin 4</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>397</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;Ireland&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>48c00e77-77ec-4244-9d94-2fd6f4b81631</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Ireland</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>398</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>21f9fed2-00ca-44a3-9267-1078e9faf781</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>399</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>e98778fc-a17b-48aa-8e8a-cbe138ff09c4</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>400</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;8.       MARKETING AUTHORISATION NUMBER(S)&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>fefa296f-e154-42b7-8416-72c6b78230fa</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>8.       MARKETING AUTHORISATION NUMBER(S)</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>401</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d3c33c17-e1b6-4954-be6b-c384593de96c</td>\n",
       "      <td>line-height:normal;page-break-after:avoid</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>402</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\" style=\"color:black\"&gt;EU/1/20/1476/001&lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>317e074d-c34f-4f1f-890c-df3b4c5a19ae</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>EU/1/20/1476/001</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>403</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>36bce19f-089e-4025-a9d9-3b41061b9947</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>404</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>bcde3901-95f7-48b8-9dbc-01fc7f2ef0e3</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>405</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;9.       DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>acaf6790-3f91-4b6f-99bc-199765791f5a</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>9.       DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>406</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d56760a9-7b6c-406d-a591-5c8012b57d75</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>407</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0c85ada6-10f3-4235-9810-45b382d68edb</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>408</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"&gt;&lt;b&gt;&lt;span lang=\"EN-GB\"&gt;10.     DATE OF REVISION OF THE TEXT&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;</td>\n",
       "      <td>a86741a5-547d-4084-bbdb-e8eea5a9da42</td>\n",
       "      <td>margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>L1</td>\n",
       "      <td>10.     DATE OF REVISION OF THE TEXT</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>409</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>fd5536d3-3d24-4f8a-9a87-763251e3817b</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>410</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>66026015-c5e3-417c-ab6e-ac77e1a42b13</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>411</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt;Detailed information on this medicinal product is available on the website of the European Medicines &lt;/span&gt;&lt;span lang=\"EN-GB\"&gt;Ag...</td>\n",
       "      <td>3cd86c01-ce4b-404f-9774-5467f495dcf0</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td>Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu.</td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>412</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>201cb4bb-4df3-45ab-aaa5-bd46bb419470</td>\n",
       "      <td>margin-right:-.1pt;line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>413</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c2d1acd4-1298-4014-91a6-a105a1c9be38</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>414</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>3731cb55-5fdb-475d-bec8-bcf2fb4a5692</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>415</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>2103b9cc-b2dd-4dc7-9cca-7aaf2ca8e6dd</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>416</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>cb897326-186f-4a5f-b3b6-5eb11a2091a4</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>417</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>c33d0918-4f07-4b10-981d-3a7a2e51f4ee</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>418</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4dc1eeca-1565-4651-86de-bb0549d7050c</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>419</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ee2b1bb5-2900-4e3b-bfcc-570e2dde38e2</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>420</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>19b053f2-d9c9-4930-85f2-1f860db8cfef</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>421</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>b1edb48c-264b-4d54-92fb-cd63dad463b7</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>422</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>0e9207b1-a497-45e4-8eee-6c06c1bc16dd</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>423</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ca99e9aa-9e9e-456d-ab1b-e2d19669890d</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>424</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>ade7361e-e0bb-48cc-a7c7-2a6674f5329f</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>425</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f0c6c67a-380f-4da4-9e5a-02cd72cc4a71</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>426</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>055a5227-34c3-439a-8046-f928d2d0ea70</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>427</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>1dd82cf7-9f12-4867-91a0-c450f9ce6fcc</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>428</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>f6251986-fd21-4691-88e4-edb89b0422a4</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>429</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>a3a9a54e-fb50-404d-9510-f6300d2bbb11</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>430</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>20b168cc-9f45-4b6d-933f-6077b8af5595</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>431</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>d1d3015a-8a2b-4ab0-842d-a3cc8c9e169a</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>432</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>66e9038f-c383-4cff-95af-818e76a2091d</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>433</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>658742af-a192-4d57-8624-0f9a44426e15</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>434</th>\n",
       "      <td>&lt;p class=\"MsoNormal\" style=\"line-height:normal\"&gt;&lt;span lang=\"EN-GB\"&gt; &lt;/span&gt;&lt;/p&gt;</td>\n",
       "      <td>4af52237-24ea-434e-9e10-08277413103e</td>\n",
       "      <td>line-height:normal</td>\n",
       "      <td>['MsoNormal']</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>None</td>\n",
       "      <td></td>\n",
       "      <td>583f04cc-251b-4aa9-a300-400d62bebe5a</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                     Element  \\\n",
       "0    <div class=\"WordSection1\"> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p> <p class=...   \n",
       "1                                                                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "2                                                                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "3                                                                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "4                                                                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "5                                                                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "6                                                                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "7                                                                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "8                                                                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "9                                                                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "10                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "11                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "12                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "13                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "14                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "15                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "16                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "17                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "18                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "19                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "20                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "21                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "22                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "23                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "24                                                                             <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX I</span></b></p>   \n",
       "25                                                                                          <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "26                                                  <p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">SUMMARY OF PRODUCT CHARACTERISTICS</span></b></p>   \n",
       "27                                                   <span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif; color:green'><br clear=\"all\" style=\"page-break-before:always\"/> </span>   \n",
       "28                                                                                                                                                        <br clear=\"all\" style=\"page-break-before:always\"/>   \n",
       "29   <p class=\"MsoNormal\" style=\"line-height:normal\"><img height=\"18\" src=\"Adakveo-4874%20EN%20PI_files/image001.png\" width=\"21\"/><span lang=\"EN-GB\">This medicinal product is subject to additional moni...   \n",
       "30                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "31                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "32   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">1.       NAME OF </span></b><b><span lang=\"EN-GB\">THE MEDICIN...   \n",
       "33                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "34                                                                      <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo 10 mg/ml concentrate for solution for infusion</span></p>   \n",
       "35                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "36                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "37   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.       QUALITATIVE AND QUANTITATIVE COMPOSITION</span></b></p>   \n",
       "38                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "39                                              <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each ml of concentrate for solution for infusion contains 10 mg crizanlizumab.</span></p>   \n",
       "40                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "41                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">One vial of 10 ml contains 100 mg crizanlizumab.</span></p>   \n",
       "42                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "43         <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab is a monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.</span></p>   \n",
       "44                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "45                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For the full list of excipients, see section 6.1.</span></p>   \n",
       "46                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "47                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "48   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">3.       PHARMACEUTICAL </span></b><b><span lang=\"EN-GB\" styl...   \n",
       "49                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "50   <p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_Toc259706902\"></a><a name=\"_Toc259707071\"></a><a name=\"_Toc259707134\"></a><a name=\"_Toc259713075\"><span lang=\"EN-GB\">Concentrate for solut...   \n",
       "51                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "52                                <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Colourless to slightly brownish‑yellow liquid at pH 6 and with an osmolality of 300 mOsm/kg.</span></p>   \n",
       "53                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "54                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "55   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.       </span></b><b><span...   \n",
       "56                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "57                     <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.1     Therapeutic indications</span></b></p>   \n",
       "58                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "59   <p class=\"Standard\"><span lang=\"EN-GB\">Adakveo</span><span lang=\"EN-GB\"> is indicated for the prevention of recurrent vaso‑occlusive crises (VOCs) in sickle cell disease patients aged 16 years and...   \n",
       "60                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "61                                                 <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.2     Posology and method of administration</span></b></p>   \n",
       "62                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "63   <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Treatment should be initiated by physicians experienced in the management of </span><span lang=\"EN-GB\">sickle cell disease.</span...   \n",
       "64                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "65                                        <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Posology</span></u><a name=\"_nth_Adults_and_patients_ag4131\"></a></p>   \n",
       "66                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "67   <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The recommended dose of crizanlizumab is 5 mg/kg administered over a period of 30 minutes by intravenous infusion at week 0, week...   \n",
       "68                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "69                         <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab </span><span lang=\"EN-GB\">c</span><span lang=\"EN-GB\">an be given alone or with HU/HC.</span></p>   \n",
       "70                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "71                        <p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">If a dose is missed, the treatment should be administered as soon as possible.</span></p>   \n",
       "72   <p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt\"><span style=\"font-size:11.0pt...   \n",
       "73   <p align=\"left\" class=\"Text\" style=\"margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt\"><span style=\"font-size:11.0pt...   \n",
       "74                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "75                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Special populations</span></u></i></p>   \n",
       "76                                                                                       <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Elderly</span></i></p>   \n",
       "77   <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab has not been studied in elderly patients. No dose adjustment is required as the pharmacokinetics of crizanlizumab i...   \n",
       "78                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "79                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Renal impairment</span></i></p>   \n",
       "80   <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Based on the population pharmacokinetic (PK) results, no dose adjustment is required in patients with mild or moderate renal impa...   \n",
       "81                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "82                                                                            <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Hepatic impairment</span></i></p>   \n",
       "83   <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monocl...   \n",
       "84                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "85                                                                         <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">Paediatric population</span></i></p>   \n",
       "86   <p class=\"Standard\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety and efficacy of </span><span lang=\"EN-GB\">crizanlizumab</span><span lang=\"EN-GB\"> in paediatric patients from 6 months ...   \n",
       "87                                                                                                                            <p class=\"Standard\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "88   <p class=\"Standard\" style=\"line-height:normal\"><span lang=\"EN-GB\">There is no relevant use of crizanlizumab in infants aged less than 6 months for the indication of prevention of recurrent vaso‑oc...   \n",
       "89                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "90                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Method of administration</span></u></p>   \n",
       "91                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "92   <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo </span><span lang=\"EN-GB\">should be diluted with sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% bef...   \n",
       "93                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "94   <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The diluted solution</span><span lang=\"EN-GB\"> must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by...   \n",
       "95                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "96                               <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For instructions on dilution of the medicinal product before administration, see section 6.6.</span></p>   \n",
       "97                                                                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "98                           <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.3     Contraindications</span></b></p>   \n",
       "99                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "100                                <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.</span></p>   \n",
       "101                                                             <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hypersensitivity to Chinese Hamster Ovary (CHO) cell products.</span></p>   \n",
       "102                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "103   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.4     Special warnings and precautions for use</span></b></p>   \n",
       "104                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "105                                                                                 <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Traceability</span></u></p>   \n",
       "106                                                                          <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\"> </span></p>   \n",
       "107  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product ...   \n",
       "108                                                                         <p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\"> </span></span></u></p>   \n",
       "109                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Infusion‑related reactions</span></u></p>   \n",
       "110                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "111  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In clinical studies, infusion‑related reactions (defined as occurring within 24 hours) were observed in 2 patients (1.8%) treated...   \n",
       "112                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "113                                      <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Laboratory test interference: automated platelet counts</span></u></p>   \n",
       "114                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "115  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Interference with automated platelet counts (platelet clumping) has been observed in patients treated with crizanlizumab in clini...   \n",
       "116                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "117  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">To mitigate the potential for laboratory test interference, it is recommended to run the test as soon as possible (within 4 hours...   \n",
       "118                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "119                                                                 <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Excipients with known effect</span></u></p>   \n",
       "120                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "121                 <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially “sodium‑free”.</span></p>   \n",
       "122                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "123  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.5     Interaction with other medicinal products and other f...   \n",
       "124                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "125           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Interactions between crizanlizumab and other medicinal products have not been investigated in dedicated studies.</span></p>   \n",
       "126                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "127  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Monoclonal antibodies are not metabolised by cytochrome P450 (CYP450) enzymes. Therefore, medicinal products that are substrates,...   \n",
       "128                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "129  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No effect on exposure of co‑administered medicinal products is expected based on the metabolic pathways of monoclonal antibodies....   \n",
       "130                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "131  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.6     </span></b><b><span lang=\"EN-GB\">Fertility, p</span><...   \n",
       "132                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "133                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Pregnancy</span></u></p>   \n",
       "134                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "135  <p class=\"Standard\"><span lang=\"EN-GB\">There is a limited amount of data from the use of Adakveo in pregnant women. Based on data from animal studies, crizanlizumab has the potential to cause foet...   \n",
       "136                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "137  <p class=\"Standard\" style=\"line-height:normal\">To help determine the effects in pregnant women, healthcare professionals are encouraged to report all pregnancy cases and complications during pregn...   \n",
       "138                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "139                                                                               <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Breast‑feeding</span></u></p>   \n",
       "140                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "141  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It is unknown whether crizanlizumab is excreted in human milk after administration of Adakveo. There are no data on the effects o...   \n",
       "142                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "143  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Because many medicinal products, including antibodies, can be excreted in human milk, a risk to the newborn/infant cannot be excl...   \n",
       "144                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "145  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">A decision must be made whether to discontinue breast‑feeding or to discontinue Adakveo therapy, taking into account the benefit ...   \n",
       "146                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "147                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Fertility</span></u></p>   \n",
       "148                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "149  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There are no data on the effect of Adakveo on human fertility. Available non‑clinical data do not suggest an effect on fertility ...   \n",
       "150                                                                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal\"> </p>   \n",
       "151  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.7     Effects on ability to drive and use machines</span></...   \n",
       "152                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "153  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo may have a minor influence on the ability to drive and use machines. Dizziness, fatigue and somnolence may occur followin...   \n",
       "154                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "155                                                                  <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.8     Undesirable effects</span></b></p>   \n",
       "156                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "157  <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Summary of the safety profile</span></u><a name=\"_nth_Summary_of_the_safety_6118\">...   \n",
       "158                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "159  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The most frequently reported adverse drug reactions (≥10% of patients) in the Adakveo 5 mg/kg group were arth...   \n",
       "160                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "161                                     <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Tabulated list of adverse reactions</span></u></p>   \n",
       "162                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "163  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Table 1 lists adverse reactions based on pooled data from two studies: the pivotal study, SUSTAIN, and a sing...   \n",
       "164                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "165  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Within each system organ class, the adverse reactions are ranked by frequency, with the most frequent reactio...   \n",
       "166                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "167  <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><a name=\"_Toc272145403\"></a><a name=\"_Toc272145564\"></a><a name=\"_Toc266768477\"></a><a name=\"_Toc2609036...   \n",
       "168                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "169  <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:459.0pt;border-collapse:collapse;border:none\" width=\"612\"> <tr style=\"page-break-inside:avoid\"> <td style=\"wid...   \n",
       "170                                                                                          <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p>   \n",
       "171                               <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Description of selected adverse reactions</span></u></p>   \n",
       "172                                                                  <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after: avoid\"><span style=\"font-size:11.0pt\"> </span></p>   \n",
       "173                                       <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left;page-break-after: avoid\"><i><u><span style=\"font-size:11.0pt\">Immunogenicity</span></u></i></p>   \n",
       "174  <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">In clinical studies, treatment‑induced anti‑crizanlizumab antibodies were transiently detected in...   \n",
       "175                                                                                          <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p>   \n",
       "176  <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">There was no evidence of altered pharmacokinetics or of an altered safety profile with anti‑criza...   \n",
       "177                                                                                          <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p>   \n",
       "178                                                    <p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Paediatric population</span></u></p>   \n",
       "179                                                                               <p class=\"Standard\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "180  <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">Frequency, type and severity of adverse reactions in patients aged 16 and 17 years are expected t...   \n",
       "181                                                                                          <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\"> </span></p>   \n",
       "182                                <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Reporting of suspected adverse reactions</span></u></p>   \n",
       "183                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "184  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows co...   \n",
       "185                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "186                                   <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.9     Overdose</span></b></p>   \n",
       "187                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "188                     <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">No cases of overdose have been reported in clinical studies.</span></p>   \n",
       "189                                                                                <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "190                  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">General supportive measures and symptomatic treatment should be initiated in cases of suspected overdose.</span></p>   \n",
       "191                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "192                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "193                <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.       PHARMACOLOGICAL PROPERTIES</span></b></p>   \n",
       "194                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "195                 <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.1     Pharmacodynamic properties</span></b></p>   \n",
       "196                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "197                           <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Pharmacotherapeutic group: Other haematological agents, ATC code: B06AX01</span></p>   \n",
       "198                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "199                                                     <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Mechanism of action</span></u></p>   \n",
       "200                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "201  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Crizanlizumab is a selective IgG2 kappa humanised monoclonal antibody (mAb) that binds to P‑selectin with hig...   \n",
       "202                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "203  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Binding P‑selectin on the surface of the activated endothelium and platelets has been shown to effectively bl...   \n",
       "204                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "205                                                 <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Pharmacodynamic effects</span></u></p>   \n",
       "206                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "207  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Throughout clinical studies, treatment with crizanlizumab 5 mg/kg resulted in dose‑dependent, immediate and sustained P‑selectin ...   \n",
       "208                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "209                                            <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><u><span lang=\"EN-GB\">Clinical efficacy and safety</span></u></p>   \n",
       "210                                                                                                        <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"> </p>   \n",
       "211  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The efficacy of crizanlizumab, with or without HU/HC, was evaluated in the pivotal study SUSTAIN, a 52‑week, ...   \n",
       "212                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "213  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In this study, VOCs were defined as those leading to a healthcare visit, which captured all acute episodes of...   \n",
       "214                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "215  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">A total of 198 sickle cell disease patients aged 16 to 63 years (inclusive; mean age 30.1±10.3 years), with a...   \n",
       "216                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "217  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Treatment with Adakveo 5 mg/kg resulted in a 45.3% lower median annual rate of VOCs compared to placebo (Hodg...   \n",
       "218                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "219                  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Main efficacy outcomes of the pivotal SUSTAIN study are summarised in Tables 2 and 3.</span></p>   \n",
       "220                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "221  <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><a name=\"_Toc499550968\"></a><a name=\"_Toc517716326\"><b><span lang=\"EN-GB\">Table </span></b></a><b><span ...   \n",
       "222                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "223  <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:98.84%;border-collapse:collapse;border:none\" width=\"98%\"> <tr style=\"page-break-inside:avoid;height:1.0pt\"> <t...   \n",
       "224                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "225  <p class=\"MsoNormal\"><span lang=\"EN-GB\">The clinical effect demonstrated in the primary efficacy analysis was supported by multiple supplementary analyses including a negative binomial regression ...   \n",
       "226                                                                                                                                <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"> </p>   \n",
       "227  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In the Adakveo 5 mg/kg group, clinically significant reductions in the annual rate of VOCs were observed acro...   \n",
       "228                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "229       <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><b><span lang=\"EN-GB\">Table 3       Annual rate of VOCs in patients ‑ subgroup analyses</span></b></p>   \n",
       "230                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "231  <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\" width=\"612\"> <tr style=\"page-break-inside:avoid\"> <td style=\"width:90.45pt;bor...   \n",
       "232                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "233  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">A greater than two‑fold increase in the proportion of patients with no VOC and who completed the study was ob...   \n",
       "234                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "235  <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Treatment with Adakveo 5 mg/kg was also associated with a three‑fold longer Kaplan‑Meier estimated median tim...   \n",
       "236                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "237                                        <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Figure 1      Kaplan‑Meier curve of time to first VOC</span></b></p>   \n",
       "238                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "239  <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><span style=\"position:absolute;z-index:251748352;left:0px;margin-left:61px; margin-top:211px;width:13px;height:9px\"><img alt=\"0\" heigh...   \n",
       "240  <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"> <table align=\"left\" cellpadding=\"0\" cellspacing=\"0\"> <tr> <td height=\"1\" width=\"3\"></td> <td width=\"36\"></td> <td width=\"33\"...   \n",
       "241                                                                                                <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><span style=\"font-size:11.0pt\"> </span></p>   \n",
       "242                                                                                                <p class=\"Text\" style=\"margin-top:0in;page-break-after:avoid\"><span style=\"font-size:11.0pt\"> </span></p>   \n",
       "243                                                                              <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace: none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "244                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "245                                                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"> </span></p>   \n",
       "246                                                                                                                                                                                        <br clear=\"ALL\"/>   \n",
       "247                         <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><a name=\"_hd6_Table_2_1_Patients_wit18544\"></a><u><span lang=\"EN-GB\">Paediatric population</span></u></p>   \n",
       "248                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "249  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The efficacy of crizanlizumab in patients aged 16 and 17 years is expected to be the same as in adults. Three patients (2.7%) age...   \n",
       "250                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "251  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The European Medicines Agency has deferred the obligation to submit the results of studies with Adakveo in one or more subsets of...   \n",
       "252                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "253                                                                         <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Conditional approval</span></u></p>   \n",
       "254                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "255  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal product has been authorised under a so‑called “conditional approval” scheme. This means that further evidence on t...   \n",
       "256                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "257  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The European Medicines Agency will review new information on this medicinal product at least every year and this SmPC will be upd...   \n",
       "258                                                                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal\"> </p>   \n",
       "259                 <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.2     Pharmacokinetic properties</span></b></p>   \n",
       "260                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "261                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Absorption</span></u></p>   \n",
       "262                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "263  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The median time to reach maximum serum concentration of crizanlizumab (T<sub>max</sub>) was 1.92 hours at steady state following ...   \n",
       "264                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "265                                                                                 <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Distribution</span></u></p>   \n",
       "266                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "267  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Crizanlizumab distribution is typical of endogenous human antibodies within the vascular and extracellular spaces. The volume of ...   \n",
       "268                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "269                                                                            <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Biotransformation</span></u></p>   \n",
       "270                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "271   <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Antibodies are primarily eliminated via proteolysis by lysosomal enzymes in the liver to small peptides and amino acids.</span></p>   \n",
       "272                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "273                                                                                  <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Elimination</span></u></p>   \n",
       "274                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "275  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In healthy volunteers, the mean terminal elimination half‑life (T<sub>½</sub>) was 10.6 days and the mean clearance was 11.7 ml/h...   \n",
       "276                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "277                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Linearity/non‑linearity</span></u></p>   \n",
       "278                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "279  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The exposure to crizanlizumab (mean C<sub>max</sub>, AUC<sub>last</sub>, or AUC<sub>inf</sub>) increased in non‑linear manner ove...   \n",
       "280                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "281                                                                          <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Special populations</span></u></p>   \n",
       "282                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "283                                                                      <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Renal impairment</span></u></i></p>   \n",
       "284  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In a population PK analysis in patients with eGFR ranging from 35 to 202 ml/min/1.73 m<sup>2</sup>, no clinically important diffe...   \n",
       "285                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "286                                                                    <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Hepatic impairment</span></u></i></p>   \n",
       "287  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monocl...   \n",
       "288                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "289                  <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Paediatric <a name=\"_nth_Pediatric_patients__be14752\"></a>population</span></u></i></p>   \n",
       "290                              <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pharmacokinetics in paediatric patients below the age of 16 years have not been investigated.</span></p>   \n",
       "291                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "292                    <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.3     Preclinical safety data</span></b></p>   \n",
       "293                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "294  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">N</span><span lang=\"EN-GB\">on‑clinical data revealed no special hazard for humans based on conventional studies of safety pharmac...   \n",
       "295                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "296  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In the 26‑week repeated dose toxicity study, administration of crizanlizumab in cynomolgus monkeys at dose levels up to 50 mg/kg/...   \n",
       "297                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "298  <p class=\"MsoNormal\" style=\"line-height:normal\">Pharmacological effects of crizanlizumab on haemodynamic and electrocardiographic parameters in the cynomolgus monkey were evaluated in the 26‑week ...   \n",
       "299                                                                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal\"> </p>   \n",
       "300             <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Formal carcinogenicity, genotoxicity and juvenile toxicity studies have not been conducted with crizanlizumab.</span></p>   \n",
       "301                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "302  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In a 26‑week repeated dose toxicity study, cynomolgus monkeys were administered crizanlizumab once every 4 weeks at doses up to 5...   \n",
       "303                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "304  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In an enhanced pre‑ and postnatal development study in cynomolgus monkeys, pregnant animals received intravenous crizanlizumab on...   \n",
       "305                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "306  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Measurable crizanlizumab serum concentrations were observed in the infant monkeys at postnatal day 28, confirming that crizanlizu...   \n",
       "307                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "308                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "309                <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.       PHARMACEUTICAL PARTICULARS</span></b></p>   \n",
       "310                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "311                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.1     List of excipients</span></b></p>   \n",
       "312                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "313                                                                                             <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Sucrose</span></p>   \n",
       "314                                                                               <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Sodium citrate (E331)</span></p>   \n",
       "315                                                                                  <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Citric acid (E330)</span></p>   \n",
       "316                                                                               <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Polysorbate 80 (E433)</span></p>   \n",
       "317                                                                                                       <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Water for injections</span></p>   \n",
       "318                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "319                          <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.2     Incompatibilities</span></b></p>   \n",
       "320                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "321  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This medicinal product</span><span lang=\"EN-GB\"> must not be mixed with other medicinal products except those mentioned in sectio...   \n",
       "322                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "323                                 <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.3     Shelf life</span></b></p>   \n",
       "324                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "325                                                                                <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Unopened vial</span></u></p>   \n",
       "326                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "327                                                                        <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">18 months</span></p>   \n",
       "328                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "329                                                                             <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Diluted solution</span></u></p>   \n",
       "330                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "331  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Chemical and physical in‑use stability, from the start of preparation of the diluted solution for infusion until end of infusion,...   \n",
       "332                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "333  <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">From a microbiological point of view, the diluted solution for infusion should be used immediatel...   \n",
       "334                                                                                                                                                    <p class=\"MsoNormal\" style=\"line-height:normal\"> </p>   \n",
       "335            <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.4     Special precautions for storage</span></b></p>   \n",
       "336                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "337                                                                                       <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Store in a refrigerator (2°C – 8°C).</span></p>   \n",
       "338                                                                                                             <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not freeze.</span></p>   \n",
       "339                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep the vial in the outer carton in order to protect from light.</span></p>   \n",
       "340                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "341                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For storage conditions after dilution of the medicinal product, see section 6.3.</span></p>   \n",
       "342                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "343           <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.5     Nature and contents of container</span></b></p>   \n",
       "344                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "345  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">10 ml concentrate for solution for infusion in a type I glass vial with a coated chlorobutyl rubber stopper sealed with an alumin...   \n",
       "346                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "347                                                                                                            <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pack of 1 vial.</span></p>   \n",
       "348                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "349  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><a name=\"OLE_LINK1\"><b><span lang=\"EN-GB\">6.6     Special precautions for disposal ...   \n",
       "350                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "351                                                                                     <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Adakveo vials are for single use only.</span></p>   \n",
       "352                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "353                                                                       <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Preparing the infusion</span></u></p>   \n",
       "354                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "355                <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The diluted solution for infusion should be prepared by a healthcare professional using aseptic techniques.</span></p>   \n",
       "356                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "357  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The total dose and required volume of Adakveo depend on the patient’s body weight; 5 mg of crizanlizumab is administered per kg b...   \n",
       "358                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "359  <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">The volume to be used for the preparation of the infusion is calculated according to the following equatio...   \n",
       "360                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "361  <table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:12.5pt;border-collapse:collapse\" width=\"567\"> <tr> <td rowspan=\"2\" style=\"width:85.05pt;padding:0in 5.4p...   \n",
       "362                                                                           <p class=\"MsoNormal\" style=\"line-height:normal\"><a name=\"_hd6_Table_3_1_Example_of_d12477\"></a><span lang=\"EN-GB\"> </span></p>   \n",
       "363  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">1.       Obtain the number of vials required to deliver the pres...   \n",
       "364                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "365  <table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:28.35pt;border-collapse:collapse;border:none\" width=\"568\"> <tr style=\"page-break-inside:avoid\"> <td styl...   \n",
       "366                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "367                                                                <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">2.       Visually inspect the vials.</span></p>   \n",
       "368  <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>                 </span></span><span lang=\"E...   \n",
       "369  <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height: normal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>                 </span></span><span lang=\"E...   \n",
       "370                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "371  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">3.       Withdraw a volume equal to the required volume of Adakv...   \n",
       "372  <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>                 </span></span><span lang=\"EN-GB\">No incompatibi...   \n",
       "373                                                                                                                                                     <p class=\"MsoNormal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "374  <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\">4.       Withdraw the necessary volume of Adakveo from the vials...   \n",
       "375  <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>                 </span></span><span lang=\"EN-GB\">The </span><sp...   \n",
       "376  <p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>                 </span></span><span lang=\"EN-GB\">Keep the volum...   \n",
       "377                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "378                                      <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">5.       Mix the diluted solution by gently inverting the infusion bag. DO NOT SHAKE.</span></p>   \n",
       "379                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "380                                        <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Administration</span></u><a name=\"_nth_Administration25012\"></a></p>   \n",
       "381                                                         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "382  <p align=\"left\" class=\"Text\" style=\"margin-top:0in;text-align:left\"><span style=\"font-size:11.0pt\">Adakveo diluted solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line...   \n",
       "383                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "384  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">After administration of Adakveo, flush the line with at least 25 ml sodium chloride 9 mg/ml (0.9%) solution for injection or dext...   \n",
       "385                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "386                                                                                     <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Disposal</span></u></p>   \n",
       "387                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "388                <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</span></p>   \n",
       "389                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "390                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "391            <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">7.       MARKETING AUTHORISATION HOLDER</span></b></p>   \n",
       "392                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "393                                                     <p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Novartis Europharm Limited</span></p>   \n",
       "394                                                                  <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Vista Building</span></p>   \n",
       "395                                                          <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Elm Park, Merrion Road</span></p>   \n",
       "396                                                                        <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:black\">Dublin 4</span></p>   \n",
       "397                                                                                                <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">Ireland</span></p>   \n",
       "398                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "399                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "400         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">8.       MARKETING AUTHORISATION NUMBER(S)</span></b></p>   \n",
       "401                                                                                                   <p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\"> </span></p>   \n",
       "402                                                                                       <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">EU/1/20/1476/001</span></p>   \n",
       "403                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "404                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "405         <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">9.       DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>   \n",
       "406                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "407                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "408                                      <p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height: normal\"><b><span lang=\"EN-GB\">10.     DATE OF REVISION OF THE TEXT</span></b></p>   \n",
       "409                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "410                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "411  <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Detailed information on this medicinal product is available on the website of the European Medicines </span><span lang=\"EN-GB\">Ag...   \n",
       "412                                                                                                       <p class=\"MsoNormal\" style=\"margin-right:-.1pt;line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "413                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "414                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "415                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "416                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "417                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "418                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "419                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "420                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "421                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "422                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "423                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "424                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "425                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "426                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "427                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "428                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "429                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "430                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "431                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "432                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "433                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "434                                                                                                                          <p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"> </span></p>   \n",
       "\n",
       "                                       ID  \\\n",
       "0    583f04cc-251b-4aa9-a300-400d62bebe5a   \n",
       "1    93f99a3a-3bdb-4712-b8a2-7f7151752254   \n",
       "2    37bd41cc-5002-4d0f-b837-d1e612a8c9f4   \n",
       "3    a118066d-62a7-49fe-b164-8dc28660cc13   \n",
       "4    048fcf44-3865-41ad-aa41-6fcf26a64a4e   \n",
       "5    c31204d8-633f-4f10-ac97-914fcf46f5d7   \n",
       "6    d70aeb25-5d44-4d24-b3ba-df3f0a945409   \n",
       "7    e1477684-3361-4ca8-bd48-87fe774951b6   \n",
       "8    6144e956-79cb-4671-935e-0428d8ae9552   \n",
       "9    e8d61a67-3455-4013-b0cb-8c6be91e1dd9   \n",
       "10   5ae63bab-fd9f-4543-8da5-95385fe2878a   \n",
       "11   73b2745c-30ea-4c64-8e98-aa6a807ed175   \n",
       "12   7a8d15de-c5dc-49a9-b9f2-c06ea2aa2812   \n",
       "13   e4924fc5-14a2-4074-ba07-3827e2690bbe   \n",
       "14   5bbfb234-75ff-4d1b-ba18-79dc786c49a3   \n",
       "15   502e9ac3-58ab-4843-b8a0-5fd60ed4e9c5   \n",
       "16   48f98078-4e9d-4cf6-a2e3-6551b02a5fa4   \n",
       "17   53bfe434-4517-42ce-a813-b71d9f2e38cc   \n",
       "18   b6a38e0b-e4f8-410b-b32a-37629f9e3831   \n",
       "19   6bea775e-8180-4ac2-9e83-683b15a278e5   \n",
       "20   d352b40d-10b4-4f2b-8989-ca2a32b8214e   \n",
       "21   cdc7ad58-c7fb-4b77-bcc2-de84faab6ac6   \n",
       "22   68654a8b-654b-47e1-a598-ec1c0860df89   \n",
       "23   7a0e81a8-d56c-4500-b4fc-ed031c115ec5   \n",
       "24   dd5948fb-58d2-4893-8b10-d805f0cdf739   \n",
       "25   75c81091-3ccc-4ed5-947f-c6995c913347   \n",
       "26   70d45c8c-f80d-484f-ace5-16d07806febf   \n",
       "27   b1cb472e-16b2-4c31-9704-43221d1c8944   \n",
       "28   7b7faf20-48a0-43ba-a11c-700ccaf1b44d   \n",
       "29   5f9f4e00-1c00-4d69-ae60-3b512d354b58   \n",
       "30   f468e77c-8bbb-4e8e-a650-a4bcf4292f4e   \n",
       "31   b6444544-1b61-4ede-bcb4-292a105fdf99   \n",
       "32   bebd747b-536c-4ae8-b191-86916bb5b392   \n",
       "33   79944278-5179-4fc2-8e1d-555b0355dd79   \n",
       "34   dd38be17-c16a-4a43-bd7d-7d7de217c2ab   \n",
       "35   39eb16f8-9ea5-47dc-9002-8f3bf989f47a   \n",
       "36   ef09f9ed-de0d-4558-8fb6-f7d64aaf2336   \n",
       "37   fb95db94-3ab2-47ed-860c-1a32343cda09   \n",
       "38   a2e7bc93-c504-4cf0-a556-8dbc293ae03d   \n",
       "39   6b8c14cb-eba7-4ba3-9de8-231605835033   \n",
       "40   445c2994-215c-4b60-9e68-58b10b0bebb5   \n",
       "41   86a20c6b-f68b-4371-9f8a-a22986385994   \n",
       "42   e59ad3b0-fdc0-4860-b4cd-0ffd1f6bbfdc   \n",
       "43   9b057f63-8d47-4932-bf02-b2258fe2de4f   \n",
       "44   d82f7f95-1ede-431d-a553-e3fb38e6ff28   \n",
       "45   603928f1-93e4-4c02-bb15-6bc6cef996af   \n",
       "46   fba2229a-f0ed-4548-ad90-a381cf1a1782   \n",
       "47   f630af4e-4e7d-4c18-b043-880d0facc0eb   \n",
       "48   b61d2001-da27-4ae0-9cd3-4fb666ce3ffe   \n",
       "49   31b9ed10-5866-4e63-8cca-ce18cc144980   \n",
       "50   7d27d913-4b56-4995-9a02-920d4d6d616b   \n",
       "51   261b4958-43c7-49b9-9e5a-d08543d24acf   \n",
       "52   4252fb30-8aea-4a64-969d-9f97eac73b9b   \n",
       "53   b3f0efe9-3876-4e68-b585-60721f1c25ac   \n",
       "54   4bf7be43-25d1-4109-903f-3037ea6db68f   \n",
       "55   ee1bc075-2c6c-4e05-abb9-4907d5feeb5b   \n",
       "56   32d06a42-9c67-427c-9011-cdfa13ede737   \n",
       "57   0ebcbda6-4e48-4ae4-a098-291a1bbc76ba   \n",
       "58   adf5587b-a53f-430b-817d-38b728fcf75d   \n",
       "59   624419e5-aee7-4efc-95aa-caa3b50bc1bc   \n",
       "60   238fb2f2-6728-400a-a31d-0a902b92cac0   \n",
       "61   0ba39624-d328-423e-9451-75729da49f5e   \n",
       "62   b1d7658a-c886-4549-8199-23d497c4cc6b   \n",
       "63   b4a4dc54-4b41-43bd-b82f-06ee394b17a2   \n",
       "64   86b7bbb5-d14b-4563-8aaf-f1f0b4aaad35   \n",
       "65   490f404e-fff3-4d71-a062-145a626aa698   \n",
       "66   e714aa41-f9b5-4f9d-aa85-f59525886d3c   \n",
       "67   f658b1e4-66f8-4649-978b-497e69ca133e   \n",
       "68   ced5ba42-b690-4da6-8bf6-5d6835f95180   \n",
       "69   31210945-890b-4725-acdf-a354e5ca32d4   \n",
       "70   9667ffd4-bc6f-4ff2-87bf-e738f6faabdf   \n",
       "71   7973028c-e20f-44d7-8125-8c6ded4f2aec   \n",
       "72   1355137f-9392-440f-b76b-893e39322a99   \n",
       "73   2d7b667e-921c-42ad-9bf8-c07eb6611782   \n",
       "74   33cb5747-aeff-44e1-a295-f35fdc5df1bf   \n",
       "75   819e866d-22fe-4467-979b-2965a5b375fb   \n",
       "76   42987233-13d8-4992-85ad-cd9d26a9e675   \n",
       "77   394675e6-38ca-43f4-8fa4-67bdbdb6ac0b   \n",
       "78   4116a164-0fb0-41ec-8d4d-980eee909720   \n",
       "79   38d92515-beef-4580-a9e9-5f343ee60f2c   \n",
       "80   f485a522-47e8-4737-9053-6c37b287e4da   \n",
       "81   2c251efd-4d57-451f-8e1b-27eaf97ac3ce   \n",
       "82   d7e68ae4-e1b1-4553-913c-12635b0a51cd   \n",
       "83   cf701288-a867-47a0-925f-00f0a42b647b   \n",
       "84   9c89d2ad-1586-421e-b9ca-7af854ac5300   \n",
       "85   dec049ff-97a9-40cd-87ba-11bdfb9bb5fd   \n",
       "86   6c18b861-4477-41c9-9ae9-9694f443b12a   \n",
       "87   16108ca5-3314-48c6-9284-f29117d61350   \n",
       "88   e007eba1-3f30-455b-8bff-f4e949cbfb82   \n",
       "89   dd6230e6-42fb-460b-8a51-7d767a43daab   \n",
       "90   1f6c3414-d7c9-4cf2-aa07-d6c5b237491d   \n",
       "91   3cb6dfbf-b485-4105-bf8a-beeb14b1cd5b   \n",
       "92   90f20e2b-efa4-4ccf-a405-6e5c9d8b7bc6   \n",
       "93   07bf33aa-2f31-4389-9771-d6b30a85d0e0   \n",
       "94   e1770234-5bf8-44d0-837b-67f40bdf1237   \n",
       "95   36d5342e-92b8-4a2e-a040-eca51b686035   \n",
       "96   f9f00845-fcc7-4f6b-be21-e64dc59b00c7   \n",
       "97   a86c67ac-ec53-4b50-a9df-b960de5da5c6   \n",
       "98   1ff14bbd-0749-4766-99c0-ede09b34a7b7   \n",
       "99   10c040f8-ca46-4b5e-8749-4d38a3844796   \n",
       "100  3f6da897-613d-46df-b921-4ba67da45e6b   \n",
       "101  32559cba-bfd6-4c6e-a7ef-d4aeb35ef35d   \n",
       "102  58f5b929-00a4-4a69-9e0a-f5ced47c136a   \n",
       "103  f5687243-13a4-46e0-adc6-415bb3e4afd4   \n",
       "104  31ffed79-5a24-4559-a566-8522af32fb14   \n",
       "105  dffa9fac-aacc-4a81-914f-78b314975780   \n",
       "106  caf234ef-3b41-4f82-8ed4-bc46d48e7c7e   \n",
       "107  561c67cb-8f9c-4799-85cb-bd886d1151a2   \n",
       "108  f63d4030-776d-44db-9cc6-74ff75f1134c   \n",
       "109  001e00a6-62d2-4a45-a2ad-fab1fe9559c3   \n",
       "110  cb4bce22-89a4-4d8d-8cdd-b672d0c88b93   \n",
       "111  a1a23c97-c624-4234-ace8-a766721f187c   \n",
       "112  f75c3d59-7a58-45ed-943d-7d8406b98311   \n",
       "113  7089a4c2-8b50-4922-b050-9cc7f27af572   \n",
       "114  c55563ca-acc4-4553-8c1a-42b9387a9a78   \n",
       "115  defaa2b8-7117-4310-b347-449f40ad24ff   \n",
       "116  6642c7d0-5706-4a24-9854-a9970510af06   \n",
       "117  5acabf9d-5eae-4f56-8d4c-78dcb8e857c1   \n",
       "118  6c8ceb67-f719-4af2-bc74-70e0294ebb59   \n",
       "119  eb658930-7124-408c-958f-2862d298f571   \n",
       "120  c9fe79ab-335c-4e9e-9fba-13a4f3bfb5b1   \n",
       "121  db4cd1d3-f264-43fd-88c0-8d7655c1b47b   \n",
       "122  8eb95d23-0d6c-4f26-8a07-679ab8ac0228   \n",
       "123  11a2fcce-48eb-45a9-8b97-53ecaaa73d86   \n",
       "124  c3478606-ac0b-4307-a4bd-638df28244be   \n",
       "125  b9ff00f8-ef92-4508-b24f-5dbf91989902   \n",
       "126  42abd336-a0eb-44ad-9d11-88de09f8b841   \n",
       "127  4e8df8f7-0fac-45a5-91ad-05cf93b3622f   \n",
       "128  799d9c0e-6134-4c36-9d6e-aa95272f563e   \n",
       "129  ac9b1575-5662-4fc5-b691-e9ce93b95d88   \n",
       "130  aecf1600-19a8-484c-a6c4-f87cfacd1373   \n",
       "131  a0f6cfdc-8042-4f0f-9d78-485a5c3c23b8   \n",
       "132  8212b032-0566-40af-b4bd-ce316a313d58   \n",
       "133  1aaf948b-addf-44cb-883c-1b19ea65cd4c   \n",
       "134  e92c6478-4a6b-4f59-9269-f8fd7c1dad6b   \n",
       "135  efbd0b19-f586-45e6-8c31-559b7ddbe773   \n",
       "136  c669fdac-8dcb-44e1-b338-f22434b3a115   \n",
       "137  eef5d66e-627a-44e7-a02a-b8539854de99   \n",
       "138  0e85539e-1a02-4688-bb24-6e07397dd0de   \n",
       "139  b96d36fa-6b90-4e0c-85de-47cc7e44b538   \n",
       "140  925de404-1c57-4456-8a43-4c656c7165cb   \n",
       "141  7498a234-2fbd-4001-be5a-f3355ad472be   \n",
       "142  7cfd4607-0430-4511-b02b-066e4be8655a   \n",
       "143  e2fb457a-6e5d-47fc-8456-c8f97240e96d   \n",
       "144  ae93d231-f8ba-47e6-af36-252c58405866   \n",
       "145  92fc3a0b-228c-44b6-b207-f2a812d3484a   \n",
       "146  02868645-f69f-48cf-bcbe-f15742e8f766   \n",
       "147  5d59e941-1027-4d1d-ab03-b568b6674fec   \n",
       "148  ca98b45d-98d6-4057-8db7-9b5c039c5cfd   \n",
       "149  a1786285-9b65-4742-ac7e-5ff27e9a199c   \n",
       "150  a50561fb-4abd-468d-8584-54156b98e12c   \n",
       "151  38069b69-f6df-4f61-9c3a-a75dde9a859d   \n",
       "152  871e05ef-31a7-489f-bac3-a2f55dfdde94   \n",
       "153  c39dbd51-9328-45a4-bac6-df6d25a7b0bd   \n",
       "154  357b6cf8-c2d7-42e1-b447-0e411a254e45   \n",
       "155  de8d55e0-de1c-4d68-a1de-9ba6e3db0097   \n",
       "156  ebce1105-f4bf-482a-a497-471e1a6d1760   \n",
       "157  88452719-0800-4b2c-96cf-ea5b386f5dd9   \n",
       "158  d5b72049-2472-41d4-9e03-f6828c98ce07   \n",
       "159  c2a9225d-e718-4537-8929-46091366c628   \n",
       "160  00b99e59-7e80-422c-aef1-8e487d552f09   \n",
       "161  9e1dffa5-d254-4870-a142-824011ff734a   \n",
       "162  9eb2ea87-aa58-40dc-9578-859810a3ca3a   \n",
       "163  4d02de8f-c15b-43bc-af6d-ffe87bdf1f88   \n",
       "164  3ccb923f-936e-4539-858f-f4e4013c9548   \n",
       "165  dd4a838f-4247-40fc-b3ad-7a1ea745661a   \n",
       "166  987733b6-745e-47c1-ab4a-d39014ea48b4   \n",
       "167  12293b6d-27fc-4f51-a392-aa1d0ab58450   \n",
       "168  adae8cec-c15f-466c-87a5-d9edcbc7decd   \n",
       "169  68495d94-1d08-4794-a87d-6fdb37a548f5   \n",
       "170  5500d36a-5762-434c-8892-bf87d0e7f820   \n",
       "171  0636c563-9390-400f-9ab3-5889e217a728   \n",
       "172  f1b0b323-4845-48bd-9022-8b3498e12b3c   \n",
       "173  3598871e-6274-45f3-a079-92e6a6cc0f4b   \n",
       "174  d1523c7d-682b-40c5-a31d-0ed3c856ad76   \n",
       "175  d3b08430-cd24-4b17-aeb5-65cd8c0fa6da   \n",
       "176  06a145f3-a3b6-468f-9569-9c66e32cdd40   \n",
       "177  da312712-3361-43b0-8cb8-ebe00c656f19   \n",
       "178  b24ce283-43d1-4609-a14a-ce76aefeb6ea   \n",
       "179  837beffa-4df5-46b3-9e30-c2df0b2c0859   \n",
       "180  440ff73a-8907-4923-a5dc-f3b4ccebeec9   \n",
       "181  58b0b3ed-6191-4566-9d5d-bffd88dd7d08   \n",
       "182  9a48cf61-c759-4667-ae82-3fe92599ba09   \n",
       "183  37538e84-41d5-4dd8-a4f1-8f9d7515630d   \n",
       "184  bdd4a612-1b71-48af-bb4d-b6992a0d727d   \n",
       "185  2d6e4e03-57ab-41aa-8bb6-50da47e524a1   \n",
       "186  d64d220d-681c-41cc-be35-d2388b0fe2af   \n",
       "187  81f7f5c9-3aa9-4ca9-a6e4-18ff45f702a1   \n",
       "188  be23a4ff-636e-4419-a2b4-53c8da85fba7   \n",
       "189  d95c745f-4632-4816-93a3-bf5315fb6186   \n",
       "190  6c217e0b-6104-473f-89d1-138ec1d858ea   \n",
       "191  9021bd02-b10e-4f7a-8d6f-8607a943d54d   \n",
       "192  05b4dc55-ce07-49e7-98d0-d74847496bdc   \n",
       "193  764acee4-ad8f-4679-bfd8-2d754f01ab88   \n",
       "194  2e81c580-64f0-479b-baac-f7989c2f399c   \n",
       "195  a6d0a699-c8cf-4a9f-9667-b8f6e4efe584   \n",
       "196  b2231afc-7779-4625-8ac4-2819167847b6   \n",
       "197  38b60d54-b880-4fc5-a4f4-89ce63aeb5ce   \n",
       "198  15ae06a0-6e38-48b6-9b98-796008d0a290   \n",
       "199  fc5ac450-265a-4a49-92fd-94f18063c6e8   \n",
       "200  1dd00aad-f767-4d29-ab47-a0ece231bb21   \n",
       "201  e7c2423f-a48a-414c-9bbd-4c511efdb528   \n",
       "202  95bd2fe7-3442-4e6d-b591-1f836f48ae21   \n",
       "203  71575f83-7664-4637-beb1-6a5b97c16cfe   \n",
       "204  0d50548f-2482-4f8b-abd3-321304018d5f   \n",
       "205  ab71b0bc-5a25-48a4-a89f-1f17e668aa1a   \n",
       "206  4dd078ae-806b-4e3a-a55b-2b2c2bc1df57   \n",
       "207  f3912285-4b05-4670-a041-77eca738249c   \n",
       "208  22741a98-5799-4d6d-92ac-9aa31e592b25   \n",
       "209  472a0d46-f38f-4b06-9377-8b14a1ca58ab   \n",
       "210  9abf657f-4184-406f-9882-ccdafe7d62df   \n",
       "211  06f14b6a-445d-4929-b3f9-42c7c98bd689   \n",
       "212  1cfceb45-f752-4744-add7-e75fc2b30f0d   \n",
       "213  f2a0e2c1-e6bd-40b3-b1f9-a3b59362d87d   \n",
       "214  746abb46-4321-4390-a3d1-57628c87ee75   \n",
       "215  9df75617-c6d9-4284-99eb-9c6d286028ea   \n",
       "216  8a5bfeed-92a7-4157-aa23-5e8d782ee2f3   \n",
       "217  26b32385-ff0c-468c-8156-48e4ea2e5632   \n",
       "218  ddc462b4-8779-4b40-b2cd-13c11a5c35ea   \n",
       "219  f00331f9-91ee-4ffc-9f5b-c7b8d020d857   \n",
       "220  cc21ce0f-b181-4775-ad96-2bb33aad2435   \n",
       "221  c9fea0dd-a255-4ab8-957b-4a237116ff85   \n",
       "222  5ff0994f-3178-439a-a684-c5b18e0ff720   \n",
       "223  f6602db2-bba7-4d09-be01-924009293f42   \n",
       "224  6d24b1e8-7bcc-499b-9560-8630cab90afd   \n",
       "225  55a081a7-69be-4ffb-aade-5eaf29f54a50   \n",
       "226  90069808-d21a-40db-a5cb-79185d63ea1e   \n",
       "227  06133542-b88f-49aa-8c7f-5dbcc0f276bb   \n",
       "228  40863246-ddd2-434e-9fcc-3f487cc6f3c0   \n",
       "229  0f55922a-bcc3-477f-8e53-b7b1c53ba65a   \n",
       "230  ba08dd82-6928-449e-b2bf-28bfc45990b6   \n",
       "231  306055ba-c099-4738-bafa-dedc95f5c4e5   \n",
       "232  c2b709f0-86b2-4fa9-98d3-6988b154be09   \n",
       "233  da5c88f0-dcea-4689-938e-3c1b93d7a754   \n",
       "234  5208b575-d8b9-4b18-981d-40fcf95b2b71   \n",
       "235  976c04c1-4a00-4a08-af6a-eb33f16cc272   \n",
       "236  94b4115a-655a-4aea-9954-cf0f835aecee   \n",
       "237  ea96e98a-b631-443f-a2a7-37382a04f305   \n",
       "238  8d4fe1ee-a863-42e2-bef0-564ff21f6c0b   \n",
       "239  1f28a2cd-e389-410e-9522-6477de26e0cb   \n",
       "240  e84ed10a-b1be-47cf-8814-775d712347f9   \n",
       "241  8c14f577-cb46-494a-9162-054506680e7b   \n",
       "242  0f6cf8d7-9223-45d8-87c5-ff279c3c38b5   \n",
       "243  8ff37dc4-c898-4d52-a5aa-697fb9731068   \n",
       "244  13f05400-d25d-441b-8c2e-1bbc1ae3cc2b   \n",
       "245  e85c0863-dc1a-42dc-ab9a-7b5fac36835e   \n",
       "246  fd84f968-a97f-4259-b766-a742451e77df   \n",
       "247  3f5b8c47-c06e-451b-ad88-9ec7eda2c145   \n",
       "248  65c2aa8e-1f0d-4f53-a9a6-31e70f0e528b   \n",
       "249  c778d352-157f-4fdd-a650-9794035bb188   \n",
       "250  93e46389-181f-4b47-ac7a-0941c0257958   \n",
       "251  1d9f638b-9522-45d4-aade-2ea3ee357fce   \n",
       "252  2b0ed3b1-e815-4631-bbf0-acb3af13b8cc   \n",
       "253  85f8de6d-913b-4eb5-acc3-e28469213af1   \n",
       "254  d9ff4f36-ed04-4f6c-a5b5-0c77a32c3473   \n",
       "255  655e28b7-c7d4-4a3e-85e1-645ab4a9998f   \n",
       "256  eee72aad-0d37-4d8b-9cdc-1ebe65c0efc2   \n",
       "257  3aeb1c53-df5f-486d-8b90-194a72885c98   \n",
       "258  bc77fded-79e5-41c5-afe0-7d9019610912   \n",
       "259  ba64cecf-46c2-47ea-af81-b647e28a94ce   \n",
       "260  8b252518-6a39-496d-a2a8-1f4de11f314b   \n",
       "261  00533119-b294-4d3b-addb-f6fd4c3e35f0   \n",
       "262  f0af07b2-a8f5-48df-9990-5f017322f332   \n",
       "263  532a95ac-aa2d-482f-b98e-8087c9e1aae4   \n",
       "264  21135353-0ad7-4d0e-9182-c1205f92b29b   \n",
       "265  1c6e5ea8-2fc1-4281-bc2f-96d19363107b   \n",
       "266  73ad910b-c420-4838-ae7f-51f7dfa34806   \n",
       "267  ca25d772-76ad-4b7f-b51f-921b95efd10a   \n",
       "268  1bf44745-663f-43a1-9114-5512396fecf5   \n",
       "269  3480d3aa-b931-4d9d-8a25-ff2950f70e47   \n",
       "270  da63ad24-98cc-4f6c-a9ac-7d4eaf9df730   \n",
       "271  994c284c-fd5a-4bca-856c-a06ca2d991e3   \n",
       "272  25c08c2a-97cd-49b7-a3e6-ed7e3b2a9398   \n",
       "273  317d6b14-9c20-4bea-bf70-1dd1bfd14ee0   \n",
       "274  9644480b-9013-49d2-a9e9-2795592596a9   \n",
       "275  21be6999-4166-4ea3-bc2a-46e7e9c1f35f   \n",
       "276  fa7ee2a9-8612-4798-a0b2-e8c66dbfa3c7   \n",
       "277  eb9693fa-6305-4d68-9a84-84c27a959a65   \n",
       "278  e3091ce6-30ef-4898-95d8-5ac8dc9582e9   \n",
       "279  0f8c5072-5ed3-4aec-8749-5ac476a7e75f   \n",
       "280  09a8d525-4272-4243-a3b6-b61c438b48b5   \n",
       "281  07676513-d6ad-4403-b7f4-172327384a02   \n",
       "282  2377eb8c-a022-4bd6-9344-958346ad2a64   \n",
       "283  de6eb665-d2f6-423f-bbb4-6cf89fe19fc8   \n",
       "284  55fdf68a-b0d0-41fd-94a5-c7462d8a9ca4   \n",
       "285  ad169960-f812-480f-80f4-6c2f1384a117   \n",
       "286  1481fd7d-eec3-4db9-a8c3-2a7757e2e767   \n",
       "287  734175d6-c4a2-4df4-ad4f-c1289c180bf2   \n",
       "288  83a0b34c-87a8-4941-8bd0-9a8eacba26c2   \n",
       "289  1db6ba87-5368-4522-a96c-6bb36868e756   \n",
       "290  eab04aa6-e6d1-488b-9b0a-cdf2d9fbe1d1   \n",
       "291  06d7dc74-1123-46c5-8e58-5baba403d620   \n",
       "292  4679ecf1-e9ac-4cc6-9347-882d2b80caaa   \n",
       "293  5612455a-6bf5-4e73-875f-5525fee58655   \n",
       "294  9dfe8e22-726c-48dd-a73e-0ffca677a83e   \n",
       "295  c95b5e22-fa87-49b9-933e-1076b8325fc8   \n",
       "296  249ba44f-0806-4154-a058-151cfd72086b   \n",
       "297  aa214270-ebc8-4f85-a58a-04986ad789e3   \n",
       "298  8fb16356-f5ab-42a4-aaac-9444a3167a9a   \n",
       "299  46f8c14d-38a5-4dcb-9ddd-19fa5a0cfc57   \n",
       "300  4a51b9ef-c655-47df-8040-1454020aab38   \n",
       "301  9ccca12b-0a06-4812-95cc-48dc425408e2   \n",
       "302  2c6442f0-201f-4775-8452-1c36a089ff2a   \n",
       "303  de592949-aa05-45df-92ce-b8517448318c   \n",
       "304  1bd38c10-06fd-4517-b905-bfa5009eaa54   \n",
       "305  bfd1df42-3b6b-4eb7-9ac9-ed2f0a05e768   \n",
       "306  3fdc8ea7-8326-4261-ad5c-e716a34fdfa9   \n",
       "307  3d455957-9727-4c20-9bbc-88e5da60aa85   \n",
       "308  643d24d6-80da-4ab4-9624-0221c8465acb   \n",
       "309  1ea14223-5db3-4ba2-b1ec-4f17d58dcd5f   \n",
       "310  966675b9-690b-41d9-98ed-60967ffd9f3c   \n",
       "311  ed327a73-30e6-4081-b6de-0fe728ce8969   \n",
       "312  252756a3-2ffd-4fa1-93bf-62767e7a8c66   \n",
       "313  e42486b8-431d-489e-92e1-26e80f62c326   \n",
       "314  3382e5f0-a081-4aa4-97d5-536842c7328e   \n",
       "315  d4798f99-bb2d-4cc7-ba65-ace4e92c99d6   \n",
       "316  95540f6b-617d-48b0-a6bc-5f309ea429aa   \n",
       "317  8533427e-eca8-4d27-add7-ae84359e2b3d   \n",
       "318  0695764c-3f57-4cc5-bdc9-032776603195   \n",
       "319  93b62773-0f41-45e2-94ac-0e36099c20e6   \n",
       "320  a2269772-413a-4a40-81f3-bff5dd940e7c   \n",
       "321  c1dd7e4b-2172-4e76-b329-beee93d2cb22   \n",
       "322  823e1348-5e7b-4ece-8640-affd6e5ed5be   \n",
       "323  8d321b8f-d147-49dc-b3f2-14c13473e828   \n",
       "324  37d476c0-f943-407b-b694-73edbb744cf1   \n",
       "325  00e069bf-ec29-46b0-9da9-069be813ec77   \n",
       "326  8a8b2484-d59f-49da-88e1-b8fb42574e6d   \n",
       "327  15a7da87-7151-407a-aff9-f16540d65487   \n",
       "328  ccd15a79-4c3e-4920-a3e2-495f132624ad   \n",
       "329  fd426195-3dc5-4f10-9564-c7c5e3e9291c   \n",
       "330  e81f948d-5467-4471-a174-5542d7d5d673   \n",
       "331  6289cac5-3b81-4e28-9ad6-409df65bb1d5   \n",
       "332  9e63db32-7ab4-433c-95ed-27da07885ad9   \n",
       "333  be86aea2-b55d-411b-b239-579d9ab70e79   \n",
       "334  30dfdf90-c7c6-46dd-81ed-34040c037707   \n",
       "335  0916fc58-f815-4be1-8e43-15d87212f2ff   \n",
       "336  c05a9aae-2370-4c08-8a36-30a372a87373   \n",
       "337  0ecc299e-06ef-4489-8a36-f2034f2042ab   \n",
       "338  a112a3f4-75ce-4161-8661-ea3d6b64a170   \n",
       "339  699fc118-68a0-4d85-91f8-68906d13d935   \n",
       "340  1c6011d9-95b8-4289-88e3-be255803aa85   \n",
       "341  9d751841-7244-4356-92cd-d0d33db564a8   \n",
       "342  0566d8ce-a929-4cd0-8ac2-6d814231b189   \n",
       "343  d57803b0-6a88-44a7-88de-d89dae95ab44   \n",
       "344  558e72cd-ad45-48cc-bf26-ed0c0f1fa60a   \n",
       "345  13eb2179-b33a-48a3-81da-f9ac455031fe   \n",
       "346  f67001d0-3ed0-46c6-a74b-ceb81076f6ca   \n",
       "347  2b7c8f38-c832-4a4e-a4c8-03d1672b36c5   \n",
       "348  78af6177-82e3-47dc-bdee-a120221922fd   \n",
       "349  0562f34b-62da-4f2c-b64d-fbe84c7ab2ad   \n",
       "350  007d733a-4f29-41b2-b121-2cb115094347   \n",
       "351  bc7bcab8-dac1-4983-916e-5ffcb01f938d   \n",
       "352  c4a1d90f-bd32-4d0a-bf43-604c0b34c9af   \n",
       "353  4512dd38-a048-42e5-8029-b540a8263f2b   \n",
       "354  e23ff6b2-20ae-44b0-b64f-198e5618f75d   \n",
       "355  1473cd1c-9b6f-4370-9f72-e83e69475737   \n",
       "356  95f93264-c234-4b46-89c6-e945e5e9b31d   \n",
       "357  94346e88-c101-4bc7-8012-d3b0d77c943c   \n",
       "358  51d7f2e0-8d66-42f0-92ca-d00295fda75d   \n",
       "359  30001714-d1b1-486b-99fd-1e91d0dcec95   \n",
       "360  33a626aa-b331-405b-9e6e-973e963fc8ac   \n",
       "361  c2a797e4-ca61-4a7f-b729-32f94c299d13   \n",
       "362  29859d43-7257-48ca-82e8-4da9831cccad   \n",
       "363  985c20b0-443f-4a52-9767-84b70deae8fc   \n",
       "364  e105b8a5-3f7f-4323-88f6-c66f83ef9f97   \n",
       "365  88fa01d0-297f-44a4-9f1e-72b7db37da6e   \n",
       "366  8a5434fe-20f2-4bf7-b303-a467e4500701   \n",
       "367  f9dda721-880c-4fdd-81c9-23a61f02f35a   \n",
       "368  dfe30f25-3213-49f3-8c1a-a03428471f1d   \n",
       "369  a6daa916-3929-40ec-985a-6e34ce49cc4f   \n",
       "370  4b2604a7-15d1-4474-bf4b-c802fbbaa010   \n",
       "371  e366bb71-b7ba-4cfc-b28f-66f0bbc90eee   \n",
       "372  66a122bf-afbc-49d3-9b45-b2c7d80407c0   \n",
       "373  fac9eddc-a1cd-4099-bd26-f4664ec53a90   \n",
       "374  a15ac1bf-0bfb-4400-8bc9-b4f24a526ef8   \n",
       "375  af8f1547-b844-40e2-9fcf-393264f9fcbc   \n",
       "376  4282d2cf-94c8-463c-835c-14d070734b16   \n",
       "377  d81fb4c8-01d1-41bf-8579-8cfb069ef597   \n",
       "378  755f3b13-17d9-4fe3-9c2b-1f5fb1a5d6c0   \n",
       "379  a21c3ed4-49d7-4e66-9692-d9ddcbf7b9bf   \n",
       "380  a44b6df6-f9ab-4c89-8110-e858a2e81944   \n",
       "381  e1525e94-a89a-4533-bcd3-24d091a9a998   \n",
       "382  cc618436-4d6a-4fdc-8841-f06397bdae7a   \n",
       "383  2ca8a9c0-71bf-4f00-ac95-4f17769b0430   \n",
       "384  91651b3d-52f4-4496-9120-d585bdf34f81   \n",
       "385  fc23fa4e-5365-4897-8e35-081b5bc498e3   \n",
       "386  790d0f73-c2bb-4287-a4fd-7353eea185e6   \n",
       "387  d9bc9594-8973-438b-af6e-ce6f9f95a3e9   \n",
       "388  88caa940-38af-4a39-85ac-496e8896c678   \n",
       "389  9f3a1ca2-3874-417a-82e6-7b6dcd3a23cc   \n",
       "390  17bb70bb-c856-421e-a119-655fcd74c970   \n",
       "391  2e90cca4-467f-40f6-9d9b-7cdcc501a036   \n",
       "392  6a6d9cce-8b55-41c6-a9df-5a2974a1aff4   \n",
       "393  ee815573-69e1-4b40-9bc2-5e163d630406   \n",
       "394  80c23402-0480-4124-8f6f-46925c8e537b   \n",
       "395  dfa537c6-eb19-410c-afb9-33186c2b6b05   \n",
       "396  2b695489-cf12-4049-a2e1-1a2d14df92d2   \n",
       "397  48c00e77-77ec-4244-9d94-2fd6f4b81631   \n",
       "398  21f9fed2-00ca-44a3-9267-1078e9faf781   \n",
       "399  e98778fc-a17b-48aa-8e8a-cbe138ff09c4   \n",
       "400  fefa296f-e154-42b7-8416-72c6b78230fa   \n",
       "401  d3c33c17-e1b6-4954-be6b-c384593de96c   \n",
       "402  317e074d-c34f-4f1f-890c-df3b4c5a19ae   \n",
       "403  36bce19f-089e-4025-a9d9-3b41061b9947   \n",
       "404  bcde3901-95f7-48b8-9dbc-01fc7f2ef0e3   \n",
       "405  acaf6790-3f91-4b6f-99bc-199765791f5a   \n",
       "406  d56760a9-7b6c-406d-a591-5c8012b57d75   \n",
       "407  0c85ada6-10f3-4235-9810-45b382d68edb   \n",
       "408  a86741a5-547d-4084-bbdb-e8eea5a9da42   \n",
       "409  fd5536d3-3d24-4f8a-9a87-763251e3817b   \n",
       "410  66026015-c5e3-417c-ab6e-ac77e1a42b13   \n",
       "411  3cd86c01-ce4b-404f-9774-5467f495dcf0   \n",
       "412  201cb4bb-4df3-45ab-aaa5-bd46bb419470   \n",
       "413  c2d1acd4-1298-4014-91a6-a105a1c9be38   \n",
       "414  3731cb55-5fdb-475d-bec8-bcf2fb4a5692   \n",
       "415  2103b9cc-b2dd-4dc7-9cca-7aaf2ca8e6dd   \n",
       "416  cb897326-186f-4a5f-b3b6-5eb11a2091a4   \n",
       "417  c33d0918-4f07-4b10-981d-3a7a2e51f4ee   \n",
       "418  4dc1eeca-1565-4651-86de-bb0549d7050c   \n",
       "419  ee2b1bb5-2900-4e3b-bfcc-570e2dde38e2   \n",
       "420  19b053f2-d9c9-4930-85f2-1f860db8cfef   \n",
       "421  b1edb48c-264b-4d54-92fb-cd63dad463b7   \n",
       "422  0e9207b1-a497-45e4-8eee-6c06c1bc16dd   \n",
       "423  ca99e9aa-9e9e-456d-ab1b-e2d19669890d   \n",
       "424  ade7361e-e0bb-48cc-a7c7-2a6674f5329f   \n",
       "425  f0c6c67a-380f-4da4-9e5a-02cd72cc4a71   \n",
       "426  055a5227-34c3-439a-8046-f928d2d0ea70   \n",
       "427  1dd82cf7-9f12-4867-91a0-c450f9ce6fcc   \n",
       "428  f6251986-fd21-4691-88e4-edb89b0422a4   \n",
       "429  a3a9a54e-fb50-404d-9510-f6300d2bbb11   \n",
       "430  20b168cc-9f45-4b6d-933f-6077b8af5595   \n",
       "431  d1d3015a-8a2b-4ab0-842d-a3cc8c9e169a   \n",
       "432  66e9038f-c383-4cff-95af-818e76a2091d   \n",
       "433  658742af-a192-4d57-8624-0f9a44426e15   \n",
       "434  4af52237-24ea-434e-9e10-08277413103e   \n",
       "\n",
       "                                                                                                                                 Styles  \\\n",
       "0                                                                                                                                  None   \n",
       "1                                                                                                                    line-height:normal   \n",
       "2                                                                                                                    line-height:normal   \n",
       "3                                                                                                                    line-height:normal   \n",
       "4                                                                                                                    line-height:normal   \n",
       "5                                                                                                                    line-height:normal   \n",
       "6                                                                                                                    line-height:normal   \n",
       "7                                                                                                                    line-height:normal   \n",
       "8                                                                                                                    line-height:normal   \n",
       "9                                                                                                                    line-height:normal   \n",
       "10                                                                                                                   line-height:normal   \n",
       "11                                                                                                                   line-height:normal   \n",
       "12                                                                                                                   line-height:normal   \n",
       "13                                                                                                                   line-height:normal   \n",
       "14                                                                                                                   line-height:normal   \n",
       "15                                                                                                                   line-height:normal   \n",
       "16                                                                                                                   line-height:normal   \n",
       "17                                                                                                                   line-height:normal   \n",
       "18                                                                                                                   line-height:normal   \n",
       "19                                                                                                                   line-height:normal   \n",
       "20                                                                                                                   line-height:normal   \n",
       "21                                                                                                                   line-height:normal   \n",
       "22                                                                                                                   line-height:normal   \n",
       "23                                                                                                                   line-height:normal   \n",
       "24                                                                                                 text-align:center;line-height:normal   \n",
       "25                                                                                                 text-align:center;line-height:normal   \n",
       "26                                                                                                 text-align:center;line-height:normal   \n",
       "27                                                                   font-size:11.0pt;font-family:\"Times New Roman\",serif;\\ncolor:green   \n",
       "28                                                                                                             page-break-before:always   \n",
       "29                                                                                                                   line-height:normal   \n",
       "30                                                                                                                   line-height:normal   \n",
       "31                                                                                                                   line-height:normal   \n",
       "32                                                 margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "33                                                                                            line-height:normal;page-break-after:avoid   \n",
       "34                                                                                                                   line-height:normal   \n",
       "35                                                                                                                   line-height:normal   \n",
       "36                                                                                                                   line-height:normal   \n",
       "37                                                 margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "38                                                                                            line-height:normal;page-break-after:avoid   \n",
       "39                                                                                                                   line-height:normal   \n",
       "40                                                                                                                   line-height:normal   \n",
       "41                                                                                                                   line-height:normal   \n",
       "42                                                                                                                   line-height:normal   \n",
       "43                                                                                                                   line-height:normal   \n",
       "44                                                                                                                   line-height:normal   \n",
       "45                                                                                                                   line-height:normal   \n",
       "46                                                                                                                   line-height:normal   \n",
       "47                                                                                                                   line-height:normal   \n",
       "48                                                 margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "49                                                                                            line-height:normal;page-break-after:avoid   \n",
       "50                                                                                                                   line-height:normal   \n",
       "51                                                                                                                   line-height:normal   \n",
       "52                                                                                                                   line-height:normal   \n",
       "53                                                                                                                   line-height:normal   \n",
       "54                                                                                                                   line-height:normal   \n",
       "55                                                 margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "56                                                                                            line-height:normal;page-break-after:avoid   \n",
       "57                                                 margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "58                                                                                            line-height:normal;page-break-after:avoid   \n",
       "59                                                                                                                                 None   \n",
       "60                                                                                                                   line-height:normal   \n",
       "61                                                                                            line-height:normal;page-break-after:avoid   \n",
       "62                                                                                            line-height:normal;page-break-after:avoid   \n",
       "63                                                                                                                   line-height:normal   \n",
       "64                                                                                                                   line-height:normal   \n",
       "65                                                                                            line-height:normal;page-break-after:avoid   \n",
       "66                                                                                            line-height:normal;page-break-after:avoid   \n",
       "67                                                                                                                   line-height:normal   \n",
       "68                                                                                                                   line-height:normal   \n",
       "69                                                                                                                   line-height:normal   \n",
       "70                                                                                                                   line-height:normal   \n",
       "71                                                                                            line-height:normal;page-break-after:avoid   \n",
       "72   margin-top:0in;margin-right:0in;margin-bottom:\\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt   \n",
       "73   margin-top:0in;margin-right:0in;margin-bottom:\\n0in;margin-left:28.35pt;margin-bottom:.0001pt;text-align:left;text-indent:-28.35pt   \n",
       "74                                                                                                                   line-height:normal   \n",
       "75                                                                                            line-height:normal;page-break-after:avoid   \n",
       "76                                                                                            line-height:normal;page-break-after:avoid   \n",
       "77                                                                                                                   line-height:normal   \n",
       "78                                                                                                                   line-height:normal   \n",
       "79                                                                                            line-height:normal;page-break-after:avoid   \n",
       "80                                                                                                                   line-height:normal   \n",
       "81                                                                                                                   line-height:normal   \n",
       "82                                                                                            line-height:normal;page-break-after:avoid   \n",
       "83                                                                                                                   line-height:normal   \n",
       "84                                                                                                                   line-height:normal   \n",
       "85                                                                                            line-height:normal;page-break-after:avoid   \n",
       "86                                                                                                                   line-height:normal   \n",
       "87                                                                                                                   line-height:normal   \n",
       "88                                                                                                                   line-height:normal   \n",
       "89                                                                                                                   line-height:normal   \n",
       "90                                                                                            line-height:normal;page-break-after:avoid   \n",
       "91                                                                                            line-height:normal;page-break-after:avoid   \n",
       "92                                                                                                                   line-height:normal   \n",
       "93                                                                                                                   line-height:normal   \n",
       "94                                                                                                                   line-height:normal   \n",
       "95                                                                                                                   line-height:normal   \n",
       "96                                                                                                                   line-height:normal   \n",
       "97                                                                                                                   line-height:normal   \n",
       "98                                                 margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "99                                                                                            line-height:normal;page-break-after:avoid   \n",
       "100                                                                                                                  line-height:normal   \n",
       "101                                                                                                                  line-height:normal   \n",
       "102                                                                                                                  line-height:normal   \n",
       "103                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "104                                                                                           line-height:normal;page-break-after:avoid   \n",
       "105                                                                                           line-height:normal;page-break-after:avoid   \n",
       "106                                                                                           line-height:normal;page-break-after:avoid   \n",
       "107                                                                                                                  line-height:normal   \n",
       "108                                                                                                                  line-height:normal   \n",
       "109                                                                                           line-height:normal;page-break-after:avoid   \n",
       "110                                                                                           line-height:normal;page-break-after:avoid   \n",
       "111                                                                                                                  line-height:normal   \n",
       "112                                                                                                                  line-height:normal   \n",
       "113                                                                                           line-height:normal;page-break-after:avoid   \n",
       "114                                                                                           line-height:normal;page-break-after:avoid   \n",
       "115                                                                                                                  line-height:normal   \n",
       "116                                                                                                                  line-height:normal   \n",
       "117                                                                                                                  line-height:normal   \n",
       "118                                                                                                                  line-height:normal   \n",
       "119                                                                                           line-height:normal;page-break-after:avoid   \n",
       "120                                                                                           line-height:normal;page-break-after:avoid   \n",
       "121                                                                                                                  line-height:normal   \n",
       "122                                                                                                                  line-height:normal   \n",
       "123                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "124                                                                                           line-height:normal;page-break-after:avoid   \n",
       "125                                                                                                                  line-height:normal   \n",
       "126                                                                                                                  line-height:normal   \n",
       "127                                                                                                                  line-height:normal   \n",
       "128                                                                                                                  line-height:normal   \n",
       "129                                                                                                                  line-height:normal   \n",
       "130                                                                                                                  line-height:normal   \n",
       "131                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "132                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "133                                                                                           line-height:normal;page-break-after:avoid   \n",
       "134                                                                                           line-height:normal;page-break-after:avoid   \n",
       "135                                                                                                                                None   \n",
       "136                                                                                                                  line-height:normal   \n",
       "137                                                                                                                  line-height:normal   \n",
       "138                                                                                                                  line-height:normal   \n",
       "139                                                                                           line-height:normal;page-break-after:avoid   \n",
       "140                                                                                           line-height:normal;page-break-after:avoid   \n",
       "141                                                                                                                  line-height:normal   \n",
       "142                                                                                                                  line-height:normal   \n",
       "143                                                                                                                  line-height:normal   \n",
       "144                                                                                                                  line-height:normal   \n",
       "145                                                                                                                  line-height:normal   \n",
       "146                                                                                                                  line-height:normal   \n",
       "147                                                                                           line-height:normal;page-break-after:avoid   \n",
       "148                                                                                           line-height:normal;page-break-after:avoid   \n",
       "149                                                                                                                  line-height:normal   \n",
       "150                                                                                                                  line-height:normal   \n",
       "151                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "152                                                                                           line-height:normal;page-break-after:avoid   \n",
       "153                                                                                                                  line-height:normal   \n",
       "154                                                                                                                  line-height:normal   \n",
       "155                                                                                           line-height:normal;page-break-after:avoid   \n",
       "156                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "157                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "158                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "159                                                                                              line-height:normal;text-autospace:none   \n",
       "160                                                                                              line-height:normal;text-autospace:none   \n",
       "161                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "162                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "163                                                                                              line-height:normal;text-autospace:none   \n",
       "164                                                                                              line-height:normal;text-autospace:none   \n",
       "165                                                                                              line-height:normal;text-autospace:none   \n",
       "166                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "167                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "168                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "169                                                                                  width:459.0pt;border-collapse:collapse;border:none   \n",
       "170                                                                                                      margin-top:0in;text-align:left   \n",
       "171                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "172                                                                             margin-top:0in;text-align:left;page-break-after:\\navoid   \n",
       "173                                                                             margin-top:0in;text-align:left;page-break-after:\\navoid   \n",
       "174                                                                                                      margin-top:0in;text-align:left   \n",
       "175                                                                                                      margin-top:0in;text-align:left   \n",
       "176                                                                                                      margin-top:0in;text-align:left   \n",
       "177                                                                                                      margin-top:0in;text-align:left   \n",
       "178                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "179                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "180                                                                                                      margin-top:0in;text-align:left   \n",
       "181                                                                                                      margin-top:0in;text-align:left   \n",
       "182                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "183                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "184                                                                                              line-height:normal;text-autospace:none   \n",
       "185                                                                                                                  line-height:normal   \n",
       "186                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "187                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "188                                                                       margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal   \n",
       "189                                                                       margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal   \n",
       "190                                                                                                                  line-height:normal   \n",
       "191                                                                                                                  line-height:normal   \n",
       "192                                                                                                                  line-height:normal   \n",
       "193                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "194                                                                                           line-height:normal;page-break-after:avoid   \n",
       "195                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "196                                                                                           line-height:normal;page-break-after:avoid   \n",
       "197                                                                                           line-height:normal;page-break-after:avoid   \n",
       "198                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "199                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "200                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "201                                                                                              line-height:normal;text-autospace:none   \n",
       "202                                                                                              line-height:normal;text-autospace:none   \n",
       "203                                                                                              line-height:normal;text-autospace:none   \n",
       "204                                                                                              line-height:normal;text-autospace:none   \n",
       "205                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "206                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "207                                                                                                                  line-height:normal   \n",
       "208                                                                                              line-height:normal;text-autospace:none   \n",
       "209                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "210                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "211                                                                                              line-height:normal;text-autospace:none   \n",
       "212                                                                                              line-height:normal;text-autospace:none   \n",
       "213                                                                                              line-height:normal;text-autospace:none   \n",
       "214                                                                                              line-height:normal;text-autospace:none   \n",
       "215                                                                                              line-height:normal;text-autospace:none   \n",
       "216                                                                                              line-height:normal;text-autospace:none   \n",
       "217                                                                                              line-height:normal;text-autospace:none   \n",
       "218                                                                                              line-height:normal;text-autospace:none   \n",
       "219                                                                                              line-height:normal;text-autospace:none   \n",
       "220                                                                                              line-height:normal;text-autospace:none   \n",
       "221                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "222                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "223                                                                                   width:98.84%;border-collapse:collapse;border:none   \n",
       "224                                                                                              line-height:normal;text-autospace:none   \n",
       "225                                                                                                                                None   \n",
       "226                                                                                              line-height:normal;text-autospace:none   \n",
       "227                                                                                              line-height:normal;text-autospace:none   \n",
       "228                                                                                              line-height:normal;text-autospace:none   \n",
       "229                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "230                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "231                                                                                                border-collapse:collapse;border:none   \n",
       "232                                                                                              line-height:normal;text-autospace:none   \n",
       "233                                                                                              line-height:normal;text-autospace:none   \n",
       "234                                                                                              line-height:normal;text-autospace:none   \n",
       "235                                                                                              line-height:normal;text-autospace:none   \n",
       "236                                                                                              line-height:normal;text-autospace:none   \n",
       "237                                                                                           line-height:normal;page-break-after:avoid   \n",
       "238                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "239                                                                                               margin-top:0in;page-break-after:avoid   \n",
       "240                                                                                           line-height:normal;page-break-after:avoid   \n",
       "241                                                                                               margin-top:0in;page-break-after:avoid   \n",
       "242                                                                                               margin-top:0in;page-break-after:avoid   \n",
       "243                                                                     line-height:normal;page-break-after:avoid;text-autospace:\\nnone   \n",
       "244                                                                                              line-height:normal;text-autospace:none   \n",
       "245                                                                                              line-height:normal;text-autospace:none   \n",
       "246                                                                                                                                None   \n",
       "247                                                                                           line-height:normal;page-break-after:avoid   \n",
       "248                                                                                           line-height:normal;page-break-after:avoid   \n",
       "249                                                                                                                  line-height:normal   \n",
       "250                                                                                                                  line-height:normal   \n",
       "251                                                                                                                  line-height:normal   \n",
       "252                                                                                                                  line-height:normal   \n",
       "253                                                                                           line-height:normal;page-break-after:avoid   \n",
       "254                                                                                           line-height:normal;page-break-after:avoid   \n",
       "255                                                                                                                  line-height:normal   \n",
       "256                                                                                                                  line-height:normal   \n",
       "257                                                                                                                  line-height:normal   \n",
       "258                                                                                                                  line-height:normal   \n",
       "259                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "260                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "261                                                                                           line-height:normal;page-break-after:avoid   \n",
       "262                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "263                                                                                                                  line-height:normal   \n",
       "264                                                                                                                  line-height:normal   \n",
       "265                                                                                           line-height:normal;page-break-after:avoid   \n",
       "266                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "267                                                                                                                  line-height:normal   \n",
       "268                                                                                                                  line-height:normal   \n",
       "269                                                                                           line-height:normal;page-break-after:avoid   \n",
       "270                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "271                                                                                                                  line-height:normal   \n",
       "272                                                                                                                  line-height:normal   \n",
       "273                                                                                           line-height:normal;page-break-after:avoid   \n",
       "274                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "275                                                                                                                  line-height:normal   \n",
       "276                                                                                                                  line-height:normal   \n",
       "277                                                                                           line-height:normal;page-break-after:avoid   \n",
       "278                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "279                                                                                                                  line-height:normal   \n",
       "280                                                                                                                  line-height:normal   \n",
       "281                                                                                           line-height:normal;page-break-after:avoid   \n",
       "282                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "283                                                                                           line-height:normal;page-break-after:avoid   \n",
       "284                                                                                                                  line-height:normal   \n",
       "285                                                                                                                  line-height:normal   \n",
       "286                                                                                           line-height:normal;page-break-after:avoid   \n",
       "287                                                                                                                  line-height:normal   \n",
       "288                                                                                                                  line-height:normal   \n",
       "289                                                                                           line-height:normal;page-break-after:avoid   \n",
       "290                                                                                                                  line-height:normal   \n",
       "291                                                                                                                  line-height:normal   \n",
       "292                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "293                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "294                                                                                                                  line-height:normal   \n",
       "295                                                                                                                  line-height:normal   \n",
       "296                                                                                                                  line-height:normal   \n",
       "297                                                                                                                  line-height:normal   \n",
       "298                                                                                                                  line-height:normal   \n",
       "299                                                                                                                  line-height:normal   \n",
       "300                                                                                                                  line-height:normal   \n",
       "301                                                                                                                  line-height:normal   \n",
       "302                                                                                                                  line-height:normal   \n",
       "303                                                                                                                  line-height:normal   \n",
       "304                                                                                                                  line-height:normal   \n",
       "305                                                                                                                  line-height:normal   \n",
       "306                                                                                                                  line-height:normal   \n",
       "307                                                                                                                  line-height:normal   \n",
       "308                                                                                                                  line-height:normal   \n",
       "309                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "310                                                                                           line-height:normal;page-break-after:avoid   \n",
       "311                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "312                                                                                           line-height:normal;page-break-after:avoid   \n",
       "313                                                                                           line-height:normal;page-break-after:avoid   \n",
       "314                                                                                           line-height:normal;page-break-after:avoid   \n",
       "315                                                                                           line-height:normal;page-break-after:avoid   \n",
       "316                                                                                           line-height:normal;page-break-after:avoid   \n",
       "317                                                                                                                  line-height:normal   \n",
       "318                                                                                                                  line-height:normal   \n",
       "319                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "320                                                                                           line-height:normal;page-break-after:avoid   \n",
       "321                                                                                                                  line-height:normal   \n",
       "322                                                                                                                  line-height:normal   \n",
       "323                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "324                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "325                                                                                           line-height:normal;page-break-after:avoid   \n",
       "326                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "327                                                                       margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal   \n",
       "328                                                                                                                  line-height:normal   \n",
       "329                                                                                           line-height:normal;page-break-after:avoid   \n",
       "330                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "331                                                                                                                  line-height:normal   \n",
       "332                                                                                                                  line-height:normal   \n",
       "333                                                                                                      margin-top:0in;text-align:left   \n",
       "334                                                                                                                  line-height:normal   \n",
       "335                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "336                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "337                                                                                                                  line-height:normal   \n",
       "338                                                                                                                  line-height:normal   \n",
       "339                                                                                                                  line-height:normal   \n",
       "340                                                                                                                  line-height:normal   \n",
       "341                                                                                                                  line-height:normal   \n",
       "342                                                                                                                  line-height:normal   \n",
       "343                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "344                                                                                           line-height:normal;page-break-after:avoid   \n",
       "345                                                                                                                  line-height:normal   \n",
       "346                                                                                                                  line-height:normal   \n",
       "347                                                                                                                  line-height:normal   \n",
       "348                                                                                                                  line-height:normal   \n",
       "349                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "350                                                                                           line-height:normal;page-break-after:avoid   \n",
       "351                                                                                                                  line-height:normal   \n",
       "352                                                                                                                  line-height:normal   \n",
       "353                                                                                           line-height:normal;page-break-after:avoid   \n",
       "354                                                                                           line-height:normal;page-break-after:avoid   \n",
       "355                                                                                                                  line-height:normal   \n",
       "356                                                                                                                  line-height:normal   \n",
       "357                                                                                                                  line-height:normal   \n",
       "358                                                                                                                  line-height:normal   \n",
       "359                                                                                           line-height:normal;page-break-after:avoid   \n",
       "360                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "361                                                                                         margin-left:12.5pt;border-collapse:collapse   \n",
       "362                                                                                                                  line-height:normal   \n",
       "363                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "364                                                                                           line-height:normal;page-break-after:avoid   \n",
       "365                                                                            margin-left:28.35pt;border-collapse:collapse;border:none   \n",
       "366                                                                                                                  line-height:normal   \n",
       "367                                                                                           line-height:normal;page-break-after:avoid   \n",
       "368                                                                        margin-left:56.7pt;text-indent:-28.35pt;line-height:\\nnormal   \n",
       "369                                                                        margin-left:56.7pt;text-indent:-28.35pt;line-height:\\nnormal   \n",
       "370                                                                                                                  line-height:normal   \n",
       "371                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "372                                                                                             margin-left:56.7pt;text-indent:-28.35pt   \n",
       "373                                                                                                                                None   \n",
       "374                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "375                                                                                             margin-left:56.7pt;text-indent:-28.35pt   \n",
       "376                                                                                             margin-left:56.7pt;text-indent:-28.35pt   \n",
       "377                                                                                                                  line-height:normal   \n",
       "378                                                                                                                  line-height:normal   \n",
       "379                                                                                                                  line-height:normal   \n",
       "380                                                                                           line-height:normal;page-break-after:avoid   \n",
       "381                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "382                                                                                                      margin-top:0in;text-align:left   \n",
       "383                                                                                                                  line-height:normal   \n",
       "384                                                                                                                  line-height:normal   \n",
       "385                                                                                                                  line-height:normal   \n",
       "386                                                                                           line-height:normal;page-break-after:avoid   \n",
       "387                                                                                           line-height:normal;page-break-after:avoid   \n",
       "388                                                                                                                  line-height:normal   \n",
       "389                                                                                                                  line-height:normal   \n",
       "390                                                                                                                  line-height:normal   \n",
       "391                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "392                                                                                           line-height:normal;page-break-after:avoid   \n",
       "393                                                                                                              page-break-after:avoid   \n",
       "394                                                                                           line-height:normal;page-break-after:avoid   \n",
       "395                                                                                           line-height:normal;page-break-after:avoid   \n",
       "396                                                                                           line-height:normal;page-break-after:avoid   \n",
       "397                                                                                                                  line-height:normal   \n",
       "398                                                                                                                  line-height:normal   \n",
       "399                                                                                                                  line-height:normal   \n",
       "400                                                margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal;page-break-after:avoid   \n",
       "401                                                                                           line-height:normal;page-break-after:avoid   \n",
       "402                                                                                                                  line-height:normal   \n",
       "403                                                                                                                  line-height:normal   \n",
       "404                                                                                                                  line-height:normal   \n",
       "405                                                                       margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal   \n",
       "406                                                                                                                  line-height:normal   \n",
       "407                                                                                                                  line-height:normal   \n",
       "408                                                                       margin-left:28.35pt;text-indent:-28.35pt;line-height:\\nnormal   \n",
       "409                                                                                                                  line-height:normal   \n",
       "410                                                                                                                  line-height:normal   \n",
       "411                                                                                                                  line-height:normal   \n",
       "412                                                                                               margin-right:-.1pt;line-height:normal   \n",
       "413                                                                                                                  line-height:normal   \n",
       "414                                                                                                                  line-height:normal   \n",
       "415                                                                                                                  line-height:normal   \n",
       "416                                                                                                                  line-height:normal   \n",
       "417                                                                                                                  line-height:normal   \n",
       "418                                                                                                                  line-height:normal   \n",
       "419                                                                                                                  line-height:normal   \n",
       "420                                                                                                                  line-height:normal   \n",
       "421                                                                                                                  line-height:normal   \n",
       "422                                                                                                                  line-height:normal   \n",
       "423                                                                                                                  line-height:normal   \n",
       "424                                                                                                                  line-height:normal   \n",
       "425                                                                                                                  line-height:normal   \n",
       "426                                                                                                                  line-height:normal   \n",
       "427                                                                                                                  line-height:normal   \n",
       "428                                                                                                                  line-height:normal   \n",
       "429                                                                                                                  line-height:normal   \n",
       "430                                                                                                                  line-height:normal   \n",
       "431                                                                                                                  line-height:normal   \n",
       "432                                                                                                                  line-height:normal   \n",
       "433                                                                                                                  line-height:normal   \n",
       "434                                                                                                                  line-height:normal   \n",
       "\n",
       "                Classes   Bold  Italics  Uppercased  Underlined  Indexed  \\\n",
       "0      ['WordSection1']  False    False       False       False    False   \n",
       "1         ['MsoNormal']  False    False       False       False    False   \n",
       "2         ['MsoNormal']  False    False       False       False    False   \n",
       "3         ['MsoNormal']  False    False       False       False    False   \n",
       "4         ['MsoNormal']  False    False       False       False    False   \n",
       "5         ['MsoNormal']  False    False       False       False    False   \n",
       "6         ['MsoNormal']  False    False       False       False    False   \n",
       "7         ['MsoNormal']  False    False       False       False    False   \n",
       "8         ['MsoNormal']  False    False       False       False    False   \n",
       "9         ['MsoNormal']  False    False       False       False    False   \n",
       "10        ['MsoNormal']  False    False       False       False    False   \n",
       "11        ['MsoNormal']  False    False       False       False    False   \n",
       "12        ['MsoNormal']  False    False       False       False    False   \n",
       "13        ['MsoNormal']  False    False       False       False    False   \n",
       "14        ['MsoNormal']  False    False       False       False    False   \n",
       "15        ['MsoNormal']  False    False       False       False    False   \n",
       "16        ['MsoNormal']  False    False       False       False    False   \n",
       "17        ['MsoNormal']  False    False       False       False    False   \n",
       "18        ['MsoNormal']  False    False       False       False    False   \n",
       "19        ['MsoNormal']  False    False       False       False    False   \n",
       "20        ['MsoNormal']  False    False       False       False    False   \n",
       "21        ['MsoNormal']  False    False       False       False    False   \n",
       "22        ['MsoNormal']  False    False       False       False    False   \n",
       "23        ['MsoNormal']  False    False       False       False    False   \n",
       "24        ['MsoNormal']   True    False        True       False    False   \n",
       "25        ['MsoNormal']  False    False       False       False    False   \n",
       "26        ['MsoNormal']   True    False        True       False    False   \n",
       "27                 None  False    False       False       False    False   \n",
       "28                 None  False    False       False       False    False   \n",
       "29        ['MsoNormal']  False    False       False       False    False   \n",
       "30        ['MsoNormal']  False    False       False       False    False   \n",
       "31        ['MsoNormal']  False    False       False       False    False   \n",
       "32        ['MsoNormal']   True    False        True       False     True   \n",
       "33        ['MsoNormal']  False    False       False       False    False   \n",
       "34        ['MsoNormal']  False    False       False       False    False   \n",
       "35        ['MsoNormal']  False    False       False       False    False   \n",
       "36        ['MsoNormal']  False    False       False       False    False   \n",
       "37        ['MsoNormal']   True    False        True       False     True   \n",
       "38        ['MsoNormal']  False    False       False       False    False   \n",
       "39        ['MsoNormal']  False    False       False       False    False   \n",
       "40        ['MsoNormal']  False    False       False       False    False   \n",
       "41        ['MsoNormal']  False    False       False       False    False   \n",
       "42        ['MsoNormal']  False    False       False       False    False   \n",
       "43        ['MsoNormal']  False    False       False       False    False   \n",
       "44        ['MsoNormal']  False    False       False       False    False   \n",
       "45        ['MsoNormal']  False    False       False       False    False   \n",
       "46        ['MsoNormal']  False    False       False       False    False   \n",
       "47        ['MsoNormal']  False    False       False       False    False   \n",
       "48        ['MsoNormal']   True    False        True       False     True   \n",
       "49        ['MsoNormal']  False    False       False       False    False   \n",
       "50        ['MsoNormal']  False    False       False       False    False   \n",
       "51        ['MsoNormal']  False    False       False       False    False   \n",
       "52        ['MsoNormal']  False    False       False       False    False   \n",
       "53        ['MsoNormal']  False    False       False       False    False   \n",
       "54        ['MsoNormal']  False    False       False       False    False   \n",
       "55        ['MsoNormal']   True    False        True       False     True   \n",
       "56        ['MsoNormal']  False    False       False       False    False   \n",
       "57        ['MsoNormal']   True    False       False       False     True   \n",
       "58        ['MsoNormal']  False    False       False       False    False   \n",
       "59         ['Standard']  False    False       False       False    False   \n",
       "60        ['MsoNormal']  False    False       False       False    False   \n",
       "61        ['MsoNormal']   True    False       False       False     True   \n",
       "62        ['MsoNormal']  False    False       False       False    False   \n",
       "63        ['MsoNormal']  False    False       False       False    False   \n",
       "64        ['MsoNormal']  False    False       False       False    False   \n",
       "65        ['MsoNormal']  False    False       False        True    False   \n",
       "66        ['MsoNormal']  False    False       False       False    False   \n",
       "67        ['MsoNormal']  False    False       False       False    False   \n",
       "68        ['MsoNormal']  False    False       False       False    False   \n",
       "69        ['MsoNormal']  False    False       False       False    False   \n",
       "70        ['MsoNormal']  False    False       False       False    False   \n",
       "71         ['Standard']  False    False       False       False    False   \n",
       "72             ['Text']  False    False       False       False    False   \n",
       "73             ['Text']  False    False       False       False    False   \n",
       "74        ['MsoNormal']  False    False       False       False    False   \n",
       "75        ['MsoNormal']  False     True       False        True    False   \n",
       "76        ['MsoNormal']  False     True       False       False    False   \n",
       "77        ['MsoNormal']  False    False       False       False    False   \n",
       "78        ['MsoNormal']  False    False       False       False    False   \n",
       "79        ['MsoNormal']  False     True       False       False    False   \n",
       "80        ['MsoNormal']  False    False       False       False    False   \n",
       "81        ['MsoNormal']  False    False       False       False    False   \n",
       "82        ['MsoNormal']  False     True       False       False    False   \n",
       "83        ['MsoNormal']  False    False       False       False    False   \n",
       "84        ['MsoNormal']  False    False       False       False    False   \n",
       "85        ['MsoNormal']  False     True       False       False    False   \n",
       "86         ['Standard']  False    False       False       False    False   \n",
       "87         ['Standard']  False    False       False       False    False   \n",
       "88         ['Standard']  False    False       False       False    False   \n",
       "89        ['MsoNormal']  False    False       False       False    False   \n",
       "90        ['MsoNormal']  False    False       False        True    False   \n",
       "91        ['MsoNormal']  False    False       False       False    False   \n",
       "92        ['MsoNormal']  False    False       False       False    False   \n",
       "93        ['MsoNormal']  False    False       False       False    False   \n",
       "94        ['MsoNormal']  False    False       False       False    False   \n",
       "95        ['MsoNormal']  False    False       False       False    False   \n",
       "96        ['MsoNormal']  False    False       False       False    False   \n",
       "97        ['MsoNormal']  False    False       False       False    False   \n",
       "98        ['MsoNormal']   True    False       False       False     True   \n",
       "99        ['MsoNormal']  False    False       False       False    False   \n",
       "100       ['MsoNormal']  False    False       False       False    False   \n",
       "101       ['MsoNormal']  False    False       False       False    False   \n",
       "102       ['MsoNormal']  False    False       False       False    False   \n",
       "103       ['MsoNormal']   True    False       False       False     True   \n",
       "104       ['MsoNormal']  False    False       False       False    False   \n",
       "105       ['MsoNormal']  False    False       False        True    False   \n",
       "106       ['MsoNormal']  False    False       False       False    False   \n",
       "107       ['MsoNormal']  False    False       False       False    False   \n",
       "108       ['MsoNormal']  False    False       False       False    False   \n",
       "109       ['MsoNormal']  False    False       False        True    False   \n",
       "110       ['MsoNormal']  False    False       False       False    False   \n",
       "111       ['MsoNormal']  False    False       False       False    False   \n",
       "112       ['MsoNormal']  False    False       False       False    False   \n",
       "113       ['MsoNormal']  False    False       False        True    False   \n",
       "114       ['MsoNormal']  False    False       False       False    False   \n",
       "115       ['MsoNormal']  False    False       False       False    False   \n",
       "116       ['MsoNormal']  False    False       False       False    False   \n",
       "117       ['MsoNormal']  False    False       False       False    False   \n",
       "118       ['MsoNormal']  False    False       False       False    False   \n",
       "119       ['MsoNormal']  False    False       False        True    False   \n",
       "120       ['MsoNormal']  False    False       False       False    False   \n",
       "121       ['MsoNormal']  False    False       False       False    False   \n",
       "122       ['MsoNormal']  False    False       False       False    False   \n",
       "123       ['MsoNormal']   True    False       False       False     True   \n",
       "124       ['MsoNormal']  False    False       False       False    False   \n",
       "125       ['MsoNormal']  False    False       False       False    False   \n",
       "126       ['MsoNormal']  False    False       False       False    False   \n",
       "127       ['MsoNormal']  False    False       False       False    False   \n",
       "128       ['MsoNormal']  False    False       False       False    False   \n",
       "129       ['MsoNormal']  False    False       False       False    False   \n",
       "130       ['MsoNormal']  False    False       False       False    False   \n",
       "131       ['MsoNormal']   True    False       False       False     True   \n",
       "132       ['MsoNormal']  False    False       False       False    False   \n",
       "133       ['MsoNormal']  False    False       False        True    False   \n",
       "134       ['MsoNormal']  False    False       False       False    False   \n",
       "135        ['Standard']  False    False       False       False    False   \n",
       "136       ['MsoNormal']  False    False       False       False    False   \n",
       "137        ['Standard']  False    False       False       False    False   \n",
       "138       ['MsoNormal']  False    False       False       False    False   \n",
       "139       ['MsoNormal']  False    False       False        True    False   \n",
       "140       ['MsoNormal']  False    False       False       False    False   \n",
       "141       ['MsoNormal']  False    False       False       False    False   \n",
       "142       ['MsoNormal']  False    False       False       False    False   \n",
       "143       ['MsoNormal']  False    False       False       False    False   \n",
       "144       ['MsoNormal']  False    False       False       False    False   \n",
       "145       ['MsoNormal']  False    False       False       False    False   \n",
       "146       ['MsoNormal']  False    False       False       False    False   \n",
       "147       ['MsoNormal']  False    False       False        True    False   \n",
       "148       ['MsoNormal']  False    False       False       False    False   \n",
       "149       ['MsoNormal']  False    False       False       False    False   \n",
       "150       ['MsoNormal']  False    False       False       False    False   \n",
       "151       ['MsoNormal']   True    False       False       False     True   \n",
       "152       ['MsoNormal']  False    False       False       False    False   \n",
       "153       ['MsoNormal']  False    False       False       False    False   \n",
       "154       ['MsoNormal']  False    False       False       False    False   \n",
       "155       ['MsoNormal']   True    False       False       False     True   \n",
       "156       ['MsoNormal']  False    False       False       False    False   \n",
       "157       ['MsoNormal']  False    False       False        True    False   \n",
       "158       ['MsoNormal']  False    False       False       False    False   \n",
       "159       ['MsoNormal']  False    False       False       False    False   \n",
       "160       ['MsoNormal']  False    False       False       False    False   \n",
       "161       ['MsoNormal']  False    False       False        True    False   \n",
       "162       ['MsoNormal']  False    False       False       False    False   \n",
       "163       ['MsoNormal']  False    False       False       False    False   \n",
       "164       ['MsoNormal']  False    False       False       False    False   \n",
       "165       ['MsoNormal']  False    False       False       False    False   \n",
       "166       ['MsoNormal']  False    False       False       False    False   \n",
       "167       ['MsoNormal']   True    False       False       False    False   \n",
       "168       ['MsoNormal']  False    False       False       False    False   \n",
       "169  ['MsoNormalTable']  False    False       False       False    False   \n",
       "170            ['Text']  False    False       False       False    False   \n",
       "171       ['MsoNormal']  False    False       False        True    False   \n",
       "172            ['Text']  False    False       False       False    False   \n",
       "173            ['Text']  False     True       False        True    False   \n",
       "174            ['Text']  False    False       False       False    False   \n",
       "175            ['Text']  False    False       False       False    False   \n",
       "176            ['Text']  False    False       False       False    False   \n",
       "177            ['Text']  False    False       False       False    False   \n",
       "178        ['Standard']  False    False       False        True    False   \n",
       "179        ['Standard']  False    False       False       False    False   \n",
       "180            ['Text']  False    False       False       False    False   \n",
       "181            ['Text']  False    False       False       False    False   \n",
       "182       ['MsoNormal']  False    False       False        True    False   \n",
       "183       ['MsoNormal']  False    False       False       False    False   \n",
       "184       ['MsoNormal']  False    False       False       False    False   \n",
       "185       ['MsoNormal']  False    False       False       False    False   \n",
       "186       ['MsoNormal']   True    False       False       False     True   \n",
       "187       ['MsoNormal']  False    False       False       False    False   \n",
       "188       ['MsoNormal']  False    False       False       False    False   \n",
       "189       ['MsoNormal']  False    False       False       False    False   \n",
       "190       ['MsoNormal']  False    False       False       False    False   \n",
       "191       ['MsoNormal']  False    False       False       False    False   \n",
       "192       ['MsoNormal']  False    False       False       False    False   \n",
       "193       ['MsoNormal']   True    False        True       False     True   \n",
       "194       ['MsoNormal']  False    False       False       False    False   \n",
       "195       ['MsoNormal']   True    False       False       False     True   \n",
       "196       ['MsoNormal']  False    False       False       False    False   \n",
       "197       ['MsoNormal']  False    False       False       False    False   \n",
       "198       ['MsoNormal']  False    False       False       False    False   \n",
       "199       ['MsoNormal']  False    False       False        True    False   \n",
       "200       ['MsoNormal']  False    False       False       False    False   \n",
       "201       ['MsoNormal']  False    False       False       False    False   \n",
       "202       ['MsoNormal']  False    False       False       False    False   \n",
       "203       ['MsoNormal']  False    False       False       False    False   \n",
       "204       ['MsoNormal']  False    False       False       False    False   \n",
       "205       ['MsoNormal']  False    False       False        True    False   \n",
       "206       ['MsoNormal']  False    False       False       False    False   \n",
       "207       ['MsoNormal']  False    False       False       False    False   \n",
       "208       ['MsoNormal']  False    False       False       False    False   \n",
       "209       ['MsoNormal']  False    False       False        True    False   \n",
       "210       ['MsoNormal']  False    False       False       False    False   \n",
       "211       ['MsoNormal']  False    False       False       False    False   \n",
       "212       ['MsoNormal']  False    False       False       False    False   \n",
       "213       ['MsoNormal']  False    False       False       False    False   \n",
       "214       ['MsoNormal']  False    False       False       False    False   \n",
       "215       ['MsoNormal']  False    False       False       False    False   \n",
       "216       ['MsoNormal']  False    False       False       False    False   \n",
       "217       ['MsoNormal']  False    False       False       False    False   \n",
       "218       ['MsoNormal']  False    False       False       False    False   \n",
       "219       ['MsoNormal']  False    False       False       False    False   \n",
       "220       ['MsoNormal']  False    False       False       False    False   \n",
       "221       ['MsoNormal']   True    False       False       False    False   \n",
       "222       ['MsoNormal']  False    False       False       False    False   \n",
       "223  ['MsoNormalTable']  False    False       False       False    False   \n",
       "224       ['MsoNormal']  False    False       False       False    False   \n",
       "225       ['MsoNormal']  False    False       False       False    False   \n",
       "226       ['MsoNormal']  False    False       False       False    False   \n",
       "227       ['MsoNormal']  False    False       False       False    False   \n",
       "228       ['MsoNormal']  False    False       False       False    False   \n",
       "229       ['MsoNormal']   True    False       False       False    False   \n",
       "230       ['MsoNormal']  False    False       False       False    False   \n",
       "231  ['MsoNormalTable']  False    False       False       False    False   \n",
       "232       ['MsoNormal']  False    False       False       False    False   \n",
       "233       ['MsoNormal']  False    False       False       False    False   \n",
       "234       ['MsoNormal']  False    False       False       False    False   \n",
       "235       ['MsoNormal']  False    False       False       False    False   \n",
       "236       ['MsoNormal']  False    False       False       False    False   \n",
       "237       ['MsoNormal']   True    False       False       False    False   \n",
       "238       ['MsoNormal']  False    False       False       False    False   \n",
       "239            ['Text']  False    False       False       False    False   \n",
       "240       ['MsoNormal']  False    False       False       False    False   \n",
       "241            ['Text']  False    False       False       False    False   \n",
       "242            ['Text']  False    False       False       False    False   \n",
       "243       ['MsoNormal']  False    False       False       False    False   \n",
       "244       ['MsoNormal']  False    False       False       False    False   \n",
       "245       ['MsoNormal']  False    False       False       False    False   \n",
       "246                None  False    False       False       False    False   \n",
       "247       ['MsoNormal']  False    False       False        True    False   \n",
       "248       ['MsoNormal']  False    False       False       False    False   \n",
       "249       ['MsoNormal']  False    False       False       False    False   \n",
       "250       ['MsoNormal']  False    False       False       False    False   \n",
       "251       ['MsoNormal']  False    False       False       False    False   \n",
       "252       ['MsoNormal']  False    False       False       False    False   \n",
       "253       ['MsoNormal']  False    False       False        True    False   \n",
       "254       ['MsoNormal']  False    False       False       False    False   \n",
       "255       ['MsoNormal']  False    False       False       False    False   \n",
       "256       ['MsoNormal']  False    False       False       False    False   \n",
       "257       ['MsoNormal']  False    False       False       False    False   \n",
       "258       ['MsoNormal']  False    False       False       False    False   \n",
       "259       ['MsoNormal']   True    False       False       False     True   \n",
       "260       ['MsoNormal']  False    False       False       False    False   \n",
       "261       ['MsoNormal']  False    False       False        True    False   \n",
       "262       ['MsoNormal']  False    False       False       False    False   \n",
       "263       ['MsoNormal']  False    False       False       False    False   \n",
       "264       ['MsoNormal']  False    False       False       False    False   \n",
       "265       ['MsoNormal']  False    False       False        True    False   \n",
       "266       ['MsoNormal']  False    False       False       False    False   \n",
       "267       ['MsoNormal']  False    False       False       False    False   \n",
       "268       ['MsoNormal']  False    False       False       False    False   \n",
       "269       ['MsoNormal']  False    False       False        True    False   \n",
       "270       ['MsoNormal']  False    False       False       False    False   \n",
       "271       ['MsoNormal']  False    False       False       False    False   \n",
       "272       ['MsoNormal']  False    False       False       False    False   \n",
       "273       ['MsoNormal']  False    False       False        True    False   \n",
       "274       ['MsoNormal']  False    False       False       False    False   \n",
       "275       ['MsoNormal']  False    False       False       False    False   \n",
       "276       ['MsoNormal']  False    False       False       False    False   \n",
       "277       ['MsoNormal']  False    False       False        True    False   \n",
       "278       ['MsoNormal']  False    False       False       False    False   \n",
       "279       ['MsoNormal']  False    False       False       False    False   \n",
       "280       ['MsoNormal']  False    False       False       False    False   \n",
       "281       ['MsoNormal']  False    False       False        True    False   \n",
       "282       ['MsoNormal']  False    False       False       False    False   \n",
       "283       ['MsoNormal']  False     True       False        True    False   \n",
       "284       ['MsoNormal']  False    False       False       False    False   \n",
       "285       ['MsoNormal']  False    False       False       False    False   \n",
       "286       ['MsoNormal']  False     True       False        True    False   \n",
       "287       ['MsoNormal']  False    False       False       False    False   \n",
       "288       ['MsoNormal']  False    False       False       False    False   \n",
       "289       ['MsoNormal']  False     True       False        True    False   \n",
       "290       ['MsoNormal']  False    False       False       False    False   \n",
       "291       ['MsoNormal']  False    False       False       False    False   \n",
       "292       ['MsoNormal']   True    False       False       False     True   \n",
       "293       ['MsoNormal']  False    False       False       False    False   \n",
       "294       ['MsoNormal']  False    False       False       False    False   \n",
       "295       ['MsoNormal']  False    False       False       False    False   \n",
       "296       ['MsoNormal']  False    False       False       False    False   \n",
       "297       ['MsoNormal']  False    False       False       False    False   \n",
       "298       ['MsoNormal']  False    False       False       False    False   \n",
       "299       ['MsoNormal']  False    False       False       False    False   \n",
       "300       ['MsoNormal']  False    False       False       False    False   \n",
       "301       ['MsoNormal']  False    False       False       False    False   \n",
       "302       ['MsoNormal']  False    False       False       False    False   \n",
       "303       ['MsoNormal']  False    False       False       False    False   \n",
       "304       ['MsoNormal']  False    False       False       False    False   \n",
       "305       ['MsoNormal']  False    False       False       False    False   \n",
       "306       ['MsoNormal']  False    False       False       False    False   \n",
       "307       ['MsoNormal']  False    False       False       False    False   \n",
       "308       ['MsoNormal']  False    False       False       False    False   \n",
       "309       ['MsoNormal']   True    False        True       False     True   \n",
       "310       ['MsoNormal']  False    False       False       False    False   \n",
       "311       ['MsoNormal']   True    False       False       False     True   \n",
       "312       ['MsoNormal']  False    False       False       False    False   \n",
       "313       ['MsoNormal']  False    False       False       False    False   \n",
       "314       ['MsoNormal']  False    False       False       False    False   \n",
       "315       ['MsoNormal']  False    False       False       False    False   \n",
       "316       ['MsoNormal']  False    False       False       False    False   \n",
       "317       ['MsoNormal']  False    False       False       False    False   \n",
       "318       ['MsoNormal']  False    False       False       False    False   \n",
       "319       ['MsoNormal']   True    False       False       False     True   \n",
       "320       ['MsoNormal']  False    False       False       False    False   \n",
       "321       ['MsoNormal']  False    False       False       False    False   \n",
       "322       ['MsoNormal']  False    False       False       False    False   \n",
       "323       ['MsoNormal']   True    False       False       False     True   \n",
       "324       ['MsoNormal']  False    False       False       False    False   \n",
       "325       ['MsoNormal']  False    False       False        True    False   \n",
       "326       ['MsoNormal']  False    False       False       False    False   \n",
       "327       ['MsoNormal']  False    False       False       False    False   \n",
       "328       ['MsoNormal']  False    False       False       False    False   \n",
       "329       ['MsoNormal']  False    False       False        True    False   \n",
       "330       ['MsoNormal']  False    False       False       False    False   \n",
       "331       ['MsoNormal']  False    False       False       False    False   \n",
       "332       ['MsoNormal']  False    False       False       False    False   \n",
       "333            ['Text']  False    False       False       False    False   \n",
       "334       ['MsoNormal']  False    False       False       False    False   \n",
       "335       ['MsoNormal']   True    False       False       False     True   \n",
       "336       ['MsoNormal']  False    False       False       False    False   \n",
       "337       ['MsoNormal']  False    False       False       False    False   \n",
       "338       ['MsoNormal']  False    False       False       False    False   \n",
       "339       ['MsoNormal']  False    False       False       False    False   \n",
       "340       ['MsoNormal']  False    False       False       False    False   \n",
       "341       ['MsoNormal']  False    False       False       False    False   \n",
       "342       ['MsoNormal']  False    False       False       False    False   \n",
       "343       ['MsoNormal']   True    False       False       False     True   \n",
       "344       ['MsoNormal']  False    False       False       False    False   \n",
       "345       ['MsoNormal']  False    False       False       False    False   \n",
       "346       ['MsoNormal']  False    False       False       False    False   \n",
       "347       ['MsoNormal']  False    False       False       False    False   \n",
       "348       ['MsoNormal']  False    False       False       False    False   \n",
       "349       ['MsoNormal']   True    False       False       False     True   \n",
       "350       ['MsoNormal']  False    False       False       False    False   \n",
       "351       ['MsoNormal']  False    False       False       False    False   \n",
       "352       ['MsoNormal']  False    False       False       False    False   \n",
       "353       ['MsoNormal']  False    False       False        True    False   \n",
       "354       ['MsoNormal']  False    False       False       False    False   \n",
       "355       ['MsoNormal']  False    False       False       False    False   \n",
       "356       ['MsoNormal']  False    False       False       False    False   \n",
       "357       ['MsoNormal']  False    False       False       False    False   \n",
       "358       ['MsoNormal']  False    False       False       False    False   \n",
       "359       ['MsoNormal']  False    False       False       False    False   \n",
       "360       ['MsoNormal']  False    False       False       False    False   \n",
       "361  ['MsoNormalTable']  False    False       False       False    False   \n",
       "362       ['MsoNormal']  False    False       False       False    False   \n",
       "363       ['MsoNormal']  False    False       False       False    False   \n",
       "364       ['MsoNormal']  False    False       False       False    False   \n",
       "365  ['MsoNormalTable']  False    False       False       False    False   \n",
       "366       ['MsoNormal']  False    False       False       False    False   \n",
       "367       ['MsoNormal']  False    False       False       False     True   \n",
       "368       ['MsoNormal']  False    False       False       False    False   \n",
       "369       ['MsoNormal']  False    False       False       False    False   \n",
       "370       ['MsoNormal']  False    False       False       False    False   \n",
       "371       ['MsoNormal']  False    False       False       False     True   \n",
       "372       ['MsoNormal']  False    False       False       False    False   \n",
       "373       ['MsoNormal']  False    False       False       False    False   \n",
       "374       ['MsoNormal']  False    False       False       False     True   \n",
       "375       ['MsoNormal']  False    False       False       False    False   \n",
       "376       ['MsoNormal']  False    False       False       False    False   \n",
       "377       ['MsoNormal']  False    False       False       False    False   \n",
       "378       ['MsoNormal']  False    False       False       False     True   \n",
       "379       ['MsoNormal']  False    False       False       False    False   \n",
       "380       ['MsoNormal']  False    False       False        True    False   \n",
       "381       ['MsoNormal']  False    False       False       False    False   \n",
       "382            ['Text']  False    False       False       False    False   \n",
       "383       ['MsoNormal']  False    False       False       False    False   \n",
       "384       ['MsoNormal']  False    False       False       False    False   \n",
       "385       ['MsoNormal']  False    False       False       False    False   \n",
       "386       ['MsoNormal']  False    False       False        True    False   \n",
       "387       ['MsoNormal']  False    False       False       False    False   \n",
       "388       ['MsoNormal']  False    False       False       False    False   \n",
       "389       ['MsoNormal']  False    False       False       False    False   \n",
       "390       ['MsoNormal']  False    False       False       False    False   \n",
       "391       ['MsoNormal']   True    False        True       False     True   \n",
       "392       ['MsoNormal']  False    False       False       False    False   \n",
       "393         ['Default']  False    False       False       False    False   \n",
       "394       ['MsoNormal']  False    False       False       False    False   \n",
       "395       ['MsoNormal']  False    False       False       False    False   \n",
       "396       ['MsoNormal']  False    False       False       False    False   \n",
       "397       ['MsoNormal']  False    False       False       False    False   \n",
       "398       ['MsoNormal']  False    False       False       False    False   \n",
       "399       ['MsoNormal']  False    False       False       False    False   \n",
       "400       ['MsoNormal']   True    False        True       False     True   \n",
       "401       ['MsoNormal']  False    False       False       False    False   \n",
       "402       ['MsoNormal']  False    False        True       False    False   \n",
       "403       ['MsoNormal']  False    False       False       False    False   \n",
       "404       ['MsoNormal']  False    False       False       False    False   \n",
       "405       ['MsoNormal']   True    False        True       False     True   \n",
       "406       ['MsoNormal']  False    False       False       False    False   \n",
       "407       ['MsoNormal']  False    False       False       False    False   \n",
       "408       ['MsoNormal']   True    False        True       False     True   \n",
       "409       ['MsoNormal']  False    False       False       False    False   \n",
       "410       ['MsoNormal']  False    False       False       False    False   \n",
       "411       ['MsoNormal']  False    False       False       False    False   \n",
       "412       ['MsoNormal']  False    False       False       False    False   \n",
       "413       ['MsoNormal']  False    False       False       False    False   \n",
       "414       ['MsoNormal']  False    False       False       False    False   \n",
       "415       ['MsoNormal']  False    False       False       False    False   \n",
       "416       ['MsoNormal']  False    False       False       False    False   \n",
       "417       ['MsoNormal']  False    False       False       False    False   \n",
       "418       ['MsoNormal']  False    False       False       False    False   \n",
       "419       ['MsoNormal']  False    False       False       False    False   \n",
       "420       ['MsoNormal']  False    False       False       False    False   \n",
       "421       ['MsoNormal']  False    False       False       False    False   \n",
       "422       ['MsoNormal']  False    False       False       False    False   \n",
       "423       ['MsoNormal']  False    False       False       False    False   \n",
       "424       ['MsoNormal']  False    False       False       False    False   \n",
       "425       ['MsoNormal']  False    False       False       False    False   \n",
       "426       ['MsoNormal']  False    False       False       False    False   \n",
       "427       ['MsoNormal']  False    False       False       False    False   \n",
       "428       ['MsoNormal']  False    False       False       False    False   \n",
       "429       ['MsoNormal']  False    False       False       False    False   \n",
       "430       ['MsoNormal']  False    False       False       False    False   \n",
       "431       ['MsoNormal']  False    False       False       False    False   \n",
       "432       ['MsoNormal']  False    False       False       False    False   \n",
       "433       ['MsoNormal']  False    False       False       False    False   \n",
       "434       ['MsoNormal']  False    False       False       False    False   \n",
       "\n",
       "     IsListItem  HasBorder  IsPossibleHeading IsHeadingType  \\\n",
       "0         False      False              False          None   \n",
       "1         False      False              False          None   \n",
       "2         False      False              False          None   \n",
       "3         False      False              False          None   \n",
       "4         False      False              False          None   \n",
       "5         False      False              False          None   \n",
       "6         False      False              False          None   \n",
       "7         False      False              False          None   \n",
       "8         False      False              False          None   \n",
       "9         False      False              False          None   \n",
       "10        False      False              False          None   \n",
       "11        False      False              False          None   \n",
       "12        False      False              False          None   \n",
       "13        False      False              False          None   \n",
       "14        False      False              False          None   \n",
       "15        False      False              False          None   \n",
       "16        False      False              False          None   \n",
       "17        False      False              False          None   \n",
       "18        False      False              False          None   \n",
       "19        False      False              False          None   \n",
       "20        False      False              False          None   \n",
       "21        False      False              False          None   \n",
       "22        False      False              False          None   \n",
       "23        False      False              False          None   \n",
       "24        False      False               True          None   \n",
       "25        False      False              False          None   \n",
       "26        False      False              False          None   \n",
       "27        False      False              False          None   \n",
       "28        False      False              False          None   \n",
       "29        False      False              False          None   \n",
       "30        False      False              False          None   \n",
       "31        False      False              False          None   \n",
       "32        False      False               True            L1   \n",
       "33        False      False              False          None   \n",
       "34        False      False              False          None   \n",
       "35        False      False              False          None   \n",
       "36        False      False              False          None   \n",
       "37        False      False               True            L1   \n",
       "38        False      False              False          None   \n",
       "39        False      False              False          None   \n",
       "40        False      False              False          None   \n",
       "41        False      False              False          None   \n",
       "42        False      False              False          None   \n",
       "43        False      False              False          None   \n",
       "44        False      False              False          None   \n",
       "45        False      False              False          None   \n",
       "46        False      False              False          None   \n",
       "47        False      False              False          None   \n",
       "48        False      False               True            L1   \n",
       "49        False      False              False          None   \n",
       "50        False      False              False          None   \n",
       "51        False      False              False          None   \n",
       "52        False      False              False          None   \n",
       "53        False      False              False          None   \n",
       "54        False      False              False          None   \n",
       "55        False      False               True            L1   \n",
       "56        False      False              False          None   \n",
       "57        False      False               True            L2   \n",
       "58        False      False              False          None   \n",
       "59        False      False              False          None   \n",
       "60        False      False              False          None   \n",
       "61        False      False               True            L2   \n",
       "62        False      False              False          None   \n",
       "63        False      False              False          None   \n",
       "64        False      False              False          None   \n",
       "65        False      False               True            L3   \n",
       "66        False      False              False          None   \n",
       "67        False      False              False          None   \n",
       "68        False      False              False          None   \n",
       "69        False      False              False          None   \n",
       "70        False      False              False          None   \n",
       "71        False      False              False          None   \n",
       "72         True      False              False          None   \n",
       "73         True      False              False          None   \n",
       "74        False      False              False          None   \n",
       "75        False      False               True            L4   \n",
       "76        False      False               True            L4   \n",
       "77        False      False              False          None   \n",
       "78        False      False              False          None   \n",
       "79        False      False               True            L4   \n",
       "80        False      False              False          None   \n",
       "81        False      False              False          None   \n",
       "82        False      False               True            L4   \n",
       "83        False      False              False          None   \n",
       "84        False      False              False          None   \n",
       "85        False      False               True            L4   \n",
       "86        False      False              False          None   \n",
       "87        False      False              False          None   \n",
       "88        False      False              False          None   \n",
       "89        False      False              False          None   \n",
       "90        False      False               True            L3   \n",
       "91        False      False              False          None   \n",
       "92        False      False              False          None   \n",
       "93        False      False              False          None   \n",
       "94        False      False              False          None   \n",
       "95        False      False              False          None   \n",
       "96        False      False              False          None   \n",
       "97        False      False              False          None   \n",
       "98        False      False               True            L2   \n",
       "99        False      False              False          None   \n",
       "100       False      False              False          None   \n",
       "101       False      False              False          None   \n",
       "102       False      False              False          None   \n",
       "103       False      False               True            L2   \n",
       "104       False      False              False          None   \n",
       "105       False      False               True            L3   \n",
       "106       False      False              False          None   \n",
       "107       False      False              False          None   \n",
       "108       False      False              False          None   \n",
       "109       False      False               True            L3   \n",
       "110       False      False              False          None   \n",
       "111       False      False              False          None   \n",
       "112       False      False              False          None   \n",
       "113       False      False               True            L3   \n",
       "114       False      False              False          None   \n",
       "115       False      False              False          None   \n",
       "116       False      False              False          None   \n",
       "117       False      False              False          None   \n",
       "118       False      False              False          None   \n",
       "119       False      False               True            L3   \n",
       "120       False      False              False          None   \n",
       "121       False      False              False          None   \n",
       "122       False      False              False          None   \n",
       "123       False      False               True            L2   \n",
       "124       False      False              False          None   \n",
       "125       False      False              False          None   \n",
       "126       False      False              False          None   \n",
       "127       False      False              False          None   \n",
       "128       False      False              False          None   \n",
       "129       False      False              False          None   \n",
       "130       False      False              False          None   \n",
       "131       False      False               True            L2   \n",
       "132       False      False              False          None   \n",
       "133       False      False               True            L3   \n",
       "134       False      False              False          None   \n",
       "135       False      False              False          None   \n",
       "136       False      False              False          None   \n",
       "137       False      False              False          None   \n",
       "138       False      False              False          None   \n",
       "139       False      False               True            L3   \n",
       "140       False      False              False          None   \n",
       "141       False      False              False          None   \n",
       "142       False      False              False          None   \n",
       "143       False      False              False          None   \n",
       "144       False      False              False          None   \n",
       "145       False      False              False          None   \n",
       "146       False      False              False          None   \n",
       "147       False      False               True            L3   \n",
       "148       False      False              False          None   \n",
       "149       False      False              False          None   \n",
       "150       False      False              False          None   \n",
       "151       False      False               True            L2   \n",
       "152       False      False              False          None   \n",
       "153       False      False              False          None   \n",
       "154       False      False              False          None   \n",
       "155       False      False               True            L2   \n",
       "156       False      False              False          None   \n",
       "157       False      False               True            L3   \n",
       "158       False      False              False          None   \n",
       "159       False      False              False          None   \n",
       "160       False      False              False          None   \n",
       "161       False      False               True            L3   \n",
       "162       False      False              False          None   \n",
       "163       False      False              False          None   \n",
       "164       False      False              False          None   \n",
       "165       False      False              False          None   \n",
       "166       False      False              False          None   \n",
       "167       False      False              False          None   \n",
       "168       False      False              False          None   \n",
       "169       False      False              False          None   \n",
       "170       False      False              False          None   \n",
       "171       False      False               True            L3   \n",
       "172       False      False              False          None   \n",
       "173       False      False               True            L4   \n",
       "174       False      False              False          None   \n",
       "175       False      False              False          None   \n",
       "176       False      False              False          None   \n",
       "177       False      False              False          None   \n",
       "178       False      False               True            L3   \n",
       "179       False      False              False          None   \n",
       "180       False      False              False          None   \n",
       "181       False      False              False          None   \n",
       "182       False      False               True            L3   \n",
       "183       False      False              False          None   \n",
       "184       False      False              False          None   \n",
       "185       False      False              False          None   \n",
       "186       False      False               True            L2   \n",
       "187       False      False              False          None   \n",
       "188       False      False              False          None   \n",
       "189       False      False              False          None   \n",
       "190       False      False              False          None   \n",
       "191       False      False              False          None   \n",
       "192       False      False              False          None   \n",
       "193       False      False               True            L1   \n",
       "194       False      False              False          None   \n",
       "195       False      False               True            L2   \n",
       "196       False      False              False          None   \n",
       "197       False      False              False          None   \n",
       "198       False      False              False          None   \n",
       "199       False      False               True            L3   \n",
       "200       False      False              False          None   \n",
       "201       False      False              False          None   \n",
       "202       False      False              False          None   \n",
       "203       False      False              False          None   \n",
       "204       False      False              False          None   \n",
       "205       False      False               True            L3   \n",
       "206       False      False              False          None   \n",
       "207       False      False              False          None   \n",
       "208       False      False              False          None   \n",
       "209       False      False               True            L3   \n",
       "210       False      False              False          None   \n",
       "211       False      False              False          None   \n",
       "212       False      False              False          None   \n",
       "213       False      False              False          None   \n",
       "214       False      False              False          None   \n",
       "215       False      False              False          None   \n",
       "216       False      False              False          None   \n",
       "217       False      False              False          None   \n",
       "218       False      False              False          None   \n",
       "219       False      False              False          None   \n",
       "220       False      False              False          None   \n",
       "221       False      False              False          None   \n",
       "222       False      False              False          None   \n",
       "223       False      False              False          None   \n",
       "224       False      False              False          None   \n",
       "225       False      False              False          None   \n",
       "226       False      False              False          None   \n",
       "227       False      False              False          None   \n",
       "228       False      False              False          None   \n",
       "229       False      False              False          None   \n",
       "230       False      False              False          None   \n",
       "231       False      False              False          None   \n",
       "232       False      False              False          None   \n",
       "233       False      False              False          None   \n",
       "234       False      False              False          None   \n",
       "235       False      False              False          None   \n",
       "236       False      False              False          None   \n",
       "237       False      False              False          None   \n",
       "238       False      False              False          None   \n",
       "239        True      False              False          None   \n",
       "240        True      False              False          None   \n",
       "241       False      False              False          None   \n",
       "242       False      False              False          None   \n",
       "243       False      False              False          None   \n",
       "244       False      False              False          None   \n",
       "245       False      False              False          None   \n",
       "246       False      False              False          None   \n",
       "247       False      False               True            L3   \n",
       "248       False      False              False          None   \n",
       "249       False      False              False          None   \n",
       "250       False      False              False          None   \n",
       "251       False      False              False          None   \n",
       "252       False      False              False          None   \n",
       "253       False      False               True            L3   \n",
       "254       False      False              False          None   \n",
       "255       False      False              False          None   \n",
       "256       False      False              False          None   \n",
       "257       False      False              False          None   \n",
       "258       False      False              False          None   \n",
       "259       False      False               True            L2   \n",
       "260       False      False              False          None   \n",
       "261       False      False               True            L3   \n",
       "262       False      False              False          None   \n",
       "263       False      False              False          None   \n",
       "264       False      False              False          None   \n",
       "265       False      False               True            L3   \n",
       "266       False      False              False          None   \n",
       "267       False      False              False          None   \n",
       "268       False      False              False          None   \n",
       "269       False      False               True            L3   \n",
       "270       False      False              False          None   \n",
       "271       False      False              False          None   \n",
       "272       False      False              False          None   \n",
       "273       False      False               True            L3   \n",
       "274       False      False              False          None   \n",
       "275       False      False              False          None   \n",
       "276       False      False              False          None   \n",
       "277       False      False               True            L3   \n",
       "278       False      False              False          None   \n",
       "279       False      False              False          None   \n",
       "280       False      False              False          None   \n",
       "281       False      False               True            L3   \n",
       "282       False      False              False          None   \n",
       "283       False      False               True            L4   \n",
       "284       False      False              False          None   \n",
       "285       False      False              False          None   \n",
       "286       False      False               True            L4   \n",
       "287       False      False              False          None   \n",
       "288       False      False              False          None   \n",
       "289       False      False               True            L4   \n",
       "290       False      False              False          None   \n",
       "291       False      False              False          None   \n",
       "292       False      False               True            L2   \n",
       "293       False      False              False          None   \n",
       "294       False      False              False          None   \n",
       "295       False      False              False          None   \n",
       "296       False      False              False          None   \n",
       "297       False      False              False          None   \n",
       "298       False      False              False          None   \n",
       "299       False      False              False          None   \n",
       "300       False      False              False          None   \n",
       "301       False      False              False          None   \n",
       "302       False      False              False          None   \n",
       "303       False      False              False          None   \n",
       "304       False      False              False          None   \n",
       "305       False      False              False          None   \n",
       "306       False      False              False          None   \n",
       "307       False      False              False          None   \n",
       "308       False      False              False          None   \n",
       "309       False      False               True            L1   \n",
       "310       False      False              False          None   \n",
       "311       False      False               True            L2   \n",
       "312       False      False              False          None   \n",
       "313       False      False              False          None   \n",
       "314       False      False              False          None   \n",
       "315       False      False              False          None   \n",
       "316       False      False              False          None   \n",
       "317       False      False              False          None   \n",
       "318       False      False              False          None   \n",
       "319       False      False               True            L2   \n",
       "320       False      False              False          None   \n",
       "321       False      False              False          None   \n",
       "322       False      False              False          None   \n",
       "323       False      False               True            L2   \n",
       "324       False      False              False          None   \n",
       "325       False      False               True            L3   \n",
       "326       False      False              False          None   \n",
       "327       False      False              False          None   \n",
       "328       False      False              False          None   \n",
       "329       False      False               True            L3   \n",
       "330       False      False              False          None   \n",
       "331       False      False              False          None   \n",
       "332       False      False              False          None   \n",
       "333       False      False              False          None   \n",
       "334       False      False              False          None   \n",
       "335       False      False               True            L2   \n",
       "336       False      False              False          None   \n",
       "337       False      False              False          None   \n",
       "338       False      False              False          None   \n",
       "339       False      False              False          None   \n",
       "340       False      False              False          None   \n",
       "341       False      False              False          None   \n",
       "342       False      False              False          None   \n",
       "343       False      False               True            L2   \n",
       "344       False      False              False          None   \n",
       "345       False      False              False          None   \n",
       "346       False      False              False          None   \n",
       "347       False      False              False          None   \n",
       "348       False      False              False          None   \n",
       "349       False      False               True            L2   \n",
       "350       False      False              False          None   \n",
       "351       False      False              False          None   \n",
       "352       False      False              False          None   \n",
       "353       False      False               True            L3   \n",
       "354       False      False              False          None   \n",
       "355       False      False              False          None   \n",
       "356       False      False              False          None   \n",
       "357       False      False              False          None   \n",
       "358       False      False              False          None   \n",
       "359       False      False              False          None   \n",
       "360       False      False              False          None   \n",
       "361        True      False              False          None   \n",
       "362       False      False              False          None   \n",
       "363       False      False              False          None   \n",
       "364       False      False              False          None   \n",
       "365        True      False              False          None   \n",
       "366       False      False              False          None   \n",
       "367       False      False              False          None   \n",
       "368        True      False              False          None   \n",
       "369        True      False              False          None   \n",
       "370       False      False              False          None   \n",
       "371       False      False              False          None   \n",
       "372        True      False              False          None   \n",
       "373       False      False              False          None   \n",
       "374       False      False              False          None   \n",
       "375        True      False              False          None   \n",
       "376        True      False              False          None   \n",
       "377       False      False              False          None   \n",
       "378       False      False              False          None   \n",
       "379       False      False              False          None   \n",
       "380       False      False               True            L3   \n",
       "381       False      False              False          None   \n",
       "382       False      False              False          None   \n",
       "383       False      False              False          None   \n",
       "384       False      False              False          None   \n",
       "385       False      False              False          None   \n",
       "386       False      False               True            L3   \n",
       "387       False      False              False          None   \n",
       "388       False      False              False          None   \n",
       "389       False      False              False          None   \n",
       "390       False      False              False          None   \n",
       "391       False      False               True            L1   \n",
       "392       False      False              False          None   \n",
       "393       False      False              False          None   \n",
       "394       False      False              False          None   \n",
       "395       False      False              False          None   \n",
       "396       False      False              False          None   \n",
       "397       False      False              False          None   \n",
       "398       False      False              False          None   \n",
       "399       False      False              False          None   \n",
       "400       False      False               True            L1   \n",
       "401       False      False              False          None   \n",
       "402       False      False              False          None   \n",
       "403       False      False              False          None   \n",
       "404       False      False              False          None   \n",
       "405       False      False               True            L1   \n",
       "406       False      False              False          None   \n",
       "407       False      False              False          None   \n",
       "408       False      False               True            L1   \n",
       "409       False      False              False          None   \n",
       "410       False      False              False          None   \n",
       "411       False      False              False          None   \n",
       "412       False      False              False          None   \n",
       "413       False      False              False          None   \n",
       "414       False      False              False          None   \n",
       "415       False      False              False          None   \n",
       "416       False      False              False          None   \n",
       "417       False      False              False          None   \n",
       "418       False      False              False          None   \n",
       "419       False      False              False          None   \n",
       "420       False      False              False          None   \n",
       "421       False      False              False          None   \n",
       "422       False      False              False          None   \n",
       "423       False      False              False          None   \n",
       "424       False      False              False          None   \n",
       "425       False      False              False          None   \n",
       "426       False      False              False          None   \n",
       "427       False      False              False          None   \n",
       "428       False      False              False          None   \n",
       "429       False      False              False          None   \n",
       "430       False      False              False          None   \n",
       "431       False      False              False          None   \n",
       "432       False      False              False          None   \n",
       "433       False      False              False          None   \n",
       "434       False      False              False          None   \n",
       "\n",
       "                                                                                                                                                                                                        Text  \\\n",
       "0                                                                                                                                                                                                        ...   \n",
       "1                                                                                                                                                                                                              \n",
       "2                                                                                                                                                                                                              \n",
       "3                                                                                                                                                                                                              \n",
       "4                                                                                                                                                                                                              \n",
       "5                                                                                                                                                                                                              \n",
       "6                                                                                                                                                                                                              \n",
       "7                                                                                                                                                                                                              \n",
       "8                                                                                                                                                                                                              \n",
       "9                                                                                                                                                                                                              \n",
       "10                                                                                                                                                                                                             \n",
       "11                                                                                                                                                                                                             \n",
       "12                                                                                                                                                                                                             \n",
       "13                                                                                                                                                                                                             \n",
       "14                                                                                                                                                                                                             \n",
       "15                                                                                                                                                                                                             \n",
       "16                                                                                                                                                                                                             \n",
       "17                                                                                                                                                                                                             \n",
       "18                                                                                                                                                                                                             \n",
       "19                                                                                                                                                                                                             \n",
       "20                                                                                                                                                                                                             \n",
       "21                                                                                                                                                                                                             \n",
       "22                                                                                                                                                                                                             \n",
       "23                                                                                                                                                                                                             \n",
       "24                                                                                                                                                                                                   ANNEX I   \n",
       "25                                                                                                                                                                                                             \n",
       "26                                                                                                                                                                        SUMMARY OF PRODUCT CHARACTERISTICS   \n",
       "27                                                                                                                                                                                                             \n",
       "28                                                                                                                                                                                                             \n",
       "29   This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse react...   \n",
       "30                                                                                                                                                                                                             \n",
       "31                                                                                                                                                                                                             \n",
       "32                                                                                                                                                                    1.       NAME OF THE MEDICINAL PRODUCT   \n",
       "33                                                                                                                                                                                                             \n",
       "34                                                                                                                                                    Adakveo 10 mg/ml concentrate for solution for infusion   \n",
       "35                                                                                                                                                                                                             \n",
       "36                                                                                                                                                                                                             \n",
       "37                                                                                                                                                         2.       QUALITATIVE AND QUANTITATIVE COMPOSITION   \n",
       "38                                                                                                                                                                                                             \n",
       "39                                                                                                                            Each ml of concentrate for solution for infusion contains 10 mg crizanlizumab.   \n",
       "40                                                                                                                                                                                                             \n",
       "41                                                                                                                                                          One vial of 10 ml contains 100 mg crizanlizumab.   \n",
       "42                                                                                                                                                                                                             \n",
       "43                                                                                       Crizanlizumab is a monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.   \n",
       "44                                                                                                                                                                                                             \n",
       "45                                                                                                                                                         For the full list of excipients, see section 6.1.   \n",
       "46                                                                                                                                                                                                             \n",
       "47                                                                                                                                                                                                             \n",
       "48                                                                                                                                                                              3.       PHARMACEUTICAL FORM   \n",
       "49                                                                                                                                                                                                             \n",
       "50                                                                                                                                               Concentrate for solution for infusion (sterile concentrate)   \n",
       "51                                                                                                                                                                                                             \n",
       "52                                                                                                              Colourless to slightly brownish‑yellow liquid at pH 6 and with an osmolality of 300 mOsm/kg.   \n",
       "53                                                                                                                                                                                                             \n",
       "54                                                                                                                                                                                                             \n",
       "55                                                                                                                                                                             4.       CLINICAL PARTICULARS   \n",
       "56                                                                                                                                                                                                             \n",
       "57                                                                                                                                                                           4.1     Therapeutic indications   \n",
       "58                                                                                                                                                                                                             \n",
       "59   Adakveo is indicated for the prevention of recurrent vaso‑occlusive crises (VOCs) in sickle cell disease patients aged 16 years and older. It can be given as an add‑on therapy to hydroxyurea/hydro...   \n",
       "60                                                                                                                                                                                                             \n",
       "61                                                                                                                                                             4.2     Posology and method of administration   \n",
       "62                                                                                                                                                                                                             \n",
       "63                                                                                                         Treatment should be initiated by physicians experienced in the management of sickle cell disease.   \n",
       "64                                                                                                                                                                                                             \n",
       "65                                                                                                                                                                                                  Posology   \n",
       "66                                                                                                                                                                                                             \n",
       "67                                        The recommended dose of crizanlizumab is 5 mg/kg administered over a period of 30 minutes by intravenous infusion at week 0, week 2, and every 4 weeks thereafter.   \n",
       "68                                                                                                                                                                                                             \n",
       "69                                                                                                                                                           Crizanlizumab can be given alone or with HU/HC.   \n",
       "70                                                                                                                                                                                                             \n",
       "71                                                                                                                            If a dose is missed, the treatment should be administered as soon as possible.   \n",
       "72                                         -                 If crizanlizumab is administered within 2 weeks after the missed dose, dosing should be continued according to the patient’s original schedule.   \n",
       "73                                                          -                 If crizanlizumab is administered more than 2 weeks after the missed dose, dosing should be continued every 4 weeks thereafter.   \n",
       "74                                                                                                                                                                                                             \n",
       "75                                                                                                                                                                                       Special populations   \n",
       "76                                                                                                                                                                                                   Elderly   \n",
       "77                                        Crizanlizumab has not been studied in elderly patients. No dose adjustment is required as the pharmacokinetics of crizanlizumab in adults are not affected by age.   \n",
       "78                                                                                                                                                                                                             \n",
       "79                                                                                                                                                                                          Renal impairment   \n",
       "80   Based on the population pharmacokinetic (PK) results, no dose adjustment is required in patients with mild or moderate renal impairment (see section 5.2). Data from patients with severe renal impa...   \n",
       "81                                                                                                                                                                                                             \n",
       "82                                                                                                                                                                                        Hepatic impairment   \n",
       "83   The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monoclonal antibody and is cleared via catabolism (i.e. breakdown into pe...   \n",
       "84                                                                                                                                                                                                             \n",
       "85                                                                                                                                                                                     Paediatric population   \n",
       "86                                                               The safety and efficacy of crizanlizumab in paediatric patients from 6 months to 16 years have not been established. No data are available.   \n",
       "87                                                                                                                                                                                                             \n",
       "88                                                         There is no relevant use of crizanlizumab in infants aged less than 6 months for the indication of prevention of recurrent vaso‑occlusive crises.   \n",
       "89                                                                                                                                                                                                             \n",
       "90                                                                                                                                                                                  Method of administration   \n",
       "91                                                                                                                                                                                                             \n",
       "92                                                                                Adakveo should be diluted with sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% before administration.   \n",
       "93                                                                                                                                                                                                             \n",
       "94   The diluted solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by intravenous infusion over a period of 30 minutes. It must not be administered by intravenous...   \n",
       "95                                                                                                                                                                                                             \n",
       "96                                                                                                             For instructions on dilution of the medicinal product before administration, see section 6.6.   \n",
       "97                                                                                                                                                                                                             \n",
       "98                                                                                                                                                                                 4.3     Contraindications   \n",
       "99                                                                                                                                                                                                             \n",
       "100                                                                                                              Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.   \n",
       "101                                                                                                                                           Hypersensitivity to Chinese Hamster Ovary (CHO) cell products.   \n",
       "102                                                                                                                                                                                                            \n",
       "103                                                                                                                                                         4.4     Special warnings and precautions for use   \n",
       "104                                                                                                                                                                                                            \n",
       "105                                                                                                                                                                                             Traceability   \n",
       "106                                                                                                                                                                                                            \n",
       "107                                             In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.   \n",
       "108                                                                                                                                                                                                            \n",
       "109                                                                                                                                                                               Infusion‑related reactions   \n",
       "110                                                                                                                                                                                                            \n",
       "111  In clinical studies, infusion‑related reactions (defined as occurring within 24 hours) were observed in 2 patients (1.8%) treated with crizanlizumab 5 mg/kg. Patients should be monitored for signs...   \n",
       "112                                                                                                                                                                                                            \n",
       "113                                                                                                                                                  Laboratory test interference: automated platelet counts   \n",
       "114                                                                                                                                                                                                            \n",
       "115  Interference with automated platelet counts (platelet clumping) has been observed in patients treated with crizanlizumab in clinical studies, in particular when tubes containing EDTA (ethylenediam...   \n",
       "116                                                                                                                                                                                                            \n",
       "117  To mitigate the potential for laboratory test interference, it is recommended to run the test as soon as possible (within 4 hours of blood collection) or use citrate tubes. When needed, platelet c...   \n",
       "118                                                                                                                                                                                                            \n",
       "119                                                                                                                                                                             Excipients with known effect   \n",
       "120                                                                                                                                                                                                            \n",
       "121                                                                                               This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially “sodium‑free”.   \n",
       "122                                                                                                                                                                                                            \n",
       "123                                                                                                                         4.5     Interaction with other medicinal products and other forms of interaction   \n",
       "124                                                                                                                                                                                                            \n",
       "125                                                                                         Interactions between crizanlizumab and other medicinal products have not been investigated in dedicated studies.   \n",
       "126                                                                                                                                                                                                            \n",
       "127  Monoclonal antibodies are not metabolised by cytochrome P450 (CYP450) enzymes. Therefore, medicinal products that are substrates, inhibitors or inducers of CYP450 are not expected to affect the ph...   \n",
       "128                                                                                                                                                                                                            \n",
       "129                                                                        No effect on exposure of co‑administered medicinal products is expected based on the metabolic pathways of monoclonal antibodies.   \n",
       "130                                                                                                                                                                                                            \n",
       "131                                                                                                                                                               4.6     Fertility, pregnancy and lactation   \n",
       "132                                                                                                                                                                                                            \n",
       "133                                                                                                                                                                                                Pregnancy   \n",
       "134                                                                                                                                                                                                            \n",
       "135  There is a limited amount of data from the use of Adakveo in pregnant women. Based on data from animal studies, crizanlizumab has the potential to cause foetal losses when administered to a pregna...   \n",
       "136                                                                                                                                                                                                            \n",
       "137  To help determine the effects in pregnant women, healthcare professionals are encouraged to report all pregnancy cases and complications during pregnancy (from 105 days prior to the last menstrual...   \n",
       "138                                                                                                                                                                                                            \n",
       "139                                                                                                                                                                                           Breast‑feeding   \n",
       "140                                                                                                                                                                                                            \n",
       "141  It is unknown whether crizanlizumab is excreted in human milk after administration of Adakveo. There are no data on the effects of crizanlizumab on the breast‑fed newborn/infant or on milk product...   \n",
       "142                                                                                                                                                                                                            \n",
       "143                                                                   Because many medicinal products, including antibodies, can be excreted in human milk, a risk to the newborn/infant cannot be excluded.   \n",
       "144                                                                                                                                                                                                            \n",
       "145  A decision must be made whether to discontinue breast‑feeding or to discontinue Adakveo therapy, taking into account the benefit of breast‑feeding for the child and the benefit of therapy for the ...   \n",
       "146                                                                                                                                                                                                            \n",
       "147                                                                                                                                                                                                Fertility   \n",
       "148                                                                                                                                                                                                            \n",
       "149                        There are no data on the effect of Adakveo on human fertility. Available non‑clinical data do not suggest an effect on fertility under crizanlizumab treatment (see section 5.3).   \n",
       "150                                                                                                                                                                                                            \n",
       "151                                                                                                                                                     4.7     Effects on ability to drive and use machines   \n",
       "152                                                                                                                                                                                                            \n",
       "153                                      Adakveo may have a minor influence on the ability to drive and use machines. Dizziness, fatigue and somnolence may occur following administration of crizanlizumab.   \n",
       "154                                                                                                                                                                                                            \n",
       "155                                                                                                                                                                              4.8     Undesirable effects   \n",
       "156                                                                                                                                                                                                            \n",
       "157                                                                                                                                                                            Summary of the safety profile   \n",
       "158                                                                                                                                                                                                            \n",
       "159  The most frequently reported adverse drug reactions (≥10% of patients) in the Adakveo 5 mg/kg group were arthralgia, nausea, back pain, pyrexia and abdominal pain. Severe events were observed for ...   \n",
       "160                                                                                                                                                                                                            \n",
       "161                                                                                                                                                                      Tabulated list of adverse reactions   \n",
       "162                                                                                                                                                                                                            \n",
       "163  Table 1 lists adverse reactions based on pooled data from two studies: the pivotal study, SUSTAIN, and a single‑arm, open‑label pharmacokinetics/pharmacodynamics and safety study. Use of crizanliz...   \n",
       "164                                                                                                                                                                                                            \n",
       "165  Within each system organ class, the adverse reactions are ranked by frequency, with the most frequent reactions first. Within each frequency grouping, adverse reactions are presented in order of d...   \n",
       "166                                                                                                                                                                                                            \n",
       "167                                                                                                                                                      Table 1       Adverse reactions in clinical studies   \n",
       "168                                                                                                                                                                                                            \n",
       "169     System organ class   Frequency   Adverse reaction     Respiratory, thoracic and   mediastinal disorders   Common   Oropharyngeal pain     Gastrointestinal disorders   Very common   Nausea, abdo...   \n",
       "170                                                                                                                                                                                                            \n",
       "171                                                                                                                                                                Description of selected adverse reactions   \n",
       "172                                                                                                                                                                                                            \n",
       "173                                                                                                                                                                                           Immunogenicity   \n",
       "174                                  In clinical studies, treatment‑induced anti‑crizanlizumab antibodies were transiently detected in 1 patient (0.9%) among the 111 patients who received Adakveo 5 mg/kg.   \n",
       "175                                                                                                                                                                                                            \n",
       "176                                                                          There was no evidence of altered pharmacokinetics or of an altered safety profile with anti‑crizanlizumab antibody development.   \n",
       "177                                                                                                                                                                                                            \n",
       "178                                                                                                                                                                                    Paediatric population   \n",
       "179                                                                                                                                                                                                            \n",
       "180     Frequency, type and severity of adverse reactions in patients aged 16 and 17 years are expected to be the same as in adults. The safety of crizanlizumab was evaluated in 3 patients aged <18 years.   \n",
       "181                                                                                                                                                                                                            \n",
       "182                                                                                                                                                                 Reporting of suspected adverse reactions   \n",
       "183                                                                                                                                                                                                            \n",
       "184  Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare pro...   \n",
       "185                                                                                                                                                                                                            \n",
       "186                                                                                                                                                                                         4.9     Overdose   \n",
       "187                                                                                                                                                                                                            \n",
       "188                                                                                                                                             No cases of overdose have been reported in clinical studies.   \n",
       "189                                                                                                                                                                                                            \n",
       "190                                                                                                General supportive measures and symptomatic treatment should be initiated in cases of suspected overdose.   \n",
       "191                                                                                                                                                                                                            \n",
       "192                                                                                                                                                                                                            \n",
       "193                                                                                                                                                                      5.       PHARMACOLOGICAL PROPERTIES   \n",
       "194                                                                                                                                                                                                            \n",
       "195                                                                                                                                                                       5.1     Pharmacodynamic properties   \n",
       "196                                                                                                                                                                                                            \n",
       "197                                                                                                                                Pharmacotherapeutic group: Other haematological agents, ATC code: B06AX01   \n",
       "198                                                                                                                                                                                                            \n",
       "199                                                                                                                                                                                      Mechanism of action   \n",
       "200                                                                                                                                                                                                            \n",
       "201  Crizanlizumab is a selective IgG2 kappa humanised monoclonal antibody (mAb) that binds to P‑selectin with high affinity and blocks the interaction with its ligands, including P‑selectin glycoprote...   \n",
       "202                                                                                                                                                                                                            \n",
       "203  Binding P‑selectin on the surface of the activated endothelium and platelets has been shown to effectively block interactions between endothelial cells, platelets, red blood cells and leukocytes, ...   \n",
       "204                                                                                                                                                                                                            \n",
       "205                                                                                                                                                                                  Pharmacodynamic effects   \n",
       "206                                                                                                                                                                                                            \n",
       "207  Throughout clinical studies, treatment with crizanlizumab 5 mg/kg resulted in dose‑dependent, immediate and sustained P‑selectin inhibition (as measured ex vivo) in patients with sickle cell disease.   \n",
       "208                                                                                                                                                                                                            \n",
       "209                                                                                                                                                                             Clinical efficacy and safety   \n",
       "210                                                                                                                                                                                                            \n",
       "211  The efficacy of crizanlizumab, with or without HU/HC, was evaluated in the pivotal study SUSTAIN, a 52‑week, randomised, placebo‑controlled, double‑blind, multicentre clinical study in sickle cell...   \n",
       "212                                                                                                                                                                                                            \n",
       "213  In this study, VOCs were defined as those leading to a healthcare visit, which captured all acute episodes of pain with no other cause than a vaso‑occlusive event that required a healthcare visit ...   \n",
       "214                                                                                                                                                                                                            \n",
       "215  A total of 198 sickle cell disease patients aged 16 to 63 years (inclusive; mean age 30.1±10.3 years), with any sickle cell disease genotype (including HbSS [71.2%], HbSC [16.2%], HbSbeta0‑thalass...   \n",
       "216                                                                                                                                                                                                            \n",
       "217  Treatment with Adakveo 5 mg/kg resulted in a 45.3% lower median annual rate of VOCs compared to placebo (Hodges‑Lehmann, median absolute difference of ‑1.01 compared with placebo, 95% CI [‑2.00, 0...   \n",
       "218                                                                                                                                                                                                            \n",
       "219                                                                                                                    Main efficacy outcomes of the pivotal SUSTAIN study are summarised in Tables 2 and 3.   \n",
       "220                                                                                                                                                                                                            \n",
       "221                                                                                                                                 Table 2       Results from SUSTAIN clinical study in sickle cell disease   \n",
       "222                                                                                                                                                                                                            \n",
       "223     Event   Adakveo 5 mg/kg (N=67) (standard median)   Placebo (N=65) (standard median)   Change vs placebo   Hodges‑Lehmann median   difference (95% CI)   p-value (Wilcoxon rank sum)     Primary e...   \n",
       "224                                                                                                                                                                                                            \n",
       "225  The clinical effect demonstrated in the primary efficacy analysis was supported by multiple supplementary analyses including a negative binomial regression on investigator assessments with a conse...   \n",
       "226                                                                                                                                                                                                            \n",
       "227  In the Adakveo 5 mg/kg group, clinically significant reductions in the annual rate of VOCs were observed across important subgroups (HU/HC use, 2‑4 or 5‑10 VOCs in the previous 12 months, and HbSS...   \n",
       "228                                                                                                                                                                                                            \n",
       "229                                                                                                                                        Table 3       Annual rate of VOCs in patients ‑ subgroup analyses   \n",
       "230                                                                                                                                                                                                            \n",
       "231     Subgroup        Adakveo 5 mg/kg (N=67) (standard median)   Placebo (N=65) (standard median)   Change vs placebo   Hodges‑Lehmann median   difference (95% CI)     HU/HC use   Yes   n=42 2.43   n...   \n",
       "232                                                                                                                                                                                                            \n",
       "233  A greater than two‑fold increase in the proportion of patients with no VOC and who completed the study was observed in the Adakveo 5 mg/kg group compared to placebo (22% vs 8%; odds ratio [95% CI]...   \n",
       "234                                                                                                                                                                                                            \n",
       "235  Treatment with Adakveo 5 mg/kg was also associated with a three‑fold longer Kaplan‑Meier estimated median time to first VOC compared with placebo (4.07 vs 1.38 months; HR=0.495, 95% CI: 0.331, 0.7...   \n",
       "236                                                                                                                                                                                                            \n",
       "237                                                                                                                                                    Figure 1      Kaplan‑Meier curve of time to first VOC   \n",
       "238                                                                                                                                                                                                            \n",
       "239                                                                                                                                                                                                            \n",
       "240                                                                                                                                                                                                            \n",
       "241                                                                                                                                                                                                            \n",
       "242                                                                                                                                                                                                            \n",
       "243                                                                                                                                                                                                            \n",
       "244                                                                                                                                                                                                            \n",
       "245                                                                                                                                                                                                            \n",
       "246                                                                                                                                                                                                            \n",
       "247                                                                                                                                                                                    Paediatric population   \n",
       "248                                                                                                                                                                                                            \n",
       "249  The efficacy of crizanlizumab in patients aged 16 and 17 years is expected to be the same as in adults. Three patients (2.7%) aged less than 18 years were treated with crizanlizumab 5 mg/kg in cli...   \n",
       "250                                                                                                                                                                                                            \n",
       "251  The European Medicines Agency has deferred the obligation to submit the results of studies with Adakveo in one or more subsets of the paediatric population in the treatment of sickle cell disease ...   \n",
       "252                                                                                                                                                                                                            \n",
       "253                                                                                                                                                                                     Conditional approval   \n",
       "254                                                                                                                                                                                                            \n",
       "255                                       This medicinal product has been authorised under a so‑called “conditional approval” scheme. This means that further evidence on this medicinal product is awaited.   \n",
       "256                                                                                                                                                                                                            \n",
       "257                                                      The European Medicines Agency will review new information on this medicinal product at least every year and this SmPC will be updated as necessary.   \n",
       "258                                                                                                                                                                                                            \n",
       "259                                                                                                                                                                       5.2     Pharmacokinetic properties   \n",
       "260                                                                                                                                                                                                            \n",
       "261                                                                                                                                                                                               Absorption   \n",
       "262                                                                                                                                                                                                            \n",
       "263  The median time to reach maximum serum concentration of crizanlizumab (Tmax) was 1.92 hours at steady state following intravenous administration of 5 mg/kg over a period of 30 minutes in sickle ce...   \n",
       "264                                                                                                                                                                                                            \n",
       "265                                                                                                                                                                                             Distribution   \n",
       "266                                                                                                                                                                                                            \n",
       "267  Crizanlizumab distribution is typical of endogenous human antibodies within the vascular and extracellular spaces. The volume of distribution (Vz) was 4.26 litres after a single 5 mg/kg intravenou...   \n",
       "268                                                                                                                                                                                                            \n",
       "269                                                                                                                                                                                        Biotransformation   \n",
       "270                                                                                                                                                                                                            \n",
       "271                                                                                 Antibodies are primarily eliminated via proteolysis by lysosomal enzymes in the liver to small peptides and amino acids.   \n",
       "272                                                                                                                                                                                                            \n",
       "273                                                                                                                                                                                              Elimination   \n",
       "274                                                                                                                                                                                                            \n",
       "275  In healthy volunteers, the mean terminal elimination half‑life (T½) was 10.6 days and the mean clearance was 11.7 ml/h at crizanlizumab dose level 5 mg/kg. In patients with sickle cell disease, th...   \n",
       "276                                                                                                                                                                                                            \n",
       "277                                                                                                                                                                                  Linearity/non‑linearity   \n",
       "278                                                                                                                                                                                                            \n",
       "279                                                The exposure to crizanlizumab (mean Cmax, AUClast, or AUCinf) increased in non‑linear manner over the dose range of 0.2 to 8 mg/kg in healthy volunteers.   \n",
       "280                                                                                                                                                                                                            \n",
       "281                                                                                                                                                                                      Special populations   \n",
       "282                                                                                                                                                                                                            \n",
       "283                                                                                                                                                                                         Renal impairment   \n",
       "284  In a population PK analysis in patients with eGFR ranging from 35 to 202 ml/min/1.73 m2, no clinically important differences in the pharmacokinetics of crizanlizumab were found between patients wi...   \n",
       "285                                                                                                                                                                                                            \n",
       "286                                                                                                                                                                                       Hepatic impairment   \n",
       "287  The safety and efficacy of crizanlizumab in patients with hepatic impairment have not been established. Crizanlizumab is a monoclonal antibody and is cleared via catabolism (i.e. breakdown into pe...   \n",
       "288                                                                                                                                                                                                            \n",
       "289                                                                                                                                                                                    Paediatric population   \n",
       "290                                                                                                            Pharmacokinetics in paediatric patients below the age of 16 years have not been investigated.   \n",
       "291                                                                                                                                                                                                            \n",
       "292                                                                                                                                                                          5.3     Preclinical safety data   \n",
       "293                                                                                                                                                                                                            \n",
       "294                                        Non‑clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, tissue cross‑reactivity and repeated dose toxicity.   \n",
       "295                                                                                                                                                                                                            \n",
       "296  In the 26‑week repeated dose toxicity study, administration of crizanlizumab in cynomolgus monkeys at dose levels up to 50 mg/kg/dose once every 4 weeks (at least 13.5 times the human clinical exp...   \n",
       "297                                                                                                                                                                                                            \n",
       "298  Pharmacological effects of crizanlizumab on haemodynamic and electrocardiographic parameters in the cynomolgus monkey were evaluated in the 26‑week repeated dose toxicology study. Respiratory rate...   \n",
       "299                                                                                                                                                                                                            \n",
       "300                                                                                           Formal carcinogenicity, genotoxicity and juvenile toxicity studies have not been conducted with crizanlizumab.   \n",
       "301                                                                                                                                                                                                            \n",
       "302  In a 26‑week repeated dose toxicity study, cynomolgus monkeys were administered crizanlizumab once every 4 weeks at doses up to 50 mg/kg (at least 13.5 times the human clinical exposure based on A...   \n",
       "303                                                                                                                                                                                                            \n",
       "304  In an enhanced pre‑ and postnatal development study in cynomolgus monkeys, pregnant animals received intravenous crizanlizumab once every two weeks during the period of organogenesis, at doses of ...   \n",
       "305                                                                                                                                                                                                            \n",
       "306          Measurable crizanlizumab serum concentrations were observed in the infant monkeys at postnatal day 28, confirming that crizanlizumab, like other IgG antibodies, crosses the placental barrier.   \n",
       "307                                                                                                                                                                                                            \n",
       "308                                                                                                                                                                                                            \n",
       "309                                                                                                                                                                      6.       PHARMACEUTICAL PARTICULARS   \n",
       "310                                                                                                                                                                                                            \n",
       "311                                                                                                                                                                               6.1     List of excipients   \n",
       "312                                                                                                                                                                                                            \n",
       "313                                                                                                                                                                                                  Sucrose   \n",
       "314                                                                                                                                                                                    Sodium citrate (E331)   \n",
       "315                                                                                                                                                                                       Citric acid (E330)   \n",
       "316                                                                                                                                                                                    Polysorbate 80 (E433)   \n",
       "317                                                                                                                                                                                     Water for injections   \n",
       "318                                                                                                                                                                                                            \n",
       "319                                                                                                                                                                                6.2     Incompatibilities   \n",
       "320                                                                                                                                                                                                            \n",
       "321                                                                                            This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6.   \n",
       "322                                                                                                                                                                                                            \n",
       "323                                                                                                                                                                                       6.3     Shelf life   \n",
       "324                                                                                                                                                                                                            \n",
       "325                                                                                                                                                                                            Unopened vial   \n",
       "326                                                                                                                                                                                                            \n",
       "327                                                                                                                                                                                                18 months   \n",
       "328                                                                                                                                                                                                            \n",
       "329                                                                                                                                                                                         Diluted solution   \n",
       "330                                                                                                                                                                                                            \n",
       "331  Chemical and physical in‑use stability, from the start of preparation of the diluted solution for infusion until end of infusion, has been demonstrated for up to 8 hours at room temperature (up to...   \n",
       "332                                                                                                                                                                                                            \n",
       "333  From a microbiological point of view, the diluted solution for infusion should be used immediately. If not used immediately, in‑use storage times and conditions prior to use are the responsibility...   \n",
       "334                                                                                                                                                                                                            \n",
       "335                                                                                                                                                                  6.4     Special precautions for storage   \n",
       "336                                                                                                                                                                                                            \n",
       "337                                                                                                                                                                     Store in a refrigerator (2°C – 8°C).   \n",
       "338                                                                                                                                                                                           Do not freeze.   \n",
       "339                                                                                                                                        Keep the vial in the outer carton in order to protect from light.   \n",
       "340                                                                                                                                                                                                            \n",
       "341                                                                                                                         For storage conditions after dilution of the medicinal product, see section 6.3.   \n",
       "342                                                                                                                                                                                                            \n",
       "343                                                                                                                                                                 6.5     Nature and contents of container   \n",
       "344                                                                                                                                                                                                            \n",
       "345   10 ml concentrate for solution for infusion in a type I glass vial with a coated chlorobutyl rubber stopper sealed with an aluminium cap with a plastic flip‑off disk containing 100 mg crizanlizumab.   \n",
       "346                                                                                                                                                                                                            \n",
       "347                                                                                                                                                                                          Pack of 1 vial.   \n",
       "348                                                                                                                                                                                                            \n",
       "349                                                                                                                                              6.6     Special precautions for disposal and other handling   \n",
       "350                                                                                                                                                                                                            \n",
       "351                                                                                                                                                                   Adakveo vials are for single use only.   \n",
       "352                                                                                                                                                                                                            \n",
       "353                                                                                                                                                                                   Preparing the infusion   \n",
       "354                                                                                                                                                                                                            \n",
       "355                                                                                              The diluted solution for infusion should be prepared by a healthcare professional using aseptic techniques.   \n",
       "356                                                                                                                                                                                                            \n",
       "357                                                             The total dose and required volume of Adakveo depend on the patient’s body weight; 5 mg of crizanlizumab is administered per kg body weight.   \n",
       "358                                                                                                                                                                                                            \n",
       "359                                                                                             The volume to be used for the preparation of the infusion is calculated according to the following equation:   \n",
       "360                                                                                                                                                                                                            \n",
       "361                                                                                  Volume (ml) =   Patient’s body weight (kg) x prescribed dose   [5 mg/kg]     Concentration   of Adakveo   [10 mg/ml]      \n",
       "362                                                                                                                                                                                                            \n",
       "363  1.       Obtain the number of vials required to deliver the prescribed dose and bring them to room temperature (for a maximum of 4 hours). One vial is needed for every 10 ml of Adakveo (see below ...   \n",
       "364                                                                                                                                                                                                            \n",
       "365                                Body weight (kg)   Dose (mg)   Volume (ml)   Vials (n)     40   200   20   2     60   300   30   3     80   400   40   4     100   500   50   5     120   600   60   6      \n",
       "366                                                                                                                                                                                                            \n",
       "367                                                                                                                                                                     2.       Visually inspect the vials.   \n",
       "368                                                                          -                 The solution in the vials should be clear to opalescent. Do not use if particles are present in the solution.   \n",
       "369                                                                                                           -                 The solution should be colourless or may have a slight brownish‑yellow tint.   \n",
       "370                                                                                                                                                                                                            \n",
       "371        3.       Withdraw a volume equal to the required volume of Adakveo from a 100 ml infusion bag containing either sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% and discard.   \n",
       "372          -                 No incompatibilities between the diluted Adakveo solution and infusion bags composed of polyvinylchloride (PVC), polyethylene (PE) and polypropylene (PP) have been observed.   \n",
       "373                                                                                                                                                                                                            \n",
       "374                                                                            4.       Withdraw the necessary volume of Adakveo from the vials and inject slowly into the previously prepared infusion bag.   \n",
       "375                                                                     -                 The solution must not be mixed or co‑administered with other medicinal products through the same intravenous line.   \n",
       "376                   -                 Keep the volume of Adakveo added to the infusion bag in the range of 10 ml to 96 ml to obtain a final concentration in the infusion bag within 1 mg/ml to 9.6 mg/ml.   \n",
       "377                                                                                                                                                                                                            \n",
       "378                                                                                                                    5.       Mix the diluted solution by gently inverting the infusion bag. DO NOT SHAKE.   \n",
       "379                                                                                                                                                                                                            \n",
       "380                                                                                                                                                                                           Administration   \n",
       "381                                                                                                                                                                                                            \n",
       "382  Adakveo diluted solution must be administered through a sterile, non‑pyrogenic 0.2 micron in‑line filter by intravenous infusion over a period of 30 minutes. No incompatibilities have been observe...   \n",
       "383                                                                                                                                                                                                            \n",
       "384                                                                After administration of Adakveo, flush the line with at least 25 ml sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5%.   \n",
       "385                                                                                                                                                                                                            \n",
       "386                                                                                                                                                                                                 Disposal   \n",
       "387                                                                                                                                                                                                            \n",
       "388                                                                                              Any unused medicinal product or waste material should be disposed of in accordance with local requirements.   \n",
       "389                                                                                                                                                                                                            \n",
       "390                                                                                                                                                                                                            \n",
       "391                                                                                                                                                                  7.       MARKETING AUTHORISATION HOLDER   \n",
       "392                                                                                                                                                                                                            \n",
       "393                                                                                                                                                                               Novartis Europharm Limited   \n",
       "394                                                                                                                                                                                           Vista Building   \n",
       "395                                                                                                                                                                                   Elm Park, Merrion Road   \n",
       "396                                                                                                                                                                                                 Dublin 4   \n",
       "397                                                                                                                                                                                                  Ireland   \n",
       "398                                                                                                                                                                                                            \n",
       "399                                                                                                                                                                                                            \n",
       "400                                                                                                                                                               8.       MARKETING AUTHORISATION NUMBER(S)   \n",
       "401                                                                                                                                                                                                            \n",
       "402                                                                                                                                                                                         EU/1/20/1476/001   \n",
       "403                                                                                                                                                                                                            \n",
       "404                                                                                                                                                                                                            \n",
       "405                                                                                                                                        9.       DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION   \n",
       "406                                                                                                                                                                                                            \n",
       "407                                                                                                                                                                                                            \n",
       "408                                                                                                                                                                     10.     DATE OF REVISION OF THE TEXT   \n",
       "409                                                                                                                                                                                                            \n",
       "410                                                                                                                                                                                                            \n",
       "411                                                                   Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu.    \n",
       "412                                                                                                                                                                                                            \n",
       "413                                                                                                                                                                                                            \n",
       "414                                                                                                                                                                                                            \n",
       "415                                                                                                                                                                                                            \n",
       "416                                                                                                                                                                                                            \n",
       "417                                                                                                                                                                                                            \n",
       "418                                                                                                                                                                                                            \n",
       "419                                                                                                                                                                                                            \n",
       "420                                                                                                                                                                                                            \n",
       "421                                                                                                                                                                                                            \n",
       "422                                                                                                                                                                                                            \n",
       "423                                                                                                                                                                                                            \n",
       "424                                                                                                                                                                                                            \n",
       "425                                                                                                                                                                                                            \n",
       "426                                                                                                                                                                                                            \n",
       "427                                                                                                                                                                                                            \n",
       "428                                                                                                                                                                                                            \n",
       "429                                                                                                                                                                                                            \n",
       "430                                                                                                                                                                                                            \n",
       "431                                                                                                                                                                                                            \n",
       "432                                                                                                                                                                                                            \n",
       "433                                                                                                                                                                                                            \n",
       "434                                                                                                                                                                                                            \n",
       "\n",
       "                                 ParentId  \n",
       "0    1b945380-ed32-477d-bc89-4e43eb629b1e  \n",
       "1    583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "2    583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "3    583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "4    583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "5    583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "6    583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "7    583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "8    583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "9    583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "10   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "11   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "12   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "13   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "14   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "15   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "16   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "17   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "18   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "19   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "20   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "21   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "22   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "23   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "24   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "25   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "26   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "27   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "28   b1cb472e-16b2-4c31-9704-43221d1c8944  \n",
       "29   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "30   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "31   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "32   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "33   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "34   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "35   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "36   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "37   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "38   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "39   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "40   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "41   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "42   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "43   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "44   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "45   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "46   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "47   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "48   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "49   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "50   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "51   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "52   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "53   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "54   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "55   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "56   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "57   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "58   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "59   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "60   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "61   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "62   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "63   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "64   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "65   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "66   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "67   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "68   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "69   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "70   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "71   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "72   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "73   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "74   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "75   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "76   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "77   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "78   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "79   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "80   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "81   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "82   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "83   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "84   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "85   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "86   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "87   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "88   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "89   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "90   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "91   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "92   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "93   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "94   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "95   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "96   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "97   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "98   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "99   583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "100  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "101  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "102  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "103  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "104  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "105  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "106  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "107  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "108  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "109  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "110  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "111  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "112  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "113  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "114  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "115  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "116  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "117  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "118  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "119  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "120  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "121  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "122  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "123  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "124  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "125  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "126  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "127  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "128  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "129  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "130  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "131  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "132  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "133  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "134  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "135  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "136  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "137  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "138  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "139  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "140  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "141  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "142  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "143  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "144  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "145  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "146  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "147  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "148  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "149  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "150  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "151  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "152  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "153  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "154  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "155  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "156  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "157  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "158  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "159  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "160  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "161  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "162  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "163  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "164  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "165  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "166  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "167  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "168  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "169  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "170  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "171  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "172  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "173  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "174  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "175  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "176  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "177  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "178  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "179  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "180  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "181  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "182  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "183  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "184  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "185  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "186  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "187  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "188  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "189  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "190  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "191  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "192  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "193  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "194  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "195  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "196  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "197  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "198  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "199  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "200  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "201  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "202  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "203  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "204  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "205  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "206  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "207  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "208  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "209  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "210  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "211  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "212  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "213  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "214  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "215  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "216  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "217  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "218  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "219  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "220  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "221  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "222  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "223  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "224  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "225  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "226  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "227  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "228  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "229  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "230  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "231  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "232  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "233  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "234  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "235  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "236  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "237  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "238  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "239  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "240  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "241  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "242  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "243  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "244  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "245  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "246  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "247  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "248  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "249  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "250  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "251  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "252  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "253  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "254  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "255  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "256  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "257  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "258  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "259  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "260  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "261  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "262  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "263  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "264  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "265  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "266  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "267  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "268  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "269  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "270  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "271  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "272  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "273  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "274  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "275  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "276  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "277  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "278  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "279  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "280  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "281  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "282  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "283  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "284  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "285  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "286  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "287  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "288  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "289  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "290  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "291  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "292  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "293  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "294  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "295  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "296  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "297  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "298  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "299  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "300  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "301  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "302  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "303  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "304  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "305  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "306  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "307  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "308  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "309  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "310  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "311  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "312  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "313  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "314  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "315  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "316  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "317  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "318  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "319  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "320  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "321  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "322  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "323  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "324  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "325  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "326  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "327  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "328  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "329  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "330  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "331  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "332  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "333  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "334  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "335  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "336  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "337  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "338  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "339  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "340  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "341  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "342  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "343  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "344  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "345  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "346  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "347  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "348  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "349  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "350  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "351  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "352  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "353  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "354  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "355  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "356  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "357  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "358  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "359  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "360  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "361  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "362  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "363  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "364  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "365  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "366  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "367  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "368  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "369  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "370  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "371  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "372  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "373  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "374  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "375  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "376  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "377  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "378  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "379  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "380  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "381  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "382  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "383  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "384  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "385  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "386  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "387  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "388  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "389  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "390  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "391  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "392  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "393  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "394  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "395  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "396  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "397  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "398  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "399  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "400  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "401  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "402  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "403  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "404  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "405  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "406  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "407  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "408  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "409  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "410  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "411  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "412  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "413  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "414  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "415  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "416  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "417  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "418  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "419  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "420  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "421  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "422  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "423  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "424  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "425  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "426  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "427  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "428  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "429  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "430  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "431  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "432  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "433  583f04cc-251b-4aa9-a300-400d62bebe5a  \n",
       "434  583f04cc-251b-4aa9-a300-400d62bebe5a  "
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "####\n",
    "#Comman Parameters\n",
    "procedureType = 'CAP'\n",
    "fileNameQrd = 'qrd_canonical_mode_CAP_NAP.csv'\n",
    "fileNameMatchRuleBook = 'ruleDict.json'\n",
    "fileNameDocumentTypeNames = 'documentTypeNames.json'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "\n",
    "def convertHtmlToJson(procedureType, languageCode, fileNameHtml, fileNameQrd, fileNameLog):\n",
    "\n",
    "    module_path = os.path.join(os.path.abspath(os.path.join('..')), 'data', 'converted_to_html', f'{procedureType}', f'{languageCode}')\n",
    "\n",
    "    # Generate output folder path\n",
    "    output_json_path = module_path.replace('converted_to_html', 'outputJSON')\n",
    "\n",
    "    \"\"\"\n",
    "        Check if input folder exists, else throw exception\n",
    "    \"\"\"\n",
    "    if(os.path.exists(module_path)):\n",
    "        filenames = glob.glob(os.path.join(module_path, fileNameHtml))\n",
    "\n",
    "        # Create language specific folder in outputJSON folder if it doesn't exist\n",
    "        if(not os.path.exists(output_json_path)):\n",
    "            os.mkdir(output_json_path)\n",
    "        logger = MatchLogger(f'Parser_{getRandomString(1)}', fileNameHtml,\n",
    "                             procedureType, languageCode, \"HTML\", fileNameLog)\n",
    "\n",
    "        styleLogger = MatchLogger(\n",
    "            f'Style Dictionary_{getRandomString(1)}', fileNameHtml, procedureType, languageCode, \"HTML\", fileNameLog)\n",
    "\n",
    "        styleRulesObj = StyleRulesDictionary(styleLogger,\n",
    "                                             language=languageCode,\n",
    "                                             fileName=fileNameQrd,\n",
    "                                             procedureType=procedureType)\n",
    "\n",
    "        parserObj = parserExtractor(config, logger, styleRulesObj.styleRuleDict,\n",
    "                                    styleRulesObj.styleFeatureKeyList,\n",
    "                                    styleRulesObj.qrd_section_headings)\n",
    "        print(filenames)\n",
    "        for input_filename in filenames:\n",
    "          # if(input_filename.find('Kalydeco II-86-PI-clean')!=-1):\n",
    "            output_filename = input_filename.replace(\n",
    "                'converted_to_html', 'outputJSON')\n",
    "            output_filename = output_filename.replace('.html', '.json')\n",
    "            output_filename = output_filename.replace('.htm', '.json')\n",
    "            print(input_filename, output_filename)\n",
    "            parserObj.createPIJsonFromHTML(input_filepath=input_filename,\n",
    "                                           output_filepath=output_filename,\n",
    "                                           img_base64_dict=parserObj.convertImgToBase64(\n",
    "                                               input_filename),\n",
    "                                           )\n",
    "    else:\n",
    "        raise FolderNotFoundError(module_path + \" not found\")\n",
    "    return output_filename.split(\"\\\\\")[-1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "def splitJson(procedureType, languageCode, fileNameJson, fileNameQrd, fileNameLog):\n",
    "\n",
    "    styleLogger = MatchLogger(\n",
    "        f'Style Dictionary_{getRandomString(1)}', fileNameJson, procedureType, languageCode, \"Json\", fileNameLog)\n",
    "\n",
    "    styleRulesObj = StyleRulesDictionary(styleLogger,\n",
    "                                         language=languageCode,\n",
    "                                         fileName=fileNameQrd,\n",
    "                                         procedureType=procedureType)\n",
    "\n",
    "    path_json = os.path.join(os.path.abspath(os.path.join(\n",
    "        '..')), 'data', 'outputJSON', procedureType, languageCode, fileNameJson)\n",
    "\n",
    "    partitionLogger = MatchLogger(\n",
    "        f'Partition_{getRandomString(1)}', fileNameJson, procedureType, languageCode, \"Json\", fileNameLog)\n",
    "\n",
    "    partitioner = DocTypePartitioner(partitionLogger)\n",
    "\n",
    "    partitionedJsonPaths = partitioner.partitionHtmls(\n",
    "        styleRulesObj.qrd_section_headings, path_json)\n",
    "\n",
    "    return partitionedJsonPaths"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "def extractAndValidateHeadings(procedureType,\n",
    "                               languageCode,\n",
    "                               documentNumber,\n",
    "                               fileNameDoc,\n",
    "                               fileNameQrd,\n",
    "                               fileNameMatchRuleBook,\n",
    "                               fileNameDocumentTypeNames,\n",
    "                               stopWordFilterLen=6,\n",
    "                               isPackageLeaflet=False,\n",
    "                               medName=None):\n",
    "\n",
    "    if documentNumber == 0:\n",
    "        topHeadingsConsidered = 4\n",
    "        bottomHeadingsConsidered = 6\n",
    "    elif documentNumber == 1:\n",
    "        topHeadingsConsidered = 3\n",
    "        bottomHeadingsConsidered = 5\n",
    "    elif documentNumber == 2:\n",
    "        topHeadingsConsidered = 5\n",
    "        bottomHeadingsConsidered = 15\n",
    "    else:\n",
    "        topHeadingsConsidered = 5\n",
    "        bottomHeadingsConsidered = 10\n",
    "\n",
    "    print(f\"Starting Heading Extraction For File :- {fileNameDoc}\")\n",
    "    logger = MatchLogger(f\"Heading Extraction {fileNameDoc}\", fileNameDoc, procedureType, languageCode, documentNumber, fileNameLog=os.path.join(\n",
    "        os.path.abspath(os.path.join('..')), 'data', 'matchLog.txt'))\n",
    "    logger.logFlowCheckpoint(\"Starting Heading Extraction\")\n",
    "\n",
    "    stopWordlanguage = DocumentTypeNames(\n",
    "        fileNameDocumentTypeNames=fileNameDocumentTypeNames,\n",
    "        languageCode=languageCode,\n",
    "        procedureType=procedureType,\n",
    "        documentNumber=documentNumber).extractStopWordLanguage()\n",
    "\n",
    "    matchDocObj = MatchDocument(\n",
    "        logger,\n",
    "        procedureType,\n",
    "        languageCode,\n",
    "        documentNumber,\n",
    "        fileNameDoc,\n",
    "        fileNameQrd,\n",
    "        fileNameMatchRuleBook,\n",
    "        fileNameDocumentTypeNames,\n",
    "        topHeadingsConsidered,\n",
    "        bottomHeadingsConsidered,\n",
    "        stopWordFilterLen,\n",
    "        stopWordlanguage,\n",
    "        isPackageLeaflet,\n",
    "        medName)\n",
    "    df, coll = matchDocObj.matchHtmlHeaddingsWithQrd()\n",
    "\n",
    "    return df, coll"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "def parseDocument(htmlDocPath, fileNameQrd, fileNameMatchRuleBook, fileNameDocumentTypeNames, medName = None):\n",
    "    \n",
    "    pathComponents = htmlDocPath.split(\"\\\\\")\n",
    "    fileNameHtml = pathComponents[-1]\n",
    "    languageCode =  pathComponents[-2]\n",
    "    procedureType = pathComponents[-3]\n",
    "    #procedureType = \"CAP\"\n",
    "    print(fileNameHtml,languageCode,procedureType)\n",
    "    \n",
    "    fileNameLog = os.path.join(os.path.abspath(os.path.join('..')),'data','FinalLog.txt')\n",
    "    \n",
    "    flowLogger =  MatchLogger(\"Flow Logger HTML\", fileNameHtml, procedureType, languageCode, \"HTML\", fileNameLog)\n",
    "\n",
    "    flowLogger.logFlowCheckpoint(\"Starting HTML Conversion To Json\")\n",
    "    ###Convert Html to Json\n",
    "    fileNameJson = convertHtmlToJson(procedureType, languageCode, fileNameHtml, fileNameQrd, fileNameLog)\n",
    "    \n",
    "    flowLogger.logFlowCheckpoint(\"Completed HTML Conversion To Json\")\n",
    "\n",
    "    flowLogger.logFlowCheckpoint(\"Starting Json Split\")\n",
    "\n",
    "    ###Split Uber Json to multiple Jsons for each category.\n",
    "    partitionedJsonPaths = splitJson(procedureType, languageCode, fileNameJson, fileNameQrd, fileNameLog)\n",
    "    \n",
    "    partitionedJsonPaths = [ path.split(\"\\\\\")[-1] for path in partitionedJsonPaths]\n",
    "    #print(partitionedJsonPaths)\n",
    "    \n",
    "    flowLogger.logFlowCheckpoint(\"Completed Json Split\")\n",
    "    \n",
    "    flowLogger.logFlowCheckpoint(\"Started Processing Partitioned Jsons\")\n",
    "    \n",
    "    for index, fileNamePartitioned in enumerate(partitionedJsonPaths):\n",
    "        \n",
    "        print(index,fileNamePartitioned)\n",
    "        \n",
    "        if index == 3:\n",
    "            stopWordFilterLen = 100\n",
    "            isPackageLeaflet = True\n",
    "        else:\n",
    "            stopWordFilterLen = 6\n",
    "            isPackageLeaflet = False\n",
    "            \n",
    "        df, coll = extractAndValidateHeadings(procedureType,\n",
    "                                    languageCode,\n",
    "                                    index,\n",
    "                                    fileNamePartitioned,\n",
    "                                    fileNameQrd,\n",
    "                                    fileNameMatchRuleBook,\n",
    "                                    fileNameDocumentTypeNames,\n",
    "                                    stopWordFilterLen=stopWordFilterLen,\n",
    "                                    isPackageLeaflet=isPackageLeaflet,\n",
    "                                    medName=medName)\n",
    "        \n",
    "        \n",
    "        print(f\"Completed Heading Extraction For File\")\n",
    "        flowLogger.logFlowCheckpoint(\"Completed Heading Extraction For File\")\n",
    "        \n",
    "        print(f\"Starting Document Annotation For File :- {fileNamePartitioned}\")        \n",
    "        flowLogger.logFlowCheckpoint(\"Starting Document Annotation For File\")\n",
    "        documentAnnotationObj = DocumentAnnotation(fileNamePartitioned,'c20835db4b1b4e108828a8537ff41506','https://spor-sit.azure-api.net/pms/api/v2/',df,coll)\n",
    "        try:\n",
    "            pms_oms_annotation_data = documentAnnotationObj.processRegulatedAuthorizationForDoc()\n",
    "            print(pms_oms_annotation_data)\n",
    "        except:\n",
    "            pms_oms_annotation_data = None\n",
    "            print(\"Error Found\")\n",
    "            \n",
    "        print(f\"Completed Document Annotation\")        \n",
    "        flowLogger.logFlowCheckpoint(\"Completed Document Annotation\")\n",
    "        \n",
    "        print(f\"Starting Extracting Content Between Heading For File :- {fileNamePartitioned}\")        \n",
    "        flowLogger.logFlowCheckpoint(\"Starting Extracting Content Between Heading\")\n",
    "        \n",
    "        extractContentlogger =  MatchLogger(f'ExtractContentBetween_{index}', fileNamePartitioned, procedureType, languageCode, index, fileNameLog)\n",
    "        extractorObj = DataBetweenHeadingsExtractor(extractContentlogger, coll, procedureType, languageCode)\n",
    "        dfExtractedHierRR = extractorObj.extractContentBetweenHeadings(fileNamePartitioned)\n",
    "        \n",
    "        print(f\"Completed Extracting Content Between Heading\")        \n",
    "        flowLogger.logFlowCheckpoint(\"Completed Extracting Content Between Heading\")\n",
    "        \n",
    "        xmlLogger =  MatchLogger(f'XmlGeneration_{index}', fileNamePartitioned, procedureType, languageCode, index, fileNameLog)\n",
    "        fhirXmlGeneratorObj = FhirXmlGenerator(xmlLogger, pms_oms_annotation_data)\n",
    "        fileNameXml = fileNamePartitioned.replace('.json','.xml')\n",
    "        generatedXml = fhirXmlGeneratorObj.generateXml(dfExtractedHierRR, fileNameXml)\n",
    "        \n",
    "        fhirServiceObj = FhirService(generatedXml)\n",
    "        fhirServiceObj.submitFhirXml()\n",
    "        print(f\"Created XML File For :- {fileNamePartitioned}\")        \n",
    "\n",
    "        #return df,coll,dfExtractedHierRR\n",
    "    \n",
    "    flowLogger.logFlowCheckpoint(\"Completed Processing Partitioned Jsons\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "def convertToInt(x):\n",
    "    try:\n",
    "        return str(int(x))\n",
    "    except:\n",
    "        return x\n",
    "\n",
    "\n",
    "def convertCollectionToDataFrame(collection):\n",
    "\n",
    "    dfExtractedHier = pd.DataFrame(collection)\n",
    "    dfExtractedHier['parent_id'] = dfExtractedHier['parent_id'].apply(\n",
    "        lambda x: convertToInt(x))\n",
    "    dfExtractedHier['id'] = dfExtractedHier['id'].apply(\n",
    "        lambda x: convertToInt(x))\n",
    "\n",
    "    return dfExtractedHier"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:48:32,493 : Flow Logger HTML : Starting HTML Conversion To Json | CAP |  en | HTML | AbilifyMaintena-h-2755-e.html\n",
      "2021-05-04 19:48:32,501 : Style Dictionary_f : Reading style dictionary in file: F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\styleRules\\rule_dictionary_en.json | CAP |  en | HTML | AbilifyMaintena-h-2755-e.html\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "AbilifyMaintena-h-2755-e.html en CAP\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:48:32,823 : Style Dictionary_f : Qrd Section Keys Generated: ANNEX I, ANNEX II, ANNEX III, B. PACKAGE LEAFLET | CAP |  en | HTML | AbilifyMaintena-h-2755-e.html\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\converted_to_html\\CAP\\en\\AbilifyMaintena-h-2755-e.html F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\outputJSON\\CAP\\en\\AbilifyMaintena-h-2755-e.json\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:48:38,659 : Parser_o : Writing to file: F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\outputJSON\\CAP\\en\\AbilifyMaintena-h-2755-e.json | CAP |  en | HTML | AbilifyMaintena-h-2755-e.html\n",
      "2021-05-04 19:48:39,012 : Flow Logger HTML : Completed HTML Conversion To Json | CAP |  en | HTML | AbilifyMaintena-h-2755-e.html\n",
      "2021-05-04 19:48:39,014 : Flow Logger HTML : Starting Json Split | CAP |  en | HTML | AbilifyMaintena-h-2755-e.html\n",
      "2021-05-04 19:48:39,018 : Style Dictionary_C : Reading style dictionary in file: F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\styleRules\\rule_dictionary_en.json | CAP |  en | Json | AbilifyMaintena-h-2755-e.json\n",
      "2021-05-04 19:48:39,052 : Style Dictionary_C : Qrd Section Keys Generated: ANNEX I, ANNEX II, ANNEX III, B. PACKAGE LEAFLET | CAP |  en | Json | AbilifyMaintena-h-2755-e.json\n",
      "2021-05-04 19:48:39,058 : Partition_B : Partitioning Json: AbilifyMaintena-h-2755-e.json | CAP |  en | Json | AbilifyMaintena-h-2755-e.json\n",
      "2021-05-04 19:48:39,217 : Partition_B : Writing partition to file: F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\partitionedJSONs\\CAP\\en\\AbilifyMaintena-h-2755-e_SmPC.json | CAP |  en | Json | AbilifyMaintena-h-2755-e.json\n",
      "2021-05-04 19:48:39,268 : Partition_B : Writing partition to file: F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\partitionedJSONs\\CAP\\en\\AbilifyMaintena-h-2755-e_ANNEX II.json | CAP |  en | Json | AbilifyMaintena-h-2755-e.json\n",
      "2021-05-04 19:48:39,341 : Partition_B : Writing partition to file: F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\partitionedJSONs\\CAP\\en\\AbilifyMaintena-h-2755-e_ANNEX III.json | CAP |  en | Json | AbilifyMaintena-h-2755-e.json\n",
      "2021-05-04 19:48:39,365 : Partition_B : Writing partition to file: F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\partitionedJSONs\\CAP\\en\\AbilifyMaintena-h-2755-e_ PACKAGE LEAFLET.json | CAP |  en | Json | AbilifyMaintena-h-2755-e.json\n",
      "2021-05-04 19:48:39,386 : Flow Logger HTML : Completed Json Split | CAP |  en | HTML | AbilifyMaintena-h-2755-e.html\n",
      "2021-05-04 19:48:39,388 : Flow Logger HTML : Started Processing Partitioned Jsons | CAP |  en | HTML | AbilifyMaintena-h-2755-e.html\n",
      "2021-05-04 19:48:39,394 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Starting Heading Extraction | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "*************************** Texts with more than 2 characters**************************************\n",
      "*************************** Texts with more than 2 characters**************************************\n",
      "*************************** Texts with more than 2 characters**************************************\n",
      "*************************** Texts with more than 2 characters**************************************\n",
      "0 AbilifyMaintena-h-2755-e_SmPC.json\n",
      "Starting Heading Extraction For File :- AbilifyMaintena-h-2755-e_SmPC.json\n",
      "File being processed: F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\partitionedJSONs\\CAP\\en\\AbilifyMaintena-h-2755-e_SmPC.json\n",
      "--------------------------------------------\n",
      "SmPC\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:48:39,608 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Started Extracting Heading | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json\n",
      "2021-05-04 19:48:39,847 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'SUMMARY OF PRODUCT CHARACTERISTICS' | Qrd txt :- 'SUMMARY OF PRODUCT CHARACTERISTICS' | Matched :- 'True'\n",
      "2021-05-04 19:48:39,854 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed As This The First Heading | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20001' | currParentHeadId :- 'nan' | prevParentHeadId :- ''\n",
      "2021-05-04 19:48:39,890 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- '1.       NAME OF THE MEDICINAL PRODUCT' | Qrd txt :- '1. NAME OF THE MEDICINAL PRODUCT' | Matched :- 'True'\n",
      "2021-05-04 19:48:39,901 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Flow Is Broken | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20003' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20001'\n",
      "2021-05-04 19:48:39,908 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20003' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20001'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "True  ||    ||  SUMMARY OF PRODUCT CHARACTERISTICS  ||  SUMMARY OF PRODUCT CHARACTERISTICS\n",
      "True  ||    ||  1.       NAME OF THE MEDICINAL PRODUCT  ||  1. NAME OF THE MEDICINAL PRODUCT\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:48:40,122 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:40,503 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:40,826 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection in pre‑filled syringe' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:41,117 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection in pre‑filled syringe' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:41,364 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- '2.       QUALITATIVE AND QUANTITATIVE COMPOSITION' | Qrd txt :- '2. QUALITATIVE AND QUANTITATIVE COMPOSITION' | Matched :- 'True'\n",
      "2021-05-04 19:48:41,379 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20004' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20003'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "True  ||    ||  2.       QUALITATIVE AND QUANTITATIVE COMPOSITION  ||  2. QUALITATIVE AND QUANTITATIVE COMPOSITION\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:48:41,721 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:42,437 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Each vial contains 300 mg aripiprazole.' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-04 19:48:42,817 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:43,556 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Each vial contains 400 mg aripiprazole.' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-04 19:48:43,882 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection in pre‑filled syringe' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:44,543 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Each pre‑filled syringe contains 300 mg aripiprazole.' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-04 19:48:44,922 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection in pre‑filled syringe' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:45,468 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Each pre‑filled syringe contains 400 mg aripiprazole.' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-04 19:48:45,782 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'After reconstitution each ml of suspension contains 200 mg aripiprazole.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:46,218 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- '3.       PHARMACEUTICAL FORM' | Qrd txt :- '3. PHARMACEUTICAL FORM' | Matched :- 'True'\n",
      "2021-05-04 19:48:46,231 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Flow Is Broken | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20008' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20004'\n",
      "2021-05-04 19:48:46,240 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20008' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20004'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "True  ||    ||  3.       PHARMACEUTICAL FORM  ||  3. PHARMACEUTICAL FORM\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:48:46,574 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Powder and solvent for prolonged-release suspension for injection' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:47,266 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- '4.       CLINICAL PARTICULARS' | Qrd txt :- '4. CLINICAL PARTICULARS' | Matched :- 'True'\n",
      "2021-05-04 19:48:47,275 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20009' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20008'\n",
      "2021-05-04 19:48:47,343 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- '4.1     Therapeutic indications' | Qrd txt :- '4.1 Therapeutic indications' | Matched :- 'True'\n",
      "2021-05-04 19:48:47,350 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20010' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20009'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "True  ||    ||  4.       CLINICAL PARTICULARS  ||  4. CLINICAL PARTICULARS\n",
      "True  ||    ||  4.1     Therapeutic indications  ||  4.1 Therapeutic indications\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:48:47,615 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Abilify Maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:47,716 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- '4.2     Posology and method of administration' | Qrd txt :- '4.2 Posology and method of administration' | Matched :- 'True'\n",
      "2021-05-04 19:48:47,730 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20011' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20010'\n",
      "2021-05-04 19:48:47,780 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed In Lowercase | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Posology' | Qrd txt :- '4.2 Posology and method of administration' | Matched :- 'False'\n",
      "2021-05-04 19:48:47,783 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Posology' | Qrd txt :- 'Posology' | Matched :- 'True'\n",
      "2021-05-04 19:48:47,805 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20012' | currParentHeadId :- '20011.0' | prevParentHeadId :- '20011'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "True  ||    ||  4.2     Posology and method of administration  ||  4.2 Posology and method of administration\n",
      "\n",
      "OriginalCheck\n",
      "('<=7|412.5|(33, 100, 90)|0.73|', 'Posology', '4.2 Posology and method of administration')\n",
      "\n",
      "True  ||    ||  Posology  ||  Posology\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:48:48,053 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'For patients who have never taken aripiprazole, tolerability with oral aripiprazole must occur prior to initiating treatment with Abilify Maintena.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:48,266 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Titration of the dose for Abilify Maintena is not required. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:48,498 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'The starting dose can be administered by following one of two regimens: ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:49,011 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Special populations' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-04 19:48:49,308 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'The safety and efficacy of Abilify Maintena in the treatment of schizophrenia in patients 65 years of age or older has not been established (see section 4.4).' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:49,770 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'No dosage adjustment is required for patients with renal impairment (see section 5.2).' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:50,933 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- '•        One injection start: The starting dose should be 300 mg Abilify Maintena and continue treatment with prescribed dose of oral aripiprazole per day for 14 consecutive days. ' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:51,220 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'In patients who are known to be CYP2D6 poor metabolisers and concomitantly use a strong CYP3A4 inhibitor:' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:51,508 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- '•        The one injection start: The starting dose should be reduced to 200 mg (see section 4.5) and continue treatment with the prescribed dose of oral aripiprazole per day for 14 consecutive days.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:51,737 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- '•        Two injection start is not to be used in patients who are known to be CYP2D6 poor metabolisers and concomitantly use a strong CYP3A4 inhibitor.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:52,033 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Maintenance dose adjustments due to interactions with CYP2D6 and/or CYP3A4 inhibitors and/or CYP3A4 inducers' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:52,542 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Maintenance dose adjustments of Abilify Maintena in patients who are taking concomitant strong CYP2D6 inhibitors, strong CYP3A4 inhibitors, and/or CYP3A4 inducers for more than 14 days' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:52,749 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- '*    200 mg and 160 mg can be achieved via adjustment of the injection volume only by using Abilify Maintena powder and solvent for        prolonged-release suspension for injection.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:52,837 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'\n",
      "2021-05-04 19:48:52,851 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20013' | currParentHeadId :- '20012.0' | prevParentHeadId :- '20011'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "True  ||    ||  Paediatric population  ||  Paediatric population\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:48:53,120 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed In Lowercase | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Method of administration' | Qrd txt :- '4.2 Posology and method of administration' | Matched :- 'False'\n",
      "2021-05-04 19:48:53,125 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Method of administration' | Qrd txt :- 'Method of administration ' | Matched :- 'True'\n",
      "2021-05-04 19:48:53,142 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20014' | currParentHeadId :- '20011.0' | prevParentHeadId :- '20011'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "OriginalCheck\n",
      "('<=7|75.0|(71, 96, 90)|0.69|', 'Method of administration', '4.2 Posology and method of administration')\n",
      "\n",
      "True  ||    ||  Method of administration  ||  Method of administration \n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:48:53,324 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Abilify Maintena is only intended for intramuscular use and should not be administered intravenously or subcutaneously. It should only be administered by a healthcare professional.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:53,734 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Full instructions for use and handling of Abilify Maintena are provided in the package leaflet (information intended for healthcare professionals).' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:53,842 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'For instructions on reconstitution of the medicinal product before administration, see section 6.6.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:53,984 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- '4.3     Contraindications' | Qrd txt :- '4.3 Contraindications' | Matched :- 'True'\n",
      "2021-05-04 19:48:53,993 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20016' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20011'\n",
      "2021-05-04 19:48:54,129 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "True  ||    ||  4.3     Contraindications  ||  4.3 Contraindications\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:48:54,309 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- '4.4     Special warnings and precautions for use' | Qrd txt :- '4.4 Special warnings and precautions for use' | Matched :- 'True'\n",
      "2021-05-04 19:48:54,322 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20017' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20016'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "True  ||    ||  4.4     Special warnings and precautions for use  ||  4.4 Special warnings and precautions for use\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:48:54,672 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'During antipsychotic treatment, improvement in the patient's clinical condition may take several days to some weeks. Patients should be closely monitored throughout this period.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:54,906 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Use in patients who are in an acutely agitated or severely psychotic state' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:55,147 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Abilify Maintena should not be used to manage acutely agitated or severely psychotic states when immediate symptom control is warranted.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:56,813 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Elderly patients with dementia-related psychosis' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:56,824 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Elderly patients with dementia-related psychosis' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-04 19:48:57,560 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Aripiprazole is not indicated for the treatment of patients with dementia-related psychosis.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:57,578 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Aripiprazole is not indicated for the treatment of patients with dementia-related psychosis.' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-04 19:48:58,329 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Hypersensitivity reactions, characterised by allergic symptoms, may occur with aripiprazole (see section 4.8).' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:59,036 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Oesophageal dysmotility and aspiration have been associated with the use of aripiprazole. Aripiprazole should be used cautiously in patients at risk for aspiration pneumonia.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:59,282 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Pathological gambling and other impulse control disorders' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-04 19:48:59,695 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Abilify Maintena contains less than 1 mmol of sodium (23 mg) per dose.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:48:59,813 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- '4.5     Interaction with other medicinal products and other forms of interaction' | Qrd txt :- '4.5 Interaction with other medicinal products and other forms of interaction' | Matched :- 'True'\n",
      "2021-05-04 19:48:59,824 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20020' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20017'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "True  ||    ||  4.5     Interaction with other medicinal products and other forms of interaction  ||  4.5 Interaction with other medicinal products and other forms of interaction\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:49:00,064 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'No interaction studies have been performed with Abilify Maintena. The information below is obtained from studies with oral aripiprazole.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:49:00,410 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Due to its α1-adrenergic receptor antagonism, aripiprazole has the potential to enhance the effect of certain antihypertensive medicinal products.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:49:00,976 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'If aripiprazole is administered concomitantly with medicinal products known to cause QT prolongation or electrolyte imbalance, caution should be used.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:49:01,242 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Potential for other medicinal products to affect aripiprazole' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:49:01,264 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Potential for other medicinal products to affect aripiprazole' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-04 19:49:02,625 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- '4.6     Fertility, pregnancy and lactation' | Qrd txt :- '4.6 Fertility, pregnancy and lactation' | Matched :- 'True'\n",
      "2021-05-04 19:49:02,638 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20022' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20020'\n",
      "2021-05-04 19:49:02,709 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed In Lowercase | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Pregnancy' | Qrd txt :- '4.6 Fertility, pregnancy and lactation' | Matched :- 'False'\n",
      "2021-05-04 19:49:02,711 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Pregnancy' | Qrd txt :- 'Pregnancy' | Matched :- 'True'\n",
      "2021-05-04 19:49:02,730 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20023' | currParentHeadId :- '20022.0' | prevParentHeadId :- '20022'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "True  ||    ||  4.6     Fertility, pregnancy and lactation  ||  4.6 Fertility, pregnancy and lactation\n",
      "\n",
      "OriginalCheck\n",
      "('<=7|333.33|(34, 89, 90)|0.53|', 'Pregnancy', '4.6 Fertility, pregnancy and lactation')\n",
      "\n",
      "True  ||    ||  Pregnancy  ||  Pregnancy\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:49:02,920 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Prescribers need to be aware of the long-acting properties of Abilify Maintena.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:49:02,930 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Prescribers need to be aware of the long-acting properties of Abilify Maintena.' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-04 19:49:03,015 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Breast-feeding' | Qrd txt :- 'Breast-feeding' | Matched :- 'True'\n",
      "2021-05-04 19:49:03,033 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20024' | currParentHeadId :- '20022.0' | prevParentHeadId :- '20022'\n",
      "2021-05-04 19:49:03,173 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed In Lowercase | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Fertility' | Qrd txt :- '4.6 Fertility, pregnancy and lactation' | Matched :- 'False'\n",
      "2021-05-04 19:49:03,178 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Fertility' | Qrd txt :- 'Fertility' | Matched :- 'True'\n",
      "2021-05-04 19:49:03,193 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20025' | currParentHeadId :- '20022.0' | prevParentHeadId :- '20022'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "True  ||    ||  Breast-feeding  ||  Breast-feeding\n",
      "\n",
      "OriginalCheck\n",
      "('<=7|322.22|(38, 100, 90)|0.75|', 'Fertility', '4.6 Fertility, pregnancy and lactation')\n",
      "\n",
      "True  ||    ||  Fertility  ||  Fertility\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:49:03,410 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Aripiprazole did not impair fertility based on data from reproductive toxicity studies.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:49:03,606 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- '4.7     Effects on ability to drive and use machines' | Qrd txt :- '4.7 Effects on ability to drive and use machines' | Matched :- 'True'\n",
      "2021-05-04 19:49:03,620 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20026' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20022'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "True  ||    ||  4.7     Effects on ability to drive and use machines  ||  4.7 Effects on ability to drive and use machines\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:49:03,959 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- '4.8     Undesirable effects' | Qrd txt :- '4.8 Undesirable effects' | Matched :- 'True'\n",
      "2021-05-04 19:49:03,974 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20027' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20026'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "True  ||    ||  4.8     Undesirable effects  ||  4.8 Undesirable effects\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:49:04,725 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Tabulated list of adverse reactions' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-04 19:49:04,945 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'The incidences of the ADRs associated with aripiprazole therapy are tabulated below. The table is based on adverse reactions reported during clinical trials and/or post-marketing use.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:49:05,512 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Description of selected adverse reactions' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:49:06,118 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Neutropenia has been reported in the clinical program with Abilify Maintena and typically started around day 16 after first injection, and lasted a median of 18 days.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:49:07,216 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'In clinical trials for the approved indications and post-marketing, both increase and decrease in serum prolactin as compared to baseline was observed with aripiprazole (section 5.1).' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:49:07,576 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Pathological gambling and other impulse control disorders' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-04 19:49:07,827 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Pathological gambling, hypersexuality, compulsive shopping and binge or compulsive eating can occur in patients treated with aripiprazole (see section 4.4).' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:49:08,025 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Reporting of suspected adverse reactions' | Qrd txt :- 'Reporting of suspected adverse reactions' | Matched :- 'True'\n",
      "2021-05-04 19:49:08,046 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20029' | currParentHeadId :- '20027.0' | prevParentHeadId :- '20027'\n",
      "2021-05-04 19:49:08,210 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- '4.9     Overdose' | Qrd txt :- '4.9 Overdose' | Matched :- 'True'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "True  ||    ||  Reporting of suspected adverse reactions  ||  Reporting of suspected adverse reactions\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:49:08,227 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20030' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20027'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "True  ||    ||  4.9     Overdose  ||  4.9 Overdose\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:49:09,339 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- '5.       PHARMACOLOGICAL PROPERTIES' | Qrd txt :- '5. PHARMACOLOGICAL PROPERTIES' | Matched :- 'True'\n",
      "2021-05-04 19:49:09,348 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20032' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20030'\n",
      "2021-05-04 19:49:09,506 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- '5.1     Pharmacodynamic properties' | Qrd txt :- '5.1 Pharmacodynamic properties' | Matched :- 'True'\n",
      "2021-05-04 19:49:09,516 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20033' | currParentHeadId :- '20032.0' | prevParentHeadId :- '20032'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "True  ||    ||  5.       PHARMACOLOGICAL PROPERTIES  ||  5. PHARMACOLOGICAL PROPERTIES\n",
      "True  ||    ||  5.1     Pharmacodynamic properties  ||  5.1 Pharmacodynamic properties\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:49:09,873 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Mechanism of action' | Qrd txt :- 'Mechanism of action' | Matched :- 'True'\n",
      "2021-05-04 19:49:09,886 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20034' | currParentHeadId :- '20033.0' | prevParentHeadId :- '20033'\n",
      "2021-05-04 19:49:10,057 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Clinical efficacy and safety' | Qrd txt :- 'Clinical efficacy and safety' | Matched :- 'True'\n",
      "2021-05-04 19:49:10,081 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Validation Passed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | currHeadId :- '20036' | currParentHeadId :- '20033.0' | prevParentHeadId :- '20033'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "True  ||    ||  Mechanism of action  ||  Mechanism of action\n",
      "True  ||    ||  Clinical efficacy and safety  ||  Clinical efficacy and safety\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-04 19:49:10,377 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Maintenance treatment of schizophrenia in adults' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:49:10,391 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Maintenance treatment of schizophrenia in adults' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-04 19:49:10,696 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'The efficacy of Abilify Maintena in the maintenance treatment of patients with schizophrenia was established in two randomised, double‑blind, long-term trials.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-04 19:49:11,437 : Heading Extraction AbilifyMaintena-h-2755-e_SmPC.json : Match Failed | CAP |  en | 0 | AbilifyMaintena-h-2755-e_SmPC.json | Doc txt :- 'Figure 1      Kaplan-Meier Product Limit Plot for Time to Exacerbation of Psychotic Symptoms/Impending Relapse' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n"
     ]
    },
    {
     "ename": "KeyboardInterrupt",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mKeyboardInterrupt\u001b[0m                         Traceback (most recent call last)",
      "\u001b[1;32m<ipython-input-11-b0270f76d294>\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[1;32m----> 1\u001b[1;33m \u001b[0mparseDocument\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m\"F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\converted_to_html\\CAP\\en\\AbilifyMaintena-h-2755-e.html\"\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mfileNameQrd\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mfileNameMatchRuleBook\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mfileNameDocumentTypeNames\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mmedName\u001b[0m \u001b[1;33m=\u001b[0m \u001b[1;34m\"Aerius\"\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[1;32m<ipython-input-9-6153604a5e7e>\u001b[0m in \u001b[0;36mparseDocument\u001b[1;34m(htmlDocPath, fileNameQrd, fileNameMatchRuleBook, fileNameDocumentTypeNames, medName)\u001b[0m\n\u001b[0;32m     50\u001b[0m                                     \u001b[0mstopWordFilterLen\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mstopWordFilterLen\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     51\u001b[0m                                     \u001b[0misPackageLeaflet\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0misPackageLeaflet\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 52\u001b[1;33m                                     medName=medName)\n\u001b[0m\u001b[0;32m     53\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     54\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m<ipython-input-8-9cf09502baf0>\u001b[0m in \u001b[0;36mextractAndValidateHeadings\u001b[1;34m(procedureType, languageCode, documentNumber, fileNameDoc, fileNameQrd, fileNameMatchRuleBook, fileNameDocumentTypeNames, stopWordFilterLen, isPackageLeaflet, medName)\u001b[0m\n\u001b[0;32m     49\u001b[0m         \u001b[0misPackageLeaflet\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     50\u001b[0m         medName)\n\u001b[1;32m---> 51\u001b[1;33m     \u001b[0mdf\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mcoll\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mmatchDocObj\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mmatchHtmlHeaddingsWithQrd\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     52\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     53\u001b[0m     \u001b[1;32mreturn\u001b[0m \u001b[0mdf\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mcoll\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32mF:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\code\\match\\matchDocument\\matchDocument.py\u001b[0m in \u001b[0;36mmatchHtmlHeaddingsWithQrd\u001b[1;34m(self)\u001b[0m\n\u001b[0;32m    360\u001b[0m                             \u001b[1;31m# Call matching algorith\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    361\u001b[0m                             found, outputString = matchStringObj.matchStrings(\n\u001b[1;32m--> 362\u001b[1;33m                                 str_['Text'], qrd_str, qrd_str_row['heading_id'])\n\u001b[0m\u001b[0;32m    363\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    364\u001b[0m                             \u001b[1;32mif\u001b[0m \u001b[0mfound\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32mF:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\code\\match\\matchStrings\\matchStrings.py\u001b[0m in \u001b[0;36mmatchStrings\u001b[1;34m(self, textOriginal, textToMatch, qrdRowHeadingId, avoidLowerCaseMatch)\u001b[0m\n\u001b[0;32m    240\u001b[0m         \u001b[1;31m# Damerau Levensteins Distance\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    241\u001b[0m         levenDist = jellyfish.damerau_levenshtein_distance(\n\u001b[1;32m--> 242\u001b[1;33m             textToMatch1, textOriginal1)\n\u001b[0m\u001b[0;32m    243\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    244\u001b[0m         \u001b[1;32mif\u001b[0m \u001b[0mlen\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mtextOriginal1\u001b[0m\u001b[1;33m)\u001b[0m \u001b[1;33m!=\u001b[0m \u001b[1;36m0\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\AppData\\Local\\Continuum\\anaconda3\\lib\\site-packages\\jellyfish\\_jellyfish.py\u001b[0m in \u001b[0;36mdamerau_levenshtein_distance\u001b[1;34m(s1, s2)\u001b[0m\n\u001b[0;32m    165\u001b[0m                 \u001b[0mscore\u001b[0m\u001b[1;33m[\u001b[0m\u001b[0mi\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m[\u001b[0m\u001b[0mj\u001b[0m\u001b[1;33m]\u001b[0m \u001b[1;33m+\u001b[0m \u001b[0mcost\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    166\u001b[0m                 \u001b[0mscore\u001b[0m\u001b[1;33m[\u001b[0m\u001b[0mi\u001b[0m \u001b[1;33m+\u001b[0m \u001b[1;36m1\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m[\u001b[0m\u001b[0mj\u001b[0m\u001b[1;33m]\u001b[0m \u001b[1;33m+\u001b[0m \u001b[1;36m1\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 167\u001b[1;33m                 \u001b[0mscore\u001b[0m\u001b[1;33m[\u001b[0m\u001b[0mi\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m[\u001b[0m\u001b[0mj\u001b[0m \u001b[1;33m+\u001b[0m \u001b[1;36m1\u001b[0m\u001b[1;33m]\u001b[0m \u001b[1;33m+\u001b[0m \u001b[1;36m1\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    168\u001b[0m                 \u001b[0mscore\u001b[0m\u001b[1;33m[\u001b[0m\u001b[0mi1\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m[\u001b[0m\u001b[0mj1\u001b[0m\u001b[1;33m]\u001b[0m \u001b[1;33m+\u001b[0m \u001b[1;33m(\u001b[0m\u001b[0mi\u001b[0m \u001b[1;33m-\u001b[0m \u001b[0mi1\u001b[0m \u001b[1;33m-\u001b[0m \u001b[1;36m1\u001b[0m\u001b[1;33m)\u001b[0m \u001b[1;33m+\u001b[0m \u001b[1;36m1\u001b[0m \u001b[1;33m+\u001b[0m \u001b[1;33m(\u001b[0m\u001b[0mj\u001b[0m \u001b[1;33m-\u001b[0m \u001b[0mj1\u001b[0m \u001b[1;33m-\u001b[0m \u001b[1;36m1\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    169\u001b[0m             )\n",
      "\u001b[1;31mKeyboardInterrupt\u001b[0m: "
     ]
    }
   ],
   "source": [
    "parseDocument(\"F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\converted_to_html\\CAP\\en\\AbilifyMaintena-h-2755-e.html\", fileNameQrd, fileNameMatchRuleBook, fileNameDocumentTypeNames, medName = \"Aerius\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "fileNameQrd = 'qrd_canonical_model.csv'\n",
    "fileNameMatchRuleBook = 'ruleDict.json'\n",
    "fileNameDocumentTypeNames = 'documentTypeNames.json'\n",
    "\n",
    "fsMountName = '/mounted'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pprint\n",
    "import pandas as pd\n",
    "import uuid\n",
    "import json\n",
    "import os\n",
    "import glob\n",
    "import re\n",
    "import sys\n",
    "from bs4 import NavigableString, BeautifulSoup\n",
    "from collections import defaultdict\n",
    "import random\n",
    "import string\n",
    "\n",
    "from utils.config import config\n",
    "from utils.logger.logger import loggerCreator\n",
    "\n",
    "# ePI Modules\n",
    "from parse.rulebook.rulebook import StyleRulesDictionary\n",
    "\n",
    "from parse.extractor.parser import parserExtractor\n",
    "from match.matchDocument.matchDocument import MatchDocument\n",
    "from documentAnnotation.documentAnnotation import DocumentAnnotation\n",
    "from htmlDocTypePartitioner.partition import DocTypePartitioner\n",
    "from extractContentBetweenHeadings.dataBetweenHeadingsExtractor import DataBetweenHeadingsExtractor\n",
    "from fhirXmlGenerator.fhirXmlGenerator import FhirXmlGenerator\n",
    "from fhirService.fhirService import FhirService\n",
    "from utils.logger.matchLogger import MatchLogger\n",
    "from languageInfo.documentTypeNames.documentTypeNames import DocumentTypeNames\n",
    "\n",
    "\n",
    "class FolderNotFoundError(Exception):\n",
    "    pass\n",
    "\n",
    "\n",
    "def getRandomString(N):\n",
    "    str_ = ''.join(random.choice(string.ascii_uppercase + string.digits\n",
    "                                 + string.ascii_lowercase) for _ in range(N))\n",
    "    return str_\n",
    "\n",
    "\n",
    "def convertHtmlToJson(domain, procedureType, languageCode, fileNameHtml, fileNameQrd, fileNameLog, fsMountName, localEnv):\n",
    "\n",
    "    if localEnv is True:\n",
    "        module_path = os.path.join(os.path.abspath(os.path.join('..')), 'data', 'converted_to_html', f'{domain}', f'{procedureType}', f'{languageCode}')\n",
    "    else:\n",
    "        module_path = os.path.join(f'{fsMountName}', 'data', 'converted_to_html', f'{domain}', f'{procedureType}', f'{languageCode}')\n",
    "    \n",
    "    # Generate output folder path\n",
    "    output_json_path = module_path.replace('converted_to_html', 'outputJSON')\n",
    "\n",
    "    \"\"\"\n",
    "        Check if input folder exists, else throw exception\n",
    "    \"\"\"\n",
    "    print(module_path, fileNameHtml)\n",
    "    print(os.path.join(module_path, fileNameHtml))\n",
    "    print(os.path.exists(os.path.join(module_path, fileNameHtml)))\n",
    "    if(os.path.exists(module_path)):\n",
    "        filenames = glob.glob(os.path.join(module_path, fileNameHtml))\n",
    "\n",
    "        # Create language specific folder in outputJSON folder if it doesn't exist\n",
    "        if(not os.path.exists(output_json_path)):\n",
    "            os.mkdir(output_json_path)\n",
    "        logger = MatchLogger(f'Parser_{getRandomString(1)}', fileNameHtml,\n",
    "                             domain, procedureType, languageCode, \"HTML\", fileNameLog)\n",
    "\n",
    "        styleLogger = MatchLogger(\n",
    "            f'Style Dictionary_{getRandomString(1)}', fileNameHtml, domain, procedureType, languageCode, \"HTML\", fileNameLog)\n",
    "\n",
    "        styleRulesObj = StyleRulesDictionary(styleLogger,\n",
    "                                             language=languageCode,\n",
    "                                             fileName=fileNameQrd,\n",
    "                                             domain=domain,\n",
    "                                             procedureType=procedureType,\n",
    "                                             fsMountName=fsMountName,\n",
    "                                             localEnv=localEnv)\n",
    "\n",
    "        parserObj = parserExtractor(config, logger, styleRulesObj.styleRuleDict,\n",
    "                                    styleRulesObj.styleFeatureKeyList,\n",
    "                                    styleRulesObj.qrd_section_headings)\n",
    "        print(filenames)\n",
    "        for input_filename in filenames:\n",
    "          # if(input_filename.find('Kalydeco II-86-PI-clean')!=-1):\n",
    "            output_filename = input_filename.replace(\n",
    "                'converted_to_html', 'outputJSON')\n",
    "            output_filename = output_filename.replace('.html', '.json')\n",
    "            output_filename = output_filename.replace('.htm', '.json')\n",
    "            print(input_filename, output_filename)\n",
    "            parserObj.createPIJsonFromHTML(input_filepath=input_filename,\n",
    "                                           output_filepath=output_filename,\n",
    "                                           img_base64_dict=parserObj.convertImgToBase64(\n",
    "                                               input_filename),\n",
    "                                           )\n",
    "    else:\n",
    "        raise FolderNotFoundError(module_path + \" not found\")\n",
    "    return output_filename.split(\"\\\\\")[-1]\n",
    "\n",
    "\n",
    "def splitJson(domain, procedureType, languageCode, fileNameJson, fileNameQrd, fileNameLog, fsMountName, localEnv):\n",
    "\n",
    "    styleLogger = MatchLogger(\n",
    "        f'Style Dictionary_{getRandomString(1)}', fileNameJson, domain, procedureType, languageCode, \"Json\", fileNameLog)\n",
    "\n",
    "    styleRulesObj = StyleRulesDictionary(styleLogger,\n",
    "                                             language=languageCode,\n",
    "                                             fileName=fileNameQrd,\n",
    "                                             domain=domain,\n",
    "                                             procedureType=procedureType,\n",
    "                                             fsMountName=fsMountName,\n",
    "                                             localEnv=localEnv)\n",
    "    if localEnv is True:\n",
    "        path_json = os.path.join(os.path.abspath(os.path.join(\n",
    "                '..')), 'data', 'outputJSON', domain, procedureType, languageCode, fileNameJson)\n",
    "    else:\n",
    "        path_json = os.path.join(f'{fsMountName}', 'data', 'outputJSON', domain,  procedureType, languageCode, fileNameJson)\n",
    "        \n",
    "    partitionLogger = MatchLogger(\n",
    "        f'Partition_{getRandomString(1)}', fileNameJson, domain, procedureType, languageCode, \"Json\", fileNameLog)\n",
    "\n",
    "    partitioner = DocTypePartitioner(partitionLogger, localEnv)\n",
    "\n",
    "    partitionedJsonPaths = partitioner.partitionHtmls(\n",
    "        styleRulesObj.qrd_section_headings, path_json)\n",
    "\n",
    "    return partitionedJsonPaths\n",
    "\n",
    "\n",
    "def extractAndValidateHeadings(domain,\n",
    "                               procedureType,\n",
    "                               languageCode,\n",
    "                               documentNumber,\n",
    "                               fileNameDoc,\n",
    "                               fileNameQrd,\n",
    "                               fileNameMatchRuleBook,\n",
    "                               fileNameDocumentTypeNames,\n",
    "                               fileNameLog,\n",
    "                               stopWordFilterLen=6,\n",
    "                               isPackageLeaflet=False,\n",
    "                               medName=None,\n",
    "                               fsMountName='/mounted',\n",
    "                               localEnv=False):\n",
    "\n",
    "    if documentNumber == 0:\n",
    "        topHeadingsConsidered = 4\n",
    "        bottomHeadingsConsidered = 6\n",
    "    elif documentNumber == 1:\n",
    "        topHeadingsConsidered = 3\n",
    "        bottomHeadingsConsidered = 5\n",
    "    elif documentNumber == 2:\n",
    "        topHeadingsConsidered = 5\n",
    "        bottomHeadingsConsidered = 15\n",
    "    else:\n",
    "        topHeadingsConsidered = 5\n",
    "        bottomHeadingsConsidered = 10\n",
    "\n",
    "    print(f\"Starting Heading Extraction For File :- {fileNameDoc}\")\n",
    "    logger = MatchLogger(f\"Heading Extraction {fileNameDoc}\", fileNameDoc, domain, procedureType, languageCode, documentNumber, fileNameLog)\n",
    "    logger.logFlowCheckpoint(\"Starting Heading Extraction\")\n",
    "\n",
    "    stopWordlanguage = DocumentTypeNames(\n",
    "        fileNameDocumentTypeNames=fileNameDocumentTypeNames,\n",
    "        languageCode=languageCode,\n",
    "        domain=domain,\n",
    "        procedureType=procedureType,\n",
    "        documentNumber=documentNumber,\n",
    "        fsMountName=fsMountName,\n",
    "        localEnv=localEnv).extractStopWordLanguage()\n",
    "\n",
    "    matchDocObj = MatchDocument(\n",
    "        logger,\n",
    "        domain,\n",
    "        procedureType,\n",
    "        languageCode,\n",
    "        documentNumber,\n",
    "        fileNameDoc,\n",
    "        fileNameQrd,\n",
    "        fileNameMatchRuleBook,\n",
    "        fileNameDocumentTypeNames,\n",
    "        topHeadingsConsidered,\n",
    "        bottomHeadingsConsidered,\n",
    "        stopWordFilterLen,\n",
    "        stopWordlanguage,\n",
    "        isPackageLeaflet,\n",
    "        medName,\n",
    "        fsMountName,\n",
    "        localEnv)\n",
    "    df, coll = matchDocObj.matchHtmlHeaddingsWithQrd()\n",
    "\n",
    "    return df, coll\n",
    "\n",
    "\n",
    "def parseDocument(htmlDocPath, fileNameQrd, fileNameMatchRuleBook, fileNameDocumentTypeNames, fsMountName = '/mounted', localEnv= False, medName = None):\n",
    "    \n",
    "    if localEnv is True:\n",
    "        pathSep = \"\\\\\"\n",
    "        fileNameLog = os.path.join(os.path.abspath(os.path.join('..')),'data','FinalLog.txt')\n",
    "    else:\n",
    "        pathSep = \"/\"\n",
    "        fileNameLog = os.path.join(f'{fsMountName}','data','FinalLog.txt')\n",
    "    pathComponents = htmlDocPath.split(pathSep)\n",
    "    print(pathComponents)\n",
    "    fileNameHtml = pathComponents[-1]\n",
    "    languageCode =  pathComponents[-2]\n",
    "    procedureType = pathComponents[-3]\n",
    "    domain = pathComponents[-4]\n",
    "\n",
    "    #procedureType = \"CAP\"\n",
    "    print(fileNameHtml,languageCode,procedureType,domain)\n",
    "    \n",
    "    \n",
    "    \n",
    "    flowLogger =  MatchLogger(\"Flow Logger HTML\", fileNameHtml, domain, procedureType, languageCode, \"HTML\", fileNameLog)\n",
    "\n",
    "    flowLogger.logFlowCheckpoint(\"Starting HTML Conversion To Json\")\n",
    "    ###Convert Html to Json\n",
    "    fileNameJson = convertHtmlToJson( domain, procedureType, languageCode, fileNameHtml, fileNameQrd, fileNameLog, fsMountName, localEnv)\n",
    "    \n",
    "    flowLogger.logFlowCheckpoint(\"Completed HTML Conversion To Json\")\n",
    "\n",
    "    flowLogger.logFlowCheckpoint(\"Starting Json Split\")\n",
    "\n",
    "    ###Split Uber Json to multiple Jsons for each category.\n",
    "    partitionedJsonPaths = splitJson(domain, procedureType, languageCode, fileNameJson, fileNameQrd, fileNameLog, fsMountName, localEnv)\n",
    "    \n",
    "    partitionedJsonPaths = [ path.split(\"\\\\\")[-1] for path in partitionedJsonPaths]\n",
    "    flowLogger.logFlowCheckpoint(str(partitionedJsonPaths))\n",
    "    \n",
    "    flowLogger.logFlowCheckpoint(\"Completed Json Split\")\n",
    "    \n",
    "    flowLogger.logFlowCheckpoint(\"Started Processing Partitioned Jsons\")\n",
    "    \n",
    "    for index, fileNamePartitioned in enumerate(partitionedJsonPaths):\n",
    "        \n",
    "        flowLogger.logFlowCheckpoint(f\"\\n\\n\\n\\n||||||||||||||||||||||||||||||||{str(index)} ||||| {str(fileNamePartitioned)}||||||||||||||||||||||||||||||||\\n\\n\\n\\n\")\n",
    "        \n",
    "        if index == 3:\n",
    "            stopWordFilterLen = 100\n",
    "            isPackageLeaflet = True\n",
    "        else:\n",
    "            stopWordFilterLen = 6\n",
    "            isPackageLeaflet = False\n",
    "            \n",
    "        df, coll = extractAndValidateHeadings(domain,\n",
    "                                    procedureType,\n",
    "                                    languageCode,\n",
    "                                    index,\n",
    "                                    fileNamePartitioned,\n",
    "                                    fileNameQrd,\n",
    "                                    fileNameMatchRuleBook,\n",
    "                                    fileNameDocumentTypeNames,\n",
    "                                    fileNameLog,\n",
    "                                    stopWordFilterLen=stopWordFilterLen,\n",
    "                                    isPackageLeaflet=isPackageLeaflet,\n",
    "                                    medName=medName,\n",
    "                                    fsMountName=fileNameLog,\n",
    "                                    localEnv=localEnv)\n",
    "        \n",
    "        \n",
    "        print(f\"Completed Heading Extraction For File\")\n",
    "        flowLogger.logFlowCheckpoint(\"Completed Heading Extraction For File\")\n",
    "        \n",
    "        print(f\"Starting Document Annotation For File :- {fileNamePartitioned}\")        \n",
    "        flowLogger.logFlowCheckpoint(\"Starting Document Annotation For File\")\n",
    "        documentAnnotationObj = DocumentAnnotation(fileNamePartitioned,'c20835db4b1b4e108828a8537ff41506','https://spor-sit.azure-api.net/pms/api/v2/',df,coll)\n",
    "        try:\n",
    "            pms_oms_annotation_data = documentAnnotationObj.processRegulatedAuthorizationForDoc()\n",
    "            print(pms_oms_annotation_data)\n",
    "        except:\n",
    "            pms_oms_annotation_data = None\n",
    "            print(\"Error Found\")\n",
    "            \n",
    "        print(f\"Completed Document Annotation\")        \n",
    "        flowLogger.logFlowCheckpoint(\"Completed Document Annotation\")\n",
    "        \n",
    "        print(f\"Starting Extracting Content Between Heading For File :- {fileNamePartitioned}\")        \n",
    "        flowLogger.logFlowCheckpoint(\"Starting Extracting Content Between Heading\")\n",
    "        \n",
    "        extractContentlogger =  MatchLogger(f'ExtractContentBetween_{index}', fileNamePartitioned, domain, procedureType, languageCode, index, fileNameLog)\n",
    "        extractorObj = DataBetweenHeadingsExtractor(extractContentlogger, coll, domain, procedureType, languageCode, fsMountName, localEnv)\n",
    "        dfExtractedHierRR = extractorObj.extractContentBetweenHeadings(fileNamePartitioned)\n",
    "        \n",
    "        print(f\"Completed Extracting Content Between Heading\")        \n",
    "        flowLogger.logFlowCheckpoint(\"Completed Extracting Content Between Heading\")\n",
    "        \n",
    "        xmlLogger =  MatchLogger(f'XmlGeneration_{index}', fileNamePartitioned, domain, procedureType, languageCode, index, fileNameLog)\n",
    "        fhirXmlGeneratorObj = FhirXmlGenerator(xmlLogger, pms_oms_annotation_data, fsMountName, localEnv)\n",
    "        fileNameXml = fileNamePartitioned.replace('.json','.xml')\n",
    "        generatedXml = fhirXmlGeneratorObj.generateXml(dfExtractedHierRR, fileNameXml)\n",
    "        \n",
    "        fhirServiceObj = FhirService(generatedXml, fsMountName, localEnv)\n",
    "        fhirServiceObj.submitFhirXml()\n",
    "        print(f\"Created XML File For :- {fileNamePartitioned}\")        \n",
    "\n",
    "        #return df,coll,dfExtractedHierRR\n",
    "    \n",
    "    flowLogger.logFlowCheckpoint(\"Completed Processing Partitioned Jsons\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:39,387 : Flow Logger HTML : Starting HTML Conversion To Json | H | CAP |  en | HTML | Adakveo-4874 EN PI.html\n",
      "2021-05-05 17:11:39,398 : Style Dictionary_0 : Reading style dictionary in file: F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\styleRules\\rule_dictionary_en.json | H | CAP |  en | HTML | Adakveo-4874 EN PI.html\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['F:', 'Projects', 'EMA', 'Repository', 'EMA EPI PoC', 'function_code', 'data', 'converted_to_html', 'H', 'CAP', 'en', 'Adakveo-4874 EN PI.html']\n",
      "Adakveo-4874 EN PI.html en CAP H\n",
      "F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\converted_to_html\\H\\CAP\\en Adakveo-4874 EN PI.html\n",
      "F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\converted_to_html\\H\\CAP\\en\\Adakveo-4874 EN PI.html\n",
      "True\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:39,623 : Style Dictionary_0 : Qrd Section Keys Generated: ANNEX I, ANNEX II, ANNEX III, B. PACKAGE LEAFLET | H | CAP |  en | HTML | Adakveo-4874 EN PI.html\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['F:\\\\Projects\\\\EMA\\\\Repository\\\\EMA EPI PoC\\\\function_code\\\\data\\\\converted_to_html\\\\H\\\\CAP\\\\en\\\\Adakveo-4874 EN PI.html']\n",
      "F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\converted_to_html\\H\\CAP\\en\\Adakveo-4874 EN PI.html F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\outputJSON\\H\\CAP\\en\\Adakveo-4874 EN PI.json\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:42,157 : Parser_U : Writing to file: F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\outputJSON\\H\\CAP\\en\\Adakveo-4874 EN PI.json | H | CAP |  en | HTML | Adakveo-4874 EN PI.html\n",
      "2021-05-05 17:11:42,272 : Flow Logger HTML : Completed HTML Conversion To Json | H | CAP |  en | HTML | Adakveo-4874 EN PI.html\n",
      "2021-05-05 17:11:42,274 : Flow Logger HTML : Starting Json Split | H | CAP |  en | HTML | Adakveo-4874 EN PI.html\n",
      "2021-05-05 17:11:42,280 : Style Dictionary_A : Reading style dictionary in file: F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\styleRules\\rule_dictionary_en.json | H | CAP |  en | Json | Adakveo-4874 EN PI.json\n",
      "2021-05-05 17:11:42,319 : Style Dictionary_A : Qrd Section Keys Generated: ANNEX I, ANNEX II, ANNEX III, B. PACKAGE LEAFLET | H | CAP |  en | Json | Adakveo-4874 EN PI.json\n",
      "2021-05-05 17:11:42,325 : Partition_b : Partitioning Json: Adakveo-4874 EN PI.json | H | CAP |  en | Json | Adakveo-4874 EN PI.json\n",
      "2021-05-05 17:11:42,418 : Partition_b : Writing partition to file: F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\partitionedJSONs\\H\\CAP\\en\\Adakveo-4874 EN PI_SmPC.json | H | CAP |  en | Json | Adakveo-4874 EN PI.json\n",
      "2021-05-05 17:11:42,449 : Partition_b : Writing partition to file: F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\partitionedJSONs\\H\\CAP\\en\\Adakveo-4874 EN PI_ANNEX II.json | H | CAP |  en | Json | Adakveo-4874 EN PI.json\n",
      "2021-05-05 17:11:42,479 : Partition_b : Writing partition to file: F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\partitionedJSONs\\H\\CAP\\en\\Adakveo-4874 EN PI_ANNEX III.json | H | CAP |  en | Json | Adakveo-4874 EN PI.json\n",
      "2021-05-05 17:11:42,488 : Partition_b : Writing partition to file: F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\partitionedJSONs\\H\\CAP\\en\\Adakveo-4874 EN PI_ PACKAGE LEAFLET.json | H | CAP |  en | Json | Adakveo-4874 EN PI.json\n",
      "2021-05-05 17:11:42,497 : Flow Logger HTML : ['Adakveo-4874 EN PI_SmPC.json', 'Adakveo-4874 EN PI_ANNEX II.json', 'Adakveo-4874 EN PI_ANNEX III.json', 'Adakveo-4874 EN PI_ PACKAGE LEAFLET.json'] | H | CAP |  en | HTML | Adakveo-4874 EN PI.html\n",
      "2021-05-05 17:11:42,499 : Flow Logger HTML : Completed Json Split | H | CAP |  en | HTML | Adakveo-4874 EN PI.html\n",
      "2021-05-05 17:11:42,500 : Flow Logger HTML : Started Processing Partitioned Jsons | H | CAP |  en | HTML | Adakveo-4874 EN PI.html\n",
      "2021-05-05 17:11:42,502 : Flow Logger HTML : \n",
      "\n",
      "\n",
      "\n",
      "||||||||||||||||||||||||||||||||0 ||||| Adakveo-4874 EN PI_SmPC.json||||||||||||||||||||||||||||||||\n",
      "\n",
      "\n",
      "\n",
      " | H | CAP |  en | HTML | Adakveo-4874 EN PI.html\n",
      "2021-05-05 17:11:42,507 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Starting Heading Extraction | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "*************************** Texts with more than 2 characters**************************************\n",
      "*************************** Texts with more than 2 characters**************************************\n",
      "*************************** Texts with more than 2 characters**************************************\n",
      "*************************** Texts with more than 2 characters**************************************\n",
      "Starting Heading Extraction For File :- Adakveo-4874 EN PI_SmPC.json\n",
      "File being processed: F:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\data\\partitionedJSONs\\H\\CAP\\en\\Adakveo-4874 EN PI_SmPC.json\n",
      "--------------------------------------------\n",
      "SmPC\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:42,775 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Started Extracting Heading | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json\n",
      "2021-05-05 17:11:43,070 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'SUMMARY OF PRODUCT CHARACTERISTICS' | Qrd txt :- 'SUMMARY OF PRODUCT CHARACTERISTICS' | Matched :- 'True'\n",
      "2021-05-05 17:11:43,082 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed As This The First Heading | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20001' | currParentHeadId :- 'nan' | prevParentHeadId :- ''\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "SUMMARY OF PRODUCT CHARACTERISTICS  |===|  SUMMARY OF PRODUCT CHARACTERISTICS\n",
      "True  ||    ||  SUMMARY OF PRODUCT CHARACTERISTICS  ||  SUMMARY OF PRODUCT CHARACTERISTICS\n",
      "\n",
      "OriginalCheck\n",
      "('>7|2.88|(99, 100, 99)|0.92|', 'This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.', 'qThis medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.')\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:43,381 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'this medicinal product is subject to additional monitoring. this will allow quick identification of new safety information. healthcare professionals are asked to report any suspected adverse reactions. see section 4.8 for how to report adverse reactions.' | Qrd txt :- 'qthis medicinal product is subject to additional monitoring. this will allow quick identification of new safety information. healthcare professionals are asked to report any suspected adverse reactions. see section 4.8 for how to report adverse reactions.' | Matched :- 'True'\n",
      "2021-05-05 17:11:43,383 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed In Lowercase | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.' | Qrd txt :- 'qThis medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.' | Matched :- 'True'\n",
      "2021-05-05 17:11:43,397 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20002' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20001'\n",
      "2021-05-05 17:11:43,412 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Failed By Style | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20002' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20001'\n",
      "2021-05-05 17:11:43,518 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '1.       NAME OF THE MEDICINAL PRODUCT' | Qrd txt :- '1. NAME OF THE MEDICINAL PRODUCT' | Matched :- 'True'\n",
      "2021-05-05 17:11:43,540 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Flow Is Broken | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20003' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20001'\n",
      "2021-05-05 17:11:43,548 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20003' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20001'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.  |===|  qThis medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.\n",
      "----------------------------------\n",
      "RemovedByStyle  ||  checkLowerCase|2.88|(99, 100, 99)|0.92|  ||  This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.  ||  qThis medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.\n",
      "----------------------------------\n",
      "1.       NAME OF THE MEDICINAL PRODUCT  |===|  1. NAME OF THE MEDICINAL PRODUCT\n",
      "True  ||    ||  1.       NAME OF THE MEDICINAL PRODUCT  ||  1. NAME OF THE MEDICINAL PRODUCT\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:44,150 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '2.       QUALITATIVE AND QUANTITATIVE COMPOSITION' | Qrd txt :- '2. QUALITATIVE AND QUANTITATIVE COMPOSITION' | Matched :- 'True'\n",
      "2021-05-05 17:11:44,170 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20004' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20003'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2.       QUALITATIVE AND QUANTITATIVE COMPOSITION  |===|  2. QUALITATIVE AND QUANTITATIVE COMPOSITION\n",
      "True  ||    ||  2.       QUALITATIVE AND QUANTITATIVE COMPOSITION  ||  2. QUALITATIVE AND QUANTITATIVE COMPOSITION\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:44,458 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Each ml of concentrate for solution for infusion contains 10 mg crizanlizumab.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:44,482 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Each ml of concentrate for solution for infusion contains 10 mg crizanlizumab.' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-05 17:11:44,916 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'One vial of 10 ml contains 100 mg crizanlizumab.' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-05 17:11:45,313 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Crizanlizumab is a monoclonal antibody produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:45,748 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '3.       PHARMACEUTICAL FORM' | Qrd txt :- '3. PHARMACEUTICAL FORM' | Matched :- 'True'\n",
      "2021-05-05 17:11:45,763 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Flow Is Broken | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20008' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20004'\n",
      "2021-05-05 17:11:45,770 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20008' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20004'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "3.       PHARMACEUTICAL FORM  |===|  3. PHARMACEUTICAL FORM\n",
      "True  ||    ||  3.       PHARMACEUTICAL FORM  ||  3. PHARMACEUTICAL FORM\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:46,009 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Concentrate for solution for infusion (sterile concentrate)' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:46,317 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '4.       CLINICAL PARTICULARS' | Qrd txt :- '4. CLINICAL PARTICULARS' | Matched :- 'True'\n",
      "2021-05-05 17:11:46,329 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20009' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20008'\n",
      "2021-05-05 17:11:46,402 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '4.1     Therapeutic indications' | Qrd txt :- '4.1 Therapeutic indications' | Matched :- 'True'\n",
      "2021-05-05 17:11:46,412 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20010' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20009'\n",
      "2021-05-05 17:11:46,510 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '4.2     Posology and method of administration' | Qrd txt :- '4.2 Posology and method of administration' | Matched :- 'True'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "4.       CLINICAL PARTICULARS  |===|  4. CLINICAL PARTICULARS\n",
      "True  ||    ||  4.       CLINICAL PARTICULARS  ||  4. CLINICAL PARTICULARS\n",
      "4.1     Therapeutic indications  |===|  4.1 Therapeutic indications\n",
      "True  ||    ||  4.1     Therapeutic indications  ||  4.1 Therapeutic indications\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:46,524 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20011' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20010'\n",
      "2021-05-05 17:11:46,662 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Treatment should be initiated by physicians experienced in the management of sickle cell disease.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:46,691 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Treatment should be initiated by physicians experienced in the management of sickle cell disease.' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "4.2     Posology and method of administration  |===|  4.2 Posology and method of administration\n",
      "True  ||    ||  4.2     Posology and method of administration  ||  4.2 Posology and method of administration\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:46,769 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed In Lowercase | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Posology' | Qrd txt :- '4.2 Posology and method of administration' | Matched :- 'False'\n",
      "2021-05-05 17:11:46,772 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Posology' | Qrd txt :- 'Posology' | Matched :- 'True'\n",
      "2021-05-05 17:11:46,794 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20012' | currParentHeadId :- '20011.0' | prevParentHeadId :- '20011'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "OriginalCheck\n",
      "('<=7|412.5|(33, 100, 90)|0.73|', 'Posology', '4.2 Posology and method of administration')\n",
      "\n",
      "Posology  |===|  Posology\n",
      "True  ||    ||  Posology  ||  Posology\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:47,047 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'The recommended dose of crizanlizumab is 5 mg/kg administered over a period of 30 minutes by intravenous infusion at week 0, week 2, and every 4 weeks thereafter.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:47,463 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'If a dose is missed, the treatment should be administered as soon as possible.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:47,723 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '-                 If crizanlizumab is administered within 2 weeks after the missed dose, dosing should be continued according to the patient’s original schedule.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:47,910 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '-                 If crizanlizumab is administered more than 2 weeks after the missed dose, dosing should be continued every 4 weeks thereafter.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:48,155 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Special populations' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-05 17:11:48,485 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Crizanlizumab has not been studied in elderly patients. No dose adjustment is required as the pharmacokinetics of crizanlizumab in adults are not affected by age.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:49,195 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'\n",
      "2021-05-05 17:11:49,211 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20013' | currParentHeadId :- '20012.0' | prevParentHeadId :- '20011'\n",
      "2021-05-05 17:11:49,398 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'The safety and efficacy of crizanlizumab in paediatric patients from 6 months to 16 years have not been established. No data are available.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Paediatric population  |===|  Paediatric population\n",
      "True  ||    ||  Paediatric population  ||  Paediatric population\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:49,615 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'There is no relevant use of crizanlizumab in infants aged less than 6 months for the indication of prevention of recurrent vaso‑occlusive crises.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:49,684 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed In Lowercase | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Method of administration' | Qrd txt :- '4.2 Posology and method of administration' | Matched :- 'False'\n",
      "2021-05-05 17:11:49,693 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Method of administration' | Qrd txt :- 'Method of administration ' | Matched :- 'True'\n",
      "2021-05-05 17:11:49,710 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20014' | currParentHeadId :- '20011.0' | prevParentHeadId :- '20011'\n",
      "2021-05-05 17:11:49,870 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Adakveo should be diluted with sodium chloride 9 mg/ml (0.9%) solution for injection or dextrose 5% before administration.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "OriginalCheck\n",
      "('<=7|75.0|(71, 96, 90)|0.69|', 'Method of administration', '4.2 Posology and method of administration')\n",
      "\n",
      "Method of administration  |===|  Method of administration \n",
      "True  ||    ||  Method of administration  ||  Method of administration \n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:50,145 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'For instructions on dilution of the medicinal product before administration, see section 6.6.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:50,249 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '4.3     Contraindications' | Qrd txt :- '4.3 Contraindications' | Matched :- 'True'\n",
      "2021-05-05 17:11:50,263 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20016' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20011'\n",
      "2021-05-05 17:11:50,394 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "4.3     Contraindications  |===|  4.3 Contraindications\n",
      "True  ||    ||  4.3     Contraindications  ||  4.3 Contraindications\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:50,864 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '4.4     Special warnings and precautions for use' | Qrd txt :- '4.4 Special warnings and precautions for use' | Matched :- 'True'\n",
      "2021-05-05 17:11:50,877 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20017' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20016'\n",
      "2021-05-05 17:11:50,950 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Traceability' | Qrd txt :- 'Traceability' | Matched :- 'True'\n",
      "2021-05-05 17:11:50,966 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20018' | currParentHeadId :- '20017.0' | prevParentHeadId :- '20017'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "4.4     Special warnings and precautions for use  |===|  4.4 Special warnings and precautions for use\n",
      "True  ||    ||  4.4     Special warnings and precautions for use  ||  4.4 Special warnings and precautions for use\n",
      "Traceability  |===|  Traceability\n",
      "True  ||    ||  Traceability  ||  Traceability\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:51,128 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:51,649 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Laboratory test interference: automated platelet counts' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:51,914 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Excipients with known effect' | Qrd txt :- 'Excipient(s) with known effect' | Matched :- 'True'\n",
      "2021-05-05 17:11:51,928 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Failed As Wrong Heading Found | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20007' | currParentHeadId :- '20006.0' | prevParentHeadId :- '20017'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Excipients with known effect  |===|  Excipient(s) with known effect\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:52,302 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'This medicine contains less than 1 mmol sodium (23 mg) per vial, that is to say essentially “sodium‑free”.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:52,430 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '4.5     Interaction with other medicinal products and other forms of interaction' | Qrd txt :- '4.5 Interaction with other medicinal products and other forms of interaction' | Matched :- 'True'\n",
      "2021-05-05 17:11:52,443 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20020' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20017'\n",
      "2021-05-05 17:11:52,566 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Interactions between crizanlizumab and other medicinal products have not been investigated in dedicated studies.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:52,589 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Interactions between crizanlizumab and other medicinal products have not been investigated in dedicated studies.' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "4.5     Interaction with other medicinal products and other forms of interaction  |===|  4.5 Interaction with other medicinal products and other forms of interaction\n",
      "True  ||    ||  4.5     Interaction with other medicinal products and other forms of interaction  ||  4.5 Interaction with other medicinal products and other forms of interaction\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:52,796 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'No effect on exposure of co‑administered medicinal products is expected based on the metabolic pathways of monoclonal antibodies.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:52,965 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '4.6     Fertility, pregnancy and lactation' | Qrd txt :- '4.6 Fertility, pregnancy and lactation' | Matched :- 'True'\n",
      "2021-05-05 17:11:52,978 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20022' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20020'\n",
      "2021-05-05 17:11:53,050 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed In Lowercase | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Pregnancy' | Qrd txt :- '4.6 Fertility, pregnancy and lactation' | Matched :- 'False'\n",
      "2021-05-05 17:11:53,052 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Pregnancy' | Qrd txt :- 'Pregnancy' | Matched :- 'True'\n",
      "2021-05-05 17:11:53,070 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20023' | currParentHeadId :- '20022.0' | prevParentHeadId :- '20022'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "4.6     Fertility, pregnancy and lactation  |===|  4.6 Fertility, pregnancy and lactation\n",
      "True  ||    ||  4.6     Fertility, pregnancy and lactation  ||  4.6 Fertility, pregnancy and lactation\n",
      "\n",
      "OriginalCheck\n",
      "('<=7|333.33|(34, 89, 90)|0.53|', 'Pregnancy', '4.6 Fertility, pregnancy and lactation')\n",
      "\n",
      "Pregnancy  |===|  Pregnancy\n",
      "True  ||    ||  Pregnancy  ||  Pregnancy\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:53,167 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Breast‑feeding' | Qrd txt :- 'Breast-feeding' | Matched :- 'True'\n",
      "2021-05-05 17:11:53,188 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20024' | currParentHeadId :- '20022.0' | prevParentHeadId :- '20022'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Breast‑feeding  |===|  Breast-feeding\n",
      "True  ||  <=1|7.14|(93, 93, 100)|0.98|  ||  Breast‑feeding  ||  Breast-feeding\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:53,575 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Because many medicinal products, including antibodies, can be excreted in human milk, a risk to the newborn/infant cannot be excluded.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:53,746 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed In Lowercase | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Fertility' | Qrd txt :- '4.6 Fertility, pregnancy and lactation' | Matched :- 'False'\n",
      "2021-05-05 17:11:53,753 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Fertility' | Qrd txt :- 'Fertility' | Matched :- 'True'\n",
      "2021-05-05 17:11:53,773 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20025' | currParentHeadId :- '20022.0' | prevParentHeadId :- '20022'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "OriginalCheck\n",
      "('<=7|322.22|(38, 100, 90)|0.75|', 'Fertility', '4.6 Fertility, pregnancy and lactation')\n",
      "\n",
      "Fertility  |===|  Fertility\n",
      "True  ||    ||  Fertility  ||  Fertility\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:53,981 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'There are no data on the effect of Adakveo on human fertility. Available non‑clinical data do not suggest an effect on fertility under crizanlizumab treatment (see section 5.3).' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:54,119 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '4.7     Effects on ability to drive and use machines' | Qrd txt :- '4.7 Effects on ability to drive and use machines' | Matched :- 'True'\n",
      "2021-05-05 17:11:54,132 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20026' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20022'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "4.7     Effects on ability to drive and use machines  |===|  4.7 Effects on ability to drive and use machines\n",
      "True  ||    ||  4.7     Effects on ability to drive and use machines  ||  4.7 Effects on ability to drive and use machines\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:54,371 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Adakveo may have a minor influence on the ability to drive and use machines. Dizziness, fatigue and somnolence may occur following administration of crizanlizumab.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:54,516 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '4.8     Undesirable effects' | Qrd txt :- '4.8 Undesirable effects' | Matched :- 'True'\n",
      "2021-05-05 17:11:54,530 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20027' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20026'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "4.8     Undesirable effects  |===|  4.8 Undesirable effects\n",
      "True  ||    ||  4.8     Undesirable effects  ||  4.8 Undesirable effects\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:55,338 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Tabulated list of adverse reactions' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-05 17:11:55,646 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Table 1       Adverse reactions in clinical studies' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-05 17:11:55,995 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Description of selected adverse reactions' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:56,420 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'In clinical studies, treatment‑induced anti‑crizanlizumab antibodies were transiently detected in 1 patient (0.9%) among the 111 patients who received Adakveo 5 mg/kg.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:56,605 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'There was no evidence of altered pharmacokinetics or of an altered safety profile with anti‑crizanlizumab antibody development.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:56,672 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'\n",
      "2021-05-05 17:11:56,686 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Failed As Previous Heading Found is not matching | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20013' | currParentHeadId :- '20012.0' | prevParentHeadId :- '20027'\n",
      "2021-05-05 17:11:56,717 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'\n",
      "2021-05-05 17:11:56,728 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Failed As Previous Heading Found is not matching | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20019' | currParentHeadId :- '20017.0' | prevParentHeadId :- '20027'\n",
      "2021-05-05 17:11:56,736 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'\n",
      "2021-05-05 17:11:56,748 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Failed As Previous Heading Found is not matching | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20021' | currParentHeadId :- '20020.0' | prevParentHeadId :- '20027'\n",
      "2021-05-05 17:11:56,773 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'\n",
      "2021-05-05 17:11:56,790 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20028' | currParentHeadId :- '20027.0' | prevParentHeadId :- '20027'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Paediatric population  |===|  Paediatric population\n",
      "Paediatric population  |===|  Paediatric population\n",
      "Paediatric population  |===|  Paediatric population\n",
      "Paediatric population  |===|  Paediatric population\n",
      "True  ||    ||  Paediatric population  ||  Paediatric population\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:57,174 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Reporting of suspected adverse reactions' | Qrd txt :- 'Reporting of suspected adverse reactions' | Matched :- 'True'\n",
      "2021-05-05 17:11:57,190 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20029' | currParentHeadId :- '20027.0' | prevParentHeadId :- '20027'\n",
      "2021-05-05 17:11:57,308 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '4.9     Overdose' | Qrd txt :- '4.9 Overdose' | Matched :- 'True'\n",
      "2021-05-05 17:11:57,321 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20030' | currParentHeadId :- '20009.0' | prevParentHeadId :- '20027'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Reporting of suspected adverse reactions  |===|  Reporting of suspected adverse reactions\n",
      "True  ||    ||  Reporting of suspected adverse reactions  ||  Reporting of suspected adverse reactions\n",
      "4.9     Overdose  |===|  4.9 Overdose\n",
      "True  ||    ||  4.9     Overdose  ||  4.9 Overdose\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:57,536 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'No cases of overdose have been reported in clinical studies.' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-05 17:11:57,751 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'General supportive measures and symptomatic treatment should be initiated in cases of suspected overdose.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:11:57,986 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '5.       PHARMACOLOGICAL PROPERTIES' | Qrd txt :- '5. PHARMACOLOGICAL PROPERTIES' | Matched :- 'True'\n",
      "2021-05-05 17:11:57,999 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20032' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20030'\n",
      "2021-05-05 17:11:58,166 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '5.1     Pharmacodynamic properties' | Qrd txt :- '5.1 Pharmacodynamic properties' | Matched :- 'True'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "5.       PHARMACOLOGICAL PROPERTIES  |===|  5. PHARMACOLOGICAL PROPERTIES\n",
      "True  ||    ||  5.       PHARMACOLOGICAL PROPERTIES  ||  5. PHARMACOLOGICAL PROPERTIES\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:58,179 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20033' | currParentHeadId :- '20032.0' | prevParentHeadId :- '20032'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "5.1     Pharmacodynamic properties  |===|  5.1 Pharmacodynamic properties\n",
      "True  ||    ||  5.1     Pharmacodynamic properties  ||  5.1 Pharmacodynamic properties\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:58,578 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Mechanism of action' | Qrd txt :- 'Mechanism of action' | Matched :- 'True'\n",
      "2021-05-05 17:11:58,598 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20034' | currParentHeadId :- '20033.0' | prevParentHeadId :- '20033'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Mechanism of action  |===|  Mechanism of action\n",
      "True  ||    ||  Mechanism of action  ||  Mechanism of action\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:58,895 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Pharmacodynamic effects' | Qrd txt :- 'Pharmacodynamic effects' | Matched :- 'True'\n",
      "2021-05-05 17:11:58,912 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20035' | currParentHeadId :- '20033.0' | prevParentHeadId :- '20033'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Pharmacodynamic effects  |===|  Pharmacodynamic effects\n",
      "True  ||    ||  Pharmacodynamic effects  ||  Pharmacodynamic effects\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:11:59,153 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Clinical efficacy and safety' | Qrd txt :- 'Clinical efficacy and safety' | Matched :- 'True'\n",
      "2021-05-05 17:11:59,170 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20036' | currParentHeadId :- '20033.0' | prevParentHeadId :- '20033'\n",
      "2021-05-05 17:11:59,347 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Main efficacy outcomes of the pivotal SUSTAIN study are summarised in Tables 2 and 3.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Clinical efficacy and safety  |===|  Clinical efficacy and safety\n",
      "True  ||    ||  Clinical efficacy and safety  ||  Clinical efficacy and safety\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:12:00,044 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Table 3       Annual rate of VOCs in patients ‑ subgroup analyses' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-05 17:12:00,485 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'\n",
      "2021-05-05 17:12:00,496 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Failed As Previous Heading Found is not matching | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20013' | currParentHeadId :- '20012.0' | prevParentHeadId :- '20033'\n",
      "2021-05-05 17:12:00,518 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'\n",
      "2021-05-05 17:12:00,529 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Failed As Previous Heading Found is not matching | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20019' | currParentHeadId :- '20017.0' | prevParentHeadId :- '20033'\n",
      "2021-05-05 17:12:00,538 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'\n",
      "2021-05-05 17:12:00,551 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Failed As Previous Heading Found is not matching | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20021' | currParentHeadId :- '20020.0' | prevParentHeadId :- '20033'\n",
      "2021-05-05 17:12:00,577 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'\n",
      "2021-05-05 17:12:00,590 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Failed As Previous Heading Found is not matching | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20028' | currParentHeadId :- '20027.0' | prevParentHeadId :- '20033'\n",
      "2021-05-05 17:12:00,603 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'\n",
      "2021-05-05 17:12:00,616 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Failed As Previous Heading Found is not matching | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20031' | currParentHeadId :- '20030.0' | prevParentHeadId :- '20033'\n",
      "2021-05-05 17:12:00,640 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'\n",
      "2021-05-05 17:12:00,658 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20037' | currParentHeadId :- '20033.0' | prevParentHeadId :- '20033'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Paediatric population  |===|  Paediatric population\n",
      "Paediatric population  |===|  Paediatric population\n",
      "Paediatric population  |===|  Paediatric population\n",
      "Paediatric population  |===|  Paediatric population\n",
      "Paediatric population  |===|  Paediatric population\n",
      "Paediatric population  |===|  Paediatric population\n",
      "True  ||    ||  Paediatric population  ||  Paediatric population\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:12:01,296 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'This medicinal product has been authorised under a so‑called “conditional approval” scheme. This means that further evidence on this medicinal product is awaited.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:12:01,483 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'The European Medicines Agency will review new information on this medicinal product at least every year and this SmPC will be updated as necessary.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:12:01,643 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '5.2     Pharmacokinetic properties' | Qrd txt :- '5.1 Pharmacodynamic properties' | Matched :- 'False'\n",
      "2021-05-05 17:12:01,671 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '5.2     Pharmacokinetic properties' | Qrd txt :- '5.2 Pharmacokinetic properties' | Matched :- 'True'\n",
      "2021-05-05 17:12:01,686 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20038' | currParentHeadId :- '20032.0' | prevParentHeadId :- '20033'\n",
      "2021-05-05 17:12:01,806 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Absorption' | Qrd txt :- 'Absorption' | Matched :- 'True'\n",
      "2021-05-05 17:12:01,833 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20039' | currParentHeadId :- '20038.0' | prevParentHeadId :- '20038'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "5.2     Pharmacokinetic properties  |===|  5.2 Pharmacokinetic properties\n",
      "True  ||    ||  5.2     Pharmacokinetic properties  ||  5.2 Pharmacokinetic properties\n",
      "Absorption  |===|  Absorption\n",
      "True  ||    ||  Absorption  ||  Absorption\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:12:02,091 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Distribution' | Qrd txt :- 'Distribution' | Matched :- 'True'\n",
      "2021-05-05 17:12:02,108 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20040' | currParentHeadId :- '20038.0' | prevParentHeadId :- '20038'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Distribution  |===|  Distribution\n",
      "True  ||    ||  Distribution  ||  Distribution\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:12:02,389 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Biotransformation' | Qrd txt :- 'Biotransformation' | Matched :- 'True'\n",
      "2021-05-05 17:12:02,407 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20041' | currParentHeadId :- '20038.0' | prevParentHeadId :- '20038'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Biotransformation  |===|  Biotransformation\n",
      "True  ||    ||  Biotransformation  ||  Biotransformation\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:12:02,697 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Antibodies are primarily eliminated via proteolysis by lysosomal enzymes in the liver to small peptides and amino acids.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:12:02,840 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Elimination' | Qrd txt :- 'Elimination' | Matched :- 'True'\n",
      "2021-05-05 17:12:02,865 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20042' | currParentHeadId :- '20038.0' | prevParentHeadId :- '20038'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Elimination  |===|  Elimination\n",
      "True  ||    ||  Elimination  ||  Elimination\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:12:03,178 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Linearity/non‑linearity' | Qrd txt :- 'Linearity/non-linearity' | Matched :- 'True'\n",
      "2021-05-05 17:12:03,196 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20043' | currParentHeadId :- '20038.0' | prevParentHeadId :- '20038'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Linearity/non‑linearity  |===|  Linearity/non-linearity\n",
      "True  ||  <=1|4.35|(96, 96, 100)|0.99|  ||  Linearity/non‑linearity  ||  Linearity/non-linearity\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:12:03,393 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'The exposure to crizanlizumab (mean Cmax, AUClast, or AUCinf) increased in non‑linear manner over the dose range of 0.2 to 8 mg/kg in healthy volunteers.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:12:03,608 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Special populations' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-05 17:12:04,161 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'\n",
      "2021-05-05 17:12:04,172 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Failed As Previous Heading Found is not matching | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20013' | currParentHeadId :- '20012.0' | prevParentHeadId :- '20038'\n",
      "2021-05-05 17:12:04,201 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'\n",
      "2021-05-05 17:12:04,212 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Failed As Previous Heading Found is not matching | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20019' | currParentHeadId :- '20017.0' | prevParentHeadId :- '20038'\n",
      "2021-05-05 17:12:04,221 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'\n",
      "2021-05-05 17:12:04,231 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Failed As Previous Heading Found is not matching | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20021' | currParentHeadId :- '20020.0' | prevParentHeadId :- '20038'\n",
      "2021-05-05 17:12:04,255 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'\n",
      "2021-05-05 17:12:04,266 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Failed As Previous Heading Found is not matching | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20028' | currParentHeadId :- '20027.0' | prevParentHeadId :- '20038'\n",
      "2021-05-05 17:12:04,279 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'\n",
      "2021-05-05 17:12:04,291 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Failed As Previous Heading Found is not matching | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20031' | currParentHeadId :- '20030.0' | prevParentHeadId :- '20038'\n",
      "2021-05-05 17:12:04,309 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Paediatric population' | Matched :- 'True'\n",
      "2021-05-05 17:12:04,321 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Failed As Previous Heading Found is not matching | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20037' | currParentHeadId :- '20033.0' | prevParentHeadId :- '20038'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Paediatric population  |===|  Paediatric population\n",
      "Paediatric population  |===|  Paediatric population\n",
      "Paediatric population  |===|  Paediatric population\n",
      "Paediatric population  |===|  Paediatric population\n",
      "Paediatric population  |===|  Paediatric population\n",
      "Paediatric population  |===|  Paediatric population\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:12:04,395 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- '6.6 Special precautions for disposal <and other handling>' | Matched :- 'False'\n",
      "2021-05-05 17:12:04,406 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed In Lowercase | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Paediatric population' | Qrd txt :- 'Use in the paediatric population' | Matched :- 'False'\n",
      "2021-05-05 17:12:04,581 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Pharmacokinetics in paediatric patients below the age of 16 years have not been investigated.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "OriginalCheck\n",
      "('<=7|57.14|(75, 95, 90)|0.69|', 'Paediatric population', 'Use in the paediatric population')\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:12:04,778 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '5.3     Preclinical safety data' | Qrd txt :- '5.3 Preclinical safety data' | Matched :- 'True'\n",
      "2021-05-05 17:12:04,791 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20045' | currParentHeadId :- '20032.0' | prevParentHeadId :- '20038'\n",
      "2021-05-05 17:12:04,960 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Non‑clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, tissue cross‑reactivity and repeated dose toxicity.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "5.3     Preclinical safety data  |===|  5.3 Preclinical safety data\n",
      "True  ||    ||  5.3     Preclinical safety data  ||  5.3 Preclinical safety data\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:12:05,110 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Formal carcinogenicity, genotoxicity and juvenile toxicity studies have not been conducted with crizanlizumab.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:12:05,348 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Failed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- 'Measurable crizanlizumab serum concentrations were observed in the infant monkeys at postnatal day 28, confirming that crizanlizumab, like other IgG antibodies, crosses the placental barrier.' | Qrd txt :- '6.5 Nature and contents of container <and special equipment for use administration or implantation>' | Matched :- 'False'\n",
      "2021-05-05 17:12:05,551 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '6.       PHARMACEUTICAL PARTICULARS' | Qrd txt :- '6. PHARMACEUTICAL PARTICULARS' | Matched :- 'True'\n",
      "2021-05-05 17:12:05,563 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20047' | currParentHeadId :- '20001.0' | prevParentHeadId :- '20045'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "6.       PHARMACEUTICAL PARTICULARS  |===|  6. PHARMACEUTICAL PARTICULARS\n",
      "True  ||    ||  6.       PHARMACEUTICAL PARTICULARS  ||  6. PHARMACEUTICAL PARTICULARS\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2021-05-05 17:12:05,785 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Match Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | Doc txt :- '6.1     List of excipients' | Qrd txt :- '6.1 List of excipients' | Matched :- 'True'\n",
      "2021-05-05 17:12:05,797 : Heading Extraction Adakveo-4874 EN PI_SmPC.json : Validation Passed | H | CAP |  en | 0 | Adakveo-4874 EN PI_SmPC.json | currHeadId :- '20048' | currParentHeadId :- '20047.0' | prevParentHeadId :- '20047'\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "6.1     List of excipients  |===|  6.1 List of excipients\n",
      "True  ||    ||  6.1     List of excipients  ||  6.1 List of excipients\n"
     ]
    },
    {
     "ename": "KeyboardInterrupt",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mKeyboardInterrupt\u001b[0m                         Traceback (most recent call last)",
      "\u001b[1;32m<ipython-input-7-3f6290647f0a>\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[1;32m----> 1\u001b[1;33m \u001b[0mparseDocument\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m\"F:\\\\Projects\\\\EMA\\\\Repository\\\\EMA EPI PoC\\\\function_code\\\\data\\\\converted_to_html\\\\H\\\\CAP\\\\en\\\\Adakveo-4874 EN PI.html\"\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mfileNameQrd\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mfileNameMatchRuleBook\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mfileNameDocumentTypeNames\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mmedName\u001b[0m \u001b[1;33m=\u001b[0m \u001b[1;34m\"Aerius\"\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mfsMountName\u001b[0m \u001b[1;33m=\u001b[0m \u001b[1;34m'/mounted'\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mlocalEnv\u001b[0m\u001b[1;33m=\u001b[0m \u001b[1;32mTrue\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[1;32m<ipython-input-6-cd8c67ef62bd>\u001b[0m in \u001b[0;36mparseDocument\u001b[1;34m(htmlDocPath, fileNameQrd, fileNameMatchRuleBook, fileNameDocumentTypeNames, fsMountName, localEnv, medName)\u001b[0m\n\u001b[0;32m    253\u001b[0m                                     \u001b[0mmedName\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mmedName\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    254\u001b[0m                                     \u001b[0mfsMountName\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mfileNameLog\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 255\u001b[1;33m                                     localEnv=localEnv)\n\u001b[0m\u001b[0;32m    256\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    257\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m<ipython-input-6-cd8c67ef62bd>\u001b[0m in \u001b[0;36mextractAndValidateHeadings\u001b[1;34m(domain, procedureType, languageCode, documentNumber, fileNameDoc, fileNameQrd, fileNameMatchRuleBook, fileNameDocumentTypeNames, fileNameLog, stopWordFilterLen, isPackageLeaflet, medName, fsMountName, localEnv)\u001b[0m\n\u001b[0;32m    184\u001b[0m         \u001b[0mfsMountName\u001b[0m\u001b[1;33m,\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    185\u001b[0m         localEnv)\n\u001b[1;32m--> 186\u001b[1;33m     \u001b[0mdf\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mcoll\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mmatchDocObj\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mmatchHtmlHeaddingsWithQrd\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    187\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    188\u001b[0m     \u001b[1;32mreturn\u001b[0m \u001b[0mdf\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mcoll\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32mF:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\code\\match\\matchDocument\\matchDocument.py\u001b[0m in \u001b[0;36mmatchHtmlHeaddingsWithQrd\u001b[1;34m(self)\u001b[0m\n\u001b[0;32m    378\u001b[0m                             \u001b[1;31m# Call matching algorith\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    379\u001b[0m                             found, outputString = matchStringObj.matchStrings(\n\u001b[1;32m--> 380\u001b[1;33m                                 str_['Text'], qrd_str, qrd_str_row['heading_id'])\n\u001b[0m\u001b[0;32m    381\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    382\u001b[0m                             \u001b[1;32mif\u001b[0m \u001b[0mfound\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32mF:\\Projects\\EMA\\Repository\\EMA EPI PoC\\function_code\\code\\match\\matchStrings\\matchStrings.py\u001b[0m in \u001b[0;36mmatchStrings\u001b[1;34m(self, textOriginal, textToMatch, qrdRowHeadingId, avoidLowerCaseMatch)\u001b[0m\n\u001b[0;32m    140\u001b[0m         \u001b[0mnoWordstextToMatch1\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mlen\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mtextToMatch1\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msplit\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    141\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 142\u001b[1;33m         \u001b[0mstopWords\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mstopwords\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mwords\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mstopWordlanguage\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    143\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    144\u001b[0m         \u001b[1;32mif\u001b[0m \u001b[0mnoWordstextOriginal1\u001b[0m \u001b[1;33m>\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mstopWordFilterListSize\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\AppData\\Roaming\\Python\\Python37\\site-packages\\nltk\\corpus\\reader\\wordlist.py\u001b[0m in \u001b[0;36mwords\u001b[1;34m(self, fileids, ignore_lines_startswith)\u001b[0m\n\u001b[0;32m     21\u001b[0m         return [\n\u001b[0;32m     22\u001b[0m             \u001b[0mline\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 23\u001b[1;33m             \u001b[1;32mfor\u001b[0m \u001b[0mline\u001b[0m \u001b[1;32min\u001b[0m \u001b[0mline_tokenize\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mraw\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mfileids\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     24\u001b[0m             \u001b[1;32mif\u001b[0m \u001b[1;32mnot\u001b[0m \u001b[0mline\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mstartswith\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mignore_lines_startswith\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     25\u001b[0m         ]\n",
      "\u001b[1;32m~\\AppData\\Roaming\\Python\\Python37\\site-packages\\nltk\\corpus\\reader\\wordlist.py\u001b[0m in \u001b[0;36mraw\u001b[1;34m(self, fileids)\u001b[0m\n\u001b[0;32m     30\u001b[0m         \u001b[1;32melif\u001b[0m \u001b[0misinstance\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mfileids\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mstr\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     31\u001b[0m             \u001b[0mfileids\u001b[0m \u001b[1;33m=\u001b[0m \u001b[1;33m[\u001b[0m\u001b[0mfileids\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 32\u001b[1;33m         \u001b[1;32mreturn\u001b[0m \u001b[0mconcat\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m[\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mopen\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mf\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mread\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m \u001b[1;32mfor\u001b[0m \u001b[0mf\u001b[0m \u001b[1;32min\u001b[0m \u001b[0mfileids\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     33\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     34\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\AppData\\Roaming\\Python\\Python37\\site-packages\\nltk\\corpus\\reader\\wordlist.py\u001b[0m in \u001b[0;36m<listcomp>\u001b[1;34m(.0)\u001b[0m\n\u001b[0;32m     30\u001b[0m         \u001b[1;32melif\u001b[0m \u001b[0misinstance\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mfileids\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mstr\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     31\u001b[0m             \u001b[0mfileids\u001b[0m \u001b[1;33m=\u001b[0m \u001b[1;33m[\u001b[0m\u001b[0mfileids\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 32\u001b[1;33m         \u001b[1;32mreturn\u001b[0m \u001b[0mconcat\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m[\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mopen\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mf\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mread\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m \u001b[1;32mfor\u001b[0m \u001b[0mf\u001b[0m \u001b[1;32min\u001b[0m \u001b[0mfileids\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     33\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     34\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\AppData\\Roaming\\Python\\Python37\\site-packages\\nltk\\corpus\\reader\\api.py\u001b[0m in \u001b[0;36mopen\u001b[1;34m(self, file)\u001b[0m\n\u001b[0;32m    206\u001b[0m         \"\"\"\n\u001b[0;32m    207\u001b[0m         \u001b[0mencoding\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mencoding\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mfile\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 208\u001b[1;33m         \u001b[0mstream\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_root\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mjoin\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mfile\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mopen\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mencoding\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    209\u001b[0m         \u001b[1;32mreturn\u001b[0m \u001b[0mstream\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    210\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\AppData\\Roaming\\Python\\Python37\\site-packages\\nltk\\data.py\u001b[0m in \u001b[0;36mjoin\u001b[1;34m(self, fileid)\u001b[0m\n\u001b[0;32m    335\u001b[0m     \u001b[1;32mdef\u001b[0m \u001b[0mjoin\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mfileid\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    336\u001b[0m         \u001b[0m_path\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mos\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpath\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mjoin\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_path\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mfileid\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 337\u001b[1;33m         \u001b[1;32mreturn\u001b[0m \u001b[0mFileSystemPathPointer\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0m_path\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    338\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    339\u001b[0m     \u001b[1;32mdef\u001b[0m \u001b[0m__repr__\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mself\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\AppData\\Roaming\\Python\\Python37\\site-packages\\nltk\\compat.py\u001b[0m in \u001b[0;36m_decorator\u001b[1;34m(*args, **kwargs)\u001b[0m\n\u001b[0;32m     39\u001b[0m     \u001b[1;32mdef\u001b[0m \u001b[0m_decorator\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m*\u001b[0m\u001b[0margs\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;33m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     40\u001b[0m         \u001b[0margs\u001b[0m \u001b[1;33m=\u001b[0m \u001b[1;33m(\u001b[0m\u001b[0margs\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;36m0\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0madd_py3_data\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0margs\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;36m1\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m)\u001b[0m \u001b[1;33m+\u001b[0m \u001b[0margs\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;36m2\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 41\u001b[1;33m         \u001b[1;32mreturn\u001b[0m \u001b[0minit_func\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m*\u001b[0m\u001b[0margs\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;33m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     42\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     43\u001b[0m     \u001b[1;32mreturn\u001b[0m \u001b[0mwraps\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0minit_func\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0m_decorator\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\AppData\\Roaming\\Python\\Python37\\site-packages\\nltk\\data.py\u001b[0m in \u001b[0;36m__init__\u001b[1;34m(self, _path)\u001b[0m\n\u001b[0;32m    312\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    313\u001b[0m         \u001b[0m_path\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mos\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpath\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mabspath\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0m_path\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 314\u001b[1;33m         \u001b[1;32mif\u001b[0m \u001b[1;32mnot\u001b[0m \u001b[0mos\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpath\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mexists\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0m_path\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    315\u001b[0m             \u001b[1;32mraise\u001b[0m \u001b[0mIOError\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m\"No such file or directory: %r\"\u001b[0m \u001b[1;33m%\u001b[0m \u001b[0m_path\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    316\u001b[0m         \u001b[0mself\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0m_path\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0m_path\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\AppData\\Local\\Continuum\\anaconda3\\lib\\genericpath.py\u001b[0m in \u001b[0;36mexists\u001b[1;34m(path)\u001b[0m\n\u001b[0;32m     17\u001b[0m     \u001b[1;34m\"\"\"Test whether a path exists.  Returns False for broken symbolic links\"\"\"\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     18\u001b[0m     \u001b[1;32mtry\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 19\u001b[1;33m         \u001b[0mos\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mstat\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mpath\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     20\u001b[0m     \u001b[1;32mexcept\u001b[0m \u001b[0mOSError\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     21\u001b[0m         \u001b[1;32mreturn\u001b[0m \u001b[1;32mFalse\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;31mKeyboardInterrupt\u001b[0m: "
     ]
    }
   ],
   "source": [
    "parseDocument(\"F:\\\\Projects\\\\EMA\\\\Repository\\\\EMA EPI PoC\\\\function_code\\\\data\\\\converted_to_html\\\\H\\\\CAP\\\\en\\\\Adakveo-4874 EN PI.html\", fileNameQrd, fileNameMatchRuleBook, fileNameDocumentTypeNames, medName = \"Aerius\", fsMountName = '/mounted', localEnv= True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
